PATENTS AND DESIGNS JOURNAL

527
" / " 05/2009 ISRAEL STATE RECORDS ' " December 24, 2009 PATENTS AND DESIGNS JOURNAL PATENTS Page 3 Applications filed 310 Applications accepted 496 Patents granted 497 Patents renewed 499 Patents not in force 500 Patents renewed for 20 years 501 Extension orders renewed 502 Notices 507 Corrigenda 508 Country codes i Indices of applications accepted DESIGNS 510 Designs registered 517 Designs renewed 518 Designs void

Transcript of PATENTS AND DESIGNS JOURNAL

Page 1: PATENTS AND DESIGNS JOURNAL

05/2009ื˜"ื”ืชืฉืก/ื"ื™

ืจืฉื•ืžื•ืชISRAEL STATE RECORDS

Decemberืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009

ื™ื•ืž๏ฟฝ ื”ืคื˜ื ื˜ื™๏ฟฝ ื•ื”ืžื“ื’ืžื™๏ฟฝPATENTS AND DESIGNS JOURNAL

PATENTSืขืžื•ื“ืคื˜ื ื˜ื™๏ฟฝPage

3Applicationsื‘ืงืฉื•ืช ืฉื”ื•ื’ืฉื• filed310Applicationsื‘ืงืฉื•ืช ืฉืงื•ื‘ืœื• accepted496Patentsืคื˜ื ื˜ื™๏ฟฝ ืฉื ื™ืชื ื• granted497Patentsืคื˜ื ื˜ื™๏ฟฝ ืฉื—ื•ื“ืฉื• renewed

499Patentsืคื˜ื ื˜ื™๏ฟฝ ืฉืชื•ืงืค๏ฟฝ ืคืงืขื• not in force500Patentsืคื˜ื ื˜ื™๏ฟฝ ืฉื—ื•ื“ืฉื• ืœืขืฉืจื™๏ฟฝ ืฉื ื” renewed for 20 years

501Extensionืฆื•ื•ื™ ื”ืืจื›ื” ืฉื—ื•ื“ืฉื• orders renewed502Noticesืขื•ืชื”ื•ื“

507Corrigendaืชื™ืงื•ื ื™ ื˜ืขื•ื™ื•ืช508Countryืงื•ื“ื™๏ฟฝ ืœืžื“ื™ื ื•ืช codes

iIndicesืžืคืชื—ื•ืช ืœื‘ืงืฉื•ืช ืฉืงื•ื‘ืœื• of applications accepted

DESIGNSืžื“ื’ืžื™๏ฟฝ510Designsืžื“ื’ืžื™๏ฟฝ ืฉื ืจืฉืžื• registered517Designsืžื“ื’ืžื™๏ฟฝ ืฉื—ื•ื“ืฉื• renewed518Designsืžื“ื’ืžื™๏ฟฝ ืฉื‘ื•ื˜ืœื• void

Page 2: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 2

ื™ื“ื™ืขื•ืช ื›ืœืœื™ื•ืช

ืืœ' ื•ื›ื•, ืžืกืžื›ื™ื, ืžื›ืชื‘ื™ื :ื‘ืขื ื™ื™ื ื™ ืคื˜ื ื˜ื™ื ื•ืžื“ื’ืžื™ื ื™ืฉ ืœืฉืœื•ื— ื™ืจื•ืฉืœื™ื, ืžืœื—ื”,5ื‘ื ื™ืŸ, ื™ืจื•ืฉืœื™ื, ื’ื ื™ื ื˜ื›ื ื•ืœื•ื’ื™ื™ื, ืจืฉื ื”ืคื˜ื ื˜ื™ื ื•ื”ืžื“ื’ืžื™ื

ืคืชื•ื—ื” ื™ืจื•ืฉืœื™ื ื•ื”ื™ื, ืžืœื—ื”,5ื‘ื ื™ืŸ, ืœืฉื›ืช ื”ืคื˜ื ื˜ื™ื ื ืžืฆืืช ื‘ื’ื ื™ื ื˜ื›ื ื•ืœื•ื’ื™ื™ื ื™ืจื•ืฉืœื™ื.12:30-ื• 8:30ืœืฆื™ื‘ื•ืจ ื‘ื™ืžื™ ื—ื•ืœ ืฉืื™ื ื ืขืจื‘ื™ ืฉื‘ืช ืื• ืžื•ืขื“ ื‘ื™ืŸ ื”ืฉืขื•ืช

ื›ืœ 2.50ืœืฉื›ืช ื”ืคื˜ื ื˜ื™ื ืžืกืคืงืช ืชืฆืœื•ืžื™ื ืฉืœ ืคื™ืจื•ื˜ื™ื ื•ืฉืจื˜ื•ื˜ื™ื ื‘ืžื—ื™ืจ ืฉืœ ืฉืงืœื™ื ื‘ืขื“.ืขืžื•ื“ ืื• ื—ืœืง ืžืžื ื•

' ืื’ืจื•ืช ืœืœืฉื›ืช ื”ืคื˜ื ื˜ื™ื ืžืชืงื‘ืœื•ืช ืืš ื•ืจืง ืขืœ ื™ื“ื™ ืชืฉืœื•ื ืœื—ืฉื‘ื•ืŸ ื”ืœืฉื›ื” ื‘ื‘ื ืง ื”ื“ื•ืืจ ืžืกื’ ืงื‘ืœืช ื‘ื ืง ื”ื“ื•ืืจ ืœืœืฉื›ื” ื™ื—ื“ ืขื ื”ื‘ืงืฉื” ืœืคืขื•ืœื” ืฉืขื‘ื•ืจื” ื”ืื’ืจื” ื™ืฉ ืœื”ืฆื™. 0-24145-2

.ืฉื•ืœืžื”

GENERAL INFORMATION

Letters, documents, etc. concerning Patents and Designs should be addressed to:The Commissioner of Patents and Designs, Jerusalem Technology Park, Building 5, Malcha,Jerusalem

The Patent Office is located at Jerusalem Technology Park, Building 5, Malcha, Jerusalem andis open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to12:30 hrs.

The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50per page or part thereof.

Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theOffice, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office togetherwith the application for the action for which the fee has been paid.

ื–ื›ื•ืช ื”ื™ื•ืฆืจื™ื ื‘ืชืงืฆื™ืจื™ื ืืœื” ืฉืžื•ืจื”ืžืช, ืœืžื“ื™ื ืช ื™ืฉืจืืœ ืื™ืŸ ืœื”ืขืชื™ืง

ืงืฆื™ืจื™ื.ืืœื” ืืœื ื‘ืจืฉื•ืช ืœืฉื›ืช ื”ืคื˜ื ื˜ื™ื

Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.

ืž(ืœื›ืœ ื—ื•ื‘ืจืช ื‘ื•ื“ื“ืช: ืžื—ื™ืจ Price.96โ‚ช.)ืž.ืข.ื›ื•ืœืœ per single issue (incl. VAT) : NIS 96.

ืž(ื“ืžื™ ื—ืชื™ืžื” ืœืฉื ื” Annual.โ‚ช 1,152.)ืž.ืข.ื›ื•ืœืœ subscription (incl. VAT):NIS 1,152.

:ืืคืฉืจ ืœื”ืฉื™ื’ ืืฆืœื‘, ืฉืจื•ืช ื”ื”ืคืฆื” ืฉืœ ืคืจืกื•ืžื™ ื”ืžืžืฉืœื” ' ืจื—ื•ื‘

.ืื‘ื™ื‘-ืชืœ, ื”ืงืจื™ื”,29' ืžืก

Available at the Distribution Service ofGovernment Publications, 29 B-Street,Hakirya, Tel-Aviv.

Page 3: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 20093

ืœื—ื•ืง ื”ืคื˜ื ื˜ื™ื16ื”ื•ื“ืขื” ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›

NOTICE UNDER SECTION 16 OF THEPATENTS LAW, 5727-1967

ืœื”ืœืŸ ืจืฉื™ืžืช ื‘ืงืฉื•ืช ื—ื“ืฉื•ืช ืื—ืจ ื”ื“ืจื™ืฉื•ืช ืฉื ืงื‘ืขื•ื”ืžืžืœืื•ืช

,ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื)ื(32ื‘ืชืงื ื”:1968โ€“ื—"ืชืฉื›

In the following there are listed newApplications complying with theProvisions of rule 32(a) of the PatentRegulations, 5728-1968

ืคืจื˜ื™ ื”ื‘ืงืฉื•ืช ืžื•ื‘ืื™ื ืœืคื™:ืกื“ืจ ื–ื”

Particulars of the applications aregiven in the following order:

ื•ืชืืจื™ืš ื”ื’ืฉืชื”โ€“ ืžืกืคืจ ื”ื‘ืงืฉื” ื•ืืจื‘ืขื” ื”ืกืžื ื™ื ื”ืจืืฉื•ื ื™ื ืฉืœ

ื”ืกื™ื•ื•ื’ ื”ื‘ื™ื ืœืื•ืžื™

Number and date of applicationAnd the first four symbols of theInternational Classification

ืข( ืฉื ื”ืืžืฆืื” ื™"ื›ืคื™ ืฉื”ื•ืฆืข)ื”ืžื‘ืงืฉ

Title of invention(as proposed by applicant)

Applicant ื”ืžื‘ืงืฉ

โ€“ืžื“ื™ื ืช ื”ืื™ื’ื•ื“: ื“ื™ืŸ ืงื“ื™ืžื” ืชืืจื™ืš ื•ืžืกืคืจ ื‘ืงืฉืช ื”ื—ื•ืฅ

Priority right: Convention country โ€“Number and date ofForeign application

International ืžืกืคืจ ื‘ืงืฉื” ื‘ื™ื ืœืื•ืžื™ืช Application Number

International ื‘ื™ื ืœืื•ืžื™ืคืจืกื•ื' ืžืก Publication Number

Page 4: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 4

)2009.01 (G09B19092717/04/2008

ืฉื™ื˜ื” ืœืืจื’ื•ืŸ ื—ืคืฆื™ื ื‘ื—ืœืœ ื”ื—ื“ืจ ืœื™ืฆื™ืจืชื”ืฉืคืขื” ืจื’ืฉื™ืช ื•ืžื ื˜ืืœื™ืช ื•ืขืจื›ื”

ื”ื›ื•ืœืœืช ืื‘ื™ื–ืจื™ื ืœื™ื™ืฉื•ื ื”ืฉื™ื˜ื” ื”ืืžื•ืจื”

METHOD OF ARRANGING OBJECTSIN A ROOM TO CREATE EMOTIONALAND MENTAL EFFECTS AND KIT OFACCESSORIES FOR IMPLEMENTINGTHE METHOD

MICHAL ืžื™ื›ืœ ืื•ืจ OR

)2009.01 (F41H19289417/07/2008

ARMOR ืœื•ื— ืžื™ื’ื•ืŸ PANELPLASANืž"ืคืœืกืŸ ืกืืกื ื‘ืข SASA LTD.

)2009.01(G08B19291720/07/2008

METHOD ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื‘ืงืจืช ื’ื‘ื•ืœื•ืช AND SYSTEM FORBORDER CONTROL

VERINTืž"ื•ืจื™ื ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (G08C19291820/07/2008

ืžืขืจื›ื•ืช ื•ืฉื™ื˜ื•ืช ืœื–ื™ื”ื•ื™ ืžืกื•ืคื™ ืชืงืฉื•ืจืชืืœื—ื•ื˜ื™ื™ื ืขืœ ื’ื™ื‘ ื›ืœื™ ืจื›ื‘ ื‘ืขื–ืจืช ืžื™ื“ืข

ืขืœ ืืจืฅ ื”ืžืงื•ืจ

SYSTEMS AND METHODS FORVERIFICATION OF WIRELESSTERMINALS ON BOARD VEHICLESUSING CONTRY-OF-ORIGININFORMATION

VERINTืž"ื•ืจื™ื ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (G01S19320403/08/2008

LASERืž ืœื™ื™ื–ืจ"ืžืขืจืš ืžื› RADAR ARRAYืื•ืคื˜ื™ืงื”-ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ืืœืงื˜ืจื•

ืž"ืืœืื•ืค ื‘ืขELBIT SYSTEMS ELECTRO-OPTICALELOP LTD.

Page 5: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 20095

)2009.01 (G08B19344013/08/2008

ืžืขืจื›ื•ืช ื•ืฉื™ื˜ื” ืœืื‘ื˜ื—ืช ืื–ื•ืจ ืขืœื™ื” ืœืžื˜ื•ืก

SYSTEM AND METHOD FORBOARDING AREA SECURITY

VERINTืž"ื•ืจื™ื ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (G02F19389704/09/2008

ืกื•ืœืืจื™ืช ืœื—ืฉืžืœืžืขืจื›ืช ืœื”ืžืจืช ืงืจื™ื ื”A SYSTEM FOR CONVERTINGSOLAR RADIATION INTOELECTRICITY

TENEืž"ื˜ื ื ืกื•ืœืืจ ื‘ืข SOLAR LTD

)2009.01 (F41B19466412/10/2008

ืžืขืจื›ืช ื™ื™ืจื•ื˜ ื”ื›ื•ืœืœ ืžืกืคืจ ืžื™ื™ืจื˜ื™ื ืงื˜ื ื™ื

AN INTERCEPTION SYSTEM THATEMPLOYS MINIATURE KILLVEHICLE

ื‘ืขื”ืชืขืฉื™ื™ื” ื”ืื•ื™ืจื™ืช ืœื™ ISRAELืž"ืฉืจืืœ AEROSPACE INDUSTRIESLTD.

)2009.01 (C07K19494022/05/2008

PROTEIN ื‘ื“ื™ืงืช ื—ืœื‘ื•ืŸ ASSAYOMRIX BIOPHARMACEUTICALS INCDELAWARE CORPORATION OF

PCT/US/2008/064514

)2009.01 (F41B19517109/11/2008

ื™ืจื˜ื™ื ืžืขืจื›ืช ื™ื™ืจื•ื˜ ื”ื›ื•ืœืœ ืžืกืคืจ ืžื™ ืงื˜ื ื™ื

AN INTERCEPTION SYSTEM THATEMPLOYS MINIATURE KILLVEHICLES

ISRAELืž"ื”ืชืขืฉื™ื™ื” ื”ืื•ื™ืจื™ืช ืœื™ืฉืจืืœ ื‘ืข AEROSPACE INDUSTRIESLTD.

12/10/2008194664IL

Page 6: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 6

)2009.01 (C07K19517514/12/2007

ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ื ืชืจืŸ ื’ื•ืคืจืชื™ ื•ืžื’ื ื–ื™ื•ื ื”ื™ื“ืจื•ืงืกื™ื“ื™

PROCESS TO PRODUCE SODIUMSULFATE AND MAGNESIUMHYDROXIDESERVICIOS INDUSTRIALES PENOLESS.A. DE C.V.

PCT/MX/2007/000153WO/2009/078690

)2009.01 (C12N19532406/12/2007

ืคืœืกืžื” ื•ืฉื™ืžื•ืฉ/ื ืžืกืจื•ื"ืจื โ€“ืžื™ืงืจื• ื‘ื”ื

SERUM/PLASMA MICRORNAS ANDUSES THEREOF

JIANGSU MINGMA BIOTECH CO, LTD02/11/2007200710134620.4CN

PCT/CN/2007/003463

)2009.01 (G01R19538919/11/2008

A ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืžื™ืคื•ื™ ืฉื“ื” ืžื’ื ื˜ื™ SYSTEM AND A METHOD FORMAPPING A MAGNETIC FIELD

ELBITืž"ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (H04L19588411/12/2008

ื˜ื›ื ื•ืœื•ื’ื™ื” ืœื”ืงืžืช ืชืขืœื•ืช ืชืงืฉื•ืจืช ืžื•ื’ื ื•ืช ื‘ืจืฉืช ืชืงืฉื•ืจืช ืฆื™ื‘ื•ืจื™ืช ืœืžื ื•ื™ื™ื

TECHNIQUE FOR PROVIDINGSECURED TUNNELS IN A PUBLICNETWORK FORTELECOMMUNICATIONSUBSCRIBERS

ื‘ืข. ืื™ื™.ืกื™. ืื™ ECIืž"ื˜ืœืงื•ื TELECOM LTD.

Page 7: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 20097

)2009.01 (B64C19597716/12/2008

ื›ืœื™ ืื•ื•ื™ืจื™ ืœื ืžืื•ื™ืฉ ื‘ืขืœ ืชืฆื•ืจื” ืื™ืจื•ื“ื™ื ืืžื™ืช ืžืฉื•ืคืจืช

UNMANNED AERIAL VEHICLEHAVING AN IMPROVEDAERODYNAMIC CONFIGURATION

ISRAELืž"ื”ืชืขืฉื™ื™ื” ื”ืื•ื™ืจื™ืช ืœื™ืฉืจืืœ ื‘ืข AEROSPACE INDUSTRIESLTD.

)2009.01 (H01S19610222/12/2008

LASER ืื™ื—ื•ื“ ืืœื•ืžื•ืช ืœื™ื™ื–ืจ BEAM UNIFICATION

RAFAELืž"ืจืคืืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช ื‘ืข ADVANCED DEFENSESYSTEMS LTD.

)2009.01 (H04B19614623/12/2008

โ€“ืžืขืจื›ืช ืชืงืฉื•ืจืช ื“ื™ื’ื™ื˜ืœื™ืช ืจื˜ืจื• ื“ื™ืจืงื˜ื™ื‘ื™ืช ื•ืฉื™ื˜ื” ืžื›ืš

DIGITAL RETRO-DIRECTIVECOMMUNICATION SYSTEM ANDMETHOD THEREOF

ELTAืž"ืืœืชื ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (H04Q19615024/07/2007

ืขืจื•ืฅ ืฉืœื™ื˜ื” ืžืฉืชื ื” ืขื‘ื•ืจ ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

VARIABLE CONTROL CHANNEL FORA WIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED

24/07/200660/832487US24/07/200660/633054US

PCT/US/2007/074246WO/2008/014275

)2009.01 (C02F19623128/12/2008

ืฉื™ื˜ื•ืช ื•ื”ืชืงื ื™ื ืขื‘ื•ืจ ื™ืฆื™ืจืช ืื ืจื’ื™ื” ืขื ื–ื™ื”ื•ื ื ืžื•ืš

METHODS AND DEVICES FOR LOWCONTAMINATION ENERGYGENERATIONCLEAN MARINE

Page 8: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 8

)2009.01 (G06F19627630/12/2008

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื ื™ื•ื•ื˜ ืขืฆืžืื™ ืœืคืœื˜ืคื•ืจืžื” ืชืžืจื•ืŸื‘ืจืช

AUTONOMOUS NAVIGATIONSYSTEM AND METHOD FOR AMANEUVERABLE PLATFORM

ELBITืž"ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (H01H19637307/01/2009

DEFENSE ื—ื•ืžืช ื”ื’ื ื” ื‘ืคื ื™ ื™ืจื™ ื‘ื”ืชืจืื” ืงืฆืจื” WALL AGAINST SHORTNOTICE SHOOTING

BARAM ื‘ืจืขื ืขืžื™ AMI

)2009.01 (A61K19637507/01/2009

ืชื›ืฉื™ืจื™ื ืœื˜ื™ื”ื•ืจ ื—ื•ืžืจื™ื ื›ื™ืžื™ื™ืืฉื™ืžื•ืฉ ื‘ืชื›ืฉื™ืจื™ื ืืœื”, ื•ื‘ื™ื•ืœื•ื’ื™ื™ื

ื•ืžื›ืฉื•ืจ ืœื”ื›ื ืชื ื•ืœืฉื™ืžื•ืฉ ื‘ื”ื

COMPOSITIONS FORDECONTAMINATING HAZARDOUSCHEMICAL AND BIOLOGICALCOMPOUNDS, METHODSEMPLOYING SAME AND SYSTEMSFOR PREPARING SAME

ISRAEL ืงืจ ื‘ื™ื•ืœื•ื’ื™ ื‘ื™ืฉืจืืœื”ืžื›ื•ืŸ ืœืžื— INSTITUTE FORBIOLOGICAL RESEARCH

)2009.01 (H04B19639808/01/2009

UWB(ULTRA(ืจื—ื‘ ืกืจื˜โ€“ืžืงืœื˜ ืื•ืœื˜ืจื” WIDEBAND RECEIVERELBITืž"ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (H04Q19640608/01/2009

A ืฉื™ื˜ื” ืœื ื™ื˜ื•ืจ ืจืฉืชื•ืช ื’ื™ืฉื” METHOD FOR MONITORINGACCESS NETWORKS

ื‘ืข. ืื™ื™.ืกื™. ืื™ ECIืž"ื˜ืœืงื•ื TELECOM LTD.

Page 9: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 20099

)2009.01 (C07K19642324/07/2007

ืœ IAPDIMERICืื ื˜ื’ื•ื ื™ืกื˜ื™ื ื“ื™ืžืจื™ื™ื IAP ANTAGONISTSTETRALOGIC PHARMACEUTICALSCORPORATION

24/07/200660/820156USPCT/US/2007/074225WO/2008/014263

)2009.01 (A61K19642918/07/2007

ื˜ื›ื ื•ืœื•ื’ื™ื” ืชื”ืœื™ื›ื™ืช ืœื”ื—ื–ืจืช ืคื•ืœื™ืžืจื™ืืกื˜ื™ืจื ื™ื ืฉืขื‘ืจื• ื‘ืจื•ืžื™ื ืฆื™ื” ืžืชืขืจื•ื‘ื•ืช

ื• ืื• ืœื”ืคื™ื›ืช/ื”ืจื™ืืงืฆื™ื•ืช ื‘ื”ื ื ื•ืฆืจื• ื’ืจื’ืจื•ื ื™ื ืื• ื˜ื‘ืœื™ื•ืช, ื”ืชืขืจื•ื‘ื•ืช ืœื’ืœื•ืœื•ืช

PROCESS TECHNOLOGY FORRECOVERING BROMINATEDSTYRENIC POLYMERS FROMREACTION MIXTURES IN WHICHTHEY ARE FORMED AND/ORCONVERTING SUCH MIXTURESINTO PELLETS OR INTO GRANULESOR PASTILLESALBEMARLE CORPORATION

20/07/200660/832184US28/11/200660/867548US

PCT/US/2007/073805WO/2008/011477

)2009.01 (F41H19645612/01/2009

UDERBELLY ื’ื—ื•ืŸ ืœืจื›ื‘ ืžืฉื•ืจื™ืŸ OF ARMORD VEHICLEPLASANืž"ืคืœืกืŸ ืกืืกื ื‘ืข SASA LTD.

)2009.01 (H01L19645910/07/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ืงืจื” ืขืœ ืžื”ื™ืจื•ืช ืกื™ื‘ื•ื‘ื• ืฉืœ ืจื•ื˜ื•ืจ ืฉืœ ืžื ื•ืข ืคื™ืื–ื•ืืœืงื˜ืจื™

METHOD AND CONTROL DEVICEFOR THE SPEED OF ROTATION OF APIEZOELECTRIC MOTOR ROTORSAGEM DEFENSE SECURITE

13/07/20060606438FRPCT/FR/2007/051635WO/2008/007017

Page 10: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 10

)2009.01 (G06F19646312/01/2009

WORKSTATION ืชื—ื ืช ืขื‘ื•ื“ื” ืœื‘ืงืจืช ืคืœื˜ืคื•ืจืžื” ืžืจื•ื—ืงืช FOR REMOTEPLATFORM CONTROL

ELBITืž"ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (A61K19647412/07/2007

IMPROVED ืชื”ืœื™ืš ืžืฉื•ืคืจ ืœื”ื›ื ืช ื•ื•ืจื™ืงื•ื ืื–ื•ืœ PROCESS FOR THEPREPARATION OF VORICONAZOLEMEDICHEM, S.A.

13/07/200660/807275USPCT/IB/2007/004408WO/2008/075205

)2009.01 (H05B19650615/06/2007

THERMAL ืžื ื•ืจื”ื”ื’ื ื” ืชืจืžื™ืช ืขื‘ื•ืจ ืžื™ื™ืฆื‘ื™ PROTECTION FOR LAMPBALLASTSLUTRON ELECTRONICS CO., INC.

18/07/200611/489145USPCT/US/2007/071330WO/2008/011238

)2009.01 (E02D19657719/01/2009

UNDERGROUND ืžื—ืกื•ื ืžื ื”ืจื•ืช ืชืช ืงืจืงืขื™ TUNNEL BARRIEROFER ืขื•ืคืจ ืคื•ืจืช PORAT

Page 11: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200911

)2009.01 (A61K19682520/07/2007

ืชื›ืฉื™ืจื™ื ื•ืžื•ืฆืจื™ื ืœืฉื™ืคื•ืจ ื˜ื™ืคื•ืœ, ืฉื™ื˜ื•ืช ื‘ืกืจื˜ืŸ

METHODS, COMPOSITIONS ANDARTICLES OF MANUFACTURE FORCONTRIBUTING TO THETREATMENT OF CANCERSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,

02/08/200611/461961USPCT/US/2007/074036WO/2008/016793

)2009.01 (B60N19683702/02/2009

RASSENGER ืชื ื ื•ืกืขื™ื ืœืจื›ื‘ ืžืฉื•ืจื™ืŸ CABIN FOR ANARMORED VEHICLE

PLASANืž"ืคืœืกืŸ ืกืืกื ื‘ืข SASA LTD.29/05/2008191807IL

)2009.01 (A61K19684431/07/2007

โ€“ืจืขื” ื‘ืชืคืงื•ื“ ืชืจืžื•ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ื”ืค ืจื’ื•ืœื˜ื•ืจื™ ื‘ืืžืฆืขื•ืช ืคืืจื•ืงืกื˜ื™ืŸ

METHOD OF TREATINGTHERMOREGULATORYDYSFUNCTION WITH PAROXETINENOVEN THERAPEUTICS, LLC

04/08/200611/499586USPCT/US/2007/017062WO/2008/019010

)2009.01 (G06F19685502/02/2009

ืžืฉืชืžืฉ ื‘ืคื•ืจืžื˜ ืžืขืจื›ืช ืœืืกืคืงืช ืžื™ื“ืข20 โ€“SCTEื‘ื–ืจื™ืžืช ื•ื™ื“ืื• ื”ื›ื•ืœืœืช ืจืง

SCTEโ€“21ืžื™ื“ืข ืžืฉืชืžืฉ ื‘ืคื•ืจืžื˜

SYSTEM FOR PROVIDING SCTE - 20CLOSED CAPTION WITHIN A VIDEOSTREAM CONTAINING ONLY SCTE -21 CLOSED CAPTION

HARMONICืž"ื”ืจืžื•ื ื™ืง ื•ื™ื“ื™ืื• ื ื˜ื•ื•ืจืงืก ื‘ืข VIDEO NETWORKS LTD.

Page 12: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 12

)2009.01 (H04L19685602/02/2009

ืžืขืจื›ืช ืœืืกืคืงืช ืชืงืฉื•ืจืช ืจื—ื‘ืช ืกืจื˜ ื‘ื™ืŸ ืชื—ื ื•ืช ืงืจืงืขื™ื•ืช ื•ืžื˜ื•ืกื™ื

SYSTEM PROVIDING BROADBANDCOMMUNICATION BETWEENTERRESTRIAL STATIONS ANDAIRPLANES

ื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸDEUTSCHE ืœืžื—ืงืจ ื•ืคื™ืชื•ื— TELEKOM AG

)2009.01 (F42B19688003/02/2009

GRENADE ืžื ื’ื ื•ืŸ ืจื™ืžื•ืŸ MECHANISMISRAELืž"ื”ืชืขืฉื™ื™ื” ื”ืฆื‘ืื™ืช ืœื™ืฉืจืืœ ื‘ืข MILITARY INDUSTRIES LTD.

)2009.01 (B41J19689904/02/2009

ืžื›ืฉื™ืจ ื•ืžืขืจื›ืช ืœื–ื™ื”ื•ื™ ืคืจื™ื˜ื™ื, ืฉื™ื˜ื” ื‘ืžืกืžืš ืžื•ื“ืคืก ื”ืงืฉื•ืจื™ื ืœืื•ื‘ื™ืงื˜ื™ ืžื“ื™ื”

METHOD, APPARATUS AND SYSTEMFOR IDENTIFYING ITEMS IN APRINTED DOCUMENT ASSOCIATEDWITH MEDIA OBJECTS

XSIGHTSืž"ืืงืกื™ื™ื˜ืก ืžื“ื™ื” ื‘ืข MEDIA LTD

)2009.01 (B60J19691605/02/2009

QUICK ื”ืฆืœืœื” ืžื”ื™ืจื” ืœืจื›ื‘ CAR SUNSHADEOFIR ืื•ืคื™ืจ ืžื–ื•ืจ MAZOR

)2009.01 (G06F19692305/02/2009

ืชืงืฉื•ืจืช ื ื™ื”ื•ื’ ื”ืชืงืŸ ื“ื™ืžื•ืช ื‘ืขืจื•ืฅ ืžื•ืฉื”ื”

CONTROLLING AN IMAGINGAPPARATUS OVER A DELAYEDCOMMUNICATION LINK

ELBITืž"ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

Page 13: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200913

)2009.01 (G08B19693408/02/2009

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื‘ื™ื˜ื—ื•ืŸ ืœื ื”ื’ ืื•ืคื ื•ืข ืื•ืจื•ืœืจ ืื• ืื™ืฉ ื›ื•ื—ื•ืชโ€“ืœื”ื•ืœืš, ืื•ืคื ื™ื™ื

ื‘ื™ื˜ื—ื•ืŸ ื•ื”ื”ืฆืœื”

METHOD AND SYSTEM FOR SAFETYOF CYCLIST, ROLLER-SKATER OFEMERGENCY SERVICES PRRSON

MINUTIN ืžื™ื ื•ื˜ื™ืŸ ืœืื•ื ื™ื“ D. LEONID

)2009.01 (F24H19693508/02/2009

MAGNETIC ื’ื•ืฃ ื—ื™ืžื•ื ืžื’ื ื˜ื™ ื•ืฉื™ื˜ืช ื”ื™ื™ืฆื•ืจ HEATING ELEMENT &METHOD TO PRODUCE SAME

ื‘ืข.ื .ื˜.ื“ D.T.N.Rืž"ืจ LTD

)2009.01 (B62K19693608/02/2009

ืื•ืคื ื™ื™ื ื”ื›ื•ืœืœื™ื ืžื•ืฉื‘ ืฉื ื•ืฆืจ ืžื‘ืงื‘ื•ืง ื”ื ื™ืชืŸ ืœืฉื—ื–ื•ืจ

TOY CYCLE HAVING A SEATFORMED OF A RECYCLABLEBOTTLETOYMONSTER INTELLECTUALPROPERTY LIMITED

06/11/2008195145IL

)2009.01 (F41J19694708/02/2009

ืจื” ืขืœ ืกื›ื ื” ืฉืœ ื˜ื™ืœ ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืื–ื” ืžืกืœื•ืœโ€“ื’ื‘ื•ื”

SYSTEM AND METHOD FORWARNING OF RISK FROM A HIGH -TRAJECTORY PROJECTILE

RAFAELืž"ืจืคืืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช ื‘ืข ADVANCED DEFENSESYSTEMS LTD.

)2009.01 (H01H19695409/02/2009

A ืžื—ื‘ืจ ืœืœื ืžื’ืข NON-CONTACT CONNECTORCHUBU NIHON MARUKO CO. LTD.

13/08/20082008-208422

JP

Page 14: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 14

)2009.01 (G08B19697509/02/2009

POSITION ืžื›ืฉื™ืจ ืœื–ื™ื”ื•ื™ ืžื™ืงื•ื ื•ืฉื™ื˜ื” ืœื–ื™ื”ื•ื™ ืžื™ืงื•ื DETECTING DEVICE ANDPOSITION DETECTING METHODWACOM CO., LTD.

13/02/2008P2008-031857

JP

)2009.01 (H01L19701112/02/2009

A ืงื™ืจื•ืช ืžืกืš ื‘ืขืœ ืžื‘ื ื” ืื•ืคื˜ื™ ื™ื™ื—ื•ื“ื™ METHOD AND APPARATUS ASTRUCTURED SOLAR SCREEN WALL

SOLARORืž"ืกื•ืœืจืื•ืจ ื‘ืข LTD

)2009.01 (H01H19701212/02/2009

INPUT ืžื›ืฉื™ืจ ืงืœื˜ ืขื ืคื•ื ืงืฆื™ืช ืชืฆื•ื’ื” DEVICE WITH DISPLAYFUNCTIONWACOM CO., LTD.

25/02/2008P2008-043581

JP

)2009.01 (H01H19702912/02/2009

ื—ื‘ื™ืฉืช ืคืฆืขื™ื ื‘ืืžืฆืขื•ืช ื˜ื™ืคื•ืœ ื‘ืคืฆืขื™ื ื‘ื•ืืงื•ื ืขื ืื™ื–ื•ืจื™ ื‘ื™ืฆื•ืข ืžืฉืชื ื™ื

VACUUM WOUND THERAPYWOUND DRESSING WITH VARIABLEPERFORMANCE ZONESTYCO HEALTHCARE GROUP LP

13/03/200812/047910US

)2009.01 (H01H19703012/02/2009

ืคืชื—ื” ื‘ืชื—ื‘ื•ืฉืช ื•ืชื—ื‘ื•ืฉืช ื”ืžืชืื™ืžื” ืœื›ืš

WOUND DRESSING PORT ANDASSOCIATED WOUND DRESSING

TYCO HEALTHCARE GROUP LP07/03/200812/044051US

Page 15: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200915

)2009.01 (G02B19703612/02/2009

โ€“ื›ืื‘ืœ ืื•ืคื˜ื™ ืœืžื’ื‘ืจ ื”ืžื›ื™ืœ ื ืื ื•ืจื—ืœืงื™ืงื™ื ื•ืฉื™ื˜ืช ื™ื™ืฆื•

AMPLIFIER OPTICAL FIBERCOMPRISING NANOPARTICLES ANDPRODUCTION METHODDRAKA COMTEQ B.V.

12/02/200808/00742FR

)2009.01 (G01S19704415/02/2009

ืฉื™ื˜ื” ืœืžื“ื™ื“ืช ืžื”ื™ืจื•ืช ืจื“ื™ืืœื™ืช ืฉืœ ืžื˜ืจื” ืขื ืจื“ืืจ ื“ื•ืคืœืจ

A METHOD FOR MEASURING THERADIAL VELOCITY OF A TARGETWITH A DOPPLER RADARTHALES NEDERLAND B.V.

22/02/20081035066NL

)2009.01 (A61B19705516/02/2009

AN ืžื›ืฉื™ืจ ืœื’ื™ืœื•ื™ ืฉืชืœ ื“ื ื˜ืืœื™ APPARATUS FOR DETECTING ADENTAL IMPLANT

.DRืจ ืจืžื™ ืคื˜ืจืจื•"ื“ REMI PETRARU

)2009.01 (H01H19706416/02/2009

FLOATING ืฆืœื—ืช ืžืจื—ืคืช PLATEYITZHAK ื™ืฆื—ืง ืžืจืง MARK

Page 16: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 16

)2009.01 (H01H19706516/02/2009

ืืžืฆืขื™ื ืœื”ื—ื“ืจืช ืฆื•ืจืช ื‘ื™ื˜ื•ื™ ืฉืœ ื”ืฉื’ื—ื”ืขืœื™ื•ื ื” ืœืชื•ืš ืื•ืจื’ื ื™ื–ื ื—ื™ ื•ืœื—ืคืฆื™ื

ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจื ื•ื”ืฉื™ืžื•ืฉ ื‘ื”ื, ื“ื•ืžืžื™ืืœื˜ื™ืคื•ืœ ื•ืžื ื™ืขื” ืฉืœ ื”ืคืจืขื•ืช ืคืชื•ืœื•ื’ื™ื•ืช

ืช โ€“ื›ื•ื ื•ืช ื›ื™ืžื•ื•ืคืกื™ื›ื•ืœื•ื’ื™ื•ืช ื•ืœืฉื™ืคื•ืจ ืคื™ื–ื™ืงืœื™ื•ืช

MEANS FOR INSERTION OFEXPRESSION OF HIGHERSUPERVISION INTO LIVINGORGANISM AND INANIMATEOBJECTS, A PROCESS FOR THEMANUFACTURE THEREOF ANDTHEIR USE IN THE TREATMENT ANDPROPHYLAXIS OF PATHOLOGICALAND PSYCHOLOGICAL DISORDERSAND IMPROVEMENT OF CHEMO-PHYICAL PROPERTIES

ADI ืขื“ื™ ืœื•ื™ื˜ LAVIT

)2009.01 (E02B19706616/02/2009

SYSTEM ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืžื—ื–ื•ืจ ืžื™ื AND METHOD FORRECYCLING WATER

YUVAL ื™ื•ื‘ืœ ื™ื YAM

)2009.01 (B62J19707717/02/2009

ืขื’ืœื” ืขื‘ื•ืจ ืฉืขืจ ืชื•ืžื›ื” ืฉื ื™ืชืŸ ืœื”ื—ืœืงื” ืขื‘ื•ืจ ื™ืฆื•ืจื”ื•ืชื”ืœื™ืš

TROLLEY FOR A SLIDABLECANTILEVER GATE AND PROCESSFOR ITS MANUFACTUREFRATELLI COMUNELLO S.P.A.

12/06/200808425418.4EP

)2009.01 (B32B19708117/02/2009

, ืฆื™ืคื•ื™ ืกื•ืคื’ ืงืจื™ื ื” ื‘ืื•ืคืŸ ื‘ืจืจื ื™ ืฉืคื•ืคืจืช ืกื•ืคื’ืช ื•ืชื”ืœื™ืš ืœื”ื›ื ืชื

RADIATION-SELECTIVE ABSORBERCOATING, ABSORBER TUBE ANDPROCESS FOR PRODUCTION THEREOFSCHOTT AG

20/02/2008102008010199.0DE

Page 17: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200917

)2009.01 (H01H19708617/02/2009

ืืคื•ื™ ื•ืžืžื•ืœื ื‘ืขืœ ืชื›ื•ืœืช, ื—ื˜ื™ืฃ ืคืจื™ืš ืœื—ื•ืช ื’ื‘ื•ื”ื”

FILLED BAKED CRISPY SNACKHAVING A HIGH MOISTURECONTENTKRAFT FOODS GLOBAL BRANDSLLC

29/02/200812/040428US

)2009.01 (G06F19709223/08/2007

ืฉื™ื˜ื•ืช ื•ืžืขืจื›ื•ืช ืœื ื™ื”ื•ืœ ืžืขืจื›ื•ืช ืžื™ื“ืขMETHODS AND APPARATUS FORINFORMATION MANAGEMENTSYSTEMSRAYTHEON COMPANY

24/08/200660/823439US22/08/200711/843266US

PCT/US/2007/076621WO/2008/024900

)2009.01 (H04Q19713420/08/2007

ืชื–ืžื•ืŸ ื•ืกื™ืžื•ืŸ ืขื‘ื•ืจ, ื”ืงืฆืืช ืžืฉืื‘ ื“ื™ื ืžื™ื‘ LTEโ€“ืงืฆื‘ ืฉื™ืจื•ืช ืžื™ื“ืข ืžืฉืชื ื”

DYNAMIC RESOURCE ALLOCATION,SCHEDULING AND SIGNALING FORVARIABLE DATA RATE SERVICE INLTEINTERDIGITAL TECHNOLOGYCORPORATION

21/08/200660/839110USPCT/US/2007/018440WO/2008/024321

Page 18: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 18

)2009.01 (G01H19713616/08/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืžื ื™ืขืช ื—ืกื™ืžืช ืฉื™ื“ื•ืจHSUPAื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

METHOD AND APPARATUS FORPREVENTING TRANSMISSIONBLOCKING IN AN HSUPA WIRELESSCOMMUNICATION SYSTEMINTERDIGITAL TECHNOLOGYCORPORATION

21/08/200660/839198USPCT/US/2007/018314WO/2008/024289

)2009.01 (H01H19714219/02/2009

ื™ื“ื™โ€“ืžื›ืฉื™ืจ ื•ืฉื™ื˜ื•ืช ืœื’ื™ืœื•ื™ ื—ื•ืžืจื™ ื ืคืฅ ืขืœ ืžื’ืœื™ ืื“ื™ื

APPARATUS AND METHODS FORDETECTION OF EXPLOSIVES BY USEOF VAPOUR MARKERSICTS EUROPE HOLDINGS B.V.

)2009.01 (A61K19716015/09/2007

ืงื•ื ื™ื•ื’ื˜ื™ื ืคื•ืœื™ืžืจื™ื™ื ื”ืžื›ื™ืœื™ื ื—ืœืง ืขื ืžื˜ืขืŸ ื—ื™ื•ื‘ื™

POLYMERIC CONJUGATESCONTAINING A POSITIVELY-CHARGED MOIETYENZON PHARMACEUTICALS, INC.

15/09/200660/844944US15/09/200660/844945US27/11/200660/861349US27/11/200660/861350US13/04/200760/911734US20/08/200760/956814US

PCT/US/2007/078598WO/2008/034123

Page 19: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200919

)2009.01 (A61K19716122/08/2007

ืื ื™ืœื™ื“ื™ื)ืื–ืืฆื™ืงืœื•ืืœืงื™ืœโ€“N(โ€“4ื ื’ื–ืจื•ืช ื•ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืื•ืชื

DERIVATIVES OF 4-(N-AZACYCLOALKYL)ANILIDES ANDCOMPOSITIONS CONTAINING THESAMEVALEANT PHARMACEUTICALSINTERNATIONAL

23/08/200660/839941USPCT/US/2007/018571WO/2008/024398

)2009.01 (B01D19716222/08/2007

ืคื™ืจื•ืง ืชืจืžื™ ืฉืœ ืฉืชื ืŸ ื‘ื–ืจื ืฆื“ื“ื™ ืฉืœ ื’ื–ื‘ืขื™ืจื” ื‘ืืจื•ื‘ื” ื‘ืืžืฆืขื•ืช ืžื—ืœื™ืฃ ื—ื•ื

ืžื—ื“ืฉ

THERMAL DECOMPOSITION OFUREA IN A SIDESTREAM OFCOMBUSTION FLUE GAS USING AREGENERATIVE HEAT EXCHANGERBABCOCK POWER, INC.

22/08/200660/839364USPCT/US/2007/018515WO/2008/024367

)2009.01 (E02D19716324/08/2007

SYSTEM ืžืขืจื›ืช ืฉืœ ืœื‘ื ื” ืขื ืžื•ื˜ ืœื—ื™ื–ื•ืง ืงื™ืจ OF BRICK WITH ROD FORRATAINING WALLMARTINEZ NARANJO, JHON JAIRO

24/08/200606083678COPCT/IB/2007/002520WO/2008/023262

)2009.01 (A45D19716523/08/2007

A ืžืกืจืง ื ื’ื“ ื›ื™ื ื™ื LICE COMBSCHWARTZ, DAVID JACOB

23/08/20062006904564AUPCT/AU/2007/001202WO/2008/022387

Page 20: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 20

)2009.01 (G02C19716723/08/2007

SYSTEM ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื“ื™ื›ื•ื™ ืื•ืจ ื‘ืจืจื ื™ AND METHOD FORSELECTIVE LIGHT INHIBITIONHIGH PERFORMANCE OPTICS, INC.

23/08/200660/839432US01/09/200660/841502US28/11/200660/861247US

PCT/US/2007/018593WO/2008/024414

)2009.01 (G06F19716822/02/2009

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื—ื™ื–ื•ื™ ืคื’ื™ืฉื•ืช ืขืชื™ื“ื™ื•ืช ื‘ื™ืŸ ืžืฉืชืžืฉื™ื ื‘ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

SYSTEM AND METHOD FORPREDICTING FUTURE MEETINGS OFWIRELESS USERS

VERINTืž"ื•ืจื™ื ื˜ ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD.

)2009.01 (A61K19716924/08/2007

ื‘ ื‘ื™ื™ืฆื•ืจ ืฉืœ ืชืจื•ืคื”FGFโ€“18ืฉื™ืžื•ืฉ ืœื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ืกื—ื•ืก

USE OF FGF-18 IN THEMANUFACTURE OF A MEDICAMENTFOR TREATMENT OF CARTILAGEDISORDERSARES TRADING S.A.

25/08/200606119557.4EP28/08/200660/840600US

PCT/EP/2007/058830WO/2008/023063

)2009.01 (B67C19717021/08/2007

DEVICE ื”ืชืงืŸ ืœื”ืคื™ื›ื” ืฉืœ ืžื™ื›ืœื™ื FOR OVERTURNINGCONTAINERSARES TRADING S.A.

23/08/2006P200602238ISPCT/EP/2007/058664WO/2008/023010

Page 21: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200921

)2009.01 (G02B19717122/02/2009

APPARATUS ื”ืชืงืŸ ืœืคื™ืฆื•ืœ ืงืจืŸ ืื•ืจ FOR SPLITTING A LIGHTBEAMLIMO PATENTVERWALTUNG GMBH&CO. KG

21/02/2008102008010382.9DE

)2009.01 (H04L19717220/08/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ืงืฆืื” ื‘ืื•ืคืŸ ื“ื™ื ืžื™ ืฉืœ ื‘ืงืฉืจ ืขื ืœื•ื•ื™ื™ืŸHARQืชื”ืœื™ื›ื™

METHOD AND APPARATUS FORDYNAMICALLY ALLOCATING HARQPROCESSES IN THE UPLINKINTERDIGITAL TECHNOLOGYCORPORATION

21/08/200660/839172US13/10/200660/829457US30/10/200660/863543US01/12/200660/868185US

PCT/US/2007/018474WO/2008/024340

)2009.01 (H04W19717309/08/2007

โ€“ืชืื™ื ืœืฉื™ืจื•ืชื™ื ืจื‘ื™โ€“ืงื•ืื•ืจื“ื™ื ืฆื™ื” ืจื‘ืชื™ืขื“ ืฉืœ ืฉื™ื“ื•ืจื™ ืžื•ืœื˜ื™ืžื“ื™ื” ื‘ืžืขืจื›ืช

ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

MULTI-CELL COORDINATION FORMULTIMEDIA BROADCASTMULTICAST SERVICES IN AWIRELESS COMMUNICATIONSYSTEMINTERDIGITAL TECHNOLOGYCORPORATION

21/08/200660/839196US08/08/200760/954620US

PCT/US/2007/017712WO/2008/024214

Page 22: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 22

)2009.01 (B64C19717424/08/2007

HTAL(HIGH(ืžืขืœื™ืช ืื•ื•ื™ืจื™ืช ื‘ืคื™ืชื•ืœ ื’ื‘ื•ื” TORQUE AERIAL LIFT (HTAL)AMERICAN DYNAMICS FLIGHTSYSTEMS, INC.

24/08/200660/839774US08/08/200760/954684US08/08/200760/954685US

PCT/US/2007/076754WO/2008/105923

)2009.01 (C02F19717511/07/2007

ืฆ ืžื—ื™ ืคื•ืจืžื•ืœืฆื™ืช ืžื™ื ืขื ืงืžืฆื•ืฅ ื•ืชื”ืœื™ืš ืœื”ื›ื ืชื”

WATER FORMULATION WITH HERBALHINT AND A PROCESS THEREFORCENTURY BIOLOGICALS PRIVATELIMITED

23/08/20061495/CHE/2006INPCT/IN/2007/000287WO/2008/023387

)2009.01 (G01N19717623/02/2009

NEW ืžืขืจื›ืช ืžื“ื™ื“ืช ื–ืจื ื—ื•ื ื—ื“ืฉื” HEAT FLOW MEASURINGSYSTEM

.DRืจ ื™ื•ืœื™ ืœื•ื–ื™ื ืกืงื™"ื“ YULI LOZINSKI

)2009.01 (G01N19717723/02/2009

HEAT ื—ื™ื™ืฉืŸ ื–ืจื ื—ื•ื FLOW SENSOR.DRืจ ื™ื•ืœื™ ืœื•ื–ื™ื ืกืงื™"ื“ YULI LOZINSKI

)2009.01 (A61C19717823/02/2009

DENTAL ืฉืชืœ ื“ื ื˜ืœื™ IMPLANT.DRืจ ื™ื•ืœื™ ืœื•ื–ื™ื ืกืงื™"ื“ YULI LOZINSKI

Page 23: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200923

)2009.01 (G02B19717924/07/2007

ืื•ืคื˜ื™โ€“ื’ื•ืฃ ืชืื•ืจื” ื”ืžื›ื™ืœ ืžืชื’ ืืœืงื˜ืจื•"ืคื•ื˜ื•ื ื™"ื‘ื•ืจืจ

LIGHT INCLUDING AN ELECTRO-OPTICAL "PHOTONIC" SELECTORSWITCHSTREAMLIGHT, INC.

23/08/200611/508383USPCT/US/2007/074158WO/2008/024582

)2009.01 (F41H19718023/02/2009

GUNNER ื‘ืžืช ื™ื•ืจื™ื PLATFORMPLASANืž"ืคืœืกืŸ ืกืืกื ื‘ืข SASA LTD.

)2009.01 (C10B19718129/08/2007

ืกื•ืœืจื™ืช ืžื”ื™ืจื” ืฉืœ ืžืกื”โ€“ื”ืžืจื” ืชืจืžื™ืช ื‘ื™ื•ืœื•ื’ื™ืช ืœื’ื–

RAPID SOLAR-THERMALCONVERSION OF BIOMASS TOSYNGASTHE REGENTS OF THE UNIVERSITYOF COLORADO A BODYCORPORATE

29/08/200660/823872USPCT/US/2007/077134WO/2008/027980

)2009.01 (H04L19718223/08/2007

ืœืชืžื™ื›ื” ื‘ืชืงืฉื•ืจืชMIMOืžืฉื“ืจ ื•ืžืงืœื˜ ืœื•ื•ื™ื ื™ืช ืฉืœ ืžื™ืœื•ืช ืงื™ื“ื•ื“ ื‘ืขืจื•ืฅ ืื—ื“

MIMO TRANSMITTER ANDRECEIVER FOR SUPPORTINGDOWNLINK COMMUNICATION OFSINGLE CHANNEL CODEWORDSINTERDIGITAL TECHNOLOGYCORPORATION

24/08/200660/823484USPCT/US/2007/018727WO/2008/024462

Page 24: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 24

)2009.01 (G08B19718323/02/2009

ืžื™ืžื“ื™โ€“ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืชื›ื ื•ืŸ ื ืชื™ื‘ ืชืœืชืœืžื ื™ืขืช ืžื›ืฉื•ืœื™ื ื”ืžืฉืชืžืฉื™ื ื‘ืžื™ืฉื•ืจื™ื

ืžืจื•ื‘ื™ื

METHOD AND DEVICE FOR THREE-DIMENSIONAL PATH PLANNING TOAVOID OBSTACLES USINGMULTIPLE PLANESHONEYWELL INTERNATIONAL INC.

10/03/200812/045449US

)2009.01 (B32B19718410/09/2007

ื—ื•ืžืจื™ื ืžืจื•ื›ื‘ื™ื ื‘ืœื™ืกื˜ื™ื™ื ื‘ืขืœื™ ื‘ื™ืฆื•ืข ื•ืจืื’ื‘ื•ื” ื•ื’ืžื™ืฉื•ืช ืžืฉื•ืคืจืช ื•ืฉื™ื˜ื” ืœื™ืฆ

HIGH PERFORMANCE BALLISTICCOMPOSITIES HAVING IMPROVEDFLEXIBILITY AND METHOD OFMAKING THE SAMEHONEYWELL INTERNATIONAL INC.

12/09/200660/843868US28/06/200711/823570US

PCT/US/2007/078012WO/2008/097355

)2009.01 (A61K19718524/08/2007

ืื ื™ืœื™ื“ื™ื ืžื•ืชืžืจื™ื ื•ืฉื™ื˜ื•ืชโ€“ืืฆื™ืœ ืœืฉื™ืžื•ืฉื

SUBSTITUTED ACYLANILIDES ANDMETHODS OF USE THEREOFUNIVERSITY OF TENNESSEE RESEARCHFOUNDATION

24/08/200660/839665US28/08/2006PCT/US2006/033490US28/08/200611/510844US16/04/200760/907749US

PCT/US/2007/018686WO/2008/024456

Page 25: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200925

)2009.01 (A21D19718614/08/2007

ืฉื™ื˜ื” ืœื”ื›ื ืช ืขื•ื’ื” ืชื•ืš ืฉื™ืžื•ืฉ ื‘ืชืกืก ืฉื•ืžืŸ ื–ืจื—ื ื™

METHOD OF PREPARING A CAKEUSING PHOSPHOLIPASE

PURATOS NV28/08/200606119649.9EP

PCT/EP/2007/058418WO/2008/025674

)2009.01 (C01D19718721/08/2007

ื”ืชืงื ื™ื ื•ืฉื™ื˜ื•ืช ืœื”ื•ืจื“ืช ืจื™ื›ื•ื– ืคื—ืžืŸ ื“ื• ื—ืžืฆื ื™ ื‘ื ื•ื–ืœ

METHODS AND APPARATUSES FORDECREASING THE CO2CONCENTRATION OF A FLUID

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

29/08/200660/840708USPCT/IL/2007/001039WO/2008/026201

)2009.01 (A61K19718814/08/2007

ื˜ื™ืคื•ืœ ื‘ื–ื™ื”ื•ืžื™ื ืžื™ืงื•ื‘ืงื˜ืจื™ืืœื™ื™ื ื‘ืืžืฆืขื•ืช ืฆื™ืงืœื™ืคื•ืกื˜ื™ื ื™ื

TREATING MYCOBACTERIALINFECTIONS WITH CYCLIPOSTINS

SANOFI AVENTIS29/08/200606017963.7EP

PCT/EP/2007/007159WO/2008/025449

)2009.01 (A61K19718914/08/2007

METHODS ืฉื™ื˜ื•ืช ืœื”ื•ืจื“ืช ืจืžื•ืช ื”ื’ืœื•ืงื•ื– OF LOWERING GLUCOSELEVELSSANOFI-AVENTIS DEUTSCHLANDGMBH

28/08/200660/840850USPCT/EP/2007/007160WO/2008/025450

Page 26: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 26

)2009.01 (A61K19719024/08/2007

ื” ืจื•ืงื—ื™ืช ืžืฉื•ืœื‘ืช ื‘ืขืœืช ืคื•ืจืžื•ืœืฆื™ืฉื—ืจื•ืจ ืžื‘ื•ืงืจ ื”ืžื›ื™ืœื” ื“ื™ื”ื™ื“ืจื•ืคื™ืจื™ื“ื™ืŸื›ื—ื•ืกืžื™ ืชืขืœื•ืช ืกื™ื“ืŸ ื•ืžืขื›ื‘ื™ ืจื“ื•ืงื˜ืื–

COAโ€“HMG

COMBINED PHARMACEUTICALFORMULATION WITHCONTROLLED-RELEASECOMPRISING DIHYDROPYRIDINECALCIUM CHANNEL BLOCKERSAND HMG-COA REDUCTASEINHIBITORSHANALL PHARMACUETICAL CO.,LTD

24/08/200610-2006-0080694

KR

24/08/2007 10#2007#0085480 KR

PCT/KR/2007/004079WO/2008/023958

)2009.01 (F24F19719127/08/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืฉืœื™ื˜ื” ื‘ื›ืžื•ืช ืžื™ื ื‘ื ื•ื–ืœSYSTEM AND METHOD FORMANAGING WATER CONTENT IN AFLUIDADIR SEGAL, LTD

25/08/200660/840312USPCT/IB/2007/004333WO/2008/053367

)2009.01 (C07C19719217/08/2007

PREPARATION ื”ื›ื ืช ื“ืงื”ืœื•ื“ื™ืคื ื™ืœ ืืชืืŸ OFDECAHALODIPHENYL ETHANEALBEMARLE CORPORATION

29/08/200660/823862USPCT/US/2007/076166WO/2008/027737

Page 27: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200927

)2009.01 (A45D19719323/08/2007

A ืžืกืจืง ื ื’ื“ ื›ื™ื ื™ื LICE COMBSCHWARTZ, DAVID JACOB

24/08/20062006904605AUPCT/AU/2007/001201WO/2008/022386

)2009.01 (A01N19719415/08/2007

METHOD ืฉื™ื˜ื” ืœื”ืคื—ืชืช ื ื–ืง ืœืชืื™ ืขืฆื‘ OF REDUCING NEURONALCELL DAMAGETHE UNIVERSITY OF MONTANA

23/08/200660/839974USPCT/US/2007/076034WO/2008/024660

)2009.01 (A61K19719523/08/2007

ืชืฆืžื™ื“ื™ื ืฉืœ ืคืคื˜ื™ื“ื™ื ื”ืžื›ื™ืœื™ื ืจืฆืฃRGDื›ืœื•ืจื•ืคื™ืœ) ื‘ืงื˜ืจื™ื•(ื•ืคื•ืจืคื™ืจื™ืŸ ืื•

ืคื•ื˜ื•ืกื™ื ืชืกื™ื™ื–ืจื™ื ื•ืฉื™ืžื•ืฉื

CONJUGATES OF RGD PEPTIDESAND PORPHYRIN OR (BACTERIO)CHLOROPHYLLPHOTOSYNTHESIZERS AND THEIRUSES

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

23/08/200660/839409USPCT/IL/2007/001055WO/2008/023378

)2009.01 (G08B19719623/02/2009

ื—ื™ื–ื•ื™ ื›ื•ื•ื ื•ืช ื‘ืืžืฆืขื•ืช ืฉื™ืžื•ืฉ ื‘ืžื•ื“ืœื™ ืžืจืงื•ื‘ ื ืกืชืจื™ื ื•ื‘ืคืจื•ืคื™ืœ ืžืฉืชืžืฉ

INTENTION PREDICTION USINGHIDDEN MARKOV MODELS ANDUSER PROFILE

ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘ ื”ืจืฉื•ืช ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

Page 28: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 28

)2009.01 (A61K19719711/09/2007

โ€“ืชื•ืœื“ื•ืช ืื•ืงืกื™ื ื“ื•ืœ ื›ืกื•ื›ื ื™ื ืื ื˜ื™ ืกืจื˜ื ื™ื™ื

OXINDOLE DERIVATIVES ASANTICANCER AGENTS

F. HOFFMANN-LA ROCHE AG21/09/200660/846201US

PCT/EP/2007/059489WO/2008/034736

)2009.01 (A61F19719822/08/2007

DEVICES ื•ืช ืœืฉื™ื ื•ื™ ื”ืชื ื”ื’ื•ืช ืื›ื™ืœื”ืžื›ืฉื™ืจื™ื ื•ืฉื™ื˜ AND METHODS FORALTERING EATING BEHAVIORSVIP 2 LLC

23/08/200660/839413US24/11/200660/860806US04/06/200760/924867US

PCT/IL/2007/001047WO/2008/023374

)2009.01 (C07K19719905/09/2007

ื› ื ื’ื“ ื—ืœื‘ื•ื ื™ื ืžื•ืจืคื•ื’ื ื˜ื™ื™ื ืฉืœ ื ื•ื’ื“ื ื™ืื”ืขืฆื ื•ืงื•ืœื˜ื ื™ื ืฉืœื”ื ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ

ื‘ื”ื

ANTIBODIES TO BONEMORPHOGENIC PROTEINS ANDRECEPTORS THEREFOR ANDMETHODS FOR THEIR USEMEDAREX, INC.

05/09/200660/824596USPCT/US/2007/019652WO/2008/030611

)2009.01 (A01G19720112/09/2007

ื—ื™ื™ืฉืŸ ืžืฆื‘ ืขื‘ื•ืจ ืฉืชื™ืœื™ื ื•ืžืขืจื›ืช ืฉืชื™ื™ื” ื”ื›ื•ืœืœืช ื—ื™ื™ืฉืŸ ืžืฆื‘ ืžืกื•ื’ ื–ื”

STATE SENSOR FOR PLANTS AND AWATERING SYSTEM COMPRISING ASTATE SENSOR OF THIS TYPERAUMEDIC AG

14/09/2006102006043058.1DEPCT/EP/2007/007947WO/2008/031579

Page 29: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200929

)2009.01 (B32B19720224/02/2009

EASY ืฆื™ืคื•ื™ ืงืœ COATINGSHAY ืฉื™ ืœื•ืจื™ืื” LURIA

25/06/2008SL001US

)2009.01 (A61B19720303/10/2007

LOCKABLE ื—ื™ื‘ื•ืจ ื”ื ื™ืชืŸ ืœื ืขื™ืœื” JOINTHELMUT FRICKE

06/10/200660/850090US29/05/200760/932127US29/06/200760/963699US

PCT/EP/2007/008582WO/2008/040537

)2009.01 (A61K19720429/08/2007

ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืชืจื•ืคื” ื‘ืขืœืชื‘ืกื™ืกื™ื•ืช ื—ืœืฉื” ื•ืฆื™ืคื•ื™ ื‘ืขืœ ืฉื—ืจื•ืจ ืคื•ืขื

ืžืชื•ื–ืžืŸ

PHARMACEUTICAL COMPOSITIONSCONTAINING A WEAKLY BASICDRUG AND A TIMED PULSATILERELEASE COATINGEURAND, INC.

31/08/200660/841760US31/08/200660/841893US

PCT/US/2007/077153WO/2008/027993

)2009.01 (B23C19720524/02/2009

CUTTING ื›ืœื™ ื—ื™ืชื•ืš ื‘ืขืœ ืžื ื’ื ื•ืŸ ื›ื•ื•ื ื•ืŸ TOOL HAVINGADJUSTMENT MECHANISM

ISCARืž"ื™ืฉืงืจ ื‘ืข LTD.

Page 30: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 30

)2009.01 (E01F19720624/02/2009

ืžื—ื–ื™ืจ ืื•ืจ ืžืกื•ื’ ืขื™ื ื™ ื—ืชื•ืœ ื”ืžื•ืชืืSERVICEABLE ืœืชื—ื–ื•ืงืช ื›ื‘ื™ืฉ ROAD STUD

LIRAN ืœื™ืจืŸ ืžื–ืจื—ื™ MIZRAHI

)2009.01 (A61K19720722/08/2007

ื•, ื—ื•ืžืจื™ ื—ื™ื˜ื•ื™ ืื•/ื—ื•ืžืจื™ื ื ื’ื“ ื–ื™ื”ื•ืžื™ืื‘ืขืœื™, ื‘ืชืžื™ืกื•ืช ืžื™ื™ืžื™ื•ืช, ื—ื•ืžืจื™ื ืžืขืงืจื™ื

ืื•ืงืกื™ื’ืŸืชื›ื•ืœื” ื ืžื•ื›ื” ืฉืœ ืคืจ

AQUEOUS SANITIZERS,DISINFECTANTS, AND/ORSTERILANTS WITH LOWPEROXYGEN CONTENTSOLUTIONS BIOMED, LLC

24/08/200611/510516USPCT/US/2007/018606WO/2008/033206

)2009.01 (A46B19720817/08/2007

ืžื‘ืจืฉืช ืฉื™ื ื™ื™ื ืขื ื–ื™ืคื™ื ืžืฉื•ืคืขื™ื ื•ื–ื™ืคื™ื ื•ื“ื“ื™ืืžื—

TOOTHBRUSH WITH INCLINEDBRISTLED AND POINTES BRISTLES

GABA INTERNATIONAL AG25/08/20061364/06CH

PCT/CH/2007/000405WO/2008/022480

)2009.01 (G07B19720924/02/2009

A ืžื›ืฉื™ืจ ืœืžื“ืจื•ื’ ืฉืœ ืžื•ืฆืจ PRODUCT RATING APPARATUSAND METHOD

LIORืจืœื™ืื•ืจ ื ื  NENER

)2009.01 (G09B19721024/02/2009

CARDBOARD ืœื•ื— ืžื•ื“ืขื•ืช ืžืงืจื˜ื•ืŸ MADE BULLETINBOARD

,KLEINERืž"ืงืœื™ื™ื ืจ ืžืจื“ื›ื™ ืืฆืœ ื™ื•ื ื™ื™ื˜ื“ ืคืืง ื‘ืข MORDECHAI

Page 31: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200931

)2009.01 (A61K19721123/08/2007

METHODS ืฉื™ื˜ื•ืช ื•ื”ืจื›ื‘ื™ื ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ AND COMPOSITIONS FORTREATING CANCERCOUGAR BIOTECHNOLOGY, INC.

25/08/200660/921506USPCT/US/2007/018769WO/2008/024484

)2009.01 (A61K19721223/08/2007

ืฉื™ื˜ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ ื”ื›ื•ืœืœื•ืช ืžืชืŸื•ื”ืจื›ื‘ื™ื, ื•ื—ื•ืžืจ ืชืจื•ืคืชื™ ื ื•ืกืฃDื•ื™ื˜ืžื™ืŸ

ื”ืžื›ื™ืœื™ื ืื•ืชื

METHODS FOR TREATING CANCERCOMPRISING THE ADMINISTRATIONOF A VITAMIN D COMPOUND ANDAN ADDITIONAL THERAPEUTICAGENT, AND COMPOSITIONSCONTAINING THE SAMECOUGAR BIOTECHNOLOGY, INC.

25/08/200660/934924USPCT/US/2007/018770WO/2008/024485

)2009.01 (C12P19721307/09/2007

13INTERLEUKIN-13โ€“ื—ืœื‘ื•ื ื™ื ืงื•ืฉืจื™ ืื™ื ื˜ืจืœื•ื™ืงื™ืŸ BINDINGPROTEINSABBOTT LABORATORIES

08/09/200660/843249USPCT/US/2007/019660WO/2008/127271

Page 32: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 32

)2009.01 (A61K19721424/08/2007

ืฆื•ืจื•ืช ืžื™ื ื•ืŸ ืขืžื™ื“ื•ืช ืœืฉื™ืžื•ืฉ ืœื ืžื•ืจืฉื” ืื•ืคื™ื•ืื™ื“ื™ืœืžืชืŸ ืคื•ืžื™ ื”ืžื›ื™ืœื•ืช ืžืืœื—ืฉ

TAMPER RESISTANT ORALPHARMACEUTICAL DOSAGE FORMSCOMPRISING AN OPIOIDANALGESICPURDUE PHARMA L.P.

25/08/200660/840244USPCT/IB/2007/002515WO/2008/023261

)2009.01 (G09F19721524/02/2009

ืขืโ€“ืกื™ืžื•ืœื™ืฆื™ื” ืฉืœ ืกื™ืžื•ื ื™ื ืจื‘ ื ืงื•ื“ืชื™ื™ืืŸ ื”ืฆื‘ืขื” ื™ื—ื™ื“ื”ืชืง

SIMULATION OF MULTI-POINTGESTURES WITH A SINGLEPOINTING DEVICEAPPLE INC.

26/02/200812/037848US

)2009.01 (H03M19721631/08/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ืขื‘ืจืช ืงื•ื‘ืฅ ื ืชื•ื ื™ื ื‘ืจืฉืช ื ืชื•ื ื™ื

METHOD AND SYSTEM FORTRANSMITTING A DATA FILE OVERA DATA NETWORKPACBYTE SOFTWARE PTY LIMITED

01/09/200660/824391USPCT/IB/2007/053509WO/2008/026186

)2009.01 (C07K19721716/10/2007

NOVELืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ38CDื ื•ื’ื“ื ื™ื ื—ื“ืฉื™ื ื›ื ื’ื“ ANTI-CD38 ANTIBODIES FORTHE TREATMENT OF CANCERSANOFI-AVENTIS

19/10/200606291628.3EPPCT/IB/2007/004172WO/2008/047242

Page 33: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200933

)2009.01 (A01N19721830/08/2007

ืคื•ืจืžื•ืœืฆื™ื•ืช ื”ืžื›ื™ืœื•ืช ืื™ื ื“ื•ืงืกืืงืืจื‘ ืœืื“ืžื™ื ื™ืกื˜ืจืฆื™ื” ืžืงื•ืžื™ืช ืœืขื•ืจ

LOCAL TOPICAL ADMINISTRATIONFORMULATIONS CONTAININGINDOXACARBE.I. DUPONT DE NEMOURS ANDCOMPANY

01/09/200660/841846USPCT/US/2007/019096WO/2008/030385

)2009.01 (A61K19721924/08/2007

ืœื™ื’ื ื“ื™ื ืขื ืคืœื•ืื•ืจ ืžื›ื•ื•ื ื™ื ืœืจืฆืคื˜ื•ืจื™ื ืคืจื™ืคืจืœื™ื™ื ืฉืœ ื‘ื ื–ื•ื“ื™ืื–ืคื™ืŸ

FLUORINATED LIGANDS FORTARGETING PERIPHERALBENZODIAZEPINE RECEPTORSAUSTRALIAN NUCLEAR SCIENCEAND TECHNOLOGY ORGANISATION

24/08/20062006904617AU22/12/20062006907288AU

PCT/AU/2007/001216WO/2008/022396

)2009.01 (C07K19722027/08/2007

PROTEIN ื ื™ืงื•ื™ ื—ืœื‘ื•ื ื™ื PURIFICATIONARES TRADING S.A.

28/08/200606119611.9EP06/09/200660/842542US

PCT/EP/2007/058887WO/2008/025748

Page 34: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 34

)2009.01 (C07K19722127/08/2007

PROTEIN ื ื™ืงื•ื™ ื—ืœื‘ื•ื ื™ื PURIFICATIONARES TRADING S.A.

28/08/200606119610.1EP06/09/200660/842682US

PCT/EP/2007/058886WO/2008/025747

)2009.01 (A61L19722223/08/2007

ืคื•ืกืคืื˜ ืืคื˜ื™ื˜ื™ ื ืงื‘ื•ื‘ื™ ื‘ืขืœโ€“ื“ื‘ืง ืกื™ื“ืŸ ืกืคื™ื’ื” ื—ื•ื–ืจืช ื’ื‘ื•ื”ื”

MACROPOROUS AND HIGHLYRESORBABLE APATITIC CALCIUM-PHOSPHATE CEMENTUNIVERSITE DE NANTES OF

24/08/200606291352.0EP24/08/200660/839697US

PCT/IB/2007/002422WO/2008/023254

)2009.01 (H04L19722328/08/2007

ืžืื•ื—ื“ื™ื ืžืฉืœื™ืžื™ืIMSืฉื™ืจื•ืชื™ ืื™ืชื•ืช ื‘ืžืขื’ืœ ื•ื—ื‘ื™ืœืช ืžืจื—ื‘ื™ื

UNIFIED IMS SUPPLEMENTARYSERVICES SIGNALING ACROSSCIRCUIT AND PACKET DOMAINSLUCENT TECHNOLOGIES INC.

31/08/200611/513922USPCT/US/2007/018956WO/2008/027407

)2009.01 (A01N19722423/08/2007

ืชืจื›ื•ื‘ื•ืช ืžืฉื•ืคืจื•ืช ืžื‘ื—ื™ื ื” ืคืืจืžืืงื•ืงื™ื ื˜ื™ืช

PHARMACOKINETICALLYIMPROVED COMPOUNDS

SURFACE LOGIX, INC.24/08/200660/840306US

PCT/US/2007/018784WO/2008/024494

Page 35: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200935

)2009.01 (A61K19722523/08/2007

ืžืœื—ื™ ืฆื™ื˜ืจืื˜ ื•ื˜ืจื˜ืจืื˜ ืžื•ืฆืงื™ื ืฉืœIVโ€“DPPืžืขื›ื‘ื™

SOLID CITRATE AND TARTRATESALTS OF DPP-IV INHIBITORS

PHENOMIX CORPORATION30/08/200660/841097US

PCT/US/2007/018629WO/2008/027273

)2009.01 (A61K19722604/09/2007

ืคืขืžื™ ืขื ืžื ื’ื ื•ืŸโ€“ื”ืชืงืŸ ืื™ื ืคื•ื–ื™ื” ื—ื“ ืฉื—ืจื•ืจ ื ืขื™ืœื” ืื•ื˜ื•ืžื˜ื™

DISPOSABLE INFUSION DEVICEWITH AUTOMATIC UNLOCKINGMECHANISMCALIBRA MEDICAL, INC.

06/09/200611/516812USPCT/US/2007/019343WO/2008/030462

)2009.01 (A61M19722704/09/2007

ื—ื“ื”ืชืงืŸ ืื™ ืคืขืžื™ ืขื ืžืื’ืจ ืื•ื™ืจโ€“ื ืคื•ื–ื™ื” ืžืชืงืคืœ

DISPOSABLE INFUSION DEVICEWITH AIR TRAPPING COLLAPSIBLERESERVOIRCALIBRA MEDICAL, INC.

06/09/200611/516467USPCT/US/2007/019342WO/2008/030461

)2009.01 (B25D19722801/08/2007

WALLBOARDืจื™ืกื›ื™ืŸ ืœื˜ืคื˜ื™ื ืขื ืคื˜ื™ืฉ ืคื•ืœื™ืž TAPING KNIFE WITHPOLYMERIC HAMMERUNITED STATES GYPSUM COMPANY

25/08/200611/510452USPCT/US/2007/017183WO/2008/027149

Page 36: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 36

)2009.01 (B32B19722926/09/2006

MOLDABLE ื›ื™ื•ื•ื ื™ื™ืโ€“ืืจื™ื’ ื”ื ื™ืชืŸ ืœืขื™ืฆื•ื‘ ืขื ื—ื•ื˜ื™ื ื—ื“ FABRIC WITHUNIDIRECTIONAL YARNSMILLIKEN & COMPANY

11/09/200611/519134USPCT/US/2006/037572WO/2008/054372

)2009.01 (C07D19723011/09/2007

ืฉื™ื˜ื”, ืืžื™ื“ื™ื ืžื•ืชืžืจื™ื ืžืกื•ื™ื™ืžื™ื ืœื”ื›ื ืชื ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉ ื‘ื”ื

CERTAIN SUBSTITUTED AMIDES,METHOD OF MAKING, AND METHODOF USE THEREOFCGI PHARMACEUTICALS, INC.

11/09/200660/843959USPCT/US/2007/078181WO/2008/033854

)2009.01 (C07D19723111/09/2007

ืชื•ืœื“ื•ืช ืคื™ืจื™ืžื™ื“ื™ื ื™ื•ืช ื•ืฉื™ืžื•ืฉืŸ ื›ืžืขื›ื‘ื™ ืงื™ื ืื–

PYRIMIDINES DERIVATIVES ANDTHEIR USE AS KINASE INHIBITORS

CGI PHARMACEUTICALS, INC.11/09/200660/843836US

PCT/US/2007/078154WO/2008/033834

Page 37: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200937

)2009.01 (C07D19723220/09/2007

ืชื•ืœื“ื•ืช ืกื•ืœืคื•ื ื™ืœืคื™ืจืื–ื•ืœื•ืกื•ืœืคื•ื ื™ืœืคื™ืจืื–ื•ืœื™ืŸ ืงืจื‘ื•ืงืกืืžื™ื“ื™ืŸ

ืœ 6Hโ€“ื›ืื’ื ื˜ื’ื•ื ื™ืกื˜ื™ื Tโ€“5

SULFONYLPYRAZOLE ANDSULFONYLPYRAZOLINECARBOXAMIDINE DERIVATIVES AS5-HT6 ANTAGONISTSSOLVAY PHARMACEUTICALS B.V.

22/09/200660/846406US22/09/200606121087.8EP23/02/200760/902865US23/02/200707102965.6EP

PCT/EP/2007/059944WO/2008/034863

)2009.01 (C07C19723328/09/2007

SOLUBLE ืžืขื›ื‘ื™ ืืคื•ืงืกื™ื“ ื”ื™ื“ืจื•ืœืื– ืžืกื™ืกื™ื EPOXIDE HYDROLASEINHIBITORSARETE THERAPEUTICS, INC.

28/09/200660/848107USPCT/US/2007/079943WO/2008/039999

)2009.01 (G01S19723427/08/2007

POSITION ืฉื™ื˜ื” ืœืื•ืžื“ืŸ ืžื™ืงื•ื ื•ื”ืชืงืŸ ืงืฉื•ืจ ESTIMATION METHODAND RELATED DEVICEHARRIS CORPORATION

30/08/200611/512535USPCT/US/2007/076866WO/2008/027822

)2009.01 (A61K19723528/08/2007

THERAPEUTIC ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื COMPOSITIONSACTELION PHARMACEUTICALS LTD.

29/08/2006PCT/IB2006/052999WO19/10/2006PCT/IB2006/053857WO

PCT/IB/2007/053448WO/2008/026156

Page 38: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 38

)2009.01 (A61K19723611/09/2007

H1โ€“CAMPATHTREATMENTื˜ื™ืคื•ืœ ื‘ื˜ืจืฉืช ื ืคื•ืฆื” ืขื OF MULTIPLESCLEROSIS (MS)WITH CAMPATH-1HGENZYME CORPORATION

13/09/200660/844251US14/09/200606090169.1US

PCT/EP/2007/008084WO/2008/031626

)2009.01 (A61K19723731/08/2007

ืœืžื ื™ืขื” ื•ื˜ื™ืคื•ืœ7Cืฉื™ืžื•ืฉ ื‘ืกื•ื›ืจื™ื ื‘ืคื˜ืจืช

USE OF C7 SUGARS IN PREVENTIONAND TREATMENT OF MYCOSES

LABORATOIRES EXPANSCIENCE31/08/20060607651FR

PCT/EP/2007/059136WO/2008/025847

)2009.01 (E02D19723817/12/2007

GABION ืคืจื™ืกืช ื’ืœื™ืœื™ ืขืคืจ DEPLOYMENTHESCO BASTION LIMITED

02/01/20070700001.1GBPCT/GB/2007/050760WO/2008/081177

)2009.01 (C07C19723906/07/2007

PHENYLOXYANILINE ืชื•ืœื“ื•ืช ืคื ื™ืœ ืื•ืงืกื™ืื ื™ืœื™ืŸ DERIVATIVESBAYER SCHERING PHARMA AG

04/09/200606018455.3EPPCT/EP/2007/006148WO/2008/028533

Page 39: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200939

)2009.01 (A61K19724007/09/2007

ืœ ื•ืฉื™ืžื•ืฉื ื‘ืื‘ื—ื•ืŸWNTโ€“ืื ื˜ื’ื•ื ื™ืกื˜ื™ืWNTืกื“ืจื™ื ืžืชื•ื•ื›ื™โ€“ื•ื˜ื™ืคื•ืœ ื‘ืื™

WNT ANTAGONISTS AND THEIR USEIN THE DIAGNOSIS ANDTREATMENT OF WNT-MEDIATEDDISORDERSGENENTECH, INC.

08/09/200660/825063US20/07/200760/951175US

PCT/US/2007/077845WO/2008/031009

)2009.01 (C07K19724119/09/2007

ืชื›ืฉื™ืจื™ื ื•ืฉื™ื˜ื•ืช ื”ืงืฉื•ืจื•ืช ืœื ื•ื’ื“ื ื™ื ืœืงื•ืœื˜ืŸ ื’ืœื•ืงืื’ื•ืŸ

COMPOSITIONS AND METHODSRELATING TO GLUCAGONRECEPTOR ANTIBODIESAMGEN INC.

20/09/200660/846202US30/08/200760/968977US

PCT/US/2007/020349WO/2008/036341

)2009.01 (C07D19724227/08/2007

โ€“)ื™ืœืืžื™ื ื•โ€“2โ€“ืคื™ืจื™ื“ื™ืŸ(โ€“2ืกื ืชื™ื–ื” ืฉืœ ืื•ื ื™ืโ€“7โ€“ื“ื™ืŸืคื™ืจื™ืžื™]Dโ€“3,2[ืคื™ืจื™ื“ื•

SYNTHESIS OF 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONESPFIZER PRODUCTS INC.

08/09/200660/843051US05/06/200760/942104US

PCT/IB/2007/002524WO/2008/032157

Page 40: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 40

)2009.01 (C07D19724303/09/2007

ืคื™ืจื™ืžื™ื“ื™ื ื•ืŸ)Dโ€“3,2(ืชืจื›ื•ื‘ื•ืช ืคื™ืจื™ื“ื•3PIื•ืฉื™ืžื•ืฉืŸ ื›ืžืขื›ื‘ื™

PYRIDO (2,3-D)PYRIMIDINONECOMPOUNDS AND THEIR USE AS PI3INHIBITORSPFIZER PRODUCTS INC.

15/09/200660/845065US03/07/200760/947852US30/07/200760/952628US

PCT/IB/2007/002578WO/2008/032162

)2009.01 (C07D19724421/09/2007

ืชื•ืœื“ื•ืช ืกื•ืœืคื•ื ืืžื™ื“ ื›ืื’ื•ื ื™ืกื˜ื™ื ืื“ืจื ืจื’ื™ื™ื ื•ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืžื•ืกืงืจื ื™ื™ื

SULFONAMIDE DERIVATIVES ASADRENERGIC AGONISTS ANDMUSCARINIC ANTAGONISTSPFIZER LIMITED

04/10/200660/828099USPCT/IB/2007/002896WO/2008/041095

)2009.01 (A61B19724504/09/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืžื“ื™ื“ื” ืœื ืคื•ืœืฉื ื™ืช ืฉืœ ืคืจืžื˜ืจื™ื ืœื‘ื‘ื™ื™ื

METHOD AND SYSTEM FOR NON-INVASIVE MEASUREMENT OFCARDIAC PARAMETERS

ื‘ืข. ืื™ื™.ืื  .N.Iืž"ืžื“ื™ืงืœ MEDICAL LTD.05/09/200660/842035US

PCT/IL/2007/001088WO/2008/029396

)2009.01 (A61B19724604/09/2007

MEDICAL ืžื›ืฉื™ืจ ืจืคื•ืื™ INSTRUMENTื‘ืข. ืื™ื™.ืื  .N.Iืž"ืžื“ื™ืงืœ MEDICAL LTD.

05/09/200660/842159USPCT/IL/2007/001087WO/2008/029395

Page 41: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200941

)2009.01 (H03M19724712/09/2007

ืžืคืขื ื— ืฆื•ืคืŸ ืœืžื•ื“ื•ืœืฆื™ืช ืคืื–ื” ืจืฆื™ืคื” ื•ืฉื™ื˜ื•ืช ืงืฉื•ืจื•ืช ื”ื ื™ืชืŸ ืœืชื›ื ื•ืช

PROGRAMMABLE CONTINUOUSPHASE MODULATION (CPM)DECODER AND ASSOCIATEDMETHODSHARRIS CORPORATION

13/09/200611/531447USPCT/US/2007/078249WO/2008/033906

)2009.01 (H04L19724812/09/2007

ืžืคืขื ื— ืฆื•ืคืŸ ืจืฉืช ื”ื ื™ืชืŸ ืœืชื›ื ื•ืช ื•ืฉื™ื˜ื•ืช ื•ืจื•ืชืงืฉ

PROGRAMMABLE TRELLISDECODER AND ASSOCIATEDMETHODSHARRIS CORPORATION

13/09/200611/531462USPCT/US/2007/078261WO/2008/033915

)2009.01 (H04N19725027/08/2007

ืžืฆืœืžื” ื“ื™ื’ื™ื˜ืืœื™ืช ืžืฉื•ื›ืœืœืช ื‘ืขืœืช ืจื–ื•ืœื•ืฆื™ื™ืช ื“ืžื•ืช ืฉืื™ื ื” ืื—ื™ื“ื”

IMPROVED DIGITAL CAMERA WITHNON-UNIFORM IMAGE RESOLUTION

ITZHAK ื™ืฆื—ืง ืคื•ืžืจื ืฅ POMERANTZ25/08/200660/823508US27/08/200711/845658US

PCT/US/2007/076914WO/2008/085553

)2009.01 (B23G19725106/03/2007

TAP ืžื—ื–ื™ืง ื›ืœื™ ื”ื‘ืจื’ื” HOLDERDAISHOWA SEIKI CO,LTD.

31/10/2006PCT/JP2006/321755JPPCT/JP/2007/054309WO/2008/053606

Page 42: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 42

)2009.01 (B23G19725223/02/2007

TAP ืžื—ื–ื™ืง ื›ืœื™ ื”ื‘ืจื’ื” HOLDERDAISHOWA SEIKI CO,LTD.

PCT/JP/2007/053410WO/2008/105043

)2009.01 (B23B19725313/09/2007

ืฉ ืžื—ื–ื™ืง,ืœ ืžื—ื–ื™ืง ื›ืœื™ ืงื•ื ื™ืžืจื›ื™ื‘ ืงื•ื ื™ ื•ืื•ื ืžื”ื“ืง ื•ืžื—ื–ื™ืง ื›ืœื™ ืงื•ื ื™

CONSTITUENT MEMBER OF COLLETCHUCK, COLLET AND FASTENING NUTAND COLLET CHUCKDAISHOWA SEIKI CO,LTD.

31/10/2006PCT/JP2006/321756JPPCT/JP/2007/067853WO/2008/053638

)2009.01 (C23C19725405/09/2007

ืžืงื“ื— ืœื•ืœื™ื™ื ื™ ืขื ืฆื™ืคื•ื™ ืจื‘ ืฉื›ื‘ืชื™ ื•ืฉื™ื˜ื” ืœื”ื›ื ืชื•

A TWIST DRILL WITH A MULTI-LAYERCOATING AND METHOD FOR MAKINGTHE SAMESANDVIK INTELLECTUAL PROPERTYAB

06/09/2006102006042226.0DEPCT/SE/2007/050621WO/2008/030177

)2009.01 (B32B19725525/02/2009

INSULATED ืœื•ื—ื•ืช ืžื‘ื•ื“ื“ื™ื PANELSPOLYURETHANE LTD.

25/02/200861/064259US

Page 43: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200943

)2009.01 (F03G19725625/02/2009

POWER ื”ืชืงืŸ ืžื—ื•ืœืœ ื›ื•ื— GENERATION APPARATUSBIRAN ื‘ื™ืจืŸ ื“ื ื™ืืœ DANIEL

)2009.01 (C09K19725729/08/2007

ืฉ ืœ ื ื•ื–ืœ ืžื™ืžื™ ืขื‘ื•ืจ ืชืจื—ื™ืฃ ืชืจื›ื•ื‘ื•ืชืฉื™ื˜ื•ืช ืœื™ื™ืฆื•ืจืŸ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ, ืฉื—ื™ืงื”

ื‘ื”ืŸ

AQUEOUS FLUID COMPOSITIONSFOR ABRASIVE SLURRIES,METHODS OF PRODUCTION, ANDMETHODS OF USE THEREOFSAINT-GOBAIN CERAMICS &PLASTICS, INC.

30/08/200660/841580USPCT/US/2007/018911WO/2008/027374

)2009.01 (C09K19725829/08/2007

, ืชืจื›ื•ื‘ื•ืช ืžืจื•ื›ื–ื•ืช ืฉืœ ืชืจื—ื™ืฃ ืฉื—ื™ืงื” ืฉื™ื˜ื•ืช ืœื™ื™ืฆื•ืจืŸ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื”ืŸ

CONCENTRATED ABRASIVESLURRY COMPOSITIONS, METHODSOF PRODUCTION, AND METHODS OFUSE THEREOFSAINT-GOBAIN CERAMICS &PLASTICS, INC.

30/08/200660/841423USPCT/US/2007/018910WO/2008/027373

)2009.01 (F04C19725917/07/2008

FLUID ืžื›ื•ื ื” ืœื ื•ื–ืœ MACHINEKABUSHIKI KAISHA TOYOTAJIDOSHOKKI

19/07/20072007188312JPPCT/JP/2008/062940WO/2009/011395

Page 44: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 44

)2009.01 (G06Q19726025/02/2009

ORGANIZATION ืื•ืคื˜ื™ืžื™ื–ืฆื™ื™ืช ืืจื’ื•ืŸ OPTIMIZATIONSARA ืฉืจื” ืคื™ื ืกืงื™ PINSKY

)2009.01 (G06F19726131/08/2007

ื•ืชื•ื›ื ื” ืœืืจื›ื™ื˜ืงื˜ื•ืจื”, ืฉื™ื˜ื”, ืžืขืจื›ืช ืœืžื™ื“ืข ืฉื”ื•ื’ื“ืจ ืขืœ ื™ื“ื™ ืฆืจื›ืŸ

SYSTEM, METHOD, AND COMPUTERPROGRAM FOR A CONSUMERDEFINED INFORMATIONARCHITECTUREPETER SWEENEY

31/08/200611/469258US18/10/200611/550457US22/01/200711/625452US

PCT/CA/2007/001546WO/2008/025167

)2009.01 (A61K19726220/08/2007

ืฉื™ืžื•ืฉ ื ื’ื“ ื”ืกืจื˜ืŸ ืฉืœ ื—ื•ืžืฆื” ืงืคื™ืื™ืช ื•ื ื’ื–ืจื•ืชื™ื”

ANTI CANCER USE OF CAFFEICACID AND ITS DERIVATIVES

PIRAMAL LIFE SCIENCES LIMITED01/09/200660/842060US

PCT/IB/2007/053308WO/2008/026125

)2009.01 (E21D19726309/11/2007

IMPROVED ืขื•ื’ืŸ ืžื—ืœื™ืง ืžืฉื•ืคืจ SLIDING ANCHORATLAS COPCO MAI GMBH

10/11/2006102006053141.8DEPCT/EP/2007/009733WO/2008/055696

Page 45: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200945

)2009.01 (C07D19726411/09/2007

ืฉื™ื˜ื”, ืืžื™ื“ื™ื ืžื•ืชืžืจื™ื ืžืกื•ื™ื™ืžื™ื ืœื”ื›ื ืชื ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉ ื‘ื”ื

CERTAIN SUBSTITUTED AMIDES,METHOD OF MAKING, AND METHODOF USE THEREOFCGI PHARMACEUTICALS, INC.

11/09/200660/843833USPCT/US/2007/078185WO/2008/033857

)2009.01 (G07B19726529/08/2006

APPARATUS ืžืขืจื›ืช ืœืคืจืก ืžืฆื˜ื‘ืจ ืžื“ื•ืจื’ FOR PROGRESSIVEJACKPOTVIDEOB HOLDINGS LIMITED

PCT/IB/2006/052997WO/2008/029197

)2009.01 (A61B19726606/09/2007

ืœื ื™ื˜ื•ืจ ืœื—ืฅ ืžืขืจื›ืช ื‘ืžืจื—ื‘ ื ืชื•ืŸ ื”ืชืงืŸื•ืฉื™ื˜ื” ืœื”ืขืจื›ืช ื”ื•ืฉื˜ืช, ื‘ื”ืชืื ืœื–ืžืŸ

ื•ืชื•ืฆืจื™ื”, ืชืจื•ืคื” ื•ืชื ื’ื•ื“ืช ืœืจื™ืคื•ื™

APPARATUS FOR MONITORING ASYSTEM PRESSURE IN SPACE WITHTIME AND METHOD FOR ASSESSINGDRUG DELIVERY AND RESISTANCETO THERAPY AND PRODUCT

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

06/09/200660/824655USPCT/IL/2007/001102WO/2008/029407

Page 46: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 46

)2009.01 (A61K19726731/08/2007

ืฉื™ื˜ื•ืช ื•ืชื›ืฉื™ืจื™ื ืœื”ื’ื‘ืจืช ืกื‘ื™ืœื•ืช ื”ื—ื•ืœื” ื‘ืžื”ืœืš ืฉื™ื˜ื•ืช ืœื”ื“ืžื™ื™ืช ืฉืจื™ืจ ื”ืœื‘

METHODS AND COMPOSITIONS FORINCREASING PATIENTTOLERABILITY DURINGMYOCARDIAL IMAGING METHODSCV THERAPEUTICS, INC.

01/09/200660/841842USPCT/US/2007/077410WO/2008/028140

)2009.01 (H01H19726926/02/2009

MULTI-PIN ืคื™ื ื™ืโ€“ืžื—ื‘ืจ ื—ืฉืžืœื™ ืจื‘ ELECTRICALCONNECTORHARRIS CORPORATION

28/02/200812/038969US

)2009.01 (G01S19727008/09/2006

ืชื”ืœื™ื›ื™ื ืžืฉื•ืคืจื™ื ื”ืงืฉื•ืจื™ื ื‘ืื™ื ื˜ื’ืจืฆื™ื” ืœื ืงื•ื”ืจื ื˜ื™ืช ื‘ืžืงืœื˜

IMPROCED PROCESSES INVOLVINGNON-COHERENT INTEGRATION IN ARECEIVERNOKIA CORPORATION

PCT/IB/2006/003862WO/2008/029195

)2009.01 (G01N19727107/09/2007

BIOMARKERS ืกืžื ื™ื ื‘ื™ื•ืœื•ื’ื™ื™ื ืœื”ืขืจื›ืช ืชืคืงื•ื“ ื›ื‘ื“ FOR ASSESSINGLIVER FUNCTIONUCL BUSINESS PLC

07/09/20060617581.4GBPCT/GB/2007/003362WO/2008/029145

Page 47: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200947

)2009.01 (A61K19727207/09/2007

VACCINE ื—ื™ืกื•ืŸGLAXOSMITHKLINE BIOLOGICALSS.A.

07/09/20060617602.8GB21/12/20060625593.9GB

PCT/EP/2007/059390WO/2008/028956

)2009.01 (A61K19727330/08/2007

โ€“ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื•ืฉื™ื–ื•ืฃ ื”ืžื›ื™ืœื™ื ืงืกืคืื–14

PHARMACEUTICAL ANDSUNSCREEN COMPOSITIONSCOMPRISING CASPASE-14VIB VZW

01/09/200606119971.7EP18/12/200606126387.7EP

PCT/EP/2007/059069WO/2008/025830

)2009.01 (C07D19727407/09/2007

ืชื•ืœื“ื•ืช ืื™ื ื“ืื–ื•ืœ ื›ืžืืคื ื ื™ื ืฉืœ ืงื•ืœื˜ืŸ ืงืฉื•ืจ ืœืงื™ื ืื–1โ€“ืื™ื ื˜ืจืœื•ืงื™ืŸ

INDAZOLE DERIVATIVES ASMODULATORS OF INTERLEUKIN-1RECEPTOR-ASSOCIATED KINASEBIOGEN IDEC MA INC.

07/09/200660/842801USPCT/US/2007/019588WO/2008/030584

)2009.01 (A61K19727527/08/2007

ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ืฉืœ ืงืœื•ื ืื–ืคื ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื”ื

PHARMACEUTICAL COMPOSITIONSOF CLONAZEPAM AND METHODSOF USE THEREOFJAZZ PHARMACEUTICALS, INC.

28/08/200660/840568USPCT/US/2007/018877WO/2008/027357

Page 48: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 48

)2009.01 (A61K19727631/08/2006

ื“ื ื•ื˜ื™ืคื•ืœโ€“ืฉื™ื˜ื•ืช ืœืขื™ื›ื•ื‘ ื”ื™ื•ื•ืฆืจื•ืช ื›ืœื™ื“ืโ€“ื‘ืžื—ืœื•ืช ื”ืงืฉื•ืจื•ืช ืœื”ื™ื•ื•ืฆืจื•ืช ื›ืœื™

METHODS OF INHIBITINGANGIOGENESIS AND TREATINGANGIOGENESIS ASSOCIATEDDISEASESABRAXIS BIOSCIENCE, LLC

PCT/US/2006/034365WO/2008/027055

)2009.01 (B65D19727826/02/2009

ืฉืงื™ืช ื—ื“ ืคืขืžื™ืช ืœืงืœื™ื˜ื” ื™ืฉื™ืจื” ืฉืœ ืฆืจื›ื™ื ืฉืœ ื›ืœื‘

DISPOSALE BAG FOR DIRECTLYRECEIVING FAECES DOG

ELYAHU ืืœื™ื”ื• ืžื–ื•ืจ MAZOR

)2009.01 (A47J19727926/02/2009

ื— HOLDER.ืค.ืžื—ื–ื™ืง ื•ืžืขืžื“ ืœื›ืก AND STAND FORDISPOSABLE CUP

MOSHE ืžืฉื” ืฉื˜ื™ื™ืŸ SHTEIN

)2009.01 (G02B19728228/08/2006

ืฉื™ื˜ื” ืœื”ืฆื’ืช ืชืžื•ื ื” ื‘ืฉืœื•ืฉื” ืžื™ืžื“ื™ื ื”ื™ื•ืฆืจืช ืœื•ื—

METHOD OF DISPLAYING AN IMAGEIN THREE DIMENSIONS AND PANELTHUS PRODUCEDLIRONE

PCT/FR/2006/001998WO/2008/025888

Page 49: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200949

)2009.01 (A01N19728422/08/2007

DISINFECTANT ืžืขืจื›ื•ืช ื•ืฉื™ื˜ื•ืช ืœื—ื™ื˜ื•ื™ SYSTEMS ANDMETHODSSOLUTIONS BIOMED, LLC

31/08/200611/514721USPCT/US/2007/018603WO/2008/027264

)2009.01 (G07F19728526/02/2009

SHOPPING ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืขืจื™ื›ืช ืงื ื™ื•ืช SYSTEM AND METHODTHEREFOR

YANIV ื™ื ื™ื‘ ืฉื’ื‘ SEGEV25/02/200861/031034US

)2009.01 (H01H19728626/02/2009

WATERING ืฉื™ื˜ืช ื”ืฉืงื™ื™ื” ื•ืฉื™ื˜ื” ืœื™ื™ืฉื•ืžื” SYSTEM AND METHODOF IMPLEMENTING IT

YITZHAK ื™ืฆื—ืง ื–ื™ื ื’ืจ ZINGER

)2009.01 (B65D19728710/04/2007

DRINK ื‘ืงื‘ื•ืง ืœืฉืชื™ื” ืขื ื—ืคืฅ ืคืจืกื•ืžื™ BOTTLE WITH APROMOTIONAL OBJECTDLOUHY, PAVEL

31/08/2006PUV2006-18046

CZ

PCT/CZ/2007/000026WO/2008/025301

)2009.01 (A47J19728826/02/2009

FRUIT ื—ื•ืชืš ืคืจื•ืช ื•ื™ืจืงื•ืช AND VEGETABLE SLICERITAI ืื™ืชื™ ืขื–ืจื ื ื•ืจื™ EZRA NURI

Page 50: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 50

)2009.01 (G01N19728931/08/2007

ืืžืฆืขื™ื ื•ืฉื™ื˜ื•ืช ืœื’ื™ืœื•ื™ ืื™ื ื˜ืจืืงืฆื™ื•ืช ืคืคื˜ื™ื“โ€“ื—ืœื‘ื•ืŸ

METHODS FOR DETECTINGPROTEIN-PEPTIDE INTERACTIONS

NEXIGEN GMBH31/08/200606018277.1EP16/08/200707016137.7EP

PCT/EP/2007/007633WO/2008/025564

)2009.01 (F16L19729029/08/2007

ื”ืชืงืŸ ืฉืจื•ื•ืœ ื”ื™ืคื•ืš ืจื‘ ืคืขืžื™ ืขื‘ื•ืจ ื”ื™ืคื•ืš ืฉืœ ื›ื™ืกื•ื™ื™ื ื”ืžื•ืงืฉื™ื ื‘ืžืงื•ืžื

REUSABLE INVERSION SLEEVEASSEMBLY FOR INVERSION OFCURED IN PLACE LINERSINA ACQUISITION CORP.

29/08/200660/840818USPCT/US/2007/077123WO/2008/027973

)2009.01 (C12N19729115/08/2007

ืฉื™ื˜ื•ืช ืœื™ืฆื™ืจืช ืชืื™ ืขืฆื‘ ื•ื’ืœื™ื” ื•ืฉื™ืžื•ืฉืืœื˜ื™ืคื•ืœ ื‘ืžืฆื‘ื™ื ืจืคื•ืื™ื™ื ืฉืœ ืžืขืจื›ืช

ื”ืขืฆื‘ื™ื ื”ืžืจื›ื–ื™ืช

METHODS OF GENERATING GLIALAND NEURONAL CELLS AND USE OFSAME FOR THE TREATMENT OFMEDICAL CONDITIONS OF THE CNS

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

28/08/200660/840426USPCT/IL/2007/001026WO/2008/026198

Page 51: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200951

)2009.01 (F41H19729218/09/2007

ืŸ ืงืจืžื™ ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ืฉืœ ืฉืจื™ื•ืŸ ืฉืจื™ื• ืงืจืžื™

CERAMIC ARMORING AND METHODFOR THE PRODUCTION OF CERAMICARMORINGDEUTSCHES ZENTRUM FUR LUFT-UNDRAUMFAHRT E.V.

27/09/2006102006047110.5DEPCT/EP/2007/059832WO/2008/037623

)2009.01 (C07D19729327/09/2007

โ€“D[ืชื™ืื–ื•ืœื•]3,1[ืชื•ืœื“ื•ืช ื—ื“ืฉื•ืช ืฉืœื“ื•โ€“)H3(2โ€“ืคื™ืจื™ืžื™ื“ื™ื ]5,4 ืžื•ืชืžืจื•ืชโ€“ืื•ืŸ

ื•ืฉื™ืžื•ืฉืŸ ื‘ื˜ื™ืคื•ืœ7โ€“ื•5ื‘ืขืžื“ื•ืช

NOVEL 5,7-DISUBSTITUTED[1,3]THIAZOLO [4,5-D] PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIRUSE IN THERAPYASTRAZENECA AB

29/09/200660/827460US04/10/200660/828125US

PCT/SE/2007/000857WO/2008/039138

)2009.01 (C07D19729417/10/2007

โ€“1โ€“ืืžื™ื ื•โ€“2(โ€“4ืชื•ืœื“ื•ืช ืฉืœืฉืœ)ื”ื™ื“ืจื•ืงืกื™ืืชื™ืœ ืคื ื•ืœ ื›ืื’ื•ื ื™ืกื˜ื™ื

ืœ ืื“ืจื ืจื’ื™?2โ€“ื”ืจืฆืคื˜ื•ืจ

DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL ASAGONISTS OF THE ?2 ADRENERGICRECEPTORLABORATORIOS ALMIRALL, S.A.

20/10/2006P200602676ESPCT/EP/2007/008992WO/2008/046598

Page 52: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 52

)2009.01 (A61K19729510/09/2007

โ€“ืชื›ืฉื™ืจ ืจืคื•ืื™ ื”ืžื›ื™ืœ ืžื’ื•ื•ืŸ ืฉืœ ืžื™ื ื™XAื˜ื‘ืœื™ื•ืช ื”ืžื›ื™ืœื•ืช ืžืขื›ื‘ ืœืคืงื˜ื•ืจ

PHARMACEUTICAL COMPOSITIONCOMPRISING A PLURALITY OF MINI-TABLETS COMPRISING A FACTORXA INHIBITORGLAXO GROUP LIMITED

12/09/200660/825314USPCT/EP/2007/059443WO/2008/031782

)2009.01 (A61K19729620/09/2007

ืฉื™ื˜ื” ืœื™ื™ืขื•ืœ ื”ื˜ื™ืคื•ืœ ื‘ืœื•ืงืžื™ื” ื—ื™ื•ื‘ื™ืชืœืคื™ืœื“ืœืคื™ื” ื‘ืืžืฆืขื•ืช ืžืขื›ื‘ื™ ื˜ื™ืจื•ื–ื™ืŸ ืงื™ื ื–

ABL

METHOD OF OPTIMIZING THETREATMENT OF PHILADELPHIA-POSITIVE LEUKEMIA WITH ABLTYRO-SINE KINASE INHIBITORSNOVARTIS AG

22/09/200660/826622US05/10/200660/828278US

PCT/US/2007/078978WO/2008/036792

)2009.01 (C07D19729707/09/2007

ืฉืœืช ืจื›ื•ื‘ื•ืช ืื–ืื‘ื™ืฆื™ืงืœื™ื•ืช ื›ืžืขื›ื‘ื•ืช ืกืคื™ื’ื” ืžื—ื“ืฉ ืฉืœ ืžื•ื ื•ืืžื™ื ื™ื

AZABICYCLIC COMPOUNDS ASINHIBITORS OF MONOAMINESREUPTAKEGLAXO GROUP LIMITED

11/09/20060617863.6GB11/09/20060617868.5GB22/08/20070716371.0GB

PCT/EP/2007/059381WO/2008/031772

Page 53: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200953

)2009.01 (C07D19729827/09/2007

]Dโ€“4,5[ืชื™ืื–ื•ืœื•)3,1(ืชื•ืœื“ื•ืช ื—ื“ืฉื•ืช ืฉืœื“ื•โ€“)H3(2โ€“ืคื™ืจื™ืžื™ื“ื™ื  ืžื•ืชืžืจื•ืชโ€“ืืžื™ืŸ ื•ืฉื™ืžื•ืฉืŸ ื‘ื˜ื™ืคื•ืœ7โ€“ื•5ื‘ืืžืฆื•ืช

NOVEL 5,7-DISUBSTITUTED(1,3)THIAZOLO [4,5-D]PYRIMIDIN-2(3H)-AMINE DERIVATIVES ANDTHEIR USE IN THERAPYASTRAZENECA AB

29/09/200660/827442US04/10/200660/828122US

PCT/SE/2007/000858WO/2008/039139

)2009.01 (C07K19729904/10/2007

PTHืฉืขื‘ืจื• ืคื’ื™ืœืฆื™ื” ื›ืžืืคื ื ื™ื ืฉืœืœ ื•ืฉื™ืžื•ืฉืPTHโ€“ืจืฆืคื˜ื•ืจ

PEGYLATED PTH AS PTH RECEPTORMODULATORS AND USES THEREOF

ELI LILLY & CO.13/10/200660/829383US

PCT/US/2007/080367WO/2008/048784

)2009.01 (C07K19730012/09/2007

ื ื•ื’ื“ื ื™ื ื•ื—ืœืงื™ ื ื•ื’ื“ืŸ ื”ื•ืžื ื™ื™ื ื›ื ื’ื“ ืจืฆืคื˜ื•ืจืคื•ืœืื˜ ืœื˜ื™ืคื•ืœ ืจื“ื™ื•ืื™ืžื•ื ื™โ€“ืืœืคื ืœืื ื˜ื™

ื‘ืงืจืฆื™ื ื•ืžื” ืฉืœ ื”ืฉื—ืœื”

HUMAN ANTI-FOLATE RECEPTORALPHA ANTIBODIES ANDANTIBODY FRAGMENTS FOR THERADIOIMMUNOTHERAPY OFOVARIAN CARCINOMAISTITUTO NAZIONALE PER LOSTUDIO E LA CURA DEI TUMORI

15/09/200606019399.2EPPCT/EP/2007/007944WO/2008/031577

Page 54: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 54

)2009.01 (C07D19730118/09/2007

HTโ€“5QUINOLINEืœื™ืŸ ืขื ืชื›ื•ื ื•ืช ืงื™ืฉื•ืจ ืชื•ืœื“ื•ืช ืงื•ืื™ื ื• DERIVATIVES WITH 5-HT-BINDING PROPERTIESF. HOFFMANN-LA ROCHE AG

28/09/200606121449.0EPPCT/EP/2007/059840WO/2008/037626

)2009.01 (F24H19730226/02/2009

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื ื™ื‘ื•ื™ ื–ืžืŸ ื”ืขื‘ืจืช ืžื™ื ื•ื ืžื™ืื—ืžื™ื ื‘ืžืขืจื›ืช ื—ื™ืž

METHOD AND SYSTEM FORPREDICTING HOT WATER FLOWDURATION IN A WATER HEATINGSYSTEM

GALืž"ื’ืœ ื—ื™ื–ื•ื™ ืžื™ื ื‘ืข WATER PREDICTIONS LTD.

)2009.01 (A61K19730513/09/2006

METHODSืฉื™ื˜ื•ืช ืœื˜ื™ืคื•ืœ ื‘ื“ืœืงืช ื”ืžืขื™ ื”ื’ืก ืžื›ื•ื™ื™ื‘ืช OF TREATMENT FORULCERATIVE COLITISTHE PROCTER & GAMBLECOMPANY

PCT/US/2006/035427WO/2008/033124

)2009.01 (G01S19730626/02/2009

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ื“ืžื™ืช ืื•ืœื˜ืจืืกืื•ื ื“ ืžืœืื›ื•ืชื™ืช

METHOD AND APPARATUS FORULTRASOUND SYNTHETIC IMAGING

SUPER SONIC IMAGINE13/03/200812/047645US

Page 55: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200955

)2009.01 (C22C19730721/09/2007

METAL ืื‘ืงืช ืžืชื›ืช POWDERH. C. STARCK GMBH

22/09/2006102006045339.5DEPCT/EP/2007/060060WO/2008/034903

)2009.01 (H04M19730807/11/2006

RESILIENT ืžื ื•ืฃ ื’ืžื™ืฉ ืขื‘ื•ืจ ืžืชืงืŸ ืฉืžืชืจื•ืžื LEVER FOR A FLIP TOPDEVICENOKIA CORPORATION

PCT/FI/2006/000355WO/2008/056019

)2009.01 (A61K19730930/08/2007

ืชื›ืฉื™ืจ ืื™ื‘ื•ืคืจื•ืคืŸ ืชื•ืกืก ื‘ืขืœ ืงืฆื‘ ื”ืชืคืจืงื•ืช ื’ื‘ื•ื” ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจื•

IBUPROFEN-EFFERVESCENTPREPARATION HAVING A HIGHDISSOLUTION RATE AND METHODFOR THE PRODUCTION THEREOFLOSAN PHARMA GMBH

26/09/200606121278.3EPPCT/EP/2007/059043WO/2008/037555

)2009.01 (A61K19731007/09/2007

VACCINE ื—ื™ืกื•ืŸGLAXOSMITHKLINE BIOLOGICALSS.A.

07/09/20060617602.8GB21/12/20060625593.9GB

PCT/EP/2007/059391WO/2008/028957

Page 56: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 56

)2009.01 (G01N19731127/07/2007

ืฉื™ื˜ื•ืช ื•ืขืจื›ื•ืช ืœื’ื™ืœื•ื™ ื ื•ื–ืœ ืฉืงืฉื•ืจ ืœืžื•ื— ื•ืœื—ื•ื˜ ื”ืฉื“ืจื” ื‘ื“ื’ื™ืžื”

METHODS AND KITS FORDETECTING CEREBROSPINAL ALUIDIN A SAMPLESTONY BROOKANESTHESIOLOGISTS U.F.P.C.

06/09/200611/516385USPCT/US/2007/016907WO/2008/030305

)2009.01 (G06F19731424/08/2007

ืขืจื™ื›ืช ืคืขื•ืœื•ืช ืื‘ื—ื•ืŸ ืขืœ ื’ื‘ื™ ืžืชืงืŸ ืจื‘ ืžืขื‘ื“ื™ื ืืกื™ืžื˜ืจื™

PERFORMING DIAGNOSTICOPERATIONS UPON ANASYMMETRIC MULTIPROCESSORAPPARATUSARM LIMITED

24/10/200660/853756US11/05/20070709182.0GB

PCT/GB/2007/003223WO/2008/050076

)2009.01 (C07C19731505/09/2007

TREATMENT ื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ OF CANCERBIPAR SCIENCES, INC.

05/09/200660/842474USPCT/US/2007/077651WO/2008/030883

)2009.01 (A61K19731629/08/2007

BUPRENOPHINE-WAFER ื‘ื•ืคืจื ื•ืคื™ืŸ ืขื‘ื•ืจ ื˜ื™ืคื•ืœ ืชื—ืœื™ืคื™ ืœืกืžื™ืโ€“ื•ืคืœ FOR DRUGSUBSTITUTION THERAPYEURO-CELTIQUE S.A.

30/08/200606119839.6EPPCT/EP/2007/058978WO/2008/025791

Page 57: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200957

)2009.01 (A61M19731728/08/2007

ืชื›ื•ื ืช ืขืจื‘ื•ืœ ืขื‘ื•ืจ ืžืขืจื›ืช ืœืฉื—ืจื•ืจ ืชืจื•ืคื•ืช

VORTEX FEATURE FOR DRUGDELIVERY SYSTEMMERIDIAN MEDICALTECHNOLOGIES, INC.

31/08/200660/841709USPCT/US/2007/018920WO/2008/027382

)2009.01 (G08B19731826/02/2009

LOCATION ืžืขืจื›ืช ืžื™ืงื•ื ืขื ืžืกืš ืžื’ืข ื•ื™ืจื˜ื•ืืœื™ SYSTEM WITH VIRTUALTOUCH SCREENBIOSENSE WEBSTER, INC.

29/02/200812/039779US

)2009.01 (E04C19731926/02/2009

RETAINING ืžืขืจื›ืช ื™ื™ืฆื•ื‘ ืงื™ืจ ืชืžืš WALL STABILIZATIONSYSTEMACKERSTEIN INDUSTRIES

)2009.01 (F16K19732026/02/2009

PRESSURE ืฉืกืชื•ื ื‘ืงืจื” ื”ื™ื“ืจืื•ืœื™ ืœืฉืœื™ื˜ื” ื‘ืœื—ืฅ MANAGEMENTHYDRAULIC CONTROL VALVEBERMAD LIMITED PARTNERSHIP

)2009.01 (G08B19732129/10/2007

ืžืขืจื›ืช ืื™ืชื•ืจ ืคืจื™ืฆื” ื”ื™ืงืคื™ืช ื”ืžื•ืคืขืœืช ื‘ื›ื•ื—ื•ืช ืขืฆืžื”

SELF-OPERATED PERIMETERINTRUSION DETECTION SYSTEM

INTELGUARD LTD.01/01/200711/618919US

PCT/IL/2007/001310WO/2008/081421

Page 58: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 58

)2009.01 (B01D19732226/02/2009

ืžืชืงืŸ ืกื™ื ื•ืŸ ื•ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ืžื“ื™ื™ืช ืกื™ื ื•ืŸ ื’ืจื’ืจื™ืช

A FILTRATION APPARATUS ANDMETHOD FOR TREATINGGRANULAR FILTRATION MEDIUM

LIQUIDืž"ื‘ืข) 2001(ืงืกืœืจ ืื™ืœืŸ ื ื™ื”ื•ืœ ื•ืคื™ืชื•ื— AUTOMATION LTD

)2009.01 (A61B19732326/02/2009

ืฉื™ื˜ื” ื—ื“ืฉื ื™ืช ื•ื”ืจื›ื‘ ืœืžื ื™ืขื” ืื• ืœื˜ื™ืคื•ืœ ื‘ื’ืœืื•ืงื•ืžื” ื•ื‘ื™ืชืจ ืœื—ืฅ ืชื•ืš ืขื™ื ื™

NOVEL METHOD ANDCOMPOSITIONS FOR PREVENTIONOR TREATMENT OF GLAUCOMAAND OCULAR HYPERTENSION

MUHAMMAD ืžื•ื—ืžื“ ืขื‘ื“ืœืจืื–ืง ABDULRAZIK

)2009.01 (A61B19732426/02/2009

ื ืจื’ื™ืกื˜ื™ื™ื ืฉืœ ืชืจื•ืคื•ืช ืœืžื ื™ืขื” ืฆื™ืจื•ืคื™ื ืกื™ืื• ืœื˜ื™ืคื•ืœ ื‘ื’ืœืื•ืงื•ืžื” ื•ื‘ื™ืชืจ ืœื—ืฅ ืชื•ืš

ืขื™ื ื™

SYNERGISTIC DRUGCOMBINATIONS FOR PREVENTIONOR TREATMENT OF GLAUCOMAAND OCULAR HYPERTENSION

MUHAMMAD ืžื•ื—ืžื“ ืขื‘ื“ืœืจืื–ืง ABDULRAZIK

)2009.01 (A61K19732504/09/2007

IMATINIB ืชืจื›ื•ื‘ื•ืช ืฉืœ ืื™ืžื˜ื™ื ื™ื‘ COMPOSITIONS

TEVAืž"ื˜ื‘ืข ืชืขืฉื™ื•ืช ืคืจืžืฆื‘ื˜ื™ื•ืช ื‘ืข PHARMACEUTICALINDUSTRIES LTD.

01/09/200660/841707USPCT/US/2007/019338WO/2008/027600

Page 59: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200959

)2009.01 (A61K19732630/08/2007

SOLID ืชืจื›ื•ื‘ื•ืช ืžื•ืฆืงื•ืช ืฉืœ ืงื•ืœื˜ืŸ ืกื™ื“ืŸ ืคืขื™ืœ COMPOSITES OF A CALCIUMRECEPTOR-ACTIVE COMPOUND

TEVAืž"ื˜ื‘ืข ืชืขืฉื™ื•ืช ืคืจืžืฆื‘ื˜ื™ื•ืช ื‘ืข PHARMACEUTICALINDUSTRIES LTD.

01/09/200660/841689USPCT/US/2007/019151WO/2008/027522

)2009.01 (C07D19732718/09/2007

CRYSTALLINE ืจื•ื–ื•ื‘ืกื˜ื˜ื™ืŸ ืงืœืฆื™ื•ื ืงืจื™ืกื˜ืœื™ื ื™ ROSUVASTATINCALCIUM

TEVAืž"ื˜ื‘ืข ืชืขืฉื™ื•ืช ืคืจืžืฆื‘ื˜ื™ื•ืช ื‘ืข PHARMACEUTICALINDUSTRIES LTD.

18/09/200660/845584USPCT/US/2007/020247WO/2008/036286

)2009.01 (A01N19732828/08/2007

ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืชืžื™ืกื” ืฉืœ ื›ืœื•ืจ ืžื™ืžื™ ืœืฉื™ืžื•ืฉ ื‘ืชื•ืจ ืงื•ื˜ืœ ื—ื™ื™ื“ืงื™ื

PROCESS FOR PRODUCINGAQUEOUS CHLOROUS FOR USE ASBACTERICIDEHONBU SANKEI CO. LTD.

28/08/20062006-231280

JP

PCT/JP/2007/066691WO/2008/026607

)2009.01 (G02B19732901/03/2009

ืžื™ืงืจื•ืกืงื•ืค ื—ื™ื™ืฉืŸ ืกื•ืจืง ื‘ื™ื•ืœื•ื’ื™ ืขื ื—ื™ื™ืฉืŸื™ื—ื“ื™ ืื• ื—ื™ื™ืฉื ื™ื ืžืจื•ื‘ื™ื ืœืœื ืื™ืœื•ืฅ

ืฆื™ื” ืื•ืคื˜ื™ืช ื’ืื•ืžื˜ืจื™ ื•ืœืœื ืื™ื ื˜ืจืคืจื  ืœืคืขื•ืœื” ื‘ืื•ื•ื™ืจ ืื• ื‘ื ื•ื–ืœ

A SCANNED PROBE MICROSCOPEWITHOUT INTERFERENCE ORGEOMETRIC CONSTRAINT FORSINGLE OR MULTIPLE PROBEOPERATION IN AIR OR LIQUID

DAVIDืจ ื“ื•ื“ ืœื•ืื™ืก"ื“ LEWIS

Page 60: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 60

)2009.01 (A61M19733001/03/2009

ืข ืฆืžื™ืช ืžืชืงืŸ ืชื•ืš ื”ืคื” ื”ื ื™ืชืŸ ืœื”ืชืืžื”ื”ืžืืคืฉืจืช ืœื—ืฅ ื—ื™ื•ื‘ื™ ืชื•ืš ื“ืจื›ื™ ื”ื ืฉื™ืžื”

ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉื•

AN INTRA-ORAL SELF-ADAPTABLECONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) INTERFACE ANDNETHOD

DISCOVERืž"ื“ื™ืกืงื•ื‘ืจ ืžื“ื™ืงืœ ื“ื™ื•ื™ื™ืกื– ื‘ืข MEDICAL DEVICES LTD.

)2009.01 (A47C19733128/08/2007

ื” ืžืืคืฉืจ ื™ืฉื™ื‘ื” ื‘ืชื ื•ื—ื•ืช ื›ืกื ืžืชื›ื•ื•ื ืŸ ืžืจื•ื‘ื•ืช ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉื•

ADJUSTABLE CHAIR FORACCOMMODATING MULTIPLEBODY POSITIONS AND METHODS OFUSE THEREOF

GAYOืž"ื’ืื™ื• ื“ื™ื–ื™ื™ืŸ ื‘ืข DESIGN LTD28/08/200660/840425US03/01/200760/878045US03/01/200760/878092US

PCT/IL/2007/001067WO/2008/026209

)2009.01 (A61F19733230/08/2007

BLOOD ืชื•ืชื‘ืช ื›ืœื™ ื“ื ื•ืžืขืจื›ืช ืœื ืชื™ื ื” VESSEL PROSTHESIS ANDDELIVERY APPARATUSBARTS AND THE LONDON NHSTRUST

31/08/20060617219.1GBPCT/GB/2007/003274WO/2008/025983

)2009.01 (C11B19733330/08/2007

ืžืขืจื›ืช ืกื™ื ื•ืŸ ืžืชื ื“ื ื“ืช ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉื‘ืื•ืชื• ื”ื“ื‘ืจ ืขื‘ื•ืจ ืขื™ื‘ื•ื“ ื ื•ื–ืœื™ื ื›ื’ื•ืŸ

ืฉืžื ื™ื

STAGGERED FILTRATION SYSTEMAND METHOD FOR USING THESAME FOR PROCESSING FLUIDSSUCH AS OILSGRACE GMBH & CO. KG

01/09/200660/842067USPCT/EP/2007/007595WO/2008/025552

Page 61: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200961

)2009.01 (A61K19733430/08/2007

ืฉื™ืžื•ืฉ ื‘ืžื•ื“ื™ื•ืœื˜ื•ืจื™ื ืืœื•ืกื˜ืจื™ื™ื ืฉืœ ืœืขื™ื›ื•ื‘ ืฉืœ ื“ื™ื›ื•ื™ ื ืฉื™ืžืชื™AMPAืงื•ืœื˜ืŸ

METHOD OF INHIBITION OFRESPIRATORY DEPRESSION USINGPOSITIVE ALLOSTERIC AMPARECEPTOR MODULATORSTHE GOVERNORS OF THEUNIVERSITY OF ALBERTA

31/08/200660/824245USPCT/CA/2007/001517WO/2008/025148

)2009.01 (A61K19733527/08/2007

ืกื ืกื™ื˜ื™ื–ืฆื™ื” ืฉืœ ืชืื™ื ืกืจื˜ื ื™ื™ื ืœื˜ื™ืคื•ืœืข ื™ ืื’ื•ื ื™ืกื˜ื™ื ืฉืœ ืื ื“ื•ืชืœื™ืŸ"ืจื“ื™ื•ืืงื˜ื™ื‘ื™

SENSITIZATION OF TUMOR CELLSTO RADIATION THERAPY THROUGHTHE ADMINISTRATION OFENDOTHELIN AGONISTSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,

31/08/200660/824197USPCT/US/2007/076903WO/2008/027839

)2009.01 (G02B19733601/03/2009

ืžืขื’ืœ ืžืจื•ืงืŸ ื˜ืขื™ื ื” ืขื‘ื•ืจ ืžื•ืฆื ื˜ื•ื•ื— ืื•ืคื˜ื™

CHARGE DEPLETING CIRCUIT FOROPTICAL RANGE FINDERS

RAFAELืž"ืจืคืืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช ื‘ืข ADVANCED DEFENSESYSTEMS LTD.

)2009.01 (A22B19733730/08/2007

MEAT ืขื™ื‘ื•ื“ ื‘ืฉืจ PROCESSINGMPSC, INC

31/08/200611/513519USPCT/US/2007/019174WO/2008/027538

Page 62: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 62

)2009.01 (A61B19733830/08/2007

ืžืขืจื›ืช ื“ื™ื›ื•ื™ ืจืขืฉ ื”ืžื•ืคืขืœืช ื‘ืื•ืคืŸืื•ื˜ื•ืžืื˜ื™ ืœื—ื™ื–ื•ื™ ืžื™ืชื•ืช ื”ืงืฉื•ืจื•ืช

ื‘ื”ืคืจืขื•ืช ื‘ืงืฆื‘ ื”ืœื‘

AUTOMATED NOISE REDUCTIONSYSTEM FOR PREDICTINGARRHYTHMIC DEATHS

NONLINEAR MEDICINE, INC.31/08/200660/824170US

PCT/US/2007/077175WO/2008/028004

)2009.01 (H01M19734019/09/2007

ืกื•ืœืœื” ื‘ืขืœืช ืืœืงื˜ืจื•ื“ืช ืื•ื™ืจ ื•ืื˜ื ืžื ื•ืฃ ืžื•ื˜ื”

BATTERY HAVING AIR ELECTRODEAND BIASED LEVER GASKETEVEREADY BATTERY COMPANY,INC.

22/09/200611/525261USPCT/US/2007/020324WO/2008/039344

)2009.01 (A01P19734113/09/2007

PESTICIDE ืชื›ืฉื™ืจ ืงื•ื˜ืœ ืžื–ื™ืงื™ื COMPOSITIONBASF SE

14/09/200660/844469USPCT/EP/2007/059657WO/2008/031870

)2009.01 (B23C19734207/12/2007

CUTTING ืžื—ื–ื™ืง ืœื›ืœื™ ื•ืฉื™ื˜ื” ืงืฉื•ืจื”, ืฉื™ืžืช ื—ื™ืชื•ืš INSERT, TOOL HOLDER,AND RELATED METHODTDY INDUSTRIES, INC.

16/01/200760/885053US03/05/200711/743803US

PCT/US/2007/086717WO/2008/088621

Page 63: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200963

)2009.01 (D02J19734315/09/2007

ืชื”ืœื™ืš ืœื”ื›ื ืช ื—ื•ื˜ื™ื ื‘ืขืœื™ ื—ื•ื–ืง ื’ื‘ื•ื” ืื—ื™ื“ ื•ื™ืจื™ืขื•ืช ืกื™ื‘ื™ื•ืช

PROCESS FOR MAKING UNIFORMHIGH STRENGTH YARNS ANDFIBROUS SHEETSHONEYWELL INTERNATIONAL INC.

25/09/200611/526350USPCT/US/2007/078589WO/2008/039650

)2009.01 (B65D19734417/09/2007

ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ืžื’ื•ื‘ืฉื™ื ืฉืื™ื ื ื–ื•ืจืžื™ื ื‘ื—ื•ืคืฉื™ื•ืช ื”ืžื›ื™ืœื™ื ื’ื•ืจื ืžื“ื‘ื™ืง

COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING A GLUING AGENTMCNEIL NUTRITIONALS, LLC

18/09/200611/532667USPCT/US/2007/020120WO/2008/036229

)2009.01 (A47J19734502/03/2009

A ืžื›ืฉื™ืจ ื•ืฉื™ื˜ื” ืœืื˜ื™ืžืช ืกื™ืจ DEVICE AND METHOD FORSEALING A POT

ROMEO ืจื•ืžืื• ื’ื•ืœื“ื”ืžืจ GOLDHAMMER12/11/200861113604US

)2009.01 (G06F19734602/03/2009

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืžืชืŸ ืฉื™ืจื•ืชื™ื ื‘ืืžืฆืขื•ืช ื“ื•ืืจ ืืœืงื˜ืจื•ื ื™

A METHOD AND A SYSTEM FORPROVIDING SERVICES VIA E-MAIL

BEN-DANIEL ื‘ืŸ ื“ื ื™ืืœ ืจื•ื ืŸ RONEN

)2009.01 (E04D19734702/03/2009

ROOF ื•ืฉื™ื˜ื”ืžืจืฆืคืช ื‘ื™ื“ื•ื“ ืœื’ื’ INSULATION TILE ANDMETHOD

MANOR ืžื ื•ืจ ืขื•ื–ื™ UZI

Page 64: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 64

)2008.04 (A61K19734830/04/2002

THERAPEUTIC ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื ืœื”ื›ื•ื•ื ื” ืœืœื™ื–ื•ื–ื•ืžื™ื COMPOSITIONS FORTARGETING LYSOSOMESZYSTOR THERAPEUTICS, INC.

30/04/200160/287531US10/07/200160/304609US15/10/200160/329461US23/01/200260/351276US

PCT/US/2002/013835WO/2002/087510

)2009.01 (H01R19734902/03/2009

A ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืชื™ืงื•ืŸ ืžืขื’ืœื™ื ื—ืฉืžืœื™ื™ื METHOD AND SYSTEM FORELECTRICAL CIRCUIT REPAIR

ORBOTECHืž"ืื•ืจื‘ื•ื˜ืง ื‘ืข LTD.

)2009.01 (A61K19735005/09/2007

ื“ื™ื›ื•ื™ ืกื™ื ืชื–ื” ืฉืœ ื—ื•ืžืฆื” ืฉื•ืžื ื™ืช ืขืœ ื™ื“ื™ ื•ืฉื™ื˜ื•ืช ื˜ื™ืคื•ืœ ืžื›ืšPARPืžืขื›ื‘ื™

INHIBITION OF FATTY ACIDSYNTHESIS BY PARP INHIBITORSAND METHODS OF TREATMENTTHEREOFBIPAR SCIENCES, INC.

05/09/200660/842479USPCT/US/2007/077662WO/2008/030891

)2009.01 (H04L19735104/09/2007

ืฉื™ื˜ื” ื•ืžืชืงืŸ ืขื‘ื•ืจ ืžื™ื“ืข ื•ืฉืœื™ื˜ื” ื‘ืฉื™ื“ื•ืจ ืžืจื•ื‘ื‘

METHOD AND APPARATUS FORDATA AND CONTROLMULTIPLEXINGQUALCOMM INCORPORATED

05/09/200660/842619US29/08/200711/847307US

PCT/US/2007/077516WO/2008/030798

Page 65: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200965

)2009.01 (C07D19735219/09/2007

โ€“2,1[ืคื ื™ืœืื™ืžื™ื“ืื–ื•โ€“6โ€“ืืจื™ืœโ€“2ื ื’ื–ืจื•ืช ืฉืœ]aื”ื›ื ืชืŸ ื•ืฉื™ืžื•ืฉื™ื”ืŸ ื”ืจืคื•ืื™ื™ื, ืคื™ืจื™ื“ื™ืŸ

2-ARYL-6-PHENYLIMIDAZO[1,2-A]PYRIDINE DERIVATIVES,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

22/09/20060608350FRPCT/FR/2007/001517WO/2008/034974

)2009.01 (G01N19735305/09/2007

PARPืฉื™ื˜ื•ืช ืขื‘ื•ืจ ืชื›ื ื•ืŸ ืžืขื›ื‘ื™ ื•ืฉื™ืžื•ืฉื™ื ืžื›ืš

METHODS FOR DESIGNING PARPINHIBITORS AND USES THEREOF

BIPAR SCIENCES, INC.05/09/200660/842470US

PCT/US/2007/077655WO/2008/030887

)2009.01 (H04L19735427/09/2007

ืฉื™ื˜ื•ืช ื•ืžืชืงืŸ ืœืขื™ืฆื•ื‘ ืกืžืœ ื ื™ืกื™ื•ื ื™ ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

METHODS AND APPARATUS FORCONFIGURING A PILOT SYMBOL INA WIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED

27/09/200611/535940USPCT/US/2007/079787WO/2008/039952

Page 66: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 66

)2009.01 (H04L19735527/09/2007

ืฉื™ื˜ื•ืช ื•ืžืชืงืŸ ืขื‘ื•ืจ ืฉื™ื“ื•ืจ ืฉืœื“ ืžื‘ื ื” ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

METHODS AND APPARATUS FORTRANSMITTING A FRAMESTRUTURE IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

27/09/200611/535947USPCT/US/2007/079785WO/2008/039951

)2009.01 (B05B19735602/03/2009

ืชื›ืœื™ืชื™ ื”ื ื™ืชืŸ ืœืžืžืฉืงโ€“ืžื›ืœื•ืœ ืžื›ืกื” ืจื‘ ืขื ืืงื“ื— ืจื™ืกื•ืก ืœืฆื‘ืข

MULTI-PURPOSE LID ASSEMBLYINTERFACEABLE WITH A PAINTSPRAY GUN

EREZ ืืจื– ื ื™ืกื™ื ืœื•ื™ NISIM LEVI

)2009.01 (A61K19735702/03/2009

ืฉืœ, ืžืขืจื›ืช ืœื”ืฉืชืœื” ืฉืคืขื•ืœ ื•ืชืคืขื•ืœ ืกื•ืœืœื” ืžื•ืฉืชืœืช

A SYSTEM FOR IMPLANTING,ACTIVATING, AND OPERATING ANIMPLANTABLE BATTERY

,ORTHO-IONืž"ืื•ืจืชื•ื™ื•ืŸ ื‘ืข LTD.

)2009.01 (A61M19735824/07/2007

AUTOMATIC ืฉืกืชื•ื ืขืฆื™ืจื” ืงื•ืง ืื•ื˜ื•ืžื˜ื™ STOP COCK VALVEALCON, INC.

18/09/200611/522648USPCT/US/2007/074172WO/2008/036462

Page 67: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200967

)2009.01 (G06F19736001/11/2007

ืื‘ื˜ื—ืช ื”ืขื‘ืจืช ื™ืฉื•ืžื™ื™ ืžื™ื“ืข ืžื—ื•ืœืงื™ืSECURING DISTRIBUTEDAPPLICATION INFORMATIONDELIVERYMICROSOFT CORPORATION

01/11/200611/555610USPCT/US/2007/083390WO/2008/057970

)2009.01 (G06F19736116/10/2007

ื•ื™ืจื˜ื•ืืœื™ื–ืฆื™ื” ืขื‘ื•ืจ ื’ื™ื•ื•ืŸ ืฉืœ ืขืžื™ื“ื•ืช ืœื”ืชืขืจื‘ื•ืช

VIRTUALIZATION FOR DIVERSIFIEDTAMPER RESISTANCE

MICROSOFT CORPORATION27/10/200611/553841US

PCT/US/2007/081485WO/2008/115279

)2009.01 (A61K19736207/09/2007

ืฉื™ื˜ื” ืœื”ืคื—ืชืช ืื• ืœื”ืจื’ืขืช ื“ืœืงืช ื‘ืžืขืจื›ืช ื”ืขื™ื›ื•ืœ

METHOD FOR REDUCING ORALLEVIATING INFLAMMATION INTHE DIGESTIVE TRACTORE PHARMACEUTICALS, INC.

08/09/200660/825075US02/10/200660/827807US

PCT/US/2007/077857WO/2008/031014

)2009.01 (A61K19736307/09/2007

ืชืจื›ื•ื‘ื•ืช ื•ืฉื™ื˜ื•ืช ืขื‘ื•ืจ ื’ื•ืจืžื™ื ื”ืžืกื•ืžื ื™ืF18ืขื

COMPOUNDS AND METHODS FOR18F LABELED AGENTS

BAYER SCHERING PHARMA AG08/09/200606090166.7EP23/04/200707090079.0EP

PCT/EP/2007/008042WO/2008/028688

Page 68: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 68

)2009.01 (F41H19736415/09/2007

ื—ื•ืžืจื™ื ืžืจื•ื›ื‘ื™ื ืžื•ื›ืœืื™ื ืขื ืžืจืงืžื™ืื–ื”ื™ื ื‘ืขืœื™ ื‘ื™ืฆื•ืขื™ื ื˜ื•ื‘ื™ื ืขืœ ื™ื“ื™ ืฉื™ื ื•ื™

ืชื›ื•ืœืช ื”ืฉืจืฃ ื‘ืœื‘ื“

HIGH PERFORMANCE SAME FIBERCOMPOSITE HYBRIDS BY VARYINGRESIN CONTENT ONLY

HONEYWELL INTERNATIONAL INC.26/09/200611/527924US

PCT/US/2007/078590WO/2008/108882

)2009.01 (C07D19736526/09/2007

ืžืืคื ื ื™ ืงื•ืœื˜ืŸ ืคืจื•ื’ืกื˜ืจื•ืŸ ืคื™ืจื™ื“ื•ืื•ืงืกืื–ืคื™ื ื™ื

PYRIDOOXAZEPINE PROGESTERONRECEPTOR MODULATORS

N.V. ORGANON27/09/200606121372.4EP

PCT/EP/2007/060225WO/2008/037746

)2009.01 (B01F19736617/09/2007

DEVICE ื”ืชืงืŸ ืœื”ื•ืกืคืช ื’ื– ืœื ื•ื–ืœ FOR GASSING A LIQUIDKOCH MEMBRANE SYSTEMS GMBH

19/09/2006102006044624.0DEPCT/EP/2007/008063WO/2008/034570

)2009.01 (F04B19736718/10/2007

VIBRATION ื“ื“ ื•ื™ื‘ืจืฆื™ื•ืชืžื‘ื• ISOLATOREDWARDS LIMITED

19/10/20060620723.7GBPCT/GB/2007/050645WO/2008/047168

Page 69: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200969

)2009.01 (C22C19736821/09/2007

METAL ืื‘ืงืช ืžืชื›ืช POWDERH. C. STARCK GMBH

22/09/2006102006045481.2DEPCT/EP/2007/060058WO/2008/034902

)2009.01 (C07D19736929/09/2007

โ€“3โ€“ื›ืœื•ืจื•โ€“4[{(โ€“4[โ€“4โ€“)ืืžื™ื ื•}ืงืจื‘ืžื•ื™ืœ)]ืคื ื™ืœ)ื˜ืจื™ืคืœื•ืื•ืจื•ืžืชื™ืœ(โ€“2โ€“ืžืชื™ืœืคื™ืจื™ื“ื™ืŸโ€“Nโ€“]ืคืœื•ืื•ืจื•ืคื ื•ืงืกื™โ€“3

ืงืจื‘ื•ืงืกืืžื™ื“ ืžื•ื ื•ื”ื™ื“ืจืื˜

4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDEMONOHYDRATEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT

11/10/200606021296.6EPPCT/EP/2007/008503WO/2008/043446

)2009.01 (H01H19737003/03/2009

COMPRESSION ื”ืชืงืŸ ื“ื—ื™ืกื” ืขื ืกื•ืœื™ื” DEVICE WITH SOLETYCO HEALTHCARE GROUP LP

04/03/200812/041816US

)2009.01 (A61F19737104/09/2007

ืชื•ืชื‘ืช ืคื ื™ืžื™ืช ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ืชื•ืชื‘ืช ืคื ื™ืžื™ืช

ENDOPROSTHESIS, AND METHODFOR PRODUCING ANENDOPROSTHESISUNIVERSITE PIERRE ET MARIECURIE ( PARIS 6 )

04/09/20060607733FRPCT/FR/2007/001431WO/2008/029020

Page 70: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 70

)2009.01 (A23L19737217/09/2007

ืงืœื•ืจื™ื•ืช ืžื’ื•ื‘ืฉื™ืโ€“ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ื“ืœื™ืฉืื™ื ื ื–ื•ืจืžื™ื ื‘ื—ื•ืคืฉื™ื•ืช ืขื ื ืคื— ืžืฆื•ืžืฆื

LOW-CALORIE COHESIVE NON-FREEFLOWING SWEETENERCOMPOSITIONS WITH DECREASEDVOLUMEMCNEIL NUTRITIONALS, LLC

18/09/200611/532681USPCT/US/2007/020119WO/2008/036228

)2009.01 (A23L19737317/09/2007

ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ืžื’ื•ื‘ืฉื™ื ืฉืื™ื ื ื–ื•ืจืžื™ื ื‘ื—ื•ืคืฉื™ื•ืช ื”ืžื›ื™ืœื™ื ื—ื•ืžืจ ืžืชืคื•ืจืจ

COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING DISINTEGRANTMCNEIL NUTRITIONALS, LLC

18/09/200611/532687USPCT/US/2007/020136WO/2008/036233

)2009.01 (G01N19737403/10/2007

ELISAืขื‘ื•ืจVEGFELISA FOR VEGFGENENTECH, INC.

04/10/200660/828203USPCT/US/2007/080310WO/2008/060777

)2009.01 (C07D19737520/09/2007

PYRIDINE ื“ื™ ืคื™ืจื™ื“ื™ืŸ ื‘ื•ืจืืŸืชืฆืžื™ BORANE COMPLEXESBASF SE

21/09/200660/846144USPCT/EP/2007/060003WO/2008/034886

Page 71: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200971

)2009.01 (A61K19737613/09/2006

ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ื“ืœืงืช ืžืขื™ ื”ื’ืก ืžื›ื•ื™ื™ื‘ืช ื‘ืืžืฆืขื•ืช ืืžื™ื ื•ืกืœื™ืฆื™ืœืื˜

METHODS OF TREATMENT FORULCERATIVE COLITIS USINGAMINOSALICYLATETHE PROCTER & GAMBLECOMPANY

PCT/US/2006/035428WO/2008/033125

)2009.01 (B65D19737803/03/2009

A ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืงื™ืจื•ืจ ื‘ืงื‘ื•ืง SYSTEM AND METHOD FORCOOLING A BOTTLE

DUDU ื“ื•ื“ื• ื—ื™ื™ื HAIM

)2009.01 (B01D19737903/03/2009

ืชื”ืœื™ืš ืœื”ืคืงืช ื—ื•ืžืฆื” ื”ื™ื“ืจื•ื›ืœื•ืจื™ืชืžืชืžื™ืกื” ืžื“ื•ืœืœืช ืฉืœื” ื•ืชื›ืฉื™ืจ ืžื™ืฆื•ื™

ืœืฉื™ืžื•ืฉ ื‘ื•

A PROCESS FOR THE RECOVERY OFHCL FROM A DILUTE SOLUTIONTHEREOF AND EXTRACTANTCOMPOSITION FOR USE THEREIN

ืก ื‘ืข' ืื™ื™ืฅ HCLืž"ืืœ ืงืœื™ื ื˜ื’ CLEANTECH LTD.

)2009.01 (A61K19738004/09/2007

ื‘ื•ืขื™ื•ืชโ€“ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืžื™ืงืจื• ืืžืคื™ืคื™ืœื™ื•ืช ื”ืžืžื•ืœืื•ืช ื‘ื’ื–

COMPOSITIONS CONTAININGAMPHIPHILLIC GAS-FILLEDMICROVESICLESBRACCO RESEARCH S.A.

05/09/200606120109.1EPPCT/EP/2007/059256WO/2008/028917

Page 72: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 72

)2009.01 (C07D19738111/09/2007

KINASE ืžืขื›ื‘ ืงื™ื ืื– INHIBITORSANOFI AVENTIS

11/09/200660/825168USPCT/US/2007/078103WO/2008/033798

)2009.01 (F41H19738201/07/2004

ANTIBALLISTIC ื‘ืœื™ืกื˜ื™ื™ื ื•ืชื”ืœื™ืšโ€“ื—ื•ืžืจื™ื ืื ื˜ื™ MATERIALS ANDPROCESSANTIBALLISTIC SECURITY ANDPROTECTION INC.

01/07/200360/483630US02/04/200460/521336US05/05/200460/567795US

PCT/US/2004/020989WO/2005/043071

)2009.01 (H04N19738330/08/2007

DISPLAYING ื”ืฆื’ืช ื•ื™ื“ื™ื• VIDEONDS LIMITED

04/09/20060617385.0GB05/09/200660/842222GB

PCT/GB/2007/003264WO/2008/029086

)2009.01 (E06B19738403/09/2007

RAIL ืžืขืจื›ืช ืžืกื™ืœื•ืช ืœื“ืœืชื•ืช ื•ื—ืœื•ื ื•ืช ื”ื–ื–ื” SYSTEM FOR SLIDING DOORSAND WINDOWSSTARGET CONCEPT LTD.

03/09/200660/824441USPCT/IL/2007/001086WO/2008/029394

Page 73: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200973

)2009.01 (G06F19738505/09/2007

ืฉื™ื˜ื•ืช ืœืงื‘ื™ืขืช ืžื™ืงื•ื ืกืžืŸ ืžืžื’ืข ืืฆื‘ืข ืขื ืžืกืš ืžื’ืข

METHODS FOR DETERMINING ACURSOR POSITION FROM A FINGERCONTACT WITH A TOUCH SCREENDISPLAYAPPLE INC.

06/09/200660/824769US07/01/200760/879253US08/01/200760/879469US27/06/200760/946716US29/06/200760/937993US04/09/200711/850015US

PCT/US/2007/077645WO/2008/030880

)2009.01 (G09B19738603/03/2009

TOUCH ืžื•ื“ืœ ื ื™ื”ื•ืœ ืื™ืจื•ืข ืžื’ืข EVENT MODELAPPLE INC.

04/03/200812/042318US

)2009.01 (F02B19738703/03/2009

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื”ื ืขื” ืชื•ืš ืฉื™ืžื•ืฉ ื‘ืชื ืฉืจื™ืคื” ื”ืคื•ืœื˜ ืžืกื” ืžืจื•ื›ื–ืช

PROPULSION SYSTEM AND METHODUSING A COMBUSTION CHAMBERDISCHARGING A CONCENTRATEDMASS

TECHNIONืž"ืžื•ืกื“ ื”ื˜ื›ื ื™ื•ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT FOUNDATION LTD.

Page 74: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 74

)2009.01 (G08B19738803/03/2009

ืฉื™ื˜ื” ื”ืžืฉืชืžืฉืช ื‘ืจื“ืืจ ืœื’ื™ืœื•ื™ ืžื˜ืจื”ื‘ืœืชื™ ื™ื“ื•ืขื” ื”ืขืฉื•ื™ื” ืœื”ื™ื•ืช ืžืžื•ืงืžืช

ืœื™ื“ ืžื˜ืจื•ืช ืื—ืจื•ืช, ื‘ื’ื•ื‘ื” ื ืชื•ืŸ ื‘ืงื™ืจื•ื‘ ื”ืžืžื•ืงืžื•ืช ื‘ืื•ืชื• ื’ื•ื‘ื” ื‘ืงื™ืจื•ื‘

METHOD USING RADAR TO DETECTA KNOWN TARGET LIKELY TO BEPOSITIONED AT APPROXIMATELY AGIVEN HEIGHT, NEAR OTHERTARGETS POSTIONED ATAPPAOXIMATELY THE SAMEHEIGHTTHALES

01/04/20080801787FR

)2009.01 (C07K19738904/10/2007

ื—ื•ืžืจ ืคืจื•ืคื™ืœืงื˜ื™ ืื• ืชืจืคื•ืื˜ื™ ืœืกืจื˜ืŸ

PROPHYLACTIC OR THERAPEUTICAGENT FOR CANCERTAKEDA PHARMACEUTICAL COMPANYLIMITED

06/10/2006PCT/JP2006/320429JP04/04/2007P-070101453AR06/04/20072007#100876JP

PCT/JP/2007/069908WO/2008/044754

)2009.01 (C07K19739006/09/2007

ืžื•ืœืงื•ืœื•ืช ืงื•ืฉืจื•ืช ืื ื•ืฉื™ื•ืช ื”ืžืกื•ื’ืœื•ืช ืฉืœื”ืŸ ื•ืฉื™ืžื•ืฉื™ื1N5Hืœื ื˜ืจืœ ื ื’ื™ืฃ ืฉืคืขืช

HUMAN BINDING MOLECULESCAPABLE OF NEUTRALIZINGINFLUENZA VIRUS H5N1 AND USESTHEREOFCRUCELL HOLLAND B.V.

07/09/200606120316.2EP07/09/200660/842930US14/09/200606120644.7EP30/11/200606125107.0EP28/06/200707111235.3EP

PCT/EP/2007/059356WO/2008/028946

Page 75: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200975

)2009.01 (D06M19739104/09/2007

ืžื•ืฆืจื™ ื˜ืงืกื˜ื™ืœ ืžืขื›ื‘ื™ ื‘ืขืจื” ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจื

FLAME RETARDED TEXTILEPRODUCTS AND A METHOD OFMAKING THE SAMEALBEMARLE CORPORATION

08/09/200660/824935USPCT/US/2007/077508WO/2008/030792

)2009.01 (C12Q19739205/09/2007

GENOMIC ืฆื•ืคืŸ ืžื•ืจืก ื’ื ื•ืžื™ MORSE CODEINSTITUT PASTEUR

07/09/200611/516673USPCT/EP/2007/059299WO/2008/028931

)2009.01 (C07D19739306/09/2007

ืื™ืœ ื›ื’ื•ืจืžื™ืโ€“4โ€“ืชื•ืœื“ื•ืช ืคื™ืจื™ื“ื™ืŸืช ื”ื—ื™ืกื•ืŸืžืืคื ื ื™ ืžืขืจื›

PYRIDIN-4-YL DERIVATIVES ASIMMUNOMODULATING AGENTS

ACTELION PHARMACEUTICALS LTD.07/09/2006PCT/IB06/053147IB

PCT/IB/2007/053594WO/2008/029371

)2009.01 (C07D19739406/09/2007

ื™ืœ ื›ื’ื•ืจืžื™ื ืžืืคื ื ื™โ€“3โ€“ืชื•ืœื“ื•ืช ืคื™ืจื™ื“ื™ืŸ ื—ื™ืกื•ืŸ

PYRIDIN-3-YL DERIVATIVES AMIMMUNOMODULATING AGENTS

ACTELION PHARMACEUTICALS LTD.08/09/2006PCT/IB06/053187IB

PCT/IB/2007/053593WO/2008/029370

Page 76: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 76

)2009.01 (C07D19739510/07/2007

ืชื•ืœื“ื•ืช ืชื™ื•ืคืŸ ื›ืื’ื•ื ื™ืกื˜ื™ื ืœืงื•ืœื˜ืŸ1EDG/1P1S

THIOPHENE DERIVATIVES ASS1P1/EDG1 RECEPTOR AGONISTS

ACTELION PHARMACEUTICALS LTD.07/09/2006PCT/IB06/053150IB

PCT/IB/2007/052742WO/2008/029306

)2009.01 (C07D19739724/10/2007

ืชืจื›ื•ื‘ื•ืช ืื•ืงืกืื“ื™ืื–ื•ืœ ื•ืชื™ืื“ื™ืื–ื•ืœื•ืฉื™ืžื•ืฉ ื‘ื”ืŸ ื›ืžืืคื ื ื™ ืงื•ืœื˜ืŸ ืืฆื˜ื™ืœื›ื•ืœื™ืŸ

ื ื™ืงื•ื˜ื™ื ื™

OXADIAZOLE AND THIADIAZOLECOMPOUNDS AND THEIR USE ASNICOTINIC ACETYLCHOLINERECEPTOR MODULATORSNEUROSEARCH A/S

25/10/2006PA200601380DK25/10/200660/854078US

PCT/EP/2007/061433WO/2008/049864

)2009.01 (G01N19739804/03/2009

LONG-LASTING ืจื–ื” ืขืžื™ื“ ืœืื•ืจืš ื–ืžืŸืœ ื™ืฆื•ืง ืœืืœืงื˜ืจื•ืคื•'ื’ PRECASTELECTROPHORESIS GEL

GENEืž"ื’ืŸ ื™ื™ืฉื•ืžื™ื ื‘ื‘ื™ื•ืœื•ื’ื™ื” ื‘ืข BIO-APPLICATION LTD.

)2009.01 (A47J19739906/09/2007

PREPARING ืžื›ืฉื™ืจ ื”ื›ื ื” DEVICEBRAVILOR HOLDING B.V.

07/09/20062000218NLPCT/NL/2007/050436WO/2008/030095

Page 77: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200977

)2009.01 (C22C19740012/09/2007

MAGNESIUM ืกื’ืกื•ื’ื•ืช ืžื’ื ื–ื™ื•ื ื’ื“ื•ืœื™ืŸ GADOLINIUM ALLOYSMAGNESIUM ELEKTRON LIMITED

13/09/20060617970.9GBPCT/GB/2007/003491WO/2008/032087

)2009.01 (H01Q19740131/07/2007

ืขื’ืœื™ื ื•ื˜ื›ื ื™ืงื•ืช ืชืช ืžืขืจืš ืžืจื•ืฆืฃ ื•ืž ืงืฉื•ืจื•ืช

TILE SUB-ARRAY AND RELATEDCIRCUITS AND TECHNIQUES

RAYTHEON COMPANY21/09/200611/533848US09/11/200611/558126US

PCT/US/2007/074795WO/2008/036469

)2009.01 (C07D19740219/09/2007

ื™ืœ ืืœืงโ€“Nืชื”ืœื™ืš ืœื”ื›ื ื” ืฉืœ ื”ืืœื™ื“ื™ื ืฉืœ ื ืœื˜ืจืงืกื•ืŸ

PROCESS FOR PREPARING N-ALKYLNALTREXONE HALIDES

SANOFI-AVENTIS21/09/20060608286FR

PCT/FR/2007/001516WO/2008/034973

)2009.01 (E21B19740304/03/2009

ืžืชืงืŸ ื•ืฉื™ื˜ื” ืขื‘ื•ืจ ืคืจื™ืฆื” ืžื‘ื•ืงืจืช ืฉืœ ื‘ื˜ื•ืŸ ืžื—ื•ื–ืง

DEVICE AND METHOD FORCONTROLLED BREACHING OFREINFORCED CONCRETERAYTHEON UTD INC.

Page 78: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 78

)2009.01 (A61M19740407/09/2007

COLLAPSIBLE ืžื™ื›ืœ ืžืชืงืคืœ ืœืื™ืกื•ืฃ ื ื•ื–ืœ ืจืคื•ืื™ CANISTER LINER FORMEDICAL FLUID COLLECTIONALLEGIANCE CORPORATION

07/09/200611/517125USPCT/US/2007/019615WO/2008/030597

)2009.01 (H04N19740507/10/2007

ืžืžืฉืง ืžืฉืชืžืฉ ืื™ื ื˜ืจืืงื˜ื™ื‘ื™ ืชืœืช ืžื™ืžื“ื™ ืœืžืขืงื‘ ืœืงื•ื™

INTERACTIVE 3D SHORTAGETRACKING USER INTERFACE

MICROSOFT CORPORATION01/11/200611/591689US

PCT/US/2007/080662WO/2008/054953

)2009.01 (C07D19740827/09/2007

PROCESS ืชื”ืœื™ืš ืœื”ื›ื ืช ืื‘ืืงื‘ื™ืจ FOR THE PREPARATIONOF ABACAVIRESTEVE QUIMICA, S.A.

28/09/200606121459.9EP28/09/200660/847979US

PCT/EP/2007/060249WO/2008/037760

)2009.01 (B65D19740916/07/2007

ื•ืกื•ื’ืจ ืขื ืžืขื’ืœ ืืจื™ื–ื” ื”ื›ื•ืœืœืช ืžื™ื›ืœRFID

CLOSURE AND CONTAINERPACKAGE WITH RFID CIRCUITREXAM HEALTHCARE PACKAGINGINC.

07/09/200611/517000USPCT/US/2007/016115WO/2008/030295

Page 79: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200979

)2009.01 (G06K19741017/10/2007

ืฉื™ื˜ื” ืœืงื‘ืœืช ืชืžื•ื ื•ืช ืžืจื—ื‘ื™ื•ืช ื‘ืืžืฆืขื•ืชMRIื•ืช ื”ืžืจื—ื‘ื™ื•ืช ื•ืขื™ื‘ื•ื“ ื”ืชืžื•ื 

ื”ืžืชืงื‘ืœื•ืช ื•ืชื•ืฆืจ

METHOD FOR OBTAINING SPATIALIMAGES THROUGH MRI ANDPROCESSING THE RESULTINGSPATIAL IMAGES AND PRODUCT

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

17/10/200660/829705USPCT/US/2007/081580WO/2008/048982

)2009.01 (C25D19741105/09/2007

ืชื•ืกืฃ ื—ื“ืฉ ืขื‘ื•ืจ ืืœืงื˜ืจื•ืœื™ื˜ื™ื ืฉืœ ื›ืจื•ื

A NOVEL ADDITIVE FOR CHROMIUMELECTROLYTES

TIB CHEMICALS AG05/09/2006102006042076.4DE

PCT/EP/2007/059308WO/2008/028932

)2009.01 (B01J19741205/03/2009

ื”ื•ืžื•ื’ื ื™ ืžืฉื•ืœื‘โ€“ื”ื˜ืจื•ื’ื ื™ ื›ื•ืจCOMBINATORIALHETEROGENEOUS-HOMOGENEOUSREACTORBABCOCK & WILCOX TECHNICALSERVICES GROUP, INC.

07/03/200861/034534US03/03/200912/397070US

Page 80: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 80

)2009.01 (A61K19741306/09/2007

ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืคืคื˜ื™ื“ื™ื ืงื•ื˜ืœ ื™ื™ื“ืงื™ื ื”ืžื›ื•ื•ื ื™ื ื‘ื‘ืจืจื ื™ืชื—

COMPOSITIONS COMPRISINGSELECTIVELY TARGETEDANTIMICROBIAL PEPTIDESTHE REGENTS OF THE UNIVERSITYOF CALIFORNIA

06/09/200660/842871USPCT/US/2007/077795WO/2008/030988

)2009.01 (H01H19741405/03/2009

ืœ ืืคืงื˜ ืžื•ื’ื‘ืจ ืฉืœ ื—ื™ื“ื•ืฉ ื”ืชืงืŸ ืจืคื•ืื™ ื‘ืข ืชืื™ื ื•ื”ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉื•

A MEDICAL DEVICE WITHENHANCED EFFECT OF CELLREGENERATION AND THE METHODTHEREOFHAN, WAN-SEOK

)2009.01 (A01N19741511/09/2007

ืื–ื•ืœ ื ื•ืงืœืื•ืกื™ื“ื™ื ื•ืฉื™ืžื•ืฉ ื›ืžืขื›ื‘ื™ ืคื•ืœื™ืžืจืื–ื™ื ื•ืืจื™ืืœื™ื™ื ืฉืœ ืจื ื ื•ื“ื ื

AZOLE NUCLEOSIDES AND USE ASINHIBITORS OF RNA AND DNAVARIAL POLYMERASESSOUTHERN RESEARCH INSTITUTE

11/09/200660/843398USPCT/US/2007/078139WO/2008/067002

)2009.01 (G07B19741605/03/2009

ื”ืฉื™ื˜ื” ืœืžื“ื™ื“ื•ืช ื”ืฉืคืขืช ืคืจืกื•ื ืขืœ ืชืคื™ืกืช ื”ืžื•ืชื’

A METHOD FOR MEASURING THEIMPACT OF ADVERTISING ONBRAND PERCEPTION

RUTHIE ืจื•ืชื™ ื‘ืจื ื“ืžืŸ BRANDMAN07/03/200861/064479US

Page 81: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200981

)2009.01 (G02B19741705/03/2009

ื”ืชืงืŸ ืื•ืคื˜ื™ ื•ืฉื™ื˜ื” ืœืชื™ืงื•ืŸ ืื‘ืจืฆื™ื•ืช ื›ืจื•ืžื˜ื™ื•ืช

OPTICAL DEVICE AND METHOD FORCORRECTING CHROMATICABERRATIONS

ืื•ืคื˜ื™ืงื”-ื™ื˜ ืžืขืจื›ื•ืช ืืœืงื˜ืจื•ืืœื‘ืž"ืืœืื•ืค ื‘ืข

ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD

)2009.01 (G01C19741905/03/2009

INERTIAL ืชืฆื•ืจืช ืžื›ืœื•ืœ ื—ื™ื™ืฉืŸ ืื™ื ืจืฆื™ืืœื™ SENSOR ASSEMBLYCONFIGURATION

ืื•ืคื˜ื™ืงื”-ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ืืœืงื˜ืจื•ืž"ืืœืื•ืค ื‘ืข

ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD

)2009.01 (C07D19742015/10/2007

โ€“4(โ€“3[โ€“4ืฆื•ืจื” ืคื•ืœื™ืžื•ืจืคื™ืช ืฉืœโ€“1โ€“ืคื™ืคืจืื–ื™ืŸโ€“ืฆื™ืงืœื•ืคืจื•ืคืื ืงืืจื‘ื•ื ื™ืœ

โ€“H2โ€“]ื‘ื ื–ื™ืœโ€“ืคืœื•ืื•ืจื•โ€“4โ€“)ืงืืจื‘ื•ื ื™ืœ ืื—ื“โ€“1โ€“ืคืชืืœืื–ื™ืŸ

POLYMORPHIC FORM OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1- CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONEKUDOS PHARMACEUTICALSLIMITED

17/10/200660/829694USPCT/GB/2007/003888WO/2008/047082

)2009.01 (H04B19742109/09/2007

ACCESS ืžื›ืื ื™ื–ื ืœืชื›ื ื•ืŸ ื ืงื•ื“ืช ื’ื™ืฉื” POINT PLANNINGMECHANISM

DESIGNARTืž"ื“ื–ื™ื™ื ืืจื˜ ื ื˜ื•ื•ืจืงืก ื‘ืข NETWORKS LTD08/09/200660/843183US15/01/200711/623110US

PCT/IL/2007/001108WO/2008/029411

Page 82: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 82

)2009.01 (H04B19742209/09/2007

POINT-TO-POINT ืฉื™ื˜ืช ืชืงืฉื•ืจืช ืžื ืงื•ื“ื” ืœื ืงื•ื“ื” COMMUNICATIONMETHOD

DESIGNARTืž"ื“ื–ื™ื™ื ืืจื˜ ื ื˜ื•ื•ืจืงืก ื‘ืข NETWORKS LTD08/09/200660/843079US18/01/200711/624232US

PCT/IL/2007/001109WO/2008/029412

)2009.01 (H03C19742309/09/2006

ืฉื™ื˜ืช ืชืงืฉื•ืจืช ืžื ืงื•ื“ื” ืœื ืงื•ื“ื” ืขื ืฉื™ื›ื•ืš ื”ืคืจืขื”

POINT-TO-POINT COMMUNICATIONMETHOD WITH INTERFERENCEMITIGATION

DESIGNARTืž"ื“ื–ื™ื™ื ืืจื˜ ื ื˜ื•ื•ืจืงืก ื‘ืข NETWORKS LTD08/09/200660/843079US17/01/200711/623774US

PCT/IL/2007/001110WO/2008/029413

)2009.01 (G01N19742405/03/2009

SPRื–ื™ื”ื•ื™ ืฉื™ื™ืจื™ื ืขืœ ื™ื“ื™DETECTION OF ANALYTES BYSURFACE PLASMON RESONANCESPECTROSCOPY

ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™ืชื•ื— ื”ืžื—ืงืจ ืฉืœ ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ืื”ืื•ื ื™ื‘

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM

)2009.01 (G06F19742501/11/2007

HEALTH ื”ืžืฉืœื‘ืช ื‘ืจื™ืื•ืชAPIืชื•ื›ื ื™ืช INTEGRATION PLATFORMAPIMICROSOFT CORPORATION

01/11/200660/863897US08/05/200711/745902US

PCT/US/2007/083395WO/2008/057973

Page 83: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200983

)2009.01 (A61K19742611/09/2007

ืžืขื›ื‘ื™ ื”ื™ืกื˜ื•ืŸ ื“ืืฆื˜ื™ืœืื– ืขื ืคืขื™ืœื•ืชIืžืฉื•ืœื‘ืช ืขืœ ื”ื™ืกื˜ื•ืŸ ื“ืืฆื˜ื™ืœืื–ื™ื ืžืกื•ื’

ื‘ืฉื™ืœื•ื‘ ืขื ืžืขื›ื‘ื™ ืคืจื•ื˜ื™ืื–ื•ืIIBื•ืžืกื•ื’

HISTONE DEACETYLASEINHIBITORS WITH COMBINEDACTIVITY ON CLASS-I AND CLASS-IIB HISTONE DEACETYLASES INCOMBINATION WITH PROTEASOMEINHIBITORSJANSSEN PHARMACEUTICA, N.V.

15/09/200606120726.2EP03/05/200760/915895US

PCT/EP/2007/059518WO/2008/031817

)2009.01 (B26B19742706/09/2007

ื•ื— ืจื˜ื•ื‘ ื”ืžื›ื™ืœื” ืกื™ื™ืข ื’ื™ืœื•ื— ืžืขืจื›ืช ืœื’ื™ืœ ื”ืžืฆื•ืคื” ื‘ืฉืžืŸ ืžื™ื ืจืœื™

WET SHAVING SYSTEM INCLUDINGA MINERAL OIL COATED SHAVINGAIDTHE GILLETTE COMPANY

13/09/200611/520388USPCT/IB/2007/053598WO/2008/032242

)2009.01 (B26B19742806/09/2007

BLADE ื›ื•ืช ื’ื™ืœื•ื—ืชื•ืžื›ื™ ืœื”ื‘ ืœืฉื™ืžื•ืฉ ื‘ืžืขืจ SUPPORTS FOR USE INSHAVING SYSTEMS

THE GILLETTE COMPANY15/09/200611/521819US

PCT/IB/2007/053599WO/2008/032243

)2009.01 (B64D19742924/09/2007

DETECTING ื’ื™ืœื•ื™ ื—ืœืงื™ืงื™ ืงืจื— ICE PARTICLESROSEMOUNT AEROSPACE INC.

25/09/200660/826827USPCT/US/2007/079328WO/2008/051673

Page 84: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 84

)2009.01 (B24C19743011/09/2007

METHOD ืฉื™ื˜ื” ืœืืœื•ื— ืžืฉื˜ื—ื™ื OF DOPING SURFACESENBIO LIMITED

11/09/20062006/0669IE06/04/200760/910464US

PCT/US/2007/078197WO/2008/033867

)2009.01 (A23L19743106/09/2007

FOOD ืชื›ืฉื™ืจ ืžื–ื•ืŸ COMPOSITIONKRAFT FOODS GLOBAL BRANDSLLC

11/09/20060607937FRPCT/FR/2007/051884WO/2008/031970

)2009.01 (C07K19743207/09/2007

ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื”ื’ื•ืจืžื™ื ืœื”ืคืจืฉืช ืžื™ืื•ืช ื•ื”ืคืจืฉืช ื ืชืจืŸ ื“ืจืš ื”ืฉืชืŸ ืœืœื ืคืขื™ืœ

ืœื”ืจื—ื‘ืช ื›ืœื™ ื”ื“ื

AQUARETIC AND NATRIURETICPOLYPEPTIDES LACKINGVASODILATORY ACTIVITY

MAYO FOUNDATION FOR MEDICALEDUCATION AND RESEARCH

08/09/200660/825028USPCT/US/2007/077900WO/2008/031045

)2009.01 (A23L19743306/09/2007

FILLINGS ืžื™ืœื•ื™ื™ืKRAFT FOODS GLOBAL BRANDSLLC

11/09/20060607936FRPCT/FR/2007/051886WO/2008/031972

Page 85: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200985

)2009.01 (H04N19743401/08/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืฉื™ื“ื•ืจ ืชืžื•ื ื•ืช ืžืื™ื–ื•ืจ ื ื‘ื“ืง

METHOD AND SYSTEM FORTRASMISSION OF IMAGES FROM AMONITORED AREA

MTEYEื‘ืขืื‘ื˜ื— MTEYEืž"ื” SECURITY LTD07/09/200611/516614US

PCT/IL/2007/000963WO/2008/029385

)2009.01 (A61L19743503/09/2007

ืœื‘ื•ืฉ ื•ื—ื•ืžืจื™ื ืจืคื•ืื™ื™ื ื•ื›ื™ืจื•ืจื’ื™ื™ืื”ืžืฉื•ืœื‘ื™ื ืขื ื ื•ื–ืœื™ื ืžืขื•ื‘ื™ื ื”ืžื•ื ืขื™ื

ื—ื“ื™ืจื”

SURGICAL AND MEDICALGARMENTS AND MATERIALSINCORPORATING SHEARTHICKENING FLUIDSREGENT MEDICAL LIMITED

05/09/2006GB0617452.8

GB

PCT/GB/2007/003310WO/2008/029101

)2009.01 (G01J19743605/09/2007

PHOTODETECTOR ื’ืœืื™ ืื•ืจHAMAMATSU PHOTONICS K.K.

06/09/20062006-241797

JP

PCT/JP/2007/067297WO/2008/029840

)2009.01 (H03M19743705/09/2007

AD ื“ื™ื’ื™ื˜ืœื™ ื•ื—ื™ื™ืฉืŸ ืื•ืคื˜ื™โ€“ืžืขื’ืœ ืžืžื™ืจ ืื ืœื•ื’ื™ CONVERTER CIRCUIT ANDOPTICAL SENSORHAMAMATSU PHOTONICS K.K.

06/09/20062006-241818

JP

PCT/JP/2007/067302WO/2008/029841

Page 86: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 86

)2009.01 (B32B19743801/03/2007

ืฉื›ื‘ืชื™ืชโ€“ืžืขืจื›ืช ืžื‘ื•ื“ื“ืช ืชืื™ืช ืจื‘UVืขืฉื•ื™ื” ืžื—ื•ืžืจ ืขืžื™ื“ ื ื’ื“

UV RESISTANT MULTILAYEREDCELLULAR CONFINEMENT SYSTEM

ื‘ืข.ืืก.ืืจ.ืคื™ .P.R.Sืž"ืžื“ื™ื˜ืจื ื™ื™ืŸ MEDITERRANEAN LTD.

PCT/US/2007/063081WO/2008/105876

)2009.01 (C08L19743901/03/2007

ื—ืคืฅ ื’ื™ืื•ืกื™ื ื˜ื˜ื™ ื‘ืขืœ ื‘ื™ืฆื•ืขื™ื ื‘ืจืžื” ื’ื‘ื•ื”ื”

HIGH PERFORMANCEGEOSYNTHETIC ARTICLE

ื‘ืข.ืืก.ืืจ.ืคื™ .P.R.Sืž"ืžื“ื™ื˜ืจื ื™ื™ืŸ MEDITERRANEAN LTD.

PCT/US/2007/063084WO/2008/105878

)2009.01 (C07D19744010/09/2007

ืคื•ื ืงืฆื™ื•ื ืืœื™ื•ืชโ€“ืžื•ืœืงื•ืœื•ืช ืงื˜ื ื•ืช ืžื•ืœื˜ื™ื ื ื’ื“ ื”ืชืจื‘ื•ืชื›ืกื•ื›ื ื™

MULTI-FUNCTIONAL SMALLMOLECULES AS ANTI-PROLIFERATIVE AGENTSCURIS, INC.

11/09/200660/843590US20/03/200760/895889US

PCT/US/2007/077971WO/2008/033747

)2009.01 (A61K19744114/09/2007

1HMGBโ€“ืžAโ€“BOXืชืœื›ื™ื“ื™ ืคื•ืœื™ืžืจ ืฉืœืฉืœื• Aโ€“BOXื•ืจื™ืื ื˜ื™ื Nโ€“ 1HMGB

POLYMER CONJUGATES OF BOX-AOF HMGB1 AND BOX-A VARIANTSOF HMGB1CREABILIS THERAPEUTICS S.P.A.

15/09/200606019362.0EP05/03/200760/904776US

PCT/EP/2007/008029WO/2008/031612

Page 87: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200987

)2009.01 (C12P19744206/09/2007

FUSION ื”ืจื›ื‘ื™ื ืชืจืคื™ื•ื˜ื™ื™ื ืฉืœ ื—ืœื‘ื•ื ื™ ืื™ื—ื•ื™ PEPTIDE THERAPEUTICCOMPOSITIONSPHASEBIO PHARMACEUTICALS,INC.

06/09/200660/842464USPCT/US/2007/077767WO/2008/030968

)2009.01 (A61F19744307/09/2007

THERMAL ื›ื™ืกื•ื™ ืชืจืžื™ COVERINGWYETH

08/09/200660/843119USPCT/IB/2007/053620WO/2008/029378

)2009.01 (C12N19744413/09/2007

CELL ืฉื™ืคื•ืจื™ื ื‘ืชืจื‘ื™ืช ืชืื™ื CULTURE IMPROVEMENTSABBOTT LABORATORIES

13/09/200660/845158US21/12/200660/876374US

PCT/US/2007/020027WO/2008/033517

)2009.01 (C07D19744506/09/2007

,1,2ืชื”ืœื™ื›ื™ื ืœื”ื›ื ืช ื—ื•ืžืฆื•ืช ื‘ื ื–ื•ืื™ื•ืช ืื•ืงืกื“ื™ืื–ื•ืœโ€“4

PROCESSES FOR THE PREPARATIONOF 1,2,4-OXADIAZOLE BENZOICACIDSPTC THERAPEUTICS, INC

08/09/200660/843595USPCT/US/2007/019561WO/2008/030570

Page 88: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 88

)2009.01 (A61F19744626/07/2007

ืขื™ืฆื•ื‘ ืžื•ื“ื•ืœืจื™ ืฉืœ ืžื›ืฉื™ืจ ื‘ื“ื™ืงื” ื ื™ืชื•ื—ื™ ืฉืœ ื”ืขื™ื ื™ื™ื

MODULAR DESIGN FOROPHTHALMIC SURGICAL PROBE

ALCON, INC.31/10/200611/554812US

PCT/US/2007/074433WO/2008/054900

)2009.01 (A61K19744710/09/2007

ืง ื™ื ืื– ื”ืžื›ื™ืœื™ื ืืชืจ ืงื•ืฉืจ ืžืขื›ื‘ื™ ื˜ื™ืจื•ื–ื™ืŸ ืื‘ืฅ

TYROSINE KINASE INHIBITORSCONTAINING A ZINC BINDINGMOIETYCURIS, INC.

11/09/200660/843730US20/03/200760/895901US

PCT/US/2007/077970WO/2008/033746

)2009.01 (A61K19744812/09/2007

ื’ืœืงืžื™ื™ื ืฉื™ื˜ื•ืช ืœืžืชืŸ ืกื•ื›ื ื™ื ื”ื™ืคื• ืžืžื•ืฉื›ื™ื

METHODS FOR ADMINISTERINGLONG-LASTING HYPOGLYCEMICAGENTSSMITHKLINE BEECHAMCORPORATION

13/09/200660/825472US04/12/200660/868391US

PCT/US/2007/078226WO/2008/033888

Page 89: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200989

)2009.01 (B65D19744906/09/2007

ืœ ืคื™ืœืžื™ื ื”ืžื›ื™ืœื™ื ื—ื•ืžืจ ืคืขื™ืœ ืืจื™ื–ื” ื•ืฉื™ื˜ื” ืœื”ื›ื ืชื

PACKAGING FOR ACTIVE SUBSTANCE-CONTAINING FILMS AND METHOD FORPRODUCING THEMLTS LOHMANN THERAPIE-SYSTEMEAG

07/09/2006102006041921.9DEPCT/EP/2007/007333WO/2008/028560

)2009.01 (C12Q19745019/09/2007

, ืกืžื ื™ื ื‘ื™ื•ืœื•ื’ื™ื™ื ืฉืœ ืžืืคื ื ื™ ืžื˜ืจื”ื•, ื™ืขื™ืœื•ืช RAFืื• ื ื™ื‘ื•ื™ ืœืžืขื›ื‘ื™/ืื‘ื—ื ื”

BIOMARKERS OF TARGETMODULATION, EFFICACY,DIAGNOSIS AND/OR PROGNOSISFOR RAF INHIBITORSNOVARTIS AG

19/09/200660/845601USPCT/US/2007/078946WO/2008/082730

)2009.01 (C07D19745110/09/2007

ืžื‘ื•ืกืกื™ ืงื•ื•ื™ื ืื–ื•ืœื™ืŸEGFRืžืขื›ื‘ื™ ื”ืžื›ื™ืœื™ื ืืชืจ ื”ืงื•ืฉืจ ืื‘ืฅ

QUINAZOLINE BASED EGFRINHIBITORS CONTAINING A ZINCBINDING MOIETYCURIS, INC.

11/09/200660/843644US20/03/200760/895873US

PCT/US/2007/077977WO/2008/033749

Page 90: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 90

)2009.01 (C07D19745210/10/2007

ื”ื›ื ืชืŸ, ื ื’ื–ืจื•ืช ืื™ืžื™ื“ืื–ื•ืœื•ืŸ ื—ื“ืฉื•ืชื”ืจื›ื‘ื™ื ืคืจืžืฆื‘ื˜ื™ื™ื ื•ืฉื™ืžื•ืฉ, ื›ืชืจื•ืคื•ืช

ื‘ืžื™ื•ื—ื“, ื‘ื”ืŸ ื›ืžืขื›ื‘ื™ ืคืจื•ื˜ืื™ืŸ ืงื™ื ืื–7CDC

NEW IMIDAZOLONE DERIVATIVES,PREPARATION THEREOF AS DRUGS,PHARMACEUTICAL COMPOSITIONS,AND USE THEREOF AS PROTEINKINASE INHIBITORS, INPARTICULAR CDC7SANOFI-AVENTIS

12/10/20060608924FRPCT/FR/2007/001651WO/2008/046982

)2009.01 (A47J19745308/03/2009

ืžื›ืฉื™ืจ ืœื”ืจืžืช ืžื•ืฉื‘ ืืกืœื” ืœืœื ืžื’ืข ื™ื“ ืื“ื

A HANDS-FREE TOILET SEATLIFTING DEVICE

EREZ ืืจื– ื‘ื•ืจื•ื›ื•ื‘ BOROCHOV14/07/200861/080280US

)2009.01 (B65D19745408/03/2009

A ืคืขืžื™ ืœื›ื•ืกื™ืช ื˜ืงื™ืœื”โ€“ืžื›ืกื” ื—ื“ SINGLE-USE COVER FOR SHOT-GLASS

HAGAI ื—ื’ื™ ืคื•ืœื™ืฉื•ืง POLISHUK

)2009.01 (G08B19745509/10/2006

ื›ืœื™ ืชื›ื ื•ืŸ, ืฉื™ื˜ื” ืœืงื‘ื™ืขืช ื›ื™ืกื•ื™ ื’ืœืื™ื”ืžืฉืชืžืฉื™ื ื•ืžืขืจื›ืช ื”ื’ื ืช ื’ื‘ื•ืœื•ืช

ื‘ืฉื™ื˜ื”

METHOD FOR DETERMININGSENSOR COVERAGE, A DESIGNTOOL AND A BORDER PROTECTIONSYSTEM USING THE METHODTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

PCT/NO/2006/000349WO/2008/044933

Page 91: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200991

)2009.01 (G08B19745609/10/2006

ืœ ืงื‘ื™ืขืช ืื™ื•ื ื ื’ื“ ื’ื‘ื•ืœืฉื™ื˜ื” ื•ืžืขืจื›ืชMETHOD AND SYSTEM FORDETERMINING A THREAT AGAINSTA BORDERTELEFONAKTIEBOLAGET LMERICSSON (PUBL)

PCT/NO/2006/000350WO/2008/044934

)2009.01 (G03B19745721/09/2007

MIRROR ืžื ื™ืข ืžืจืื” ืขื‘ื•ืจ ืžืฆืœืžื” DRIVE FOR A CAMERAROLLEI GMBH

21/09/2006102006045599.1DEPCT/DE/2007/001732WO/2008/034439

)2009.01 (A01N19745810/09/2007

A ื—ื•ืžืจ ืœื”ื“ื‘ืจืช ืžื–ื™ืงื™ื ื‘ืฆื•ืจืช ืชืจื—ื™ืฃ PEST CONTROL AGENT IN THEFORM OF A SUSPENSIONNIPPON SODA COMPANY LTD.

12/09/20062006-246658

JP

PCT/JP/2007/067584WO/2008/032671

Page 92: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 92

)2009.01 (A61K19745910/09/2007

ื•ืฉื™ื˜ื•ืช, ื›ื•ืœืœ ื ื•ื’ื“ื ื™ื, ื—ืœื‘ื•ื ื™ื ืžืื•ื ืฉื™ื ืœื”ื›ื ืชื

HUMANIZED PROTEINS, INCLUDINGANTIBODIES AND METHODS FORPRODUCING THE SAMEGLYCOTOPE GMBH

10/09/200606090162.6EP18/09/200606090171.7EP13/10/200606090190.7EP04/05/200707090094.9EP

PCT/EP/2007/007877WO/2008/028686

)2009.01 (H04L19746025/10/2007

ืžืขืงื‘ ืื—ืจ ื ืชื•ื ื™ ืžืฆื‘ ืžืฉืชื ื™ื ืœืกื™ื™ืข ื‘ืื‘ื˜ื—ืช ืจืฉืช ืžื—ืฉื‘

TRACKING CHANGING STATE DATATO ASSIST IN COMPUTER NETWORKSECURITYARCSIGHT, INC.

25/10/200660/862932US24/10/200711/923502US

PCT/US/2007/082560WO/2008/052133

)2009.01 (G06F19746125/10/2007

ื–ื™ื”ื•ื™ ื‘ื–ืžืŸ ืืžืช ืฉืœ ืžื•ื“ืœ ื ื›ืก ื•ืกื™ื•ื•ื’ ืฉืœ ื ื›ืก ืœืกื™ื™ืข ื‘ืื‘ื˜ื—ืช ืจืฉืช ืžื—ืฉื‘ื™ื

REAL-TIME IDENTIFICATION OF ANASSET MODEL ANDCATEGORIZATION OF AN ASSET TOASSIST IN COMPUTER NETWORKSECURITYARCSIGHT, INC.

25/10/200660/862930US24/10/200711/923513US

PCT/US/2007/082562WO/2008/052135

Page 93: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200993

)2009.01 (A46B19746204/07/2007

ื ื™ืงื•ื™ ื‘ืฆื•ืจืช ืคืก ืฉื›ื‘ืชื™ ืงื˜ื™ืคืชื™ ื™ื—ื™ื“ืชืขื‘ื•ืจ ื™ื™ืฆื•ืจ ืžื‘ืจืฉื•ืช ืกื™ื‘ื•ื‘ื™ื•ืช

ืœืžืขืจื›ื•ืช ืฉื˜ื™ืคืช ืžื›ื•ื ื™ื•ืช

VELVETY LAMINAR STRIP CLEANINGELEMENT FOR MAKING ROTARYBRUSHES FOR MOTOR VEHICLEWASHING SYSTEMSFAVAGROSSA EDOARDO S.R.L.

12/09/2006MI2006A001742ITPCT/IT/2007/000481WO/2008/032344

)2009.01 (B82B19746308/03/2009

THIN-LAYERED ืžื‘ื ื” ืขื ืฉื›ื‘ื•ืช ื“ืงื•ืช STRUCTUREACKTARืž"ืืงื˜ืจ ื‘ืข LTD.

)2009.01 (A61K19746408/03/2009

FOAMABLE ืชื›ืฉื™ืจ ื˜ื•ืคื™ืงืœื™ ืžื•ืงืฆืฃ TOPICAL COMPOSITIONืชืจื™ืžื” ืชื•ืฆืจื™ ืจืคื•ืื” ื™ืฉืจืืœื™ื™ื ืžืขื‘ืจื•ืช

ืž"ื‘ืขTRIMA ISRAEL PHARMACEUTICALPRODUCTS MAABAROT LTD.

)2009.01 (A61F19746505/09/2007

PELVIC ื”ืชืงืŸ ืชืžื™ื›ื” ืœืื’ืŸ ANCHOR BRACEKOALAืž"ืงื•ืืœื” ืื‘ื™ื–ืจื™ ื‘ืจื™ืื•ืช ื‘ืข HEALTH ACCESSORIES LTD

07/09/200660/842663US20/02/200760/902047US

PCT/IL/2007/001099WO/2008/029404

Page 94: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 94

)2009.01 (F02B19746610/09/2007

ืžืขืจื›ืช ื•ืžืชื•ื“ื•ืœื•ื’ื™ื” ืœื™ื™ืฆื•ืจ ื—ืฉืžืœ ืขืœ ื™ื“ื™ืฉื™ืžื•ืฉ ื‘ืžื ื•ืข ื—ื•ื ื›ื™ืžื™ ื•ื—ื•ืžืจ

ืคื™ื™ื–ื•ืืœืงื˜ืจื™

SYSTEM AND METHODOLOGY FORGENERATING ELECTRICITY USINGA CHEMICAL HEAT ENGINE ANDPIEZOELECTRIC MATERIALPEACOCK, KIMBERLY

08/09/200611/530147USPCT/US/2007/078031WO/2008/031096

)2009.01 (G02C19746712/09/2007

MECHANICAL ืฆื™ืจ ืžื›ื ื™ ืื•ื ื™ื‘ืจืกืœื™ UNIVERSAL HINGECHIC OPTIC, INC.

12/09/200611/531180USPCT/CA/2007/001594WO/2008/031204

)2009.01(A61K19746810/09/2007

ืชื›ืฉื™ืจื™ ืงืฆืฃ ื˜ื•ืคื™ืงืœื™ื™ื ืฆื‘ื•ืขื™ื ื•ื ื™ืชื ื™ื ืœืฆื‘ื™ืขื”

COLORED OR COLORABLEFOAMABLE COMPOSITION ANDFOAM

FOAMIXืž"ืคื•ืืžื™ืงืก ื‘ืข LTD08/09/200660/843144US

PCT/IB/2007/003351WO/2008/032212

)2009.01 (F16F19746913/09/2007

ื›ื—ืžืชืงืŸ ื—ื™ ื•ืžืฉื›ืš, ื›ื•ืš ืœืฉืœื™ื˜ื” ืขืœ ื—ื™ื›ื•ืš ื”ืžื›ื™ืœ ืืช ื”ืžืชืงืŸ

FRICTION DEVICE FORCONTROLLING FORCE, AND AFRICTION DAMPER COMPRISINGSUCH A DEVICEMESSIER-DOWTY SA

14/09/20060653744FRPCT/FR/2007/051931WO/2008/031998

Page 95: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200995

)2009.01 (A61K19747011/09/2007

ืœื™ื™ืฆื•ืจ ืื™ื ืกื•ืœื™ืŸ ื‘ืฆื•ืจืช ืฉืœ ืชื›ืฉื™ืจ ืฉื™ื˜ื” ืื•ืจืœื™

METHOD FOR PRODUCING INSULININ THE FORM OF AN ORALPREPARATIONCONCERN 03" COMPANY LIMITED

13/09/20062006132763RUPCT/RU/2007/000483WO/2008/033058

)2009.01 (A61F19747103/11/2002

NON-PENETRATINGืจื ื™ืชื•ื— ืกื™ื ื•ืŸ ืœื ื—ื•ื“ FILTRATIONSURGERY

Iืž"ืื™ื™ ืื•ืคื˜ื™ืžื” ื‘ืข OPTIMA LTD.15/11/200160/331402US

PCT/IL/2002/000872WO/2003/041623

)2009.01 (C01B19747213/09/2007

ืฉื™ื˜ื” ื•ืžืชืงืŸ ืœืงื‘ืœืช ืกื™ืœื™ืงื•ืŸ ื˜ื”ื•ืจPROCESS AND APPARATUS FORPURIFYING LOW-GRADE SILICONMATERIALSILICIUM BECANCOUR INC.

14/09/200660/844372USPCT/CA/2007/001646WO/2008/031229

)2009.01 (A61K19747308/03/2009

ืืกื˜ืจื™ื ืคืจื•ื“ืจื’ื™ื ื’ืœื•ืงื•ืจื•ื ื™ื“ื™ื ืฉืœืจื”ืฆื™ืงืœื™ื ื™ื ื•ืฉื™ื˜ื” ืœื”ื›ื ื” ื•ืฉื™ืžื•ืฉ'ืื ืช

ื‘ื›ื™ืžื•ืชืจืคื™ื” ืฉืœ ื’ื™ื“ื•ืœ ืกืœืงื˜ื™ื‘ื™

ESTERS OF GLUCURONIDEPRODRUGS OF ANTHRACYCLINESAND METHOD OF PREPARATIONAND USE IN TUMOR-SELECTIVECHEMOTHERAPYPHARMACHEMIE B.V.

07/03/200808004249.2EP

Page 96: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 96

)2009.01 (A61K19747417/10/2007

LONG-TERM ื”ื–ื ื” ืœื˜ื•ื•ื— ืืจื•ืš ืฉืœ ื”ืžืขื™ ืขื‘ื•ืจ ืชื—ื–ื•ืงื” ENTERAL FEED FORMAINTENANCENESTEC S.A.

19/10/200660/862168USPCT/EP/2007/061086WO/2008/046857

)2009.01 (A23L19747517/10/2007

LONG-TERM ื”ื–ื ื” ืœื˜ื•ื•ื— ืืจื•ืš ืฉืœ ืงืฉื™ืฉื™ื FEED-ELDERLYNESTEC S.A.

19/10/200660/862156USPCT/EP/2007/061098WO/2008/046865

)2009.01 (A23L19747617/10/2007

LONG-TERM ื”ื–ื ื” ืœื˜ื•ื•ื— ืืจื•ืš ืฉืœ ืงืฉื™ืฉื™ื FEED-CANCERPATIENTNESTEC S.A.

19/10/200660/862159USPCT/EP/2007/061108WO/2008/046870

)2009.01 (G06F19747708/03/2009

, ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื–ื™ื”ื•ื™ ืงื‘ืฆื™ื ืžื–ื™ืงื™ืืœื•ื™ ื•ื ื™ื˜ื•ืจ ืจืฆืคื™ื ื”ืžื‘ื•ืกืกื•ืช ืขืœ ื’ื™

ืื•ืคื™ื™ื ื™ื™ื ืฉืœ ืงืจื™ืื•ืช ืžืขืจื›ืช ื”ืคืขืœื”

SYSTEM AND METHOD FORDETECTING NEW MALICIOUSEXECUTABLES, BASED ONDISCOVERING AND MONITORINGOF CHARACTERISTIC SYSTEM CALLSEQUENCES

ื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

Page 97: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200997

)2009.01 (G06F19747807/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืฉืœื˜ ืจื—ื•ืง, ื™ื—ื™ื“ืช ืžืžืฉืง ืœืžื—ืฉื‘

COMPUTER REMOTE CONTROLMODULE, INTERFACE, SYSTEM ANDMETHODPOWERDESK LTD.

07/09/20060617583.0GB07/09/200660/843285US

PCT/GB/2007/003413WO/2008/029174

)2009.01 (C07K19747902/10/2007

ื ื•ื’ื“ื ื™ื ืžืื•ื ืฉื™ื ื‘ืขืœื™ ื–ื™ืงื” ื’ื‘ื•ื”ื” ืžืื•ื ืฉILโ€“4ืœืงื•ืœื˜ืŸ

HIGH AFFINITY HUMANANTIBODIES TO HUMAN IL-4RECEPTORREGENERON PHARMACEUTICALS,INC.

02/10/200660/848694US24/08/200760/957738US

PCT/US/2007/021210WO/2008/054606

)2009.01 (H04W19748003/10/2007

ืฉื™ื“ื•ืจ ืื•ืชื•ืช ื’ื™ืฉื” ืืงืจืื™ืช ืžืื•ืชืช ืขื‘ื•ืจ ื’ื™ืฉืช ืžืขืจื›ืช ื‘ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

RANDOM ACCESS SIGNALINGTRANSMISSION FOR SYSTEMACCESS IN WIRELESSCOMMUNICATIONQUALCOMM INCORPORATED

03/10/200660/828058USPCT/US/2007/080319WO/2008/042967

Page 98: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 98

)2009.01 (H04B19748101/10/2007

ืกื ื›ืจื•ืŸ ืฉื™ื“ื•ืจื™ื ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

SYNCHRONIZATIONTRANSMISSIONS IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

03/10/200660/828051USPCT/US/2007/080111WO/2008/042865

)2009.01 (H04L19748229/11/2001

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืชื™ืงื•ืฃ ื”ืงืฆื‘ ื”ืžื–ื•ื”ื” ืฉืœืžืกื’ืจื•ืช ื“ื™ื‘ื•ืจ ื ื›ื ืกื•ืช ื‘ืขืœื•ืช ืงืฆื‘

ืžืฉืชื ื”

METHOD AND SYSTEM FORVALIDATING DETECTED RATES OFRECEIVED VARIABLE RATE SPEECHFRAMESQUALCOMM INCORPORATED

04/12/200009/730147USPCT/US/2001/044574WO/2002/047316

)2009.01 (G01V19748310/10/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืฉื™ื“ื•ืจ ืกื“ืจืชื™ ื‘ื–ืžืŸ ืฉืœืื•ืชื•ืช ืงืœื™ื˜ื” ืฉืœ ืžืชืžืจื™ื

ืืœืงื˜ืจื•ืืงื•ืกื˜ื™ื

METHOD AND DEVICE FOR THE TIMESERIAL TRANSMISSION OF RECEPTIONSIGNALS OF ELECTROACOUSTICTRANSDUCERSATLAS ELEKTRONIK GMBH

30/10/2008102006051065.8DEPCT/EP/2007/008798WO/2008/052641

Page 99: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 200999

)2009.01 (C07D19748407/01/2003

โ€“ 3,1โ€“)ืื™ืœโ€“2โ€“ืื™ื ื“ื•ืœโ€“1H(โ€“7โ€“ืืžื™ื ื•โ€“5ื•โ€“2โ€“ืคื™ืจื™ื“ื™ืŸ]Bโ€“5,4ืื™ืžื™ื“ื–ื•โ€“ื“ื™ื”ื™ื“ืจื• โ€“ืื•ืŸ

7โ€“)1Hโ€“3โ€“ืžืชื™ืœโ€“2โ€“)ืื™ืœโ€“2โ€“ืื™ื ื“ื•ืœHโ€“ ืื™ืžื™ื“ื–ื•

]5,4โ€“B[ืื™ืœืืžื™ืŸ ืืฉืจ ื‘ื• ืื˜ื•ืžื™โ€“5โ€“ืคื™ืจื™ื“ื™ืŸื•ืชื›ืฉื™ืจื™BOCื”ื—ื ืงืŸ ืžื•ื’ื ื™ื ื‘ืงื‘ื•ืฆื•ืช ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชื

5-AMINO-7-(1H-INDOL-2-YL)-1,3-DIHYDRO-IMIDAZOL[4,5-b]PYRIDIN-2-ONE AND ITS N- BOC PROTECTED-7-(1H-INDOL-2-YL)-2-METHYL-3H-IMIDAZO[4,5-b]PYRIDIN-5-YLAMINEAND PHARMACEUTICALCOMPOSITIONS COMPRISING THEM

EISAI R&D MANAGEMENT CO., LTD.07/01/200260/346598US

PCT/US/2003/000366WO/2003/057696

)2009.01 (A61K19748521/09/2007

ืœืžื ื™ืขืชDืฉื™ืžื•ืฉ ื‘ืชืจื›ื•ื‘ื•ืช ืฉืœ ื•ื™ื˜ืžื™ืŸ ื”ื™ื“ื‘ืงื•ื™ื•ืช

USE OF VITAMIN D COMPOUNDSFOR THE PREVENTION OFADHESIONSBIOXELL SPA

22/09/20060618700.9GB22/09/200660/846832IL

PCT/EP/2007/060068WO/2008/034908

)2009.01 (A61K19748612/10/2007

NOVEL ืฉื™ื˜ื” ื—ื“ืฉื” ืœื˜ื™ืคื•ืœ ื‘ืื™ืŸ ืื•ื ื•ืช ื’ื‘ืจื™ืช METHOD OF TREATMENT OFMALE SUB-FERTILITYBIOXELL SPA

13/10/20060620284.0GB13/10/200660/851683US

PCT/EP/2007/060923WO/2008/043857

Page 100: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 100

)2009.01 (G01N19748712/09/2007

IMPROVED ืฉื™ื˜ืช ืชื‘ื—ื™ืŸ ืื™ืžื•ื ื™ ืžืฉื•ืคืจื•ืช IMMUNOASSAYMETHODSONCIMMUNE LIMITED

13/09/200660/844158US13/09/20060618055.8GB

PCT/GB/2007/003486WO/2008/032084

)2009.01 (A23L19748817/09/2007

ื—ื™ืžื•ื ืžืื•ื–ืŸ ืฉืœ ืชืžื™ืกื” ื‘ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ืฉืื™ื ื ื–ื•ืจืžื™ื ื‘ื—ื•ืคืฉื™ื•ืช

BALANCING HEAT OF SOLUTION INNON-FREE FLOWING SWEETENERCOMPOSITIONSMCNEIL NUTRITIONALS, LLC

18/09/200611/532880USPCT/US/2007/020229WO/2008/036276

)2009.01 (C01F19748922/08/2007

ื˜ื™ื— ืงื™ืจื•ืช?โ€“ื•? ืชื”ืœื™ืš ืœื™ืฆื•ืจ ืชืขืจื•ื‘ืช ื‘ืขืœ ืขืงื‘ื™ื•ืช ื ืžื•ื›ื”

PROCESS FOR MANUFACTURINGULTRA LOW CONSISTENCY ? AND?-BLEND STUCCOUNITED STATES GYPSUM COMPANY

20/09/200611/533604USPCT/US/2007/018558WO/2008/036160

)2009.01 (A23L19749017/09/2007

ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ืžื’ื•ื‘ืฉื™ื ืฉืื™ื ื ื–ื•ืจืžื™ื ืงืœื•ืจื™ื•ืชโ€“ื‘ื—ื•ืคืฉื™ื•ืช ื”ืžื›ื™ืœื™ื ืจื›ื™ื‘ื™ื ื“ืœื™

COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSINCLUDING LOW-CALORIEINGREDIENTSMCNEIL NUTRITIONALS, LLC

18/09/200611/532885USPCT/US/2007/020220WO/2008/036270

Page 101: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009101

)2009.01 (A23L19749117/09/2007

SOLID ื™ื—ื™ื“ืช ืžื™ื ื•ืŸ ืžื•ืฆืงื” ืฉืœ ืชื›ืฉื™ืจื™ ื”ืžืชืงื” UNIT DOSE, SWEETENINGCOMPOSITIONSMCNEIL NUTRITIONALS, LLC

18/09/200611/532887USPCT/US/2007/020137WO/2008/036234

)2009.01 (A61B19749220/09/2007

ื”ืชืงืŸ ืœืžืชืŸ ื—ื•ืžืจ ื”ื ื™ืชืŸ ืœืขื™ืฆื•ื‘ ื”ืžื›ื™ืœ ื—ืœืง ืžืกืชื•ื‘ื‘ ืœืืกืคืงืช ื”ื—ื•ืžืจ

CURABLE MATERIAL DELIVERYDEVICE WITH A ROTATABLESUPPLY SECTIONALLEGIANCE CORPORATION

22/09/200611/526164USPCT/US/2007/020421WO/2008/039355

)2009.01 (A61B19749325/09/2007

HEAT ืงื‘ืœ ื—ื ืขื‘ื•ืจ ืžื—ื•ืœืœ ืชืจืกื™ืก ืงืคื™ืœืจื™ CAPACITOR FOR CAPILLARYAEROSOL GENERATORPHILIP MORRIS PRODUCTS S.A.

25/09/200611/526123USPCT/IB/2007/003701WO/2008/038144

)2008.04 (H04J19749419/05/2000

โ€“ืงื“ื™ืžื•ืช ื•ื‘ืงืจืช ื–ืจื™ืžื” ืฉืœ ืขืจื•ืฅ ืจื‘ ืžืฉืชืžืฉื™ื

PRIORITIZATION AND FLOWCONTROL OF A SPREADSPERCTRUM MULTIUSER CHANNELINTERDIGITAL TECHNOLOGYCORPORATION

20/05/199960/135073USPCT/US/2000/013918WO/2000/072608

Page 102: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 102

)2009.01 (C12N19749510/09/2007

ื• ืœืขื™ื›ื•ื‘siRNAsโ€“ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืชEBP?/C

COMPOSITIONS AND siRNAs FORINHIBITING C/EBP?

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

10/09/2006177989ILPCT/IL/2007/001112WO/2008/029414

)2009.01 (A61K19749625/09/2007

ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื ื”ืžื›ื™ืœื™ื ื ื™ืœื•ื˜ื™ื ื™ื‘ ืื• ืžืœื— ืฉืœื•

PHARMACEUTICAL COMPOSITIONSCOMPRISING NILOTINIB OR ITSSALTNOVARTIS AG

27/09/200606121371.6EPPCT/EP/2007/060165WO/2008/037716

)2009.01 (A61K19749714/09/2007

ืžืขืจื›ื•ืช ื”ื•ื‘ืœื” ืฉืœ ืื•ืœื™ื’ื•ื ืงืœืื•ื˜ื™ื“ ืœื ื•ื™ืจืืœื™

OLIGONUCLEOTIDE NON-VIRALDELIVERY SYSTEMS

FMC BIOPOLYMER AS15/09/200660/844729US

PCT/EP/2007/059740WO/2008/031899

)2009.01 (C08B19749805/09/2007

ื”ื™ืืœื•ืจื•ื ื™ืช ื”ืžื•ืฉื’ืช ืชื•ืœื“ื•ืช ื—ื•ืžืฆื”"ื›ื™ืžื™ื™ืช ื ืงื™ืฉื”"ื“ืจืš ืงื™ืฉื•ืจ ืžืฆื•ืœื‘ ืฉืœ

HYALURONIC ACID DERIVATIVESOBTAINED VIA CLICK CHEMISTRY'CROSSLINKINGFIDIA FARMACEUTICI S.P.A.

11/09/2006MI2006A001726ITPCT/EP/2007/007758WO/2008/031525

Page 103: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009103

)2009.01 (G07B19749909/03/2009

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื‘ื™ืฆื•ืข ืขื™ืกืงื•ืช ืืฉืจืื™ ืœืœื ืฆื•ืจืš ื‘ื›ืจื˜ื™ืก

METHOD AND SYSTEM FORPERFORMING CREDITTRANSACTIONS WITH NO CARD

YUVAL ื™ื•ื‘ืœ ืžื•ืกืงื•ื‘ื™ืฅ MOSCOVICH

)2009.01 (A61K19750021/09/2007

ืื™ื ื“ื•ืœื™ื–ื™ืŸ, ื ื’ื–ืจื•ืช ืฉืœ ืคื™ืจื•ืœื™ื–ื™ืŸื™ืื”ื›ื ืชืŸ ื•ืฉื™ืžื•ืฉื™ื”ืŸ ื”ืจืคื•ืื™, ื•ืงื•ื•ื™ื ื•ืœื™ื–ื™ืŸ

DERIVATIVES OF PYRROLIZINE,INDOLIZINE AND QUINOLIZINE,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS

22/09/20060608348FRPCT/FR/2007/001545WO/2008/037881

)2009.01 (A61K19750111/09/2007

ื ืžื•ื“ื™ืคื™ืงืฆื™ื•ืช ืฉืœ ืคืคื˜ื™ื“ื™ื ื ื’ื–ืจื™ ืžืงื•ืคืจื“ื•ืงืกื™ืŸ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื”ื

MODIFICATIONS OF CUPREDOXINDERIVED PEPTIDES AND METHODSOF USE THEREOFTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS

11/09/200660/843388USPCT/US/2007/078136WO/2008/033820

Page 104: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 104

)2009.01 (A61K19750211/09/2007

ื‘ โ€“ืคื™ืคืจื™ื“ื™ืŸโ€“ืืžื™ื ื•โ€“3ืโ—Œ(โ€“6โ€“2ืฉื™ืžื•ืฉโ€“3,4โ€“ื“ื™ืื•ืงืกื•โ€“2,4โ€“ืžืชื™ืœ3โ€“)ืื™ืœโ€“1

โ€“1โ€“ืคื™ืจื™ืžื™ื“ื™ืŸโ€“H2โ€“ื“ื™ื”ื™ื“ืจื•โ€“4โ€“ืื™ืœืžืชื™ืœ ื‘ื ื–ื•ื ื™ื˜ืจื™ืœโ€“ืคืœื•ืื•ืจื•

USE OF 2-6-(3-AMINO-PIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMET HYL-4-FLUORO-BENZONITRILE

TAKEDA PHARMACEUTICAL COMPANYLIMITED

13/09/2006PCT/US2006/035958US13/03/200760/894628US

PCT/US/2007/078177WO/2008/033851

)2009.01 (F41B19750309/03/2009

GUIDED ื˜ื™ืœ ืžื•ื ื—ื” MISSILEDIEHL BGT DEFENCE GMBH & CO. KG

13/03/2008102008014257.3DE

)2009.01 (C07C19750431/08/2007

ื ื’ื–ืจื•ืช ืื™ื–ื•ืกืจื™ืŸ ื›ืžืขื›ื‘ื™ ืคืงื˜ื•ืจ ืงืจื™ืฉื”IXa

ISOSERINE DERIVATIVES ASINHIBITORS OF COAGULATIONFACTOR IXaSANOFI AVENTIS

13/09/2006102006042926.5DEPCT/EP/2007/007613WO/2008/031509

)2009.01 (C07C19750531/08/2007

ื ื’ื–ืจื•ืช ื˜ืจื˜ืจื˜ ืœืฉื™ืžื•ืฉ ื›ืžืขื›ื‘ื™ ืคืงื˜ื•ืจIXaืงืจื™ืฉื”

TARTRATE DERIVATIVES FOR USE ASCOAGULATION FACTOR IXaINHIBITORSSANOFI AVENTIS

13/09/2006102006042927.3DEPCT/EP/2007/007612WO/2008/031508

Page 105: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009105

)2009.01 (C07D19750610/09/2007

NOVELืช ื—ื“ืฉื” ืฉืœ ื—ื•ืžืฆื” ืคื ื™ืœืืฆื˜ื™ืชื ื’ื–ืจ PHENYLACETIC ACIDDERIVATIVEFUJI YAKUHIN CO., LTD.

11/09/20062006-245194

JP

PCT/JP/2007/067568WO/2008/032665

)2009.01 (C07D19750710/09/2007

โ€“4ืชื•ืœื“ื•ืช ื“ื™ื‘ื ื–ื•ืคื•ืจืื ื™ื•ืช ื›ืžืขื›ื‘ื™PDE10โ€“ื•โ€“PDE

DIBENZOFURAN DERIVATIVES ASINHIBITORS OF PDE-4 AND PDE-10

MATRIX LABORATORIES LIMITED11/09/20061647/CHE/2006IN

PCT/IB/2007/002596WO/2008/032171

)2009.01 (A01N19750801/09/2007

OIL-BASED ืชืจื›ื™ื–ื™ ืชืจื—ื™ืคื™ื ืžื‘ื•ืกืกื™ ืฉืžืŸ SUSPENSIONCONCENTRATESBAYER CROPSCIENCE AG

15/09/2006102006043444.7DEPCT/EP/2007/007655WO/2008/031512

)2009.01 (A61K19750905/10/2007

ื• ืื• ืฉื™ืคื•ืจ ืฉืœ ืงืจื™ืฉื” ืชื•ืš/ื’ื•ืจื ืœื˜ื™ืคื•ืœ ืขื•ืจืงื™ืช ืžืชืคืฉื˜ืช

THERAPEUTIC AND/ORAMELIORATING AGENT FORDISSEMINATED INTRAVASCULARCOAGULATIONASAHI KASEI PHARMACORPORATION

06/10/20062006-274573

JP

PCT/JP/2007/069560WO/2008/044631

Page 106: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 106

)2009.01 (C07D19751002/10/2007

PROCESS ืชื”ืœื™ืš ืœื”ื›ื ืช ื ื‘ื™ื•ื•ืœื•ืœ FOR PREPARING NEBIVOLOLZACH SYSTEM S.P.A.

03/10/2006MI2006A001889ITPCT/EP/2007/008549WO/2008/040528

)2009.01 (A61F19751119/09/2007

ืฉืœโ€“ืคืจื™ื˜ ื—ื“ ืคืขืžื™ ื”ืžื›ื™ืœ ืคืกื•ืœืช ื•ืฉื™ืœื•ื‘ ื–ืžื ื™ืชโ€“ืฉื ื™ ืคืจื™ื˜ื™ื ื”ื ืœื‘ืฉื™ื ื‘ื•

A DISPOSABLE WASTECONTAINMENT ARTICLE AND ACOMBINATION OF TWO ARTICLESWORN SIMULTANEOUSLYTISTERON, LTD.

20/09/200660/845771US17/09/200711/901635US

PCT/US/2007/020264WO/2008/036296

)2009.01 (A61K19751210/10/2007

ื—ื™ืกื•ืŸ ื”ืžื›ื™ืœ ืชื•ืกืฃ ืฉื”ื ื• ืืžื•ืœืกื™ื™ืช ืฉืžืŸ ื‘ืžื™ื

VACCINE COMPRISING AN OIL INWATER EMULSION ADJUVANT

GLAXOSMITHKLINE BIOLOGICALS S.A.12/10/20060620336.8GB12/10/20060620337.6GB19/10/20060620815.1GB19/10/20060620816.9GB20/12/2006PCT/EP06/069977EP20/12/2006PCT/EP06/069979EP20/04/20070707697.9GB12/06/20070711357.4GB21/06/20070712062.9GB

PCT/EP/2007/060743WO/2008/043774

Page 107: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009107

)2009.01 (C07D19751314/09/2007

ืชื•ืœื“ื•ืช ืคื™ืจื–ื•ืœื•ืคื™ืจื™ืžื™ื“ื™ืŸ ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

PYRAZOLOPYRIMIDINEDERIVATIVES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAMEDAIICHI SANKYO COMPANY,LIMITED

19/09/20062006-253465

JP

PCT/JP/2007/067933WO/2008/035629

)2009.01 (C23C19751407/09/2007

ืžื›ืฉื™ืจ ื—ื™ืชื•ืš ืžืฆื•ืคื” ื•ืฉื™ื˜ื” ืœื”ื›ื ืชื•COATED CUTTING TOOL ANDMETHOD FOR THE PRODUCTIONTHEREOFSANDVIK INTELLECTUALPROPERTY AB

15/09/20060601950-9SEPCT/EP/2007/059376WO/2008/031768

)2009.01 (A61K19751515/09/2007

ืืกืคืงื” ืคื•ืœื™ืžืจื™ื•ืช ื”ืžื›ื™ืœื•ืช ืžืขืจื›ื•ืช ืคื•ืœื™ืืœืงื™ืœืŸ ืื•ืงืกื™ื“ื™ื

POLYMERIC DELIVERY SYSTEMSCONTAINING POLYALKYLENEOXIDESENZON PHARMACEUTICALS, INC.

15/09/200660/844942USPCT/US/2007/078593WO/2008/034119

Page 108: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 108

)2009.01 (A01N19751615/09/2007

ืคื•ืœื™ืžืจื™ื•ืช ืขืœ ื‘ืกื™ืก ืžืขืจื›ื•ืช ืืกืคืงื” ืืกื˜ืจ

ESTER-BASED POLYMERICDELIVERY SYSTEMS

ENZON PHARMACEUTICALS, INC.15/09/200660/845028US

PCT/US/2007/078597WO/2008/034122

)2009.01 (A61K19751715/09/2007

ืชืจื•ืคื•ืช ืคื•ืœื™ืžืจื™ื•ืช ืžื›ื•ื•ื ื•ืช ื”ืžื›ื™ืœื™ืโ€“ืคืจื•ื•ืฉโ€“ืžืงืฉืจื™ื ืจื‘ ื™ื˜ื•ืช ืœื”ื›ื ืชืืชื›ืœื™ืชื™ื™ื

TARGETED POLYMERIC PRODRUGSCONTAINING MULTIFUNCTIONALLINKERS AND METHODS OF USETHEREOFENZON PHARMACEUTICALS, INC.

15/09/200660/844943USPCT/US/2007/078600WO/2008/034124

)2009.01 (A61K19751812/10/2007

ื›ื™ืœื” ืื•ืœืžืกืจื˜ืŸ ืฆื•ืจืช ืžื™ื ื•ื™ ืžื•ืฆืงืช ื”ืž ืžื“ื•ืงืกื•ืžื™ืœ ื•ืืžืœื•ื“ื™ืคื™ืŸ

SOLID DOSAGE FORM OFOLMESARTAN MEDOXOMIL ANDAMLODIPINEDAIICHI SANKYO COMPANY,LIMITED

15/09/200660/845090USPCT/GB/2007/003933WO/2008/032107

Page 109: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009109

)2009.01 (A61K19751915/09/2007

ืžืจื™ื•ืช ืขืœ ื‘ืกื™ืก ืžืขืจื›ื•ืช ืืกืคืงื” ืคื•ืœื™ ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื, ืœื™ืกื™ืŸ

LYSINE-BASED POLYMERICDELIVERY SYSTEMS AND METHODSOF PRODUCING THE SAMEENZON PHARMACEUTICALS, INC.

15/09/200660/844945US27/11/200660/861349US13/04/200760/911734US

PCT/US/2007/078594WO/2008/034120

)2009.01 (A47J19752010/03/2009

ืžืชืงืŸ ืœื’ืœื™ืœื™ ื ื™ื™ืจ ื˜ื•ืืœื˜ ื”ืžื•ืจื›ื‘ ืžืชื—ืช ืœื›ื™ื•ืจ ืขืœ ืฆื™ื ื•ืจ ื”ื ื™ืงื•ื–

A TOILET PAPER ROLL DEVICEASSEMBLED UNDERNETH THE SINKON THE DRAINAGE PIPE

COHEN ืžืœื›ื” ื›ื”ืŸ MALKA04/02/200961/147764US

)2009.01 (B01F19752112/09/2007

ืฆื™ืคื•ื™ ืงืฆื” ื‘ืขืœ ืขืžื™ื“ื•ืช ืœืืฆื” ื•ืฉื™ื˜ื” ืœื”ื›ื ืชื•

ALGAE RESISTANT EDGE COATINGAND METHOD OF FORMING SAME

MUNTERS CORPORATION12/09/200611/518959US

PCT/US/2007/019750WO/2008/033354

Page 110: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 110

)2009.01 (B01J19752316/09/2007

ืื•ืจื’ื ื™ื ื”ืžืชืงื‘ืœื™ื ื—ืœืงื™ืงื™ืโ€“ื ื ื• ืืžื•ืœืกื™ื•ืช ืขืœ ื™ื“ื™ ืื™ื“ื•ื™ ื”ืžืžืกโ€“ืžืžื™ืงืจื•

ORGANIC NANOPARTICLESOBTAINED FROMMICROEMULSIONS BY SOLVENTEVAPORATION

ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™ืชื•ื— ื”ืžื—ืงืจ ืฉืœืž"ื”ืื•ื ื™ื‘ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ื ื‘ืข

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

14/09/200660/844365USPCT/IL/2007/001136WO/2008/032327

)2009.01 (A01N19752416/09/2007

ื—ืœืงื™ืงื™ื ืฉืœ ืงื•ื˜ืœื™ ืขืฉื‘ื™ืโ€“ื ื ื•โ€“ืืžื•ืœืกื™ื•ืช ื•ื ื ื•โ€“ื”ืžืชืงื‘ืœื™ื ืžืžื™ืงืจื•

ืืžื•ืœืกื™ื•ืช

PESTICIDE NANOPARTICLESOBTAINED FROMMICROEMULSIONS ANDNANOEMULSIONS

ื‘ืขืžื›ืชืฉื™ ืž"ื ืžืคืขืœื™ื ื›ื™ืžื™ื™ืYISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

14/09/200660/844366USPCT/IL/2007/001137WO/2008/032328

)2009.01 (A61B19752511/03/2009

ืฉื™ื˜ื” ื‘ืœืชื™ ืคื•ืœืฉื ื™ืช ื•ืžื›ืฉื™ืจ ืœื ื™ื‘ื•ื™ืขืชื™ื“ื™ื™ื ื•ืžื—ืœื•ืช ื”ืคืœื” ืื• ืœื™ื“ื” ืžื•ืงื“ืžืช

ืื—ืจื•ืช ืืฆืœ ื ืฉ ื™ื ืืกื™ืžืคื˜ื•ืžื˜ื™ื•ืช ื•ื—ื™ื•ืช ืžืฉืง ื‘ื’ื™ืœืื™ื ืฉื•ื ื™ื

A NON INVASIVE METHOD ANDDEVICE FOR PREDICTION OFFUTURE ABORTION OR PRETERMDELIVERY AND OTHER MEDICALDISORDERS IN ASYMPTOMATICWOMEN AND DOMESTIC ANIMALSOF VARIOUS AGES

ABRAHAM ืื‘ืจื”ื ืงืกืœืจ KESSLER

Page 111: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009111

)2009.01 (A61M19752611/09/2007

ื”ืชืงืŸ ืœื”ื’ื ื” ืžืคื ื™ ืชืกื—ื™ืฃ ื“ื ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉ

EMBOLIC PROTECTION DEVICE ANDMETHOD OF USEEMBRELLA CARDIOVASCULAR ,INC.

11/09/200611/518865USPCT/US/2007/078170WO/2008/033845

)2009.01 (C07C19752711/09/2007

ืชื”ืœื™ืš ื•ื—ื•ืžืจื™ ื‘ื™ื ื™ื™ื ืœื”ื›ื ืช ืžืขื›ื‘ื™ ืื™ื ื˜ื’ืจืื–

PROCESS AND INTERMEDIATES FORPREPARING INTEGRASE INHIBITORS

GILEAD SCIENCES, INC.12/09/200660/844020US07/03/200760/905365US

PCT/US/2007/078157WO/2008/033836

)2009.01 (A61K19752817/09/2007

ืฉืœ, ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ, ืกื™ื ืชื™ื–ื” ื•ืชื›ืฉื™ืจื™ื ืฆื™ืงืœื•ืืœืงื™ืœืžืชื™ืœืืžื™ื ื™ื

SYNTHESIS, METHODS OF USING,AND COMPOSITIONS OFCYCLOALKYLMETHYLAMINESREVIVA PHARMACEUTICALS, INC

15/09/200660/825868USPCT/US/2007/078682WO/2008/034142

)2009.01 (C12N19752901/10/2007

ืชื›ืฉื™ืจื™ื ื•ืฉื™ื˜ื•ืช ืœื™ื™ืฆื•ืจ ืกื˜ื˜ื™ื ื™ื ื˜ื”ื•ืจื™ืื‘ืื•ืคืŸ ืกื˜ืจื™ืื•ืื™ื–ื•ืžืจื™ ื•ื—ื•ืžืจื™ ื‘ื™ื ื™ื™ื

ืกื™ื ืชื˜ื™ื™ื ืขื‘ื•ืจื

COMPOSITIONS AND METHODS FORPRODUCING STEREOISOMERICALLYPURE STATINS AND SYNTHETICINTERMEDIATES THEREFORCODEXIS, INC

02/10/200660/848951USPCT/US/2007/080125WO/2008/042876

Page 112: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 112

)2009.01 (C07D19753010/09/2007

ืชื•ืœื“ื•ืช ืงื•ื•ื™ื ืื–ื•ืœื™ื ื•ืŸ ื•ืื™ื–ื•ืงื•ื•ื™ื ื•ืœื™ื ื•ืŸ ืืฆื˜ืืžื™ื“

QUINAZOLINONE ANDISOQUINOLINONE ACETAMIDEDERIVATIVESPHARMASCOPEIA, LLC

11/09/200660/843718USPCT/US/2007/078022WO/2008/033764

)2009.01 (C07H19753120/09/2007

ื‘ื™ื˜ื•ื™ ืžืชื•ื›ื ืช ื’ื ื˜ื™ืช ืฉืœ ื—ืœื‘ื•ื ื™ืื”ืžื•ืชืžืจื™ื ื‘ืกื•ืœืคืื˜ ื‘ืื•ืคืŸ ื‘ืจืจื ื™

ื‘ืื™ื•ื‘ืงื˜ืจื™ื”

GENETICALLY PROGRAMMEDEXPRESSION OF SELECTIVELYSULFATED PROTEINS INEUBACTERIATHE SCRIPPS RESEARCH INSTITUTE

21/09/200660/846519US28/10/200660/855210US

PCT/US/2007/020459WO/2008/036392

)2009.01 (A61K19753211/03/2009

ANALYTE ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื‘ื“ื™ืงืช ื—ื•ืžืจ TESTING METHOD ANDSYSTEMLIFESCAN SCOTLAND LTD.

21/03/200861/038624US

)2009.01 (A01N19753324/09/2007

ื• ืืฉ/ืชื›ืฉื™ืจ ืœื˜ื™ืคื•ืœ COMPOSITION ืื• ืžื ื™ืขืช ืคื’ื™ืขืช FOR THE TREATMENTAND/OR PREVENTION OF FIRE BLIGHTLANXESS DISTRIBUTION GMBH

27/09/2006102006045505.3DEPCT/EP/2007/060078WO/2008/037677

Page 113: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009113

)2009.01 (H01G19753427/09/2007

ENERGY ื—ืกื•ืŸ ืื ืจื’ื™ื”ืžื•ื“ื•ืœ ืœื STORAGE MODULESIEMENS AKTIENGESELLSCHAFT

28/09/2006102006046042.1DEPCT/EP/2007/060253WO/2008/037763

)2009.01 (A61F19753510/09/2007

ืกื“ ื”ื ื™ืชืŸ ืœื ื™ืคื•ื— ื”ืžืฉืžืฉ ืœืงื™ื‘ื•ืข ืื™ื‘ืจINFLATABLE ืคื’ื•ืข SPLINT

ORTHO-FLEXืž"ืื•ืจืชื•ืคืœืงืก ื‘ืข LTD14/09/200660/844383US

PCT/IL/2007/001111WO/2008/032309

)2009.01 (C07D19753626/09/2007

H3(4โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ]Dโ€“4,3[ืชื•ืœื“ื•ืช ืคื™ืจื™ื“ื• ืื•ืŸ ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืฉืœ ืงื•ืœื˜ืŸ ืกื™ื“ืŸโ€“)

PYRIDO [4,3-D]PYRIMIDIN-4(3H)-ONEDERIVATIVES AS CALCIUMRECEPTOR ANTAGONISTSPFIZER PRODUCTS INC.

04/10/200660/828162US30/08/200760/969083US

PCT/IB/2007/002976WO/2008/041118

)2009.01 (F03G19753720/09/2007

ื›ื‘ื™ืฉ ืœื—ืฉืžืœ ื”ืงื‘ื•ืขโ€“ืžืžื™ืจ ืชื ื•ืขืช ืจื›ื‘ ื‘ืชื•ืš ืคืก ื”ืื˜ื”

VEHICULAR MOVEMENTELECTRICITY CONVERTEREMBEDDED WITHIN A ROAD BUMP

INNOVATIVEืž"ืื™ื ื•ื‘ื˜ื™ื‘ ืคื˜ื ื˜ื™ื ื‘ืข PATENTS LTD.20/09/200660/845772US

PCT/IL/2007/001165WO/2008/035348

Page 114: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 114

)2009.01 (E04F19753811/09/2007

ืคื ืœ ื›ื™ืกื•ื™ ืขื ืงืฆื•ื•ืช ืžืฉื•ืคืขื™ื ื‘ืขืœ ื—ืชืš ืžืฉืชื ื” ื•ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจื•

COVERING PANEL WITH BEVELLEDEDGES HAVING VARYING CROSS-SECTION, AND APPARATUS ANDMETHOD OF MAKING THE SAMESPANOLUX N.V. -DIV. BALTERIO

11/09/200606120427.7EP20/02/200707102710.6EP

PCT/EP/2007/059544WO/2008/031829

)2009.01 (C07K19753927/08/2002

ื‘ื™ ื—ื•ืžืฆื•ืช ืขื8.ื•ื™.ื’ืจืขื™ืŸ ื•ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ืคืขื™ืœื•ืช ืžื™ื˜ื•ื’ื ื™ืช

BV8 NUCLEIC ACIDS ANDPOLYPEPTIDES WITH MITOGENICACTIVITYGENENTECH, INC.

29/08/200160/316184USPCT/US/2002/027571WO/2003/020892

)2009.01 (A61K19754010/09/2007

ืŸ ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ื˜ืœื•ืจื™ื•ื ืœืžืช ื˜ื•ืคื™ืงืœื™

TOPICAL FORMULATIONS OFTELLURIUM-CONTAININGCOMPOUNDS

BIOMASืž"ื‘ื™ื•ืžืืก ื‘ืข LTD.11/09/200660/843402US

PCT/IB/2007/004220WO/2008/032227

)2009.01 (E04B19754108/03/2007

SPACE ืกื™ื“ื•ืจ ื‘ืœื™ื˜ืช ื—ื™ื‘ื•ืจ ืžืกื’ืจืช ืžืจื—ื‘ื™ืช FRAME CONNECTION NODEARRANGEMENTGOSSAMER SPACE FRAMES

22/09/200611/525721USPCT/US/2007/005761WO/2008/039233

Page 115: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009115

)2008.04 (A61B19754219/06/2003

ืฉืœโ€“ืฉื™ื˜ื” ื•ืžืชืงืŸ ืœื˜ื™ืคื•ืœ ืคื•ื˜ื• ืชืจืžื™ ืจืงืžื” ื‘ืขื•ืžืง

METHOD AND APPARATUS FORPHOTOTHERMAL TREATMENT OFTISSUE AT DEPTH

THE GENERAL HOSPITALCORPORATION

19/06/200260/389871USPCT/US/2003/019474WO/2004/000150

)2009.01 (C12Q19754305/10/2007

ืžืคืกืงื™ื ืžื•ืœืงื•ืœืจื™ื ื•ืฉื™ื˜ื•ืช ืขื‘ื•ืจ ืฉื™ืžื•ืฉื™ื ืฉืœื”ื

MOLECULAR SWITCHES ANDMETHODS FOR THEIR USEJOHNSON & JOHNSON RESEARCHPTY LIMITED

06/10/200660/828451USPCT/AU/2007/001517WO/2008/040095

)2009.01 (H04N19754417/09/2007

ื—ื™ื™ืฉืŸ ืชืžื•ื ื” ื ืขื” ื‘ืืžืฆืขื•ืช ืžื™ื–ื•ื’ ื•ื—ื™ื‘ื•ืจ ืืงื˜ื™ื‘ื™ื™ืCMOSืจืฆื™ืคื™ื ืขื ืคื™ืงืกืœื™

MOVING IMAGE SENSOR BYSUCCESSIVE INTEGRATION ANDSUMMATION, WITH ACTIVE CMOSPIXELSE2V SEMICONDUCTORS

19/09/20060608187FRPCT/EP/2007/059777WO/2008/034794

)2009.01 (F03G19754512/03/2009

ื”ืชืงืŸ ืœืื™ืกื•ืฃ ื”ืื ืจื’ื™ื” ืฉืœ ื›ืœื™ ืจื›ื‘ ื”ื ืข ืขืœ ื”ื›ื‘ื™ืฉ

A DEVICE FOR THE TAKING OFENETGY FROM THE MOTION OFVEHICLES, TRAVELING ON A ROAD

MICHAEL ืžื™ื›ืืœ ื’ืจื ื“ืจ GRENADER

Page 116: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 116

)2009.01 (A61N19754612/03/2009

A ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื˜ื™ืคื•ืœ ืจืคื•ืื™ ื‘ืื•ืจ METHOD AND A DEVICE FORTREATMENT BY LIGHT

YOHAI ืจื•ืฉืœ ืžื™ืจื–ืงื ื“ื•ื‘ TAHOR

)2009.01 (F24F19754712/03/2009

PERSONAL ืžื˜ื”ืจ ืžื™ื ืื™ืฉื™ WATER PURIFIERFREE-OXืž"ื‘ืข ืคืจื™ืื•ืงืก LTD

)2009.01 (G11B19754803/11/2007

TIMING ื”ื™ื‘ื˜ื™ื ืชื–ืžื•ื ื™ื™ื ืฉืœ ื”ื’ืฉืช ืชื•ื›ืŸ ืฉื™ื“ื•ืจ ASPECTS OF MEDIACONTENT RENDERINGMICROSOFT CORPORATION

07/11/200611/594352USPCT/US/2007/083553WO/2008/058041

)2009.01 (C12N19754925/09/2007

ืœ ืื•ืœื™ื’ื•ื ื•ืงืœื™ืื•ื˜ื™ื“CPGโ€“ืื ืœื•ื’ื™ืืขืTื”ืžื›ื™ืœื™ื ืื ืœื•ื’ื™ื ืœื”ื™ื“ืจื•ืคื•ื‘ื™ืง

ืคืขื™ืœื•ืช ืžื•ื’ื‘ืจืช ืœื”ืžืจืฆืช ื”ืžืขืจื›ืช ื”ื—ื™ืกื•ื ื™ืช

CPG OLIGONUCLEOTIDE ANALOGSCONTAINING HYDROPHOBIC TANALOGS WITH ENHANCEDIMMUNOSTIMULATORY ACTIVITY

COLEY PHARMACEUTICAL GMBH27/09/200660/847811US

PCT/IB/2007/004389WO/2008/068638

Page 117: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009117

)2009.01 (A01N19755028/12/2006

INHIBITORS ืžืขื›ื‘ื™ื ืฉืœ ื‘ืจื•ื˜ื•ืŸ ื˜ื™ืจื•ืกื™ืŸ ืงื™ื ืื– OF BRUTON'STYROSINE KINASEPHARMACYCLICS, INC.

22/09/200660/826720US06/10/200660/828590US

PCT/US/2006/049626WO/2008/039218

)2009.01 (G06F19755121/04/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื‘ืœื‘ื•ืœ ื ืชื•ื ื™ื ื‘ืžื”ืœืš ืžื™ื–ื

SYSTEM AND METHOD FOROBFUSCATION OF DATA ACROSSAN ENTERPRISEDIRECT COMPUTER RESOURCES,INC.

27/09/200660/848015USPCT/US/2007/067164WO/2008/039565

)2009.01 (A61M19755228/09/2007

FLASHBACK ืฉื™ืคื•ืจ ื—ื–ื•ืชื™ ืฉืœ ืชื ืคืœืฉื‘ืง CHAMBER VISUALENHANCEMENTTYCO HEALTHCARE GROUP LP

29/09/200660/848250USPCT/US/2007/020997WO/2008/042293

)2009.01 (A61K19755304/10/2007

USE ืจืžื•ืช ืœื”ื™ืคื•ืชืจืžื™ื”ืฉื™ืžื•ืฉ ื‘ืชืจื•ืคื•ืช ื”ื’ื• OF HYPOTHERMIA INDUCINGDRUGSNEUROKEY A/S

04/10/2006PA200601289DK06/03/2007PA200700335DK

PCT/DK/2007/050137WO/2008/040360

Page 118: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 118

)2009.01 (C09K19755414/09/2007

PHOSPHORESCENT ืชื›ืฉื™ืจื™ื ืคื•ืกืคื•ืจืฆื ื˜ื™ื™ื ืœื–ื™ื”ื•ื™ COMPOSITIONSFOR IDENTIFICATIONPERFORMANCE INDICATOR L.L.C

15/09/200660/844647US07/06/200711/808266US

PCT/US/2007/019950WO/2008/105830

)2009.01 (B05D19755514/09/2007

ืชื›ืฉื™ืจื™ื ืคื•ืกืคื•ืจืฆื ื˜ื™ื™ื ื•ืฉื™ื˜ื•ืช ืœื–ื™ื”ื•ื™ ื‘ืขื–ืจืชื

PHOSPHORESCENT COMPOSITIONSAND METHODS FORIDENTIFICATION USING THE SAMEPERFORMANCE INDICATOR L.L.C

15/09/200660/844647US07/06/200711/808262US

PCT/US/2007/019949WO/2009/002329

)2009.01 (G06F19755613/09/2007

ื”ืชืงืŸ ืœืฉื™ืคื•ืจ ื‘ื™ืฆื•ืข ืฉืœ ืคืจื•ื˜ื•ืงื•ืœื™ ืœื•ืœื™ืชื”ืขื‘ืจื” ื‘ืกื‘ื™ื‘ื” ืจื‘ ืžืก

DEVICE FOR IMPROVINGPERFORMANCE OF TRANSPORTPROTOCOLS IN A MULTI-PATHENVIRONMENTASANKYA NETWORKS, INC.

13/09/200660/844226USPCT/US/2007/078395WO/2008/034000

)2009.01 (A61K19755712/09/2007

LONG ืชืจื•ืคื•ืช ืจื•ืงื—ื™ื•ืช ืขืžื™ื“ื•ืช LASTING DRUGFORMULATIONS

ื‘ืข'ืžื“ื’ MEDGENICSืž"ื ื™ืงืก LTD.14/09/200660/844351US

PCT/US/2007/019774WO/2008/033375

Page 119: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009119

)2009.01 (H04M19755812/09/2007

ืฉื™ืจื•ืชื™ ื˜ืœืคื•ืŸ ืœื‘ืงืจ ืžื•ืœื˜ื™ืžื“ื™ื” ื ื™ืชืŸ ืœืชื›ื ื•ืช

TELEPHONY SERVICES FORPROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC

12/09/200611/519981USPCT/US/2007/019795WO/2008/033387

)2009.01 (H04N19755913/09/2007

ืชื›ื ื•ืช ืกื‘ื™ื‘ื” ื•ื ื™ื”ื•ืœ ืžื™ื“ืข ืื•ื“ื•ืช ื ืชื•ื ื™ื ืœื‘ืงืจ ืžื•ืœื˜ื™ืžื“ื™ื” ื”ื ื™ืชืŸ ืœืชื›ื ื•ืช

PROGRAMMING ENVIRONMENTAND METADATA MANAGEMENTFOR PROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC

13/09/200611/520215USPCT/US/2007/019912WO/2008/033453

)2009.01 (G08C19756013/09/2007

ืฉืœื˜ ืจื—ื•ืง ืœื‘ืงืจ ืžื•ืœื˜ื™ืžื“ื™ื” ื”ื ื™ืชืŸ ืœืชื›ื ื•ืช

REMOTE CONTROL UNIT FOR APROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC

13/09/200611/520328USPCT/US/2007/019842WO/2008/033414

)2009.01 (G10L19756101/10/2007

ENCODING ืงื™ื“ื•ื“ ืื•ืช ืžื™ื“ืข AN INFORMATION SIGNALFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.

18/10/2006102006049154.8DEPCT/EP/2007/008527WO/2008/046505

Page 120: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 120

)2009.01 (A61K19756211/09/2007

SELECTIVE ืืคื ื•ืŸ ืกืœืงื˜ื™ื‘ื™ ืฉืœ ื›ืžื•ืงื™ืŸ CHEMOKINEMODULATIONPROPHY MED AB

12/09/200660/843760USPCT/SE/2007/000785WO/2008/033069

)2009.01 (H01H19756318/09/2006

ืฉืœ, ืงืŸ ืœื—ืœื•ืงืช ื›ื•ื—ืžื™ืช ื•ืฉื™ืžื•ืฉื™ื ื”ืžื™ืชืงืŸ

A RETROFITTING POWERDISTRIBUTION DEVICE AND USESTHEREOFHINBIT DEVELOPMENT

PCT/IL/2006/001091WO/2008/035322

)2009.01 (H01G19756417/09/2007

METAL ืžืขืจื›ื•ืช ื’ื˜ืจ ืžืชื›ืชื™ื•ืช GETTER SYSTEMSSAES GETTERS S.P.A.

15/09/200660/844879USPCT/US/2007/020172WO/2008/033560

)2009.01 (A61J19756517/10/2007

METHODS ืฉื™ื˜ื•ืช ืœื”ืกืคืงืช ืชื–ื•ื ื” ืœื˜ื•ื•ื— ืืจื•ืš OF PROVIDING LONG-TERM NUTRITIONNESTEC S.A.

19/10/200660/862165USPCT/EP/2007/061112WO/2008/046871

Page 121: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009121

)2009.01 (A61K19756614/09/2007

โ€“Nืชืจื›ื•ื‘ื•ืช ื•ื”ืจื›ื‘ื™ื ืฉืœืžืชื™ืœืืžื™ื ื•ืžืชื™ืœ ืื™ื–ื•ืื™ื ื“ื•ืœ ื•ืฉื™ื˜ื•ืช

ืœืฉื™ืžื•ืฉ ื‘ื”ื

N-METHYLAMINOMETHYLISOINDOLE COMPOUNDS ANDCOMPOSITIONS COMPRISING ANDMETHODS OF USING THE SAMECELGENE CORPORATION

15/09/200660/845227USPCT/US/2007/020201WO/2008/033567

)2009.01 (C07D19756713/09/2007

ื ื’ื–ืจื•ืช ืื–ื˜ื™ื“ื™ืŸ ื•ืื–ื˜ื™ื“ื•ืŸ ื™ืขื™ืœื•ืช ื‘ื˜ื™ืคื•ืœ ื‘ื›ืื‘ ื•ื‘ื”ืคืจืขื•ืช ืฉืœ ืžื˜ื‘ื•ืœื™ื–ื ืฉืœ ืฉื•ืžืŸ

AZETIDINE AND AZETIDONEDERIVATIVES USEFUL IN TREATINGPAIN AND DISORDERS OF LIPIDMETABOLISMSCHERING CORPORATION

15/09/200660/845076USPCT/US/2007/019934WO/2008/033468

)2009.01 (A61K19756813/09/2007

ืฉืœ, ื‘ืกื•ื›ืจืช, ื˜ื™ืคื•ืœ ื‘ื›ืื‘ ื•ื‘ื”ืคืจืขื•ืช ืžื˜ื‘ื•ืœื™ื–ื ืฉืœ ืฉื•ืžืŸ

TREATING PAIN, DIABETES, ANDDISORDERS OF LIPID METABOLISM

SCHERING CORPORATION15/09/200660/844810US

PCT/US/2007/019925WO/2008/033460

)2009.01 (G01S19756912/03/2009

ืืžืฆืขื™ ืชืžื™ื›ื” ืœืžื—ื–ื™ืจ ืงืจื™ื ื” ืกื•ืœืจื™ืช ืžืกื•ื’ ืฉื•ืงืช ืคืจื‘ื•ืœื™ืช

SUPPORTING MEANS FORPARABOLIC TROUGH SOLARREFLECTOR

ื‘ืข- ื–ื™ื• ZIV-AVืž"ืื‘ ื”ื ื“ืกื” ENHINEERING LTD

Page 122: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 122

)2009.01(A61B19757012/03/2009

ืคืขืžื™ ืขื ืžืขืจื›ืช ืžืฉื•ืœื‘ืชโ€“ื—ื™ืชื•ืœ ื—ื“ ืœืกื™ืœื•ืง ืœืืฉืคื”

DISPOSABLE DIAPER WITHINTEGRAL DISPOSAL SYSTEM

SAMUEL ืฉืžื•ืืœ ืงืจืกื ื˜ื™ KARSENTI

)2009.01 (G03B19757112/03/2009

DIGITAL ืžืฆืœืžื” ื“ื™ื’ื™ื˜ืืœื™ืช ืžืฉื•ืคืจืช CAMERACOHEN ืžืื•ืจ ื›ื•ื”ืŸ MAOR

)2009.01 (C07D19757213/03/2008

PROCESS ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืžื™ืจืชืื–ืืคื™ืŸ FOR PRODUCTION OFMIRTAZAPINESUMITOMO CHEMICAL COMPANY,LIMITED

22/03/20072007-075573

JP

PCT/JP/2008/054628WO/2008/114691

)2009.01 (A61M19757327/09/2007

DIRECTIONAL ืฉื™ืžื•ืฉ ื›ื™ื•ื•ื ื™ USENICONOVUM AB

27/09/2006PA200601246DK24/07/200760/951619US

PCT/EP/2007/008420WO/2008/037470

)2009.01 (A61K19757426/09/2007

PHARMACEUTICAL ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื COMPOSITIONSZYSIS LIMITED

26/09/20060618879.1GBPCT/GB/2007/003677WO/2008/038003

Page 123: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009123

)2009.01 (C12N19757511/09/2007

ืฉื™ื˜ืช ื”ืจื—ื‘ื” ืœืชืื™ ืื‘ ื‘ื•ื’ืจื™ืื•ืฉื™ืžื•ืฉ, ื‘ืžื™ื•ื—ื“ ื“ื ืคืจื™ืคืจื™, ืžื”ื“ื

ืงืฉื•ืจ ื‘ืชื—ื•ื ื”ืจืคื•ืื”

EXPANSION METHOD FOR ADULT STEMCELLS FROM BLOOD, PARTICULARLYPERIPHERAL BLOOD, AND RELATIVEAPPLICATION IN MEDICAL FIELDSALES ENGINEERING AG

20/09/2006RM2006A000498ITPCT/EP/2007/059531WO/2008/034740

)2009.01 (H04M19757612/03/2009

ืฉื™ื˜ื” ื•ื›ืœื™ ืœื™ืฆื™ืจืช ืžื•ื“ืœ ืฉืœ ืžืฉื™ืžื•ืช ื‘ื™ื™ืฉื•ืžื™ื ืœืžื›ืฉื™ืจ ื ื™ื™ื“

A METHOD AND TOOL FOR TASKMODELING OF MOBILE PHONEAPPLICATIONS

ื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

)2009.01 (C07D19757724/09/2007

ืคื™ืจื™ื“ื™ื ืงืจื‘ื•ืงืกืืžื™ื“ ื•ืฉืœโ€“3ืชื•ืœื“ื•ืช ืฉืœืคื™ืจืื–ื™ื ืงืจื‘ื•ืงืกืืžื™ื“ ื›ืกื•ื›ื ื™ื ื”ืžืขืœื™ืโ€“2

HDLื›ื•ืœืกื˜ืจื•ืœ

3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDEDERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTSF. HOFFMANN-LA ROCHE AG

04/10/200606121755.0EPPCT/EP/2007/060094WO/2008/040651

)2009.01 (A61K19757912/03/2009

ื“ื™ื›ื•ื™ ื™ืขื™ืœ ืจื‘ ืžื™ืžื“ื™ ืฉืœ ืื ื•ื ื™ืžื™ื•ืชKืžื“ืจื’ื”

EFFICIENT MULTI-DIMENSIONALSUPPRESSION FOR K-ANONYMITY

ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘ ื”ืจืฉื•ืช ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

Page 124: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 124

)2009.01 (A61K19758013/09/2007

ALBUMIN ื—ืœื‘ื•ื ื™ ืืœื‘ื•ืžื™ืŸ ืžืื•ื—ื™ื FUSION PROTEINSHUMAN GENOME SCIENCES, INC.

14/09/200660/844349US13/11/200660/858410US20/02/200760/902039US07/06/200760/942647US12/09/200760/960039US

PCT/US/2007/019841WO/2008/033413

)2009.01 (G06F19758114/09/2006

MATCHINGื ืœืฆืจื›ื ื™ืื”ืชืืžืช ืžื™ื“ืช ื‘ื’ื“ื™ THE FIT OF GARMENTSTO CONSUMERSMYSHAPE, INC.

PCT/US/2006/035965WO/2008/033138

)2009.01 (A61K19758204/03/2003

ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืฆื•ืจื” ืงืจื™ืกื˜ืœื™ื ื™ืช ืฉืœื—ื•ืžืฆื” ื”ื™ื“ืจื•ืงืกืžื™ืช ืฉืœ ืกื‘ืจื•ืื™ืœืื ื™ืœื™ื“

)SAHA(ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชSAHA

COMPOSITIONS COMPRISING ACRYSTALLINE FORM OFSUBEROYLANILIDE HYDROXAMICACID (SAHA) AND METHODS FORSAHA PREPARATIONSLOAN-KETTERING INSTITUTE FORCANCER RESEARCH

04/03/200260/361759USPCT/US/2003/006451WO/2003/075839

Page 125: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009125

)2009.01 (G06F19758303/04/2008

ืžืขืจื›ืช ืžื—ืฉื‘ ืœื”ืชืืžืช ืœื‘ื•ืฉ ืžื‘ื•ืกืกืชืขืœ ื›ืœืœื™ื ื•ืกื™ื ื•ืŸ ื”ืžื‘ื•ืกืก ืขืœ ื›ืœืœื™ ืื•ืคื ื”

ื•ื”ืชืืžื”

COMPUTER SYSTEM FOR RULE-BASED CLOTHING MATCHING ANDFILTERING CONSIDERING FIT RULESAND FASHION RULESMYSHAPE, INC.

06/04/200711/697688USPCT/US/2008/059278WO/2008/124511

)2009.01 (C07D19758527/10/2007

ืชื•ืœื“ื•ืช ื‘ื ื–ืืžื™ื“ื™ื•ืช ื—ื“ืฉื•ืช ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืœื‘ืจื“ื™ืงื™ื ื™ืŸ

NEW BENZAMIDE DERIVATIVES ASBRADYKININ ANTAGONISTS

RICHTER GEDEON NYRT.27/10/2006P0600808HU

PCT/HU/2007/000102WO/2008/068540

)2009.01 (C07C19758627/10/2007

ืชื•ืœื“ื•ืช ืคื ื™ืœืกื•ืœืคืืžื•ื™ืœ ื‘ื ื–ืืžื™ื“ ื—ื“ืฉื•ืช ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืœื‘ืจืื“ื™ืงื™ื ื™ืŸ

NEW PHENYLSULFAMOYLBENZAMIDE DERIVATIVES ASBRADYKININ ANTAGONISTSRICHTER GEDEON NYRT.

27/10/2006P0600809HUPCT/HU/2007/000103WO/2008/050167

Page 126: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 126

)2009.01 (A61F19758813/09/2007

ืžื‘ื ื™ื ืกืคื•ื’ื™ื™ื ื”ื™ื“ืจื•ืคื™ืœื™ื™ื ืคื•ืœื™ืžืจื™ื™ื ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื

HYDROPHILLIC POLYMER SPONGESTRUCTURES AND METHODS OFPRODUCING THE SAMEHEMCON, MEDICAL TECHNOLOGIESINC.

13/09/200611/520230US13/09/200611/520357US02/10/200611/541988US02/10/200611/541991US13/09/200711/900854US

PCT/US/2007/019927WO/2008/033462

)2009.01 (A61B19758910/09/2007

THREE ืžืขืจื›ืช ื’ื™ืฉื•ืจ ืื•ืคื˜ื™ืช ื‘ืช ืฉืœื•ืฉ ื“ื™ื•ื“ื•ืช DIODA OPTICAL BRIDGESYSTEMGROVE INSTRUMENTS, INC.

25/09/200611/526564USPCT/US/2007/019635WO/2008/039299

)2009.01 (H04L19759005/10/2007

METHOD ืฉื™ื˜ื” ื•ืžืชืงืŸ ืขื‘ื•ืจ ืื™ืžื•ืช ื”ื“ื“ื™ AND APPARATUS FORMUTUAL AUTHENTICATIONQUALCOMM INCORPORATED

10/10/200660/850882US03/10/200711/866946US

PCT/US/2007/080525WO/2008/045773

)2009.01 (H01H19759115/03/2009

ื˜ื‘ืขืช ืœื”ื—ื–ืงืช ืžืคืชื—ื•ืช ืขื ืืžืฆืขื™ืื”ืžืืคืฉืจื™ื ื”ื›ื ืกื” ืงืœื” ื•ื”ื•ืฆืื” ืงืœื” ืฉืœ

ื”ืžืคืชื—ื•ืช ืžื”ื˜ื‘ื•ืช

KEYS RING WITH MEANS, THETALLOW EASY INSERTION ANDTAKING OUT OF THE KEYS IN ANDFROM THE RING RESPECTIVELY

.DR ืขืžืจื ื‘ืŸ ืฉืžื—ื•ืŸืจ ื—ื™ื™ื"ื“ HAIM AMRAM BEN-SIMHON

Page 127: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009127

)2009.01 (F41H19759215/03/2009

,ืฉ ืื• ืจื›ื‘"ื ื’ืž, ืฉืจื™ื•ืŸ ืจื™ืืงื˜ื™ื‘ื™ ืœื˜ื ืงืื•(ื›ื ื’ื“ ืคื’ื–ื™ื ืื• ื˜ื™ืœื™ื ื‘ืขืœื™ ืžื˜ืขืŸ ื—ืœื•ืœ

)ื—ื•ื“ืจ ืฉืจื™ื•ืŸ

REACTIVE ARMOR FOR A TANK,APC(ARMOURED PERSONNELCARRIER) OR A VEHICLE, AGAINSTSHELLS OR MISSILES WITHHOLLOW EXPLOSIVE CHARGE(ARMOR PENETRATINGAMUNITION).

.DRืจ ื—ื™ื™ื ืขืžืจื ื‘ืŸ ืฉืžื—ื•ืŸ"ื“ HAIM AMRAM BEN-SIMHON

)2009.01 (G06F19759317/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืื•ื˜ื•ืžืฆื™ื” ืฉืœ ื”ืขื‘ืจืช ื ืชื•ื ื™ื ืžืžืžืฉืง ืื™ื ื˜ืจื ื˜ื™ ืœืžืžืฉืง ืื—ืจ

SYSTEM AND METHOD FORAUTOMATING THE TRANSFER OFDATA FROM A WEB INTERFACE TOANOTHERJOBDIVA, INCORPORATED

15/09/200660/844646US17/09/200711/856586US

PCT/US/2007/078677WO/2008/034139

)2009.01 (C07K19759417/09/2007

ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ื—ืœื‘ื•ื ื™ื ื”ืžื˜ื•ืคืœื™ืืช ืœื”ื›ื ืชืื‘ืœื—ืฅ ื’ื‘ื•ื” ื•ืฉื™ื˜ื•

COMPOSITIONS COMPRISING HIGHPRESSURE-TREATED PROTEINS ANDMETHODS OF PREPARING THESAMEBAROFOLD, INC.

15/09/200660/844996USPCT/US/2007/020128WO/2008/033556

Page 128: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 128

)2009.01 (H04Q19759511/09/2007

ืฉื™ื˜ื” ืœืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช ื•ืžืขืจื›ืช ื”ืงืฆื‘ืช ื‘ืœื•ืงื™ื ืœืชื ื•ืžืฉืื‘ืœ

WIRELESS COMMUNICATIONMETHOD AND APPARATUS FORASSIGNING CELL AND RESOURCEBLOCKSINTERDIGITAL TECHNOLOGYCORPORATION

14/09/200660/844428USPCT/US/2007/019768WO/2008/033369

)2009.01 (H04Q19759613/09/2007

ืขืจื›ืช ืœืขื“ื›ื•ื ื™ื ื“ื™ื ืืžื™ื™ื ืฉืœ ืฉื™ื˜ื” ื•ืž ืคืจืžื˜ืจื™ ื’ื™ืฉื” ืืงืจืื™ื™ื

METHOD AND APPARATUS FORDYNAMIC UPDATES OF RANDOMACCESS PARAMETERSINTERDIGITAL TECHNOLOGYCORPORATION

15/09/200660/825759USPCT/US/2007/019928WO/2008/033463

)2009.01 (C03B19759712/09/2007

ืœื™ื™ืฆื•ืจ ื–ื›ื•ื›ื™ืช ืงื•ื•ืืจืฅ2SIOืชืขืจื•ื‘ืช ื•ื™ื™ืฉื•ื ื”ืชืขืจื•ื‘ืช

SIO2 SLURRY FOR THE PRODUCTIONOF QUARTZ GLASS AS WELL AS THEAPPLICATION OF THE SLURRYHERAEUS QUARZGLAS GMBH & CO.KG

29/09/2006102006046619.5DEPCT/EP/2007/059565WO/2008/040615

Page 129: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009129

)2009.01 (B62B19759814/09/2007

ื”ืชืงืŸ ืขื‘ื•ืจ ืขื’ืœืช ืชื™ื ื•ืง ื•ืฉื™ืžื•ืฉ ืœืžื•ื˜ ื“ื—ื™ืคื” ืฉืœื”

DEVICE FOR A PRAM AND USE OF APUSH BAR

MUTSY B.V.14/09/20061032494NL

PCT/NL/2007/000227WO/2008/033014

)2009.01 (A61C19759914/09/2007

ื•ืช ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื™ื™ืฆื•ืจ ืชื•ืชื‘ ื“ื ื˜ืœื™ื•ืช

METHOD AND SYSTEM FORPRODUCING A DENTAL PROSTHESISDENTAL CONSULTING MONKMEYERS.L.

14/09/2006102006043284.3DEPCT/EP/2007/008031WO/2008/031614

)2009.01 (H04N19760017/08/2007

ืœื™ื ื™ืืจื™ ื”ืคื•ืขืœCMOSื—ื™ืฉืŸ ืชืžื•ื ื” ื‘ืืžืฆืขื•ืช ื”ืขื‘ืจืช ืžื˜ืขืŸ

CMOS LINEAR IMAGE SENSOROPERATING BY CHARGE TRANSFER

E2V SEMICONDUCTORS19/09/20060608188FR

PCT/EP/2007/058549WO/2008/034677

Page 130: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 130

)2009.01 (C12N19760118/09/2007

ืคื—ืžื™ืžื ื™ื ื•ื—ื•ืžืฆื•ืช ืฉื•ืžืŸ ืฉืœ ืืฆื•ืช ื‘ืื•ืจืš ืฉืจืฉืจืช ื‘ื™ื ื•ื ื™

ALGAL MEDIUM CHAIN LENGTHFATTY ACIDS ANDHYDROCARBONSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY

18/09/200660/825946USPCT/US/2007/078760WO/2008/036654

)2009.01 (C07K19760213/09/2007

ืชืจื›ื•ื‘ื•ืช ื•ืฉื™ื˜ื•ืช ืœืžื ื™ืขืช ืกืจื˜ืŸ ืขื ืงื•ืคืจื“ื•ืงืกื™ื ื™ื

COMPOSITIONS AND METHODS TOPREVENT CANCER WITHCUPREDOXINSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,

14/09/200660/844358USPCT/US/2007/078371WO/2008/033987

)2009.01 (H04L19760310/10/2007

ืชื™ืขื•ืœ ื—ืœื•ืงืช ืžืจื—ื‘ ืžืจื•ื‘ืช ื›ื ื™ืกื•ืช ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

SPACE DIVISION MULTIPLE ACCESSCHANNELIZATION IN WIRELESSCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED

10/10/200660/828821US09/10/200711/869589US

PCT/US/2007/081013WO/2008/045980

Page 131: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009131

)2009.01 (A61K19760514/09/2007

ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ ื”ืžื˜ืคื—ืช ืžื•ื˜ืฆื™ื•ืชEGFRโ€“ื‘

METHOD FOR TREATING CANCERHARBORING EGFR MUTATIONSBOEHRINGER INGELHEIMINTERNATIONAL GMBH

18/09/200606120856.7EP31/01/200707101505.1EP

PCT/EP/2007/059735WO/2008/034776

)2009.01 (H04B19760620/09/2007

ืฉื—ื–ื•ืจ ื•ืจืกื˜ื•ืจืฆื™ื” ืฉืœ ืฉื“ื” ืื•ืช ืื•ืคื˜ื™RECONSTRUCTION ANDRESTORATION OF AN OPTICALSIGNAL FIELDLUCENT TECHNOLOGIES INC.

22/09/200611/525786USPCT/US/2007/020367WO/2008/036356

)2009.01 (A23L19760717/09/2007

ืชื›ืฉื™ืจื™ ื”ืžืชืงื” ืžื’ื•ื‘ืฉื™ื ืฉืื™ื ื ื–ื•ืจืžื™ืื‘ื—ื•ืคืฉื™ื•ืช ื”ืžื›ื™ืœื™ื ื’ื•ืจื ื”ื“ื‘ืงื”

ื”ื™ื’ืจื•ืกืงื•ืคื™ ื•ื—ื•ืžืจ ืžื™ื™ื‘ืฉ

COHESIVE NON- FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING A HYGROSCOPICGLUING AGENT AND A DESICCANTMCNEIL NUTRITIONALS, LLC

18/09/200611/532709USPCT/US/2007/020122WO/2008/036230

Page 132: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 132

)2009.01 (A23G19760808/08/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื™ืฆื•ืจ ืงื•ื ืคื™ื˜ื•ืจื” ืžืžืกืคืจ ืžืจื›ื™ื‘ื™ื

METHOD AND APPARATUS FORPRODUCING A CONFECTIONARYPRODUCT FROM MULTIPLECOMPONENTSKRAFT FOODS R&D, INC.

20/09/200606019675.5EPPCT/US/2007/075435WO/2008/036476

)2009.01 (C07K19760920/09/2007

PROTEASE ืื ืœื•ื’ื™ื ืœืื™ื ืกื•ืœื™ืŸ ืขืžื™ื“ื™ื ืœืคืจื•ื˜ื™ืื– RESISTANT INSULINANALOGUESNOVO NORDISK A/S

22/09/200606121113.2EPPCT/EP/2007/059990WO/2008/034881

)2009.01 (B05D19761010/10/2007

RADIATION ื“ื™ื• ื”ื ื™ืชืŸ ืœืขื™ืฆื•ื‘ ื‘ืงืจื™ื ื” CURABLE INKSHEXION SPECIALTY CHEMICALS,INC.

11/10/200660/851036USPCT/US/2007/021670WO/2008/045480

)2009.01 (C08J19761111/10/2007

ื™ืช ืชื›ืฉื™ืจื™ ื“ื™ื• ื”ื ื™ืชื ื™ื ืœื”ื–ืจืงื” ืกื™ืœื•ื  ื•ืœืขื™ืฆื•ื‘ ื‘ื”ืงืจื ื”

RADIATION CURABLE ANDJETTABLE INK COMPOSITIONSHEXION SPECIALTY CHEMICALS,INC.

11/10/200660/851023USPCT/US/2007/021754WO/2008/045517

Page 133: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009133

)2009.01 (A01N19761215/09/2007

ืžื•ืฆืจื™ื ื•ืฉื™ื˜ื•ืช ื”ืžืฉืชืžืฉื™ื ื‘ืคืคื˜ื™ื“ื™ืื” ื”ื›ืœืœื™ืช ื•ืจืžืช ืฉืœ ืกื•ื™ื” ืœื”ื•ืจื“ืช ื”ืจืž

LDLืฉืœ ื›ื•ืœืกื˜ืจื•ืœ

PRODUCTS AND METHODS USINGSOY PEPTIDES TO LOWER TOTALAND LDL CHOLESTEROL LEVELS

SOY LABS LLC16/09/200660/966529US17/07/200761/007925US

PCT/US/2007/078584WO/2008/034116

)2009.01 (C07K19761321/11/2003

ืชื›ืฉื™ืจื™ื ื•ืคื•ืจืžื•ืœืฆื™ื•ืช ืฉืœ ื’ืกื˜ืจื™ืŸ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื•ื”ื›ื ื”

GASTRIN COMPOSITIONS ANDFORMULATIONS, AND METHODS OFUSE AND PREPARATIONWARATAH PHARMACEUTICALS,INC.

21/11/200260/428100US22/11/200260/428562US03/12/200260/430590US14/11/200360/519933US

PCT/CA/2003/001778WO/2004/045640

)2009.01 (C07D19761417/09/2007

THIAZOLE ืชืจื›ื•ื‘ื•ืช ืชื™ืื–ื•ืœ ืคื™ืจืื–ื•ืœื•ืคื™ืจื™ืžื™ื“ื™ืŸ PYRAZOLOPYRIMIDINECOMPOUNDSELI LILLY & CO.

20/09/200660/826264USPCT/US/2007/078605WO/2008/036579

Page 134: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 134

)2009.01 (C07K19761530/04/2004

SECRETED ืžืฉืคื—ืช ื—ืœื‘ื•ืŸ ืžื•ืคืจืฉ PROTEIN FAMILYARES TRADING S.A.

30/04/20030309916.5GBPCT/GB/2004/001890WO/2004/096856

)2009.01 (G06F19761616/03/2009

ืžืขืจื›ืช ืชืงืฉื•ืจืช ื‘ืืžืฆืขื•ืช ืžื™ืœื•ืช ืงื•ื“SMSื‘ื”ื•ื“ืขื•ืช) ื“ื•ืžื™ื™ื ื™ื(

COMMUNICATION SYSTEM VIA SMSDOMAIN NAME

ARI ืืจื™ ืืœื™ืขื– ELIAZ16/03/200961036965US

)2009.01 (H04Q19761712/10/2007

ื”ืขื‘ืจืช ืžืฉืื‘ื™ื ื‘ืงื™ืฉื•ืจ ื”ืคื•ืš ื•ื‘ืงืจืชื›ื•ื— ื‘ืงื™ืฉื•ืจ ื”ืคื•ืš ืขื‘ื•ืจ ืžืขืจื›ืช ืชืงืฉื•ืจืช

ืืœื—ื•ื˜ื™ืช

REVERSE LINK RESOURCEASSIGNMENT AND REVERSE LINKPOWER CONTROL FOR WIRELESSCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED

13/10/200660/829388US11/10/200711/870962US

PCT/US/2007/081238WO/2008/048894

)2009.01 (C07D19761801/11/2007

ืกื•ื’ ืืžื™ื“ ืกืœืงื˜ื™ื‘ื™ ืงื•ืœื˜ ื ื™ืงื•ื˜ื™ืŸ ื™ืงืœื•ืืœื ื™ืืืฆื˜ื™ืœื›ื•ืœื™ืŸ ืฉืœ ื“ื™ืื–ื‘ื™ืก

NICOTINIC ACETYLCHOLINERECEPTOR SUB-TYPE SELECTIVEAMIDES OFDIAZABICYCLOALKANESTARGACEPT, INC.

02/11/200660/856079USPCT/US/2007/083330WO/2008/057938

Page 135: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009135

)2009.01 (B01L19761926/09/2007

CARTRIDGE ืžืขืจื›ืช ืžื—ืกื ื™ื•ืช SYSTEMITI SCOTLAND LIMITED

26/09/20060618966.6GBPCT/GB/2007/003666WO/2008/037995

)2009.01 (E04G19762016/03/2009

STRUCTURE ื—ื™ื–ื•ืง ืœืžื‘ื ื” REINFORCEMENTAHARON ืื”ืจื•ืŸ ืจื‘ื™ืฅ RAVITZ

)2009.01 (C12N19762104/09/2003

ืฉื™ืžื•ืฉ ื‘ืžื•ื˜ื ื˜ื™ื ืžืกื•ื’ ืกื›ืจื•ืžื™ืกืืกืœื‘ื™ื˜ื•ื™ ืฉืœ ื ืฉืื™ ื’ืœื•ืงื•ื–4ERGื” ืกืจื•ื™ื–ื™

ืžื™ื•ื ืงื™ื

USE OF SACCHAROMYCESCEREVISIAE ERG4 MUTANTS FORTHE EXPRESSION OF GLUCOSETRANSPORTERS FROM MAMMALSSANOFI-AVENTIS DEUTSCHLANDGMBH

14/09/200210242763.1DEPCT/EP/2003/009812WO/2004/026907

)2009.01 (A01G19762215/10/2007

ื‘ืžื™ื•ื—ื“ ืขื‘ื•ืจ ื—ืžืžื•ืช, ืžืกืš ืœื‘ื™ื“ื•ื“ ืชืจืžื™ ืฉืœ ื’ื ื ื•ืช ื•ื’ื™ื ื•ืŸ

THERMAL INSULATION SCREEN,ESPECIALLY FOR HORTICULTURALAND MARKET GARDENINGGREENHOUSESMDB TEXINOV SA

26/10/20060654538FRPCT/FR/2007/052143WO/2008/050029

Page 136: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 136

)2009.01 (H01L19762323/10/2007

IMPROVED ื›ื™ื•ืœ ืžืฉื•ื›ืœืœ ืฉืœ ืจื•ื‘ื•ื˜ ื”ืžื˜ืคืœ ื‘ืžืฆืข CALIBRATION OF ASUBSTRATE HANDLING ROBOTCYBEROPTICS SEMICONDUCTOR,INC.

23/10/200660/853660USPCT/US/2007/022490WO/2008/051544

)2009.01 (B65B19762403/09/2003

A ืœื™ืฆื•ืจ ื•ืžื™ืœื•ื™ ืฉืœ ืžื™ื›ืœ ืื˜ื•ืืฉื™ื˜ื” METHODS OF MAKING ANDFILLING SEALED CONTAINERSMEDICAL INSTILL TECHNOLOGIES,INC.

03/09/200260/408068USPCT/US/2003/027545WO/2004/026695

)2009.01 (B01D19762531/07/2007

ืžืžื‘ืจื ื•ืช ืกื™ื ื•ืŸ ืขืœ ื‘ืกื™ืก ืคื•ืœื™ืžืจืœ ื”ื›ื ืชืื•ืฉื™ื˜ื•ืช

POLYMER-BASED FILTRATIONMEMBRANES AND METHODS OFPRODUCING THE SAMEGKSS-FORSCHUNGSZENTRUMGEESTHACHT GMBH

22/09/2006102006045282.8DEPCT/EP/2007/006759WO/2008/034487

)2009.01 (G07G19762618/03/2008

A ืงื•ืคื” ืจื•ืฉืžืช CASH REGISTER MACHINESIMCHA ืฉืžื—ื” ื™ืฉืจืืœ ืกืžื•ืืœืก ISRAEL SAMUELS

20/03/200760/895745US18/03/2008PCT/IL/000372WO

PCT/IL/2008/000372WO/2008/114251

Page 137: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009137

)2009.01 (H04M19762817/03/2009

A ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื˜ืœืคื•ื ื™ื” TELEPHONY SYSTEM ANDMETHOD

SHAI ืฉื™ ื—ื›ื™ื HAKIM

)2009.01 (H04M19762917/03/2009

ืฉื™ื˜ื” ืœื ื™ื”ื•ืœ ืฉื™ื—ื•ืช ื ื›ื ืกื•ืช ื•ื™ื•ืฆืื•ืชMETHOD OF INBOUND ANDOUTBOUND CALL WITHTRANSPARENT HAND-OFF

DAN ื ืงื•'ื“ืŸ ืคืจื•ืžืฆ FROMCHENKO

)2009.01 (A47J19763020/09/2007

ืžืขืจื›ืช ืกื—ื™ื˜ื” ืขื‘ื•ืจ ื”ื›ื ืช ืžืฉืงื” ืžืžื—ืกื ื™ืช

EXTRACTION SYSTEM FOR THEPREPARATION OF A BEVERAGEFROM A CARTRIDGENESTEC S.A.

26/09/200606121239.5EPPCT/EP/2007/059930WO/2008/037642

)2009.01 (A23P19763101/10/2007

CO-EXTRUDED ืžื•ืฆืจ ื”ืžื•ืฆื ื™ื—ื“ PRODUCTNESTEC S.A.

05/10/2006PCT/EP2006/067110EPPCT/EP/2007/060394WO/2008/040705

Page 138: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 138

)2009.01 (A61K19763228/09/2007

Cโ€“JAMUSEืฉื™ืžื•ืฉ ื‘ืชืจื›ื•ื‘ื•ืช ื”ืงื•ืฉืจื•ืช OF JAM-C BINDINGCOMPOUNDSMERCK SERONO S.A.

28/09/200660/827389USPCT/IB/2007/002861WO/2008/038127

)2009.01 (A01N19763402/10/2007

ืชื›ืฉื™ืจ ื ื•ื–ืœื™ ืœืงื˜ื™ืœืช ืžื–ื™ืงื™ื ื”ืžื›ื™ืœโ€“Nืชืจื›ื•ื‘ื•ืช ืงื•ื˜ืœื•ืช ืžื–ื™ืงื™ื

ืคื ื™ืœืกืžื™ืงืจื‘ืื–ื•ื ื™ื•ืช

LIQUID PESTICIDE COMPOSITIONCONTAINING N-PHENYLSEMICARBAZONEPESTICIDE COMPOUNDSBASF SE

03/10/200660/849145US08/11/200606123698.0EP

PCT/EP/2007/060449WO/2008/040727

)2009.01 (A61M19763528/09/2007

SURGICAL ืžืขืจื›ืช ื›ื™ืจื•ืจื’ื™ืช ืœื”ืขื‘ืจืช ื ื•ื–ืœ FLUID TRANSFERAPPARATUSTYCO HEALTHCARE GROUP LP

29/09/200660/848519USPCT/US/2007/020987WO/2008/042285

)2009.01 (C07K19763601/10/2007

ืง Aื•ืฉืจื™ ืื ื˜ื™ื’ืŸ ืœืงื•ืœื˜ืŸ ื—ืœื‘ื•ื ื™ื 17โ€“ILIL-17 RECEPTOR A ANTIGENBINDING PROTEINSAMGEN INC.

02/10/200660/827882US05/12/200660/873072US04/09/200760/969895US

PCT/US/2007/021174WO/2008/054603

Page 139: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009139

)2009.01 (C07K19763716/10/2007

BBืœื™ื’ื ื“ 4-1 ื—ืœื•ืช ื“ืœืงืชื™ื•ืชื‘ืž 4โ€“1 BB LIGAND IN INFLAMMATORYDISEASESTHE SCRIPPS RESEARCH INSTITUTE

16/10/200660/852022US11/05/200760/917561US

PCT/US/2007/022103WO/2008/057171

)2009.01 (C07D19763817/03/2009

ืชื”ืœื™ืš, ืชืจื›ื•ื‘ื•ืช ื“ื™ืื•ืกืžืชื™ืŸ ื—ื“ืฉื•ืช ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸืœื”ื›ื ืชืŸ

NEW DIOSMETIN COMPOUNDS, APROCESS FOR THEIR PREPARATIONAND PHARMACEUTICALCOMPOSITIONS CONTAINING THEMLES LABORATOIRES SERVIER

01/04/200808/01779FR

)2009.01 (C07D19763924/09/2007

ืชื”ืœื™ืš ืœื”ื›ื ืช ืชื•ืœื“ื•ืช ืคื ื•ืงืกื™ ื™ื ื•ืคื™ืจื™ืžื™ื“ื™ืŸื“ื™ืืž

PROCESS FOR SYNTHESIS OFPHENOXY DIAMINOPYRIMIDINEDERIVATIVESF. HOFFMANN-LA ROCHE AG

04/10/200660/849203USPCT/EP/2007/060095WO/2008/040652

)2009.01 (C07D19764020/09/2007

, ืชื•ืœื“ื•ืช ืงื˜ืจืื ื˜ื™ืŸ ืžื•ืชืžืจื•ืช ื‘ืคืœื•ืื•ืจืจืงืจืกื•ืจื™ื ืœื•ื™ื ืงื” ื”ื›ื ืชืŸ ื•ืฉื™ืžื•ืฉืŸ ื›ืค ืืœืงืœื•ืื™ื“ ื“ื™ืžืจื™

FLUORINATED CATHARANTHINEDERIVATIVES, THEIR PREPARATIONAND THEIR UTILISATION AS VINCADIMERIC ALKALOID PRECURSORSPIERRE FABRE MEDICAMENT

20/09/200660/826245US20/09/200606/08226FR

PCT/EP/2007/059991WO/2008/034882

Page 140: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 140

)2009.01 (C07D19764128/09/2007

FIRE-RESISTANTืืฉโ€“ืœื•ื— ื’ื‘ืก ื—ืกื™ืŸ GYPSUM PANELUNITED STATES GYPSUM COMPANY

12/10/200611/546736USPCT/US/2007/020906WO/2008/045217

)2009.01 (C07D19764217/04/2003

ื ืฉืœ ื ื’ื–ืจื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื›ืžื•ื“ื•ืœื˜ื•ืจื™ ืื•ืคื™ื•ืื™ื“

HETEROCYCLIC DERIVATIVES ASOPIOID MODULATORS

JANSSEN PHARMACEUTICA N.V.29/04/200260/376,406US26/03/200310/400,006US

PCT/US/2003/011872WO/2003/092688

)2009.01 (B29B19764317/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืฉื™ืžื•ืฉ ื—ื•ื–ืจ ื‘ืคืกื•ืœืชืฉืœืž ืชื”ืœื™ืš ื™ื™ืฆื•ืจ ื—ื™ืชื•ืœื™ื ืขื‘ื•ืจ ื”ื”ืคืงื”

ืžื™ื›ืœื™ ืคืกื•ืœืช ืจืคื•ืื™ืช

SYSTEM AND METHOD FORRECLAIMING WASTE FROM DIAPERMANUFACTURE FOR THEPRODUCTION OF MEDICAL WASTECONTAINERSTYCO HEALTHCARE GROUP LP

21/09/200660/846292USPCT/US/2007/020104WO/2008/036223

)2009.01 (G06F19764424/01/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืื‘ื—ื•ืŸ ืืจื•ืขื™ื ื‘ืžืขืจื›ืช ื‘ืžืขืจื›ืช ืžืžื•ื—ืฉื‘ืช

A METHOD AND APPARATUS FOREVENT DIAGNOSIS IN ACOMPUTERIZED SYSTEMCORRELSENSE LTD.

PCT/IL/2007/000089WO/2008/900536

Page 141: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009141

)2009.01 (A01G19764521/09/2007

ื—ื•ืžืจ ืžืขื•ื‘ื“ ืžืงืœื™ืคืช ืื•ืจื– ื›ืžืฆืข ืœื ื‘ื™ื˜ื” ื•ืฆืžื™ื—ื”

PROCESSED RICE HULL MATERIALAS GERMINATION AND PLANTGROWTH MEDIUMBENTLE PRODUCTS AG

22/09/2006PA200601222DK21/12/200660/876136US

PCT/IB/2007/004352WO/2008/059387

)2009.01 (A61B19764619/09/2007

ืžืขืจื›ืช ืœื˜ื™ืคื•ืœ ื‘ืœื—ืฅ ืžื•ืคื—ืช ื‘ืขืœ ืคืชื™ื—ืช ืื–ื•ืจื™ืชโ€“ื—ืกื™ืžื” ื•ื™ื›ื•ืœื•ืช ื”ื’ื ืช ืœื—ืฅ ื“ื•

REDUCED PRESSURE TREATMENTSYSTEM HAVING BLOCKAGECLEARING AND DUAL-ZONEPRESSURE PROTECTIONCAPABILITIESKCI LICENSING, INC.

19/09/200660/845993US02/10/200660/849138US19/09/200711/903165US

PCT/US/2007/020375WO/2008/036361

)2009.01 (A61F19764719/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืงื‘ื™ืขืช ืกื˜ื˜ื•ืก ืžื™ืœื•ื™ ืฉืœ ืžื™ื›ืœ ื ื•ื–ืœ ื‘ืžืขืจื›ืช ื˜ื™ืคื•ืœ ื‘ืœื—ืฅ ืžื•ืคื—ืช

SYSTEM AND METHOD FORDETERMINING A FILL STATUS OF ACANISTER OF FLUID IN A REDUCEDPRESSURE TREATMENT SYSTEMKCI LICENSING, INC.

19/09/200660/845993US18/09/200711/901664US

PCT/US/2007/020374WO/2008/036360

Page 142: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 142

)2009.01 (G06F19764819/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื ื™ื”ื•ืœ ืžื”ืœืš ืžื—ืœื” ืฉืœ ื”ื•ืœื” ื•ื˜ื™ืคื•ืœ ืœืจื™ืคื•ื™ ืคืฆืขื™ื

SYSTEM AND METHOD FORMANAGING HISTORY OF PATIENTAND WOUND THERAPYTREATMENTKCI LICENSING, INC.

19/09/200660/845993US18/09/200711/901601US

PCT/US/2007/020355WO/2008/036345

)2009.01 (A61B19764919/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืžืขืงื‘ ืื—ืจ ื”ืชืงื“ืžื•ืช ื”ื”ื—ืœืžื” ืฉืœ ืจืงืžื”

SYSTEM AND METHOD FORTRACKING HEALING PROGRESS OFTISSUEKCI LICENSING, INC.

19/09/200660/845993US18/09/200711/901663US

PCT/US/2007/020353WO/2008/036343

)2009.01 (C12Q19765021/09/2007

A ืฉื™ื˜ื” ืœื›ื™ืžื•ืช ืงื•ืœื’ืŸ ื‘ืจืงืžื” METHOD FOR QUANTITATION OFCOLLAGEN IN TISSUEKCI LICENSING, INC.

21/09/200660/846250US20/09/200711/858737US

PCT/US/2007/079153WO/2008/036891

Page 143: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009143

)2009.01 (A61M19765119/09/2007

ื™ื—ื™ื“ืช ืจื›ื™ื‘ ืœืžืขืจื›ืช ื˜ื™ืคื•ืœ ื‘ืœื—ืฅ ืžื•ืคื—ืชCOMPONENT MODULE FOR AREDUCED PRESSURE TREATMENTSYSTEMKCI LICENSING, INC.

19/09/200660/845993US18/09/200711/901602US

PCT/US/2007/020373WO/2008/036359

)2009.01 (F16M19765219/09/2007

ืžืชืงืŸ ืชืœื™ื” ืœืงื™ื‘ื•ืข ืžื›ืฉื™ืจ ืจืคื•ืื™ ืœืžื‘ื ื” ืชื•ืžืš ืื•ืคืงื™ ืื• ืื ื›ื™ ื‘ืขื™ืงืจ

HANGING APPARATUS FOR FIXINGA MEDICAL DEVICE TO ASUBSTANTIALLY HORIZONTAL ORSUBSTANTIALLY VERTICALSUPPORT STRUCTUREKCI LICENSING, INC.

19/09/200660/845993USPCT/US/2007/020354WO/2008/036344

)2009.01 (G01N19765322/04/2003

ื™ื” ืื ื˜ื™ ื•ื•ื™ืจืืœื™ืช ืฉืœ ื—ืœื‘ื•ื ื™ ืื™ื ื”ื‘ื™ืฆ ืงืคืกื™ื“

ANTIVIRAL INHIBITION OF CAPSIDPROTEINSUNIVERSITY OF MARYLAND,BALTIMORE COUNTY

22/04/200260/374,557US25/04/200260/375,852US16/08/200260/404,043US

PCT/US/2003/012260WO/2003/089615

Page 144: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 144

)2009.01 (H04L19765425/07/2007

SECURE ืžืขืจื›ืช ืžืื•ื‘ื˜ื—ืช ืœื‘ื™ืฆื•ืข ื”ืขื‘ืจื•ืช UNIVERSAL TRANSACTIONSYSTEMFRANCHI, JOHN FRANCO

18/09/200611/532580US19/12/200606256440.6US19/12/20060625304.1US

PCT/US/2007/074327WO/2008/060725

)2009.01 (A61K19765517/03/2009

EMULSIONS ืชืจื—ื™ืคื™ื ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื AND METHODS OFTHEIR PRODUCTION

ื‘ืข-ืื”ื‘ื” -AHAVAืž"ืžืขื‘ื“ื•ืช ื™ื ื”ืžืœื— DEAD SEA LABORATORIESLTD.

17/03/200861/064617US

)2009.01 (A61M19765618/09/2007

BIOLOGICAL ื›ืœื™ ืงื™ื‘ื•ืœ ืœื ื•ื–ืœ ื‘ื™ื•ืœื•ื’ื™ FLUID RECEPTACLELOTUS BIO INC.

18/09/200660/845173USPCT/IL/2007/001144WO/2008/035333

)2009.01 (A61M19765718/09/2007

ืฆื™ื ื•ืจื•ืช ืœื”ืฉืงื™ื” ื‘ื˜ืคื˜ื•ืฃ ืžืกื•ื’ ืžื‘ื•ืšื•ืจื›ื™ื‘ื™ื ืœื‘ืงืจืช ื–ืจื™ืžื” ืœื™ื™ืฆื•ืจ ืฆื™ื ื•ืจื•ืช

ื›ืืœื”

DRIP IRRIGATION HOSES OF THELABYRINTH TYPE AND FLOW-CONTROL ELEMENTS FORPRODUCING SUCH HOSES

AMIR ืืžื™ืจ ื›ื”ืŸ COHEN18/09/200611/522445US

PCT/IL/2007/001146WO/2008/035335

Page 145: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009145

)2009.01 (A62D19765821/09/2007

GASIFIER ื’ื–ื™ื” ื•ืชื ื•ืจ ืœื”ืฉืžื“ืช ืคืกื•ืœืช ื‘ื™ื•ืœื•ื’ื™ืช AND INCINERATOR FORBIOMASS SLUDGE DESTRUCTIONBROOKES, DAVID, R.

22/09/200611/534452USPCT/CA/2007/001701WO/2008/034263

)2009.01 (C02F19765924/09/2007

METHOD ืงื•ืœื—ื™ืŸโ€“ืฉื™ื˜ื” ื•ืžืชืงืŸ ืœื˜ื™ืคื•ืœ ื‘ืžื™ AND APPARATUS FORTREATMENT OF WASTEWATERWILLIAM G. SMITH

25/09/200611/534770US15/02/200711/675113US

PCT/US/2007/079274WO/2008/039711

)2009.01 (H04L19766006/11/2007

ืฉื™ื˜ื•ืช ื•ืžืชืงื ื™ื ืœื”ืขื‘ืจืช ื”ื•ื“ืขื•ืชMETHODS AND APPARATUS FORCOMMUNICATION OFNOTIFICATIONSQUALCOMM INCORPORATED

06/11/200660/864567US12/04/200711/734640US

PCT/US/2007/083808WO/2008/058140

)2009.01 (B65D19766117/03/2009

CONTAINERS ืžื›ืœื™ื ื•ืžืขืจื›ืช ืžื›ืœื™ื AND CONTAINERSYSTEM

THEืž"ื“ื” ืกื˜ื ืœื™ ื•ื•ืจืงืก ื™ืฉืจืืœ ื‘ืข STANLEY WORKS ISRAEL LTD15/04/200812/081369US

Page 146: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 146

)2009.01 (A61B19766221/10/2003

ื”ืชืงืŸ ืœื‘ื™ืฆื•ืข ืื ื•ืœื•ืคืœืกื˜ื™ื” ืžื‘ื•ืกืกืช ืขืœ ืฆื ืชืจ ื‘ืืžืฆืขื•ืช ืงื™ืคื•ืœื™ื ืžืงื•ืžื™ื™ื

APPARATUS FOR PERFORMINGCATHETER-BASED ANNULOPLASTYUSING LOCAL PLICATIONSMITRALIGN, INC.

21/10/200260/420095USPCT/US/2003/033382WO/2004/037317

)2009.01 (C07K19766317/07/2003

ื˜ื™ืคื•ืœ ื‘ื›ืฉืœ ื›ืœื™ื™ืชื™ ื‘ืืžืฆืขื•ืช ืื™ื ื˜ืจืคืจื•ืŸ?

THERAPIES FOR RENAL FAILUREUSING INTERFERON ?

BIOGEN IDEC MA INC.17/07/200260/396393US

PCT/US/2003/022440WO/2004/006756

)2009.01 (C07D19766405/10/2007

BIARYL ืชืจื›ื•ื‘ื•ืช ื‘ื™ืืจื™ืœ ืืชืจ ืื•ืจื™ืื” ETHER UREA COMPOUNDSPFIZER PRODUCTS INC.

18/10/200660/829966US17/08/200760/965210US

PCT/IB/2007/003202WO/2008/047229

)2009.01 (B05D19766518/09/2007

ืฉื™ื˜ื” ื•ืืžืฆืขื™ื ืœื™ืฆื•ืจ ืื™ื ื“ื™ืงืฆื™ื” ืžื•ืฉืจืช ืžื’ื ื˜ื™ืช ื‘ืฆื™ืคื•ื™ ื”ืžื›ื™ืœ ื—ืœืงื™ืงื™ื ืžื’ื ื˜ื™ื™ื

METHOD AND MEANS FORPRODUCING A MAGNETICALLYINDUCED INDICIA IN A COATINGCONTAINING MAGNETICPARTICLESSICPA HOLDING S.A.

17/10/200606122467.1EPPCT/EP/2007/059818WO/2008/046702

Page 147: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009147

)2009.01 (B61C19766618/09/2007

ืจื›ื‘ ื”ื ืข ืขืœ ืžืกื™ืœื” ืขื ื™ื—ื™ื“ืชโ€“ื›ืœื™RAIL ื ื”ื™ื’ื” VEHICLE WITH A DRIVE UNIT

BOMBARDIER TRANSPORTATIONGMBH

18/09/2006102006044396.9DEPCT/EP/2007/059860WO/2008/034830

)2009.01 (A23L19766718/10/2007

POLYPHENOL-RICE ืชืžืฆื™ืช ืขืฉื™ืจื” ื‘ืคื•ืœื™ืคื ื•ืœ ืžื—ื•ืžืจ ืฆืžื—ื™ EXTRACT FROMPLANT MATERIALKRAFT FOODS R&D, INC.

20/10/200606022029.0EPPCT/US/2007/081801WO/2008/051799

)2009.01 (C12N19766809/10/2007

ืœ ืœืืคื ื•ืŸRNAโ€“ืชืจื›ื•ื‘ื•ืช ืื ื˜ื’ื•ื ื™ืกื˜ื™ื•ืช9PCSK

RNA ANTAGONIST COMPOUNDSFOR THE MODULATION OF PCSK9

SANTARIS PHARMA A/S09/10/200660/828735US17/09/200760/972932US04/10/200760/977409US

PCT/EP/2007/060703WO/2008/043753

)2009.01 (B32B19766909/10/2007

ืฉื›ื‘ืชื™ื™ื ื”ืžื›ื™ืœื™ืโ€“ื—ื•ืžืจื™ื ืจื‘ืงื•ืคื•ืœื™ืžืจื™ื ืชืจืžื•ืคืœืกื˜ื™ื ืฉืœ

ืคื•ืœื™ืกื™ืœื•ืงืกืืŸ ืื•ืจื™ืื”

LAMINATES COMPRISINGTHERMOPLASTIC POLYSILOXANEUREA COPOLYMERS

WACKER CHEMIE AG11/10/2006102006048216.6DE

PCT/EP/2007/060693WO/2008/043749

Page 148: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 148

)2009.01 (A61F19767025/09/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืฉื™ืคื•ืจ ื”ืชืคืงื•ื“ ื”ื™ื“ืืกื˜ื•ืœื™ ืฉืœ ื”ืœื‘

METHOD AND SYSTEM FORIMPROVING DIASTOLIC FUNCTIONOF THE HEART

CORASSISTืž"ืงื•ืจืืกื™ืกื˜ ืงืจื“ื™ื•ื•ืกืงื•ืœืจ ื‘ืข CARDIOVASCULAR LTD.25/09/200660/846748US

PCT/IL/2007/001180WO/2008/038276

)2009.01 (G08G19767119/09/2007

METHOD ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืžื ื™ืขืช ืชืื•ื ื•ืช AND SYSTEM FORPREVENTING ACCIDENTSUNIFIED MESSAGING SYSTEMS AS

19/09/200620064234NO19/09/200660/826090US

PCT/NO/2007/000329WO/2008/035981

)2009.01 (G01J19767218/09/2007

DEVICE ืžื›ืฉื™ืจ ื•ืฉื™ื˜ื” ืœื‘ื—ื™ื ืช ื“ื’ื™ืžืช ืฉื™ืขืจ AND METHOD FORINSPECTING A HAIR SAMPLE

ื‘ืข'ืกื™ืช SEETHROUGHืž"ืจื• LTD19/09/200611/523009US

PCT/IL/2007/001147WO/2008/035336

)2009.01 (G06F19767318/09/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืขื‘ื•ืจ ืื™ื ืคื•ื–ื™ื” ืžื‘ื•ืงืจืช ืฉืœ ื—ื•ืžืจื™ื ื˜ื™ืคื•ืœื™ื™ื

METHOD AND SYSTEM FORCONTROLLED INFUSION OFTHERAPEUTIC SUBSTANCESBAXTER INTERNATIONAL INC.

18/09/200611/523794USPCT/US/2007/078765WO/2008/036658

Page 149: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009149

)2009.01 (H04Q19767418/09/2007

ื”ื—ืœืคืช ืžืฉืื‘ื™ื ืžืจื•ื‘ื™ ืงื™ืฉื•ืจ ืฉื›ื‘ืชื™ ืชืœื•ื™ื” ืฉืœ ืžื“ื™ื”โ€“ืขื‘ื•ืจ ื”ืขื‘ืจื” ื‘ืœืชื™

SWITCHING MULTIPLE LINK LAYERRESOURCES FOR MEDIAINDEPENDENT HANDOVERINTERDIGITAL TECHNOLOGYCORPORATION

18/09/200660/826024US12/03/200760/894370US

PCT/US/2007/020232WO/2008/036278

)2009.01 (C07K19767520/09/2007

PEPTIDES ืคืคื˜ื™ื“ื™ืLEXCICON LIMITED

20/09/20060618512.8GB19/04/20070707626.8GB

PCT/GB/2007/003592WO/2008/035093

)2009.01 (A47D19767618/03/2009

ืฉื•ืœื—ืŸ ื”ืžืชืงืคืœ ื”ื—ื•ืฆื” ืขื ื”ืจื›ื‘ื” ืขืœ ื‘ื ื•ื™ ืขืœ ืชืžื•ื›ื•ืช ื‘ื—ืœืงื™ื, ืฆื™ืจ

FOLD OUT SAWHORSE WITHPIVOTABLE, CANTILEVEREDSUPPORT MEMBERSDARRYL W. HULS

20/03/200812/052685US

)2009.01 (C07K19767724/10/2007

ืชืžืจื™ื ื•ืฉื™ื˜ื•ืช ืœืื™ืžื•ื ื•ื’ืœื™ืงื•ืคืจื•ื˜ืื™ื ื™ื ืžืฉื•ืคืจื™ื

MATERIALS AND METHODS FORIMPROVEDIMMUNOGLYCOPROTEINSTRUBION PHARMACEUTICALS, INC.

24/10/200660/853944USPCT/US/2007/082343WO/2008/052030

Page 150: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 150

)2009.01 (G01N19767810/07/2002

ื”ื™ื™ืขื•ื“ื™ื™ื ื–ื”ื•ื™R2Tื˜ืขื ืฉื™ืžื•ืฉ ื‘ืงื•ืœื˜ื ื™ ืชืจื›ื•ื‘ื•ืช ื”ื—ื•ืกืžื•ืช ื˜ืขื ืžืจ

USE OF SPECIFIC T2R TASTERECEPTORS TO IDENTIFYCOMPOUNDS THAT BLOCK BITTERTASTESENOMYX, INC.

10/07/200160/303811US15/04/200260/372089US

PCT/US/2002/021602WO/2003/006482

)2009.01 (A23N19767919/09/2007

ืžื›ื•ื ื” ืื•ื˜ื•ืžื˜ื™ืช ืœืžื™ืฆื•ื™ ืžื™ืฅ ืžืคืจื™ื”ื“ืจ ืขื ืืœืžื ื˜ื™ื ืคื•ื ืงืฆื™ื•ื ืืœื™ื

ื”ืžืืคืฉืจื™ื ื ื™ืงื•ื™ ืงืœ ื™ื•ืชืจ

AUTOMATIC MACHINE FOR CITRUSFRUIT JUICE EXTRACTION WITHFUNCTIONAL ELEMENTS ALLOWINGEASIER CLEANINGA.A.T.-AGROINDUSTRY ADVANCEDTECHNOLOGIES S.P.A

19/09/2006BO2006A000640ITPCT/IT/2007/000650WO/2008/035388

)2009.01 (A61K19768024/09/2007

ืชื›ืฉื™ืจื™ื ื•ืฉื™ื˜ื•ืช ืœืžืชืŸ ืชืจื•ืคื•ืช ืžื›ื•ื•ื ื•ืชpH

COMPOSITIONS AND METHODS FORpH TARGETED DRUG DELIVERYLABOPHARM, INC.

22/09/200660/846355USPCT/IB/2007/004171WO/2008/035229

Page 151: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009151

)2009.01 (C08B19768126/09/2007

ื“ืงืกื˜ืจืืŸ ื”ืžืฉื•ืคืขืœ ืขื ื—ื•ืžืฆื•ืช ืืžื™ื ื• ื”ื™ื“ืจื•ืคื•ื‘ื™ื•ืช

DEXTRAN FUNCTIONALIZED WITHHYDROPHOBIC AMINO ACIDS

ADOCIA26/09/2006PCT/IB06/002666WO29/03/20070702316FR

PCT/IB/2007/002807WO/2008/038111

)2009.01 (A63B19768219/09/2007

EXERCISE ืžื›ืฉื™ืจ ื”ืชืขืžืœื•ืช APPARATUSHARRY MOK,

20/09/200611/523293USPCT/US/2007/078925WO/2008/036758

)2009.01 (C07K19768327/02/1998

ืžื•ืœืงื•ืœื” ืฉืœ ืคื ื™ ืฉื˜ื— ื”ืชื ื”ืžืชื•ื•ื›ืชื™ ื•ื”ืขื‘ืจืช ืื•ืชื•ืชืฆื™ืžื•ื“ ืชื

CELL SURFACE MOLECULEMEDIATING CELL ADHESION ANDSIGNAL TRANSMISSIONJAPAN TOBACCO INC.

27/02/19979/62290JP26/02/199810/62217JP

PCT/JP/1998/000837WO/1998/038216

)2009.01 (C12N19768424/09/2007

ื‘ื• ืžื“ื™ื•ื ืชืจื‘ื•ืช ืœืชืื™ ื’ื–ืข STEM ื•ืฉื™ืžื•ืฉื™ื CELL CULTURE MEDIUM ANDMETHODS OF USE THEREOFRIKEN

22/09/20062006257780JP27/04/20072007118183JP25/05/20070710095.1JP

PCT/GB/2007/003636WO/2008/035110

Page 152: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 152

)2008.04 (C07D19768511/05/1999

ื• ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

HETEROCYCLIC COMPOUNDS ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAMEVERTEX PHARMACEUTICALSINCORPORATED

11/05/199860/085053US01/04/199960/127626US13/04/199960/129099US

PCT/US/1999/010291WO/1999/058502

)2009.01 (H04L19768726/08/2007

REMOTE ืžืขืจื›ืช ืœืฉื™ื“ื•ืจ ืžืจื•ื—ืง TRANSMISSION SYSTEMLIVEUืž"ืœื™ื™ื•ื™ื• ื‘ืข LTD

26/09/200660/847148USPCT/IL/2007/001057WO/2008/038261

)2009.01 (B01J19768824/09/2007

ืฆื‘ืจื™ื ืคื•ืจื•ื–ื™ื‘ื™ื™ื ืฉืœ ืื‘ืงืช ื›ืกืฃ ืžื—ื•ื–ืงื™ืื‘ืชื—ืžื•ืฆืช ื–ื™ืจืงื•ื ื™ื•ื ืœืฉื™ืžื•ืฉ ื›ื–ืจื– ื‘ืืœืงื˜ืจื•ื“ื•ืช ืขืœ ื‘ืกื™ืก ื“ื™ืคื•ื–ื™ื™ืช ื’ื–

POROUS CLUSTERS OF SILVERPOWDER PROMOTED BYZIRCONIUM OXIDE FOR USE AS ACATALYST IN GAS DIFFUSIONELECTRODES, AND METHOD FORTHE PRODUCTION THEREOF

BAR-ILAN ืื™ืœืŸ-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืจ UNIVERSITY22/09/200660/846346US

PCT/US/2007/079261WO/2008/036962

Page 153: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009153

)2009.01 (C12N19768919/09/2007

ืžื•ื•ืกืชื™ื ื•ืžืขื‘ืจื™ืMIRโ€“ 200ื’ื ื™ื ื›ืžื˜ืจื•ืช ืœื”ืชืขืจื‘ื•ืช ืจืคื•ืื™ืช

MIR-200 REGULATED GENES ANDPATHWAYS AS TARGETS FORTHERAPEUCTIC INTERENTIONASURAGEN INC.

19/09/200660/826173US21/05/200760/939309US

PCT/US/2007/078894WO/2008/036741

)2009.01 (C12N19769019/09/2007

ืžื™ืงืจื• ืจื ื ื”ืžืชื‘ื˜ืื™ื ื‘ืฆื•ืจื•ืช ืฉื•ื ื•ืช ื‘ืžื—ืœื•ืช ืฉืœ ื”ืœื‘ืœื‘ ื•ืฉื™ืžื•ืฉื™ื ืฉืœื”ื

MICRORNAS DIFFERENTIALLYEXPRESSED IN PANCREATICDISEASES AND USES THEREOFASURAGEN INC.

19/09/200660/826173USPCT/US/2007/078936WO/2008/036765

)2009.01 (C12N19769119/09/2007

ืžื•ื•ืกืชื™ื ื•ืžืขื‘ืจื™ืMIRโ€“ 143ื’ื ื™ื ื›ืžื˜ืจื•ืช ืœื”ืชืขืจื‘ื•ืช ืจืคื•ืื™ืช

MIR-143 REGULATED GENES ANDPATHWAYS AS TARGETS FORTHERAPEUTIC INTERVENTIONASURAGEN INC.

19/09/200660/826173US22/05/200760/939573US

PCT/US/2007/078859WO/2008/036718

)2009.01 (C07D19769310/07/2007

ืชื•ืœื“ื•ืช ืคื ื™ืœื™ื•ืช ื•ื”ืฉื™ืžื•ืฉ ื‘ื”ืŸ ื—ื™ืกื•ืŸโ€“ื›ืžืืคื ื ื™

PHENYL DERIVATIVES AND THEIR USEAS IMMUNOMODULATORS

ACTELION PHARMACEUTICALS LTD.21/09/2006PCT/IB06/053426WO

PCT/IB/2007/052746WO/2008/035239

Page 154: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 154

)2009.01 (C07D19769420/09/2007

ืกื“ืจื™ืโ€“ืชื•ืœื“ื•ืช ืคื™ืจื™ื“ื™ืŸ ืœื˜ื™ืคื•ืœ ื‘ืื™ืžื˜ืื‘ื•ืœื™ื™ื ื”ืงืฉื•ืจื™ื ืœืขืžื™ื“ื•ืช ืœืื™ื ืกื•ืœื™ืŸ

ืื• ืœื”ื™ืคืจื’ืœื™ืงืžื™ื”

PYRIDINE DERIVATIVES FOR THETREATMENT OF METABOLICDISORDERS RELATED TO INSULINRESISTANCE OR HYPERGLYCEMIAPIRAMAL LIFE SCIENCES LIMITED

21/09/200660/846194US18/12/200660/875672US

PCT/IB/2007/053811WO/2008/035305

)2009.01 (C07D19769520/09/2007

โ€“ื™ืŸ ืœื˜ื™ืคื•ืœ ื‘ืื™ืคื™ืจื™ื“โ€“ืืžื™ื ื•โ€“3ืชื•ืœื“ื•ืช ืกื“ืจื™ื ืžื˜ืื‘ื•ืœื™ื™ื

3-AMINO-PYRIDINE DERIVATIVESFOR THE TREATMENT OFMETABOLIC DISORDERSPIRAMAL LIFE SCIENCES LIMITED

21/09/200660/846194US18/12/200660/875672US

PCT/IB/2007/053812WO/2008/035306

)2009.01 (B01D19769620/09/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ืขืฉืจืช ืื™ื–ื•ื˜ื•ืคื™ื ืฉืœ ื—ืžืฆืŸ ื›ื‘ื“

METHOD AND EQUIPMENT FOR THEENRICHMENT OF HEAVY OXYGENISOTOPESTAIYO NIPPON SANSOCORPORATION

26/09/20062006-260894

JP

PCT/JP/2007/068253WO/2008/038561

Page 155: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009155

)2009.01 (H04Q19769718/09/2007

ื”ื‘ื“ืœ ื‘ื–ืžืŸ ื”ื•ืคืขื” ืฉืœ ืงื™ืฉื•ืจ ื‘ืžื™ืฉื•ืจ ืžืฉืชืžืฉ

USER PLANE UPLINK TIMEDIFFERENCE OF ARRIVAL (U-TDOA)

TRUEPOSITION, INC19/09/200611/533310US

PCT/US/2007/078783WO/2008/036673

)2009.01 (H04Q19769818/09/2007

LOCATION ืื™ื›ื•ืช ืžื™ืงื•ื ืฉืœ ืžื—ื•ืŸ ืฉื™ืจื•ืช QUALITY OF SERVICEINDICATORTRUEPOSITION, INC

21/09/200611/534137USPCT/US/2007/078786WO/2008/036676

)2009.01 (A01K19769928/09/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ื‘ืงืจื” ืœื”ืงื˜ื ืช ื”ืขื•ืžืก ื”ืชืจืžื™ ืขืœ ื—ื™ื•ืช

A METHOD AND CONTROL SYSTEMFOR DECREASING THE THERMALLOAD ON ANIMALSDELAVAL HOLDING AB

29/09/20060602048-1SEPCT/SE/2007/050690WO/2008/039150

)2009.01 (E02D19770024/09/2007

CELLULAR ืžืขืจื›ื•ืช ืฉืœ ืชืื™ื ืžื•ื’ื‘ืœื™ื CONFINEMENTSYSTEMSTERRAM LIMITED OF

25/09/20060618868.4GB27/06/20070712510.7GB

PCT/GB/2007/003630WO/2008/037972

Page 156: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 156

)2009.01 (A61K19770119/10/2007

MICELLAR ื ื ื•ื—ืœืงื™ืงื™ื ืžื™ืฆืœื™ื ืฉืœ ื—ื•ืžืจื™ื ื›ื™ืžื™ื™ื NANOPARTICLES OFCHEMICAL SUBSTANCESSOLVAY PHARMACEUTICALS B.V.

20/10/200606122648.6EP20/10/200660/853023US

PCT/EP/2007/061194WO/2008/046905

)2009.01 (C07K19770219/11/2007

ืชืฆืžื™ื“ ื ื•ื’ื“ ืื™ื“ื•ื˜ื™ืค ื•ืฉื™ืžื•ืฉ ื‘ื• ื›ืกื˜ื ื“ืจื“ ื‘ื‘ื•ื—ืŸ ื—ื™ืกื•ืŸ

ANTI-IDIOTYPE CONJUGATE ANDITS USE AS A STANDARD IN ANIMMUNASSAYF. HOFFMANN-LA ROCHE AG

21/11/200606024133.8EPPCT/EP/2007/009980WO/2008/061684

)2009.01 (A01N19770317/09/2007

ื—ื•ืžืจ ืœื˜ื™ืคื•ืœ ื‘ื–ื™ื”ื•ืžื™ื ืžืชื—ืช ืœืฆื™ืคื•ืจื ื™ื™ื ื•ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ื–ื™ื”ื•ืžื™ื ืคื˜ืจื™ืชื™ื™ื

SUBUNGUICIDE, AND METHOD FORTREATING ONYCHOMYCOSIS

JAY E. BIRNBAUM19/09/200611/523508US

PCT/US/2007/078632WO/2008/036595

Page 157: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009157

)2008.04 (H04J19770402/04/2003

ืžืขืจื›ืช ืœืฉื™ื—ืจื•ืจ ื™ืขื™ืœ ืฉืœ ืžื™ื“ืข ื‘ืขืงื‘ื•ืชื‘ HSโ€“DSCHโ€“ืฉื™ื ื•ื™

SYSTEM FOR EFFICIENT RECOVERYOF NODE B BUFFERED DATAFOLLOWING SERVING HIGH SPEEDDOWNLINK SHARED CHANNELCELL CHANGEINTERDIGITAL TECHNOLOGYCORPORATION

05/04/200260/370740US30/12/200210/334489US

PCT/US/2003/000100WO/2003/087978

)2009.01 (A61K19770512/11/2002

ืฉื™ื˜ื” ืœื™ืฆื•ืจ,Apo2ื”ืจื›ื‘ ื™ืฆื™ื‘ ืœื™ื’ื ื“ื’ื‘ื™ืฉื™ ื•ื”ืฉื™ืžื•ืฉ ื‘ื”ื ืœื”ื›ื ืช2Apoืœื™ื’ื ื“

ืชืจื•ืคื•ืช

STABLE FORMULATION OF Apo2LIGNAD, A METHOD OF MAKINGCRYSTALIZED Apo2 LIGNAD ANDUSE THEREOF IN THEMANUFACTURE OF MEDICAMENTSGENENTECH, INC.

13/11/200160/338249USPCT/US/2002/036251WO/2003/042344

)2009.01 (G01V19770619/09/2007

ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœื–ื™ื”ื•ื™ ื•ืžื™ื•ืŸ ืฉืœ, ื‘ื”ืขื“ืคื”, ืงื˜ื™ื ื ืกืชืจื™ืืื•ื‘ื™ื™

ื• ืื“ืโ€“ืื• ืชื ื•ืขืช ื‘ื ื™/ื‘ืื•ื‘ื™ื™ืงื˜

ARRANGEMENT AND METHOD FORRECOGNISING AND CLASSIFYINGPREFERABLY HIDDEN OBJECTS INOBJECT AND/OR HUMAN TRAFFICDISPLAYCOM TRACK TECHNOLOGIESGMBH

19/09/2006102006044398.5DEPCT/DE/2007/001704WO/2008/034434

Page 158: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 158

)2009.01 (A61F19770720/09/2007

INTRAUTERINE ืจื—ืžื™ ืœืžื ื™ืขืช ื”ืจื™ื•ืŸโ€“ื”ืชืงืŸ ืชื•ืš CONTRACEPTIVEDEVICEKARPATI, MELINDA-KINGA

20/09/200606019697.9EPPCT/EP/2007/008202WO/2008/034619

)2009.01 (C01F19770803/04/2007

ืฆื•ืจ ื—ืœืงื™ืงื™ื ื ื ื•ืžื˜ืจื™ื™ื ืชื”ืœื™ืš ืœื™ื™ืื—ื™ื“ื™ื ื•ื™ืฆื™ื‘ื™ื ืฉืœ ืžื’ื ื–ื™ื•ื

ื•ื”ืžื•ืฆืจ ื”ืžืชืงื‘ืœ, ื”ื™ื“ืจื•ืงืกื™ื“ ืžื”ืชื”ืœื™ืš

PROCESS FOR THE FABRICATION OFMANOMETRIC, ZONODISPERSED ANDSTABLE MAGNESIUM HYDROXIDE ANDPRODUCT OBTAINED

SERVICIOS INDUSTRIALES PENOLES S.A.DE C.V.

10/10/2006NL/A/2006/000070MXPCT/MX/2007/000045WO/2008/041833

)2009.01 (F24F19770919/03/2009

SUPPORT ืžืขืจื›ืช ืชืžื™ื›ื” ืœื™ื—ื™ื“ืช ืžื–ื’ืŸ SYSTEM FOR AN AIRCONDITIONER

COOOLืž"ืงื•ืœ ืขื™ืฆื•ื‘ ืื•ื•ื™ืจ ื‘ืข AIR DESIGN LTD

)2009.01 (C02F19771021/09/2007

ื›ื™ื ืชื”ืœื™, ืžืขืจื›ื•ืช ืžืฉื•ืคืจื•ืช ื•ืžืชื•ื“ื•ืœื•ื’ื™ื•ืช ืœื™ื™ืฆื•ืจ ืžื™ื ื ืงื™ื™ื ื•ืชื•ืฆืจื™ื”ื

NOVEL ENHANCED SYSTEMS,PROCESSES AND METHODLOGIESFOR PRODUCING CLEAN WATERAND PRODUCTS THEREBYALTELA INC.

22/09/200660/826730USPCT/US/2007/079197WO/2008/036925

Page 159: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009159

)2009.01 (B60R19771123/09/2007

ืžืขืจื›ืช ืฉืœื™ื˜ื” ืžืจื—ื•ืง ืœืจื›ื‘ ืฉื›ื•ืœืœืช ืจื›ื™ื‘ ื”ื—ืœืคื” ืžื•ืชืื

VEHICLE REMOTE CONTROLSYSTEM WITH ADJUSTABLEREPLACEMENT DEVICE

GOREN ื ื™ืจ ื’ื•ืจืŸ NIR21/09/200660/846112US

PCT/IL/2007/001171WO/2008/035351

)2009.01 (C07C19771218/09/2007

SULFONAMIDE ืžื™ื“ืชื•ืœื“ื•ืช ืกื•ืœืคื•ื ื DERIVATIVESF. HOFFMANN-LA ROCHE AG

29/09/200606121544.8EPPCT/EP/2007/059842WO/2008/037628

)2009.01 (C12N19771321/09/2007

ื˜ืจื ืกืคื•ืจืžืฆื™ื” ื‘ื’ื•ืฃ ื”ื—ื™ ืฉืœ ืชืื™ ืืงื™ื ืจ ืฉืœ ื”ืœื‘ืœื‘ ืœืชืื™ื ืžื™ื™ืฆืจื™ ืื™ื ืกื•ืœื™ืŸ

IN VIVO TRANSFORMATION OFPANCREATIC ACINAR CELLS INTOINSULIN-PRODUCING CELLSBAYLOR RESEARCH INSTITUTE

22/09/200660/846465USPCT/US/2007/079242WO/2008/036953

)2009.01 (C07D19771405/10/2007

ืคื™ืจื™ื“ื™ื ืงืจื‘ื•ืงืกืืžื™ื“ ื‘ืขืœืชโ€“2ื ื’ื–ืจืช ืฉืœGKืคืขื™ืœื•ืช ืฉืคืขื•ืœ ืฉืœ

2-PYRIDINECARBOXAMIDEDERIVATIVE HAVING GK-ACTIVATING ACTIVITYBANYU PHARMACEUTICAL CO.,LTD.

06/10/20062006-275824

JP

PCT/JP/2007/070014WO/2008/044777

Page 160: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 160

)2009.01 (E01F19771519/09/2007

ENHANCED ืžืขืจื›ืช ืžืฉื•ืคืจืช ืœื—ืกื™ืžืช ื›ืœื™ ืจื›ื‘ VEHICLE BARRIERSYSTEMUNIVERSAL SAFETY RESPONSE,INC.

22/09/200611/525479US14/05/200711/803445US

PCT/US/2007/020270WO/2008/039336

)2009.01 (C07D19771625/09/2007

5ื ื’ื–ืจื•ืช ืงื•ื•ื™ื ื–ื•ืœื™ื ื•ืŸ ื”ืžื•ืชืžืจื•ืช ื‘ืขืžื“ื” ืกืจื˜ื ื™ื™ืโ€“ื›ื—ื•ืžืจื™ื ืื ื˜ื™

5-SUBSTITUTED QUINAZOLINONEDERIVATIVES AS ANTITUMORAGENTSCELGENE CORPORATION

26/09/200660/847471USPCT/US/2007/020765WO/2008/039489

)2009.01 (C07D19771724/09/2007

โ€“5[โ€“3โ€“ืฆื•ืจื•ืช ื’ื‘ื™ืฉื™ื•ืช ืฉืœ ื—ื•ืžืฆื” ื‘ื ื–ื•ืื™ืช]4,2,1[โ€“)ืคืœื•ืื•ืจื•ืคื ื™ืœโ€“2(

]ืื™ืœโ€“3โ€“ืื•ืงืกื“ื™ืื–ื•ืœ

CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOICACIDPTC THERAPEUTICS, INC.

25/09/200660/847326USPCT/US/2007/020633WO/2008/039431

Page 161: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009161

)2009.01 (A61K19771824/09/2007

HDACืชื›ืฉื™ืจื™ื ืจื•ืงื—ื™ื™ื ืฉืœ ืžืขื›ื‘ื™ื•ืชืจื›ื•ื‘ื•ืช ืžืชื›ืช ื”ื ื™ืชื ื•ืช ืœืงืœืืฆื™ื”

ืžืขื›ื‘โ€“ืื˜ ืžืชื›ืชื•ืงื•ืžืคืœืงืกื™ื ืฉืœ ืงืœHDAC

PHARMACEUTICAL COMPOSITIONSOF HDAC INHIBITORS ANDCHELATABLE METAL COMPOUNDS,AND METAL-HDAC INHIBITORSCHELATE COMPLEXESMERCK & CO., INC.

28/09/200660/848300USPCT/US/2007/020609WO/2008/039421

)2009.01 (E04H19771919/09/2007

REMOVABLE ืžืขืจื›ืช ื‘ืจื™ืงื“ื” ืฉื ื™ืชื ืช ืœื”ื–ื–ื” BARRICADE SYSTEMUNIVERSAL SAFETY RESPONSE,INC.

22/09/200611/525478USPCT/US/2007/020280WO/2008/039338

)2009.01 (C07D19772027/09/2007

โ€“3โ€“ืื™ื ื“ื•ืœโ€“1Hโ€“ืคืœื•ืจื•โ€“6(โ€“2[ืœื˜]ื‘ื ื–ื™ืœ)ืื™ืœืกื•ืœืคื ื™ืœ ื™ืคื•ืœ ืžืชื™ืœ ืืžื™ืŸ ื‘ื”ืคืจืขื•ืช

[2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THETREATMENT OFAFFECTIVE DISORDERSH. LUNDBECK A/S

28/09/2006PA200601251DK20/03/2007PA200700432DK

PCT/DK/2007/000419WO/2008/037258

Page 162: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 162

)2009.01 (C07K19772128/09/2007

ืชืจื›ื•ื‘ื•ืช ื•ืฉื™ื˜ื•ืช ืœืื‘ื—ื•ืŸ ื•ื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸCOMPOSITIONS AND METHODS FORDIAGNOSING AND TREATINGCANCERONCOMED PHARMACEUTICALS,INC.

29/09/200660/847904US23/01/200760/886260US07/06/200760/942542US

PCT/US/2007/020889WO/2008/042236

)2009.01 (C07D19772225/09/2007

5MGLURMGLUR5ืžืืคื ื ื™ื ืฉืœ MODULATORSASTRAZENECA AB

05/10/200660/828325USPCT/IB/2007/002784WO/2008/041075

)2009.01 (C07D19772302/10/2007

3/5STATSTAT3/5ืžืขื›ื‘ ืฉืคืขื•ืœ ืฉืœ ACTIVATION INHIBITOROTSUKA PHARMACEUTICAL CO.,LTD.

02/10/20062006-271172

JP

PCT/JP/2007/069645WO/2008/044667

)2009.01 (C07D19772424/09/2007

ืชืจื›ื•ื‘ื•ืช ื•ืชื›ืฉื™ืจื™ื ื›ืžืขื›ื‘ื™ ืคืจื•ื˜ืื™ืŸ ืงื™ื ืื–

COMPOUNDS AND COMPOSITIONSAS PROTEIN KINASE INHIBITORS

NOVARTIS AG02/10/200660/827873US

PCT/US/2007/079340WO/2008/042639

Page 163: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009163

)2009.01 (A61K19772526/09/2007

NUTRIENT ื—ื™ื™ืฉืŸ ืฉืœ ื—ื•ืžืจ ืžื–ื™ืŸ SENSORBAYLOR RESEARCH INSTITUTE

26/09/200660/847252USPCT/US/2007/079570WO/2008/039855

)2009.01 (A61K19772620/09/2007

ื”ื˜ืจื•ืฆื™ืงืœื™ื ืžื•ืชืžืจื™ื ื”ืžื›ื™ืœื™ื ื—ื ืงืŸ ื‘ื˜ืกื™ืชADPื›ืžืขื›ื‘ื™ ืจืฆืคื˜ื•ืจ

NITROGEN CONTAININGSUBSTITUTED HETEROCYCLES ASPLATELET ADP RECEPTORINHIBITORSPORTOLA PHARMACEUTICALS, INC.

20/09/200660/846328US17/09/200711/856616US

PCT/US/2007/079076WO/2008/036843

)2009.01 (A61K19772726/09/2007

38CDCOMBINATIONื˜ื™ืคื•ืœ ืžืฉื•ืœื‘ ื‘ื’ื™ื“ื•ืœื™ื ื”ืžื‘ื˜ืื™ื TREATMENT OFCD38-EXPRESSING TUMORSGENMAB A/S

26/09/2006PA200601232DK26/09/200660/847329US

PCT/DK/2007/000418WO/2008/037257

)2009.01 (H02M19772822/09/2006

VACUUMืชืžืฆื™ืช ืื ืจื’ื™ื” QUANTUMQUANTUM VACUUM ENERGYEXTRACTIONJOVION CORPORATION

PCT/US/2006/037096WO/2008/039176

Page 164: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 164

)2009.01 (B29B19772903/10/2007

IMPROVED ืชื‘ื ื™ื•ืช ืคืœืกื˜ื™ืง ืžืฉื•ืคืจื•ืช PLASTIC PREFORMCONCORDIA DEVELOPMENT S.R.L

06/10/2006MI2006A001922ITPCT/IB/2007/054015WO/2008/041186

)2009.01 (G01N19773020/09/2007

ื ื•ื’ื“ืŸ ืœื–ื™ื”ื•ื™ ืžืชืžืจื™ืโ€“ืžืขืจื›ื™ื ืžื‘ื•ืกืกื™ ืžืจื•ื‘ื™ ืื•ืช ื‘ืชืื™ื ื ืขื™ื ื ื“ื™ืจื™ื

ANTIBODY-BASED ARRAYS FORDETECTING MULTIPLE SIGNALTRANSDUCERS IN RARECIRCULATING CELLSPROMETHEUS LABORATORIES, INC.

21/09/200611/525598US20/04/200760/913087US

PCT/US/2007/079002WO/2008/036802

)2009.01 (A47K19773122/03/2009

ืžื›ืฉื™ืจ ืœืื—ื™ื–ืช ืžื’ื‘ื•ืŸ ืœื— ื‘ืขืช ื”ืฉื™ืžื•ืฉDEVICE FOR HOLDING A PRE-MOISTENED TOWELLETTE DURINGUSE

ื’ GALIA ื•ืœื™ื” ืœื•ื™'ื’ืœื™ื” GULYA LEVY

)2009.01 (A61J19773228/09/2007

ืžืขืจื›ืช ืœืืจื™ื–ืช ืชื›ืฉื™ืจื™ื ืจื•ืงื—ื™ื™ืื•ืจื™ื“ื™ ื•ืขืจื›ื•ืช ื”ืžื›ื™ืœื•ืชโ€“ืœืžืชืŸ ืชื•ืš

ืื•ืชืŸ

PACKAGING SYSTEM FORPHARMACEUTICAL COMPOSITIONSFOR INTRAVENOUS ADMINISTRATIONAND KITS COMPRISING THE SAMEINFA S.A.

29/09/2006MI2006A001881IT29/03/2007MI2007A000635IT

PCT/IB/2007/002857WO/2008/038126

Page 165: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009165

)2009.01 (H04M19773329/10/2007

, ืœื™ื™ืขื•ืœ, ืœืชื–ืžื•ืŸ, ืฉื™ื˜ื•ืช ื•ืžืขืจื›ื•ืช ืœืงื‘ื™ืขื”ื•ืœืืชื—ื•ืœ ืฉืœ ืชืงืฉื•ืจืช ืื™ืฉื™ืช ื•ืœืงื‘ื•ืข

ืงื™ ืชืงืฉื•ืจืช ืกื“ืจ ืขื“ื™ืคื•ื™ื•ืช ืขื‘ื•ืจ ืืคื™ ื•ืžืชืงื ื™ ืชืงืฉื•ืจืช

METHODS AND SYSTEMS FORSETTING, SCHEDULING,OPTIMIZING, AND INITIATINGPERSONAL COMMUNICATION ANDPRIORITIZING COMMUNICATIONCHANNELS AND DEVICESNEATCALL LTD.

29/10/200660/863368USPCT/IL/2007/001309WO/2008/053467

)2009.01 (G06K19773407/08/2008

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื‘ื™ืฆื•ืข ืื™ืชื•ืจ ื•ืžืขืงื‘ ืชื ื•ืขื” ืื•ืคื˜ื™ืช ืฉืœ ื—ืคืฅ ืขืœ ืคื ื™ ืฉื˜ื— ืจื—ื‘

METHOD AND SYSTEM TOPERFORM OPTICAL MOVINGOBJECT DETECTION AND TRACKINGOVER A WIDE AREAVISIONMAP LTD.

07/08/200760/954366USPCT/IL/2008/001085WO/2009/019695

)2009.01 (G06K19773524/09/2007

ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช ืขืœ ื’ื‘ื™ ืจืฉืช ืื•ืคื˜ื™ืชPON(WIRELESS(ืกื‘ื™ืœื” OVER PON

PASSOVER, INC.22/09/200660/826679US

PCT/US/2007/079322WO/2008/036976

Page 166: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 166

)2009.01 (C07H19773624/09/2007

ืฉื™ื˜ื•ืช, ื•ืงื˜ื•ืจื™ื, ื ื•ืงืœืื•ื˜ื™ื“ื™ืืคื•ืœื™ื•"ื•ืขืจื›ื•ืช ืœืœื•ืงืœื™ื–ืฆื™ื” ืฉืœ ืจื  ืื•/ื

ื—ืœื‘ื•ื ื™ื ื‘ืชืื™ื ื—ื™ื™ื

ISOLATED POLYNUCLEOTIDES,NUCLEIC ACID CONSTRUCTS,METHODS AND KITS FORLOCALIZATION OF RNA AND/ORPOLYPEPTIDES WITHIN LIVINGCELLS

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

28/09/200660/847664USPCT/IL/2007/001175WO/2008/038272

)2009.01 (C07K19773723/09/2007

ANTIGEN ื—ื™ืกื•ื ื™ื ืจื‘ื™ ืืคื™ื˜ื•ืคื™ื ืœืื ื˜ื™ื’ืŸ ืžืกื•ื™ื SPECIFIC MULTI EPITOPEVACCINES

VAXIL ืœื™ืื•ืจ ื›ืจืžื•ืŸ BIO TERAPEUTICS LTD.21/09/200660/846087US

PCT/IL/2007/001168WO/2008/035350

)2009.01 (A61L19773814/09/2007

ืฉื›ื‘ืช ืฉืžืŸ ืžื—ื•ืจืจืช ื”ื ืกืคื’ืช ื‘ื’ื•ืฃ ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื”

PERFORATED BIOABSORBABLE OILFILM AND METHODS FOR MAKINGTHE SAMEATRIUM MEDICAL CORPORATION

22/09/200611/525390USPCT/US/2007/019978WO/2008/039308

Page 167: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009167

)2009.01 (A61K19773914/01/2004

ืื™ื ืกื•ืœื™ืŸ ืืจื•ืš ื˜ื•ื•ื— ืœื”ื•ืจื“ืช ื”ืชื—ืœื•ืื”ื”ืงืจื“ื™ื•ื•ื•ืกืงื•ืœืจื™ืช ื•ื”ืชืžื•ืชื” ื‘ื—ื•ืœื™ื ืงื“ื

2ืกื›ืจืชื™ื™ื ื•ื‘ื—ื•ืœื™ื ืขื ืกื›ืจืช ืžืกื•ื’

LONG ACTING INSULIN FORREDUCING CARDIOVASCULARMORBIDITY AND MORTALITY INPREDIABETIC PATIENTS ANDPATIENTSWITH TYPE 2 DIABETESAVENTIS PHARMACEUTICALS INC.

14/01/200360/439941USPCT/US/2004/000879WO/2004/064862

)2009.01 (E04B19774020/09/2007

ืžื‘ื ื” ื”ืžื•ืจื›ื‘ ืžืืœืžื ื˜ ื”ืจื›ื‘ื” ื•ื›ืœื™ ื‘ื ื™ื”ASSEMBLY COMPOSED OF ACONSTRUCTION ELEMENT AND AMASONRY TOOLDI TRAPANI, AGOSTINO

22/09/200606121158.7EPPCT/EP/2007/060008WO/2008/034888

)2009.01 (H02K19774114/06/2007

MAGNETIC ืžื™ืกื‘ ืžื’ื ื˜ื™ BEARINGTREUBERT, KIRK

22/09/200611/525398USPCT/US/2007/014090WO/2008/039256

)2009.01 (G02C19774222/03/2009

ืฉื™ืคื•ืจื™ื ืœืžืขืจื›ื•ืช ืขื“ืฉื” ืžืกืชื’ืœืช ืชื•ืš)AIOL(ืขื™ื ื™ืช

IMPROVEMENTS INACCOMMODATING INTRAOCULARLENS (AIOL) ASSEMBLIES

NULENSืž"ื ื™ื•ืœื ืก ื‘ืข LTD.

Page 168: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 168

)2009.01 (H04L19774323/10/2007

ืืœืžื‘ื ื™ ืžืกื’ืจืช ืขื‘ื•ืจ ืžืขืจ โ€“ื›ื•ืช ืชืงืฉื•ืจืช ื—ื•ื˜ื™ืช

FRAME STRUCTURES FORWIRELESS COMMUNICATIONSYSTEMSQUALCOMM INCORPORATED

24/10/200660/862641US24/10/200660/862744US

PCT/US/2007/082209WO/2008/070316

)2009.01 (H04L19774416/10/2007

ืช ืงืฉื•ืจืช ื”ื’ื‘ืจื•ืช ื—ื™ืกื›ื•ืŸ ืื ืจื’ื™ื” ืขื‘ื•ืจ ื—ื•ื˜ื™ืชโ€“ืืœ

POWER SAVE ENHANCEMENTS FORWIRELESS COMMUNICATION

QUALCOMM INCORPORATED19/10/200660/862146US12/10/200711/871874US

PCT/US/2007/081562WO/2008/115282

)2009.01 (A61K19774520/11/2003

ืฉื™ื˜ื•ืช ืœืขืฉื™ื™ืช ืคื•ืจืžื•ืœืฆื™ื•ืช ืจืงื—ื™ื•ืชื—ืœืงื™ืงื™ื ืฉื ื”ืคื›ื•โ€“ื›ื™ืœื•ืช ืžื™ืงืจื•ื”ืž

ืžื’ื•ืฉื™ื

METHODS FOR MAKINGPHARMACEUTICAL FORMULATIONSCOMPRISING DEAGGLOMERATEDMICROPARTICLESACUSPHERE, INC.

19/12/200210/324558USPCT/US/2003/037100WO/2004/060344

Page 169: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009169

)2009.01 (C07C19774613/09/2007

2CBCOMPOUNDSื•ื‘ื•ืช ื”ืžืืคื ื ื•ืช ืืช ื”ืงื•ืœื˜ืŸ ืชืจื› WHICH MODULATETHE CB2 RECEPTORBOEHRINGER INGELHEIMINTERNATIONAL GMBH

25/09/200660/826819USPCT/US/2007/078341WO/2008/039645

)2009.01 (C09B19774724/09/2007

PIGMENT ืชืจื›ื™ื– ืฆื‘ืขืŸ CONCENTRATEAKZO NOBEL COATINGSINTERANTIONAL B.V.

26/09/2006981/ KOL/2006

IN

09/11/200606123764.0EP10/11/200660/858290US

PCT/EP/2007/060079WO/2008/037678

)2009.01 (B64F19774824/09/2007

SYSTEM ืชื ื•ืขืช ืžื˜ื•ืกื™ื ื‘ืฉื“ื•ืช ืชืขื•ืคื” AND METHOD FORTRANSFERRING AIRPLANES

ISRAELืž"ื”ืชืขืฉื™ื™ื” ื”ืื•ื™ืจื™ืช ืœื™ืฉืจืืœ ื‘ืข AEROSPACE INDUSTRIESLTD.

28/09/200611/528647US16/05/200711/798777US

PCT/IL/2007/001172WO/2008/038270

)2009.01 (B64F19774926/09/2007

CYTOKINE ืกื™ืžื•ืŸ ืฆื™ื˜ื•ืงื™ื ื™ SIGNALINGCASE WESTERN RESERVEUNIVERSITY

26/09/200660/847656USPCT/US/2007/079602WO/2008/039876

Page 170: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 170

)2009.01 (C07D19775004/10/2007

ืคื™ืจืื–ื•ืœื™ืœ ืชื™ืื ื•ืคื™ืจื™ื“ื™ื ื™ื ื›ืืžืฆืขื™ื ื˜ื™ืคื•ืœื™ื™ื

THERAPEUTIC PYRAZOLYLTHIENOPYRIDINES

PFIZER PRODUCTS INC.16/10/200660/851982US

PCT/IB/2007/002994WO/2008/047198

)2009.01 (C25B19775109/10/2007

CATHODE ืงืชื•ื“ื” ืขื‘ื•ืจ ืชื”ืœื™ื›ื™ื ืืœืงื˜ืจื•ืœื™ื˜ื™ื FOR ELECTROLYTICPROCESSESINDUSTRIE DE NORA S.P.A

11/10/2006MI2006A001947ITPCT/EP/2007/060728WO/2008/043766

)2009.01 (C07C19775214/09/2007

HDACHDACืžืขื›ื‘ื™ INHIBITORSCHROMA THERAPEUTICS LTD.

06/10/20060619753.7GBPCT/GB/2007/003504WO/2008/040934

)2009.01 (C07C19775306/09/2007

TOILET ืžื›ืฉื™ืจ ืœืืกืœื” DEVICEGILLIAN PAULA WRIGHT

29/09/20060619171.2GBPCT/GB/2007/050526WO/2008/038036

Page 171: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009171

)2009.01 (G10K19775423/03/2009

CROSSLINKED ืžืฆื•ืžื“ื•ืชPANื“ื—ืก ืฉืœ ืคื™ื‘ืจื™ืœื•ืช PAN FIBERSCOMPACT

ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™ืชื•ื— ื”ืžื—ืงืจ ืฉืœ ื”ืื•ื ื™ื‘ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ื

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM

)2009.01 (A61K19775501/10/2007

โ€“ืฉืœ ืจื™ื ื•)NIMIV(ืื™ืžื•ื ื•ื’ืŸ ืžื ื˜ืจืœ ื—ื“ืฉื•ื™ืจื•ืก ื•ื”ืฉื™ืžื•ืฉ ื‘ื• ืœื™ื™ืฉื•ืžื™ื ืฉืœ ืชืจื›ื™ื‘ื™

ื—ื™ืกื•ืŸ

NOVEL NEUTRALIZINGIMMUNOGEN (NIMIV) OFRHINOVIRUS AND ITS USE FORVACCINE APPLICATIONSSANOFI PASTEUR BIOLOGICS CO.

29/09/200660/848451USPCT/US/2007/021053WO/2008/057158

)2009.01 (C12N19775601/10/2007

RECOMBINANT ื•ื™ืจื•ืก ื”ืฆืจืคื™โ€“ื•ืงื˜ื•ืจื™ื ืฉืœ ืจื™ื ื• RHINOVIRUSVECTORSSANOFI PASTEUR BIOLOGICS CO.

29/09/200660/848308US15/01/200760/880664US

PCT/US/2007/021102WO/2008/100290

Page 172: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 172

)2009.01 (G10L19775729/08/2007

ืžืขืจืš, ืžืขืจื›ืช ืฉืœ ืžืขืจืš ืžืกื ื ื™ื ืœื ื™ืชื•ื—ืžืขืจื‘ืœ,ืžืคืขื ื—, ืžืงื“ื“, ืžืกื ื ื™ื ืœืกื™ื ืชื–ื” ื•ื ื™ื”ื•ืœ ื•ืขื™ื“ื•ืช

ANALYSIS FILTERBANK, SYNTHESISFILTERBANK, ENCODER, DECODER,MIXER AND CONFERENCINGSYSTEMFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.

18/10/200660/862032US04/05/200711/744641US

PCT/EP/2007/007553WO/2008/046468

)2009.01 (C07D19775802/10/2007

ืชื›ืฉื™ืจ, ื ื’ื–ืจื•ืช ื—ื“ืฉื•ืช ืžืกื•ื’ ื‘ื ื–ื•ืคื•ืจืŸืื• ื”ื›ื•ืœืœ ืืช ื”ืืžื•ืจ ืœืฆื•ืจืš ื˜ื™ืคื•ืœ

ื•ืฉื™ืžื•ืฉ, ืžื ื™ืขืช ืชืคืงื•ื“ ืงื•ื’ื ื™ื˜ื™ื‘ื™ ืœืงื•ื™ ื‘ืืœื”

NOVEL BENZOFURAN TYPEDERIVATIVES, A COMPOSITIONCOMPRISING THE SAME FORTREATING OR PREVENTINGCOGNITIVE DYSFUNCTION AND THEUSE THEREOFDIGITAL BIOTECH CO. LTD

02/10/20061020060097388KRPCT/KR/2007/004833WO/2008/041826

)2009.01 (B05B19775923/03/2009

ULTRASONIC ืžืจืกืก ืื•ืœื˜ืจืืกื•ื ื™ ืžืขืจื›ืช ื•ืฉื™ื˜ื” SPRAYER SYSTEMAND METHOD

.U.Sืž"ืžื™ื™ื‘ืฉ ืื•ืœื˜ืจืกื•ื ื™ ื‘ืข DRYER LTD

)2009.01 (A61K19776027/09/2007

FORMULATIONS ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ื—ื•ืžืจื™ื ืฆื™ืงืœื™ื™ื COMPRISINGCYCLIC COMPOUNDSPAOLO BOTTI

27/09/200606020286.8EPPCT/EP/2007/008442WO/2008/037484

Page 173: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009173

)2009.01 (A61C19776123/03/2009

ื›ืžื•ืกื” ืœืขืจื‘ื•ื‘ ื–ื•ื’ ื—ื•ืžืจื™ ืฉื˜ืฃ ื•ืขืจื›ื•ืชื‘ืžื™ื•ื—ื“, ื”ื›ื•ืœืœื•ืช ื›ืžื•ืกื•ืช ืฉื›ืืœื• ืœืฉื™ืžื•ืฉ ื‘ืจื™ืคื•ื™ ืฉื™ื ื™ื™ื

CAPSULE FOR MIXING TOGETHERTWO FLOWABLE MATERIALS, ANDKITS INCLUDING SUCH CAPSULES,PARTICULARLY USEFUL INDENTISTRY

MOSHE ืžืฉื” ื–ืœืฆืžืŸ ZALSMAN

)2009.01 (A61K19776223/03/2009

ืœืฉื™ืžื•ืฉ ื‘ื˜ื™ืคื•ืœ ื‘ืชืื™ืG6ืจื•ื“ืžื™ืŸ ืกืจื˜ื ื™ื™ื

RHODAMINE 6G FOR USE INTREATING CANCEROUS CELLS

ANISOPHARM INC.

)2009.01 (C07D19776324/09/2007

PYRAZINE-2-CARBOXAMIDE ืงืจื‘ื•ืงืกืืžื™ื“โ€“2โ€“ืชื•ืœื“ื•ืช ืคื™ืจืื–ื™ื DERIVATIVESF. HOFFMANN-LA ROCHE AG

04/10/200606121749.3EPPCT/EP/2007/060090WO/2008/040649

)2009.01 (C07D19776404/10/2007

VINYLOGOUSื•ื’ื™ื•ืช ื›ืžืขื›ื‘ื™ ื›ื™ืžืื–ืชื•ืœื“ื•ืช ื—ื•ืžืฆื•ืช ื•ื™ื ื™ืœ ACIDS DERIVATIVESAS CHYMASE INHIBITORSF. HOFFMANN-LA ROCHE AG

13/10/200606122239.4EPPCT/EP/2007/060528WO/2008/043698

Page 174: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 174

)2009.01 (C07K19776503/10/2007

METHODS ืฉื™ื˜ื•ืช ืœื˜ื™ื”ื•ืจ ืชืœื›ื™ื“ื™ื ืฉืœ ืคื•ืœื™ืคืคื˜ื™ื“ื™ื FOR PURIFICATION OFPOLYPEPTIDE CONJUGATESNOVO NORDISK A/S

03/10/200660/848969US02/11/200660/864117US30/11/200660/868057US31/01/200760/887517US20/07/200760/951159US09/08/200760/955001US17/08/200760/956468US

PCT/US/2007/080353WO/2008/057683

)2009.01 (A61K19776624/09/2007

ืฉื™ืžื•ืฉ ื‘ืื•ืจื™ื˜ืื•ื•ืื ืฆื™ืŸ ืœืžื ื™ืขื” ื•ืœื˜ื™ืคื•ืœ ื‘ืื ืชืจืงืก

USE OF ORITAVANCIN FOR THEPREVENTION AND TREATMENT OFANTHRAXTARGANTA THERAPEUTICS CORP

25/09/200660/847397USPCT/US/2007/079277WO/2008/097364

)2009.01 (A61K19776726/09/2007

CAPECITABINE ืคื“ื™ืื˜ืจื™ื•ืช ื˜ื‘ืœื™ื•ืช ืงืคืฆื™ื˜ื‘ื™ืŸ PEDIATRIC TABLETSF. HOFFMANN-LA ROCHE AG

06/10/200660/850174US24/07/200760/951557US

PCT/EP/2007/060186WO/2008/040665

Page 175: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009175

)2009.01 (A61K19776802/10/2007

IMMUNISATION ืกืจื•ื˜ื™ืคื™ื ืฉืœ ื“ื ื’ื™4ืฉื™ื˜ื” ืœื—ื™ืกื•ืŸ ื›ื ื’ื“ METHOD AGAINSTTHE 4 DENGUE SEROTYPESSANOFI PASTEUR

04/10/200606/08660FRPCT/FR/2007/052054WO/2008/047023

)2009.01 (C07H19776911/10/2007

NOVEL ืชื•ืœื“ื•ืช ืžื•ืจืคื™ืŸ ื—ื“ืฉื•ืช MORPHINE DERIVATIVESNEORPHYS

12/10/20060654247FRPCT/FR/2007/052122WO/2008/043962

)2009.01 (A61K19777004/10/2007

ืกื•ื›ืจื™ื ืฉืขื‘ืจื• ืคื’ื™ืœืฆื™ื” ื•ื’ืœื™ืงื•ืคืคื˜ื™ื“ื™ื ื”ืงืฉื•ืจื™ื ืœื’ืœื™ืฆืจื•ืœ

GLYCEROL LINKED PEGYLATEDSUGARS AND GLYCOPEPTIDES

NOVO NORDISK A/S04/10/200660/828208US

PCT/US/2007/080471WO/2008/060780

)2009.01 (A61B19777123/03/2009

GLUCOSE ื—ื™ื™ืฉืŸ ืœื’ืœื•ืงื•ื– DETECTORIRINA ื‘ื ื™ ืื‘ื ื™ ONUFRIEVICH,

Page 176: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 176

)2009.01 (C25D19777207/10/2007

ืœ ื‘ืฉื™ื˜ื”'ื’โ€“ืจื™ื‘ื•ืฅ ืฉืœ ืฉื›ื‘ื•ืช ืกื•ืœ ืืœืงื˜ืจื•ื›ื™ืžื™ืช

ELECTROCHEMICAL CO-DEPOSITION OF SOL-GEL FILMS

ืฉ ืœ ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™ืชื•ื— ื”ืžื—ืงืจืž"ื”ืื•ื ื™ื‘ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ื ื‘ืข

YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

27/09/200660/847378USPCT/IL/2007/001216WO/2008/038293

)2009.01 (C07D19777310/10/2007

A ืื•ืŸโ€“4โ€“ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืชื•ืœื“ืช ืคื™ืคื™ืจื™ื“ื™ื  PROCESS FOR THE PRODUCTIONOF A PIPERIDIN -4-ONE DERIVATIVENIPPON SODA COMPANY LTD.

11/10/20062006-277086

JP

PCT/JP/2007/069741WO/2008/044701

)2009.01 (C12N19777416/01/2003

ืื’ื•ื ื™ืกื˜ื™ื ืฉืœ ืงื•ืœื’ืŸ ืžืฉื—ืจืจ2ืงื•ืจื˜ื™ืงื•ื˜ืจื•ืคื™ืŸ ืžื˜ื™ืคื•ืก

CORTICOTROPIN RELEASINGFACTOR 2 RECEPTOR AGONISTSTHE PROCTER & GAMBLECOMPANY

16/01/200260/349117US29/04/200260/376337US14/06/200260/388895US19/09/200260/411988US

PCT/US/2003/001461WO/2003/062269

Page 177: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009177

)2009.01 (G06F19777519/11/2007

ืื™ื—ื•ื“ ืžืฆื‘ ื—ื•ืคืฉื™ ืžื ืขื™ืœื” ื‘ืคืชืจื•ืŸ ื‘ืขื™ื•ืช ืœืœื ืžื’ื‘ืœื•ืช ืžืงื‘ื™ืœื•ืช

LOCK-FREE STATE MERGING INPARALLELIZED CONSTRAINTSATISFACTION PROBLEM SOLVERSMICROSOFT CORPORATION

20/11/200611/602092USPCT/US/2007/085149WO/2008/064185

)2009.01 (A61K19777620/11/2007

F/Aืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื”ื˜ืจื•ื“ื™ืžืจื™ื ืฉืœ 17โ€“IL ื•ืฉื™ืžื•ืฉื™ื”ื ื”ืจืคื•ืื™ื™ื

IL-17A/F HETERODIMERICPOLYPEPTIDES AND THERAPEUTICUSES THEREOFGENENTECH, INC.

29/11/200611/606192USPCT/US/2007/085269WO/2008/067223

)2009.01 (C07F19777728/09/2007

ืื™ื ื“ื•ืœื™ื ื˜ื”ื•ืจื™ื ืžื‘ื—ื™ื ื” ืคื•ืกืคื•HIVืื ื ื˜ื™ื•ืžืจื™ืช ื›ืžืขื›ื‘ื™

ENANTIOMERICALLY PUREPHOSPHOINDOLES AS HIVINHIBITORSIDENIX PHARMACEUTICALS, INC.

29/09/200660/848584US09/11/200660/857980US23/02/200760/903115US

PCT/US/2007/020900WO/2008/042240

Page 178: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 178

)2009.01 (A61K19777812/10/2007

ืฉื™ื ื•ื™ ื—ื•ื–ืง ื™ื•ื ื™ ื‘ืชืžื™ืกื•ืช ืฉืœ ื ื•ื’ื“ื ื™ื ื’ื•ืฉื™ื/ืœื”ืงื˜ื ืช ื”ื‘ื”ืงื”

MODIFICATION FOR IONICSTRENGTH IN ANTIBODY-SOLUTIONS TO REDUCEOPALESCENCE/AGGREGATESWYETH

12/10/200660/851651USPCT/US/2007/021904WO/2008/045563

)2009.01 (F41H19777915/09/2007

POLYOLEFIN ื’ื•ืžื™ ืžื—ื•ื–ืง ื‘ืกื™ื‘ ืคื•ืœื™ืื•ืœืคื™ืŸ FIBER REINFORCEDHONEYWELL INTERNATIONAL INC.

25/09/200611/526353USPCT/US/2007/078592WO/2008/097363

)2009.01 (H01Q19778024/03/2009

ื™ืชืŸ ืœื ื•ื•ื˜ ืื•ืชื” ืžืขืจื›ืช ืื ื˜ื ื” ื›ื™ื•ื•ื ื™ืช ืฉื ืขื‘ื•ืจ ืชืงืฉื•ืจืช ืื•ื˜ื•ื ื•ืžื™ืช ืฉืœ ื›ืœื™ ืจื›ื‘

ืื•ื•ื™ืจื™ื™ื

STEERABLE DIRECTIONALANTENNA SYSTEM FORAUTONOMOUS AIR VEHICLECOMMUNICATIONHONEYWELL INTERNATIONAL INC.

03/06/200812/132474US

)2009.01 (F26B19778103/10/2007

LYOPHILIZATION ื–ืฆื™ื”ืฉื™ื˜ื•ืช ื•ื”ืชืงื ื™ื ืœืœื™ืื•ืคื™ืœื™ METHODS ANDAPPARATUSESWYETH

03/10/200660/849040USPCT/US/2007/021240WO/2008/042408

Page 179: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009179

)2009.01 (C12P19778209/10/2007

ื˜ื™ื”ื•ืจ ืฉืœ ืคื•ืœื™ืกืื›ื›ืจื™ื“ื™ื ืฉืœPNEUMONIAE STREPTOCOCCUS

3ืžื˜ื™ืคื•ืก

PURIFICATION OF STREPTOCOCCUSPNEUMONIAE TYPE 3POLYSACCHARIDES

WYETH10/10/200660/850665US

PCT/US/2007/080768WO/2008/045852

)2009.01 (C07D19778326/09/2007

ื’ื•ืจืžื™ื ืคื•ืœื™ืฆื™ืงืœื™ื™ื ืœื˜ื™ืคื•ืœ ื‘ื ืฉื™ืžื” ืกื™ื ืกื™ืฆื™ืืœื™ืช ื‘ื–ื™ื”ื•ื ื•ื™ืจืืœื™

POLYCYCLIC AGENTS FOR THETREATMENT OF RESPIRATORYSYNCYTIAL VIRUS INFECTIONSBIOTA SCIENTIFIC MANAGEMENTPTY LTD.

28/09/200660/848073USPCT/AU/2007/001429WO/2008/037011

)2009.01 (A63F19778424/03/2009

A ืžืฉื—ืง ืœื•ื— ื•ืฉื™ื˜ืช ืžืฉื—ืง ืขื‘ื•ืจื• DICE BOARD GAME AND PLAYINGMETHOD THEREOF

YAN ื™ืืŸ ืคื™ืฉื’ื•ืœื“ FISHGOLD

)2009.01 (F25J19778524/03/2009

POWER-POINT ืชื—ื ืช ื›ื•ื— ืขืœ ื—ื•ื ื”ืฉืžืฉ FROM THE HEAT OFFTHE SUN

BOAZ ื‘ืขื– ืžืœื˜ MELET

Page 180: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 180

)2009.01 (F21S19778605/10/2007

DIRECTIONAL ืกืคื•ื˜ ื›ื™ื•ื•ื ื™ DOWNLIGHTFRANCIS WILLIAM AUSTIN

06/10/2006550427NZPCT/NZ/2007/000291WO/2008/041870

)2009.01 (C23C19778730/08/2007

WORKPIECE ื›ืœื™ ืขื‘ื•ื“ื” ืขื ืฆื™ืคื•ื™ ืงืฉื” WITH HARD COATINGOERLIKON TRADING AG,TRUBBACH

26/09/200660/826943US02/04/200760/909559US

PCT/EP/2007/059070WO/2008/037556

)2009.01 (C07D19778827/09/2007

ืชืจื›ื•ื‘ื•ืช ืื ื˜ื’ื•ื ื™ืกื˜ื™ื•ืช ืœืจืฆืคื˜ื•ืจื”ืจื›ื‘ื™ื ื”ืžื›ื™ืœื™ื ืชืจื›ื•ื‘ื•ืช ืืœื•, ืœื’ืœื•ืงื’ื•ืŸ

ื•ืฉื™ื˜ื•ืช ืฉื™ืžื•ืฉ

GLUCAGON RECEPTORANTAGONIST COMPOUNDS,COMPOSITIONS CONTAINING SUCHCOMPOUNDS AND METHODS OFUSEMERCK & CO., INC.

03/10/200660/848967USPCT/US/2007/020858WO/2008/042223

)2009.01 (H04L19778918/12/2001

TELEVISION ืžืงืœื˜ ื˜ืœื•ื™ื–ื™ื” ื•ืฉื™ื˜ื” ืœื”ืคืขืœืช ืฉืจืช RECEIVER ANDMETHOD OF OPERATING A SERVERWAPTV LIMITEd

12/01/20010100912.5GBPCT/GB/2001/005599WO/2002/056590

Page 181: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009181

)2009.01 (A61K19779027/09/2007

ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ื ื•ื’ื“ื ื™ื ืคืขื™ืœื™ื ื ื’ื“ ืื ื˜ื™ื’ืŸื ื•ื’ื“ื ื™ื ืฉื™ื•ืฆืจื• ืขืœ ื™ื“ื™ ื”ืฉื™ื˜ื”, ืขืžื™ื“ื•ืช

ื•ืฉื™ืžื•ืฉื™ื ื‘ื”ื

METHOD FOR GENERATING ACTIVEANTIBODIES AGANIST ARESISTANCE ANTIGEN, ANTIBODIESOBTAINED BY SAID METHOD ANDTHEIR USESPIERRE FABRE MEDICAMENT

28/09/200606/08514FRPCT/EP/2007/060243WO/2008/046724

)2009.01 (C11D19779101/10/2007

ืชืžื™ืกื” ืœื ื™ืงื•ื™ ื›ืชื•ื‘ืช ืงื™ืจ ื”ืžื›ื™ืœื” ืชืจื›ื™ื– ืืœ ืžื™ืžื™ ื•ืชืžื™ืกื” ืžื™ืžื™ืช ืžื”ื•ืœื”

GRAFFITI CLEANING SOLUTIONINCLUDING A NON-AQUEOUSCONCENTRATE AND DILUTEDAQUEOUS SOLUTIONECO HOLDINGS LLC

29/09/200611/540330USPCT/US/2007/080060WO/2008/042840

)2009.01 (C08J19779226/09/2007

ื”ืจื›ื‘ื™ื ืžืขื›ื‘ื™ ื‘ืขืจื” ืžื‘ื•ืกืกื™ ืงืฆืฃ ืคื•ืœื™ืกื˜ื™ืจื ื™ ืฉืขื‘ืจ ืืงืกื˜ืจื•ื–ื™ื”

FLAME RETARDANT EXTRUDEDPOLYSTYRENE FOAMCOMPOSITIONSALBEMARLE CORPORATION

26/09/200660/827020USPCT/US/2007/079520WO/2008/039836

Page 182: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 182

)2009.01 (G06Q19779314/09/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืื™ืžื•ืช ื–ื”ื•ืช ื”ืžืฉืชืžืฉ ื‘ื˜ืจื ื–ืงืฆื™ื•ืช ืืœืงื˜ืจื•ื ื™ื•ืช

A SYSTEM AND METHOD FORVERIFYING A USER'S IDENTITY INELECTRONIC TRANSACTIONSSCAMMELL DAN

29/09/200611/537461USPCT/CA/2007/001639WO/2008/037062

)2009.01 (C02F19779428/08/2007

LIQUID ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœื˜ื™ื”ื•ืจ ื ื•ื–ืœื™ื PURIFICATION DEVICE ANDMETHOD

H2Q WATER INDUSTRIES LTDH2Q WATER INDUSTRIES LTD.28/08/200660/823664US09/07/200760/929668US

PCT/IL/2007/001066WO/2008/026208

)2009.01 (H04B19779507/01/2005

ืชืฆืจื™ืคื™ื ื•ื‘ื—ื™ืจืช ืคื•ืจืžืื˜ ืœื”ืขื‘ืจื” ืงืœื™ื˜ื” ืืœื—ื•ื˜ื™ืช/ื‘ื™ื—ื™ื“ืช ืฉื™ื“ื•ืจ

TRANSPORT FORMATCOMBINATION SELECTION IN AWIRELESS TRANSMIT/RECEIVEUNITINTERDIGITAL TECHNOLOGYCORPORATION

09/01/200460/535426US22/12/200411/019489US

PCT/US/2005/000571WO/2005/067659

Page 183: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009183

)2009.01 (A61K19779624/09/2007

ื” โ€“Nโ€“ืื ืœื•ื’ื™ื ืฉืœ ื’ืจืœื™ืŸ ื”ืžื•ืชืžืจื™ื ื‘ืงืฆื” ื˜ืจืžื™ื ืœื™

ANALOGS OF GHRELINSUBSTITUTED AT THE N-TERMINAL

IPSEN PHARMA S.A.S27/09/200660/847423US

PCT/US/2007/020595WO/2008/039415

)2009.01 (A21D19779913/12/2006

ืขื•ื’ื™ื•ืช ื”ืžื›ื™ืœื•ืช ืื™ื ื•ืœื™ืŸ ื•ืขืžื™ืœืŸ ืขืžื™ื“ืžืขื•ืฆื‘ื•ืช ื‘ืกื—ืจื•ืจ ื•ื‘ืขืœื•ืช ืชื›ื•ืœืช ืกื™ื‘ื™ื

ื’ื‘ื•ื”ื”

HIGH FIBER ROTARY MOLDEDCOOKIES CONTAINING INULIN ANDRESISTANT STARCH

KRAFT FOODS GLOBAL BRANDSLLC

12/12/200611/637589USPCT/US/2006/062022WO/2008/073127

)2009.01 (B01D19780025/03/2009

INTERNAL ื”ืชืงืŸ ืกื™ื ื•ืŸ ืคื ื™ืžื™ FILTERING DEVICESHMUEL ืฉืžื•ืืœ ื‘ืŸ ืžื•ื‘ื—ืจ BEN MUVHAR

)2009.01 (A61K19780426/09/2006

ื•ืฉื™ื˜ื•ืชCืชืจื›ื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ื”ืคื˜ื™ื˜ื™ืกCืœืฉื™ืžื•ืฉ ื‘ืชืจื›ื•ื‘ื•ืช ืœื˜ื™ืคื•ืœ ื‘ื”ืคื˜ื™ื˜ื™ืก

COMPOSITIONS FOR THETREARMENT OF HEPATITIS C ANDMETHODS FOR USINGCOMPOSITIONS FOR THETREATMENT OF HEPATITIS CLOTSOF HOWARD L.

PCT/US/2006/037231WO/2008/039179

Page 184: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 184

)2009.01 (B60R19780525/03/2009

WEIGHING ื”ืชืงืŸ ืฉืงื™ืœื” SCALEBEN ื‘ืŸ ืฆื™ื•ืŸ ื˜ื™ ZION THEE

)2009.01 (G06F19780620/09/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ื™ื“ื•ื“ ืจื›ื™ื‘ื™ ืชื•ื›ื ื”METHOD AND SYSTEM FORISOLATING SOFTWARECOMPONENTS

TYPEMOCKืž"ื˜ื™ื™ืคืžื•ืง ื‘ืข LTD25/09/200660/826749US

PCT/IL/2007/001152WO/2008/038265

)2009.01 (G06T19780725/03/2009

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื’ื™ืœื•ื™ ืกืคืื ื‘ื ืชื•ื ื™ื ืฉืœ ืชืžื•ื ื”

SYSTEM AND METHOD FOR SPAMDETECTION IN IMAGE DATA

PINEAPPืž"ืคื™ื™ื ืืค ื‘ืข LTD26/03/200812/055812US

)2009.01 (A61B19780825/09/2007

EXAMINATION ื”ืชืงืŸ ื‘ื“ื™ืงื” DEVICEMEDVISION ืžื“ื•ื™ื–ื™ื•ืŸ ืื™ื ืง INC.

28/09/200660/847648USPCT/IL/2007/001190WO/2008/038281

)2009.01 (A44B19780925/03/2009

SOCKS ื’ืจื‘ื™ื™ืDALITEX ื“ืœื™ืงื˜ืงืก LTD

Page 185: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009185

)2009.01 (B23H19781025/03/2009

INDEXABLE ืชื•ืชื‘ ื”ื“ืจื’ืชื™ ืขื ื—ืจื™ืฅ INSERT WITH NICKSUMITOMO ELECTRIC HARDMETALCORP.

31/03/20082008-091447

JP

)2009.01 (A61K19781126/09/2007

ืฉื™ื˜ื•ืช ืœืฉื™ืคื•ืจ ื”ื—ื“ืจื” ืœืžืขืจื›ื•ืช ื‘ื™ื•ืœื•ื’ื™ื•ืช

MEANS AND METHODS OFENHANCING DELIVERY TOBIOLOGICAL SYSTEMSPAOLO BOTTI

27/09/200606020286.8EP05/07/200707013218.8EP

PCT/EP/2007/008396WO/2008/037463

)2009.01 (G06F19781224/09/2007

ืžื›ืฉื™ืจ ื•ืฉื™ื˜ื” ืœืžืื’ืจ ืžื™ื“ืข ืžื‘ื•ื–ืจAN APPARATUS AND METHOD FORA DISTRIBUTED STORAGE GLOBALDATABASE

ื‘ืขืงืกืจืื•ื ื“ ืžืขืจื› XEROUNDืž"ื•ืช SYSTEMS LTD28/09/200660/847613US

PCT/IL/2007/001173WO/2008/038271

)2009.01 (A61B19781307/10/2007

ORTHOPEDIC ืงื™ื‘ื•ืข ืขืฆื ืื•ืจื˜ื•ืคื“ื™ BONE FIXATION

OGENืž"ืขื•ื’ืŸ ืชืขืฉื™ื•ืช ืจืคื•ืื™ื•ืช ื—ื“ืฉื ื™ื•ืช ื‘ืข INNOVATIVE MEDICALDEVICES LTD

28/09/200660/847681USPCT/IL/2007/001197WO/2008/038286

Page 186: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 186

)2009.01 (C07D19781427/09/2007

SUBSTITUTED ืชื•ืœื“ื•ืช ืกื•ืœืคื•ื ืืžื™ื“ ืžื•ืชืžืจื•ืช SULFONAMIDEDERIVATIVESGRUNENTHAL GMBH

29/09/2006102006046743.4DEPCT/EP/2007/008417WO/2008/040492

)2008.04 (C07D19781505/09/2003

ืชื•ืœื“ื•ืช ื˜ืงืกืืŸ ืคื•ื ืงืฆื™ื•ื ืืœื™ื•ืช ื‘ืขืžื“ื” ื•ืชื”ืœื™ืš ืœื”ื›ื ืชืŸ 14

TAXANE DERIVATIVESFUNCTIONALIZED AT THE 14-POSITIONAND A PROCESS FOR THEPREPARATION THEREOFINDENA S.P.A.

10/09/2002MI2002A001921ITPCT/EP/2003/009866WO/2004/024706

)2009.01 (F42B19781619/09/2007

DEVICE ื”ืชืงืŸ ืœื”ืกืจืช ืืจื™ื–ืช ืชื—ืžื•ืฉืช FOR THE DECONFINEMENTOF AN AMMUNITION CASINGNEXTER MUNITIONS

29/09/20060608681FRPCT/FR/2007/001518WO/2008/040860

)2009.01 (C07K19781707/09/2007

PETSILICONืŸ ืขื‘ื•ืจ ื”ื“ืžื™ื™ืช ืชื•ืœื“ื•ืช ืกื™ืœื™ืงื• DERIVATIVES FOR PETIMAGINGBAYER SCHERING PHARMA AG

02/10/200606076823.1EP11/10/200606076869.4EP12/03/200707090043.6EP23/04/200707090079.0EP

PCT/EP/2007/008044WO/2008/040441

Page 187: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009187

)2009.01 (A61K19781802/11/2007

MULTIPLE ืชืจื•ืคื” ืœื˜ืจืฉืช ื ืคื•ืฆื” SCLEROSIS THERAPYNORTHWESTERN UNIVERSITY

03/11/200660/864295USPCT/US/2007/083525WO/2008/063849

)2009.01 (A47J19781926/03/2009

ืžื™ืชืงืŸ ืœืงื™ืจื•ืจ ื•ืœื”ื’ื–ื” ืฉืœ ืคื—ื™ื•ืช ื•ื‘ืงื‘ื•ืงื™ ืžืฉืงื”

APPARATUS FOR COOLING ANDCARBONATION BEVERAGE CANSAND BOTTLES

PAVEL ืคืื‘ืœ ืœืจื ืจ LERNER

)2009.01 (H01R19782026/03/2009

ื ื™ื™ื— ื”ื›ื•ืœืœ ืชืื•ืจืช ื—ื™ืจื•ื/ ืฉืงืข ื ื™ื™ื“ ื•ืœื™ืœื” ื•ืžืขืจื›ื•ืช ื”ื’ื ื” ื•ื”ืชืจืขื”

PORTABLE/STATIONARY SOCKETWITH EMERGENCY AND NIGHTLIGHTING AND PROTECTION ANDWARNING SYSTEMS

DAN ืขืฆืžื•ืŸ ื“ืงืœ KATZ

)2009.01 (F16L19782103/10/2007

ืคืก ืžื•ืจื›ื‘ ื•ืžื—ื•ื–ืง ื”ื ื™ืชืŸ ืœืœื™ืคื•ืฃ ืœื™ืฆื•ืจ ืฆื™ื ื•ืจ ืกืœื™ืœื™ ื•ืฉื™ื˜ื” ืขื‘ื•ืจื•

COMPOSITE REINFORCED STRIPWINDABLE TO FORM A HELICALPIPE AND METHOD THEREFORRIB LOC AUSTRALIA PTY LIMITED

04/10/20062006905464AUPCT/AU/2007/001463WO/2008/040052

Page 188: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 188

)2009.01 (A45F19782229/10/2007

PROTECTIVE ืžืกืš ืžื’ืŸ ื‘ืคื ื™ ื—ืจืงื™ื ANTI-INSECT SCREENMDB TEXINOV SA

31/10/20060654680FRPCT/FR/2007/052263WO/2008/053116

)2009.01 (C07H19782330/10/2007

METHODS ืฉื™ื˜ื•ืช ืœืฉื™ืคื•ืจ ื™ื™ืฆื•ืจ ื ื•ื’ื“ื ื™ื FOR IMPROVINGANTIBODY PRODUCTIONIMMUNOGEN, INC.

31/10/200660/855361USPCT/US/2007/082994WO/2008/073598

)2009.01 (C07D19782410/10/2007

ืฉื™ื˜ื•ืช ืœื™ื™ืฆื•ืจ ื ื’ื–ืจืช ืื–ืื‘ื™ืฆื™ืงืœื•ืืœืงื ื•ืœPROCESS FOR THE PRODUCTION OFAN AZABICYCLOALKANOLDERIVATIVENIPPON SODA COMPANY LTD.

11/10/20062006-278150

JP

PCT/JP/2007/069742WO/2008/044702

)2009.01 (C07D19782508/02/2008

ืฆื•ืจืช ื’ื‘ื™ืฉื™ื•ืช ืฉืœ ืชืจื›ื•ื‘ืช ืชื™ืื–ื•ืœื™ื“ื™ื ื“ื™ื•ืŸ ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื

CRYSTALLINE FORMS OF ATHIZOLIDINEDIONE COMPOUNDAND MANUFACTURING METHODSTHEREOFDAIICHI SANKYO COMPANY,LIMITED

08/02/200760/900251USPCT/JP/2008/052594WO/2008/099944

Page 189: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009189

)2008.04 (C12N19782601/12/1998

ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื•ื—ื•ืžืฆื•ืช ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ื•ืช ืื•ืชื

POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME

GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US

PCT/US/1998/025108WO/1999/028462

)2009.01 (A61K19782707/10/2007

ืฉื™ืžื•ืฉ ื‘ื’ืœื™ืฆืจื•ืคื•ืกืคื•ืœื™ืคื™ื“ื™ื ืœืกื™ื›ื•ืš ืคืจืงื™ื

USE OF GLYCEROPHOSPHOLIPIDSFOR JOINT IUBRICATION

ืž"ืžื•ืกื“ ื”ื˜ื›ื ื™ื•ืŸ ืœืžื—ืงืจ ื•ืคืชื•ื— ื‘ืขYISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

28/09/200660/847651USPCT/IL/2007/001215WO/2008/038292

Page 190: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 190

)2009.01 (C07D19782805/10/2007

ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื‘ื™ืฆื™ืงืœื™ื•ืชื”ืžื›ื™ืœื•ืช ื—ื ืงืŸ ืœืฉื™ืžื•ืฉ ื›ืžืขื›ื‘ื™

ื“ืกืื˜ื•ืจืื–CoAืกื˜ื™ืืจื•ืื™ืœ

BICYCLIC NITROGEN-CONTAININGHETEROCYCLIC COMPOUNDS FORUSE AS STEAROYL COADESATURASE INHIBITORSCV THERAPEUTICS, INC.

05/10/200660/849648USPCT/US/2007/080627WO/2008/043087

)2009.01 (H04L19782906/08/2007

ENCRYPTION ื”ืฆืคื ื” ื‘ื˜ืœืงื•ืžื•ื ื™ืงืฆื™ื” ืืœื—ื•ื˜ื™ืช IN A WIRELESSTELECOMMUNICATIONSLUCENT TECHNOLOGIES INC.

03/10/20060619499.7GBPCT/EP/2007/006995WO/2008/040412

)2009.01 (F24J19783028/09/2007

RADIATION ืื’ืจืŸ ืงืจื™ื ื” COLLECTORALE AIRLIGHT ENERGY SA

27/09/20061562/06CH29/05/2007846/07CH

PCT/CH/2007/000480WO/2008/037108

)2009.01 (A61K19783101/10/2007

4CXCRื ื•ื’ื“ื ื™ื ืื ื•ืฉื™ื™ื ื”ืงื•ืฉืจื™ื ื•ืฉื™ืžื•ืฉื™ื”ื

HUMAN ANTIBODIES THAT BINDCXCR4 AND USES THEREOF

MEDAREX, INC.02/10/200660/827851US

PCT/US/2007/021152WO/2008/060367

Page 191: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009191

)2009.01 (A61K19783219/10/2007

ืœื˜ื™ืคื•ืœILโ€“1ืฉื™ืžื•ืฉ ื‘ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืฉื™ื’ื“ื•ืŸโ€“ื•ืคืกื•ื™ื“ื•ื‘ืฉื™ื’ื“ื•ืŸ

USE OF IL-1 ANTAGONISTS TOTREAT GOUT AND PSEUDOGOUTREGENERON PHARMACEUTICALS,INC.

20/10/200660/853385USPCT/US/2007/022377WO/2008/051496

)2009.01 (A61B19783326/03/2009

ื• ืื• ืื–ื•ืจื™ืช/ื”ืชืงืŸ ืœื ืชื™ื ืช ืชืจื•ืคื•ืช ืžืงื•ืžื™ืชื ื•ื–ืœื™ื™ื ืฉืœ ื’ื•ืจืžื™ื ืขื‘ื•ืจ ื”ืจื›ื‘ื™ื

ื˜ื™ืคื•ืœื™ื™ื

DEVICE FOR LOCAL AND/ORREGIONAL DELIVERY EMPLOYINGLIQUID FORMULATIONS OFTHERAPEUTIC AGENTSCORDIS CORPORATION

31/03/200812/059291US

Page 192: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 192

)2008.04 (C12N19783401/12/1998

ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ื•ืช ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื•ื—ื•ืžืฆื•ืช ืื•ืชื

POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME

GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US

PCT/US/1998/025108WO/1999/028462

Page 193: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009193

)2008.04 (C12N19783501/12/1998

ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื•ื—ื•ืžืฆื•ืช ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ื•ืช ืื•ืชื

POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME

GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US

PCT/US/1998/025108WO/1999/028462

)2009.01 (C07D19783627/09/2007

ืื ืœื•ื’ื™ื ืฉืœ ืคืœื•ืจื™ื–ื™ืŸ ื›ืžืขื›ื‘ื™ ื ืชืจืŸ ื’ืœื•ืงื•ื–COโ€“2ื˜ืจื ืกืคื•ืจื˜ืจ

PHLORIZIN ANALOGS ASINHIBITORS OF SODIUM GLUCOSECO-TRANSPORTER 2LEXICON PHARMACEUTICALS, INC.

29/09/200660/848156US08/03/200760/905714US10/07/200760/948780US

PCT/US/2007/079654WO/2008/042688

Page 194: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 194

)2009.01 (C40B19783728/09/2007

ืชื›ื ื•ืŸ ื•ื‘ื ื™ื” ืฉืœ ืกืคืจื™ื•ืช ืคืคื˜ื™ื“ ื•ืคื•ืœื™ืคืคื˜ื™ื“ ืžื•ื’ื“ืจื•ืช

DESIGN AND CONSTRUCTION OFDIVERSE SYNTHETIC PEPTIDE ANDPOLYPEPTIDE LIBRARIESSEA LANE BIOTECHNOLOGIES, LLC.

02/10/200660/849035USPCT/US/2007/079849WO/2008/042754

)2009.01 (A61K19783804/10/2007

ื”ื›ื ืช ืกื˜ื ืกื•ืคื•ืจืคื™ืŸ ืขื ื“ืจื’ืช ื˜ื™ื”ื•ืจ ื’ื‘ื•ื”ื” ื‘ืงื ื” ืžื™ื“ื” ื’ื“ื•ืœ

HIGH-PURITY LARGE SCALEPREPARATION OF STANNSOPORFININFACARE PHARMACEUTICALCORPORATION

04/10/200660/849641US28/02/200760/904601US

PCT/US/2007/021485WO/2008/045377

)2009.01 (A61K19783904/10/2007

ื˜ื™ืคื•ืœ ื‘ื™ืชืจ ื‘ื™ืœื™ืจื•ื‘ื™ืŸ ื‘ื“ื ื‘ืชื™ื ื•ืงื•ืชื‘ืืžืฆืขื•ืช ืฉื™ืžื•ืฉ ื‘ืžื™ื ื•ื ื™ื ื ืžื•ื›ื™ื ืฉืœ

ืกื˜ืื ืกื•ืคื•ืจืคื™ืŸ

TREATMENT OF INFANTHYPERBILIRUBINEMIA USING LOWDOSAGES OF STANNSOPORFIN

INFACARE PHARMACEUTICALCORPORATION

04/10/200660/849509USPCT/US/2007/021486WO/2008/045378

Page 195: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009195

)2009.01 (C01G19784026/09/2006

โ€“ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ืชื—ืžื•ืฆื•ืช ื˜ื™ื˜ื ื™ื•ื ืชืช ืกื˜ื•ื™ื›ื™ื•ืžื˜ืจื™ื•ืช ื‘ืืžืฆืขื•ืช ื”ืคื—ืชืช ืžื™ืžืŸ

A METHOD OF PRODUCINGSUBSTOICHIOMETRIC OXIDES OFTITANIUM BY REDUCTION WITHHYDROGENATRANOVA LTD

PCT/GB/2006/003573WO/2008/037941

)2009.01 (A61C19784126/03/2009

INCLINED ื”ืชืงืŸ ืžื›ืœื•ืœ ืชื•ืžืš ื“ื ื˜ืœื™ ืžืฉื•ืคืข DENTAL ABUTMENTASSEMBLY DEVICE

ื‘ืข.ืื™ื™.ืื MIS-IMPLANTSืž"ืืก ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ืฉืชืœื™ื TECHNOLOGIESLTD.

27/05/200812/127227US

)2009.01 (B23B19784218/07/2007

SURFACE ื›ืœื™ ื—ื™ืชื•ืš ืžืฆื•ืคื” COATING CUTTING TOOLSUMITOMO ELECTRIC INDUSTRIES,LTD.

02/10/20062006-271066

JP

PCT/JP/2007/064135WO/2008/041402

Page 196: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 196

)2009.01 (C07C19784311/06/2002

, ืชืจื•ืคื•ืช ืฉืœ ืื ืœื•ื’ื™ื ืฉืœ ื’ืื‘ืโ€“ืงื“ื ืชื›ืฉื™ืจื™ื ื•ืฉื™ืžื•ืฉื™ื ืฉืœื”ื

PRODRUGS OF GABA ANALOGS,COMPOSITIONS AND USES THEREOF

XENOPORT, INC.11/06/200160/297521US14/06/200160/298514US19/03/200260/366090US

PCT/US/2002/018689WO/2002/100347

)2009.01 (C12N19784403/10/2006

ืชื”ืœื™ืš ืœืฉื™ืœื•ื‘ ื›ืจื•ืžื•ื–ื•ืžืœื™ ื•ื”ื—ืœืคืช ืจืฆืคื™DNAื‘ืงืœื•ืกื˜ืจื™ื“ื™ื”

PROCESS FOR CHROMOSOMALINTEGRATION AND DNA SEQUENCEREPLACEMENT IN CLOSTRIDIAMETABOLIC EXPLORER

PCT/EP/2006/066997WO/2008/040387

)2009.01 (C12N19784504/10/2007

ื”ื›ื ื” ืฉืœ ืชืื™ื ื”ืžืฆื™ื’ื™ื ืื ื˜ื™ื’ืŸ ืžืœืื›ื•ืชื™ืฉืขื‘ืจื• ืื™ื ืืงื˜ื™ื‘ืฆื™ื” ื•ืฉื™ืžื•ืฉื ื‘ื˜ื™ืคื•ืœื™ื

ืชืื™ื™ื

PREPARATION OF INACTIVATEDARTIFICIAL ANTIGEN PRESENTINGCELLS AND THEIR USE IN CELLTHERAPIESJANSSEN PHARMACEUTICA, N.V.

04/10/200660/849299USPCT/US/2007/021326WO/2008/045286

)2009.01 (A61K19784610/10/2007

STICK ืžืงืœื•ืŸ ืœื—ื•ืช ืœืฉืคืชื™ื™ื LIP BALMWYETH

11/10/200660/850724USPCT/US/2007/021667WO/2008/045479

Page 197: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009197

)2009.01 (G05B19784714/11/2006

ื” ื”ื™ื“ืจืื•ืœื™ืช ื‘ืœื•ืง ื”ื ืขื” ื‘ืขืœ ืคืขื•ืœื™ ื‘ื—ื™ืจืช ืจื•ื‘ ืงื•ืœื•ืช"ื™ืฉื™ืจื” ื”ื ืงื‘ืขืช ืขืค

DIRECT ACTING HYDRAULIC TRIPBLOCK WITH MAJORITY VOTING

ELLIOTT COMPANY16/10/200611/581799US

PCT/US/2006/044255WO/2008/048290

)2009.01 (G07D19784826/09/2007

ืžืชืงืŸ ื•ืฉื™ื˜ื” ืœื‘ื“ื™ืงื” ืื•ืคื˜ื™ืช ืฉืœ ื›ื™ื ื‘ืขืœื™ ืขืจืšืžืกืž

APPARATUS AND METHOD FOR THEOPTICAL EXAMINATION OF VALUEDOCUMENTSGIESECKE & DEVRIENT GMBH

27/09/2006102006045626.2DEPCT/EP/2007/008383WO/2008/037457

)2009.01 (A61K19784928/09/2007

2Eืคืจื•ืกื˜ื’ืœื ื“ื™ืŸ (2PGE(ื›ืžืกื™ื™ืข ื‘ื™ืฆื™ืจืช ื’ื“ืŸ ืžื•ื ื•ืงืœื•ื ืœื™ื ื•

PROSTAGLANDIN E2 (PGE2) AS ANADJUVANT IN MONOCLONALANTIBODY GENERATIONCENTOCOR ORTHO BIOTECH INC.

28/09/200660/827229USPCT/US/2007/079968WO/2008/400019

)2009.01 (G01B19785317/04/2008

ืžืชืงืŸ ืœื‘ื—ื™ืจืช ืžืกืคืจ ืฉืœ ื—ืœืง ืฉืกืชื•ื ืื• ืžืกืคืจ ืฉืœ ื—ืœืง ืžืคืจืง

JIG FOR SELECTING VALVE PARTNUMBER OR JOINT PART NUMBER

KABUSHIKI KAISHA FUJIKIN

29/06/20072007-173099

JP

PCT/JP/2008/057524WO/2009/004850

Page 198: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 198

)2009.01 (A61F19785426/03/2009

ืฉื™ื˜ื” ื•ืžื›ืฉื™ืจ ืœื”ื—ื–ืงืช ืชื—ื‘ื•ืฉืช ื‘ืื•ืคืŸ ื”ื ื™ืชืŸ ืœืฉื™ื—ืจื•ืจ

METHOD AND APPARATUS FORRELEASABLY RETAININGBANDAGES

FIRSTืž"ืžื•ืฆืจื™ ืคื™ืจืกื˜ ืงื™ื™ืจ ื‘ืข CARE PRODUCTS LTD.

)2009.01 (C05G19785524/07/2007

NUTRIENT ืชืžื™ืกืช ืžื–ื•ืŸ FEED SOLUTIONCARBON STIMULATED GROWTH(PROPRIETY) LIMITED

27/09/20062006/08027ZAPCT/IB/2007/052929WO/2008/038165

)2009.01 (H03G19785625/09/2007

ืขื™ื‘ื•ื“ ื“ื™ื ืžื™ืงื” ืฉืžื™ืขืชื™ืช ื‘ืืžืฆืขื•ืช ืื™ืคื•ืก

AUDIO DYNAMICS PROCESSINGUSING A RESETDOLBY LABORATORIES LICENSINGCORPORATION

20/10/200660/853127USPCT/US/2007/020747WO/2008/051347

)2009.01 (C12N19785714/08/2002

ื—ื•ืžืฆื•ืช ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ื•ืช ืœืคื•ืœื™ืคืคื˜ื™ื“ื™ืืฉื™ืฉ ืœื”ื ืœืคื—ื•ืช ืชื›ื•ื ื” ืื—ืช ืฉืœ ืงื•ืœื˜ืŸ

B83ORืจื™ื—

NUCLEIC ACID MOLECULESENCODING POLYPEPTIDES HAVINGAT LEAST ONE PROPERTY OF ANINSECT 0R83B ODORANT RECEPTORSENTISEARCH, INC.

14/08/200160/312319USPCT/US/2002/025869WO/2003/016477

Page 199: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009199

)2009.01 (C12N19785914/08/2002

ื—ื•ืžืฆื•ืช ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ื•ืช ืœืคื•ืœื™ืคืคื˜ื™ื“ื™ืืฉื™ืฉ ืœื”ื ืœืคื—ื•ืช ืชื›ื•ื ื” ืื—ืช ืฉืœ ืงื•ืœื˜ืŸ

ืฉืœ ื—ืจืงB83ORืจื™ื—

NUCLEIC ACID MOLECULESENCODING POLYPEPTIDES HAVINGAT LEAST ONE PROPERTY OF ANINSECT 0R83B ODORANT RECEPTORSENTISEARCH, INC.

14/08/200160/312319USPCT/US/2002/025869WO/2003/016477

)2009.01 (A61K19786007/10/2007

ื•ืจื™ืื ื˜ื™ื ื‘ืงืฆื” ื”ืืžื™ื ื• ืฉืœ ื’ื•ืจื ื’ื“ื™ืœื”ืคื™ื‘ืจื•ื‘ืœืกื˜ื™ ื‘ืขืœื™ ืกืœืงื˜ื™ื‘ื™ื•ืช ืžื•ื’ื‘ืจืช

ืœืงื•ืœื˜ืŸ ื•ืฉื™ืžื•ืฉื™ื ื‘ื”ื

N-TERMINAL FGF VARIANTSHAVING INCREASED RECEPTORSELECTIVITY AND USES THEREOF

HEPACOREืž"ื”ืคืืงื•ืจ ื‘ืข LTD.28/09/200660/847658US

PCT/IL/2007/001199WO/2008/038287

)2009.01 (G06F19786126/03/2009

IMPROVED ืฉื™ื˜ื•ืช ืžืฉื•ืคืจื•ืช ืœื”ื›ื ืกืช ื ืชื•ื ื™ื DATA ENTRY SYSTEMSBENJAMIN ื‘ื ื™ืžื™ืŸ ืคื™ืจื•ื– ื’ืกื‘ื™ืืŸ FIROOZ GHASSABIAM

)2009.01 (B23P19786326/03/2009

PIEZO ืžืชื’ ืงื‘ืœ ืคื™ืื–ื• CAPACITANCE SWITCH

BARANืž"ื‘ืข) 1986(ื‘ืจืŸ ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ืžืชืงื“ืžื•ืช ADVANCED TECHNOLOGIES(1986) LTD.

Page 200: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 200

)2009.01 (A61K19786427/09/2007

ืงื™ื˜ื™ื ื•ืชื›ืฉื™ืจื™ื ืœื™ื™ืฆื•ืจ ื–ืงื™ืงื™, ืฉื™ื˜ื•ืช ืฉื™ืขืจ ื—ื“ืฉื™ื ื•ื’ื™ื“ื•ืœ ืฉื™ืขืจ

METHODS, KITS, ANDCOMPOSITIONS FOR GENERATINGNEW HAIR FOLLICLES ANDGROWING HAIRTHE TRUSTEES OF THE UNIVERSITYOF PENNSYLVANIA

28/09/200660/847854USPCT/US/2007/020842WO/2008/042216

)2009.01 (G01C19786504/10/2007

ืฉื™ื˜ื” ืœืฉืœื™ื˜ื” ืคื•ื ืงืฆื™ื•ื ืืœื™ืช ืฉืœ ืคืœื˜ืคื•ืจืžื” ืื™ื ืจื˜ื™ืช ืฉืœ ื›ืœื™ ื ืข

METHOD OF FUNCTIONALCONTROL OF AN INERTIALPLATFORM OF A MOVING CRAFTMBDA FRANCE

05/10/20060654113FRPCT/FR/2007/052076WO/2008/040917

)2009.01 (F24J19786629/09/2006

ื”ืจื›ื‘ืช ืืจื™ื–ื” ืœื”ืชืงื ืช ืฆื ืจืช ืงื™ืจื•ืจืžืชื—ืช ืœืคื ื™ ื”ืฉื˜ื— ื‘ืžืขืจื›ืช ื—ื™ืœื•ืฃ ื™ืฉื™ืจ

ืงื™ืจื•ืจ/ืฉืœ ื—ื™ืžื•ื

ENCASEMENT ASSEMBLY FORINSTALLATION OF SUB-SURFACEREFRIGERANT TUBING IN A DIRECTEXCHANGE HEATING/COOLINGSYSTEMEARTH TO AIR SYSTEMS, LLC

PCT/US/2006/038220WO/2008/039202

Page 201: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009201

)2009.01 (A61F19786728/09/2007

ืžื›ืฉื™ืจ ื”ืขื‘ืจื” ืœื”ืขื‘ืจืช ืชื•ืชื‘ืช ื“ืจืš ื”ืขื•ืจ

DELIVERY TOOL FORPERCUTANEOUS DELIVERY OF APROSTHESISHEART LEAFLET TECHNOLOGIES,INC.

28/09/200660/827373USPCT/US/2007/079978WO/2008/040014

)2009.01 (C07K19786828/09/2007

ืื ื˜ื™ื’ื ื™ื ื•ื ื•ื’ื“ื ื™ื ื—ื“ืฉื™ื ื”ืงืฉื•ืจื™ื ืœืื“ื ื•ืงืจืฆื™ื ื•ืžื” ืฉืœ ืชืขืœืช ื”ืœื‘ืœื‘

NOVEL ANTIGENS AND ANTIBODIESASSOCIATED TO PANCREATICDUCTAL ADENOCARCINOMARIBOVAX BIOTECHNOLOGIES S.A.

29/09/200606121552.1EP20/12/200606126726.6EP

PCT/EP/2007/060305WO/2008/037792

)2009.01 (A61K19786902/10/2007

1CHKCOMPOSITIONSืชืจื›ื•ื‘ื•ืช ืฉืœ ืžืขื›ื‘ื™ OF CHK1INHIBITORSICOS CORPORATION

20/10/200660/853056USPCT/US/2007/080150WO/2008/067027

Page 202: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 202

)2009.01 (A61L19787012/10/2007

ืขื“ืฉื•ืช ืชื•ืš ืขื™ื ื™ื•ืช ื‘ืขืœื•ืช ืžืืคื™ื™ื ื™ื ืฉืœืกื’ื•ืœ ืžื™ื•ื—ื“ ื•ื”ืขื‘ืจืช ืื•ืจโ€“ืฆืžืฆื•ื ื›ื—ื•ืœ

ื›ื—ื•ืœ

INTRAOCULAR LENSES WITHUNIQUE BLUE-VIOLET CUTOFF ANDBLUE LIGHT TRANSMISSIONCHARACTERISTICSALCON, INC.

13/10/200660/851666US09/02/200760/889131US

PCT/US/2007/081204WO/2008/048880

)2009.01 (A61K19787104/10/2007

ืฆื•ืจื•ืช ืžื™ื ื•ืŸ ืคืจืžืงื•ืœื•ื’ื™ื•ืช ืžื•ืฆืงื•ืชืžืงื•ื‘ืขื•ืช ื‘ืชื•ืšโ€“ื”ืžื›ื™ืœื•ืช ืชืจื›ื•ื‘ื•ืช ืžื™ืงืจื•

ืคื•ืœื™ืžืจื™ื ื™ื•ื ื™ื™ื ื‘ืœืชื™ ืžืกื™ืกื™ื ื‘ืžื™ื

PHARMACEUTICAL SOLID DOSAGEFORMS COMPRISING COMPOUNDSMICRO-EMBEDDED IN IONICWATER-INSOLUBLE POLYMERS

F. HOFFMANN-LA ROCHE AG13/10/200660/851852US07/08/200760/954401US

PCT/EP/2007/060542WO/2008/043701

)2009.01 (C07D19787209/10/2007

ืื™ืžื™ื“ืื–ื•ืœื™ื ื‘ืขืœื™ ืืคื™ื ื™ื•ืชโ€“2โ€“ืืžื™ื ื•ืžืชื™ืœ ืืžื™ืŸืœืจืฆืคื˜ื•ืจื™ื ื”ืงืฉื•ืจื™ื ืœืฉื™ื™ืจ

AMINOMETHYL-2-IMIDAZOLESWITH AFFINITY WITH THE TRACEAMINE ASSOCIATED RECEPTORSF. HOFFMANN-LA ROCHE AG

19/10/200606122553.8EPPCT/EP/2007/060664WO/2008/046756

Page 203: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009203

)2009.01 (B01D19787302/10/2007

ืฉื™ื˜ื” ื•ืžื›ืฉื™ืจ ืœื”ื•ืฆืืช ื“ื• ืชื—ืžื•ืฆืช ืžืŸ ืžืื•ื•ื™ืจื”ืคื—

METHOD AND APPARATUS FOREXTRACTING CARBON DIOXIDEFROM AIRGLOBAL RESEARCHTECHNOLOGIES, LLC.

02/10/200660/827849US13/10/200660/829376US

PCT/US/2007/080229WO/2008/042919

)2009.01 (A61B19787426/03/2009

RELIGIOUS ืคืจื™ื˜ ืœื‘ื•ืฉ ื“ืชื™ GARMENTMATITYAHU TENENBAUM

)2009.01 (C07D19787516/10/2007

ื•โ€“Cื”ืจื›ื‘ื™ื ื•ืฉื™ื˜ื•ืช ืœื•ื•ื™ืกื•ืช ืงื•ืœื˜ื ื™ โ€“ืงื™ื˜PDGFR

COMPOSITIONS AND METHODS FORMODULATING C-KIT AND PDGFRRECEPTORSIRM LLC

20/10/200660/862430USPCT/US/2007/081538WO/2008/051757

Page 204: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 204

)2009.01 (C07D19787619/10/2007

Nโ€“(2โ€“ื”ื™ื“ืจื•ืงืกื™ืืชื™ืœ(โ€“Nโ€“4โ€“ืžืชื™ืœโ€“โ€“4โ€“ืชื™ืื–ื•ืœ(โ€“1(ื™ืœโ€“8โ€“ืงื•ื•ื™ื ื•ืœื™ื (

, ื‘ื ื–ืืžื™ื“)ืžืชื™ืœ)ื™ืœื™ื“ืŸโ€“4โ€“ืคื™ืคืจื™ื“ื™ื )ื™ืœืžืชื™ืœ, ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจื• ื•ืฉื™ืžื•ืฉื• ืœื˜ื™ืคื•ืœ ื‘ื›ืื‘

ื—ืจื“ื” ื•ื“ื™ื›ืื•ืŸ

N-(2-HYDROXYETHYL)-N-METHYL-4-(QUINOLIN-8-YL(1-(THIAZOL-4-YLMETHYL)PIPERIDIN-4-YLIDENE)METHYL)BENZAMIDE,THE PROCESS OF MAKING IT ASWELL AS ITS USE FOR THETREATMENT OF PAIN, ANXIETYAND DEPRESSIONASTRAZENECA AB

20/10/200660/862327USPCT/SE/2007/000924WO/2008/048171

)2009.01 (C07D19787709/10/2007

AMINOMETHYL-4-IMIDAZOLES ืื™ืžื™ื“ืื–ื•ืœื™ืโ€“4โ€“ืืžื™ื ื•ืžืชื™ืœF. HOFFMANN-LA ROCHE AG

19/10/200606122586.8EPPCT/EP/2007/060666WO/2008/046757

)2009.01 (G06F19787827/09/2007

ืคื™ืชื•ื— ืชื•ื›ื ื” ื•ืฉื™ืจื•ืชื™ ืžื›ื™ืจื•ืช ืœืื•ืจืš ืชืงื•ืคืช ื—ื™ื™ื

SOFTWARE DEVELOPMENT ANDSALES LIFE-CYCLE SERVICES

BRIGHTHUB, INC.27/09/200660/827203US

PCT/US/2007/079801WO/2008/039958

)2009.01 (B65D19787910/12/2007

CONTAINER ืžื™ื›ืœHAGLEITNER, HANS, GEORG

23/01/200707001378.4ATPCT/AT/2007/000559WO/2008/089500

Page 205: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009205

)2009.01 (F16L19788028/09/2007

INSULATED ืžื•ืฆืจื™ ืžืขืจื›ืช ืชื™ืขื•ืœ ืžื‘ื•ื“ื“ื™ื DUCTWORK PRODUCTSSPECIALIST INSULATION LIMITED

29/09/20060619178.7GB11/06/20070711224.6GB

PCT/GB/2007/003692WO/2008/038013

)2009.01 (A61K19788305/10/2007

COMBINATIONื” ืžืฉื•ืœื‘ืชืชืจื•ืค DRUGTAKEDA PHARMACEUTICALCOMPANY LIMITED

06/10/20062006-275841

JP

07/03/20072007#057902JPPCT/JP/2007/070026WO/2008/044782

)2009.01 (H04Q19788430/10/2007

Bืชื”ืœื™ืš ื”ืขื‘ืจื” ENODEโ€“INTERINTER-ENODE B HANDOVERPROCEDUREQUALCOMM INCORPORATED

31/10/200660/863791USPCT/US/2007/083033WO/2008/055169

)2009.01 (A01N19788505/10/2007

STABILIZED ืžื™ื•ืฆื‘Eืชืจื›ื•ื‘ืช ืคืจื•ืกื˜ื’ืœื ื“ื™ืŸ PROSTAGLANDINE ECOMPOSITIONNEXMED HOLDINGS, INC.

11/10/200611/546196USPCT/US/2007/021374WO/2008/045309

Page 206: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 206

)2009.01 (H01L19788626/09/2007

FORMED ืืœืงื˜ืจื™ ืžืขื•ืฆื‘โ€“ืžื•ื“ื•ืœ ืขืจื•ืฅ ื—ืฉืžืœื™ ืคื•ื˜ื• PHOTOVOLTAIC MODULEBUSBARSSUNPOWER CORPORATION

03/10/200611/543440USPCT/US/2007/020801WO/2008/042194

)2009.01 (C07D19788717/10/2007

ืชืจื›ื•ื‘ื•ืช, ื ื’ื–ืจื•ืช ืคืœื•ืื•ืจืŸ ื—ื“ืฉื•ืชื”ืžื›ื™ืœื•ืช ืื•ืชื• ื”ื“ื‘ืจ ื•ืฉื™ืžื•ืฉ ื‘ื”ืŸ

90HSPื›ืžืขื›ื‘ื•ืช ืฉืœ ื—ืœื‘ื•ืŸ ืœื™ื•ื•ื™

NEW FLUORENE DERIVATIVES,COMPOSITIONS CONTAINING THESAME AND USE THEREOF ASINHIBITORS OF THE PROTEINCHAPERONE HSP 90SANOFI-AVENTIS

24/10/20060609331FRPCT/FR/2007/001703WO/2008/049994

)2009.01 (F23G19788828/09/2007

INTEGRATED ืžืขืจื›ืช ืื ืจื’ื™ื” ื‘ื™ื•ืžืกื” ืžืฉื•ืœื‘ืช BIOMASS ENERGYSYSTEMZILKHA BIOMASS ENERGY LLC

29/09/200660/848466USPCT/US/2007/079895WO/2008/091415

)2009.01 (C07D19788904/03/2004

ืงืœื•ืืœืงืืŸ ื•ืฉื™ื˜ื•ืช'ืชืจื›ื•ื‘ื•ืช ืืจื™ืœื•ื•ื™ื ื™ืœืฆ ื”ื›ื ืชืŸ ื•ืฉื™ืžื•ืฉืŸ

ARYLVINYLAZACYCLOALKANECOMPOUNDS AND METHODS OFPREPARATION AND USE THEREOFTARGACEPT, INC.

05/03/200310/379868USPCT/US/2004/006530WO/2004/078752

Page 207: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009207

)2009.01 (C07D19789004/03/2004

ืงืœื•ืืœืงืืŸ ื•ืฉื™ื˜ื•ืช'ืชืจื›ื•ื‘ื•ืช ืืจื™ืœื•ื•ื™ื ื™ืœืฆ ื”ื›ื ืชืŸ ื•ืฉื™ืžื•ืฉืŸ

ARYLVINYLAZACYCLOALKANECOMPOUNDS AND METHODS OFPREPARATION AND USE THEREOFTARGACEPT, INC.

05/03/200310/379868USPCT/US/2004/006530WO/2004/078752

)2009.01 (H04L19789126/10/2007

ืฉื™ื˜ื” ื•ืžืชืงืŸ ืขื‘ื• ื—ื™ืœื•ืคื™ ืกืคืจ ืงื•ื“ ื‘ืžืขืจื›ืช ืืœื—ื•ื˜ื™ืช ืžืจื•ื‘ืช ื’ื™ืฉื•ืช

METHOD AND APPARATUS FORCODEBOOK EXCHANGE IN AMULTIPLE ACCESS WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED

26/10/200660/854898US27/10/200660/863313US25/10/200711/923967US

PCT/US/2007/082734WO/2008/052191

)2009.01 (C07D19789216/10/2007

โ€“ืžื•ื“ื•ืœื˜ื•ืจื™ื ืžืกื•ื’ ื‘ื™ืคื ื™ืœ ืกื•ืœืคื•ื ื™ืœ ื•ืคื ื™ืœ3Hื”ื˜ืจื•ืืจื™ืœ ืกื•ืœืคื•ื ื™ืœ ืฉืœ ืจืฆืคื˜ื•ืจ

ืœื”ื™ืกื˜ืžื™ืŸ ื”ืฉื™ืžื•ืฉื™ื™ื ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ื‘ืงืฉื•ืจื•ืช ืืœื™ื•

BIPHENYL SULFONYL AND PHENYL-HETEROARYL SULFONYLMODULATORS OF THE HISTAMINEH3-RECEPTOR USEFUL FOR THETREATMENT OF DISORDERSRELATED THERETOARENA PHARMACEUTICALS, INC.

17/10/200660/852610US11/06/200760/934358US

PCT/US/2007/022086WO/2008/048609

Page 208: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 208

)2009.01 (C07J19789324/10/2007

ื”ืจื›ื‘ื™ื ื•ืฉื™ื˜ื•ืช ืœืขื™ื›ื•ื‘ ืฉืœ ืฉื’ืฉื•ื’ ื‘ืื ื“ื•ืžื˜ืจื™ื•ื

COMPOSITIONS AND METHODS FORSUPPRESSING ENDOMETRIALPROLIFERATIONREPROS THERAPEUTICS INC.

24/10/200660/862632US17/01/200760/885348US

PCT/US/2007/082432WO/2008/067086

)2009.01 (A01N19789402/10/2007

ืžื›ืฉื•ืจ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ืชืจื›ื•ื‘ื•ืช ืกืžื™ื•ื›ื™ืžื™ื•ืช ืœืฉื ื”ื“ื‘ืจืช ื—ืจืงื™ื

APPARATUS AND SYSTEMS FORUSING SEMIOCHEMICALCOMPOSITIONS FOR INSECT PESTCONTROLSUTERRA LLC

02/10/2006US60/827878USPCT/US/2007/080220WO/2008/063751

)2009.01 (A47J19789705/04/2009

PLACEMENT ืžืฉื˜ื— ืœื”ื ื—ืช ืื•ื›ืœ ื•ืฉื™ื˜ื” ืœื™ืฆื•ืจื• DEVICE AND METHODOFER ืขื™ื“ืŸ ื‘ืŸ ืขืžื™ MANOR

07/04/2008GB0806168.1GB

)2009.01 (B23C19789805/04/2009

CUTTING ืฉื™ืžื” ื•ื›ืœื™ ื—ื™ืชื•ืš ืขื‘ื•ืจื” INSERT AND CUTTINGTOOL THEREFOR

ISCARืž"ื™ืฉืงืจ ื‘ืข LTD.

Page 209: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009209

)2009.01 (B23C19789905/04/2009

CUTTING ื›ืœื™ ื—ื™ืชื•ืš ื•ืžื—ื–ื™ืง ื›ืœื™ ืขื‘ื•ืจื• TOOL ASSEMBLY ANDTOOL HOLDER THEREFOR

ISCARืž"ื™ืฉืงืจ ื‘ืข LTD.

)2009.01 (A47C19790105/04/2009

A ืžื™ื˜ืช ื•ื•ืงื•ืื•ื VACUUM BEDMAYMON ืžื™ืžื•ืŸ ืกื™ื’ืจื•ืŸ SIGRON

)2009.01 (C12N19790318/02/2000

ืจื™ืื•ื•ื™ืจื•ืก ืœื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ื”ืชืจื‘ื•ืช ืชืื™ืช

REOVIRUS FOR THE TREATMENTOF CELLULAR PROLIFERATIVEDISORDERSONCOLYTICS BIOTECH INC.

24/02/199909/256824USPCT/CA/2000/000178WO/2000/050051

)2009.01 (H04L19790427/09/2007

ืœ ื”ืคืขืœืช ื™ื—ื™ื“ื” ืืœื—ื•ื˜ื™ืช ืฉื™ื˜ื” ื•ืžืขืจื›ืชืงืœื™ื˜ื” ื‘ืชืื™ ืฉื™ืจื•ืช ื”ืžื•ืงื“ืฉื™ื/ืœืฉื™ื“ื•ืจ

ื™ืขื“โ€“ืœืฉื™ื“ื•ืจื™ ืžื•ืœื˜ื™ืžื“ื™ื” ืจื‘ื™

METHOD AND APPARATUS FORWIRELESS TRANSMIT/RECEIVEUNIT OPERATION IN DEDICATEDMULTIMEDIA BROADCASTMULTICAST SERVICES CELLSINTERDIGITAL TECHNOLOGYCORPORATION

29/09/200660/827551USPCT/US/2007/020861WO/2008/042225

Page 210: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 210

)2009.01 (B32B19790529/08/2007

COMPOSITE ืงื™ืจ ื’ื‘ืก ืžื—ื•ืžืจ ืžืจื•ื›ื‘ ื‘ืขืœ ืžืฉืงืœ ื ืžื•ืš LIGHT WEIGHTGYPSUM WALLBOARDUNITED STATES GYPSUM COMPANY

29/09/200611/537395USPCT/US/2007/018978WO/2008/042060

)2009.01 (C07H19790704/10/2007

HCV ื ื•ืงืœื™ืื•ื–ื™ื“ื™HCVืžืขื›ื‘ NUCLEOSIDE INHIBITORMEDIVIR AB

10/10/200660/850926USPCT/EP/2007/060557WO/2008/043704

)2009.01 (A61K19790817/10/2007

ืชื›ืฉื™ืจ ื‘ืฆื•ืจืช ืชืจืกื™ืก ืฉืื™ื ื• ืชื—ืช ืœื—ืฅ ื ื•ืจืคื™ืŸ ืœืžืชืŸ ื“ืจืš ื”ืจื™ืจื™ืชื”ืžื›ื™ืœ ื‘ื•ืคืจ

BUPRENORPHINE-CONTAININGNON-PRESSURISED SPRAYCOMPOSITION FORTRANSMUCOSAL ADMINISTRATIONPHARMASOL LIMITED,

18/10/20060620661.9GBPCT/GB/2007/050639WO/2008/047163

)2009.01 (A23L19790926/12/2007

REDUCTION ื™ืจื™ ืคื•ืœื™ืคื ื•ืœื”ืงื˜ื ืช ืงืฉื™ื•ืช ื‘ืชื›ืฉ OF ASTRINGENCY INPOLYPHENOL COMPOSITIONSKRAFT FOODS GLOBAL BRANDSLLC

27/12/200611/616572US18/12/200711/958556US

PCT/US/2007/088814WO/2008/083152

Page 211: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009211

)2009.01 (B32B19791029/09/2007

ื™ื ืžืจื‘ื“ื™ื ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืžื•ืฆืจื™ื ื”ืžื•ืจื›ื‘ืฉืœ ืจืฆื•ืขื•ืช ืคื•ืœื™ืžืจื™ื•ืช ื”ืžืกื•ื“ืจื•ืช ื‘ืื•ืคืŸ

ื›ื™ื•ื•ื ื™โ€“ื—ื“

PROCESS FOR PRODUCINGLAMINATES OFUNIDIRECTIONALLY ARRANGEDPOLYMERIC TAPESNOVAMEER B.V.

05/10/200606020909.5EPPCT/EP/2007/008495WO/2008/040506

)2009.01 (B32B19791129/09/2007

ืœื™ืš ืœื™ื™ืฆื•ืจ ืœื•ื—ื•ืช ื’ืžื™ืฉื™ื ื”ืžื›ื™ืœื™ื ืชื”ืžื•ืฆืจื™ื ื”ืžื•ืจื›ื‘ื™ื ืžืจื‘ื“ื™ื ืฉืœ ืจืฆื•ืขื•ืช

ื›ื™ื•ื•ื ื™โ€“ืคื•ืœื™ืžืจื™ื•ืช ื”ืžืกื•ื“ืจื•ืช ื‘ืื•ืคืŸ ื—ื“

PROCESS FOR PRODUCINGFLEXIBLE PANELS COMPRISINGLAMINATES OFUNIDIRECTIONALLY ARRANGEDPOLYMERIC TAPESNOVAMEER B.V.

05/10/200606020902.0EPPCT/EP/2007/008500WO/2008/040511

)2009.01 (B32B19791229/09/2007

ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืืจื™ื’ื™ื ื”ื›ื•ืœืœื™ื ืจืฆื•ืขื•ืช ื›ื™ื•ื•ื ื™โ€“ืคื•ืœื™ืžืจื™ื•ืช ื”ืžืกื•ื“ืจื•ืช ื‘ืื•ืคืŸ ื—ื“

PROCESS FOR PRODUCING FABRICSCOMPRISING UNIDIRECTIONALLYARRANGED POLYMERIC TAPESNOVAMEER B.V.

05/10/200606020901.2EPPCT/EP/2007/008499WO/2008/040510

Page 212: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 212

)2009.01 (A01N19791320/09/2007

ื”ืจื›ื‘ื™ ืจื•ืงื—ื•ืช ืฉืœ ืžื˜ืจื™ืžื™ ืชืจื•ืคื•ืช ืฉืœ ืคืจื•ืคื•ืคื•ืœ ืžื‘ื•ืกืกื™ ืžื™ื

AQUEOUS BASEDPHARMACEUTICAL FORMULATIONSOF WATER-SOLUBLE PRODRUGS OFPROPOFOLEISAI INC.

05/10/200660/828307USPCT/US/2007/020351WO/2008/045189

)2009.01 (A61K19791412/10/2007

ื“ื™ืื’ื ื•ื–ื” ื•ื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ ื‘ืืžืฆืขื•ืช ืฉื™ืžื•ืฉEREGื‘ื ื•ื’ื“ืŸ ืื ื˜ื™

DIAGNOSIS AND TREATMENT OFCANCER USING ANTI-EREGANTIBODYTHE UNIVERSITY OF TOKYO

12/10/20062006-278819

JP

PCT/JP/2007/069988WO/2008/047723

)2009.01 (H04R19791525/09/2007

โ€“ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืฉืคื•ื™ ืขื™ื•ื•ืช ื–ื›ืจื•ืŸ ืœื ืœื™ื ืืจื™ ืฉืœ ืžืชืžืจ ืื•ื“ื™ื•

SYSTEM AND METHOD FORCOMPENSATING MEMORYLESSNON-LINEAR DISTORTION OF ANAUDIO TRANSDUCERDTS, INC.

18/10/200611/583190USPCT/US/2007/020652WO/2008/048413

Page 213: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009213

)2009.01 (C07H19791605/10/2007

ืชื›ืฉื™ืจื™ื ืžื™ื™ืฆื‘ื™ื ื•ืฉื™ื˜ื•ืช ืœืžื™ืฆื•ื™ ื—ื•ืžืฆื” ืจื™ื‘ื•ื ื•ืงืœื™ืื™ืช

STABILIZING COMPOSITIONS ANDMETHODS FOR EXTRACTION OFRIDONUCLEIC ACIDDNA GANOTEK INC

06/10/200660/828563US22/11/200660/866985US13/07/200760/949778US

PCT/CA/2007/001785WO/2008/040126

)2009.01 (C07K19791717/10/2007

ื”ื›ืœืœื” ื’ื ื˜ื™ืช ืฉืœ ื—ื•ืžืฆื•ืช ืืžื™ื ื• ืฉืื™ื ืŸ ื˜ื‘ืขื™ื•ืช ืœืชื•ืš ื—ืœื‘ื•ื ื™ื ื‘ืชืื™ ื™ื•ื ืงื™ื

GENETIC INCORPORATION OFUNNATURAL AMINO ACIDS INTOPROTEINS IN MAMMALIAN CELLSTHE SCRIPPS RESEARCH INSTITUTE

18/10/200660/853008US12/04/200760/923458US

PCT/US/2007/022232WO/2008/073184

)2009.01 (H04B19791805/04/2009

ืžืขืจื›ืช ืชืงืฉื•ืจืช ื•ื”ืชืงืŸ ื”ืžืฉืชืžืฉื™ืืคืกโ€“ื‘ืคืขื•ืœื” ื‘ื• ืฆืจโ€“ืจื—ื‘ ื•ืคืกโ€“ื–ืžื ื™ืช ืฉืœBANDโ€“INื•ืฉื™ื˜ื” ืงืฉื•ืจื”

COMMUNICATIONS SYSTEM ANDDEVICE USING SIMULTANEOUSWIDEBAND AND IN-BANDNARROWBAND OPERATION ANDRELATED METHODHARRIS CORPORATION

04/04/200812/062550US

)2009.01 (A61J19791901/10/2007

INFANT ืžื™ื›ืœ ืœื”ืื›ืœืช ืชื™ื ื•ืงื•ืช FEEDING CONTAINERADIRI, INC.

06/10/200611/539572USPCT/US/2007/080123WO/2008/045714

Page 214: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 214

)2009.01 (C07K19792003/07/2007

โ€“ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ืขื ืชื›ื•ื ื•ืช ืื ื˜ื™ื“ืœืงืชื™ืช ืžื•ื’ื‘ืจืช ื•ืฆื™ื˜ื•ื˜ื•ืงืกื™ืช

ืžื•ืคื—ืชืช ื•ืฉื™ื˜ื•ืช ืงืฉื•ืจื•ืช

POLYPEPTIDES WITH ENHANCEDANTI-INFLAMMATORY ANDDECREASED CYTOTOXIC PROPERTIESAND RELATING METHODSTHE ROCKEFELLER UNIVERSITY

26/10/2006PCT/US06/41791US03/04/2007PCT/US07/08396US

PCT/US/2007/072771WO/2008/057634

)2009.01 (C08F19792104/10/2007

ืคื•ืœื™ืžืจื™ ืžืกืจืง ื•ืฉื™ืžื•ืฉื™ื”ื ืœื™ื™ืฆื•ืจ ืจื›ื™ื‘ื™ื ืคืขื™ืœื™ื ืื• ื™ืขื™ืœื™ื ื”ืจื›ื‘ื™ื ืฉืœ

COMB POLYMERS AND USETHEREOF FOR THE PRODUCTION OFACTIVE OR EFFECTIVE INGREDIENTFORMULATIONSBASF SE

05/10/200606121851.7EPPCT/EP/2007/060553WO/2008/040786

)2009.01 (G06F19792230/10/2007

ืคื•ืจืžืฆื™ื” ืžืจื—ื‘ ืžืฉื•ืชืฃ ืขื‘ื•ืจ ืื™ื  ืœืชืงืฉื•ืจืช

SHARED SPACE FORCOMMUNICATING INFORMATION

MICROSOFT CORPORATION13/11/200611/599599US

PCT/US/2007/083024WO/2008/063833

)2009.01 (C07K19792312/11/2007

SYNTHETIC ืืžื™ื“ื™ื ืคืคื˜ื™ื“ื™ื ืกื™ื ืชื˜ื™ื™ื PEPTIDE AMIDESCARA THERAPEUTICS, INC.

10/11/200660/858109US10/05/200760/928550US

PCT/US/2007/023858WO/2008/057608

Page 215: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009215

)2009.01 (C07K19792413/11/2007

ืืžื™ื“ื™ื ืคืคื˜ื™ื“ื™ื ืกื™ื ืชื˜ื™ื™ื ื•ื“ื™ืžืจื™ื ืฉืœื”ื

SYNTHETIC PEPTIDE AMIDES ANDDIMERS THEREOF

CARA THERAPEUTICS, INC.10/11/200660/858121US10/11/200660/858120US10/11/200660/858123US10/05/200760/928551US10/05/200760/928527US10/05/200760/928557US

PCT/US/2007/023874WO/2008/060552

)2009.01 (B02C19792530/10/2007

METHOD ืฉื™ื˜ื” ืœืžื™ืงืจื•ื ื™ื–ืฆื™ื” OF MICRONIZATION

OMRIXืž"ืื•ืžืจื™ืงืก ื‘ื™ื•ืคืืจืžืืฆื‘ื˜ื™ืงื” ื‘ืข BIOPHARMACEUTICALSLTD.

02/11/200660/856042USPCT/IL/2007/001318WO/2008/053475

)2009.01 (A61K19792726/10/2007

W/O/WW/O/Wืชื›ืฉื™ืจ ืืžื•ืœืกื™ื” EMULSION COMPOSITIONCONTROLLED LIPO TECHS, INC.

27/10/20062006-292426

JP

PCT/JP/2007/070896WO/2008/053799

Page 216: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 216

)2009.01 (C07K19792826/10/2007

ื ื•ื’ื“ื ื™ื ื•ืชืฆืžื™ื“ื™ื ื—ื™ืกื•ื ื™ื™ื ื•ืฉื™ืžื•ืฉื™ื”ืANTIBODIES ANDIMMUNOCONJUGATES AND USESTHEREFORGENENTECH, INC.

27/10/200660/863295US05/12/200660/868707US30/03/200760/921300US29/06/200760/937857US

PCT/US/2007/082726WO/2008/052187

)2009.01 (C07K19792919/12/2007

ืฉืœ ื‘ื™ื˜ื•ื™ ืฉืœSHRNAโ€“ืขื™ื›ื•ื‘ ืžืชื•ื•ืš ืคื•ืงื•ืกื™ืœื˜ืจืื ืกืคืจืื–โ€“6,1โ€“ืืœืคื

SHRNA-MEDIATED INHIBITION OFEXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASEF. HOFFMANN-LA ROCHE AG

22/12/200606026653.3EPPCT/EP/2007/011160WO/2008/077547

)2009.01 (C07D19793012/10/2007

โ€“ื“ื™ื”ื™ื“ืจื•โ€“6,3[โ€“5โ€“ื›ืœื•ืจื•โ€“2ื”ื™ื“ืจืื˜ื™ื ืฉืœโ€“ื˜ืจื™ืคืœื•ืื•ืจื•(โ€“4โ€“ื“ื™ืื•ืงืกื•โ€“6,2โ€“ืžืชื™ืœโ€“3

โ€“Nโ€“ืคืœื•ืื•ืจื•โ€“4โ€“]ืคื™ืจื™ืžื™ื“ื™ื ื™ืœ)H2(โ€“1โ€“)ืžืชื™ืœืืžื™ื ื•โ€“)ืžืชื™ืœืืชื™ืœโ€“1(โ€“ืžืชื™ืœ[[

ื‘ื ื–ืืžื™ื“]ืกื•ืœืคื•ื ื™ืœ

HYDRATES OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYLETHYL)-AMINO]SULPHONY]BENZAMIDEBASF SE

13/10/200606122264.2EPPCT/EP/2007/060880WO/2008/043836

Page 217: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009217

)2009.01 (A23F19793118/12/2007

ืฉื™ื˜ื” ืœื”ื›ื ืช ื”ืจื›ื‘ื™ ืžืฉืงื” ื‘ืขืœื™ ืชื›ื•ื ื•ืชืžืฉื•ืคืจื•ืช ืœืฉื—ืจื•ืจ ืืจื•ืžื” ื•ื”ืจื›ื‘ื™ื

ืœืฉื™ืžื•ืฉ

METHOD FOR PREPARINGBEVERAGE COMPOSITIONS HAVINGIMPROVED AROMA RELEASECHARACTERISTICS ANDCOMPOSITIONS FOR USE THEREINKRAFT FOODS GLOBAL BRANDSLLC

29/12/200660/882743US13/12/200711/955778US

PCT/US/2007/087927WO/2008/082953

)2009.01 (A61K19793210/10/2007

FAAHื—ื•ืžืฆื•ืช ื•ืืกื˜ืจื™ื ื‘ื•ืจื•ื ื™ื ื›ืžืขื›ื‘ื™BORONIC ACIDS AND ESTERS ASINHIBITORS OF FATTY AMIDEHYDROLASEINFINITY DISCOVERY, INC.

10/10/200660/850520USPCT/US/2007/021626WO/2008/063300

)2009.01 (A61K19793311/10/2007

ืžืขื›ื‘ื™ ืงื ืื– ื”ื™ืขื™ืœื™ื ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ืฉืœืจื™ื‘ื•ื™ ืžืจื›ื™ื‘ื™ ืžื•ื— ื”ืขืฆื ื•ืžื—ืœื•ืช ืฉื’ืฉื•ื’

ื ื•ืกืคื•ืช

KINASE INHIBITORS USEFUL FORTHE TREATMENT OFMYLEOPROLIFERATIVE DISEASESAND OTHER PROLIFERATIVEDISEASESDECIPHERA PHARMACEUTICALS,LLC

11/10/200660/850834US10/10/200711/870388US

PCT/US/2007/081098WO/2008/046003

Page 218: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 218

)2009.01 (C07D19793412/10/2007

90HSPHYDROBENZAMIDEื”ื™ื“ืจื•ื‘ื ื–ืืžื™ื“ ื›ืžืขื›ื‘ื™ ืชื•ืœื“ื•ืช DERIVATIVESAS INHIBITORS OF HSP90ASTEX THERAPEUTICS LIMITED

12/10/20060620259.2GB12/10/200660/829243GB

PCT/GB/2007/003871WO/2008/044034

)2009.01 (A47J19793530/10/2007

JUGื™ืืฆื ืฆื ืช ืœืกื™ื ื•ืŸ ื ื•ื–ืœ FOR FILTERING LIQUIDSLAICA S.P.A.

15/11/2006PD2006A000425ITPCT/EP/2007/009412WO/2008/058632

)2009.01 (A61B19793605/10/2007

IMPLANTABLE ื”ืชืงืŸ ื”ื ื™ืชืŸ ืœื”ืฉืชืœื” DEVICEPFM PRODUKTE FUR DIE MEDIZINAKTIENGESELLSCHAFT

05/10/2006102006047494.5DE20/10/2006102006050385.6DE

PCT/EP/2007/008656WO/2008/040555

)2009.01 (C07K19793711/10/2007

ANTIBODIES ื ื•ื’ื“ื ื™ื ืœืœื™ืžืคื•ื˜ื•ืงืกื™ืŸ ืืœืคื TO LYMPHOTOXIN-ALPHAGENENTECH, INC.

12/10/200660/829257US18/05/200760/938999US

PCT/US/2007/081154WO/2008/063776

Page 219: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009219

)2009.01 (C07K19793826/10/2007

ืฉืœ ILIL-21โ€“21ื•ืจื™ืื ื˜ื™ื VARIANTSNOVO NORDISK A/S

26/10/200606123040.5EPPCT/EP/2007/061543WO/2008/049920

)2009.01 (H04L19793928/09/2007

ืฉืœ ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืงื™ื“ื•ื“ ืžื—ื•ืŸ ืื™ื›ื•ืชืงื™ื“ื•ื“ ืฉืœ ื‘ื™ื˜ื™ื ืฉืœ ืžื™ื“ืขโ€“ืขืจื•ืฅ ื•ืงื“ื

ื‘ืงืจื”

METHOD AND APPARATUS FORENCODING CHANNEL QUALITYINDICATOR AND PRECODINGCONTROL INFORMATION BITSINTERDIGITAL TECHNOLOGYCORPORATION

02/10/200660/827829US30/10/200660/855682US09/01/200760/884116US02/02/200760/887829US05/02/200760/888272US08/02/200760/888867US09/02/200760/889038US15/03/200760/895093US

PCT/US/2007/020924WO/2008/042255

)2009.01 (H04B19794026/09/2007

)CQIืžื‘ื•ืกืก(ื•ื™ื™ืŸ ืœื•ื— ื‘ืงืจืช ื›ื— ืฉื™ื“ื•ืจ ืœืœื•ืขื/ืžืฉื•ืœื‘ ืœื•ืœืื” ืคืชื•ื—ื” ืœื•ืœืื” ืกื’ื•ืจื”

UTRAโ€“Eื”ืฉืงื˜ืช ื”ืคืจืขื•ืช ืขื‘ื•ืจ

COMBINED OPEN LOOP/CLOSEDLOOP (CQI-BASED) UPLINKTRANSMIT POWER CONTROL WITHINTERFERENCE MITIGATION FOR E-UTRAINTERDIGITAL TECHNOLOGYCORPORATION

03/10/200660/827965US27/10/200660/863188US

PCT/US/2007/020779WO/2008/042187

Page 220: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 220

)2009.01 (A61K19794104/10/2007

ืฉื™ืžื•ืฉ ื‘ืชื•ืœื“ื•ืช ืื ื™ืœื™ื ื•ืคื™ืจื™ืžื™ื“ื™ืŸ ื‘ื™ื™ืฆื•ืจืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ื›ื‘ื“

ืฉืื™ื ืŸ ืงืฉื•ืจื•ืช ืœืฉืชื™ื”

USE OF ANILINOPYRIMIDINEDERIVATIVES FOR THEPREPARATION OFPHARMACEUTICAL COMPOSITIONSFOR TREATING NON-ALCOHOLICLIVER DISEASESARES TRADING SA

04/10/200660/849251US28/02/200760/904116US

PCT/EP/2007/008627WO/2008/040548

)2009.01 (H04R19794210/10/2007

ื”ืขื‘ืจื”, ืชื”ืœื™ืš ื•ื”ืชืงืŸ ืœื”ืฉื’ื”ืขื™ ืงื•ืœ ืขื‘ื•ืจ ื™ื™ืฉื•ืžื™ ื•ื”ืฉืžืขื” ืฉืœ ืื™ืจื•

ืชืงืฉื•ืจืช

PROCESS AND DEVICE FOR THEACQUISITION, TRANSMISSION, ANDREPRODUCTION OF SOUND EVENTSFOR COMMUNICATION APPLICATIONSANDREAS MAX PAVEL

12/10/2006102006048295.6DEPCT/DE/2007/001805WO/2008/043349

)2009.01 (C23C19794306/03/2003

ืฉื›ื‘ื” ื•ืฉื™ื˜ื”โ€“ื›ืœื™ ื—ื™ืชื•ืš ืžืฆื•ืคื” ื‘ื ื ื• ืœื™ืฆื•ืจื•

NANOLAYERED COATED CUTTINGTOOL AND METHOD FOR MAKINGTHE SAMEKENNAMETAL INC.

14/03/200210/097487USPCT/US/2003/006953WO/2003/078689

Page 221: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009221

)2009.01 (B65B19794409/10/2007

ื˜ืคื•ืœ ื‘ื—ื™ืžื•ื ื•ืขื™ื‘ื•ื“ ื—ื•ืžืจ ืฉื™ื˜ื” ืœื™ ื‘ื™ื•ืœื•ื’ื™

METHOD FOR HEAT TREATMENTAND PROCESSING OF BIOLOGICALMATERIALSSTEINAR GJERSDAL

09/10/200620064604NOPCT/NO/2007/000354WO/2008/044940

)2009.01 (A61K19794505/10/2007

ืชื›ืฉื™ืจื™ ืฆืืœืงื•ื’ื ื™ื ื ื•ื–ืœื™ื™ื ื•ืฉื™ื˜ื•ืชืชืืœื”ื›ื 

LIQUID CHALCOGENIDECOMPOSITIONS AND METHODS OFPRODUCING THE SAMEIKARIA, INC.

05/10/200660/849900US23/03/200760/896727US

PCT/US/2007/080613WO/2008/043081

)2009.01 (A61K19794603/10/2007

ืชื›ืฉื™ืจื™ ืื™ื—ืกื•ืŸ ืœื”ื–ืจืงื” ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื

INJECTABLE DEPOT COMPOSITIONSAND PROCESS FOR PRODUCING THESAMEPANACEA BIOTEC LTD

05/10/20062195/DEL/2006INPCT/IN/2007/000454WO/2008/041245

)2009.01 (A61K19794703/10/2007

ืชื›ืฉื™ืจื™ ืื™ื—ืกื•ืŸ ืœื”ื–ืจืงื” ื•ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื

INJECTABLE DEPOT COMPOSITIONSAND PROCESS FOR PRODUCING THESAMEPANACEA BIOTEC LIMITED

05/10/20062195/DEL/2006INPCT/IN/2007/000473WO/2008/041246

Page 222: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 222

)2009.01 (B62B19794805/04/2009

A ืขื’ืœืช ืชื™ื ื•ืง BABY STROLLERYOHANAN ืฉื ื™ ื™ื•ื—ื ืŸ SHANI

)2009.01 (B65D19794905/04/2009

ื”ืชืงืŸ ืขื‘ื•ืจ ื”ืคื—ืชืช ื›ืžื•ืช ืฉืœ ื—ื•ืžืจ ืœื—ื™ืœื•ืฅ ืžืžื™ื›ืœ

A DEVICE FOR REDUCING THEAMOUNT OF MATERIALEXTRACTED FROM A CONTAINER

TSUK ืขืจืŸ ื’ื•ืœื“ื‘ืจื’ CHEN

)2009.01 (A61K19795024/10/2007

ืขื™ื›ื•ื‘ ืจื•ืงื—ื™ ืžื™ืžื™ ื”ืžื›ื™ืœ ืจืื‘ืืžื™ืคื™ื“ ื•ื”ืœื™ืš ื™ื™ืฆื•ืจ ืžื–ื”

AQUEOUS PHARMACEUTICALSUSPENSIONS CONTAININGREBAMIPIDE ANDMANUFACTURING PROCESSTHEREOFOTSUKA PHARMACEUTICAL CO.,LTD.

26/10/20062006-291535

JP

PCT/JP/2007/071167WO/2008/050896

)2009.01 (A61J19795115/11/2007

ืื—ืกื•ืŸ ืžืฉื•ืœื‘ ื•ืžืขืจื›ื•ืช ืžืกื™ืจื” ืขื‘ื•ืจ ืชืจื›ื•ื‘ื•ืช ืชื–ื•ื ืชื™ื•ืช

INTEGRATED STORAGE ANDDELIVERY SYSTEMS FORNUTRITIONAL COMPOSITIONSNOVARTIS AG

17/11/200660/866297USPCT/US/2007/084734WO/2008/064046

Page 223: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009223

)2009.01 (A61M19795205/11/2007

FLOW ื‘ืงืจ ื–ืจื™ืžื” CONTROLLERNESTEC S.A.

07/11/200606123583.4EPPCT/EP/2007/061889WO/2008/055876

)2009.01 (F24J19795309/10/2006

ื”ืœื™ืš ืขื‘ื•ืจ ื™ื™ืฆื•ืจ ืคื ืœื™ื ืคื•ื˜ื•ื•ืœื˜ื™ื™ืืกื•ืœืจื™ื™ื ืžืฉื•ืœื‘ื™ื ื•ืกื•ื’ ืชืจืžื™ ื•ืคื ืœ ืกื•ืœืจื™

ื”ืงืฉื•ืจ ืœืฉื“ื” ื˜ื›ื ื™

PROCESS FOR MANUFACTURINGCOMBINED SOLAR PANELS OFPHOTOVOLTAIC AND THERMALTYPE AND RELATED SOLAR PANELTECHNICAL FIELDS.I.E.M. S.R.L.

PCT/IT/2006/000712WO/2008/044250

)2009.01 (C07D19795415/11/2007

ืชื”ืœื™ืš ืœื”ื›ื ืช ืื™ืžื˜ื™ื ื™ื‘ ื•ืชื•ืฆืจื™ ื‘ื™ื ื™ื™ื ืฉืœื•

PROCESS FOR THE PREPARATION OFIMATINIB AND INTERMEDIATESTHEREOFF.I.S. FABBRICA ITALIANA SINTETICIS.p.A.

16/11/2006MI2006A002208IT09/05/2007MI2007A000942IT

PCT/IT/2007/000804WO/2008/059551

Page 224: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 224

)2009.01 (C07D19795509/10/2007

ืชื•ืœื“ื•ืช ืื™ืžื™ื“ืื–ื•ืœื•ืŸ ื•ืื™ืžื™ื“ืื–ื•ืœื™ื“ื™ื ื•ืŸ ืขื‘ื•ืจ ืกื•ื›ืจืช1HSDโ€“B11ื›ืžืขื›ื‘ื™

IMIDAZOLONE ANDIMIDAZOLIDINONE DERIVATIVESAS 11B-HSD1 INHIBITORS FORDIABETESF. HOFFMANN-LA ROCHE AG

19/10/200606122591.8EPPCT/EP/2007/060667WO/2008/046758

)2009.01 (C07D19795609/11/2007

POLYMORPHS ืคื•ืœื™ืžื•ืจืคื™ื ืฉืœ ืชื•ืฆืจื™ ื‘ื™ื ื™ื™ื ื ื™ืงื•ื˜ื™ื ื™ื™ื OF NICOTINICINTERMEDIATESPFIZER PRODUCTS, INC.

09/11/200660/865077US05/11/200760/985406US

PCT/US/2007/023683WO/2008/060487

)2009.01 (A61M19795729/10/2007

INFUSION ืขืจื›ื” ืœืื™ื ืคื•ื–ื™ื” SETUNOMEDICAL A/S

31/10/200606022674.3EP31/10/200660/855554US

PCT/DK/2007/000459WO/2008/052545

Page 225: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009225

)2009.01 (C07D19795818/10/2007

ื˜ืจื™ืื–ื•ืœื™ื ื‘ื™ืฆื™ืงืœื™ื™ื ื›ืžืืคื ื ื™ื ืฉืœ ืคืจื•ื˜ืื™ืŸ ืงื™ื ืื–

BICYCLIC TRIAZOLES AS PROTEINKINASE MODULATORS

SGX PHARMACEUTICALS, INC.23/10/200660/862552US15/12/200660/870309US24/04/200760/913766US30/07/200760/952840US

PCT/US/2007/081841WO/2008/051808

)2009.01 (A01N19795911/12/2007

ื”ืจื›ื‘ ืžื“ื‘ื™ืจ ืžื–ื™ืงื™ื ื”ืžื›ื™ืœ ืชืจื›ื•ื‘ืชืกื™ื ื˜ื˜ื™ืช ืฉื™ืžื•ืฉื™ืช ื›ื—ื•ืžืจ ื ื•ื“ื•ืœืฆื™ื” ืฉืœ ืฆืžื—ื™ ืงื˜ื ื™ื•ืช ื•ืชืจื›ื•ื‘ืช ืžื“ื‘ื™ืจืช ื—ืจืงื™ื

PESTICIDAL COMPOSITIONCOMPRISING A SYNTHETICCOMPOUND USEFUL ASNODULATION AGENT OFLEGUMINOUS PLANTS AND ANINSECTICIDE COMPOUNDBAYER CROPSCIENCE SA

12/12/200606356144.3EPPCT/EP/2007/063639WO/2008/071674

)2009.01 (C07D19796012/10/2007

BICYCLIC ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืืจื•ืžื˜ื™ื•ืช ื‘ื™ืฆื™ืงืœื™ื•ืช HETEROAROMATICCOMPOUNDSGLAXO GROUP LIMITED

13/10/200660/829328US25/01/200711/626882US

PCT/US/2007/081165WO/2008/048866

)2009.01 (G06F19796105/04/2009

METHODS ืฉื™ื˜ื•ืช ืœืขื™ื‘ื•ื“ ื™ืขื™ืœ ืฉืœ ืกื“ืจื•ืช ื–ืžืŸ FOR EFFECTIVEPROCESSING OF TIME SERIES

HYPERROLLืž"ื”ื™ืคืจืจื•ืœ ื™ืฉืจืืœ ื‘ืข ISRAEL LTD

Page 226: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 226

)2009.01 (C07D19796218/10/2007

โ€“4โ€“)ื™ืœโ€“3โ€“ืื™ื ื“ื•ืœโ€“1H(โ€“3โ€“ืฉื™ื ื•ื™ื™ ื’ื‘ื™ืฉ ืฉืœโ€“ืงื•ื™ื ืื–ื•ืœื™ืŸโ€“)ื™ืœโ€“1โ€“ืคื™ืคืจืื–ื™ืŸโ€“ืžืชื™ืœโ€“4(โ€“2[

ื“ื™ืื•ืŸโ€“2,5โ€“ืคื™ืจื•ืœโ€“]ื™ืœโ€“4

CRYSTAL MODIFICATIONS OF -3-(1H-INDOL-3-YL)-4-[2-(4-METHYL-PIPERAZIN-1-YL)-QUINAZOLIN-4-YL]-PYRROLE-2,5-DIONENOVARTIS AG

20/10/200660/853384USPCT/US/2007/022241WO/2008/051440

)2009.01 (B60F19796301/10/2007

AMPHIBIOUS ื›ืœื™ ืจื›ื‘ ืืžืคื™ื‘ื™ VEHICLEGIBBS TECHNOLOGIES LIMITED

29/09/20060619244.7GBPCT/GB/2007/003723WO/2008/038029

)2009.01 (A01N19796408/10/2007

PROCESS ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืฉืœ ื‘ืจื•ืžื•ื‘ื ื–ื ื™ื ืžื•ืชืžืจื™ื FOR THE PRODUCTION OFSUBSTITUTED BROMOBENZENESSYNGENTA PARTICIPATIONS AG

25/10/200606022279.1EPPCT/EP/2007/008697WO/2008/049507

)2009.01 (C07C19796503/10/2007

ืคืœื•ืื•ืจื• ื›ืžืขื›ื‘ื™โ€“ืชืจื›ื•ื‘ื•ืช ื”ืžื›ื™ืœื•ืช ื“ื™ ืฆื™ืกื˜ืื™ืŸ ืคืจื•ื˜ืื–

DI-FLUORO CONTAININGCOMPOUNDS AS CYSTEINEPROTEASE INHIBITORSVIROBAY, INC.

04/10/200660/849587USPCT/US/2007/080320WO/2008/042968

Page 227: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009227

)2009.01 (A61K19796610/10/2007

USE ืฉื™ืžื•ืฉ ื‘ืฆื™ืงืœื•ืกืคื•ืจื™ืŸ ืฉืขื‘ืจ ืฉื™ื ื•ื™ OF MODIFIED CYCLOSPORINNOVARTIS AG

12/10/200660/829228USPCT/EP/2007/060794WO/2008/043797

)2009.01 (G06F19796710/10/2007

โ€“ืื”ืžืขืจื›ืช ืกืคืจื™ื” ืฆื™ื‘ื•ืจื™ืช ืœืืกืคืงืช ืงืจื™ื‘ื™ื—ื“ ืฉืœ ืคืจื™ื˜ ืกืคืจื•ืช ื ื‘ื—ืจ ื‘ืฉื ื™ ืžืงื•ืžื•ืช

ืžืจื•ื—ืงื™ื

PUBLIC LIBRARY SYSTEM FORPROVIDING READING-TOGETHERAT TWO REMOTE LOCATIONS OF ASELECTED CHILDREN LITERATUREITEM

DROR ื“ืจื•ืจ ืื•ื‘ืจืžืŸ OBERMAN16/10/2006178653IL

PCT/IL/2007/001222WO/2008/047344

)2009.01 (A01N19796811/12/2007

ื”ืจื›ื‘ ืžื“ื‘ื™ืจ ืžื–ื™ืงื™ื ื”ืžื›ื™ืœ ืชืจื›ื•ื‘ืชืกื™ื ื˜ื˜ื™ืช ืฉื™ืžื•ืฉื™ืช ื›ื—ื•ืžืจ ื ื•ื“ื•ืœืฆื™ื” ืฉืœ ืฆืžื—ื™ ืงื˜ื ื™ื•ืช ื•ืชืจื›ื•ื‘ืช ืงื•ื˜ืœืช ืคื˜ืจื™ื•ืช

PESTICIDAL COMPOSITIONCOMPRISING A SYNTHETICCOMPOUND USEFUL ASNODULATION AGENT OFLEGUMINOUS PLANTS AND AFUNGICIDE COMPOUNDBAYER CROPSCIENCE SA

12/12/200606356143.5EPPCT/EP/2007/063637WO/2008/071672

Page 228: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 228

)2009.01 (G06Q19796930/07/2007

ื”ืชืงืŸ ื•ืชื•ืฆืจ, ืฉื™ื˜ื” ืœื”ืขืจื›ืช ื™ื”ืœื•ื ืืžืฆืขื™ ื”ื ื™ืชืŸ ืœืงืจื™ืื” ืขืœ ื™ื“ื™ ืžื—ืฉื‘

DIAMOND VALUATION METHOD,APPARATUS AND COMPUTERREADABLE MEDIUM PRODUCTROSY BLUE DMCC

11/10/200660/828981USPCT/US/2007/074726WO/2008/045613

)2009.01 (C07D19797003/10/2007

PROCESS ืชื”ืœื™ืš ืœื”ื›ื ืช ืคืœื•ืจื•ืžื•ื˜ื™ืœื™ื ื™ื FOR THE PREPARATIONOF PLEUROMUTILINSNABRIVA THERAPEUTICS AG

05/10/200606121852.5EPPCT/AT/2007/000468WO/2008/040043

)2009.01 (C07K19797125/09/2007

โ€“ื‘ืงื˜ืจื™ืืœื™ื™ื ื•ืื ื˜ื™โ€“ืคืคื˜ื™ื“ื™ื ืื ื˜ื™ ื•ื™ืจืืœื™ื™ื ืžืืงื˜ื™ื ื•ืžื“ื•ืจื” ื ืžื™ื‘ื™ืื ืกื™ืก

ANTIBACTERIAL AND ANTIVIRALPEPTIDES FROM ACTINOMADURANAMIBIENSISSANOFI AVENTIS

06/10/200606020980.6EPPCT/EP/2007/008294WO/2008/040469

)2009.01 (A61K19797202/07/2007

ืกื™ื ืชื–ื” ื™ืขื™ืœื” ืฉืœ ื›ืœื˜ื•ืจื™ื ืœื”ื“ืžื™ื”ืชื›ืฉื™ืจื™ื: ื’ืจืขื™ื ื™ืช ื•ืจื“ื™ื•ืชืจืืคื™ื”

ื•ืืคืœื™ืงืฆื™ื•ืช

EFFICIENT SYNTHESIS OFCHELATORS FOR NUCLEARIMAGING AND RADIOTHERAPY:COMPOSITIONS AND APPLICATIONSTHE BOARD OF REGENTS OF THEUNIVERSITY OF TEXAS SYSTEM

05/10/200660/828347US28/06/200711/770395US

PCT/US/2007/072669WO/2008/045604

Page 229: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009229

)2009.01 (A61M19797326/09/2007

ืžืฉืื‘ื” ืฉืœ ื ื™ืขืช ื”ืžืขื™ื™ืโ€“ืžื™ืงืจื• ื‘ืขืœืช ืจืืฉ ืžืฉืื‘ื” ื”ื ื™ืชืŸ ืœื”ื—ืœืคื”

PERISTALTIC MICROPUMP WITHEXCHANGEABLE PUMP HEADSANOFI-AVENTIS DEUTSCHLANDGMBH

07/10/2006102006047613.1DEPCT/EP/2007/008361WO/2008/040477

)2009.01 (A61M19797426/09/2007

ืžืขืจื›ืช ืœื—ืœื•ืงืช ืžื ื•ืช ืฉืœ ืชืจื•ืคื” ืžืฉืื‘ื”โ€“ื”ืžื•ืคืขืœืช ื‘ืืžืฆืขื•ืช ืžื™ืงืจื•

MICROPUMP-OPERATED DRUGDOSING SYSTEMSANOFI-AVENTIS DEUTSCHLANDGMBH

07/10/2006102006047538.0DEPCT/EP/2007/008362WO/2008/040478

)2009.01 (A61M19797526/09/2007

ืงื‘ื™ืขื” ืื•ืคื˜ื™ืช ืฉืœ ืžื™ืงื•ื ื”ืคืงืง ื‘ืžื—ืกื ื™ื•ืช ื–ื›ื•ื›ื™ืช

OPTICAL DETERMINATION OF THESTOPPER POSITION IN GLASSCARTRIDGESSANOFI-AVENTIS DEUTSCHLANDGMBH

07/10/2006102006047537.2DEPCT/EP/2007/008363WO/2008/040479

Page 230: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 230

)2009.01 (G10L19797623/10/2007

โ€“ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœื™ืฆื™ืจืช ืขืจื›ื™ ืฉืžืข ืชืชืคืกื™ื™ื ื•ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœื™ืฆื™ืจืช ื“ื•ื’ืžื™ื•ืช ืฉืžืข

ื”ื–ืžืŸโ€“ื‘ืžืชื—ื

APPARATUS AND METHOD FORGENERATING AUDIO SUBBANDVALUES, AND APPARATUS ANDMETHOD FOR GENERATING TIME-DOMAIN AUDIO SAMPLESFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.

25/10/200660/862954USPCT/EP/2007/009199WO/2008/049589

)2009.01 (G06F19797730/10/2007

PRIVACY-AWARE ืคืจื˜ื™ื•ืช ืœื”ื’ื ืช ืชื•ื›ืŸโ€“ืžืขืจื›ืช ืžื•ื“ืขืช CONTENTPROTECTION SYSTEMNDS LIMITED

02/11/2006179023IL29/03/2007182338IL

PCT/IL/2007/001314WO/2008/053471

)2009.01 (E03B19797805/10/2007

ืžืขืจื›ืช ื‘ืจื–ื™ ื›ื™ื‘ื•ื™ ืืฉ ื’ืœื™ืœื™ืช ืจื˜ื•ื‘ื” ืขื ืฉืกืชื•ื ืฉื ื™

WET BARREL FIRE HYDRANTSYSTEM WITH SECOND VALVEDAVIDSON HYDRANTTECHNOLOGIES, INC.

06/10/200611/544429USPCT/US/2007/080572WO/2008/045785

Page 231: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009231

)2009.01 (C07K19797903/10/2007

METHOD ืฉื™ื˜ื” ืœืกื™ื ืชื™ื–ื” ืฉืœ ืคืคื˜ื™ื“ FOR PEPTIDE SYNTHESISLONZA AG

05/10/2006EP06020893EPPCT/EP/2007/008581WO/2008/040536

)2008.04 (H04Q19798020/03/2001

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ืงืจืช ืฉื™ื“ื•ืจื™ื ื‘ืžืขืจื›ืช ืชืงืฉื•ืจื•ืช

METHOD AND APPARATUS FORCONTROLLING TRANSMISSIONS OFA COMMUNICATIONS SYSTEMQUALCOMM INCORPORATED

30/03/2000539157USPCT/US/2001/009325WO/2001/076098

)2009.01 (C07D19798108/10/2007

KINASE ืžืขื›ื‘ื™ ืงื™ื ืื– INHIBITORSTAKEDA PHARMACEUTICAL COMPANYLIMITED

09/10/200611/539857US10/10/2006PCT/US2006/039667US18/04/200760/912629US

PCT/US/2007/080714WO/2008/054956

)2009.01 (A61K19798210/10/2007

ืชื›ืฉื™ืจื™ ืžืฉื•ืœื‘ ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืชืงืจื“ื™ื•ื•ืกืงื•ืœืจื™ื•ืช ื”ืžื‘ื•ืกืก ืขืœ ืชื™ืื•ืจื™ื”

ืฉืœ ื›ืจื•ื ื•ืชืจืคื™ื”

COMBINED PREPARATION FOR THETREATMENT OF CARDIOVASCULARDISEASES BASED ONCHRONOTHERAPY THEORYHANALL PHARMACUETICAL CO., LTD

10/10/20061020060098438KR09/10/20071020070101492KR

PCT/KR/2007/004929WO/2008/044862

Page 232: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 232

)2009.01 (C07H19798312/10/2007

ื ื’ื–ืจืช ืฉืœ ืชื™ื•ื’ืœื•ืงื•ื–ื” ืกืคื™ืจื•ืงื˜ืœ ื•ืฉื™ืžื•ืฉ ื‘ื• ื›ืชื›ืฉื™ืจ ืจืคื•ืื™ ืœืกื•ื›ืจืช

THIOGLUCOSE SPIROKETALDERIVATIVE AND USE THEREOF ASTHERAPEUTIC AGENT FORDIABETESCHUGAI SEIYAKU KABUSHIKIKAISHA

13/10/20062006-280159

JP

PCT/JP/2007/069933WO/2008/044762

)2009.01 (A61M19798415/10/2007

ืžืขืจื›ืช ืœืžืชืŸ ืœื—ืฅ ืžื•ืคื—ืช ื‘ืขืœืช ืžืฉืื‘ื”ื‘ื“ืจื’ืช ื™ื“ื ื™ืช ืœืืกืคืงืช ื˜ื™ืคื•ืœ ืœืคืฆืขื™ื

ื—ื•ืžืจื” ื ืžื•ื›ื”

REDUCED PRESSURE DELIVERYSYSTEM HAVING A MANUALLY-ACTIVATED PUMP FOR PROVIDINGTREATMENT TO LOW-SEVERITYWOUNDSKCI LICENSING, INC.

13/10/200660/851494USPCT/US/2007/021947WO/2008/048527

)2009.01 (C07H19798505/10/2007

ANTICOAGULANT ืชืจื›ื•ื‘ื•ืช ืœืžื ื™ืขืช ืงืจื™ืฉื” COMPOUNDSENDOTIS PHARMA

05/10/200606291556.6EPPCT/IB/2007/003938WO/2008/041131

Page 233: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009233

)2009.01 (A61K19798602/10/2007

ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื ื”ืžื›ื™ืœื™ื ืื ื ื˜ื™ื•ืžืจ ืฉืœ ืงื˜ื•ืงื•ื ืื–ื•ืœ

KETOCONAZOLE ENANTIOMER INHUMANS

CORTENDO INVEST AB02/10/200660/848963US

PCT/US/2007/080186WO/2008/042898

)2009.01 (B01J19798712/12/2002

ืชื”ืœื™ืš ื˜ืจืžื™ ื•ื‘ื• ื ื•ื–ืœ ืงืจ ื”ืžื•ืงืจืŸ ื‘ืงืจื™ื ืชืชื“ืจ ืจื“ื™ื• ื›ืฉื™ื˜ื” ื‘ืกื™ืกื™ืช ืœื™ืฆื•ืจ ื—ืœืงื™ืงื™ื

ื‘ื’ื•ื“ืœ ื ื ื•

A THERMAL PROCESS INVOLVINGCOLD RF IRRADIATED LIQUID AS ACORE METHOD FOR PRODUCINGNANO-SIZE PARTICLES

ื‘ืข-ื“ื• DO-COOPืž"ืงื•ืค ื˜ื›ื ื•ืœื•ื’ื™ื•ืช TECHNOLOGIES LTD.12/12/2001147049IL

PCT/IL/2002/001004WO/2003/053647

)2009.01 (C07K19798811/08/2000

ืื ื˜ื™ื’ืŸ ืœืงื˜ื™ืŸ ื˜ืจื ืกืžืžื‘ืจื ื” ืžื˜ื™ืคื•ืก ืกื™ืจื˜ืŸ ื‘ืœื•ื˜ืช ื”ืขืจืžื•ื ื™ืช ื‘ื‘ื ื™ ื”ืžืชื‘ื˜ื ื‘ืก

ืื“ื ื•ื”ืฉื™ืžื•ืฉ ื‘ื•

C-TYPE LECTIN TRANSMEMBRANEANTIGEN EXPRESSED IN HUMANPROSTATE CANCER AND USESTHEREOFAGENSYS, INC.

12/08/199960/148935USPCT/US/2000/022065WO/2001/012811

Page 234: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 234

)2009.01 (B44F19798903/10/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื™ื™ืฆื•ืจ ืœื•ื— ื‘ืขืœ ืคื ื™ ืฉื˜ื—ืœื•ื— ื‘ืขืœ ืคื ื™ ืฉื˜ื— ื’ื“ื•ืœื™ื, ื’ื“ื•ืœื™ื

ื•ืžืขืจื›ืช ืฉืœ ืœื•ื—ื•ืช ืื™ื ื“ื™ื‘ื™ื“ื•ืืœื™ื

METHOD OF AND APPARATUS FORMANUFACTURING A LARGESURFACE PANEL, A LARGESURFACE PANEL, AND A SET OFINDIVIDUAL PANELSSPANOLUX N.V. -DIV. BALTERIO

05/10/200606121829.3EP13/04/200707106127.9EP

PCT/EP/2007/060503WO/2008/040760

)2009.01 (G01N19799008/10/2007

ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ืคืจื•ืคื™ืœ ืจื™ืืงื˜ื™ื‘ื™ื•ืช ืฉืœ ื˜ืกื™ืช ื“ื ืขื‘ื•ืจ ื”ืคืจื˜

A METHOD OF GENERATING APLATELET REACTIVITY PROFILEFOR AN INDIVIDUALROYAL COLLEGE OF SURGEONS INIRELAND

06/10/200606394020.9EPPCT/IE/2007/000096WO/2008/041220

)2009.01 (B25J19799102/10/2007

ROBOTIC ื›ืœื™ ืจื›ื‘ ืจื•ื‘ื•ื˜ื™ VEHICLEIROBOT CORPORATION

06/10/200660/828606US05/01/200760/878877US29/03/200760/908782US07/06/200760/942598US13/06/200711/762458US13/06/200711/762315US06/08/200711/834658US06/08/200760/954227US

PCT/US/2007/080138WO/2008/105948

Page 235: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009235

)2009.01 (B25J19799205/10/2007

ืžืชโ€“ื›ืœื™ ืžืจื ื™ื ื‘ืขืœื™ ืจืืฉ ืจื›ื‘ ืจื•ื‘ื•ื˜ื™ื™ื ื—ื™ื™ืฉื ื™ ื”ื ื™ืชืŸ ืœืžื™ืงื•ื

MANEUVERING ROBOTIC VEHICLESHAVING A POSITIONABLE SENSORHEADIROBOT CORPORATION

06/10/200660/828611US05/01/200760/883731US21/08/200711/842881US21/08/200711/842868US

PCT/US/2007/080541WO/2008/097376

)2009.01 (H04B19799314/05/2002

ืžื“ื™ื“ืช ืื™ื›ื•ืช ืœืขืจื•ืฅ ืขื‘ื•ืจ ืžื—ืœืง ืžืฉืื‘ื™ื ืฉืœ ืื•ืช ืžืฉื•ื“ืจ ืžืœื•ื•ื™ืŸ ืืจืฆื”

CHANNEL QUALITYMEASUREMENTS FOR DOWNLINKRESOURCE ALLOCATIONINTERDIGITAL TECHNOLOGYCORPORATION

14/05/200160/290739USPCT/US/2002/015242WO/2002/093757

)2009.01 (C07C19799409/05/2007

INSECTICIDAL ื‘ื ื–ืืžื™ื“ื™ื ื™ื ืงื•ื˜ืœื™ ื—ืจืงื™ื BENZAMIDINESBAYER CROPSCIENCE AG

16/05/20062006-136726

JP

PCT/EP/2007/004092WO/2007/131680

Page 236: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 236

)2009.01 (G09G19799507/10/2007

ืข ืžืชืงื ื™, ืžืชืงื ื™ ืžืฉื“ืจ,ื˜ ื“ื™ื’ื™ื˜ืœื™ืžืขืจื›ืช ื•ืฉื™ื˜ื•ืช ืœื™ืฆื•ืจ ื•ืฉื™ืžื•ืฉ ื‘ื”ื, ืงืœื™ื˜ื”

DIGITAL PEN SYSTEM,TRANSMITTER DEVICES, RECEIVINGDEVICES, AND METHODS OFMANUFACTURING AND USING THESAME

PEGASUSืž"ืคื’ืกื•ืก ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ื‘ืข TECHNOLOGIES LTD.05/10/200660/828240US

PCT/IL/2007/001205WO/2008/041234

)2009.01 (A23D19799705/10/2007

โ€“ื”ืงืฆืคื” ื•ื ื˜ื•ืœโ€“ื‘ืจ, ืžื•ืฆืจ ืžื–ื•ืŸ ื™ืฆื™ื‘ ืคืจื•ื˜ืื™ืŸ

STABLE PROTEIN-FREE WHIPPABLEFOOD PRODUCT

RICH PRODUCTS CORPORATION06/10/200660/850166US

PCT/US/2007/080582WO/2008/045790

)2009.01(H02H19799826/09/2007

ื™ืชืจโ€“ื—ื•ืžืจื” ื ื’ื“ ื–ืจืโ€“ืžืขื’ืœ ื”ื’ื ื” ืžื‘ื•ืกืก ืขื‘ื•ืจ ืžืขืจื›ื•ืช ื—ืœื•ืงืช ื›ื•ื—

HARDWARE BASED OVER-CURRENTPROTECTION CIRCUITRY FORPOWER DISTRIBUTION SYSTEMSAVOCENT HUNTSVILLE CORP.

29/09/200611/529214USPCT/US/2007/020716WO/2008/042173

)2009.01 (H01H19799905/04/2009

ืžืžื˜ืจื” ืขื ืžืขื›ื‘ ืฆืžื™ื’ ื‘ืขืœ ื”ื™ืœื•ื›ื™ื ื•ืชื”ืœื™ืš ืงืฉื•ืจ

SPRINKLER WITH GEARED VISCOUSHESITATOR AND RELATED METHODNELSON IRRIGATIONCORPORATION

29/04/200812/149264US

Page 237: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009237

)2009.01 (H01H19800005/04/2009

SPRINKLER ื•ืชื”ืœื™ืš ืงืฉื•ืจ ืžืžื˜ืจื” ืขื ืžืขื›ื‘ ืฆืžื™ื’ WITH VISCOUSHESITATOR AND RELATED METHODNELSON IRRIGATIONCORPORATION

29/04/200812/149265US

)2009.01 (F03G19800104/10/2007

REACTION ื˜ื•ืจื‘ื™ื ื” ืกื•ืœืืจื™ืช SOLAR TURBINEJOSE ANTONIO BARBEROFERRANDIZ

10/10/2006P200602605ES01/10/2007P200702556ES

PCT/ES/2007/000558WO/2008/043867

)2009.01 (C07D19800416/10/2007

โ€“ืื™ืžื™ื“ื–ื•ืœื™ื ืžื•ืชืžืจื™ื ื›ืžื•ื“ื•ืœื˜ื•ืจื™ื ืœืชืช ืฉืœ ืจืฆืคื˜ื•ืจ ืœื‘ื•ืžื‘ืกื™ืŸ3ืกื•ื’

SUBSTITUTED IMIDAZOLES ASBOMBESIN RECEPTOR SUBTYPE-3MODULATORSMERCK & CO., INC.

20/10/200660/853193USPCT/US/2007/022087WO/2008/051406

)2009.01 (A61K19800505/10/2007

ืœ ืขื‘ื•ืจ ื˜ื™ืคื•ืœ2CCRืื ื˜ื’ื•ื ื™ืกื˜ื™ื ื‘ืคื™ื‘ืจื•ื–ื™ืก

CCR2 ANTAGONISTS FORTREATMENT OF FIBROSIS

CENTOCOR ORTHO BIOTECH INC.05/10/200960/828253US

PCT/US/2007/080542WO/2008/060783

Page 238: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 238

)2009.01 (H01R19800602/05/2008

ืžื•ื“ื•ืœื™ื ื‘ืฆื•ืจืช ืชื•ืฃ ืขื ื˜ื‘ืขื•ืช ืœื”ืขื‘ืจืช ื ืชื•ื ื™ื ื‘ืชื“ื™ืจื•ืช ื’ื‘ื•ื”ื”

HIGH-FREQUENCY DRUM-STYLESLIP-RING MODULES

MOOG INC15/05/200711/803483US

PCT/US/2008/005669WO/2008/143771

)2009.01 (C07D19800719/10/2007

ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื•ืฉื™ืžื•ืฉื ื›ืžืขื›ื‘ื™3ื’ืœื™ืงื•ื’ืŸ ืกื™ื ื˜ืื– ืงื™ื ืื–

HETEROCYCLIC COMPOUNDS ANDTHEIR USE AS GLYCOGENSYNTHASE KINASE 3 INHIBITORSABBOTT LABORATORIES

21/10/200606022094.4EP22/06/200760/936837US

PCT/EP/2007/061231WO/2008/046919

)2009.01 (C12N19800823/10/2007

ืฉื™ื˜ื•ืช ื•ื”ืจื›ื‘ื™ื ืœื˜ื™ืคื•ืœ ื‘ืคื’ืžื™ื ืฉืœื”ืขืฆื ื‘ืืžืฆืขื•ืช ืื•ื›ืœื•ืกื™ื™ืช ืชืื™ื

ืฉื™ืœื™ืชื™ื™ื

METHODS AND COMPOSITIONS FORTREATMENT OF BONE DEFECTSWITH PLACENTAL CELLPOPULATIONSANTHROGENESIS CORPORATION

23/10/200660/853971US30/10/200660/855629US28/09/200760/997022US

PCT/US/2007/022545WO/2008/051568

Page 239: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009239

)2009.01 (C07D19800902/10/2007

ื ื’ื–ืจื•ืช ื‘ื™ืฆื™ืงืœื™ื•ืช ื•ื˜ืจื™ืฆื™ืงืœื™ื•ืช ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืœืจืฆืคื˜ื•ืจ ืœื˜ืจื•ืžื‘ื™ืŸ

BICYCLIC AND TRICYCLICDERIVATIVES AS THROMBINRECEPTOR ANTAGONISTSSCHERING CORPORATION

04/10/200660/849354USPCT/US/2007/021277WO/2008/042422

)2009.01 (A61K19801031/10/2007

ืชืจื›ื•ื‘ื•ืช ืคื ื™ืœืคืจื•ืคื™ื•ื ืืžื™ื“ ื•ื”ืฉื™ืžื•ืฉ ื‘ื”ืŸPHENYLPROPIONAMIDECOMPOUNDS AND THE USETHEREOFPURDUE PHARMA L.P.

01/11/200660/855826USPCT/IB/2007/003411WO/2008/053352

)2009.01 (C07D19801102/10/2007

ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืœืจืฆืคื˜ื•ืจ ืœื˜ืจื•ืžื‘ื™ืŸื”ืžื‘ื•ืกืกื™ื ืขืœ ื™ื—ื™ื“ื” ื˜ืจื™ืฆื™ืงืœื™ืช ืฉืœ

ื”ื™ืžื‘ืฆื™ืŸ ืฉืขื‘ืจื” ืฉื™ื ื•ื™

THROMBIN RECEPTORANTAGONISTS BASED ON THEMODIFIED TRICYCLIC UNIT OFHIMBACINESCHERING CORPORATION

04/10/200660/849284USPCT/US/2007/021259WO/2008/060372

Page 240: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 240

)2009.01 (C07K19801209/10/2007

ื—ืœื‘ื•ืŸ ืžืื•ื—ื” ืฉืœ ื˜ืœื•ืžืจืื– ืจื•ื•ืจืกื ื•ืงืœืื•ื˜ื™ื“ื™ื ื”ืžืงื•ื“ื“ื™ื, ื˜ืจื ืกืงืจื™ืคื˜ืื–

ื•ืฉื™ืžื•ืฉื™ื ืฉืœื”ื, ืื•ืชื•

TELOMERASE REVERSETRANSCRIPTASE FUSION PROTEIN,NUCLEOTIDES ENCODING IT, ANDUSES THEREOFISTITUTO DI RICERCHE DIBIOLOGIA MOLECOLARE P.ANGELETTI SPA

12/10/200660/851183USPCT/EP/2007/060713WO/2008/043760

)2009.01 (A62C19801312/07/2007

APPLYING ื—ืžืฆื ื™ ืขืœ ื—ื•ืžืจ ืžื˜ืจื”โ€“ืคื™ื–ื•ืจ ืคื—ืžืŸ ื“ื• SOLID CARBON DIOXIDETO A TARGET MATERIALCRYO RESPONSE, INC.

02/10/200611/542324USPCT/US/2007/073365WO/2008/042488

)2009.01 (C07D19801421/09/2007

ืžืขื›ื‘ื™ื ืœืžื˜ืืœื•ืคืจื•ื˜ื™ืื– ืฉื”ื ืชื•ืฆืจื™ื ื”ื˜ืจื•ืฆื™ืงืœื™ื™ื

HETEROCYCLIC DERIVEDMETALLOPROTEASE INHIBITORS

JANSSEN PHARMACEUTICA, N.V.05/10/200960/828226US

PCT/US/2007/079114WO/2008/045668

)2009.01 (A61K19801509/10/2007

ื”ืจื›ื‘ื™ื ืฉืœ ืงื•ืœื’ืŸ ืฉืœื™ื™ืชื™ ื˜ื‘ืขื™)ื˜ืœื•ืคืคื˜ื™ื“(

NATIVE (TELOPEPTIDE)PLACENTALCOLLAGEN COMPOSITIONS

ANTHROGENESIS CORPORATION06/10/200660/850131US

PCT/US/2007/021677WO/2008/057162

Page 241: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009241

)2009.01 (A61K19801605/10/2007

โ€“S)โ€“(+)โ€“2โ€“(2(ืงืจื™ืกื˜ืœ ื—ื“ืฉ ืฉืœ ืงืจื‘ืžื˜โ€“ืืชื™ืœโ€“ื”ื™ื“ืจื•ืงืกื™โ€“2โ€“)ื›ืœื•ืจื•ืคื ื™ืœ

NOVEL CRYSTAL OF (S)-(+)-2-(2-CHLOROPHENYL)-2-HYDROXY-ETHYL CARBAMATEJANSSEN PHARMACEUTICA, N.V.

06/10/200660/828392USPCT/US/2007/021502WO/2008/045391

)2009.01 (C12Q19801813/10/2007

ืฉื™ื˜ื” ืœืงื‘ื™ืขืช ืคืขื™ืœื•ืช ืื ื–ื™ื)ื”ืคืจืื ืื–(ืื ื“ื•ื’ืœื™ืงื•ืกื™ื“ืื–

METHOD FOR DETERMININGENDOGLYCOSIDASE(HEPARANASE)ENZYME ACTIVITYHANS-DIETER HAUBECK,

07/11/200606023091.9EPPCT/EP/2007/008905WO/2008/055575

)2009.01 (F42B19801906/04/2009

ืชื—ืžื•ืฉืช ื‘ืขืœืช ืงื•ื˜ืจ ื’ื“ื•ืœ ื”ื ื˜ืขื ืช ืžืื—ื•ืจ

LARGE CALIBRE AMMUNITIONLOADED FROM THE REAR

NEXTER MUNITIONS09/04/20080801943FR

)2009.01 (C07K19802010/10/2007

ANTI-CD20 ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ20CDโ€“ื ื•ื’ื“ื ื™ื ืื ื˜ื™ ANTIBODIES ANDMETHODS OF USEVACCINEX, INC.

10/10/200660/850604US09/10/200711/869170US

PCT/US/2007/080925WO/2008/063771

Page 242: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 242

)2009.01 (A61K19802122/10/2007

ืžื•ื˜ื ื˜ื™ื ืขืžื™ื“ื™ื ืœืคืจื•ื˜ื™ืื– ืฉืœ ืชืื‘ืชื™ืงื•ืŸ ืฉืœ ื ื–ืง1ืžืฉืชื™ืชื™ ื”ื ื’ื–ืจ ืžืคืงื˜ื•ืจ

ืœืจืงืžื”

PROTEASE RESISTANT MUTANTS OFSTROMAL CELL DERIVED FACTOR-1IN THE REPAIR OF TISSUE DAMAGE

THE BRIGHAM AND WOMEN'SHOSPITAL, INC.

23/10/200660/853441US22/06/200760/929353US19/10/200711/976032US

PCT/US/2007/022394WO/2008/051505

)2009.01 (C07C19802230/10/2007

ืขืโ€“Lื—ื•ืžืฆื” ,18Fื’ืœื•ื˜ืžื™ืช ื”ืžืกื•ืžื ืช Lโ€“, ื ื’ื–ืจื•ืชื™ื”ื,18Fื’ืœื•ื˜ืืžื™ืŸ ื”ืžืกื•ืžืŸ ืขื

ื”ืฉื™ืžื•ืฉ ื‘ื”ื ื•ืชื”ืœื™ื›ื™ื ืœื”ื›ื ืชื

[F-18]-LABELED L-GLUTAMIC ACID,[F-18]-LABELED-L-GLUTAMINEDERIVATIVES THEREOF AND USETHEREOF AND PROCESSES FORTHEIR PREPARATIONINSTITUTE OF THE HUMAN BRAINRUSSIAN ACADEMY OF SCIENCE(IHB RAS)OF

01/11/20062006138584RU18/11/200606090211.1EP

PCT/EP/2007/009518WO/2008/052788

)2009.01 (D21F19802314/08/2007

ืžืœืžืœื™ืช ืžืขื•ืฆื‘ื•ืช ืขืœ ื™ื“ื™ ืœื—ืฅ ื‘ืชื ืื™MOLDED ืจื˜ื™ื‘ื•ืช WET-PRESSED TISSUE

KIMBERLY-CLARK WORLDWIDE,INC.

27/10/200611/588652USPCT/IB/2007/053230WO/2008/050246

Page 243: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009243

)2009.01 (E21B19802419/10/2007

ื—ื™ืžื•ื ืฉื›ื‘ืช ืื“ืžื” ื–ืคืชื™ืช ืชื•ืš ื›ื“ื™ ื‘ืงืจืช ืœื—ืฅ

HEATING TAR SANDS FORMATIONSWHILE CONTROLLING PRESSURESHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.

20/10/200660/853096US20/04/200760/925685US

PCT/US/2007/081901WO/2008/051827

)2009.01 (C07D19802515/10/2007

NOVEL ื”ื˜ืจื•ืืจื™ืœ ืงืจื‘ื•ืงืกืืžื™ื“ื™ื ื—ื“ืฉื™ื HETEROARYLCARBOXAMIDESF. HOFFMANN-LA ROCHE AG

25/10/200606122944.9EPPCT/EP/2007/060928WO/2008/049747

)2009.01 (A61K19802617/10/2007

SEQUENTIAL ื˜ื™ืคื•ืœ ืžืฉื•ืœื‘ ืจืฆื™ืฃ COMBINATIONTHERAPYDYAX CORP.

17/10/200660/852263US19/12/200660/875736US

PCT/US/2007/081621WO/2008/048996

)2009.01 (C07K19802705/11/1999

ืจืฆืคื™ ื ื•ืงืœื™ืื•ื˜ื™ื“ื™ื ื•ื—ืœื‘ื•ื ื™ื ืฉืœ ื’ืŸNOGOื•ืฉื™ื˜ื•ืช ื”ืžื‘ื•ืกืกื•ืช ืขืœื™ื”ื

NUCLEOTIDE AND PROTEINSEQUENCES OF NOGO GENES ANDMETHODS BASED THEREONUNIVERSITAT ZURICH

06/11/199860/107446USPCT/US/1999/026160WO/2000/031235

Page 244: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 244

)2009.01 (C12Q19802804/10/2007

ืฉื™ื˜ื” ืขื‘ื•ืจ ืžืขืจื›ืช ืžื—ื–ื•ืจ ืชืจืžื™ ืžื”ื™ืจ ืจืฆื™ืฃ

METHOD FOR A CONTINUOUSRAPID THERMAL CYCLE SYSTEM

VANDALIA RESEARCH, INC.06/10/200660/850103US

PCT/US/2007/021328WO/2008/045288

)2009.01 (C07B19802906/04/2009

ืชื”ืœื™ืš ืœื”ืคืงืช ื—ื•ืžืฆื” ื”ื™ื“ืจื•ื›ืœื•ืจื™ืชืžืชืžื™ืกื” ืžื“ื•ืœืœืช ืฉืœื” ื•ืชื›ืฉื™ืจ ืžื™ืฆื•ื™

ืœืฉื™ืžื•ืฉ ื‘ื•

A PROCESS FOR THE RECOVERY OFHCL FROM A DILUTE SOLUTIONTHEREOF AND EXTRACTANTCOMPOSITION FOR USE THEREIN

ืก ื‘ืข' ืื™ื™ืฅ HCLืž"ืืœ ืงืœื™ื ื˜ื’ CLEANTECH LTD.

)2009.01 (G06F19803015/10/2007

LOCATING ืื™ืชื•ืจ ืคื’ื™ืขื•ืช ืื‘ื˜ื—ืชื™ื•ืช ื‘ืงื•ื“ ืžืงื•ืจ SECURITYVULNERABILITIES IN SOURCE CODECHECKMARX LTD

19/10/200660/853349USPCT/IL/2007/001233WO/2008/047351

)2009.01 (E06B19803106/04/2009

ืชืจื™ืก ืขื ืžืจื•ื•ื—ื™ ืื•ืจ ื‘ื—ื•ืœื™ื™ืช ืงื™ืฉื•ืจ ืืฉืจืข ื™ ืžืคืจืง ื•ืื—ื™ื–ืช ืงืจืก"ืžื—ื•ื‘ืจืช

ROLLER SHUTTER WITH AERATIONGAPS APERTURES BETWEEN SLATSBASED ON A COUPLING LINK.COMPRISED BY ARTICULATE JOINTAND A SLIDING HOOK GRIP

ARNON ืืจื ื•ืŸ ื‘ืจืง BARAK

Page 245: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009245

)2009.01 (H04M19803206/04/2009

TELEPHONE ืžืขืจื›ื•ืช ื•ืฉื™ื˜ื•ืช ืœืกื™ื ื•ืŸ ืชื•ื›ืŸ ื˜ืœืคื•ื ื™ CONTENT FILTERINGSYSTEMS AND METHODS

ื‘ืข.ื™.ืฉ .S.Jืž"ืžืจืงื˜ ืคื•ืŸ MARKET PHONE LTD.

)2009.01 (H01H19803306/04/2009

ืžืขืจืš ืขืฆื™ืฆื™ื ื”ื ื™ืชืŸ ืœื”ื–ื–ื” ืขื ืžื—ื–ื•ืจ ื•ื”ืฉืœืžื” ืฉืœ ืžื™ื ื•ื—ื•ืžืจื™ื ืžื–ื™ื ื™ื

MOVABLE PLANTER ARRAYSYSTEM WITH WATER ANDNUTRIENT RECYCLE ANDREPLENISHMENT

RON ืจื•ืŸ ืžื™ื“ื•ื‘ืกืงื™ MIDOVSKY

)2009.01 (B65G19803406/04/2009

A ืžืชืงืŸ ืœื”ืขื‘ืจืช ื ื•ื–ืœื™ื DEVICE FOR THE TRANSFER OFLIQUIDS

YOSEF ืขื•ื–ื™ ืขื–ืจื ื—ื‘ื•ืฉื” ORPELI

)2009.01 (B67B19803506/04/2009

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืกื’ื™ืจื” ื•ืœืื˜ื™ืžื” ืฉืœ ื›ืœื™ ืคืœืกื˜ื™ืง

A SYSTEM AND METHOD FOR APLASTIC CLOSURE WITH INTEGRALLINER

AMARAZืž"ืืžืจื– ื‘ืข LTD

)2009.01 (A47K19803606/04/2009

A ืžื›ืฉื™ืจ ืœื”ื“ื—ื” ื•ื—ื™ื˜ื•ื™ ื›ืœื™ื MACHINE FOR WASHING &STERILIZING DISHES

GIL ื’ื™ืœ ืฉืžืฉ SHEMESH

Page 246: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 246

)2009.01 (B62B19803706/04/2009

A ื—ื•ืคืช ืื•ืคื ื™ื ื•ืฉื™ื˜ื” ืขื‘ื•ืจื” BICYCLE CANOPY AND METHODTHEREFOR

SHLOMO ืฉืœืžื” ืžืžืŸ MAMAN

)2009.01 (A47B19803806/04/2009

ืชื™ืง ื ืฉื™ืื” ืžื•ื’ืŸ ื‘ืคื ื™ ื’ื ื™ื‘ื” ื‘ืžื™ื•ื—ื“ ืœืžื—ืฉื‘ื™ื ื ื™ืฉืื™ื

THEFT PROTECTABLE CARRYINGBAG IN PARTICULAR FORPORTABLE COMPUTERS

MEIR ืžืื™ืจ ืื‘ื’ื ื™ื AVGANIM

)2009.01 (G01C19803906/04/2009

AID ืžื›ืฉื™ืจ ืขื–ืจ ืœืกืจื˜ ืžื“ื™ื“ื” DEVICE FOR TAPE MEASURE

MEDVAืž"ืžื“ื‘ื ืžื“ื™ื“ื•ืช ื•ื”ื ื“ืกื” ื‘ืข SURVEY & ENGINEERINGLTD

)2009.01 (C07D19804002/12/1999

ืœื”ื›ื ืช ืชืจื›ื•ื‘ื•ืช ื˜ืจื™ืื–ื•ืœื• ื—ื•ืžืจื™ ื‘ื™ื ื™ื™ื)5,4โ€“D(ืคื™ืจื™ืžื™ื“ื™ืŸ

INTERMEDIATES FOR THEPREPARATION OF TRIAZOLO (4,5-D)PYRIMIDINE COMPOUNDSASTRAZENECA AB

04/12/19989804211-2SE09/04/19999901271#8SE

PCT/SE/1999/002256WO/2000/034283

Page 247: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009247

)2009.01 (F24J19804109/10/2007

TWO-AXLE ืกืจื ื™โ€“ื’ืฉืฉ ืกื•ืœืจื™ ื“ื• SOLAR TRACKERCABANILLAS INGENIEROS, S.L.

09/10/2006U200602226ES25/10/2006U200602371ES22/12/2006U200602756ES

PCT/ES/2007/000574WO/2008/043871

)2009.01 (G06F19804207/10/2007

ืขืช ืžืฉืชื ื™ ื–ืจื™ืžื” ืฉืœ ื ื•ื–ืœ ื”ื–ื•ืจื ื“ืจืš ืงื‘ื™ืขืœ ื™ื“ื™ ืฉื™ืžื•ืฉ, ืงื•ืœื™ืชโ€“ืžืขื‘ืจ ื‘ืฆื•ืจื” ืขืœ

ANALYSIS(ื‘ืื ืœื™ื–ืช ืฉื“ื” ืžืจื•ื—ืง FIELDโ€“FAR(

ULTRASONICALLY DETERMININGFLOW PARAMETERS OF A FLUIDFLOWING THROUGH A PASSAGE, BYUSING FAR-FIELD ANALYSIS

YEDAืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD

10/10/200660/850266USPCT/IL/2007/001207WO/2008/044232

)2009.01 (A61K19804315/10/2007

ืœื˜ื™ืคื•ืœ151CDโ€“ืฉื™ืžื•ืฉ ื‘ื ื•ื’ื“ืŸ ืื ื˜ื™ ืœืกืจื˜ืŸ

USE OF AN ANTI-CD151 ANTIBODYIN THE TREATMENT OF CANCER

PIERRE FABRE MEDICAMENT18/10/20060609135FR

PCT/FR/2007/001688WO/2008/049990

Page 248: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 248

)2009.01 (C23C19804403/09/2007

ืžืขืจื›ืช ืฉื›ื‘ื” ื‘ืขืœืช ืœืคื—ื•ืช ืฉื›ื‘ื” ืื—ืช ืฉืœ ืชืขืจื•ื‘ืช ืงืจื™ืกื˜ืœ ืฉืœ ืคื•ืœื™ืื•ืงืกื™ื“

LAYER SYSTEM HAVING AT LEASTONE MIXED CRYSTAL LAYER OF APOLYOXIDEOERLIKON TRADING AG,TRUBBACH

10/10/200601614/06SEPCT/EP/2007/059196WO/2008/043606

)2009.01 (G02B19804506/04/2009

IMAGE ืžืขืจื›ืช ื—ื™ื™ืฉืŸ ื”ื“ืžื™ื™ื” SENSOR SYSTEMDIEHL BGT DEFENCE GMBH & CO. KG

07/04/2008102008017585.4DE

)2009.01 (C07K19804624/10/2007

METASTIN ื ื’ื–ืจื•ืช ืฉืœ ืžื˜ืกื˜ื™ืŸ ื•ืฉื™ืžื•ืฉื™ื”ืŸ DERIVATIVES AND USETHEREOFTAKEDA PHARMACEUTICALCOMPANY LIMITED

25/10/20062006-290536

JP

31/01/20072007#021387JP28/08/20072007#221911JP

PCT/JP/2007/071169WO/2008/050897

)2009.01 (C07C19804715/10/2007

ืœ 1SELECTIVEื‘ื˜ืโ€“TRโ€“ืื’ื•ื ื™ืกื˜ ืกืœืงื˜ื™ื‘ื™ TR-BETA 1 AGONISTCADILA HEALTHCARE LIMITED

31/10/20061813/MUM/2006INPCT/IN/2007/000493WO/2008/062469

Page 249: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009249

)2009.01 (A61K19804806/09/2001

CARDIAC ืฉื™ื˜ื•ืช ืœื˜ื™ืคื•ืœ ืจืคื•ืื™ ื‘ื”ืคืจืขื•ืช ืงืฆื‘ ื”ืœื‘ ARRHYTHMIATREATMENT METHODSJOHNS HOPKINS UNIVERSITY

06/09/200060/230311US05/06/200160/295889US

PCT/US/2001/027623WO/2002/019966

)2009.01 (A61G19804925/10/2007

ืžืชืงืŸ ืฉื™ืคื•ืข ืœื—ื•ืœื” ื‘ืขืœ ืชืžื™ื›ืช ืฉื™ื“ืจื” ืžืจื›ื–ื™ืช

PATIENT INCLINE DEVICE HAVINGCENTERLINE SPINAL SUPPORT

PATIENT TRANSFER SYSTEMS, INC.01/11/200660/855874US20/11/200660/860044US03/04/200711/732184US

PCT/US/2007/022621WO/2008/057239

)2009.01 (A61K19805012/10/2007

7CXCRANTIBODIESื ื•ื’ื“ื ื™ื ื”ืงื•ืฉืจื™ื ืืคื™ื˜ื•ืค ืฉืœ THAT BIND CXCR7EPITOPESCHEMOCENTRYX, INC.

18/10/200660/852745US10/10/200711/869883US

PCT/US/2007/021927WO/2008/048519

Page 250: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 250

)2009.01 (H04Q19805119/12/1997

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ื™ืฆื•ืข ืžืกื™ืจื” ืงืฉื™ื—ื” ืจื›ื•ืช ืชืงืฉื•ืจืชืžืกื•ื™ื™ืขืช ื ื™ื™ื“ื•ืช ื‘ื™ืŸ ืžืข

METHOD AND APPARATUS FORPERFORMING MOBILE ASSISTEDHARD HANDOFF BETWEENCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED

15/01/199708/784280USPCT/US/1997/236450WO/1998/032262

)2009.01 (B23C19805207/04/2009

CUTTINGื”ืฉื™ืžื” ื•ื›ืœื™ ื—ื™ืชื•ืš ืขื‘ื•ืจ INSERT AND CUTTINGTOOL THEREFOR

ISCARืž"ื™ืฉืงืจ ื‘ืข LTD.

)2009.01 (B23B19805307/04/2009

CUTTING ื›ืœื™ ื—ื™ืชื•ืš ื•ืฉื™ืžื” ืขื‘ื•ืจื• TOOL AND CUTTINGINSERT THEREFOR

ISCARืž"ื™ืฉืงืจ ื‘ืข LTD.

)2009.01 (G06F19805405/12/2007

ืช ืขืœ ืฆื™ืจื•ืฃ ืฉืœ ื”ื’ื”ื•ืช ื˜ืขื•ื™ื•ืช ื”ืžื‘ื•ืกืก ืจืฉืช ืชืงืฉื•ืจืช

WEB-BASED COLLOCATION ERRORPROOFING

MICROSOFT CORPORATION05/12/200611/633788US

PCT/US/2007/086560WO/2008/070750

Page 251: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009251

)2009.01 (G06F19805507/12/2007

OPERATING ื”ืคืขืœืช ืžืžืฉืงื™ ืžื’ืข ื‘ืžืกืš TOUCH SCREENINTERFACESMICROSOFT CORPORATION

07/12/200611/635730USPCT/US/2007/086707WO/2008/070815

)2009.01 (G06Q19805606/12/2007

PATIENT ื ื™ื˜ื•ืจ ื—ื•ืœื” ื‘ืืžืฆืขื•ืช ืงื‘ืœืช ืชืžื•ื ื” MONITORING VIA IMAGECAPTUREMICROSOFT CORPORATION

06/12/200611/567455USPCT/US/2007/086596WO/2008/070759

)2009.01 (G06F19805706/12/2007

ืืกื˜ืจื˜ื’ื™ื•ืช ืœื—ืงื™ืจืช ื•ืžื™ืชื•ืŸ ืคื’ื™ืขื•ื™ื•ืช ื”ื ื’ืจืžื•ืช ืžืจื›ื™ืฉืช ืžื›ืชื‘ื™ ื”ืžืœืฆื”

STRATEGIES FOR INVESTIGATINGAND MITIGATINGVULNERABILITIES CAUSED BY THEACQUISITION OF CREDENTIALSMICROSOFT CORPORATION

07/12/200611/608126USPCT/US/2007/086694WO/2008/070805

)2009.01 (G06F19805827/11/2007

ื”ืฆืจืช ืงื•ื“ ืœื‘ื™ืฆื•ืข ืœื›ืชื•ื‘ืช ื‘ืขืœืช ืืžื™ื ื•ืช ืคื—ื•ืชื”

COMPILING EXECUTABLE CODEINTO A LESS-TRUSTED ADDRESSSPACEMICROSOFT CORPORATION

28/11/200611/564249USPCT/US/2007/085664WO/2008/067329

Page 252: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 252

)2009.01 (C07D19805912/10/2007

AMINOCARBONYL-PYRIDINE-2 ืืžื™ื ื• ืงืจื‘ื•ื ื™ืœ ืคื™ืจื™ื“ื™ืŸโ€“2ืชื•ืœื“ื•ืชDERIVATIVESACTELION PHARMACEUTICALS LTD.

13/10/2006PCT/IB06/053773WO17/10/2006PCT/IB06/053817WO

PCT/IB/2007/054155WO/2008/044217

)2009.01 (G06K19806010/10/2007

ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ื ืฉื ื–ื™ื”ื•ื™ ืื• ืžืคืชื—ืืœืงื˜ืจื•ื ื™ ืขื‘ื•ืจ ืžื ืขื•ืœื™ื ืขื‘ื•ืจ ืžื ืขื•ืœื™ื

ื”ืžื•ืคืขืœื™ื ืืœืงื˜ืจื•ื ื™ืช

METHOD FOR THE PRODUCTION OFAN IDENTIFICATION CARRIER ORELECTRONIC KEY FORELECTRONICALLY ACTUATEDLOCKSEVVA-WERK SPEZIALERZEUGUNGVON ZYLINDER-UNDSICHERHEITSSCHLOSSERNGESELLSCHAFT M.B.H. & CO. KG

11/10/2006A1694/2006ATPCT/AT/2007/000474WO/2008/043117

)2009.01 (C07K19806118/10/2007

โ€“ื•A17โ€“ILืžื•ืœืงื•ืœื•ืช ื ื•ื’ื“ื ื™ื ื”ืงื•ืฉืจื•ืชF17โ€“IL

ANTIBODY MOLECULES WHICEBIND IL-17A AND IL-17FUCB PHARMA S.A.

18/10/20060620729.4GBPCT/GB/2007/003983WO/2008/047134

Page 253: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009253

)2009.01 (G06F19806210/10/2007

IMPROVEMENTS ืฉื™ืคื•ืจื™ื ื”ืงืฉื•ืจื™ื ืœื–ื™ื”ื•ื™ ืชื‘ื ื™ื•ืช RELATING TO THEDETECTION OF PATTERNSTHE QUEEN'S UNIVERSITY OFBELFAST

10/10/20060620043.0GBPCT/GB/2007/003833WO/2008/044004

)2009.01 (E21B19806319/10/2007

ื—ื™ืžื•ื ืฉื›ื‘ืช ืื“ืžื” ื”ืžื›ื™ืœื” ืคื—ืžื™ืžื ื™ื ื‘ืชื”ืœื™ืš ืฉืœื‘ ืงื•ื•ื™

HEATING HYDROCARBONCONTAINING FORMATIONS IN ALINE DRIVE STAGED PROCESSSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.

20/10/200660/853096US20/04/200760/925685US

PCT/US/2007/081905WO/2008/051831

)2009.01 (E21B19806419/10/2007

ื—ื™ืžื•ื ืฉื›ื‘ืช ืื“ืžื” ื”ืžื›ื™ืœื” ืคื—ืžื™ืžื ื™ื ื‘ืชื”ืœื™ืš ืฉืœื‘ื™ ื‘ืขืœ ืฆื•ืจืช ืœื•ื— ืฉื—ืžื˜

HEATING HYDROCARBONCONTAINING FORMATIONS IN ACHECKERBOARD PATTERN STAGEDPROCESSSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.

20/10/200660/853096US20/04/200760/925685US

PCT/US/2007/081910WO/2008/051833

Page 254: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 254

)2009.01 (E21B19806519/10/2007

ื‘ืช ืื“ืžื” ื”ืžื›ื™ืœื” ืคื—ืžื™ืžื ื™ื ื—ื™ืžื•ื ืฉื› ื‘ืชื”ืœื™ืš ืฉืœื‘ื™ ืกื™ื‘ื•ื‘ื™

HEATING HYDROCARBONCONTAINING FORMATIONS IN ASPIRAL STARTUP STAGEDSEQUENCESHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.

20/10/200660/853096US20/04/200760/925685US

PCT/US/2007/081915WO/2008/051834

)2009.01 (E21B19806619/10/2007

ืชื”ืœื™ืš ื˜ื™ืคื•ืœ ื‘ื—ื ืคื ื™ืžื™ ื”ืžืฉืชืžืฉ ื‘ืžืขืจื›ืช ื—ื™ืžื•ื ื‘ืžืกืœื•ืœ ืกื’ื•ืจ

IN SITU HEAT TREATMENT PROCESSUTILIZING A CLOSED LOOPHEATING SYSTEMSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.

20/10/200660/853096US20/04/200760/925685US

PCT/US/2007/081918WO/2008/051836

)2009.01 (G06F19806807/04/2009

IMPROVED ืฉื™ื˜ื•ืช ืžืฉื•ืคืจื•ืช ืœื”ื›ื ืกืช ื ืชื•ื ื™ื DATA ENTRY SYSTEMSBENJAMIN ื‘ื ื™ืžื™ืŸ ืคื™ืจื•ื– ื’ืกื‘ื™ืืŸ FIROOZ GHASSABIAM

)2009.01 (C07H19807025/10/2007

NOVEL ื—ื“ืฉื•ืช ื•ืฉื™ืžื•ืฉืŸsiRNAืžื•ืœืงื•ืœื•ืช siRNAS AND METHODS OFUSE THEREOFQUARK PHARMACEUTICALS, INC.

25/10/200660/854503US15/05/200760/930493US

PCT/IL/2007/001278WO/2008/050329

Page 255: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009255

)2009.01 (C07D19807210/10/2007

ืชื•ืœื“ื•ืช ืคื™ืจืื–ื™ื ื•ืŸ ืžื•ืชืžืจื•ืช ืœืฉื™ืžื•ืฉ ื›ืชืจื•ืคื”

SUBSTITUTED PYRAZINONEDERIVATIVES FOR USE AS AMEDICINEJANSSEN PHARMACEUTICA, N.V.

12/10/200606122173.5EPPCT/EP/2007/060748WO/2008/043775

)2009.01 (C07D19807316/10/2007

ืชืจื›ื•ื‘ื•ืช ื˜ื˜ืจืื”ื™ื“ืจื•ืคื™ืจื•ืœื•ืคื™ืจืื–ื™ืŸK+ืžื•ืชืžืจื•ืช ื‘ืขืœื•ืช ื–ื™ืงื” ืœืขืจื•ืฅ 2/3

KCNQื•ืฉื™ืžื•ืฉืŸ ื‘ืชืจื•ืคื”

SUBSTITUTEDTETRAHYDROPYRROLOPYRAZINECOMPOUNDS HAVING AFFINITY WITHTHE KCNQ2/3 K+ CHANNEL AND USETHEREOF IN MEDICAMENTSGRUNENTHAL GMBH

17/10/2006102006049452.0DEPCT/EP/2007/008957WO/2008/046582

)2009.01 (C12N19807412/12/2003

IL-21 ื‘ืชืื™ื ืคืจื•ื™ื™ืงื˜ื™ืILโ€“21ื™ื™ืฆื•ืจ ืฉืœ PRODUCTION INPROKARYOTIC HOSTSZYMOGENETICS INC.

13/12/200260/433448US13/12/200260/433452US

PCT/US/2003/039764WO/2004/055168

)2009.01 (C07K19807528/09/2007

ืž ืฉื•ื—ื–ืจื™ื ื‘ืขืœื™ ื—ื•ืžืจื™ื ืคืขื™ืœื™ ืฉื˜ื— ืชื›ื•ื ื•ืช ืžืฉื•ืคืจื•ืช

RECONSTITUTED SURFACTANTSHAVING IMPROVED PROPERTIES

CHIESI FARMACEUTICI S.P.A.13/10/200606021521.7EP

PCT/IB/2007/002841WO/2008/044109

Page 256: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 256

)2009.01 (C12N19807610/10/2000

ื” CTSโ€“ื•cPPTโ€“ื•ืงื˜ื•ืจ ื‘ื•ื™ื˜ื•ื™ ื”ืžื›ื™ืœ ืื–ื•ืจื™ืฉืœ ืจื˜ืจื•ื™ืจื•ืก ื•ืจืฆืฃ ื—ื•ืžืฆืชcisืœ ื”ืคื•ืข

ื’ืจืขื™ืŸ ื”ื˜ืจื•ืœื•ื’ื™

AN HIV - 1 EXPRESSION VECTORCOMPRISING THE cPPT AND CTS cis-ACTING REGIONS OF ARETROVIRUS AND AHETEROLOGOUS NUCLEIC ACIDSEQUENCEINSTITUT PASTEUR

12/10/199960/158387USPCT/EP/2000/010418WO/2001/027304

)2009.01 (A63F19807715/10/2006

METHOD ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืžืฉื—ืง ืžืงื•ื•ืŸ ื‘ืžืกื•ืคื™ื AND APPARATUS FORONLINE GAMING ON TERMINALSVIDEOB HOLDINGS LIMITED

PCT/IB/2006/053781WO/2008/047176

)2009.01 (B01D19807819/12/2007

ื™ืฆื•ืจ ืื ืจื’ื™ื” ืžืคื—ืžืŸ ืฉื™ื˜ื•ืช ื•ืžืขืจื›ื•ืช ืœื™ ื—ืžืฆื ื™โ€“ื“ื•

METHODS AND SYSTEM FORPRODUCING ENERGY FROMCARBON DIOXIDE

ื‘ืข'ืื ื’ ื—ื‘ืจื”,ืž"ื™ื ื™ื•ืื™ื˜ื™ ืžื—ืงืจ ื•ืคื™ืชื•ื— ื™ืฉืจืืœื™ืช ืžืื–ื•ืจ ื”ืชืขืฉื™ื” ื”ื“ืจื•ืžื™

ENGINEUITY RESEARCH &DEVELOPMENT LTD

25/10/200660/862827US13/07/200711/818967US

PCT/IL/2007/001576WO/2008/050350

Page 257: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009257

)2009.01 (C07K19807918/10/2007

ื•ื”ืฉื™ืžื•ืฉ3NOTCHโ€“ื ื•ื’ื“ื ื™ ืื’ื•ื ื™ืกื˜ ืื ื˜ื™ืœ โ€“ื‘ื”ื ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ื”ืงืฉื•ืจื•ืช

3NOTCH

ANTI-NOTCH3 AGONISTANTIBODIES AND THEIR USE IN THETREATMENT OF NOTCH3-RELATEDDISEASESGENENTECH, INC.

19/10/200660/852861US06/01/200760/879218US

PCT/US/2007/081797WO/2008/051797

)2009.01 (C07D19808019/10/2007

THETAโ€“PKCPURINESืคื•ืจื™ื ื™ื ื›ืžืขื›ื‘ื™ AS PKC-THETAINHIBITORSPHARMACOPEIA, LLC

20/10/200660/853396USPCT/US/2007/081899WO/2008/051826

)2009.01 (C07D19808119/10/2007

ืชืจื›ื•ื‘ื•ืช ืคื ื™ืœ ืื•ืจื™ืื” ื›ืžืขื›ื‘ื™ ืืคื•ืงืกื™ื“ ื”ื™ื“ืจื•ืœืื– ืžืกื™ืกื™ื

PHENYLUREA COMPOUNDS ASSOLUBLE EPOXIDE HYDROLASEINHIBITORSARETE THERAPEUTICS, INC.

20/10/200660/853226US13/03/200760/894639US

PCT/US/2007/082009WO/2008/051873

Page 258: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 258

)2009.01 (C07D19808219/10/2007

โ€“ืชื•ืœื“ื•ืช ืคื˜ืจื™ื“ื™ืŸ ื›ืžืขื›ื‘ื™ ืงื™ื ืื– ื“ืžื•ื™POLOื”ืžืฉืžืฉื™ื ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ

PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFULIN THE TREATMENT OF CANCERCHROMA THERAPEUTICS LTD.

25/10/20060621205.4GB10/08/20070715614.4GB

PCT/GB/2007/003998WO/2008/050096

)2009.01 (B01D19808328/08/2007

FLUID ื”ืชืงืŸ ืœื ื™ื˜ื•ืจ ืคื™ืœื˜ืจ ื ื•ื–ืœื™ื FILTER MONITORING DEVICEH2Q WATER INDUSTRIES LTDH2Q WATER INDUSTRIES LTD.

08/10/200660/828643US04/12/200660/872489US

PCT/IL/2007/001065WO/2008/044230

)2009.01 (A61K19808406/11/2007

ืฉื™ื˜ื•ืช ืœื‘ืงืจืช ืื™ื›ื•ืช ืขื‘ื•ืจ ืืžื•ืœืกื™ื•ืช ื‘ืžื™ื ื”ืžื›ื™ืœื•ืช ืกืงื•ื•ืœืŸโ€“ืฉืžืŸ

QUALITY CONTROL METHODS FOROIL-IN-WATER EMULSIONSCONTAINING SQUALENENOVARTIS AG

08/11/20060622282.2GBPCT/IB/2007/004229WO/2008/056263

)2009.01 (A63B19808510/10/2007

INDIVIDUAL ื”ืชืงืŸ ืœืื™ืžื•ืŸ ื’ื•ืคื ื™ PHYSICAL TRAININGDEVICE

AMIT ืขืžื™ืช ื™ืฉืจืืœื™ ISRAELI10/10/200660/850292US

PCT/IL/2007/001224WO/2008/044238

Page 259: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009259

)2009.01 (C07H19808605/10/2007

ื”ื›ื ืช ื ื•ืงืœื™ืื•ื–ื™ื“ื™ื ืจื™ื‘ื•ืคื•ืจืื ื•ื–ื™ืœ ืคื™ืจื™ืžื™ื“ื™ื ื™ื

PREPARATION OF NUCLEOSIDESRIBOFURANOSYL PYRIMIDINES

PHARMASSET, INC.10/10/200660/850962US

PCT/US/2007/021548WO/2008/045419

)2009.01 (A61K19808709/10/2007

METHODS ื•ืช ืœื”ืฉื‘ืชืช ื•ื™ืจื•ืกื™ืืฉื™ื˜ OF INACTIVATINGVIRUSESRUDYARD LYLE ISTVAN

10/10/200660/851028USPCT/US/2007/080788WO/2008/045860

)2009.01 (A61K19808815/10/2007

ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื‘ืขืœืช ืžื‘ื ื”ืกืคืฆื™ืคื™ ื‘ืžืขื›ื‘ืช ื“ืคื•ื–ื™ืฆื™ื” ืฉืœ ื‘ืชื

ื’ ื ื•ื’ื“ืช ื“ื™ื›ืื•ืŸ,ื™ืœืืžื™ืœื•ืื™ื“ ืื• ืžืขื›ื‘ืช ื•ืžื’ื ื” ื ื•ื™ืจื•ื ื™ืช

ANTIDEPRESSANT,NEUROPROTECTANT, AMYLOIDBETA DEPOSITION INHIBITOR ORAGE RETARDANT CONTAININGHETEROCYCLIC COMPOUNDHAVING SPECIFIC STRUCTUREZENYAKU KOGYOKABUSHIKIKAISHA

13/10/20062006-280768

JP

PCT/JP/2007/070963WO/2008/047952

Page 260: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 260

)2009.01 (A61K19808915/10/2007

ืžืขื›ื‘ ื”ืชืงื“ืžื•ืช ืฉืœ ืžื—ืœืช ื”ืืœืฆื”ื™ื™ืžืจื”ื›ื•ืœืœ ืชืจื›ื•ื‘ืช ื”ื˜ืจื•ืฆื™ืงืœื™ืช ื‘ืขืœืช ืžื‘ื ื”

ืกืคื™ืฆื™ืคื™

AN ALZHEIMER'S DISEASEPROGRESSION INHIBITORCONTAINING HETEROCYCLICCOMPOUND HAVING SPECIFICSTRUCTUREZENYAKU KOGYOKABUSHIKIKAISHA

13/10/20062006-280768

JP

PCT/JP/2007/070962WO/2008/047951

)2009.01 (A61M19809012/10/2007

ืžืื•ืจืจ ืขื‘ื•ืจ ืชื’ื•ื‘ื” ืžื”ื™ืจื” ืœืชื ืื™ ืžื—ืœื” ื ืฉื™ืžืชื™ืช

VENTILATOR FOR RAPID RESPONSETO RESPIRATORY DISEASECONDITIONSSPACELABS HEALTHCARE, LLC

13/10/200660/829502USPCT/US/2007/081198WO/2008/048876

)2009.01 (H01M19809130/10/2007

ืงื•ืžืคืœืงืกื™ื ืฉืœ ืื•ืงืกื™ื“ื™ื ื”ืžื˜ื•ืคืœื™ื ืขื ืคื—ืžืŸ ื•ืฉื™ื˜ื” ืœื”ื›ื ืชื

CARBONATED COMPLEX OXIDESAND METHOD FOR MAKING THESAMEUNIVERSITE DE MONTREAL

30/10/20062566906CAPCT/FR/2007/001803WO/2008/062111

Page 261: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009261

)2009.01 (C07D19809212/10/2007

โ€“6,3[โ€“5โ€“ื›ืœื•ืจื•โ€“2ืฆื•ืจื” ื’ื‘ื™ืฉื™ืช ืฉืœโ€“4โ€“ื“ื™ืื•ืงืกื•โ€“6,2โ€“ืžืชื™ืœโ€“3โ€“ื“ื™ื”ื™ื“ืจื•

โ€“1โ€“)ื˜ืจื™ืคืœื•ืื•ืจื•ืžืชื™ืœ()2H(ืคืœื•ืื•ืจื•โ€“4โ€“]ืคื™ืจื™ืžื™ื“ื™ื ื™ืœโ€“Nโ€“โ€“ืžืชื™ืœโ€“1(โ€“ืžืชื™ืœ[[

ื‘ื ื–ืืžื™ื“]ืกื•ืœืคื•ื ื™ืœ]ืืžื™ื ื•)ืืชื™ืœ

CRYSTALLINE FORM OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUOROMETHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYL)ETHYL)AMINO]SULPHONYL]BENZAMIDE

BASF SE13/10/200606122265.9EP

PCT/EP/2007/060879WO/2008/043835

)2009.01 (H04L19809329/10/2007

CDMโ€“FDMืฉื™ื˜ื” ื•ืžืชืงืŸ ืขื‘ื•ืจ ืžื‘ื ื”ื”ื™ื‘ืจื™ื“ื™ ืขื‘ื•ืจ ืขืจื•ืฆื™ ื‘ืงืจื” ืžื‘ื•ืกืกื™ ื ื•ืฉื

ื™ื—ื™ื“

METHOD AND APPARATUS FORHYBRID FDM-CDM STRUCTURE FORSINGLE CARRIER BASED CONTROLCHANNELSQUALCOMM INCORPORATED

01/11/200660/863955USPCT/US/2007/082881WO/2008/057836

)2009.01 (H04B19809431/10/2007

ืขื™ืฆื•ื‘ ืกื™ืžืŸ ื™ื™ื—ื•ืก ืขื‘ื•ืจ ื—ืงื™ืจืช ืชื ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช ืื•ืจืชื•ื’ื•ื ืœื™ืช

REFERENCE SIGNAL DESIGN FORCELL SEARCH IN AN ORTHOGONALWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED

01/11/200660/863965USPCT/US/2007/083267WO/2008/057899

Page 262: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 262

)2009.01 (A63F19809529/06/2003

INTERACTIVE ืžืฉื—ืง ื‘ื™ืŸ ืขืจื•ืฆื™ ืื™ื ื˜ืจืืงื˜ื™ื‘ื™ INTER-CHANNELGAMENDS LIMITED

PCT/IL/2003/000543WO/2005/002697

)2009.01 (G06F19809609/11/2006

ืฉื™ืžื•ืฉ ืืœื—ื•ื˜ื™ ืฉืœ ื›ืจื˜ื™ืกื™ื ื—ื›ืžื™ื ื•ืช ื’ื™ืฉื” ื‘ื˜ื•ื—ื•ืชื‘ืžืขืจื›

REMOTE ADMINISTRATION OFSMART CARDS FOR SECURE ACCESSSYSTEMNDS LIMITED

)2009.01 (H04L19809718/10/2007

ื”ืฉืžืขื” ื—ื•ื–ืจืช, ืฉื™ื˜ื•ืช ื•ืžืขืจื›ื•ืช ืœื”ืงืœื˜ื”ื•ื—ื™ืคื•ืฉ ืžื™ื“ืข ืฉืœ ืคืจื•ื˜ื•ืงื•ืœ, ื‘ื–ืžืŸ ืืžืช

ืฉื›ื‘ืช ื”ืฆื’ื”

METHODS AND SYSTEMS FORRECORDING AND REAL-TIMEPLAYBACK AND SEEKING OF APRESENTATION LAYER PROTOCOLDATA STREAMCITRIX SYSTEMS INC.

20/10/200660/862349US01/11/200611/555611US01/11/200611/555615US

PCT/US/2007/081751WO/2008/055005

)2009.01 (A01G19810109/10/2007

ื  PORTABLE ื™ื™ื“ืช ืœื‘ืงืจืช ืืงืœื™ืืžืขืจื›ืช CLIMATE CONTROLSYSTEM

BABYืž"ื‘ื™ื™ื‘ื™ ืงื•ืžืคื•ืจื˜ ื‘ืข COMFORT LTD10/10/200660/850293US

PCT/IL/2007/001218WO/2008/044234

Page 263: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009263

)2009.01 (A61K19810222/03/2004

ื‘ื™ื™ืฆื•ืจILโ€“21ืฉื™ืžื•ืฉ ืคื•ืœื™ืคืคื˜ื™ื“ ืฉืœื•ื,10โ€“ืชืจื•ืคื” ืœืกื“ืจ ื—ื•ืกืจ ื‘ืื™ื ื˜ืจืœื•ืงื™ืŸ

ืžื—ืœื” ื”ืงืฉื•ืจื” ืœืื•ืชื• ื—ื•ืกืจ ื‘ื™ื•ื ืง

USE OF AN IL-21 POLYPEPTIDE INTHE MANUFACTURE OF AMEDICAMENT FOR MODULATINGAN IL-10 DEFICIENCY, OR ADISORDER ASSOCIATEDTHEREWITH IN A MAMMALWYETH

21/03/200360/456920USPCT/US/2004/008833WO/2004/084835

)2009.01 (F16L19810307/04/2009

ื–ืžื ื™ืชโ€“ืžื ื’ื ื•ืŸ ื•ืฉื™ื˜ื” ืœืฉื—ืจื•ืจ ื•ื ืขื™ืœื” ื‘ื• ืฉืœ ืžื ื’ื ื•ืŸ ื”ื™ื ืข ื‘ื• ืžืคืจืงื™ื ืจื‘ื™ื

METHOD AND SYSTEM FORSIMULTANEOUS LOCKING ANDUNLOCKING OF MECHANISMCOMPRISING A PLURALITY OFJOINTS

MORDEHAI ืžืจื“ื›ื™ ืฉื•ืœื‘ SHOLEV

)2009.01 (G09G19810414/05/2007

AUTONOMOUS ื”ืชื ื”ื’ื•ื™ื•ืช ืื•ื˜ื•ื ื•ืžื™ื•ืช ืœืจื›ื‘ ืžืจื•ื—ืง BEHAVIROS FOR AREMOTE VEHICLEIROBOT CORPORATION

06/10/200660/828632US13/04/200760/911785US24/04/200711/739590US

PCT/US/2007/068890WO/2008/060689

)2009.01 (B65D19810507/04/2009

ืžืขืจื›ืช ื•ืืžืฆืขื™ ืœื‘ื“ื™ืงื” ื•ืคืงื•ื— ืขืœ ื›ืžื•ืช ื•ื˜ืžืคืจื˜ื•ืจืช ื ื•ื–ืœ ื‘ืžื™ื›ืœ

SYSTEM AND MEANS FORCONTROLLING AND CHECKING THETEMPERATURE AND QUANITY OFLIQUID IN A CONTAINER

,GROFF ื ื™ืจ ื’ืจื•ืฃ NIR

Page 264: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 264

)2009.01 (B03C19810611/10/2007

ืžื–ืจื ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœื”ืคืจื“ืช ื—ื•ืžืจ ื—ืœืงื™ืงื™ ื’ื–

DEVICE AND METHOD FORSEPARATING PARTICULATEMATERIAL FROM A GAS FLOWVIRUS FREE AIR B.V.

11/10/20061032666NLPCT/NL/2007/000259WO/2008/044922

)2009.01 (G09B19810808/11/2007

ืฉื™ื˜ื” ื•ืžื“ื™ื™ืช ืžื—ืฉื‘ ืœื”ืขื‘ืจืช ืคืจืกื•ืžื•ืช ื™ื“ื™ืืœืžืฉืชืžืฉื™ื ืฉืœ ื”ืชืงื ื™ื ื ื™

METHOD AND COMPUTERPROGRAM PRODUCT FORPROVIDING ADVERTISEMENTS TO AMOBILE USER DEVICE

MEDIAืž"ืžื“ื™ื” ืœื™ื™ืจืก ื‘ืข LAYERS LTD10/11/200660/865200US25/12/200660/871834US

PCT/IL/2007/001362WO/2008/056358

)2009.01 (A47L19811005/10/2007

VACUUM ืžืขืจื›ืช ื”ืคืจื“ื” ืœื ื™ืงื•ื™ ืฆื™ื ื•ืจ ืฉื•ืื‘ ืื‘ืง LINE CLEAN-OUTSEPARATOR SYSTEMTBW INDUSTRIES, INC.

07/10/200660/849896USPCT/US/2007/021371WO/2008/042444

)2009.01 (G06G19811119/10/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ื™ืฆื•ืข ืžื•ื“ืœื™ื ืฉืœ ื˜ืจืฉืช ืขื•ืจืงื™ื

METHOD AND APPARATUS FORMODELING ATHEROSCLEROSIS

ENTELOS, INC.19/10/200660/853280US

PCT/US/2007/082024WO/2008/049125

Page 265: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009265

)2009.01 (C07D19811227/09/2007

โ€“A[ืืžื™ื ื•ืื™ืžื™ื“ืื–ื•โ€“3ื ื’ื–ืจื•ืช ืฉืœืฉืœ]1,2 โ€“1ืคื™ืจื™ื“ื™ืŸ ืขื ืคืขื™ืœื•ืช ืื™ื›ื•ื‘

SGLT2โ€“ื•โ€“SGLTืœื˜ื™ืคื•ืœ ื‘ืกื•ื›ืจืช ืžืกื•ื’2ื•ืกื•ื’1

3-AMINOIMIDAZO [1,2-A]PYRIDINEDERIVATIVES HAVING AN SGLT1-ANDSGLT2-INHIBITING ACTION FOR THETREATMENT OF TYPE 1 AND TYPE 2DIABETESMERCK PATENT GMBH

16/10/2006102006048728.1DEPCT/EP/2007/008424WO/2008/046497

)2009.01 (C12M19811310/10/2007

REDUCING ื”ืคื—ืชืช ื”ืคืจืขื” ืื•ืคื˜ื™ืช ื‘ืžืชืงืŸ ืœื ื•ื–ืœื™ื OPTICAL INTERFERENCEIN A FLUIDIC DEVICETHERANOS, INC.

13/10/200611/549558US13/03/200711/685615US

PCT/US/2007/080917WO/2008/063770

)2009.01 (A01N19811405/10/2007

ืฉืœ ืงืจื™ืกื˜ืœ โ€“S)โ€“(+)โ€“2โ€“(2(ื—ื“ืฉ ืงืจื‘ืžื˜โ€“ืืชื™ืœโ€“ื”ื™ื“ืจื•ืงืกื™โ€“2โ€“)ื›ืœื•ืจื•ืคื ื™ืœ

NOVEL CRYSTAL OF (S)-(+)-2-(2-CHLOROPHENYL)-2-HYDROXY-ETHYL CARBAMATEJANSSEN PHARMACEUTICA, N.V.

10/10/200660/828785USPCT/US/2007/021423WO/2008/063284

Page 266: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 266

)2009.01 (C07D19811518/10/2007

ื”ืจื›ื‘ื™ื ืฉืœื”ืŸ, ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืืจื™ืœื™ื•ืช ื•ืฉื™ืžื•ืฉ ื‘ื”ืŸ ื›ืžืขื›ื‘ื™ ืคืจื•ื˜ืื™ืŸ ืงื™ื ืื–

HETEROARYL COMPOUNDS,COMPOSITIONS THEREOF, ANDTHEIR USE AS PROTEIN KINASEINHIBITORSSIGNAL PHARMACEUTICALS, LLC

19/10/200660/853166USPCT/US/2007/022374WO/2008/051493

)2009.01 (C07D19811618/10/2007

ื”ืจื›ื‘ื™ื ืฉืœื”ืŸ, ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืืจื™ืœื™ื•ืช ื•ืฉื™ืžื•ืฉ ื‘ื”ืŸ ื›ืžืขื›ื‘ื™ ืคืจื•ื˜ืื™ืŸ ืงื™ื ืื–

HETEROARYL COMPOUNDS,COMPOSITIONS THEREOF, AND USETHEREOF AS PROTEIN KINASEINHIBITORSSIGNAL PHARMACEUTICALS, LLC

19/10/200660/853135USPCT/US/2007/022375WO/2008/051494

)2009.01 (C07D19811701/11/2007

โ€“ืื•ืงืกื™โ€“5โ€“ืชื”ืœื™ืš ืœื”ื›ื ืช ื ื’ื–ืจื•ืช ืื™ื ื“ื•ืœ ืงื•ื•ื™ื ืื–ื•ืœื™ืŸ ื•ื—ื•ืžืจื™ ื‘ื™ื ื™ื™ื

PROCESS FOR PREPARING INDOL-5-OXY-QUINAZOLINE DERIVATIVESAND INTERMEDIATESASTRAZENECA AB

02/11/200660/864036US22/08/200760/957401US

PCT/GB/2007/004176WO/2008/053221

)2009.01 (H01R19811807/04/2009

MULTIPLE ืฉืงืข ื—ืฉืžืœื™ ืžื•ืจื›ื‘โ€“ืจื‘ ELECTRICAL SOCKETASSEMBLY

YOAV ื™ื•ืื‘ ืจื•ื˜ื ื‘ืจื’ ROTTENBERG

Page 267: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009267

)2009.01 (A01N19811921/12/2007

ืืžื™ื“ื•ืŸ ื”ืจื›ื‘ ืžื“ื‘ื™ืจ ืžื–ื™ืงื™ื ื”ืžื›ื™ืœ ืคื  ื•ืชืจื›ื•ื‘ืช ืžื“ื‘ื™ืจืช ื—ืจืงื™ื

PESTICIDAL COMPOSITIONCOMPRISING FENAMIDONE AND ANINSECTICIDE COMPOUNDBAYER CROPSCIENCE AG

22/12/200606127142.5EPPCT/EP/2007/064421WO/2008/077922

)2009.01 (C12N19812009/10/2007

ืœ ื‘ืกื—ื•ืก ืœื™ื’ื ื“ื™ื ืฉืœ ืคื•ืœื™ืคืคื˜ื™ื“ ืœื˜ื™ืคื• ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื”ื

POLYPEPTIDE LIGANDS FORTARGETING CARTILAGE ANDMETHODS OF USE THEREOFECOLE POLYTECHNIQUE FEDERALEDE LAUSANNE

10/10/200611/545819USPCT/US/2007/021529WO/2008/063291

)2009.01 (A63B19812107/04/2009

PROTECTING ืœืกืคื•ืจื˜ ืœื—ื™ืžื”ื›ืคืคืช ื”ื’ื ื” GLOVE FOR FIGHTINGSPORTS

ELDAN ืืœื“ืŸ ืงืจ KER

)2009.01 (C07D19812222/04/2003

ื ื’ื–ืจื•ืช ื˜ืจื™ืื–ื•ืœื™ื ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืฉืœ ืงื•ืœื˜ืŸ ืฉืœ ื˜ืืงื™ืงื™ื ื™ืŸ

TRIAZOLE DERIVATIVES ASTACHYKININ RECEPTORANTAGONISTSELI LILLY & CO.

26/04/200260/376,121USPCT/US/2003/010681WO/2003/091226

Page 268: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 268

)2009.01 (F27B19812307/04/2009

A ืชื ื•ืจ ืœื˜ื™ืคื•ืœ ื‘ื—ื•ื ืขื ื—ื™ืžื•ื ืื™ื ื“ื•ืงื˜ื™ื‘ื™ HEAT TREATMENT OVEN WITHINDUCTIVE HEATINGSNECMA PROPULSION SOLIDE

18/04/20080852641FR

)2009.01 (F24F19812516/04/2009

AIR ืžืขืจื›ืช ืžื™ื–ื•ื’ ืื•ื™ืจ CONDITIONING SYSTEMLAMOS INC.

)2009.01 (C22B19812616/04/2009

DUCTILE ืกื’ืกื•ื’ืช ืžื’ื ื–ื™ื•ื ืจืงื™ืข MAGNESIUM ALLOYGKSS-FORSCHUNGSZENTRUMGEESTHACHT GMBH

23/04/2008102008020523.0DE

)2009.01 (C07K19812708/11/2007

)GLPโ€“2(2โ€“ืคืคื˜ื™ื“โ€“ืฉื•ื•ื”โ€“ืœื•ื’ื™ ื’ืœื•ืงื’ื•ืŸืื  ืกืœืงื˜ื™ื‘ื™ื™ื

SELECTIVE GLUCAGON-LIKE-PEPTIDE-2 (GLP-2)ANALOGUES

ZEALAND PHARMA A/S08/11/2006PA2006.01456DK15/11/200660/859313US

PCT/GB/2007/004273WO/2008/056155

)2009.01 (A63B19812816/04/2009

ืช ืœืžื“ื™ื“ืช ื ืชื•ื ื™ื ื‘ืžื›ืฉื™ืจ ืœืื™ืžื•ืŸ ืžืขืจื› ื›ื•ื—

A SYSTEM FOR MEASUREMENTDATA IN GYM EQUIPMENT

ROM ืจื•ื ืื™ื–ื ื‘ืจื’ EUSENBERG

Page 269: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009269

)2009.01 (B05D19812916/04/2009

A ืžื‘ืจืฉืช ืœืžืจื™ื—ื” ืžื•ืชืืžืช ืœืฉืคื•ืคืจืช ืงืจื SPREADING BRUSH SUITABLEFOR TUBE OF CREAM

ILANA ืื™ืœื ื” ืžืœื™ื—ื™ MALIHI

)2009.01 (A61K19813102/04/2001

KBNUCLEARืคืงื˜ื•ืจ ืžืฉืจื” ืคืงื˜ื•ืจ ื’ืจืขื™ืŸ FACTOR KB INDUCINGFACTORAVENTIS PHARMACEUTICALS INC.

31/03/200060/193905US26/07/20000018307.9GB

PCT/US/2001/010719WO/2001/074900

)2009.01 (C07K19813202/04/2001

KBNUCLEARืคืงื˜ื•ืจ ืžืฉืจื” ืคืงื˜ื•ืจ ื’ืจืขื™ืŸ FACTOR KB INDUCINGFACTORAVENTIS PHARMACEUTICALS INC.

31/03/200060/193905US26/07/20000018307.9GB

PCT/US/2001/010719WO/2001/074900

)2009.01 (A61K19813312/10/2007

ื—ื•ืžืฆื” ืฉืœ ื•ื ื™ืœ, ื—ื•ืžืฆื” ืฆื™ื ืžื™ืชื’ื–ืจื•ืช ืฉืœ ื‘ื ื–ื•ืคื•ืจืŸ ืœืฉื™ืžื•ืฉ ื‘ื˜ื™ืคื•ืœ ื•ื 

ื‘ื“ืœืงืช ื•ืกืจื˜ืŸ

CINNAMIC ACID, VANILLIC ACID ANDBENZOFURAN DERIVATIVES FOR USEIN THE TREATMENT OFINFLAMMATION AND CANCERRELIANCE LIFE SCIENCES PVT. LTD.

13/10/20061696/MUM/2006INPCT/IN/2007/000488WO/2008/062466

Page 270: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 270

)2009.01 (A61K19813418/10/2007

ืฉื™ืœื•ื‘ ืฉืœ ืชืจื•ืคื•ืช ืื ื˜ื™ืคืกื™ื›ื•ื˜ื™ื•ืชื•ื˜ื˜ืจืืฆื™ืงืœื™ื ื™ื ื‘ื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช

ืคืกื™ื›ื™ืื˜ืจื™ื•ืช

COMBINED THERAPIES OFANTIPSYCHOTIC DRUGS ANDTETRACYCLINES IN THE TREATMENT OFPSYCHIATRIC DISORDERS

MORืž"ืžื•ืจ ืžื—ืงืจื™ื ื™ื™ืฉื•ืžื™ื™ื ื‘ืข RESEARCH APPLICATIONS LTD.19/10/200660/852646US29/03/2007PCT/IL2007/000414IL

PCT/IL/2007/001251WO/2008/047365

)2009.01 (A47D19813516/04/2009

SHABAT ื ืจื•ืช ื—ืฉืžืœ ืœืฉื‘ืช ELECTRICAL CANDLESNISIM ื ื™ืกื™ื ืื•ื–ืŸ OUZAN

)2009.01 (A47J19813627/07/2007

METHOD ืฉื™ื˜ื” ืœื”ืขื‘ืจืช ื—ื•ื ื•ืžืชืงืŸ ืขื‘ื•ืจ ื–ื” FOR HEAT TRANSFER ANDDEVICE THEREFORJEONG HYUN LEE

11/10/2006200607076-7

SG

PCT/KR/2007/003622WO/2008/044823

)2009.01 (A23L19813710/10/2007

KETOGENIC ื“ื™ืื˜ื” ืงื˜ื•ื’ื ื™ืช DIETN.V. NUTRICIA

17/10/200611/581749USPCT/NL/2007/050491WO/2008/048094

Page 271: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009271

)2009.01 (G06K19813816/10/2007

BIOMETRIC ืžืขืจื›ื•ืช ื‘ื™ื•ืžื˜ืจื™ืงื” SYSTEMSื‘ืข.ืงื™ื•.ืื™ I.Q.Sืž"ืืก ืฉืœื• SHALEV LTD

19/10/200611/583044USPCT/IL/2007/001240WO/2008/047356

)2009.01 (A47D19813923/10/2007

TOILET ืฉื˜ื™ืคืช ืืกืœื” ื‘ืœื™ ืฉื™ืžื•ืฉ ื‘ืžื™ื›ืœ ืืกืœื” FLUSHING WITHOUT USINGA TOILET TANK

BRAVERMAN-ABADI ืขื‘ืื“ื™ ืขื•ื‘ื“ MICHAL24/10/200660/862615US

PCT/IL/2007/001272WO/2008/050324

)2009.01 (A47D19814020/11/2007

FURNITURE ืกื’ื™ืจื” ืœืจื”ื™ื˜ื™ื CLOSUREFRITZ HAKEMANN

28/11/2006PCT/EP2006/011428EPPCT/EP/2007/010038WO/2008/046666

)2009.01 (C07D19814222/10/2007

ืชืจื›ื•ื‘ื•ืช ื‘ื ื–ื•ื™ืœ ืืžื™ื ื• ื”ื˜ืจื•ืฆื™ืงืœื™ืœื”ืฉื™ืžื•ืฉื™ื•ืช ื‘ื˜ื™ืคื•ืœ ืฉืœ ืžื—ืœื” ื”ืžืชื•ื•ื›ืช

GLKืขืœ ื™ื“ื™

BENZOYL AMINO HETEROCYCLYLCOMPOUNDS USEFUL IN THETREATMENT OF A DISEASEMEDIATED THROUGH GLKASTRAZENECA AB

23/10/200660/862493US28/02/200760/891993US

PCT/GB/2007/004018WO/2008/050101

Page 272: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 272

)2009.01 (C07D19814325/10/2007

ืชืจื›ื•ื‘ื•ืช ื‘ื ื–ื•ื™ืœ ืืžื™ื ื• ื”ื˜ืจื•ืฆื™ืงืœื™ืœ)GLK(ื ืื– ื›ืžืฉืคืขืœื™ ื’ืœื•ืงื•ืงื™

BENZOYL AMINO HETEROCYCLYLCOMPOUNDS AS GLUCOKINASE(GLK) ACTIVATORSASTRAZENECA AB

26/10/200660/863056US22/08/200760/957370US

PCT/GB/2007/004057WO/2008/050117

)2009.01 (A61K19814408/10/2007

PHENYLALKYL ื”ืจื›ื‘ื™ื ืฉืœ ืคื ื™ืœืืœืงื™ืœ ืงืจื‘ืžืื˜ CARBAMATECOMPOSITIONSJANSSEN PHARMACEUTICA, N.V.

13/10/200660/829355USPCT/US/2007/080677WO/2008/048802

)2009.01 (A61K19814508/10/2007

PHENYLALKYLAMINO ื”ืจื›ื‘ื™ื ืฉืœ ืคื ื™ืœืืœืงื™ืœืืžื™ื ื• ืงืจื‘ืžืื˜ CARBAMATECOMPOSITIONSJANSSEN PHARMACEUTICA, N.V.

13/10/200660/829342USPCT/US/2007/080675WO/2008/048801

)2009.01 (A61L19814610/10/2007

ืชื›ืฉื™ืจื™ื ื•ื”ืชืงื ื™ื ื”ืžื•ืจื›ื‘ื™ื ืžืกื™ืœื™ืงื•ืŸ ื•ืคื•ืœื™ืคื•ืกืคื–ื ื™ื ืกืคืฆื™ืคื™ื™ื

COMPOSITIONS AND DEVICESCOMPRISING SILICONE ANDSPECIFIC POLYPHOSPHAZENESCELONOVA BIOSCIENCES, INC.

10/10/200660/828833USPCT/US/2007/080976WO/2008/045953

Page 273: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009273

)2009.01 (A61K19814711/10/2007

ืื•ืงืกื“ื™ืื–ื•ืœ ืคืขื™ืœโ€“4,2,1ืฉื™ื˜ื•ืช ืžื™ื ื•ืŸ ืกื ืกโ€“ื‘ืžืชืŸ ืคื•ืžื™ ืœื“ื™ื›ื•ื™ ืžื•ื˜ืฆื™ื™ืช ื ื•ืŸ

METHODS FOR DOSING AN ORALLYACTIVE 1,2,4-OXADIAZOLE FORNONSENSE MUTATIONSUPPRESSION THERAPYPTC THERAPEUTICS, INC

12/10/200660/851450USPCT/US/2007/021921WO/2008/045566

)2009.01 (A61L19814810/10/2007

BIOPROSTHETIC ืฉืกืชื•ื ืœื‘ ื‘ื™ื•ืคืจื•ืกืชื˜ื™ ืขื ืคื•ืœื™ืคื•ืกืคื–ืŸ HEART VALVEWITH POLYPHOSPHAZENECELONOVA BIOSCIENCES, INC.

10/10/200660/828840USPCT/US/2007/080969WO/2008/045949

)2009.01 (C07D19814918/10/2007

NOVEL ืžืขื›ื‘ื™ื ื—ื“ืฉื™ื ืฉืœ ืงื™ืžื– INHIBITORS OF CHYMASEJANSSEN PHARMACEUTICA, N.V.

18/10/200660/852604USPCT/US/2007/022244WO/2008/048668

)2009.01 (C07D19815023/10/2007

4,2ื ื’ื–ืจื•ืช ื‘ื™ืฆื™ืงืœื™ื•ืช ืžืื•ื—ื•ืช ืฉืœCโ€“METโ€“ื•ALKื“ื™ืืžื™ื ื•ืคื™ืจื™ืžื™ื“ื™ืŸ ื›ืžืขื›ื‘ื™

FUSED BICYCLIC DERIVATIVES OF2,4-DIAMINOPYRIMIDINE AS ALKAND C-MET INHIBITORSCEPHALON, INC.

23/10/200660/853562USPCT/US/2007/022496WO/2008/051547

Page 274: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 274

)2009.01 (H04Q19815131/10/2007

)UPLINK(ื‘ืงืฉืช ืžืฉืื‘ ืขืจื•ืฅ ืขื•ืœื” ืžื”ื™ืžืŸ

RELIABLE UPLINK RESOURCEREQUEST

QUALCOMM INCORPORATED31/10/200660/863794US

PCT/US/2007/083244WO/2008/055239

)2009.01 (H01L19815216/10/2007

ืื“ื•ืžื•ืชโ€“ืื•ืจ ืื™ื ืคืจืโ€“ืžืขืจื›ื™ ื“ื™ื•ื“ื•ืชื•ืžืขืจื›ื•ืช ื—ื™ื™ืฉื ื™ื ืขื ืฉื›ื‘ืช ืคืกื™ื‘ืฆื™ื”

ืžืฉื•ืคืจืช ื•ืฉื™ื˜ื•ืช ืฉืœ ื™ื™ืฆื•ืจ

INFRARED PHOTODIODES ANDSENSOR ARRYS WITH IMPROVEDPASSIVATION LAYERS ANDMETHODS OF MANUFACTURERAYTHEON COMPANY

17/10/200611/582937USPCT/US/2007/022003WO/2008/048555

)2009.01 (B01D19815310/10/2007

DESALINATION ืžืขืจื›ืช ื”ืชืคืœื” SYSTEMTHE TEXAS A & M UNIVERSITYSYSTEM

10/10/200660/828882USPCT/US/2007/080954WO/2008/045943

)2009.01 (C07D19815418/10/2007

INDOLE ืชืจื›ื•ื‘ืช ืื™ื ื“ื•ืœ COMPOUNDTAKEDA PHARMACEUTICALCOMPANY LIMITED

19/10/20062006-285551

JP

PCT/JP/2007/070772WO/2008/050821

Page 275: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009275

)2009.01 (B65B19815516/04/2009

DOUBLE ืืจื™ื–ื” ืขื ืื™ื˜ื•ื ื›ืคื•ืœ SEAL PACKAGE

NAKNIKืž"ื ืงื ื™ืง ื ื”ืจื™ื” ื›ืฉืจ ื–ื•ื’ืœื•ื‘ืง ื‘ืข HAHARIYA KASHER,SOGLOWEK LTD.

)2009.01 (C23C19815624/10/2007

METHOD ืฉื™ื˜ื” ืœื“ื—ื™ืกืช ื—ืคืฆื™ื ื ืงื‘ื•ื‘ื™ื™ื OF DENSIFYING POROUSARTICLESMESSIER-BUGATTI

29/10/200660/863377USPCT/EP/2007/061429WO/2008/052923

)2009.01 (C07D19815722/10/2007

ื•ืœื™ื ืฉืœ ืชื•ืœื“ื•ืช ืืชืจ ืžื•ื“ื•ืœื˜ื•ืจื™ื ื›ืคืœ 3Dโ€“ื• A2HTโ€“5โ€“ื”ืงื•ืœื˜ื ื™ื

ETHER DERIVATIVES DUALMODULATORS OF THE 5-HT2A ANDD3 RECEPTORSF. HOFFMANN-LA ROCHE AG

31/10/200606123274.0EPPCT/EP/2007/061253WO/2008/052899

)2009.01 (H01S19815816/04/2009

ื”ื›ื•ืœืœื™ื ืžืขืจื›ื™ ืžื•ื˜ ืœื™ื™ื–ืจ ืžืงื•ืจืจื™ ื ื•ื–ืœ ื ื—ื•ืฉืช ืžื—ื•ืžืจื™ื ืžืชืื™ืžื™ื/ื”ืจื—ื‘ืช ื™ื”ืœื•ื

LIQUID COOLED LASER BARARRAYS INCORPORATINGDIAMOND/COPPER EXPANSIONMATCHED MATERIALSLASERTEL, INC.

17/04/200812/105126US

Page 276: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 276

)2009.01 (A61M19815925/10/2007

ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ื•ืฉื™ืžื•ืฉ, ืžืชืงืŸ ืœืคื™ื–ื•ืจ ืื‘ืงื”ื•ืจื›ื™ื‘ื™ื ื”ื ื™ืชื ื™ื ืœืฉื™ืžื•ืฉ ื‘ืžืชืงืŸ, ืžืชืงืŸื‘

ื•ื‘ืžื›ืฉื™ืจื™ื ืื—ืจื™ื

POWDER DISPERSION APPARATUS,METHOD OF MAKING AND BEUSING THE APPARATUS, ANDCOMPONENTS THAT CAN BE USEDON THE APPARATUS AND OTHERDEVICESNOVARTIS AG

25/10/200660/854601US13/03/200760/906977US

PCT/US/2007/022830WO/2008/051621

)2009.01 (A61K19816012/10/2007

PHARMACEUTICAL ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื FORMULATIONSFOURNIER LABORATORIESIRELAND LTD

12/10/200660/829255USPCT/US/2007/081267WO/2008/046052

)2009.01 (A61K19816117/10/2007

DICLOFENACืœ ื“ื™ื›ืœื•ืคื ื™'ื’ GELNUVO RESEARCH

17/10/200660/829756USPCT/US/2007/081674WO/2008/049020

)2009.01 (H04M19816216/04/2009

ื”ืชืงืŸ ืืœืงื˜ืจื•ื ื™ ื‘ืฆื•ืจื” ืฉืœ ืžืขืจื›ืชื• ืื• ื”ืชืงืŸ/ื˜ืœืคื•ื ื™ื” ืœืœื ืฉื™ืžื•ืฉ ื™ื“ื ื™

ื ื™ื•ื•ื˜

ELECTRONIC DEVICE IN THE FORM OFA HANDS-FREE TELEPHONE SYSTEMAND/OR A NAVIGATION DEVICE

BURY SP. Z.O.O.22/04/2008102008020551.6DE

Page 277: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009277

)2009.01 (G03B19816302/10/2005

GIMBAL ืžืขืจื›ืช ื’ื™ืžื‘ืœ SYSTEMFLIR SYSTEMS, INC

01/10/200410/956738US01/10/200410/956739US

)2009.01 (H04N19816430/01/2003

ืžืขืจื›ืช ืœืงื™ื•ื ื•ืขื™ื“ืช ืฉืžืข ื•ืžืจืื” ืžืจื•ื‘ืช ื ืงื•ื“ื•ืช ื—ื™ื‘ื•ืจ

MULTIPOINT AUDIOVISUALCONFERENCING SYSTEM

LARRY E. ROHER30/01/200260/353053US

PCT/US/2003/002759WO/2003/065706

)2009.01 (A61N19816623/10/2007

ELECTROLYTIC ืืœืงื˜ืจื•ืœื™ืกื” ืœื˜ื™ืคื•ืœ ื‘ืจืงืžื•ืช ืžืชืงื ื™ TISSUETREATMENT DEVICESECPOINT MEDICAL INC.

24/10/200660/853747USPCT/US/2007/082267WO/2008/051993

)2009.01 (G06F19816718/10/2007

METHOD ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ืจื›ื‘ืช ืชื•ื›ืŸ AND SYSTEM FORCONTENT COMPOSITION

ื‘ืข. ื˜ื‘ื•ืœื” .TABOOLAืž"ืงื•ื COM LTD19/10/200660/852648US10/05/200760/924361US

PCT/IL/2007/001249WO/2008/047363

Page 278: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 278

)2009.01 (A61K19816810/10/2006

ROBUST ื”ืจื›ื‘ื™ื ื™ืฆื™ื‘ื™ื ืœืฉื—ืจื•ืจ ืžื‘ื•ืงืจ SUSTAINED RELEASEFORMULATIONSPENWEST PHARMACEUTICALSCOMPANY

PCT/US/2006/039923WO/2008/045060

)2009.01 (A61K19816910/10/2006

ื”ืจื›ื‘ื™ื ื™ืฆื™ื‘ื™ื ืœืฉื—ืจื•ืจ ืžื‘ื•ืงืจ ืฉืœ ืื•ืงืกื™ืžื•ืจืคื•ืŸ

ROBUST SUSTAINED RELEASEFORMULATIONS OFOXYMORPHONEPENWEST PHARMACEUTICALSCOMPANY

PCT/US/2006/039767WO/2008/045046

)2009.01 (A61K19817010/10/2006

ื”ืจื›ื‘ ื™ืฆื™ื‘ ืœืฉื—ืจื•ืจ ืžื‘ื•ืงืจ ืฉืœ ืื•ืงืกื™ืžื•ืจืคื•ืŸ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื•

ROBUST SUSTAINED RELEASEFORMULATIONS OFOXYMORPHONE AND METHODS OFUSE THEREOFPENWEST PHARMACEUTICALSCOMPANY

PCT/US/2006/039781WO/2008/045047

Page 279: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009279

)2009.01 (C07D19817112/12/2007

ืชื•ืœื“ื•ืช ื“ื™ื”ื™ื“ืจื•ืคื™ืจื™ื“ื™ืŸ ื”ืžืฉืžืฉื•ืช ื›ืžืขื›ื‘ื™ ืคืจื•ื˜ื™ืื™ืŸ ืงื™ื ืื–

DIHYDROPYRIDINE DERIVATIVESUSEFUL AS PROTEIN KINASEINHIBITORSBAYER SCHERING PHARMA AG

14/12/200660/875124USPCT/EP/2007/011076WO/2008/071451

)2009.01 (H04B19817209/01/2007

ืžืขืจื›ืช ืœืชืงืฉื•ืจืช ืื•ืคื˜ื™ืช ื‘ื—ืœืœ ื•ืฉื™ื˜ื” ืœืชืคืขื•ืœื”

SYSTEM FOR FREE SPACE OPTICALCOMMUNICATION AND METHODFOR METHOD FOR OPERATIONTHEREOF

OPTIGOืž"ืืœืชื ืžืขืจื›ื•ืช ื‘ืข SYSTEMS LTD07/11/2006179089IL

PCT/IL/2007/000023WO/2008/056347

)2009.01 (C07D19817311/08/2007

PEGืงื™ืœืื˜ื™ื ืžืชื›ืชื™ื™ื ื‘ืขืœื™ ืงื‘ื•ืฆืชืฉื™ื˜ื” ืœื™ืฆื•ืจื, ืžื•ืชืžืจืช ื›ื•ืœื” ื‘ืคืœื•ืื•ืจ

ื•ืฉื™ืžื•ืฉ ื‘ื”ื

METAL CHELATES HAVING APERFLUORINATED PEG GROUP,METHOD FOR THE PRODUCTIONTHEREOF, AND USE THEREOFBAYER SCHERING PHARMA AG

18/10/2006102006049821.6DE20/10/200660/852963US15/02/200760/890071US

PCT/EP/2007/007284WO/2008/046463

Page 280: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 280

)2009.01 (F16K19817419/10/2007

FLUID ืžืขืจื›ืช ืฉืกืชื•ืžื™ืช ืœื‘ืงืจืช ื ื•ื–ืœ ื•ืฉื™ื˜ื•ืช CONTROL VALVA SYSTEMAND METHODSTYCO FIRE PRODUCTS LP

20/10/200660/862305US29/01/200760/887040US

PCT/US/2007/082006WO/2008/051871

)2009.01 (A61P19817518/10/2007

ืฉื™ื˜ื” ื•ืชื›ืฉื™ืจ ืจื•ืงื—ื•ืช ืœื˜ื™ืคื•ืœ ื‘ืชืช ืคื•ืจื™ื•ืช ื‘ื–ื›ืจื™ื

METHOD AND PHARAMCOLOGICALCOMPOSITION FOR THE DIAGNOSISAND TREATMENT OF MALE SUB-FERTILITY

PERINESSืž"ืคืจื™ื ืก ื‘ืข LTD18/10/200660/852402US

PCT/IL/2007/001250WO/2008/047364

)2009.01 (H04Q19817610/10/2007

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืฉืœื™ื—ืช ืžืฉื•ื‘ ืขื‘ื•ืจ ืฉืจื•ืชืžืฉื•ืชืฃ ืžื”ืœื•ื•ื™ืŸ ืœืืจืฅ ื”ืžืฉื•ื“ืจ ืœืžืกืคืจ

ืœ ืงืœื™ื˜ื”/ืฉื™ื“ื•ืจืจื‘ ืฉืœ ื™ื—ื™ื“ื•ืช ืืœื—ื•ื˜ื™ื•ืช

METHOD AND APPARATUS FORSENDING FEEDBACK FOR ADOWNLINK SHARED SERVICETRANSMITTED TO A PLURALITY OFWIRELESS TRANSMIT/RECEIVEUNITSINTERDIGITAL TECHNOLOGYCORPORATION

10/10/200660/828881US05/01/200760/883594US

PCT/US/2007/021642WO/2008/045471

Page 281: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009281

)2009.01 (B67D19817710/10/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื ื™ืคื•ืง ืžื ืชื™ ืฉืœ ื ื•ื–ืœ ืžื•ื’ื– ืœืื—ืจ ื”ืฉื•ื•ืืช ืœื—ืฆื™ื

METHOD AND APPARATUS FORDOSED DISPENSING OF GASIFIEDLIQUID AFTER PRESSUREEQUALISATIONDISPENSING TECHNOLOGIES B.V.

10/10/20061032658NLPCT/NL/2007/000256WO/2008/044920

)2009.01 (C01B19817817/10/2007

HYDROGEN ื™ื™ืฆื•ืจ ืžื™ืžืŸ ืžื—ื•ืžืฆื” ืคื•ืจืžื™ืช PRODUCTION FROMFORMIC ACIDECOLE POLYTECHNIQUE FEDERALELAUSANNE (EPFL)

18/10/200606122534.8EPPCT/IB/2007/054222WO/2008/047312

)2009.01 (A61N19817916/10/2007

OCULAR ื ื™ืชื•ื— ืขื™ื ื™ ื‘ืืžืฆืขื•ืช ืงืจื™ื ื” RADIOSURGERYORAYA THERAPEUTICS, INC.

16/10/200660/829676US18/10/200660/862044US19/10/200660/862210US13/12/200660/869872US09/04/200760/922741US 04/06/200760/933220US

PCT/US/2007/081569WO/2008/118198

Page 282: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 282

)2009.01 (A01N19818016/10/2007

ืฉืœโ€“Pืžืœื— โ€“5ื˜ื•ืœื•ืืŸ ื—ื•ืžืฆื” ืกื•ืœืคื•ื ื™ืชโ€“Dโ€“?โ€“ื“ืื•ืงืกื™โ€“'3โ€“ืืฆื˜ื™ืœโ€“0โ€“'2(โ€“3โ€“ืืžื™ื ื•

โ€“5,4[ืชื™ืื–ื•ืœโ€“3Hโ€“)ืจื™ื‘ื•ืคื•ืจืื ืื•ื–ื™ืœD[ืื•ืŸ ื•ืฉื™ื˜ื•ืช ืœื™ืฆื•ืจื•โ€“2โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ

P-TOLUENE SULFONIC ACID SALTOF 5-AMINO-3-(2'-O-ACETYL-3'-DEOXY-?-D-RIBOFURANOSYL-3H-THIAZOLE[4,5-D]PYRIMIDINE-2-ONEAND METHODS FOR PREPARATIONANADYS PHARMACEUTICALS, INC.

17/10/200660/852002US05/02/200760/899405US02/08/200760/953597US

PCT/US/2007/081526WO/2008/140549

)2009.01 (H01Q19818103/10/2007

RAPIDLY ืžืขืจื›ืช ืื ื˜ื ื” ื”ื ื™ืชื ืช ืœืคืจื™ืกื” ื‘ืžื”ื™ืจื•ืช DEPLOYABLE ANTENNASYSTEMHARRIS CORPORATION

17/10/200611/550129USPCT/US/2007/080309WO/2008/115267

)2009.01 (A61K19818229/08/2007

โ€“ืฉื™ืžื•ืฉ ื‘ืฆื™ื˜ืจื•ืœื™ืŸ ืœื˜ื™ืคื•ืœ ื‘ืชื ืื™ ืชืช ืชื–ื•ื ื”

USE OF CITRULLINE FOR TREATINGUNDERNUTRITION CONDITIONSUNIVERSITE RENE DESCARTES(PARIS V) OF

17/10/200606/09077FRPCT/FR/2007/001407WO/2008/049984

Page 283: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009283

)2009.01 (A61K19818327/09/2007

ืชื›ืฉื™ืจื™ื ื•ื”ืจื›ื‘ื™ื ืœื˜ื™ืคื•ืœ, ืฉื™ื˜ื•ืช ื‘ืžื—ืœืช ืขื™ื ื™ื™ื ืชื™ืจื•ืื™ื“ื™ืช

METHODS, COMPOSITIONS, ANDFORMULATIONS FOR THETREATMENT OF THYROID EYEDISEASELITHERA, INC.

17/10/200660/852221US29/01/200760/898009US20/03/200760/919011US

PCT/US/2007/079740WO/2008/048770

)2009.01 (A61K19818416/10/2007

ื‘ ืจืงืžื” ื”ืžื›ื™ืœื” ืชืื™ ื”ืจื›ื‘ื™ื ืœื˜ื™ืคื•ืœืกื“ืจื™ื ื•ืจืงืžื”โ€“ืจืงืžื” ืขื•ืจื™ืช ื•ืื™, ืฉื•ืžืŸ

ืฉืจื™ืจื™ืช

FORMULATIONS FOR TREATMENTOF ADIPOSE TISSUE, CUTANEOUSTISSUE AND DISORDERS, ANDMUSCULAR TISSUELITHERA, INC.

17/10/200660/852221US29/01/200760/898009US20/03/200760/919011US

PCT/US/2007/081568WO/2008/067060

)2009.01 (G01N19818518/10/2007

ื–ืจื ืฆื“ื“ื™ ื•ื–ืจื ืžื‘ืขื“ ืœื ื‘ื“ืง ืื•ืจื’ื ื™ื–ืžื™ ื—ื™ืฉื™ื˜ื•ืช, ื”ืžื‘ื•ืกืก ืขืœ ืชื‘ื ื™ืช ืžื“ื™ื” ื ืงื‘ื•ื‘ื™ืช

ืœื”ื›ื ื” ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ

LATERAL FLOW AND FLOW-THROUGH BIOASSAY BASED ONPATTERNED POROUS MEDIA,METHODS OF MAKING SAME, ANDMETHODS OF USING SAMEPRESIDENT AND FELLOWS OFHARVARD COLLEGE

18/10/200660/852751US26/04/200760/914252US

PCT/US/2007/081848WO/2008/049083

Page 284: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 284

)2009.01 (C07K19818616/10/2007

ื—ื™ืกื•ื ื™ ืคืคื˜ื™ื“ ืœืกืจื˜ื ื™ื ื”ืžื‘ื˜ืื™ื1DEPDCืื•1MPHOSPHืคื•ืœื™ืคืคื˜ื™ื“ื™ื

PEPTIDE VACCINES FOR CANCERSEXPRESSING MPHOSPH1 OR DEPDC1POLYPEPTIDESONCOTHERAPY SCIENCE, INC.

17/10/200660/852575USPCT/JP/2007/001122WO/2008/047473

)2009.01 (C08L19818712/10/2007

ืชื›ืฉื™ืจ ืคื•ืœื™ืžืจื™ ื”ืžื›ื™ืœ ืคืœื•ืื•ืจ ื”ื ื™ืชืŸ ืจื™ืคื•ื™ืœ

CURABLE FLUORINE-CONTAININGPOLYMER COMPOSITION

DOW CORNING CORPORATION

12/10/20062006-279147

JP

PCT/JP/2007/069941WO/2008/044765

)2009.01 (H01H19818818/10/2007

BIFURCATED ื”ืจื›ื‘ื™ ืกื˜ื ื˜ื™ื ืžืคื•ืœื’ื™ื STENT ASSEMBLIESื‘ืข.ืื™ื ืกืคื™ื™ืจ ืืž INSPIREMDืž"ื“ื™ LTD.

18/10/200660/852392US18/10/200611/582354US22/11/200660/860485US27/12/200660/877162US01/05/200711/797168US

PCT/IL/2007/001253WO/2008/047367

)2009.01 (B01D19818918/10/2007

FILTER ื”ืชืงื ื™ ืžืกื ื ื™ื ASSEMBLIESื‘ืข.ืื™ื ืกืคื™ื™ืจ ืืž INSPIREMDืž"ื“ื™ LTD.

18/10/200660/852392US18/10/200611/582354US

PCT/IL/2007/001254WO/2008/047368

Page 285: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009285

)2009.01 (A61B19819018/10/2007

KNITTED ืขื˜ื™ืคื•ืช ืกื˜ื ื˜ื™ื ืกืจื•ื’ื™ื STENT JACKETSื‘ืข.ืื™ื ืกืคื™ื™ืจ ืืž INSPIREMDืž"ื“ื™ LTD.

18/10/200660/852392US22/11/200660/860485US27/12/200660/877162US

PCT/IL/2007/001255WO/2008/047369

)2009.01 (C07K19819124/10/2007

NEURONAL ืคืคื˜ื™ื“ื™ื ืžืขื›ื‘ื™ ืืงื–ื•ืฆื™ื˜ื•ื–ื™ืก ื‘ื ื•ื™ืจื•ื ื™ื EXOCYTOSISINHIBITING PEPTIDESLIPOTEC S.A.

25/10/2006200602720ESPCT/ES/2007/000603WO/2008/049945

)2009.01 (G10L19819228/09/2007

ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœืขื™ื‘ื•ื“ ื ื•ืกืฃ ืฉืœ ืขืจื›ื™ืืกืคืงื˜ืจื™ื™ื ื•ืžืงื“ื“ ื•ืคืขื ื— ืขื‘ื•ืจ ืื•ืชื•ืช

ืื•ื“ื™ื•

DEVICE AND METHOD FORPOSTPROCESSING SPECTRAL VALUESAND ENCODER AND DECODER FORAUDIO SIGNALSFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.

02/11/2006102006051673.7DEPCT/EP/2007/008477WO/2008/052627

)2009.01 (B60S19819319/04/2009

CHASSIS ืฉืกื™ ืœืขื’ืœื” ืื• ืœืจื›ื‘ FOR CART OF VEHICLEYARON ืœืื•ื ื™ื“ ืžื™ื ื•ื˜ื™ืŸ LEVY

Page 286: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 286

)2009.01 (B23K19819417/11/2001

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื ื™ืชื•ืจ ื•ื‘ืงืจื” ื‘ื–ืžืŸ ืืžืชื’ื•ื‘ื” ืžืฉืงืข ื‘ืฉื™ืžื•ืฉ ื‘ื˜ื›ื ื•ืœื•ื’ื™ื™ืช ืฆื™ืœื•ื

ื“ืžื•ืช ื•ืขื™ื‘ื•ื“ ื“ืžื•ืช ื‘ืฆืคื•ื™ ื‘ืœื™ื™ื–ืจ ื•ื‘ืชื”ืœื™ืš ื™ื™ืฆื•ืจ ืžืชื›ืช ื™ืฉื™ืจ ื‘ืกื™ื•ืข ืœื™ื™ื–ืจ

METHOD AND SYSTEM FOR REAL-TIME MONITORING ANDCONTROLLING HEIGHT OF DEPOSITBY USING IMAGE PHOTOGRAPHINGAND IMAGE PROCESSINGTECHNOLOGY IN LASER CLADDINGAND LASER AIDED DIRECT METALMANUFACTURING PROCESSINSSTEK INC

PCT/KR/2001/001970WO/2003/042895

)2009.01 (C03C19819519/10/2007

ืœ ื”ื›ื ืชืื—ื•ืžืจื™ื ืžื•ืจื›ื‘ื™ื ื•ืฉื™ื˜ื•ืชCOMPOSITE MATERIALS ANDPROCESSES FOR PRODUCING THESAMEMILLENIUM RESEARCH PTY LTD.

19/10/20062006905838AUPCT/AU/2007/001588WO/2008/046152

)2009.01 (A61K19819618/10/2007

TREATMENT ืกื“ืจื™ื ื“ืžื™ืืœื™ื ืื™ืโ€“ื˜ื™ืคื•ืœ ื‘ืื™ OF DEMYELINATINGDISORDERSTHE UNIVERSITY OF NORTHCAROLINA AT CHAPEL HILL

20/10/200660/862343USPCT/US/2007/081761WO/2008/049053

Page 287: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009287

)2009.01 (B32B19819718/10/2007

ืข ื™"ืฉื™ื˜ื•ืช ื•ืžืขืจื›ืช ืœื”ื›ื ืช ืฆื™ืคื•ื™ื™ื ืฉื™ืžื•ืฉ ื‘ืชืจืกื™ืก ืืœืงื˜ืจื•ืกื˜ืื˜ื™

METHODS AND APPARATUS FORMAKING COATINGS USINGELECTROSTATIC SPRAYTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ARKANSAS

19/10/200660/852931USPCT/US/2007/022220WO/2008/051433

)2009.01 (G08B19819819/04/2009

TRACKING ืžืขืงื‘ ืขื‘ื•ืจ ืžืขืจื›ื•ืช ืื•ื˜ื•ื ื•ืžื™ื•ืช OF AUTONOMOUSSYSTEMSHONEYWELL INTERNATIONAL INC.

20/06/200812/143055US

)2009.01 (B05D19819918/10/2007

ืข ื™"ืฉื™ื˜ื•ืช ื•ืžืขืจื›ืช ืœื”ื›ื ืช ืฆื™ืคื•ื™ื™ื ืฉื™ืžื•ืฉ ื‘ืฉื™ืงื•ืข ืชืจืกื™ืก ืื•ืœื˜ืจืืกื•ื ื™

METHODS AND APPARATUS FORMAKING COATINGS USINGULTRASONIC SPRAY DEPOSITIONNANOMECH, LLC

19/10/200660/852863USPCT/US/2007/022221WO/2008/051434

)2009.01 (A61K19820012/10/2007

โ€“?17ืฉื™ืžื•ืฉ ื‘ืืกื˜ืจืื“ื™ืื•ืœ ื•ื•ืœืจืื˜ ืื•ืกื˜ ืœื˜ื™ืคื•ืœ'ืืกื˜ืจืื“ื™ืื•ืœ ื™ื—ื“ ืขื ื“ื™ืื ื•ื’

ื• ืื• ื”ื’ื‘ืจืช ืื‘ื™ื•ื ื”/ืจืคื•ืื™ ืคื•ืžื™ ืœืฉืžื™ืจื” ื ืฉื™ืช

USE OF ESTRADIOL VALERATE OR17?-ESTRADIOL IN COMBINATIONWITH DIENOGEST FOR ORALTHERAPY FOR MAINTAININGAND/OR INCREASING THE FEMALELIBIDOBAYER SCHERING PHARMA AG

20/10/200606022091.0EP10/05/200707009373.7EP

PCT/EP/2007/008866WO/2008/046559

Page 288: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 288

)2009.01 (A01M19820119/10/2007

A ื›ื•ื“ืช ืœื—ื•ืœื“ื”ืžืœ RAT TRAPPAF HOLDING APS

19/10/2006PA200601357DK26/02/200711/678687US

PCT/DK/2007/000449WO/2008/046424

)2009.01 (C07K19820217/10/2007

PEPTIDE-CYTOTOXIC ืฆื™ื˜ื•ื˜ื•ืงืกื™ืโ€“ืชืฆืžื™ื“ื™ ืคืคื˜ื™ื“ CONJUGATESIPSEN PHARMA S.A.S

20/10/200660/853140US15/03/200760/918133US

PCT/US/2007/022179WO/2008/051421

)2009.01 (C07D19820322/10/2007

โ€“3,2[ืคื™ืจื•ืœื•โ€“7Hโ€“ืืœืงื™ืœโ€“5ืชื”ืœื™ืš ืœื”ื›ื ืชD[ืื•ืœื™ืโ€“2โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ

PROCESS FOR PREPARING 5-ALKYL-7H-PYRROLO[2,3-D]PYRIMIDINE-2-OLSLEXICON PHARMACEUTICALS, INC.

23/10/200660/853891USPCT/US/2007/082049WO/2008/051887

)2009.01 (C12M19820419/10/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื’ื™ื“ื•ืœ ืชืื™ื ืคื•ื˜ื•ืกื™ื ืชื˜ื™ื™ื

SYSTEM AND METHOD FORGROWING PHOTOSYNTHETIC CELLSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY

20/10/200660/862366USPCT/US/2007/081994WO/2008/051865

Page 289: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009289

)2009.01 (C12N19820519/10/2007

MODIFIED ืฆื™ืื ื•ื‘ืงื˜ืจื™ื” ืžื•ืชืืžืช CYANOBACTERIATHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY

20/10/200660/853285USPCT/US/2007/082000WO/2008/130437

)2009.01 (A61M19820616/10/2007

ืฉื™ื˜ื•ืช ื•ื”ืชืงื ื™ื ืขื‘ื•ืจ ื”ืชืงื“ืžื•ืช ืฆื ืชืจ ื•ืžืชืŸ ื—ื•ืžืจื™ื ื“ืจื›ื•

METHODS AND DEVICES FORCATHETER ADVANCEMENT ANDDELIVERY OF SUBSTANCESTHERETHROUGHGUIDED DELIVERY SYSTEMS, INC.

18/10/200611/583627USPCT/US/2007/022122WO/2008/048626

)2009.01 (A61L19820719/10/2007

ื“ื ืœืžืชืŸ ืชืจื•ืคื•ืช ื•ืฉื™ื˜ื”โ€“ืชื•ืžื›ืŸ ื‘ืชื•ืš ื›ืœื™ ืœืฉื™ืžื•ืฉ

DRUG-DELIVERY ENDOVASCULARSTENT AND METHOD OF USEBIOSENSORS INTERNATIONALGROUP

20/10/200660/853077US23/03/200711/690768US21/05/200711/751268US

PCT/US/2007/022284WO/2008/051453

Page 290: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 290

)2009.01 (A61K19820822/10/2007

โ€“ืขื™ื›ื•ื‘ ืคื™ืจื•ืง ื‘ืฉืœื‘ื™ื ืฉืœ ืžื˜ืจื™ืฆื” ื—ื•ืฅ ืชืื™ืช

INHIBITION OF DEGRADATION OFEXTRACELLULAR MATRIXTHE AUSTRALIAN NATIONALUNIVERSITY A BODY CORPORATEESTABLISHED BY THE AUSTRALIAN

20/10/20062006905854AUPCT/AU/2007/001603WO/2008/046162

)2009.01 (B65B19821019/04/2009

FILLABLE ืžื™ืœื•ื™ ืœืฉื•ื—ืช ื‘ื™ื•ื‘โ€“ืžื›ืกื” ื‘ืจ LID FOR SEWAGEMANHOLE

ROMOLDืž"ืจื•ืžื•ืœื“ ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ื‘ืข TECHNOLOGIES LTD.

)2009.01 (F23R19821118/10/2007

ืขืจื‘ื•ื‘ ืœื’ื– ื•ื“ืœืง ืœืฉื™ืžื•ืฉโ€“ืชืขืจื•ื‘ืช ืงื“ื ืžืžื™ืจ ืื ืจื’ื™ื”/ื™ื—ื“ ืขื ืžื›ืฉื™ืจื™ ืžืฉื—ืจืจ

PREMIXER FOR GAS AND FUEL USEIN COMBINATION WITH ENERGYRELEASE/CONVERSION DEVICELEAN FLAME INC.

18/10/200660/829993USPCT/US/2007/081803WO/2008/049067

)2009.01 (A61B19821217/10/2007

ืžื™ื›ืฉื•ืจ ืœืžืชืŸ ืžืจื•ื•ื— ื‘ื™ืŸ ืงื•ืฆื ื™ ื‘ืขืœ ืคื•ืœืฉื ื•ืช ืžื™ื ื™ืžืœื™ืช

MINIMALLY INVASIVE TOOLINGFOR DELIVERY OF INTERSPINOUSSPACERVERTIFLEX, INC.

18/10/200611/582874USPCT/US/2007/022171WO/2008/048645

Page 291: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009291

)2009.01 (G06F19821322/10/2007

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื”ืคืงืช ืžื”ื™ืจื•ืช ืจื•ื— ื‘ื˜ื•ืจื‘ื™ื ืช ืจื•ื— ืœื ืžื•ืคืขืœืช

METHOD AND SYSTEM FORDERIVING WIND SPEED IN A STALLCONTROLLED WIND TURBINESOUTH WEST WINDPOWER, INC

20/10/200660/853036USPCT/US/2007/022400WO/2008/097286

)2009.01 (H04B19821531/10/2007

ืฉื™ื˜ื” ื•ืžืชืงืŸ ืขื‘ื•ืจ ื—ื™ืคื•ืฉ ืชื ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช ืื•ืจืชื•ื’ื•ื ืœื™

METHOD AND APPARATUS FORCELL SEARCH IN AN ORTHOGONALWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED

01/11/200660/863965USPCT/US/2007/083265WO/2007/057898

)2009.01 (A61K19821603/10/2007

ื”ืžื•ื’ืœื•ื‘ื™ืŸ ื˜ื˜ืจืืžืจื™ ืžืฆื•ืœื‘ ืฉืขืžื™ื“ ืœื—ื ืงืŸ ื—ืžืฆื ื™

NITRIC OXIDE-BLOCKED CROSSLINKED TETRAMERIC HEMOGLOBIN

IKOR, INC.23/10/200660/853968US24/10/200611/586312US01/03/200711/713195US

PCT/US/2007/080337WO/2008/051689

Page 292: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 292

)2009.01 (H04L19821731/10/2007

ืžืชืงืŸ ื•ืฉื™ื˜ื” ืœื’ื™ืฉื” ืืงืจืื™ืช ืขื‘ื•ืจ ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

APPARATUS AND METHOD OFRANDOM ACCESS FOR WIRELESSCOMMUNICATIONQUALCOMM INCORPORATED

31/10/200660/855903USPCT/US/2007/083239WO/2008/055235

)2009.01 (G01J19821823/10/2007

ืกื•ืจืง ืคืก ื›ืคื•ืœ ืขื ื’ืœืื™ื ื ืจืื™ื ืœืขื™ืŸ ืื•ืœืLWIR ืžืฉื•ืœื‘ื™ื ืขื ื’ืœืื™SWIRื’ืœืื™

ืžืงื•ืจืจื™ื

DUAL BAND IMAGER EITH VISIBLEOR SWIR DETECTORS COMBINEDWITH UNCOOLED LWIR DETECTORS

RAYTHEON COMPANY24/10/200611/586323US

PCT/US/2007/022461WO/2008/127297

)2009.01 (H04L19821901/11/2007

SUB-BAND ืคืก ื ืชืžืšโ€“ื ื™ื”ื•ืœ ืžืฉืื‘ ืชืช DEPENDENT RESOURCEMANAGEMENTQUALCOMM INCORPORATED

01/11/200660/863889US06/11/200660/864579US

PCT/US/2007/083393WO/2008/057971

)2009.01 (A61K19822009/08/2004

ENTRAPPED ืชืื™ ื’ื–ืข ื›ืœื•ืื™ื ื•ืฉื™ืžื•ืฉื STEM CELLS AND USESTHEREOFTHE ROGOSIN INSTITUTE

04/09/200310/655275USPCT/US/2004/025713WO/2005/026320

Page 293: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009293

)2009.01 (H04L19822130/10/2007

ื‘ืงืจืช ืฉื™ื“ื•ืจ ืžืจื•ื‘ื‘ ื•ืžื™ื“ืข ืขื ืขื•ืฆืžืชFDMAโ€“SCืงื™ื–ื•ื– ืžืฉืชื ื” ื‘ืžืขืจื›ืช

MULTIPLEXING OF CONTROL ANDDATA WITH VARYING POWEROFFSETS IN A SC-FDMA SYSTEMQUALCOMM INCORPORATED

01/11/200660/863960USPCT/US/2007/082931WO/2008/057843

)2009.01 (H04B19822206/11/2007

)UPLINK(ื ื™ื”ื•ืœ ื”ื˜ืขื ืช ืขืจื•ืฅ ืชืžืกื•ืจืชืคืกโ€“ืชืœื•ื™ ืชืช

SUB-BAND DEPENDENT UPLINKLOAD MANAGEMENT

QUALCOMM INCORPORATED06/11/200660/864576US

PCT/US/2007/083840WO/2008/058162

)2009.01 (C07K19822325/10/2007

CRYSTALLINE ืืœืคื TNFโ€“hโ€“ื ื•ื’ื“ื ื™ื ื’ื‘ื™ืฉื™ื™ื ืฉืœ ืื ื˜ื™ ANTI-HTNFALPHAANTIBODIESABBOTT BIOTECHNOLOGY LTD.

27/10/200660/855104USPCT/US/2007/022622WO/2008/057240

)2009.01 (A01N19822419/10/2007

ืฆื•ืจื•ืช ืžืœื— ืฉืœ ืชืจื›ื•ื‘ื•ืช ื‘ื ื–ื•ืชื™ืื ื™ืœ ืžื•ืชืžืจื•ืช

SALT FORMS OF SUBSTITUTEDBENZOTHIENYL COMPOUNDS

JANSSEN PHARMACEUTICA, N.V.20/10/200660/853407US

PCT/US/2007/022370WO/2008/051489

Page 294: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 294

)2009.01 (A61K19822519/10/2007

ืงืคืกื•ืœื•ืช ืจื›ื•ืช ื”ืžื›ื™ืœื•ืช ืคืœื•ื ื•ืกื˜ืจื•ืŸื”ื™ื“ืจื•ื›ืœื•ืจื™ื“ ื‘ืขืœื•ืช ื™ืฆื™ื‘ื•ืช ื•ื–ืžื™ื ื•ืช

ื‘ื™ื•ืœื•ื’ื™ืช ืžืฉื•ืคืจื•ืช

SOFT CAPSULES COMPRISINGPALONOSETRON HYDROCHLORIDEHAVING IMPROVED STABILITY ANDBIOAVAILABILITYHELSINN HEALTHCARE S.A.

24/10/200660/854342USPCT/EP/2007/009098WO/2008/049552

)2009.01 (C07D19822623/10/2007

โ€“ื”ื™ื“ืจื•ืงืกื™โ€“5โ€“ืคื ื™ืœโ€“L[โ€“2ื ื’ื–ืจื•ืช ืฉืœโ€“ืžืชื™ืœโ€“ืืœืคื4

โ€“5โ€“ืื™ื ื“ื–ื•ืœ]F[ื”ืงืกืื”ื™ื“ืจื•ืฆื™ืงืœื•ืคื ื˜ื”ืฉืœ]ืื™ืœ ืืชื™ืœ ืคื ื™ืœ ื›ืœื™ื’ื ื“ื™ื

ืจืฆืคื˜ื•ืจ ืœื’ืœื•ืงื•ืงื•ืจื˜ื™ืงื•ืื™ื“

2-[L-PHENYL-5-HYDROXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES ASGLUCOCORTICOID RECEPTOR LIGANDS

MERCK & CO, INC.23/10/200660/853655US13/04/200760/923337US

PCT/US/2007/022449WO/2008/060391

)2009.01 (C07D19822726/10/2007

โ€“9[โ€“4ืฆื•ืจื•ืช ืžื•ืฆืงื•ืช ื”ืžื›ื™ืœื•ืชโ€“6,4,2(โ€“8โ€“)ืื™ืœโ€“3โ€“ืคื•ืจืืŸโ€“ื•ื˜ื˜ืจืื”ื™ื“ืจ(

โ€“2โ€“ืคื•ืจื™ืŸโ€“9Hโ€“)ืคื ื™ืœืืžื™ื ื•โ€“ื˜ืจื™ืคืœื•ืื•ืจื•ื”ืจื›ื‘ื™ื, ืื•ืœโ€“1โ€“ืฆื™ืงืœื•ื”ืงืกืŸโ€“]ืื™ืœืืžื™ื ื•

ืฉืœื”ืŸ ื•ืฉื™ืžื•ืฉ ืื™ืชืŸ

SOLID FORMS COMPRISING 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL, COMPOSITIONSTHEREOF, AND USE THEREWITHSIGNAL PHARMACEUTICALS, LLC

27/10/200660/854757USPCT/US/2007/022648WO/2008/057252

Page 295: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009295

)2009.01 (A47K19822820/04/2009

VENTILATOR ืงื•ืœื˜ ืจื™ื—ื•ืช ืœืืกืœื” SMELLS TO THETOILET

JOUL ื’ื•ืœ ืกืจื—ืืŸ SRHAN

)2009.01 (F24J19822920/04/2009

HEATING ื’ื•ืฃ ื—ื™ืžื•ื ื”ืคืจืฉื” ืœืงื•ืœื˜ ELEMEN SECRETION TOTHE SOLAR COLLECTOR

JOUL ื’ื•ืœ ืกืจื—ืืŸ SRHAN

)2009.01 (B41M19823016/11/2007

ืžืฉืžืขื™ ืœื—ื•ืžืจื™ื ื•ื“ื™ื•โ€“ืฉื™ื˜ื” ืœืกื™ืžื•ืŸ ื—ื“ ืœื‘ื™ืฆื•ืข ืื•ืชื” ื”ืคืขื•ืœื”

METHOD FOR THE UNIVOCALMARKING OF MATERIALS, AND INKFOR CARRYING OUT THE SAMECLAUDIO SELVA

16/11/2006BI2006A000010IT04/12/2006BI2006A000013IT21/02/2007BI2007A000002IT

PCT/IT/2007/000809WO/2008/059552

)2009.01 (C07D19823131/10/2007

1HSDืคื™ืจื™ื“ื™ืŸ ืงืจื‘ื•ืงืกืืžื™ื“ื™ื ื›ืžืขื›ื‘ื™?11

PYRIDINE CARBOXAMIDES AS11?HSD1 INHIBITORSASTRAZENECA AB

03/11/200660/864303US03/11/200660/864247US

PCT/GB/2007/004131WO/2008/053194

Page 296: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 296

)2009.01 (H04L19823206/11/2007

ืจืžืช ืขืจื‘ื•ืœ ืžื™ืœืช ืฆื•ืคืŸ ืขื‘ื•ืจ ืฉื™ื“ื•ืจMIMO

CODEWORD LEVEL SCRAMBLINGFOR MIMO TRANSMISSIONQUALCOMM INCORPORATED

06/11/200660/864582USPCT/US/2007/083730WO/2008/058109

)2009.01 (H04B19823306/11/2007

ื• ืื•/ืฉื™ื˜ื•ืช ื•ืžืชืงื ื™ื ืขื‘ื•ืจ ื”ืงืฆืืช ื›ื•ื—SIMO/MIMOื‘ื—ื™ืจืช ืฉื™ืขื•ืจ ืขื‘ื• ืคืขื•ืœื•ืช

ULืขื ืฉื™ืงื•ืœื™PAR

METHODS AND APPARATUS FORPOWER ALLOCATION AND/OR RATESELECTION FOR UL MIMO/SIMOOPERATIONS WITH PARCONSIDERATIONSQUALCOMM INCORPORATED

06/11/200660/864573USPCT/US/2007/083814WO/2008/058143

)2009.01 (H04B19823406/11/2007

ืขื ืฉื›ื‘ืช ืคืจืžื•ื˜ืฆื™ื”MIMOืฉื™ื“ื•ืจื ืœื—ื•ื˜ื™ืชื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช

MIMO TRANSMISSION WITH LAYERLAYER PERMUTATION IN AWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED

06/11/200660/864581USPCT/US/2007/083739WO/2008/058112

Page 297: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009297

)2009.01 (C07C19823601/11/2007

โ€“ื™ืœื“ื™ืคื™ืจื™ื“ื™ื ื™ืœ ื•ืืจ, ื ื’ื–ืจื•ืช ื“ื™ืืจื™ืœ ืคืจื™ื“ื™ื ื™ืœ ื•ืฉื™ืžื•ืฉื™ื ืฉืœื”ื

DIARYL, DIPYRIDINYL AND ARYL-PYRIDINYL DERIVATIVES AND USESTHEREOFPFIZER PRODUCTS INC.

13/11/200660/865479USPCT/IB/2007/003393WO/2008/059335

)2009.01 (H04Q19823707/05/2002

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื™ืฆื™ืจืช ืžื™ื“ืข ื‘ืงืจื” ืœืžืืจื– ื ืชื•ื ื™ื

METHOD AND APPARATUS FORGENERATING CONTROLINFORMATION FOR PACKET DATAQUALCOMM INCORPORATED

07/05/200160/289450US30/05/200160/294674US11/04/200210/121648US

PCT/US/2002/014530WO/2002/091767

)2009.01 (G01S19823806/11/2007

ืกื™ื“ื•ืจ ื•ืชืคืขื•ืœ ืžืขืจืš ืžืชืžืจ ืขื‘ื•ืจ ื™ื™ืฉื•ืžื™SODAR

TRANSDUCER ARRAYARRANGEMENT AND OPERATIONFOR SODAR APPLICATIONSSECOND WIND, INC.

06/11/200660/864429US01/06/200760/941302US05/11/200711/934915US

PCT/US/2007/083690WO/2008/108894

Page 298: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 298

)2009.01 (C07D19823906/11/2007

โ€“2โ€“ืคื™ืคืจื™ื“ื™ื ื™ืœโ€“8ื ื’ื–ืจื•ืช ืžื•ืชืžืจื•ืช ืฉืœโ€“6โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ]Aโ€“1,2[ืคื™ืจื™ืžื™ื“ื•โ€“ืคื™ืจื™ื“ื™ื ื™ืœ

ื• โ€“ืคื™ืจื™ืžื™ื“ื™ื ื™ืœโ€“2โ€“ืคื™ืคืจื™ื“ื™ื ื™ืœโ€“8โ€“ืื•ืŸ ืื•ืŸโ€“6โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ]Aโ€“1,2[ืคื™ืจื™ืžื™ื“ื•

SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO [1,2-A]PYRIMIDIN -6- ONE AND 8-PIPERIDINYL-2- PYRIMIDINYL [1,2-A] PYRIMIDIN -6- ONE DERIVATIVESSANOFI-AVENTIS

07/11/200606291725.7EPPCT/IB/2007/004272WO/2008/056266

)2009.01 (H04B19824010/11/2007

ืžืขืจื›ื•ืช ื•ืฉื™ื˜ื•ืช ืขื‘ื•ืจ ื’ื™ืœื•ื™ ื”ื ื•ื›ื—ื•ืช ืฉืœ ื•ื˜ื™ืื•ืช ืฉื™ื“ื•ืจ ื‘ืขืจื•ืฅ ืืœื—

SYSTEMS AND METHODS FORDETECTING THE PRESENCE OF ATRANSMISSION SIGNAL IN AWIRELESS CHANNELQUALCOMM INCORPORATED

10/11/200660/865348US06/11/200711/935911US

PCT/US/2007/084369WO/2008/061044

)2009.01 (C07D19824117/10/2007

ืชืจื›ื•ื‘ื•ืช ืคื™ืจืื–ื•ืœื™ืŸ ื›ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืœืงื•ืœื˜ืŸ ืœืžื™ื ืจืœื•ืงื•ืจื˜ื™ืงื•ืื™ื“

PYRAZOLINE COMPOUNDS ASMINERALOCORTICOID RECEPTORANTAGONISTSPFIZER PRODUCTS INC.

31/10/200660/863606USPCT/IB/2007/003207WO/2008/053300

Page 299: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009299

)2009.01 (A01N19824225/10/2007

HERBICIDAL ื›ื‘ื™ื ืงื•ื˜ืœื™ ืขืฉื‘ื™ืื”ืจ COMPOSITIONSSYNGENTA PARTICIPATIONS AG

27/10/20060621440.7GBPCT/EP/2007/009276WO/2008/049618

)2008.04 (C07D19824310/01/2003

โ€“3,2[ืคื™ืจื™ื“ื•โ€“)ื™ืœืžื™ื ื•โ€“2โ€“ืคื™ืจื™ื“ื™ืŸ(โ€“2D[ืื•ื ื™ืโ€“7โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ

2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONES

WARNER-LAMBERT COMPANY LLC22/01/200260/350877US

PCT/IB/2003/000059WO/2003/062236

)2009.01 (C07D19824423/10/2007

PYRIDAZINE ืชื•ืœื“ื•ืช ืคื™ืจื™ื“ื–ื™ืŸ DERIVATIVESSYNGENTA PARTICIPATIONS AG

25/10/200606022285.8EPPCT/EP/2007/009189WO/2008/049585

)2009.01 (C09D19824525/10/2007

ื‘ื™ื’ื•ื“ ืื•ืคื ื” ื•ืคืจื™ื˜ื™ื ืื—ืจื™ื ื‘ืขื™ืฆื•ื‘ ืขืฆืžื™

SELF DESIGNED FASHION WEARAND OTHER ARTICLES

MY DESIGN LTD25/10/200660/862775US05/11/200660/864402US

PCT/IL/2007/001292WO/2008/050338

Page 300: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 300

)2009.01 (C07D19824722/10/2007

ืชื•ืœื“ื•ืช ืื™ื ื“ืื–ื•ืœ ื”ืžืฉืžืฉื•ืช ื›ืžืขื›ื‘ื™1CPTโ€“L

INDAZOLE DERIVATIVES USEFULAS L-CPT1 INHIBITORS

F. HOFFMANN-LA ROCHE AG01/11/200606123321.9EP

PCT/EP/2007/061251WO/2008/052898

)2009.01 (C07D19824808/11/2007

ื•ืชื›ืฉื™ืจื™ืCืžื“ื›ืื™ ื•ื™ืจื•ืก ื”ืคื˜ื™ื˜ื•ืก ื”ืžื›ื™ืœื™ื ืื•ืชื

HEPATITIS C VIRUS INHIBITORSAND COMPOSITIONS COMPRISINGTHE SAMEBRISTOL-MYERS SQUIBB COMPANY

09/11/200660/865034US05/11/200711/934840US

PCT/US/2007/084012WO/2008/060927

)2009.01 (A61K19824907/11/2007

ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืื’ื•ื ื™ืกื˜ ืื•ืคื™ื•ื™ื“ ื•ืื ื˜ืื’ื•ื ื™ืกื˜ ืื•ืคื™ื•ื™ื“

COMPOSITIONS COMPRISING ANOPIOID AGONIST AND AN OPIOIDANTAGONISTNEKTAR THERAPEUTICS AL,CORPORATION

07/11/200660/857610USPCT/US/2007/023534WO/2008/057579

Page 301: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009301

)2009.01 (C07D19825008/11/2007

โ€“ื“ื™ืžื™ื˜ื•ืงืกื™โ€“10,9โ€“ืื™ื–ื•ื‘ื•ื˜ื™ืœโ€“3ืชืจื›ื•ื‘ื•ืช11,7,6,4,3,1Bโ€“ื”ืงืกื”ื™ื“ืจื•โ€“H2โ€“1,2[ืคื™ืจื™ื“ื•โ€“

A[ืชื›ืฉื™ืจื™ื, ืื•ืœ ืžื•ืชืžืจื•ืชโ€“2โ€“ืื™ื–ื•ื›ื™ื ื•ืœื™ืŸ ื•ื ื™ืฆื•ืœืŸ, ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-OL COMPOUNDS,COMPOSITIONS COMPRISING THE

SAME AND USES THEREOFNEUROCRINE BIOSCIENCES, INC.

08/11/200660/864944USPCT/US/2007/084176WO/2008/058261

)2009.01 (C12N19825106/11/2007

ืคืกืื•ื“ื•ืžื•ื ืก ืจื•ื“ื™ืกื™ื ื”ื ื™ืชืŸ ืœื•ื™ืกื•ืช ืžื—ืœื•ืช ืฆืžื—ื™ื

PSEUDOMONAS RHODESIAECAPABLE OF CONTROLLING PLANTDISEASESNIPPON SODA COMPANY LTD.

08/11/20062006-302263

JP

PCT/JP/2007/071531WO/2008/056653

)2009.01 (C04B19825217/12/2007

ืชื”ืœื™ืš ื˜ื™ืคื•ืœ ื‘ืงืœืฆื™ื•ื ืกื•ืœืคืื˜ ื”ืžื™ื”ื™ื“ืจืื˜

CALCIUM SULFATE HEMIHYDRATETREATMENT PROCESS

THE NUGYP CORP.20/12/200660/871039US

PCT/CA/2007/002300WO/2008/074137

Page 302: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 302

)2009.01 (G06F19825320/11/2007

ื™ืฆื™ืจืช ืžื™ื“ืข ื‘ืื—ืกื•ืŸ ืžื™ื“ืข ืชื•ืš ืฉื™ืžื•ืฉ ื‘ืื•ื ืชื•ืœื•ื’ื™ื” ื“ื™ื ืืžื™ืช

CREATING DATA IN A DATA STOREUSING A DYNAMIC ONTOLOGY

PALANTIR TECHNOLOGIES, INC.20/11/200611/602626US

PCT/US/2007/085202WO/2008/064207

)2009.01 (C07D19825422/10/2007

MAPK/ERKMAPK/ERKืžืขื›ื‘ื™ ืงื™ื ืื– KINASE INHIBITORSTAKEDA PHARMACEUTICALCOMPANY LIMITED

23/10/200660/862569USPCT/US/2007/082138WO/2008/140553

)2009.01 (G01N19825514/09/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื™ื™ืฆื•ืจ ืื ืœื™ื˜ื™ื ืฉืœ ื’ื–ื• ืื• ืฉืœื™ืœื™ืช ืขื‘ื•ืจ ืื ืœื™ื–ืช/ืžื™ื•ื ืŸ ื—ื™ื•ื‘ื™ืช

ื’ื–

METHOD AND DEVICE FORPRODUCING POSITIVELY AND/ORNEGATIVELY IONIZED GAS ANALYTESFOR GAS ANALYSISGESELLSCHAFT ZUR FORDERUNG DERANALYTISCHEN WISSENSCHAFTENE.V.

25/10/2006102006050136.5DEPCT/EP/2007/007999WO/2008/049488

)2009.01 (C07F19825609/06/2006

ืชื”ืœื™ืš ืœื”ื›ื ืช ืื•ืงืกื–ืื‘ื•ืจื•ืœื™ื“ื™ื ื™ื ืื•ืจื’ื ื™ื™ื

PROCESS FOR SYNTHESIS OFORGANO OXAZABOROLOLDINES

BASF SE13/06/200560/690113US

PCT/EP/2006/063044WO/2006/134074

Page 303: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009303

)2009.01 (G10K19825725/10/2007

ืฉื™ื˜ื” ืœื™ืฆื•ืจ ื’ืœื™ื ืžื›ืื ื™ื™ื ื‘ืืžืฆืขื•ืช ื™ืฆื™ืจืช ื›ื•ื— ืงืจื™ื ื” ืืงื•ืกื˜ื™ืช ืžืžืฉืงื™ืช

METHOD FOR GENERATINGMECHANICAL WAVES BYCREATING AN INTERFACIALACOUSTIC RADIATION FORCESUPER SONIC IMAGINE

25/10/20060654502FR03/01/200760/883233US

PCT/FR/2007/052247WO/2008/050072

)2009.01 (C07F19825805/11/2007

DIALKYLBORANE ืงื•ืžืคืœืงืกื™ื ืฉืœ ื“ื™ืืœืงื™ืœื‘ื•ืจืืŸ ืืžื™ืŸ AMINECOMPLEXESBASF SE

09/11/200660/865100USPCT/EP/2007/061859WO/2008/055859

)2009.01 (C07D19825905/11/2007

ืชื”ืœื™ืš ืขื‘ื•ืจ ืกื•ืœืคื™ื ื™ืœืืฆื™ื” ืฉืœ ื ื’ื–ืจืช ืคื™ืจืื–ื•ืœ

PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE

BASF SE10/11/200660/865178US24/04/200760/913617US

PCT/EP/2007/061891WO/2008/055877

)2009.01 (C07D19826005/11/2007

ืชื”ืœื™ืš ืขื‘ื•ืจ ืกื•ืœืคื™ื ื™ืœืืฆื™ื” ืฉืœ ื ื’ื–ืจืช ืคื™ืจืื–ื•ืœ

PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE

BASF SE10/11/200660/865178US24/04/200760/913638US

PCT/EP/2007/061893WO/2008/055879

Page 304: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 304

)2009.01 (C07D19826105/11/2007

ืชื”ืœื™ืš ืขื‘ื•ืจ ืกื•ืœืคื™ื ื™ืœืืฆื™ื” ืฉืœ ื ื’ื–ืจืช ืคื™ืจืื–ื•ืœ

PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE

BASF SE10/11/200660/865178US24/04/200760/913646US

PCT/EP/2007/061894WO/2008/055880

)2009.01 (A01N19826205/11/2007

CRYSTALLINE ืฉื™ื ื•ื™ ื’ื‘ื™ืฉื™ ืฉืœ ืคื™ืคืจื•ื ื™ืœ MODIFICATION OFFIPRONILBASF SE

10/11/200606023438.2EPPCT/EP/2007/061895WO/2008/055881

)2009.01 (C07D19826330/10/2006

ื”ื™ื“ืจื•ืงืกืžืื˜ื™ื ื›ืžืขื›ื‘ื™ ื”ื™ืกื˜ื•ืŸ ื“ืืฆื˜ื™ืœืื–

HYDROXAMATES AS INHIBITORS OFHISTONE DEACETYLASE

CHROMA THERAPEUTICS LTD.

PCT/GB/2006/004034WO/2008/053131

)2009.01 (A01N19826405/11/2007

CRYSTALLINE ืฉื™ื ื•ื™ ื’ื‘ื™ืฉื™ ืฉืœ ืคื™ืคืจื•ื ื™ืœ MODIFICATION OFFIPRONILBASF SE

10/11/200606023437.4EPPCT/EP/2007/061896WO/2008/055882

Page 305: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009305

)2009.01 (A01N19826505/11/2007

CRYSTALLINE ืฉื™ื ื•ื™ ื’ื‘ื™ืฉื™ ืฉืœ ืคื™ืคืจื•ื ื™ืœ MODIFICATION OFFIPRONILBASF SE

10/11/200606023436.6EPPCT/EP/2007/061897WO/2008/055883

)2009.01 (A01N19826605/11/2007

CRYSTALLINE ืฉื™ื ื•ื™ ื’ื‘ื™ืฉื™ ืฉืœ ืคื™ืคืจื•ื ื™ืœ MODIFICATION OFFIPRONILBASF SE

10/11/200606023435.8EPPCT/EP/2007/061898WO/2008/055884

)2009.01 (C07D19826729/10/2007

ืชืจืื•ื ื™ืŸ ืคืจื•ื˜ืื™ืŸโ€“ืกืจื™ืŸ?โ€“IKKืžืขื›ื‘ื™ ืงื™ื ืื–

IKK-? SERINE-THREONINE PROTEINKINASE INHIBITORS

CHROMA THERAPEUTICS LTD.01/11/20060621720.2GB09/08/20070715470.1GB

PCT/GB/2007/004114WO/2008/053182

)2009.01 (C23C19826812/10/2007

METHOD ืฉื™ื˜ื” ืœืฆื™ืคื•ื™ ืžืฆืข ื•ืชื•ืฆืจ ืžืฆื•ืคื” FOR COATING ASUBSTRATE AND COATED PRODUCTH. C. STARCK GMBH

07/11/200660/864729USPCT/US/2007/081200WO/2008/057710

Page 306: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 306

)2009.01 (G01N19826907/11/2007

ืฉื™ื˜ื” ืœื˜ื™ื”ื•ืจ ืฉืœ ืœืคื—ื•ืช ื—ื•ืžืจ ืžื˜ืจื” ืื—ื“ ืืฉืจ ื™ืฉ ืœื–ื”ื•ืชื•

METHOD FOR THE PURIFICATION OFAT LEAST ONE TARGET SUBSTANCETHAT IS TO BE IDENTIFIEDJOCHEN PETER

08/11/2006102006052923.5DE21/12/2006102006060717.1DE

PCT/EP/2007/009648WO/2008/055671

)2009.01 (C07D19827009/11/2007

โ€“3,2[ืฉื™ื˜ื•ืช ืœื”ื›ื ืช ื”ืงืกืื”ื™ื“ืจื•ืคื•ืจื•B[ืื•ืœโ€“3โ€“ืคื•ืจืืŸ

METHODS FOR THE PREPARATIONOF HEXAHYDROFURO[2,3-B]FURAN-3-OLTIBOTEC PHARMACEUTICALS LTD.

09/11/200606123752.5EPPCT/EP/2007/062119WO/2008/055970

)2009.01 (C07K19827108/11/2007

ืžืฉืชื ื™ื ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื’ื•ืจื ื’ื™ื“ื•ืœBETAโ€“9ืžืชืžื™ืจ

VARIANTS AND METHODS OFUSING TRANSFORMING GROWTHFACTOR BETA-9ZYMOGENETICS INC.

08/11/200660/864873USPCT/US/2007/084145WO/2008/058251

Page 307: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009307

)2009.01 (A43B19827220/11/2007

ืกื•ืœื™ื” ืœื ืขืœื™ื™ื ื”ืขืžื™ื“ื” ืœืžื™ื ื•ื—ื“ื™ืจื”ื ืขืœื™ื™ื ื”ืžืฉืชืžืฉื•ืช, ืœืื“ื™ ืžื™ื

ื‘ืกื•ืœื™ื” ื–ื• ื•ืฉื™ื˜ื” ืœื™ืฆื•ืจ ืกื•ืœื™ื” ื•ื ืขืœื™ื™ื ืืœื•

VAPOR-PERMEABLE WATERPROOFSOLE FOR SHOES, SHOE WHICH USESSAID SOLE, AND METHOD FORMANUFACTURING SAID SOLE ANDSAID SHOEGEOX S.P.A.

23/11/2006PD2006A000437ITPCT/EP/2007/010045WO/2008/061710

)2009.01 (A01N19827305/12/2007

โ€“3,2ืชื•ืœื“ื•ืช ืžื•ืชืžืจื•ืช ืฉืœืงื•ื•ื™ื ืื–ื•ืœื™ืŸ]Cโ€“2,1[ื“ืื–ื• ื“ื™ื”ื™ื“ืจื•ืื™ืžื™

ื”ื™ืขื™ืœื™ื ืœื˜ื™ืคื•ืœ ื‘ืื™ ืกื“ืจื™ื ื”ื ื•ื‘ืขื™ื ืขืโ€“ืžืฉื’ืฉื•ื’ ื™ืชืจ ื•ืžื—ืœื•ืช ื”ืงืฉื•ืจื•ืช

ื”ืชืคืชื—ื•ืช ื›ืœื™ ื“ื ื—ื“ืฉื™ื

SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVESUSEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS ANDDISEASES ASSOCIATED WITHANGIOGENESISBAYER SCHERING PHARMA AG

05/12/200660/873090USPCT/US/2007/024985WO/2008/070150

)2009.01 (C07D19827431/10/2007

ืชื”ืœื™ืš ืœื”ื›ื ืช ื—ื•ืžืฆื•ืช ืืœื“ื•ื ื™ื•ืช ื•ืชื•ืœื“ื•ืชื™ื”ืŸ

PROCESS OF PREPARATION OFALDONIC ACIDS AND DERIVATIVESTHEROFC.B. FLEET COMPANY,INCORPORATED VIRGINIACORPORATION,

31/10/20060621669.1GBPCT/GB/2007/004149WO/2008/053206

Page 308: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 308

)2009.01 (A47D19827521/04/2009

BED ืžื™ื˜ื” ื‘ืขืœืช ื—ืœืง ืขืœื™ื•ืŸ ืžืชืจื•ืžื WITH RAISABLE PORTIONKACTELืž"ืงืกื˜ืœ ื‘ื•ืจื•ื›ื•ื‘ ื”ื—ื–ืงื•ืช ื‘ืข BOROCHOV HOLDINGS LTD

)2009.01 (G06F19827621/04/2009

A ืขืจื›ื” ืœืžื ื™ืขืช ืฉื›ื—ืช ื™ืœื“ื™ื ื‘ืจื›ื‘ KIT TO PREVEN FORGETTING ACHILD IN A CAR

YAMIT ืขื™ื“ืŸ ื ื—ืžื ื™ ATTIAS

)2009.01 (B65D19827719/10/2007

ืžื›ืกื” ืœืžื™ื›ืœ ื”ืžื™ื•ืขื“ ื‘ืขื™ืงืจ ืœืžืฉืงืื•ืชAN END CLOSURE OF A CONTAINERPRIMARILY INTENDED FORBEVERAGESINVENTO SP. Z O.O.

23/10/2006P-380896PLPCT/PL/2007/000070WO/2008/051099

)2009.01 (G01S19827922/11/2007

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื’ื™ืœื•ื™ ืื•ื‘ื™ื™ืงื˜ ื”ื™ื›ื•ืœ ืœื”ื—ื–ื™ืจ ืื•ืจ ื‘ืื•ืคืŸ ืจื˜ืจื•

METHOD AND DEVICE FORDETECTING AN OBJECT THAT CANRETROREFLECT LIGHTCOMPAGNIE INDUSTRIELLE DESLASERS CILAS

28/11/200606/10392FRPCT/FR/2007/001919WO/2008/071866

Page 309: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009309

)2009.01 (F41G19828015/11/2007

AIMING ืžืขืจื›ืช ื”ื›ื•ื•ื ื” ืขื ืžื“ื“ ืกื˜ื™ื™ื” ืžื›ื•ืœืœ SYSTEM WITH INTEGRATEDDEVIATION METERMBDA FRANCE

21/11/200606/10165FRPCT/FR/2007/001876WO/2008/062114

)2009.01 (G06F19828121/04/2009

ื—ื™ื” ื•ื™ืจื˜ื•ืืœื™ืช ื”ืฉื•ื›ื ืช ื‘ื”ืชืงืŸ ื–ื™ื›ืจื•ืŸ ื ื™ื™ื“

AN EXTERNAL-MEMORY DEVICERESIDENT VITUAL ANIMAL

NOAM ื ืขื ื”ื“ืก HADAS

)2009.01 (F03B19828221/04/2009

ืœ ื”ืคืงืช ืื ืจื’ื™ื™ืช ื—ืฉืžืœ ื‘ืืžืฆืขื•ืช ืžืชืงืŸ ืžื™ืžื™ื™ืโ€“ื ื™ืฆื•ืœ ื–ืจืžื™ื ืชืช

A DEVICE FOR OBTAININGELECTRIC ENERGY USINGUNDERWATER CURRENTS

VLADIMIR ื•ืœื“ื™ืžื™ืจ ืกื—ืจื•ื‘ SAKHAROV

Page 310: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 310

-ื–"ืœื—ื•ืง ื”ืคื˜ื ื˜ื™ื ืชืฉื›26ื”ื•ื“ืขื” ืœืคื™ ืกืขื™ืฃ1976

NOTICE UNDER SECTION 26 OF THEPATENTS LAW, 5727-1967

ื”ื‘ืงืฉื•ืช ืฉืคืจื˜ื™ื”ืŸ ืžืชืคืจืกืžื™ื ืœื”ืœืŸ ืงื•ื‘ืœื•ื›ืœ ื”ืžืขื•ื ื™ืŸ. ืœื—ื•ืง ื”ืคื˜ื ื˜ื™ื17ืœืคื™ ืกืขื™ืฃ

ืœื”ืชื ื’ื“ ืœืžืชืŸ ืคื˜ื ื˜ ืขืœ ืคื™ ื‘ืงืฉื” ืžื”ื‘ืงืฉื•ืช ืชื•ืš ืฉืœื•ืฉื” ื—ื“ืฉื™ื, ื”ืžืชืคืจืกืžื•ืช ืจืฉืื™

ืœื”ื’ื™ืฉ ืœืจืฉื ื”ืคื˜ื ื˜ื™ื, ืžืชืืจื™ืš ื™ื•ืžืŸ ื–ื”ืœื—ื•ืง ื”ืคื˜ื ื˜ื™ื30ื”ื•ื“ืขืช ื”ืชื ื’ื“ื•ืช ืœืคื™ ืกืขื™ืฃ

ืœืชืงื ื•ืช ื•ืื™ืœืš57ื‘ื“ืจืš ื”ืงื‘ื•ืขื” ื‘ืชืงื ื” .1968โ€“ื—"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968

ืคืจื˜ื™ ื”ื‘ืงืฉื•ืช ื‘ืžื™ื“ื” ื•ื™ื™ืฉื™ืžื™ื ืžื•ื‘ืื™ื ืœืคื™ื–ื”ืก :ื“ืจ

Particulars of the applications, whereapplicable, are given in the following order:

[11] ืžืกืคืจ ื”ื‘ืงืฉื” [21] Number of application[54] ืฉื ื”ืืžืฆืื” Title of invention

[22] ืชืืจื™ืš ื”ื‘ืงืฉื” Application dateืžื“ื™ื ืชโ€“ืžืกืคืจ ื•ืชืืจื™ืš ืฉืœ ื‘ืงืฉื•ืช ื”ื—ื•ืฅ

ื”ืื’ื•ื“[31] [32] [33] Number and date of foreignapplication โ€“ convention country.

[51]* ืžื”ื“ื•ืจื” ืฉื‘ื™ืขื™ืชโ€“ืกื™ื•ื•ื’ ื‘ื™ื ืœืื•ืžื™* Int.Cl.[61] ื‘ืงืฉื” ืœืคื˜ื ื˜ ืžื•ืกืฃ Application for patent of addition

[62] ื‘ืงืฉืช ื—ืœื•ืงื” Divisional application[71] ื”ืžื‘ืงืฉ Applicant[72] ื”ืžืžืฆื™ื Inventor

[87] ืคืจืกื•ื ืฉืœ ื‘ืงืฉื” ื”ื‘ื™ื ืœืื•ืžื™ืช' ืžืก International Publication Number[74] ืžืขืŸ ืœืžืกื™ืจืช ืžืกืžื›ื™ื Address for service

[57])ื‘ืฉืคื” ื‘ื” ืขืจื•ืš ื”ืคื™ืจื•ื˜(ืชืงืฆื™ืจ ื”ืืžืฆืื” Abridgement of invention (in thelanguage in which the specification is drawnup)

ืžืกื”ื—ืœ ืžื™ื•ืž: ื”ืขืจื”* 'ืŸ ื”ืคื˜ื ื˜ื™ื ื•ื”ืžื“ื’ืžื™ืื ื™ืชืŸ ืฆื™ื•ืŸ ืœื‘ืงืฉื•ืช ืคื˜ื ื˜ื™ื ื”ืกื™ื•ื•ื’ ืœืคื™ 1/06

ื”ืžื”ื“ื•ืจื” ื”ืฉืžื™ื ื™ืช ืฉืœ ื”ืกื™ื•ื•ื’ ื”ื‘ื™ื ืœืื•ืžื™ )2006ืžืฉื ื”(ืฉืœ ืคื˜ื ื˜ื™ื

*Note: As from Patents and Designs JournalNo.1/06, patent applications are classifiedaccording to the Eighth Edition of theInternational Patent Classification (2006)

Page 311: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009311

124636]21][11[

ื•ืงื˜ื•ืจื™ื ื ื’ื–ืจื™ื ืžื ื’ื™ืฃ ืฉืฉื›ืคื•ืœื ืžื•ืชื ื” ื•ืฉื™ืžื•ืฉื

CONDITIONALLY REPLICATINGVIRAL VECTORS AND THEIRUSE

]54[

27.11.1996]22[US]33[28.11.1995]32[08/563459]31[

Int. Cl.(2008.04) A61K 48/00, C12N 15/11, 15/40, 15/48, 15/63, 15/69, 15/86, 5/10]51[THE JOHNS HOPKINS UNIVERSITYSCHOOL OF MEDICINE, U.S.A.

]71[

WO/1997/020060]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The present invention provides a conditionally replicating viral vector, methods ofmaking, modifying, propagating and selectively packaging, and using such a vector,isolated molecules of specified nucleotide and amino acid sequences relevant to suchvectors, a pharmaceutical composition and a host cell comprising such a vector, theuse of such a host cell to screen drugs. The methods include the prophylactic andtherapeutic treatment of viral infection, in particular HIV infection, and, thus, are alsodirected to viral vaccines and the treatment of cancer, in particular cancer of viraletiology. Other methods include the use of such conditionally replicating viral vectors ingene therapy and other applications.

]57[

__________

Page 312: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 312

126626]21][11[

ืคืคื˜ื™ื“ื™ื ื—ื“ืฉื™ื ื”ืžืขื›ื‘ื™ื ื’ื“ื™ืœืช ื›ืœื™ืคื•ืœื™ื ื•ืงืœื™ืื•ื˜ื™ื“ื™ื ื”ืžืงื“ื“ื™ื ืื•ืชื, ื“ื

ื•ืฉื™ื˜ื•ืช ืœืขื™ื›ื•ื‘ ื’ื“ื™ืœืช ื›ืœื™ ื“ื

NOVEL ANTIANGIOGENICPEPTIDES, POLYNUCLEOTIDESENCODING SAME ANDMETHODS FOR INHIBITINGANGIOGENESIS

]54[

05.05.1997]22[US]33[03.05.1996]32[08/643219]31[US03.04.1997 08/832087

Int. Cl.(2009.01) A61K 38//43, 48//00, A61P 19//02, 27//02, 35//00, C07K 14//47,14//515, 19//00, C12N 09//68, 15//57, C12P 21//06

]51[

ABBOTT LABORATORIES, U.S.A.THE CHILDREN'S MEDICALCENTER CORPORATION, U.S.A.

]71[

WO/1997/041824]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

Mammalian kringle (5) fragments of plasminogen and kringle (5) fusion proteins aredisclosed as compounds for treating angiogenic diseases. Methods and compositionsfor inhibiting angiogenic diseases are also disclosed.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

195827,The applications for divisionfrom this application havenot yet been published

__________

Page 313: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009313

126728]21][11[

ื ื’ื–ืจื•ืช ืืชื™ืœืŸ ื•ืชื›ืฉื™ืจื™ื ืื’ืจื•ื›ื™ืžื™ื™ืื”ืžื›ื™ืœื™ื ืืช ื”ื ื’ื–ืจื•ืช ื”ืืžื•ืจื•ืช ื›ืžืจื›ื™ื‘

ืคืขื™ืœ

ETHYLENE DERIVATIVES ANDAGROCHEMICALCOMPOSITIONS CONTAININGSAID DERIVATIVES AS ANACTIVE INGREDIENT

]54[

24.04.1997]22[JP]33[25.04.1996]32[8-104878]31[JP07.06.1996 8-145802 JP20.06.19968-159346JP13.02.19979-28916

Int. Cl.(2008.04) A01N 43/56, 43/78, C07D 207/30, 215/12, 217/12, 231/06, 231/10,231/56, 233/54, 233/70, 233/72, 235/06, 237/08, 237/14, 237/28, 237/30, 239/26,239/72, 241/10, 241/40, 249/04, 251/14, 2530/65, 257/04, 257/08, 261/04, 261/06,263/08, 263/30, 263/54, 271/06, 271/10, 275/02, 277/08, 277/30, 277/64, 285/06,285/08, 285/12, 307/10, 333/06, 401/06, 401/14, 403/06, 403/14, 405/06, 409/06,409/14, 413/06, 413/14, 417/06, 417/14, 521/00, C07F 7/08, 9/28

]51[

NISSAN CHEMICAL INDUSTRIESLTD., JAPAN

]71[

WO/1997/040009]87[',ื”ื•ืจื•ื‘ื™ืฅ ื•ืฉื•ืช.ืฉ

ืชืœ, 41-45ืฉื“ืจื•ืช ืจื•ื˜ืฉื™ืœื“, ื‘ื™ืช ืฆื™ื•ืŸ ืื‘ื™ื‘

S. HOROWITZ & CO.,ZION HOUSE,

41-45 ROTHSCHILD BLVD.,TEL AVIV 65784

]74[

Ethylene derivatives of general formula (I) and pesticides or aquatics adhesioninhibitors characterized by containing at least one of the derivatives, wherein Q isoptionally substituted phenyl or a hetero-cyclic group (particularly, 4-thiazolyl, 1- or 3-pyrazolyl, 1,3-oxazol-4-yl, phenyl or pyridyl); E is cyano or the like; A is 4-pyrrazolyl,thiazolyl or the like; and B is alkylcarbonyl or the like.

]57[

__________

Page 314: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 314

129966]21][11[

ื’ื•ืคื™ืคื™ื ืขื•ื‘ืจื™ื™ื ืฉืžืงื•ืจื ื‘ืชืื™ ืžืงื•ืจ ืขื•ื‘ืจื™ื™ื ืฉืœ ืื“ื

ISOLATED HUMAN EMBRYOIDBODIES (HEB) DERIVED FROMHUMAN EMBRYONIC STEMCELLS

]54[

14.05.1999]22[Int. Cl.(2008.04) A61K 35/54, 48/00, C12N 5/08]51[

ื—ื™ืคื”,ืž"ืžื•ืกื“ ื”ื˜ื›ื ื™ื•ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืขืชื•ื— ื”ืžื—ืงืจ ืฉืœ ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™

,ืž"ื”ืื•ื ื™ื‘ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ื ื‘ืข ื™ืจื•ืฉืœื™ื

TECHNION RESEARCH ANDDEVELOPMENT FOUNDATIONLTD.YISSUM RESEARCHDEVELOPMENT COMPANY OFTHE HEBREW UNIVERSITY OFJERUSALEM LTD

]71[

NISSIM ืืœื“ื•ืจ-ื™ื•ืกืฃ ืื™ืฆืงื•ื‘ื™ืฅ, ื ืกื™ื ื‘ื ื‘ื ื™ืกื˜ื™ BENVENISTY, JOSEPHITSKOVITZ-ELDOR

]72[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

An isolated human embryoid body (hEB) derived from human embryonic stem cells andcontaining mesoderm, ectroderm and endoderm cell lineages.

]57[

__________

131197]21][11[

APPARATUS ื”ืชืงืŸ ืœื˜ื™ืคื•ืœื™ื ื‘ืขืžื•ื“ ื”ืฉื“ืจื” FOR SPINALPROCEDURES

]54[

01.08.1999]22[Int. Cl.(2009.01) A61B 17//00]51[KYPHON SARL, SWITZERLAND]71[

ASSAF ืืกืฃ ื“ืงืœ DEKEL]72[,ืž"ื‘ืข) 1995(ืืจืœื™ืš.ืื™.ื™'ื’

,11ืจื—ื•ื‘ ืžื ื—ื ื‘ื’ื™ืŸ,15ืงื•ืžื”, ืžื’ื“ืœ ืื™ืœื•ืŸ ืจืžืช ื’ืŸ

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

Apparatus configured for entering the spine of a body of a live human patient throughseparate first and second incisions, made in the patient adjacent to different vertebraein the spine, to remove material from the spine, the apparatus comprising: a handle(210), first (208) and second (200) elongate extensions, attached to said handle, long

]57[

Page 315: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009315

enough to extend, simultaneously, from the handle respectively through the first andsecond incisions to separate first and second locations along the length of the spine;and a flexible rasp (202) configured to pass along the first extension into the bodythrough the first incision and up to the first location on the spine, through a spinalchannel from the first location to the second location, and from the second locationalong the second extension out of the body through the second incision.

__________

132251]21][11[

ื‘ืขืœื™ ื”ื—ืœืคื•ืชNGFื•ืจื™ืื ื˜ื™ื ืฉืœืœ trkCโ€“ื—ื•ืžืฆื•ืช ืืžื™ื ื• ื”ืžืงื ื•ืช ืงืฉื•ืจ

NGF VARIANTS HAVING AMINOACID SUBSTITUTIONS THATIMPART TRKC BINDING

]54[

23.04.1998]22[US]33[25.04.1997]32[08/845541]31[US29.04.1997 08/841045

Int. Cl.(2009.01) A61K 38//18, C07K 14//48, C12N 15//12, 15//85]51[GENENTECH, INC., U.S.A.]71[WO/1998/049308]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

NGF variants which have trkC-binding activity and trkC-signal inducing activity areprovided. The variants optionally have trkA or trkB binding and signal induction activity.The NGF variants of the present invention are useful in the treatment of neuronaldisorders. Nucleic acids and expression vectors encoding the NGF variantneurotrophins are also provided.

]57[

__________

Page 316: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 316

136219]21][11[

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื ื™ื”ื•ืœ ื—ืฉื‘ื•ื ื•ืช ื•ื—ื™ื•ื‘ื™ื ื‘ืจืฉืช

NETWORK ACCOUNTING ANDBILLING SYSTEM AND METHOD

]54[

20.10.1998]22[US]33[20.11.1997]32[60/066898]31[US19.11.1998 60/109095

Int. Cl.(2008.04) G06F 13/00, H04L 12/24, H04M 15/00]51[XACCT TECHNOLOGIES, INC.,U.S.A.

]71[

WO/1999/027556]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

In some embodiments, network traffic information is captured at network informationsources. These sources provide detailed information about the networkcommunications transactions at a network device. Importantly, different types ofsources can provide different types of information. Gatherer devices gather the detailedinformation from the various information source devices and convert the informationinto standardized information. The gatherer devices can correlate the gatheredinformation with account information for network transaction accounting. Managerdevices manage the gatherer devices and store the gathered standardized information.The manager devices eliminate duplicate network information that may exist in thestandardized information. The manager devices also consolidate the information.Importantly, the information stored by the manager devices represents theconsolidated, account correlated, network transaction information that can be used forbilling or network accounting. The system thereby provides a distributed networkaccounting and billing system.

]57[

__________

137462]21][11[

AIR ื›ื•ื ืก ืื•ื™ืจ INTAKE]54[

24.07.2000]22[Int. Cl.(2009.01) F28F 03//12, 09//22, 13//08]51[

OREN ืื•ืจืŸ ืืœื•ืก ALOUCE]71[,ืื•ืจืŸ ืืœื•ืก

ื˜ื™ืจืช ื”ื›ืจืžืœ 5/2ื”ืืœื”' ืจื—OREN ALOUCE,6/2 ELLA ST. TIRAT HACARMEL

]74[

ืฉืœ,ืŸ ื‘ื—ืœื•ืŸ ืื• ื‘ืงื“ืžืช ืžืื•ื•ืจืจืœื•ื— ื”ืžื™ื•ืขื“ ืœืงื™ืจื•ืจ ืฉืœ ื—ืœืœื™ื ื”ืžื•ืชืง]57[ ื›ืืฉืจ ื”ืœื•ื— ื‘ืขืœ ืžืกืคืจ ืจื‘ื›ืœ, ื—ื•ืจื™ื ื”ื™ื•ืฆืจื™ื ื‘ืขื•ื‘ื™ ื”ืœื•ื— ืฆื™ื ื•ืจื•ืช ืฉื”ืงื•ื˜ืจ ืฉืœื”ื ื”ื•ืœืš ื•ืงื˜ืŸ ืžืคืชื— ื”ืฆื™ื ื•ืจ ืœื™ืฆื™ืืช ื”ืฆื™ื ื•ืจ ื›ืืฉืจ

ืฆื™ื ื•ืจ ืžื•ืจื›ื‘ ืžืžืกืคืจ ืฉืจื•ื•ืœื™ื ื”ืžื—ื•ื‘ืจื™ื ื‘ื ื™ื”ื ื›ืš ืฉื”ืื•ื•ื™ืจ ื”ื–ื•ืจื ื‘ืชื•ื›ื ืžืฉื ื” ืืช ืžืกืœื•ืœื• ื‘ื–ื•ื™ืช ืฉืœ ืขืœ ืžื ืช ืœื’ืจื•ื ืœืงื™ืจื•ืจ ื”ืื•ื•ื™ืจ ื”ื™ื•ืฆื ืžื”ืฉืจื•ื•ืœ ื‘ืขืœ ื”ืงื•ื˜ืจ, ื•ืฉืจื•ื•ืœ ืžืขืœื•ืช ื‘ืžืขื‘ืจ ืฉื‘ื™ืŸ ื›ืœ ืฉืจื•ื•ืœ 90

.ื”ืงื˜ืŸ ื‘ื™ื•ืชืจ

Page 317: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009317

ืœืชืงื ื•ืช35ืคื™ืจื•ื˜ ื–ื” ื ื‘ื—) ื‘ื”ืชื๏ฟฝ ืœืชืงื ื” 1968โ€“ื—"ืชืฉื›, ื”ืคื˜ื ื˜ื™๏ฟฝ

This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968

__________

138380]21][11[

ืžื‘ืขืจ ื‘ืžื—ื–ื•ืจ ื‘ืจื™ื™ื˜ื•ืŸ ื”ื™ื‘ืจื™ื“ื™ ื‘ืขืœ ื ืฆื™ืœื•ืช ื’ื‘ื•ื”ื” ื•ื–ื™ื”ื•ื ืกื‘ื™ื‘ืชื™ ื ืžื•ืš

HIGH EFFICIENCY LOWPOLLUTION HYBRID BRAYTONCYCLE COMBUSTOR

]54[

10.03.1999]22[US]33[13.03.1998]32[09/042231]31[

Int. Cl.(2008.04) F01K 21/04, F02C 3/30]51[VAST POWER PORTFOLIO, LLC,U.S.A.

]71[

WO/1999/046484]87[',ื“ื ื™ืืœ ืคืจื™ื™ืžืŸ ื•ืฉื•ืช

ืชืœ ืื‘ื™ื‘,10ื‘ื™ืช ื›ืœืœ ืงื•ืžื”5ื“ืจื•ื™ืื ื•ื‘DANIEL FREIMANN & CO.,5 DROYANOV ST., 10TH FLOOR ,

TEL AVIV 63143

]74[

A power generating system is described which operates at high pressure and utilizes aworking fluid consisting of a mixture of compressed non-flammable air components,fuel combustion products and steam. The working fluid exiting the power generatingsystem is substantially free of NOx and CO. Working fluid is provided at constantpressure and temperature. Combustion air is supplied by one or more stages ofcompression. Fuel is injected at pressure as needed. Substantially all of the oxygen inthe compressed air is consumed when the fuel is burned. Inert liquid is injected at highpressure to produce an inert mass of high specific heat diluent vapor for use for internalcooling of the combustion chamber. The use of non-flammable liquid injection inhibitsthe formation of pollutants, increases the efficiency and available horsepower from thesystem, and reduces specific fuel consumption. Control systems allow the independentcontrol of the quantity, temperature and pressure of the air, fuel and non-flammableliquid introduced in the combustion chamber allowing control of the maximumtemperature and average temperature within the combustion chamber as well as thetemperature of the exhaust from the combustion chamber. Substantially all of thetemperature control of the system is provided by the latent heat of vaporization of theinert liquid, which is preferably water, the latent heat of vaporization counteracting theheat generated by combustion of the fuel. If the injected water contains inorganic ororganic contaminants, they are collected as a molten or solid residue or, if flammable,ignited by the flame.

]57[

__________

Page 318: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 318

138716]21][11[

GENES ื’ื ื™ื ื”ืžืงื•ื“ื“ื™ื ืขื‘ื•ืจ ืกื™ื ืชื–ื” ืฉืœ ืคืœื•ื•ืŸ CODING FOR FLAVONESYNTHASES

]54[

28.01.2000]22[JP]33[29.01.1999]32[11-22427]31[JP19.07.1999 11-205229

Int. Cl.(2009.01) A01H 05//00, C12N 09//02, 15//53, 15//82]51[SUNTORY LIMITED, JAPAN]71[WO/2000/044907]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A DNA encoding an enzyme capable of converting flavanone directly into flavone whichis obtained from, for example, antirrhinum and torenia, and utilization thereof. Theamino acid sequences of this DNA and the enzyme encoded thereby are representedby, for example, SEQ ID NOS: 1, 2, 3 and 4. Transfer of this gene into a plant makes itpossible to, for example, change the flower color of the plant.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

195809,195808,The applications for divisionfrom this application havenot yet been published

__________

Page 319: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009319

139674]21][11[

ื”ืืจื›ืช ื˜ื•ื•ื— ืฉื“ื•ืช ื”ืžื™ื—ืฉื•ื‘ ืฉืœ ืžืกืคืจื™ืืฉืœืžื™ื ื•ืจื•ื—ื‘ ื•ืื•ืคืจื ื“ื™ื ื”ื”ื–ื ื” ื”ืกื“ืจืชื™ืช

ืขื‘ื“ื™ื ืžืฉื ื™ื™ื ืœื—ืฉื‘ื•ืŸ ืžื•ื“ื•ืœืจื™ ืฉืœ ื‘ืžืžืคืชื— ืฆื™ื‘ื•ืจื™ ืงืจื™ืคื˜ื•ื’ืจืคื™ ื”ืžืชื•ื›ื ื ื™ื

ืื™โ€“ืืกโ€“ืืจโ€“ืœื—ื™ืฉื•ื‘ ืžืกื•ื’ ืขื™ืงื•ืœ ืืœื™ืคื˜ื™ื• )RSA(

EXTENDING THE RANGE OFCOMPUTATIONAL FIELDS OFINTEGERS AND WIDTH OFSERIAL INPUT OPERANDS INMODULAR ARITHMETICPUBLIC KEY CRYPTOGRAPHICCO-PROCESSORS DESIGNEDFOR ELLIPTIC CURVE AND RSATYPE COMPUTATIONS

]54[

14.11.2000]22[Int. Cl.(2008.04) G06F 7/60, 7/72, G09C 1/00, H04L 9/00]51[

SANDISK ืกื‘ื- ื›ืคืจ,ืž"ืกืื ื“ื™ืกืง ืื™ื™ืืœ ื‘ืข IL LTD.]71[, ืืœื›ืกื™ ืžื•ืœืฆื ื•ื‘, ืื™ืชื™ ื“ืจื•ืจ, ื›ืจืžื™ ื’ืจืกืœ

ืžื™ื›ืืœ ืžื•ืกื˜ื•ื‘ื•ื™CARMI GRESSEL, ITAYI DROR,ALEXEY MOLCHANOV,MICHAEL MOSTOVOY

]72[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“ืจื—ื•ื‘ื•ืช, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A public key encryption system comprising: a processor for performing a modulararithmetic multiplication, A-B (mod N), of an integer multiplier, denoted A, with aninteger multiplicand, denoted B, modulo an integer modulus, denoted N, using base rinteger arithmetic and without performing an integer division operation, wherein at leastone of A, B and N is a large integer, comprising: memory registers storingrepresentations of each of A, B and N in base r as a sequence of at least one segment,wherein a segment is a k-character integer, and wherein a character is an integerbetween 0 and r-1, and wherein k is a pre-selected segment length; a multipliermultiplying two k-character integers in base r; an accumulator summing two k-characterintegers in base r; and a logical unit adjusting a k-character base r integer so as toforce its least significant character to be zero.

]57[

__________

Page 320: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 320

140492]21][11[

POLYMORPH ืคื•ืœื™ืžื•ืจืฃ ืฉืœ ื—ื•ืžืจ ืจื•ืงื—ื™ OF APHARMACEUTICAL

]54[

19.07.1999]22[US]33[20.07.1998]32[09/119345]31[US04.06.1999 09/326093

Int. Cl.(2009.01) A61K 31//426, A61P 31//18, C07D 417/00]51[ABBOTT LABORATORIES, U.S.A.]71[WO/2000/004016]87[

',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“ ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœ

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

A new crystalline polymorph of ritonavir and methods for its use andpreparation are disclosed.

]57[

__________

140625]21][11[

ืฉื™ืžื•ืฉ ื‘ืคืคื˜ื™ื“ื™ื ืื ื˜ื™ื•ื™ืจืœื™ื™ื ืื•ืื ื˜ื™ืคืจื•ืœื™ืคืจื˜ื™ื‘ื™ื™ื ื‘ื”ื›ื ืช ืชืจื•ืคื”

ืœื˜ื™ืคื•ืœ ื‘ืกืจื˜ืŸ ื•ื‘ื–ื™ื”ื•ื ื ื’ื™ืคื™

USE OF AN ANTIVIRAL ORANTIPROLIFERATIVE PEPTIDEIN THE PREPARATION OF AMEDICAMENT FOR TREATINGCANCER AND VIRAL INFECTION

]54[

30.06.1999]22[US]33[02.07.1998]32[60/091579]31[US09.02.1999 60/119264

Int. Cl.(2008.04) A61K 38/02, 38/08, C07K 7/06]51[ENVISION BIOMEDICALCONSULTING, U.S.A.

]71[

WO/2000/001402]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ืฉื‘, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื” ืขื‘ืืจLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The present invention relates to peptides and proteins which may be used to inhibitinfection or cell proliferation. It is based, at least in part, on the discovery of peptidesand proteins isolated from embryonic tissue which have been found to exhibit anantiproliferative effect on a variety of cancer cells and/or to act as broad-spectrumantiviral agents.

]57[

__________

Page 321: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009321

140793]21][11[

ืžืขืจื›ืช ื’ืœื•ื‘ืœื™ืช ืœืืจื•ื— ืžืกืžื›ื™ืืžืฉืช ื‘ืฉืจืชื™ื ืžืฉื•ื›ืคืœื™ื ืžื‘ื•ื–ืจื™ื ื”ืžืฉืช

ื‘ืขืœื™ ืชื›ื•ืœื” ืžืฉื•ื‘ืฆืช

GLOBAL DOCUMENT HOSTINGSYSTEM UTILIZING EMBEDDEDCONTENT DISTRIBUTED GHOSTSERVERS

]54[

14.07.1999]22[US]33[14.07.1998]32[60/092710]31[US10.05.1999 09/314863

Int. Cl.(2008.04) G06F 12/00, 13/00, 17/30, H04L 29/06, 29/08, 29/12]51[MASSACHUSETTS INSTITUTE OFTECHNOLOGY, U.S.A.

]71[

WO/2000/004458]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A network architecture or framework that supports hosting and content distribution on atruly global scale. The framework allows a Content Provider to replicate and serve itsmost popular content at an unlimited number of points throughout the world. Theframework comprises a set of servers operating in a distributed manner. The actualcontent to be served is preferably supported on a set of hosting servers (36),sometimes referred to as ghost servers. This content comprises HTML page objectsthat, conventionally, are served from a Content Provider site. In accordance with theinvention, however, a base HTML document portion of a web page is served from theContent Provider's site (1), while one or more embedded objects for the page areserved from the hosting servers (3, 4), preferably those hosting servers (5) near theclient machine. By serving the base HTML document from the Content Provider's site,the Content Provider maintains control over the content.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198508,The applications for divisionfrom this application havenot yet been published

__________

Page 322: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 322

141061]21][11[

ื—ืœื‘ื•ืŸ ืœืฉื™ืžื•ืฉ ื›ืกืžืŸ ืœืกืจื˜ืŸ ื•ืฉื™ื˜ื”ืœืื‘ื—ื•ืŸ ืกืจื˜ืŸ ื”ืขืจืžื•ื ื™ืช ืื• ืกืจื˜ืŸ

ืœ"ืฉืœืคื•ื—ื™ืช ื”ืฉืชืŸ ื‘ืฉื™ืžื•ืฉ ื‘ื—ืœื‘ื•ืŸ ื”ื 

PROTEIN USEFUL AS A MARKERFOR CANCER AND METHOD FORDIAGNOSING PROSTATE ORBLADDER CANCER USING SAIDPROTEIN

]54[

10.08.1999]22[US]33[10.08.1998]32[60/095982]31[

Int. Cl.(2009.01) C07K 14//47, C12N 15//12, C12Q 01//68]51[AGENSYS, INC., U.S.A.]71[WO/2000/009691]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, andto diagnostic and therapeutic methods and compositions useful in the management ofvarious cancers which express BPC-1, particularly including prostate cancer andbladder cancer. In human normal tissues, BPC-1 is only expressed in certain tissues ofthe brain. However, BPC-1 is expressed at high levels in prostate cancer cells and isalso expressed in bladder cancer cells. The structure of BPC-1 includes a signalsequence and a CUB domain. BPC-1 protein is secreted. Preliminary experimentalevidence suggests that BPC-1 is directly involved in oncogenesis or maintenance ofthe transformed phenotype of cancer cells expressing BPC-1. BPC-1 also appears tobind specifically to a cellular protein expressed in prostate cancer cells and other cells.

]57[

__________

Page 323: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009323

142025]21][11[

ื—ืœื‘ื•ื ื™ื/ืคืคื˜ื™ื“ื™ื) ืคื•ืœื™(ืฉื™ื˜ื•ืช ืœื”ืฆื’ืชื’ ื“ืจืš ืงืฉืจื™ื'ืขืœ ื—ืœืงื™ืงื™ ื‘ืืงื˜ืจื™ื•ืคื

ื“ื™ืกื•ืœืคื™ื“ื™ื™ื

METHODS FOR DISPLAYING(POLY) PEPTIDES/PROTEINS ONBACTERIOPHAGE PARTICLESVIA DISULFIDE BONDS

]54[

20.07.2000]22[EP]33[20.07.1999]32[99114072.4]31[EP18.02.2000 00103551.8

Int. Cl.(2008.04) C07K 14/01, C12N 15/10, 15/33, 7/01, C40B 40/02]51[MORPHOSYS AG, GERMANY]71[WO/2001/005950]87[

,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸ ื”ืจืฆืœื™ื”, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจ

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

The present invention relates to methods for displaying (poly)peptides/proteins on thesurface of bacteriophage particles by attaching the (poly)peptide/proteins via disulfidebonds.

]57[

__________

142905]21][11[

ืœื•ืช ืื ื˜ื’ื•ื ื™ืกื˜ื™ื ืคื•ื ืงืฆื™ื•ื ืœื™ื™ื ืฉืœ ืคืขื™HEDGEHOG

FUNCTIONAL ANTAGONISTS OFHEDGEHOG ACTIVITY

]54[

02.11.1999]22[US]33[02.11.1998]32[60/106703]31[

Int. Cl.(2009.01) A61K 38//17, 48//00, C07K 14//435, C12N 15//12]51[CURIS INC., U.S.A.]71[WO/2000/025725]87[

,ื•ืฉื•ืชืคื™ื• ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Variants of hedgehog protein that contain N-terminal modifications are described thatcan block hedgehog function; thus allowing these variants to serve as functionalantagonists. These peptides have a primary amino acid sequence lacking the ability toelicit a hedgehog-dependent response in C3H 10T1/2 cells but having the ability to bindto the hedgehog receptor, patched-1. Methods for producing such functionalantagonists and methods of using the ๏ฟฝ unctional antagonists are also described.

]57[

__________

Page 324: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 324

143015]21][11[

ื—ืœื•ืงื” ื•ื’ื™ืœื•ื™ ืฉืœ ืžืกื’ืจื•ืช ื™ื™ืฆื•ื’ื™ื•ืช ื‘ืกื“ืจื•ืช ืฉืœ ื•ื™ื“ืื•

SEGMENTATION ANDDETECTION OFREPRESENTATIVE FRAMES INVIDEO SEQUENCES

]54[

07.05.2001]22[US]33[09.05.2000]32[60/202794]31[US09.09.2000 09/677446

Int. Cl.(2009.01) H04N 05//76, 07//12]51[IBM CORPORATION, U.S.A.]71[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A computer-implemented method for organizing a sequence of video frames,comprising: generating a first portion of a segment of the sequence by: for each framebeginning from an initial frame in the sequence, computing a multi-dimensional vectorof parameters indicative of a characteristic of the frame; determining vector distancesbetween the frames in the sequence responsively to differences in the multi-dimensional vector of parameters among the frames; and finding, responsively to thedistances, a bounding subset comprising at least three of the frames in the sequence,chosen so as to maximize a sum of the distances between all of the at least threeframes in the subset, while each of the distances is no greater than a predeterminedmaximum, such that the first portion comprises the frames in the sequence that arebounded by the at least three of the frames in the bounding subset; selecting one of theframes in the first portion to be a representative frame for the segment; and generatinga second portion of the segment by adding to the segment further frames in thesequence subsequent to the first portion while determining that the respectivedistances between the added further frames and the representative frame are within apredefined bound.

]57[

__________

143351]21][11[

ื•ืจ ืื ื•ืฉื™ ืœื‘ื™ื˜ื•ื™ ืชื ืžืืจื— ื”ื™ื‘ืจื™ื“ื™ ืžืžืง ื’ื ื™ื ืฉืœ ื™ื•ื ืงื™ื

HUMAN HYBRID HOST CELLFOR MAMMALIAN GENEEXPRESSION

]54[

08.12.1999]22[US]33[10.12.1998]32[09/209920]31[

Int. Cl.(2008.04) C12N 15/08, 5/02, 5/22, 5/24]51[BAYER CORPORATION, U.S.A.]71[WO/2000/034462]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•ื™ืœืจืžืช ื”ื—ื™',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Page 325: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009325

Human/human hybrid cells were made via fusion of human embryonic kidney cells(293S) and modified Burkitt's lymphoma cells (2B8). The fusion cells are useful as hostcells for the recombinant expression of mammalian genes. The advantages of usingthese hybrid clones of human kidney- and B-cells, called HKBs, for mammalian geneexpression, include (i) the cells are negative for immunoglobulin expression, (ii) thecells grow easily in plasma protein-free medium (with or without the addition ofrecombinant insulin) as suspension cultures in a shake flask or in a fermenter (iii) thecells are very susceptible for transfection of DNA, and (iv) the cells secrete high levelsof heterologous recombinant proteins, such as recombinant monoclonal antibodies,soluble ICAM-1, rIL-4, and rFVIII.

]57[

__________

144043]21][11[

ืฉื™ืžื•ืฉ ื‘ืจื™ืื•ื•ื™ืจื•ืก ืœื”ื›ื ืช ืชื›ืฉื™ืจ ืจืคื•ืื™ ืœื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ื”ืชืจื‘ื•ืช ืชืื™ืช

USE OF REOVIRUS FOR THEPREPARATION OF APHARMACEUTICALCOMPOSITION FOR THETREATMENT OF CELLULARPROLIFERATIVE DISORDERS

]54[

18.02.2000]22[US]33[24.02.1999]32[09/256824]31[

Int. Cl.(2008.04) A61K 35/76, A61P 35/00]51[ONCOLYTICS BIOTECH INC.,CANADA

]71[

WO/2000/050051]87[,ื•ืฉื•ืชืคื™ื• ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that itultimately directly contacts ras-mediated proliferating cells. Proliferative disordersinclude but are not limited to neoplasms. Human reovirus, non-human mammalianreovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, serotype1 (e.g., strain Lang), serotype 2 (e.g., strain Jones), serotype 3 (e.g., strain Dearing orstrain Abney), as well as other serotypes or strains of reovirus can be used.Combinations of more than one type and/or strain of reovirus can be used, as canreovirus from different species of animal. Either solid neoplasms or hematopoieticneoplasms can be treated.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

197903,The applications for divisionfrom this application havenot yet been published

__________

Page 326: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 326

145145]21][11[

ืฆื ืชืจื™ื ื”ืžื™ื•ืขื“ื™ื ืœื”ื—ืœืคื” ืขืœ ื™ื“ื™ ืžืคืขื™ืœ ื™ื—ื™ื“ ื•ืฉื™ื˜ื•ืช ืœืฉื™ืžื•ืฉ ื‘ื”ื

SINGLE OPERATOR EXCHANGECATHETERS AND METHODS OFUSE

]54[

14.12.2000]22[US]33[04.02.2000]32[09/498104]31[

Int. Cl.(2009.01) A61M 25//09, 29//00]51[BOSTON SCIENTIFIC LIMITED,BARBADOS

]71[

WO/2001/056645]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

A single operator exchange biliary catheter having a tubular member extendingproximally from the proximal guidewire port. The tubular member defines a guidewirelumen extension adapted to permit the guidewire to be retracted from guidewire lumenand re-inserted therein. By retracting the guidewire from the guidewire lumen and intothe guidewire lumen extension, fluid may be readily injected via the guidewire lumenwithout encountering resistance to fluid flow from the guidewire. The guidewire lumenextension also maintains guidewire lumen access such that the guidewire may beeasily re-inserted into the guidewire lumen.

]57[

__________

145381]21][11[

ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื ืœื˜ื™ืคื•ืœ ื‘ืžื—ืกื•ืจAื’ืœืงื˜ื•ืกื™ื“ืื– ืžืกื•ื’โ€“ื‘ืืœืคื

MEDICAL PREPARATIONS FORTHE TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY

]54[

09.03.2000]22[US]33[11.03.1999]32[09/266014]31[

Int. Cl.(2008.04) A61K 38/46, C12N 15/52, 15/54, 15/56, 15/63, 9/40, C12P 21/02]51[SHIRE HUMAN GENETICTHERAPIES, INC., U.S.A.

]71[

WO/2000/053730]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Page 327: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009327

The invention provides highly purified $g(a)-Gal A, and various methods for purifying it;$g(a)-Gal A preparations with altered charge and methods for making thosepreparations; $g(a)-Gal A preparations that have an extended circulating half-life in amammalian host, and methods for making same; and methods and dosages foradministering an $g(a)-Gal A preparation to a subject.

]57[

__________

145688]21][11[

COATING ืžืขืจื›ืช ืฆื™ืคื•ื™ SYSTEM]54[

29.03.2000]22[US]33[29.03.1999]32[60/126692]31[

Int. Cl.(2008.04) A61K 9/00, 9/28]51[WYETH, U.S.A.]71[WO/2000/057838]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A coating system for application to solid pharmaceutical dosage units, said systemcomprising:(a) a subcoat comprising (i) a water soluble cellulosic material and (ii) a sugarcomponent; and(b) a polish coat comprising polyethylene glycol, wherein the weight ratio of cellulosicmaterial to sugar component within the subcoat ranges from about 40:60 to about85:15 percent by weight.

]57[

__________

Page 328: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 328

145759]21][11[

ืชื•ืœื“ื•ืช ืืžื™ืŸ ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

AMINE DERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

06.04.2000]22[JP]33[07.04.1999]32[11/99981]31[

Int. Cl.(2008.04) A61K 314/22, 314/27, 314/37, A61P 19/10, 29/00, 3/10, 35/00,37/02, 43/00, C07D 413/12, 417/12, 471/04

]51[

DAIICHI SANKYO COMPANYLIMITED, JAPAN

]71[

WO/2000/061581]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Amine derivatives represented by general formula (I) or pharmacologically acceptablesalts thereof, which are useful as therapeutic and/or preventive agents for diabetes,hyperlipemia, arteriosclerosis, cancers, and so on: wherein Rยฟ1? is optionallysubstituted carbamoyl or the like; Rยฟ2? is hydrogen or the like; Rยฟ3? is Cยฟ1?-Cยฟ10?alkyl or the like; Wยฟ1?, Wยฟ2? and Wยฟ3? are each independently a single bond orCยฟ1?-Cยฟ8? alkylene; X, Y and Q are each sulfur or the like; Z is =CH- or the like; Ar isa benzene ring or the like; and L is hydrogen or the like.

]57[

__________

145982]21][11[

VACCINE ืชืจื›ื™ื‘ื™ ื—ื™ืกื•ืŸ ADJUVANTS]54[

04.04.2000]22[GB]33[19.04.1999]32[9908885.8]31[US29.04.1999 09/301829

Int. Cl.(2008.04) A61K 39/00, 39/39]51[SMITHKLINE BEECHAMBIOLOGICALS S.A., BELGIUM

]71[

WO/2000/062800]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Page 329: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009329

The present invention relates to adjuvant compositions which are suitable to be used invaccines. In particular, the adjuvant compositions of the present invention comprises asaponin and an immunostimulatory oligonucleotide, optionally with a carrier. Alsoprovided by the present invention are vaccines comprising the adjuvants of the presentinvention and an antigen. Further provided are methods of manufacture of theadjuvants and vaccines of the present invention and their use as medicaments.Methods of treating an individual susceptible to or suffering from a disease by theadministration of the vaccines of the present invention are also provided.

]57[

ื–ื• ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื”.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

189736,The applications for divisionfrom this application havenot yet been published

__________

146679]21][11[

SIGNATURE ืœื›ื™ื“ืช ื—ืชื™ืžื” ื‘ืืžืฆืขื•ืช ืฉื˜ื— ืžืžืฉืง CAPTURE VIAINTERFACE SURFACE

]54[

24.05.2000]22[AU]33[25.05.1999]32[PQ0559]31[AU30.06.1999 PQ1313AU25.10.1999PQ3632AU01.12.1999PQ4392

Int. Cl.(2009.01) G06K 09//62]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[

WO/2000/072246]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ื™ืœืจืžืช ื”ื—ื™',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method of enabling user interaction with computer software running in a computersystem via an interface surface and a sensing device. The interface surface containsinformation relating to the computer software and coded data indicative of a signaturefield relating to the computer software. When the sensing device is placed in anoperative position relative to the interface surface, it senses indicating data indicative ofthe signature field. The sensing device also generates movement data indicative of thesensing device's movement. The indicating data and the movement data are receivedfrom the sensing device, and the signature field is identified. Once the signature hasbeen identified, the computer software is operated in reliance on the movement data,and in accordance with instructions associated with the signature field.

]57[

Page 330: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 330

__________

146887]21][11[

ืคืจื•ืกืชื–ื” ืกืงืœืจืœื™ืช ืœื˜ื™ืคื•ืœ ื‘ืคืจืกื‘ื™ื•ืคื™ื” ื•ืžื—ืœื•ืช ืื—ืจื•ืช ืฉืœ ื”ืขื™ืŸ

IMPROVED SCLERALPROSTHESIS FOR TREATMENTOF PRESBYOPIA AND OTHEREYE DISORDERS

]54[

07.06.2000]22[US]33[07.06.1999]32[60/138105]31[

Int. Cl.(2009.01) A61F 02//14]51[RAS HOLDING CORPORATION,U.S.A.

]71[

WO/2000/074600]87[,ื•ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Presbyopia and other eye disorders are treated by implanting within a plurality ofelongated pockets formed in the tissue of the sclera of the eye transverse to a meridianof the eye, a prosthesis having an elongated base member having an inward surfaceadapted to be placed against the inward wall of the pocket and having a ridge on theinward surface of the base extending along at least a major portion of the majordimension of the base. The combined effect of the implanted prostheses is to exert aradially outward traction of the sclera in the region overlying the ciliary body whichexpands the sclera in the affected region together with the underlying ciliary body. Theexpansion of the ciliary body restores the effective working distance of the ciliarymuscle in the presbyopic eye and thereby increases the amplitude of accommodation.Introduced is an improved scleral prosthesis for the treatment of presbyopia and othereye disorders. An exemplary prosthesis is adapted for contact with the sclera of aneyeball, and comprises a body having a first end and a second end wherein the bodyhas (i) a planform adapted to expand the contacted sclera to increase the effectiveworking distance of the ciliary muscle of the eyeball, and (ii) means for stabilizing theprosthesis within the surgically formed pocket within the sclera of the eyeball.

]57[

Page 331: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009331

__________

147214]21][11[

ืžืชื™ืœ ืงืจื‘ืืคื™ื ื ื•ืชื›ืฉื™ืจื™โ€“1ืชื•ืœื“ื•ืช ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸืจื•ืงื—

1-METHYLCARBAPENEMDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

06.07.2000]22[JP]33[06.07.1999]32[11/191368]31[

Int. Cl.(2008.04) A61K 314/07, C07D 477/20]51[DAIICHI SANKYO COMPANYLIMITED, JAPAN

]71[

WO/2001/002401]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Crystals of compound (I) or pharmacologically acceptable salts thereof, which exhibitan excellent antimicrobial activity and are so excellent in storage stability andhandleability as to be put into practical use as antimicrobial agents. Crystals ofcompound (I) or pharmacologically acceptable salts thereof, which exhibit an excellentantimicrobial activity and are so excellent in storage stability and handleability as to beput into practical use as antimicrobial agents.

]57[

__________

Page 332: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 332

147963]21][11[

ืžืขืจื›ืช ืฉืชืœ ืจืคื•ืื™ืช ืขื ืฉื™ื“ื•ืจ ืื ืจื’ื™ื” ืืœื—ื•ื˜ื™

MEDICAL IMPLANT APPARATUSWITH WIRELESS ENERGYTRANSMISSION

]54[

01.08.2000]22[US]33[12.08.1999]32[60/148345]31[US14.02.2000 60/182223

Int. Cl.(2008.04) A61F 2/48]51[POTENCIA MEDICAL AG,SWITZERLAND

]71[

WO/2001/012108]87[,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸ

ื”ืจืฆืœื™ื”, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

A medical implant apparatus include or use an energy transmission means for wirelesstransmission of energy of a first form from outside a patient's body. An implantedmedical device is operable in response to energy of a second form different than theenergy of the first form. An implanted energy transforming means transforms energy ofthe first form wirelessly transmitted by the energy transmission means into energy ofthe second form for use in the control and operation of the medical device.

]57[

__________

148505]21][11[

PROGRESSIVE ืขื“ืฉื•ืช ื”ืžืชื•ื•ืกืคื•ืช ื‘ืื•ืคืŸ ื”ื“ืจื’ืชื™ ADDITIONLENSES

]54[

25.08.2000]22[US]33[05.09.1999]32[391095]31[

Int. Cl.(2009.01) G02C 07//00, 07//06]51[ESSILOR INTERNATIONAL(COMPAGNIE GENERALED'OPTIQUE), FRANCE

]71[

WO/2001/018591]87[The present provides progressive addition lens designs and lenses in which unwantedlens astigmatism is reduced as compared to conventional progressive addition lenses.

]57[

Page 333: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009333

__________

149108]21][11[

ืชื”ืœื™ืš, ืชืจื›ื•ื‘ื•ืช ืื•ืงืกืื‘ื™ืกืคื™ื“ื™ืŸื”ืจื›ื‘ื™ื ืจื•ืงื—ื™ื™ื ื”ืžื›ื™ืœื™ื ืื•ืชืŸ, ืœื”ื›ื ืชืŸ

ื•ืฉื™ืžื•ืฉื™ื”ืŸ ื‘ื”ื›ื ืช ืชืจื•ืคื” ืœื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื” ื‘ืงืฆื‘ ื”ืœื‘

OXABISPIDINE COMPOUNDS,PROCESS FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF INTHE PREPARATION OF AMEDICAMENT FOR THETREATMENT OF ARRHYTHMIA

]54[

13.10.2000]22[SE]33[18.10.1999]32[9903759-0 ]31[

Int. Cl.(2008.04) A61K 315/383, A61P 9/06, C07D 265/30, 303/36, 498/08]51[ASTRAZENECA AB, SWEDEN]71[PEDER SVENSSON, ANNIKABJORE, MAGNUS BJORSNE, DAVIDCALDINGBOEL, KURT-JURGENHOFFMAN, JOHN PAVEY, FRITIOFPONTEN, GERT STRANDLUND,COLIN THOMSON, JOHANMICHAEL WILSTERMANN

]72[

WO/2001/028992]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

There is provided compounds of formula (I), wherein R?1ยฟ, R?2ยฟ, R?3ยฟ, R?4ยฟ,R?41ยฟ to R?46ยฟ, A, B and G have meanings given in the description, which are usefulin the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventriculararrhythmias.

]57[

Page 334: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 334

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

183854,183853,183852,The applications for divisionfrom this application havenot yet been published

__________

149249]21][11[

ืจื™ืฉื•ื ื•ืฉื™ืžื•ืฉ ื‘ืฉื ื“ื•ืžื™ื™ืŸ ื‘ืฉืคื” ืžืงื•ืžื™ืช

NATIVE LANGUAGE DOMAINNAME REGISTRATION ANDUSAGE

]54[

17.08.2001]22[US]33[21.08.2000]32[09/642471]31[

Int. Cl.(2008.04) G06F 17/28, H04L 29/06]51[KI SEOK KIM, U.S.A.JIYUL YOO, U.S.A.

]71[

WO/2002/017204]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A domain name system includes a native language domain name registrar (105), whichreceives a native language domain name, containing at least one non-alphanumericcharacter, registration request and converts the native language domain name into analphanumeric domain name. The alphanumeric domain name is used in the domainname/IP address entry in the domain name server (DMS) (103).

]57[

__________

Page 335: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009335

149325]21][11[

ื’ื ื™ื ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื”ื•ืžื ื™ื™ื ืกื™ื ืชื˜ื™ื™ื ื•ืฉื™ืžื•ืฉื ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ืื•ื˜ื•ืื™ืžื•ื ื™ื•ืช

SYNTHETIC HUMAN GENES ANDPOLYPEPTIDES AND THEIR USEIN THE TREATMENT OFAUTOIMMUNE DISEASES

]54[

26.10.2000]22[IL]33[27.10.1999]32[132611]31[

Int. Cl.(2008.04) A61K 38/17, C07K 14/47, C12N 15/62]51[AVRAHAM ื™ื‘ื ื”, ื ื•ืŸ-ืื‘ืจื”ื ื‘ืŸ BEN-NUN]71[

ื‘ืŸ, ื ื™ืงื•ืœ ืงืจืœื• ื“ื” ืจื•ืกื‘ื• ืคื•ืœ, ื ื•ืŸ-ืื‘ืจื”ื ื’ืจื’ื•ืจ ืกืคืœืจ

NICOLE KERLERO DE ROSBO,AVRAHAM BEN-NUN, PAULGREGOR SAPPLER

]72[

WO/2001/031037]87[',ืจ ื•ื‘ ื•ืฉื•ืช"ื“

ืจื—ื•ื‘ื•ืช, 2189.ื“.ืช,2ืคืงืจื™ืก' ืจื—WEBB & ASSOCIATES,2 PEKERIS ST., P.O.B. 2189,

REHOVOT 76121

]74[

Synthetic human target autoantigen genes comprising sequences coding for at leasttwo immunogenic epitopic clusters (hereinafter IEC) of autoantigen(s) related to aspecific autoimmune disease, wherein said at least two IECs may be derived from asole autoantigen or from at least two different autoantigens related to said autoimmunedisease, and polypeptides encoded thereby, can be used for the treatment and thediagnosis of autoimmune diseases such as multiple sclerosis (MS), insulin-dependentdiabetes mellitus (IDDM), rheumatoid arthritis (RA), myasthenia gravis (MG) anduveitis.

]57[

__________

149496]21][11[

ืจื•ืงื—ื™ื™ื ื•ืฉื™ืžื•ืฉื ืœื˜ื™ืคื•ืœ ื”ืจื›ื‘ื™ื ื‘ืžืขืจื›ืช ื”ืขื™ื›ื•ืœ

PHARMACEUTICALCOMBINATIONS AND THEIR USEIN TREATINGGASTROINTESTINALDISORDERS

]54[

08.12.2000]22[US]33[10.12.1999]32[09/458388]31[

Int. Cl.(2008.04) A61K 45/00]51[NOVARTIS AG, SWITZERLAND]71[WO/2001/041748]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The present invention relates to a combination of a first agent including either a 5-HTยฟ4? receptor agonist or antagonist or a 5-HTยฟ3? receptor antagonist and a co-agentand pharmaceutical compositions and formulations containing the combination. The

]57[

Page 336: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 336

pharmaceutical combination may be employed for the treatment of alteredgastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage ispreferably oral. The preferred first agent is tegaserod.

__________

150153]21][11[

ืชื›ืฉื™ืจื™ื ื•ืฉื™ืžื•ืฉื™ื,Gโ€“CSFืชืฆืžื™ื“ื™ ืฉืœื”ื

G-CSF CONJUGATES,COMPOSITIONS AND USESTHEREOF

]54[

09.01.2001]22[DK]33[10.01.2000]32[PA200000024]31[DK02.03.2000 PA200000341DK16.06.2000PA200000943

Int. Cl.(2008.04) A61K 45/00, 47/48, C07K 145/35, 17/08, C12N 15/27]51[MAXYGEN HOLDINGS LTD., U.S.A.]71[WO/2001/051510]87[

,ื•ืฉื•ืชืคื™ื•ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acidsequence of human G-CSF in at least one specified introduced and/or removed aminoacid residue comprising an attachment group for a non-polypeptide moiety, and havingat least one non-polypeptide moiety attached to an attachment group of thepolypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid orglutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g.be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate hasone or more improved properties such as increased biological half-life and reducedside effects.

]57[

__________

Page 337: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009337

150636]21][11[

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื™ื™ืฆื•ืจ ืืจื™ื’ื™ื ืžืจื•ื›ื‘ื™ืื™ื“ื™ ืชืคื™ืจื”โ€“ืžืกื™ื‘ื™ื ืœื ืจืงื•ืžื™ื ืขืœ

ื“ื™ื ืžื™ืชโ€“ื”ื™ื“ืจื•

METHOD AND DEVICE FORPRODUCTION OF COMPOSITENON-WOVEN FIBRE FABRICS BYMEANS OF HYDRODYNAMICNEEDLING

]54[

13.01.2001]22[DE]33[17.01.2000]32[10001723.1]31[DE03.02.2000 10004448.4

Int. Cl.(2009.01) A61F 13//15, 13//511, D04H 01//46, 13//00]51[FLEISSNER GMBH & CO.MASCHINENFABRIK, GERMANY

]71[

WO/2001/053588]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A conventional method for the production of a composite non-woven fibre fromat least one spun non-woven fibre and subsequent application of a wood pulplayer to the above for production of a hygiene product is known. Accordingly,the spunbonded non-woven fibre is hydrodynamically needled, before theapplication of the pulp layer, in order to increase the fluid dispersionproperties. Consequently, the pulp layer can no longer be needled, as the pulpwould be washed out through the non-woven fibre. Due to the requiredabrasion resistance a bonding of the non-woven fibre is, however, necessary.According to the invention, the above problem is resolved, whereby a non-woven fibre is compressed or calendered with compressed air, as a pre-bonding treatment, before coating with the super-absorbent material, then thewoodpulp layer is applied and both are bonded with a hydrodynamic waterneedling, followed by drying. A further calandering can be added. A furtherpre-bonded, in other words, calendered spunbonded, or card non-woven fibrecan be applied to the spunbonded non-woven fibre as support layer, or thereverse.

]57[

__________

Page 338: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 338

150972]21][11[

ืžื™ ื™ืโ€“ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืคื™ืงื•ื— ืขืœ ื—ื“ื™ืจืชืœืืงื•ื•ื™ืคืจื™ื ืฉืœ ืžื™ื ืžืชื•ืงื™ื ื”ืกืžื•ื›ื™ื

ืœืขืจื™ ื—ื•ืฃ

METHOD AND APPARATUS FORMONITORING THE ADVANCE OFSEAWATER INTO FRESH WATERAQUIFERS NEAR COASTALCITIES

]54[

30.01.2001]22[US]33[04.02.2000]32[60/180572]31[US08.02.2000 60/180981

Int. Cl.(2009.01) E03B 01//00, E21B 47//10]51[SCHLUMBERGER TECHNOLOGYCORPORATION, U.S.A.

]71[

WO/2001/057361]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Sensors are permanently placed in the ground near observation and injection wells inorder to passively and continuously monitor the status of seawater advance towardfresh water aquifers near coastal cities as well as the status of fresh water injected intothe injection wells. Such sensor devices are installed in the ground and electricallyconnected to surface acquisition equipment that would, without human intervention,transmit acquired data to a centralized facility for processing and interpretation. Varioustypes of sensors can be used: the sensors used for general reservoir monitoring and/orthe sensors used for leak detection, soil heating, and temperature mapping.Alternatively, a special type of sensor can be designed and provided for the purpose ofmonitoring the status of seawater advance toward fresh water aquifers.

]57[

__________

Page 339: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009339

151139]21][11[

ื–ืจื–, ืชื”ืœื™ืš ืœืคื™ืจื•ืง ืชื—ืžื•ืฆืช ื—ื ืงื ื™ืช ืงืชื•ืขื‘ื•ืจื• ื•ืชื”ืœื™ืš ืœื”ืค

PROCESS FOR DECOMPOSINGN2O, CATALYST THEREFOR ANDPROCESS FOR ITS PRODUCTION

]54[

07.02.2001]22[DE]33[11.02.2000]32[10006103.6]31[

Int. Cl.(2008.04) B01D 53/86]51[UHDE GMBH, GERMANY]71[WO/2001/058570]87[

,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ื’ื‘ ืžืจื›ื–

ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to a method for decomposing Nยฟ2?O during theproduction of nitric acid by bringing the waste gas, which containsNยฟ2?O and which is exiting the absorption column, into contact with acatalyst containing at least one oxidic cobalt compound and at least oneoxidic magnesium compound. The waste gas is brought into contactwith the catalyst under conditions that permit Nยฟ2?O to be convertedinto gaseous nitrogen and oxygen. The content of oxidic cobaltcompounds ranges from 0.1 to 50 wt. %, and the content of oxidicmagnesium compounds range from 50 to 99.9 wt. % each with regard tothe total mass of the catalyst. At least 30 % of the cobalt atoms in thecatalyst are provided in a trivalent state. The production of the catalystincludes a dry mixing of the oxidic cobalt compounds and the oxidicmagnesium compounds or corresponding precursors, which aretransformed into oxidic compounds by annealing, and involves acompacting of the mixture while eliminating water until the resultingcatalyst has the desired bulk density.

]57[

__________

Page 340: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 340

151216]21][11[

ืคืœื•ืจืคืœื‘ื™ื ื™ื ื•ื ื’ื–ืจื•ืช ืฉืœื”ื ืชื”ืœื™ืš ืœื”ื›ื ืชื ื•ื”ืฉืžื•ืฉ ื‘ื”ื

PLURAFLAVINS ANDDERIVATIVES THEREOF,PROCESS FOR THEIRPREPARATION AND USETHEREOF

]54[

15.02.2001]22[EP]33[18.02.2000]32[00103540.1]31[

Int. Cl.(2009.01) A61K 31//70, A61P 03//00, 31//00, 35//02, C07H 05//06, 17//04,C12P 19//26, 19//60, C12R 01//04

]51[

SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2001/060832]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to a compound of formula (I) wherein Rยฟ1? is a sugar; Rยฟ2? is -CHยฟ2?-O-(Rยฟ7?)m, Rยฟ7? representing a sugar, or Rยฟ2? is -COOH; Rยฟ3? is anepoxide-comprising group, Cยฟ1?-Cยฟ6?-alkyl or Cยฟ2?-Cยฟ6?-alkenyl, unsubstituted orsubstituted by at least one OH; Rยฟ5? is H, Cยฟ1?-Cยฟ6?-alkyl, Cยฟ2?-Cยฟ6?-alkenyl orCยฟ2?-Cยฟ6?-alkynyl; Rยฟ4?, Rยฟ6?, Rยฟ8? and Rยฟ10? independently of one another areH,Cยฟ1?-Cยฟ6?-alkyl, Cยฟ2?-Cยฟ6?-alkenyl, Cยฟ2?-Cยฟ6?-Alkynyl, -Xยฟ2?H, or -Xยฟ2?Rยฟ12?, or Rยฟ4? and Rยฟ6? together and/or Rยฟ8? and Rยฟ10? together are =Xยฟ2?;Xยฟ2? is O, NH, N-Cยฟ1?-Cยฟ6?-alkyl, N-Cยฟ2?-Cยฟ6?-alkenyl, N-Cยฟ2?-Cยฟ6?-alkynyl or S;Rยฟ12? is Cยฟ1?-Cยฟ6?-Alkenyl, Cยฟ2?-Cยฟ6?-alkynyl, Cยฟ2?-Cยฟ6?-alkynyl, aryl or acyl;and m and n are 1 or 2; and its physiologically acceptable salts. The compounds areobtainable from a culture of the microorganism Actinomycetales species HAG 003959,DSM 12931, by fermentation. Accordingly, the invention relates to a process for theirpreparation and to the use of the compounds as pharmaceuticals, for example as anti-tumor agents.

]57[

__________

Page 341: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009341

151240]21][11[

POLYPROPYLENE ืกื™ื‘ื™ ืคื•ืœื™ืคืจื•ืคื™ืœืŸ FIBRES]54[

19.02.2001]22[EP]33[18.02.2000]32[00200552.8]31[

Int. Cl.(2008.04) D01F 6/06, 6/46, D04H 3/00]51[ATOFINA RESEARCH, BELGIUM]71[WO/2001/061084]87[

,ืž"ื‘ืข) 1995(ืืจืœื™ืš.ืื™.ื™'ื’ืจื—ื•ื‘ ืžื ื—ื ื‘ื’ื™ืŸ,15ืงื•ืžื”, ืžื’ื“ืœ ืื™ืœื•ืŸ

ื’ืŸ, 11 ืจืžืช

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A polypropylene fibre including at least 80 % by weight of a first isotactic polypropyleneproduced by a metallocene catalyst, and from 5 to 20 by weight of a second isotacticpolypropylene produced by a Ziegler-Natta catalyst.

]57[

__________

151372]21][11[

ืชื•ืœื“ื•ืช ืคื™ืจื•ืœื™ื“ื™ืŸ ืขื ืฆื™ืงืœื•ืคืจื•ืคื™ืœ ืžื•ืชืš ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

CYCLOPROPYL-FUSEDPYRROLIDINE DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

05.03.2001]22[US]33[10.03.2000]32[60/188555]31[

Int. Cl.(2008.04) A61K 314/03, A61P 3/04, 3/06, 3/10, C07D 209/52]51[BRISTOL-MYERS SQUIBBCOMPANY, U.S.A.

]71[

WO/2001/068603]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I)where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1);n is 0 or 1; X is H or CN; and wherein R?1ยฟ, R?2ยฟ, R?3ยฟ and R?4ยฟ are as describedherein. A method is also provided for treating diabetes and related diseases, especiallyType II diabetes, and other diseases as set out herein, employing such DP 4 inhibitoror a combination of such DP 4 inhibitor and one or more of another antidiabetic agentsuch as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulinand/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or othertherapeutic agent.

]57[

Page 342: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 342

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

177019,177018,The applications for divisionfrom this application havenot yet been published

__________

151705]21][11[

ื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ืงืจืช ืฉื™ื“ื•ืจื™ื ื‘ืžืขืจื›ืชืฉ ืชืงืฉื•ืจืช

METHOD AND APPARATUS FORCONTROLLING TRANSMISSIONSOF A COMMUNICATIONSSYSTEM

]54[

20.03.2001]22[US]33[30.03.2000]32[09/539157]31[

Int. Cl.(2008.04) H04B 17/00, 17/07, 7/26, 70/05, H04J 1/00, 1/05, 11/00, 3/00,H04Q 7/28, 7/36, 7/38

]51[

QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2001/076098]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

In some aspects, each cell in the communications system can bedesigned to operate in accordance with a set of back-off factors thatidentify the reductions in peak transmit power levels for the channelsassociated with the back-off factors. The back-off factors are defined toprovide the required power to a large percentage of the users whilereducing the amount of interference. In some other aspects, the cellsoperate using an adaptive reuse scheme that allows the cells toefficiently allocate and reallocate the system resources to reflectchanges in the system. A reuse scheme is initially defined and resourcesare allocated to the cells. During operation, changes in the operatingconditions of the system are detected and the reuse scheme is redefinedas necessary based on the detected changes. For example, the loadingconditions of the cells can be detected, and the resources can be

]57[

Page 343: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009343

reallocated and/or the reuse scheme can be redefined. In yet otheraspects, techniques are provided to efficiency schedule datatransmissions and to assign channels to users. Data transmissions can bescheduled based on user priorities, some fairness criteria, systemrequirements, and other factors. Users are assigned to available channelsbased on a number of channel assignment schemes. Channel metrics arealso provided, which can be used to prioritize users and for channelassignments.

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

197980,The applications for divisionfrom this application havenot yet been published

__________

151772]21][11[

ืงืคืกื•ืœืจื™ ืกื•ื›ืจโ€“ืชื”ืœื™ื›ื™ื ืœื”ื›ื ืช ืจื‘ ืคื ื•ืžื•ืงื•ืงืœื™

METHODS FOR PRODUCINGPNEUMOCOCCAL CAPSULARPOLYSACCHARIDE

]54[

16.03.2001]22[US]33[16.03.2000]32[60/189847]31[

Int. Cl.(2009.01) A61K 39//09, C12N 01//20, C12P 19//00, C12Q 01//04]51[THE CHILDREN'S HOSPITAL OFPHILADELPHIA, U.S.A.

]71[

WO/2001/068903]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The invention relates to methods of modulating capsular polysaccharide production inpneumococci such as Streptococcus pneumoniae. The invention further relates tomethods of alleviating pneumococcal infections in animals, and to methods ofidentifying both agents capable of modulating pneumococcal infections in animals.Figure (1) comprising figures 1Ai-1Avi and 1Bi-1Bvi is a series of images indicating theeffect of environmental oxygen and carbon dioxide concentration on colony morphologyand capsule size, as assessed using the Quellung reaction.

]57[

Page 344: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 344

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

191962,The applications for divisionfrom this application havenot yet been published

__________

151858]21][11[

ืžืชืงืŸ ื•ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ืื™ ืฉืœื™ื˜ื” ื‘ืžืชืŸ ืฉืชืŸ ื‘ื ืงื‘ื•ืช

DEVICE AND METHOD FORTREATING URINARYINCONTINENCE IN FEMALES

]54[

21.03.2001]22[US]33[21.03.2000]32[09/531856]31[

Int. Cl.(2009.01) A61F 05//48]51[DURAMED PHARMACEUTICALS,INC., U.S.A.

]71[

WO/2001/070154]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

Provided herein is a novel and useful device and method for locallydelivering and controllably releasing oxybutynin in the cervical regionof a female. A device of the invention comprises a ring comprisingtrifluoropropylmethyl/dimethyl siloxane elastomer. A pharmaceuticalcomposition comprising oxybutynin and an excipient is placed within abore located in the ring, wherein the bore runs from the surface of thering into the ring. The ring has a sufficient size such that it can beinserted into the vaginal canal of a female. A cap comprising is placedover the bore at the surface of the ring in order to contain thepharmaceutical composition within the bore. When the ring is insertedinto the vaginal canal, the trifluoropropylmethyl/dimethyl siloxaneelastomer controllably releases and locally delivers a therapeuticallyeffective amount of oxybutynin to the detrusor muscle to treat thefemale's urinary incontinence.

]57[

__________

Page 345: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009345

152328]21][11[

ืฉืœ ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืฉื™ืœื•ื‘ื™ ื•ืชืจ ืคืงื˜ื•ืจื™ื ื“ืคื™ื‘ืจื•ื˜ื™ื“ ื•ืื—ื“ ืื•

ื”ืžื˜ื•ืคื•ืื˜ื™ื™ื ื•ืฉื™ืžื•ืฉื

FORMULATIONS CONTAINING ACOMBINATION OFDEFIBROTIDE AND ONE ORMORE HAEMATOPOIETICFACTORS AND USES THEREOF

]54[

10.04.2001]22[EP]33[18.04.2000]32[00830293.7]31[

Int. Cl.(2008.04) A61K 31/70, 38/19, A61P 7/00]51[GENTIUM SPA, ITALY]71[WO/2001/078761]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A description is given of a method of increasing the amount of stem cells andprogenitor cells in the peripheral blood of a mammal; the method is characterised bythe administration of defibrotide in combination or in temporal proximity with at leastone haematopoietic factor, (preferably G-CSF) having the capacity to mobilisehaematopoietic progenitors.

]57[

__________

152372]21][11[

ื’ื•ืฃ ื—ื™ืžื•ื ื—ืฉืžืœื™ ื˜ื‘ื•ืœ ื•ื“ื•ื“ ืžื™ื ื”ืžืฉืžืฉ ื‘ื•

ELECTRIC IMMERSIONELEMENT AND WATERHEATER USING SAME

]54[

20.10.2002]22[Int. Cl.(2008.04) F24H 1/20]51[

HAIM ื™ืจื•ื—ื, ื—ื™ื™ื ื—ื–ืŸ HAZAN]71[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Page 346: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 346

152528]21][11[

,3ืื’ื•ื ื™ืกื˜ื™ื ืื“ืจื ืจื’ื™ื™ื ืฉืœ ื‘ื˜ื ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื•ื”ื›ื ืชื

BETA3 ADRENERGIC AGONISTS,PHARMACEUTICALCOMPOSITIONS AND THEIRPREPARATION

]54[

09.07.2001]22[US]33[13.07.2000]32[60/217965]31[US19.10.2000 60/241614 US23.05.200160/292988

Int. Cl.(2009.01) A61K 31//14, A61P 03//04, C07D 20/7/333, 40/9/00]51[ELI LILLY & CO., U.S.A.]71[WO/2002/006276]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The present invention relates to a $g(b)ยฟ3? adrenergic receptor agonist of formula (I)or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energyexpenditure in cells and, therefore, is useful for treating Type II diabetes and/or obesity.The compound can also be used to lower triglyceride levels and cholesterol levels orraise high density lipoprotein levels or to decrease gut motility. In addition, thecompound can be used to reduced neurogenic inflammation or as an antidepressantagent. Compositions and methods for the use of the compounds in the treatment ofdiabetes and obesity and for lowering triglyceride levels and cholesterol levels orraising high density lipoprotein levels or for decreasing gut motility are also disclosed.

]57[

__________

Page 347: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009347

152561]21][11[

DISPOSABLE ื”ืชืงืŸ ืงื‘ื•ืข ื—ื™ืฆื•ื ื™ ื—ื“ ืคืขืžื™ EXTERNALFIXATION DEVICE

]54[

02.03.2001]22[EP]33[26.05.2000]32[00830380.2]31[

Int. Cl.(2008.04) A61B 17/64]51[ORTHOFIX S.R.L., ITALY]71[DANIELE VENTURINI, SANDORBERKI, ANTAL INSPERGER

]72[

WO/2001/091655]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to a novel disposable axial external fixation device for reducingbone fractures, of the type comprising an extendible rod-like middle body (2) andoppositely located bone screw clamps (5, 6) which are articulated to the respectiveends (3, 4) of the rod-like middle body (2) by means of ball joints. Advantageously, aball-and-socket joint (16) is mounted to each clamp (5, 6), within a main body (20) withwhich means (25, 26, 21, 22, 23) for clamping bone screws clamping is associated orco-operates. It is also provided an ancillary member (30) adapted for releasableassociation with one end of each clamp (5, 6) to better adapt each clamp for use indifferent conditions of installation of the fixation device.

]57[

__________

Page 348: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 348

152625]21][11[

ืœื ืคืคื˜ื™ื“ื™ื ืื™ืžื•ื ื’ื ื™ื™ื ืกื™ื ืชื˜ื™ื™ื ืืšbืืžื™ืœื™ื•ื“ื•ื’ื ื™ื™ื ืฉื•ื•ื™ ืขืจืš ืœืืžื™ืœื™ื•ืื™ื“

ืœืฉื ื™ืฆื™ืจืช ืชื’ื•ื‘ื” ื—ื™ืกื•ื ื™ืช ืœืืžื™ืœื™ื•ืื™ื“bื•ืœืžืฉืงืขื™ื ืืžื™ืœื™ื•ืื™ื“ื™ื™ื

SYNTHETIC IMMUNOGENIC BUTNON-AMYLOIDOGENICPEPTIDES HOMOLOGOUS TOAMYLOID B FOR INDUCTION OFAN IMMUNE RESPONSE TOAMYLOID B AND AMYLOIDDEPOSITS

]54[

22.05.2001]22[US]33[22.05.2000]32[60/205578]31[

Int. Cl.(2009.01) A61K 38//17, 39//00, A61P 03//00, 37//04, C07K 14//47, 19//00]51[NEW YORK UNIVERSITY, U.S.A.]71[WO/2001/090182]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The present invention relates to synthetic immunogenic but non-amyloidogenicpeptides homologous to amyloid $g(b) which can be used alone or conjugated to animmunostimulatory molecule in an immunizing composition for inducing an immuneresponse to amyloid $g(b) peptides and amyloid deposits.

]57[

__________

152645]21][11[

METHOD ืฉื™ื˜ื” ืขื‘ื•ืจ ื”ื”ื›ื ื” ืฉืœ ืฆื™ื˜ื”ืœื•ืคืจืื FOR THEPREPARATION OF CITALOPRAM

]54[

10.05.2001]22[DK]33[12.05.2000]32[PA200000783]31[

Int. Cl.(2009.01) C07D 30/7/00, 30/7/87]51[H. LUNDBECK A/S, DENMARK]71[WO/2001/085712]87[

',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“ ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœ

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

Page 349: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009349

A method for the preparation of citalopram comprising reaction of acompound of formula 5-aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran with an oxidising agent toprepare citalopram.

]57[

__________

152770]21][11[

ืฉื™ืžื•ืฉ ื‘ืื ืœื•ื’ื™ื ืฉืœ ื’ืื‘ืืคื ื˜ื™ืŸ ืœื”ื›ื ืช ืชื›ืฉื™ืจื™ื ืœื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ืฉื™ื ื”

GABAPENTIN ANALOGUES FORUSE IN THE PREPARATION OFCOMPOSITIONS FOR TREATINGSLEEP DISORDERS

]54[

18.05.2001]22[US]33[26.06.2000]32[60/214171]31[

Int. Cl.(2008.04) A61K 311/97, A61P 25/00, C07C 229/28]51[WARNER-LAMBERT COMPANYLLC, U.S.A.

]71[

WO/2002/000209]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The invention provides a new use of compounds for formula (1) or (1A) or apharmaceutically acceptable salt thereof. The compounds are useful in the treatment ofinsomnia and related disorders.

]57[

__________

Page 350: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 350

152786]21][11[

ืชื—ื‘ื•ืฉืช ืขื•ืจื™ืช ืœื”ืงืœื” ืขืœ ื”ืกื™ืžืคื˜ื•ืžื™ื ืฆื™ื ื•ืŸ ื•ื’ื•ื“ืฉ ื‘ืืฃ, ืฉืœ ืฉื™ืขื•ืœ

SKIN PATCH FOR THE RELIEFOF THE SYMPTOMS OF COUGH,COLD AND NASALCONGESTION

]54[

12.05.2000]22[Int. Cl.(2009.01) A61K 09//00, 09//70]51[LECTEC CORPORATION, U.S.A.]71[WO/2001/089475]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A vaporizable decongestant is supported and stabilized on a flexible foraminous carriercomposed typically of open-cell plastic foam, cloth or other fibrous material such asnonwoven fabric. The term 'foraminous' herein is intended to refer to a substance ormedium containing minute openings or perforated by many minute apertures. Thedecongestant is placed on the surfaces within the interstices and minute apertures oron fibers from which the foraminous carrier is formed. Vaporization of the inhalabledecongestant is facilitated by providing the potential for greatly increasing its exposedsurface area. Distributing the decongestant composition over the large, expandedsurface within the foraminous carrier is beneficial in enhancing both the volatilizationand evaporation of the decongestant agent. It also prolongs the useful life of theproduct. Once vaporized, the aromatic decongestant is available for natural inhalationthrough the nose or mouth to help relieve one or more of the symptoms of cough,colds, nasal or chest congestion and related symptoms. The foraminous carrier ispreferably provided in the form of a patch or sheet that is bonded to the skin to serveas a supporting base for the active decongestant agent. The patch defining the carrieris typically adhesively bonded to the upper part of the body, e.g. on the face, neck orchest, in a location where the decongestant is liberated into the air and can be inhaledthrough the mouth or nose.

]57[

__________

Page 351: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009351

153100]21][11[

ื— PARTICULATE ืœืงื™ืงื™ืื•ืงืกื™ื“ ืžืชื›ืชื™ METAL OXIDE]54[

25.06.2001]22[GB]33[26.06.2000]32[0015381.7]31[

Int. Cl.(2008.04) C01B 13/14, C01G 230/53, C09C 1/36]51[CRODA INTERNATIONAL PLC,UNITED KINGDOM

]71[

WO/2002/000797]87[',ื”ื•ืจื•ื‘ื™ืฅ ื•ืฉื•ืช.ืฉ

ืชืœ, 41-45ื“ืจื•ืช ืจื•ื˜ืฉื™ืœื“ืฉ, ื‘ื™ืช ืฆื™ื•ืŸ ืื‘ื™ื‘

S. HOROWITZ & CO.,ZION HOUSE,

41-45 ROTHSCHILD BLVD.,TEL AVIV 65784

]74[

A particulate metal oxide having the mean length of the primaryparticles in the range from 50 to 90 nm, the mean width of the primaryparticles in the range from 5 to 20 nm, and the median volume particlediameter of the secondary particles is less than 45 nm. The metal oxidecan be used in a sunscreen product that exhibits both effective UVprotection and improved transparency.

]57[

__________

153257]21][11[

ืฉื™ื—ื” ืืœืงื˜ืจื•ื ื™ืช ื•ื”ืขื‘ืจื” ืžื™ื“ื™ืช ืฉืœ ืฉื™ื—ื” ืขื ืžื™ื“ืข ื“ื™ื•

ELECTRONIC CHAT ANDINSTANT MESSAGING WITH INKDATA

]54[

01.06.2001]22[US]33[19.06.2000]32[09/596926]31[

Int. Cl.(2008.04) G06F 13/00, 3/00]51[INTEL CORPORATION, U.S.A.]71[WO/2001/098929]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A method and apparatus for implementing ink data communication between multipleparties using computing and/or communication devices on a network is disclosed. Anelectronic chat system comprising a hardware interface layer for receiving raw ink datafrom an input device, an ink management layer for processing the raw ink data into aform usable by a chat interface layer, and a network interface layer for transferring theprocessed ink data across a network to a chat interface layer on a remote computer.

]57[

Page 352: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 352

__________

153719]21][11[

ืžื›ืฉื™ืจ ื•ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ืชื•ืš ื ืจืชื™ืงื™ ืื•, ื—ื•ืฅ ื ืจืชื™ืงื™ ื‘ื“ืœืงื•ืช ืคื™ื˜ืจื™ืชื™ื•ืช

ื•ื™ืจืืœื™ื•ืช ืื• ื˜ืคื™ืœื™ื•ืช, ื—ื™ื™ื“ืงื™ื•ืช

DEVICE AND METHOD FORINTRAVAGINAL ORTRANSVAGINAL TREATMENTOF FUNGAL,BACTERIAL, VIRAL ORPARASITIC INFECTIONS

]54[

25.06.2001]22[US]33[11.07.2000]32[09/613441]31[

Int. Cl.(2008.04) A61F 6/06, A61K 9/00]51[UMD, INC., U.S.A.]71[WO/2002/003896]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

Devices, methods, and compositions for treating vaginal fungal,bacterial, viral and parasitic infections by intravaginal or transvaginaladministration of therapeutic and/or palliative antifungal, antibacterial,antiviral or parasiticidal drugs to the vagina or to the uterus.

]57[

__________

Page 353: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009353

153804]21][11[

ื ื’ื–ืจื•ืช ื˜ื™ืจื•ื–ื™ืŸ ื•ืชื›ืฉื™ืจื™ื ืคืจืžืฆื‘ื˜ื™ื™ื ื›ื™ืœื™ื ืื•ืชืŸื”ืž

TYROSINE DERIVATIVES ANDPHARMACEUTICALFORMULATIONS CONTAININGTHEM

]54[

05.07.2001]22[US]33[06.07.2000]32[60/216201]31[

Int. Cl.(2008.04) A61K 31/10, 31/18, A61P 3/10, 35/00, C07C 311/06, 311/13,311/19, 311/29, 317/28, 317/32, 323/24, 323/31

]51[

ARRAY BIOPHARMA INC., U.S.A.AMGEN INC., U.S.A.

]71[

WO/2002/004412]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Disclosed are compounds of the Formula (I), and pharmaceutically acceptable saltsand prodrugs thereof, wherein A, B, R?1ยฟ, R?2ยฟ, R?3ยฟ, R?4ยฟ and R?5ยฟ are asdefined in the specification. Such compounds are tyrosine phosphatase inhibitors anduseful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed bythe invention are formulations comprising the noted compounds, processes forpreparing such compounds, a method for treating or preventing Type II DiabetesMellitus.

]57[

__________

154130]21][11[

ISO-TRUSS ืงื•ืจื•ืชโ€“ืžื‘ื ื” ืฉื•ื•ื” STRUCTURE]54[

27.07.2001]22[US]33[28.07.2000]32[60/221445]31[

Int. Cl.(2008.04) B62K 19/02, E01D 6/00, E01F 90/11, E04C 3/08, E04H 12/00]51[BRIGHAM YOUNG UNIVERSITY,U.S.A.

]71[

WO/2002/010535]87[,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸ

ื”ืจืฆืœื™ื”, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

Page 354: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 354

An iso-truss structure (10) includes at least two helical components (30, 32) and atleast one reverse helical component (34) attached thereto with opposing angularorientations. Each helical and reverse helical component preferably includes at leastfour elongate, straight segments (22) rigidly connected end to end in a helicalconfiguration forming a single, substantially complete rotation about a common axis(14) forming a first square cross section. The structure may further include at least tworotated helical components (80, 92) and at least one rotated reverse helical component(98) which are rotated with respect to the helical and reverse helical componentsforming a second square cross section, rotated with respect to the first. The structuremay be straight, curved, flexible, or form angles.

]57[

__________

154334]21][11[

ืžืขืจื›ืช ืœืชืงืฉื•ืจืช ื‘ื™ืŸ ืžื“ื•ืจ ืคื ื™ืžื™ ืœืžื“ื•ืจ ื—ื™ืฆื•ื ื™

SYSTEM FOR PROVIDINGCOMMUNICATION BETWEENTHE INTERIOR AND THEEXTERIOR OF ACOMPARTMENT

]54[

13.08.2001]22[GB]33[18.08.2000]32[0020272.1]31[

Int. Cl.(2009.01) G21F 07//005]51[ASEPTIC TECHNOLOGIES S.A.,BELGIUM

]71[

WO/2002/017332]87[,ื•ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A system for making a connection between the interior and exterior of a compartment,comprising a door opening through the compartment wall, a connector body which canengage with the wall, and having a connection port through it, and a removable coveron the connector body. The body is engaged with the door opening, and an inner doorwithin the compartment engages and removes the cover. A preferred constructioncreates a single line of confidence seal. The system is particularly suited for sterilecompartments.

]57[

Page 355: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009355

__________

154495]21][11[

ErbB4ืฉื™ืžื•ืฉ ื‘ื ื•ื’ื“ ืกืคืฆื™ืคื™ ืœืจืฆืคื˜ื•ืจ ื˜ื‘ืขื™ ืœื™ืฆื•ืจ ืชืจื•ืคื” ืœื˜ื™ืคื•ืœ ื‘ืกื˜ื ื•ื–ื™ืก

USE OF AN ANTAGONISTSPECIFIC FOR A NATIVE ERBB4RECEPTOR IN THEMANUFACTURE OF AMEDICAMENT FOR THETREATMENT OF STENOSIS

]54[

29.08.2001]22[US]33[01.09.2000]32[60/229679]31[US31.01.2001 60/265516 US27.08.200109/940101

Int. Cl.(2009.01) A61K 39//395, C07K 16//28]51[GENENTECH, INC., U.S.A.]71[WO/2002/018444]87[

',ื”ื•ืจื•ื‘ื™ืฅ ื•ืฉื•ืช.ืฉืชืœ, 41-45ืฉื“ืจื•ืช ืจื•ื˜ืฉื™ืœื“, ื‘ื™ืช ืฆื™ื•ืŸ

ืื‘ื™ื‘

S. HOROWITZ & CO.,ZION HOUSE,

41-45 ROTHSCHILD BLVD.,TEL AVIV 65784

]74[

The present invention concerns methods and means for controlling excessiveproliferation and/or migration of smooth muscle cells, and in particular for treatingstenosis, by using antagonists of a native ErbB4 receptor. The invention furtherconcerns a method for the identification of ErbB4 agonists and antagonists capable ofinhibiting or enhancing the proliferation or migration of smooth muscle cells.

]57[

__________

Page 356: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 356

154538]21][11[

ืจื™ืืงืฆื™ืช ื”ืคื—ืžืŸ ื”ืฉื—ื•ืจ ืขื ืžืœื—ื™ืชื•ืฆืจื™ ื”ืคื—ืžืŸ ื”ืฉื—ื•ืจ ื”ื ื•ืฆืจื™ื, ื“ื™ืื–ื•ื ื™ื•ื

ืžื›ืš

REACTION OF CARBON BLACKWITH DIAZONIUM SALTS,RESULTANT CARBON BLACKPRODUCTS AND THEIR USES

]54[

13.12.1995]22[US]33[15.12.1994]32[356660]31[

Int. Cl.(2008.04) C01B 31/08, C08K 9/04, C09C 1/56, 3/08, D01F 11/14, D21H17/67

]51[

DIVISION FROM 116377]62[CABOT CORPORATION, U.S.A.]71[

',ืจื™ืืœื™ ื•ืฉื•ืชื–ืœื™ื’ืกื•ืŸ ื’ื‘ ืชืœ ืื‘ื™ื‘, 1426.ื“.ืช,31ื™ื‘ื ื”' ืจื—

SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,

P.O.B. 1426,TEL AVIV 61013

]74[

A carbon black product having attached to the carbon black either an aliphatic group ora cyclic group selected from alicyclic hydrocarbon groups and heterocyclic hydrocarbongroups, said groups being substituted by a functional group selected from the consisting of OR, COR, COOR, OCOR, halogen, NR2, SO3H, sulfonate salts, OSO3H, OSO3 saltsNR(COR), CONR2, NO2 PO3H2, phosphonate salts, phosphate salts, NR3

+X-, PR3+X-,

SkR, SS03H, SS03 salts, S02NRR', S02SR, SNRR', SNQ, S02NQ, C02NQ, S-(1,4-piperazinediyl)-SR, 2-(1,3-dithianyl), 2(1,3-dithiolanyl), SOR, and S02R; when theattached group is an aliphatic group it may also be substituted by a functional groupselected COOLi, COONa, COO+NR4

+, and when the attached group is a cyclic group itmay also be substituted by a functional group selected from R, CN, N=NR or acarboxylate salt, wherein R and R' nay be the same or different, branched orunbranced C1-C20 unsubstituted or substituted alkyl, alkenyl or alkynyl; unsubstituted orsubstituted aryl; unsubstituted or substituted heteroaryl; unsubstituted or substitutedalkylaryl; or unsubstituted or substituted arylalkyl groups, and when the ๏ฟฝ roup attachedto the carbon black is a cyclic group R and R' may also be hydrogen, k is an integerfrom 1 to 8; X-is a halide or an anion derived from a mineral or organic acid; and Q is(CH2)w, (CH2)xO(CH2)z, (CH2)xNR(CH2)z or (CH2)xS(CH2)z where x is 1 to 6, z is 1 to 6,and w is 2 to 6.

]57[

__________

154581]21][11[

JOINT ืžืคืจืง ืœื—ื™ื‘ื•ืจ ืฉื ื™ ืฉืœื‘ื™ื ืฉืœ ืžื•ื˜ FOR CONNECTING TWOADJACENT SECTIONS OF AROD

]54[

23.02.2003]22[Int. Cl.(2009.01) F16B 07//00]51[

REFAEL ืžื•ืฉื‘ ื‘ื ื™ ืขื˜ืจื•ืช, ืจืคืืœ ืคืœื“ PELED]71[,ืจืคืืœ ืคืœื“

ืžื•ืฉื‘ ื‘ื ื™ ืขื˜ืจื•ืช,REFAEL PELED,MOSHAV BENE ATAROT

]74[

Page 357: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009357

:ื”ืžืคืจืง ืžื›ื™ืœ,)10(ืžืคืจืง ืœื—ื™ื‘ื•ืจ ืฉื ื™ ืฉืœื‘ื™๏ฟฝ ืกืžื•ื›ื™๏ฟฝ ืฉืœ ืžื•ื˜]57[;ืฉืœ ื”ืžื•ื˜)1(ื”ืžืงื•ื‘ืข ืœืฉืœื‘ ืจืืฉื•), ื‘ืขืœ ืžื‘ื ื” ืžืจื—ื‘ื™ ืงื•ื ื™ ื–ื›ืจื™, ื ื‘ื•ื‘)3(, ืคืจืง ืจืืฉื•)

ืฉืœ)5(ื•ื‘ืข ืœืฉืœื‘ ืฉื ื™ ื”ืžืง, ื‘ืขืœ ืžื‘ื ื” ืžืจื—ื‘ื™ ืงื•ื ื™ ื–ื›ืจื™ ื•ื ื‘ื•ื‘)4(, ืคืจืง ืฉื ื™ ื”ืกืžื•1 ืœืฉืœื‘ ื”ืจืืฉื•)ืžื‘ื ื”ื• ื”ืžืจื—ื‘ื™ ืฉืœ ื”ืคืจืง ื‘ืขืœ ื”ืžื‘ื ื” ื”ืงื•ื ื™ ื”ื–ื›ืจื™ ืžืชืื™๏ฟฝ ืœืžื‘ื ื”ื• ื”ืžืจื—ื‘ื™ ืฉืœ ื”ืคืจืง ื‘ืขืœ, ื”ืžื•ื˜

ืžืฉื™ื›ื” ื’ืžื™ืฉ ื”ืขื•ื‘ืจ ื‘ืžืจื›ื– ื”ืคืจืงื™๏ฟฝ ื•ืžื—ื•ื‘ืจ ืžืฆื™ื“ื• ื”ืื—ื“ ืœืฉืœื‘)6(ื•ืžื ื’ื ื•); ื”ืžื‘ื ื” ื”ืงื•ื ื™ ื”ื ืงื‘ื™ืœ, ื”ืจืืฉื•) ื•ืžืฆื™ื“ื• ื”ืฉื ื™ ืœืฉืœื‘ ื”ืฉื ื™ .ื–ื”ืœืฆื•ืจ1 ื”ืฆืžื“ืช ื”ืฉืœื‘ื™๏ฟฝ ื–ื”

__________

154663]21][11[

ืฉื™ื˜ื” ืœืงื‘ื™ืขืช ื“ืจื’ืช ื”ืžืชื™ืœืฆื™ื” ืฉืœโ€“3'ืฆื™ื˜ื•ื–ื™ื ื™ื ืžื•ื’ื“ืจื™ื ื‘ื“ื ื ื’ื ื•ืžื™ ื‘ืจืฆืฃ

CPG โ€“ '5

METHOD FOR DETERMININGTHE DEGREE OFMETHYLATION OF DEFINEDCYTOSINES IN GENOMIC DNA INTHE SEQUENCE CONTEXT 5'-CPG-3'

]54[

01.09.2001]22[DE]33[01.09.2000]32[10043826.1]31[DE05.09.2000 10044543.8

Int. Cl.(2008.04) C12Q 1/68]51[EPIGENOMICS AG, GERMANY]71[WO/2002/018632]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a method for detecting the degree ofmethylation of a defined cytosine in the sequence context 5โ€ฒ-CpG-3โ€ฒ of agenomic DNA sample. The first stage involves chemically treating thegenomic DNA in such a way that the cytosine bases, but not the 5-methylcytosine bases, are converted into uracil. Parts of the genomicDNA containing the defined cytosine are then amplified. The amplifiedparts are given a detectable mark and the extent of the hybridisation ofthe amplified parts on the two classes of oligonucleotides is thendetermined by detecting the mark of the amplified parts. The degree ofmethylation of the defined cytosine in the genomic DNA sample can bededuced on the basis of the relationship between the marks detected onthe two classes of oligonucleotides following the hybridisation.

]57[

__________

Page 358: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 358

154897]21][11[

HIGH ืกื’ืกื•ื’ืช ืžื’ื ื–ื™ื•ื ื—ื–ืงื” ืžืื“ ื•ืฉื™ื˜ืช ื”ื›ื ืชื” STRENGTH MAGNESIUMALLOY AND ITS PREPARATIONMETHOD

]54[

26.09.2000]22[Int. Cl.(2008.04) C22C 23/04]51[KWANG SEON SHIN, REPUBLICOF KOREA

]71[

WO/2002/027053]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

ืจื—ื•ื‘ื•ืช, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ืSANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The present invention provides high strength magnesium alloys consisting essentiallyof 3 $m(k) 10 wt.% Zn, 0.25 $m(k) 3.0 wt.% Mn, and the balance of Mg and inevitableimpurities, the high strength magnesium alloy further containing 1 $m(k) 6 wt.% Al, 0.1$m(k) 4.0 wt.% Si, and 0.1 $m(k) 2.0 wt.% Ca, in order to provide a high strengthmagnesium alloy having an improved hardness and strength, and an excellentelongation at an ambient temperature. In addition, the present invention provides amethod for preparing the high strength magnesium alloy characterized in that a Zn-Mnmother alloy is added to a magnesium melt by a fluxless melting method, and processconditions for working and heat-treating an obtained cast material.

]57[

__________

Page 359: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009359

155183]21][11[

, ืงืกื™ืœื™ื•ืชื—ื•ืžืฆื•ืช ืงืจื‘ื•โ€“3โ€“ืื•ืงืกืืคื ืืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชื” ื•ืฉื™ืžื•ืฉ

ื‘ื”ืŸ

OXAPENEM - 3 - CARBOXYLICACID, PHARMACEUTICALCOMPOSITIONS CONTAINING ITAND USES THEREOF

]54[

11.10.2001]22[EP]33[19.10.2000]32[00309207.9]31[GB08.03.2001 0105766.0 GB06.08.20010119165.9

Int. Cl.(2009.01) A61K 09//00, 31//424, 47//10, A61P 31//04, C07D 50/3/00]51[AMURA LIMITED, UNITEDKINGDOM

]71[

WO/2002/032423]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

An oxapenem compound which is, or is capable of forming, a zwitterionof formula Ia or Ib: (Ia), (Ib) wherein R is a Cยฟ1?-Cยฟ8? branched orstraight chain alkyl group which includes a protonated basic substituent.The compounds find particular use as high bioavailability $g(b)-lactamase inhibitors.

]57[

__________

155507]21][11[

PESTICIDAL ืชื›ืฉื™ืจ ืงื•ื˜ืœ ืžื–ื™ืงื™ื COMPOSITION]54[

22.10.2001]22[JP]33[23.10.2000]32[2000-322558]31[

Int. Cl.(2008.04) A01N 43/40, C07D 213/82, 417/12]51[ISHIHARA SANGYO KAISHA LTD.,JAPAN

]71[

WO/2002/034050]87[ืขื•ืจื›ื™ ื“ื™ืŸ ื•ืขื•ืจื›ื™, ืงื‘ื•ืฆืช ืื™ืชืŸ ืžื”ื•ืœืœ

,ืคื˜ื ื˜ื™ื ื”ืจืฆืœื™ื”, 2081.ื“.ืช,10ืฉื“ืจื•ืช ืื‘ื ืื‘ืŸ

EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,

P.O. B. 2081,HERZLIYA 46120

]74[

A pesticidal composition comprisinig a pesticidally effective amount of at least one of apyridic compound of the formula (I) or it salt and at least one of otherpesticides:wherein Y is a haloalkyl group, m is 0 or 1, and Q is or a substituted orunsubstituted heterocyclic group, (wherein X is an oxygen atom or a sulfur atom, R?1ยฟand R?2ยฟ are respectively independently a hydrogen atom, a substituted orunsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or

]57[

Page 360: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 360

unsubstituted alkynyl group, a substituted or unsubstituted cycloalkyl group, and thelike.

__________

155545]21][11[

SOLVATE ืฆื•ืจืช ืกื•ืœื‘ืื˜ ืฉืœ ืงื‘ืจื’ื•ืœื™ืŸ FORM OFCABERGOLINE

]54[

21.04.2003]22[Int. Cl.(2008.04) C07D 457/06]51[

FINETECH ื ืฉืจ,ืž"ืคื™ื™ื ื˜ืง ืคืืจืžืฆื‘ื˜ื™ืงื” ื‘ืข PHARMACEUTICALLTD.

]71[

,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

Amorphous physical form of cabergoline substantially free of other physical forms,which is characterized by a halo x-ray powder diffraction pattern having a range ofsignals from between about 15 to about 23 degrees 2-theta.

]57[

__________

Page 361: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009361

155801]21][11[

ืจืฆืฃ ื—ื•ืžืฆืช ื’ืจืขื™ืŸ ื”ืžืงื•ื“ื“ ืงื™ื ื–ื™ื ืกืคืฆื™ืคื™ื ืœืืฉืš ืื ื•ืฉื™

NUCLEIC ACID SEQUENCEENCODING HUMAN TESTISSPECIFIC KINASES

]54[

09.11.2001]22[US]33[09.11.2000]32[60/246939]31[US30.01.2001 60/264921

Int. Cl.(2008.04) A01K 670/27, A61K 38/45, A61P 15/16, C07K 16/40, C12N 15/52,15/54, 9/12

]51[

UNIVERSITY OF VIRGINIAPATENT FOUNDATION, U.S.A.GREGORY S. KOPF, U.S.A.

]71[

WO/2002/038732]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The present invention relates to a family of testis specific kinases (thetssk family), nucleic acid sequences encoding those kinases andantibodies against the kinases. The invention is further directed to theuse of thise kinases as targets for isolating specific inhibitors oranagonists of tssk kinase activity. Such inhibitors are anticipated to haveuse as contraceptive agents.

]57[

__________

155901]21][11[

โ€“ืชื”ืœื™ืš ื”ืคืจื“ื” ืกื•ืคื— ืœืงื‘ืœืช ืคืืจื ืงืกื™ืœืŸ

ADSORPTIVE SEPARATIONPROCESS FOR RECOVERY OFPARA-XYLENE

]54[

15.11.2001]22[US]33[16.11.2000]32[713082]31[

Int. Cl.(2008.04) C07C 7/13]51[UOP LLC, U.S.A.]71[WO/2002/040432]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The performance of an adsorptive separation process recovering para-xylene from a Cยฟ8? aromatic hydrocarbon feed mixture is improved byoperating the process at higher desorbent purity. The improved

]57[

Page 362: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 362

performance allows for tradeoffs in other operating parameters and ratesor improved product rates. The process preferably employs a bariumand potassium exchanged zeolitic molecular sieve as the adsorbent andtoluene as the desorbent.

__________

156049]21][11[

TAPPING ื‘ืจื– ROD]54[

21.11.2001]22[NL]33[23.11.2000]32[1016687]31[

Int. Cl.(2008.04) B67D 1/08]51[HEINEKEN TECHNICAL SERVICESB.V, THE NETHERLANDS

]71[

WO/2002/048019]87[,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸ

ื”ืจืฆืœื™ื”, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

A tapping rod (2) with a beverage valve (16), a gas valve (14) cooperating therewith,and a collar (24), while in or on the collar a connecting device (26) is fitted, whichconnecting device comprises a pressure body (30) for opening the beverage valve (16)and the gas valve (14), wherein: the pressure body (30) comprise or defines at leastone first beverage channel (50) for bringing, with the beverage valve in open position,the inner space of a keg, in particular a riser of the taping rod, into fluid communicationwith a beverage dispensing line; the pressure body comprises or defines at least onegas channel (48) for bringing, with the gas valve in open position, the inner space of thekeg into fluid communication with a gas supply line.

]57[

__________

Page 363: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009363

156115]21][11[

ื“ื STENT ืžืขืจื›ืช ืœืžื™ืงื•ื ืชื•ืžืš ืœื›ืœื™ POSITIONING SYSTEM]54[

26.05.2003]22[Int. Cl.(2008.04) A61F 2/06, A61M 29/00]51[

,ืž"ื”ื“ืกื™ืช ืฉืจื•ืชื™ ืžื—ืงืจ ืจืคื•ืื™ ื•ืคื™ืชื•ื— ื‘ืข ื™ืจื•ืฉืœื™ื

HADASIT MEDICAL RESEARCHSERVICES & DEVELOPMENTLTD.

]71[

, ื™ืก ื•ืจืฉื™ืฆืงื™ื‘ื•ืจ, ื ื—ื•ื ื‘ื•ืจื™ื‘ืงืจ, ื—ื™ื™ื ืœื•ื˜ืŸ ืžื•ืจื™ืก ืžื•ืกืจื™

HAIM LOTAN, NACHUMBORIVKER, BORIS VARSHITSKY,MORRIS MOSSERI

]72[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A stent positioning system, comprising: a guide catheter 912); an inflatable balloon (22)connected to said catheter for expanding a stent, said balloon, in its collapsed state,fitting into and being adapted to carry said stent in its pre-expanded condition;characterized by a stent locator means (14) slidably coupled to said guide catheter andadapted to change its shape from a contracted shape extending along said guidecatheter to an expanded shape extending laterally from said guide catheter, andmechanical means for changing the shape of said stent locator means; wherein thechange of shape enables said locator means to about an interior wall surface of amajor blood vessel in the ostial region of a smaller blood vessel branching off from saidmajor blood vessel, therby ensuring correct position between the stent and an ostium ofsaid smaller blood vessel.

]57[

__________

156227]21][11[

MULTILAYER ืจืฆื•ืขื” ื“ืงื” ืจื‘ ืฉื›ื‘ืชื™ืช ืฉืœ ื’ื˜ืจ ืžื™ืžืŸ THIN FILMHYDROGEN GETTER

]54[

26.09.2002]22[US]33[28.09.2001]32[09/965759]31[

Int. Cl.(2008.04) H01L 23/26]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/028096]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Page 364: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 364

A thin film hydrogen getter is provided for protecting GaAs circuitry sealed in anhermetic package. The thin film getter which comprises a multilayer metal film which isdeposited by vacuum evaporation techniques onto a surface of the packaging. Themultilayer film comprises (1) a titanium film and (2) palladium film which is depositedonto the titanium film. Both the titanium and the palladium are deposited during thesame coating process run, thereby preventing the titanium from being oxidized. Thepalladium continues to prevent the titanium from being oxidized once the getter isexposed to the atmosphere. However, hydrogen is easily able to diffuse through thepalladium into the titanium where it is chemically bound up, since palladium is highlypermeable to hydrogen. If EMI shielding is desired, a conductive metal, such asaluminum or copper, can first be formed between the packaging and the titanium layer.

]57[

__________

156254]21][11[

ANALYTE ื”ืชืงืŸ ืœื‘ื—ื™ื ืช ืžื•ืžืก TESTING DEVICE]54[

02.06.2003]22[GB]33[05.06.2002]32[0212920.3]31[

Int. Cl.(2008.04) G01N 334/87]51[DIABETES DIAGNOSTICS, INC.,U.S.A.

]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A testing device (100) for testing an analyte in a sample of bodily fluid, comprising:memory storing data, said data being analyte data related to analyte measurementscarried out by the testing device and lifestyle data, and the analyte data includes apointer to a bodily location from which an analyte sample was taken by an individualusing the testing device, wherein the testing device utilizes a plurality of data pointers,each of said data pointers indicating a separate bodily location; initiation means (102)for initiating immediate entry of data related to a specific category of lifestyle data;navigation means (104) for entry and navigation of said data; and transfer means fortransferring said data to said memory.

]57[

Page 365: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009365

__________

156277]21][11[

ืชืจื•ืคื•ืช ื”ืžื›ื™ืœื•ืช, ื ื’ื–ืจื•ืช ืงื•ื•ื™ื ืื–ื•ืœื™ืŸืฉื™ืžื•ืฉ ื‘ื”ืŸ ื•ืฉื™ื˜ื”, ืชืจื›ื•ื‘ื•ืช ืืœื•

ืœื”ื›ื ืชืŸ

QUINAZOLINE DERIVATIVES,MEDICAMENTS CONTAININGSAID COMPOUNDS, THEIRUTILIZATION AND METHODFOR THE PRODUCTIONTHEREOF

]54[

12.12.2001]22[DE]33[20.12.2000]32[10063435.4]31[

Int. Cl.(2008.04) A61K 314/95, C07D 239/94]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY

]71[

WO/2002/050043]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to quinazoline derivatives of general formula (I),wherein Rยฟa?, Rยฟb? and Rยฟc? have the meaning defined in claim 1, totheir tautomers, their stereoisomers and their salts, especially theirphysiologically acceptable salts with inorganic or organic acids. Saidcompounds have valuable pharmacological properties, especially aninhibiting effect upon signal transduction caused by tyrosine kinase.The invention further relates to their utilization in the treatment ofdiseases, especially of tumoral diseases, diseases of the lung and therespiratory tract and to the production of said compounds.

]57[

Page 366: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 366

__________

156330]21][11[

ARTICLE ืžืขืจื›ืช ืœื”ืขื‘ืจืช ืคืจื˜ื™ื TRANSFER SYSTEM]54[

05.06.2003]22[Int. Cl.(2008.04) G05G 11/00]51[

NOVA ืจื—ื•ื‘ื•ืช,ืž"ื ื•ื‘ื” ืžื›ืฉื™ืจื™ ืžื“ื™ื“ื” ื‘ืข MEASURINGINSTRUMENTS LTD.

]71[

ื• ,ืฉื•ืชืคื™ื•ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A system (100) for controlling a movement of an article, the system comprising: asupport stage assembly (112); a spring suspension arrangement (110) mounted onsaid support stage assembly and comprising first and second assemblies (114A, 114B)arranged in a coaxial relationship with respect to the axis of the article movement, andone inside the other, the first assembly being attached to said support stage assemblyand the second assembly serving for supporting an article-carrying member (118) andbeing driven for a movement along said axis of the article movement with respect to thefirst assembly, the outer one of the first and second assemblies being configured todefine two spaced-apart parallel planes perpendicular to said axis of the articlemovement, said first and second assemblies being attached to each other by first andsecond membrane members (M1 M2) arranged in a spaced-apart parallel relationshipalong said axis of the article movement; and a motor operable for rotating said supportstage assembly around said axis, said motor being located inside the inner one of saidfirst and second assemblies.

]57[

__________

Page 367: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009367

156579]21][11[

INJECTION ืชืงืŸ ื”ื–ืจืงื”ื” DEVICE]54[

30.07.1998]22[GB]33[31.07.1997]32[9716065.9]31[

Int. Cl.(2009.01) A61M 05//178]51[DIVISION FROM 134284]62[ARES-TRADING S.A.,SWITZERLAND

]71[

WO/1999/006100]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื•ืฉืœื™ืื™ืจ, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

An injection device has a barrel (1) for housing and guiding a syringe (13) as it is urgedforward to project its needle (14), while the dose is ejected, and as a return spring (22)retracts it. A firing mechanism (6) is connectable to the rear end of the barrel and is re-usable, whereas the barrel (1) with its spent syringe (13) is disposable. The connection(4) has limited freedom of axial movement so that, once made, forward pressure on thefiring mechanism (6) moves the syringe (13) up to a ready position. A number of barrels(1) with syringes (13) can be housed in a common box (31) with a single firingmechanism (6), the forward end of each barrel (1) being screwed to a locator (32) onthe base of the box. The engagement of the firing mechanism (16) with the rear end ofeach barrel (1) is also screw-threaded, but of opposite hand, so that screwing the firingmechanism (6) on and continuing to turn releases the complete device; andcorrespondingly the barrel (1) can be returned and located in the box (31) while thefiring mechanism (6) is separated from it.

]57[

__________

Page 368: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 368

156626]21][11[

SYSTEM ืžืขืจื›ืช ืœื”ืจื™ืกืช ืชืื™ื ืกืœืงื˜ื™ื‘ื™ืช FOR SELECTIVE CELLDESTRUCTION

]54[

24.06.2003]22[Int. Cl.(2009.01) G01N 21//00]51[

YEDA ืจื—ื•ื‘ื•ืช,ืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD.

]71[

YARON ื“ืŸ ืื•ืจื•ืŸ, ื“ื‘ื™ืจ ื™ืœื™ืŸ, ื™ืจื•ืŸ ื–ื™ืœื‘ืจื‘ืจื’ SILBERBERG, DVIRYELIN, DAN ORON

]72[

,ืž"ื‘ืข) 1995(ืืจืœื™ืš.ืื™.ื™'ื’,11ืžื ื—ื ื‘ื’ื™ืŸ ืจื—ื•ื‘,15ืงื•ืžื”, ืžื’ื“ืœ ืื™ืœื•ืŸ

ืจืžืช ื’ืŸ

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A system (10) for destroying living cells (12), the cells being characterized by anionization threshold, the system comprising: an optical device (14) for providing at leastone optical pulse having an optical field power which is smaller than the ionizationthreshold of the cells; and a mechanism (16) for locally increasing said optical fieldpower per unit area beyond the ionization threshold of the cells, thereby destroying thecells via ionization.

]57[

__________

Page 369: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009369

156764]21][11[

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ื™ืฆื•ืข ืžืกื™ืจื” ืงืฉื™ื—ื” ืžืกื•ื™ื™ืขืช ื ื™ื™ื“ื•ืช ื‘ื™ืŸ ืžืขืจื›ื•ืช ืชืงืฉื•ืจืช

METHOD AND APPARATUS FORPERFORMING MOBILEASSISTED HARD HANDOFFBETWEEN COMMUNICATIONSYSTEMS

]54[

19.12.1997]22[US]33[15.01.1997]32[08/784280]31[

Int. Cl.(2008.04) H04Q 7/38]51[DIVISION FROM 130734]62[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/1998/032262]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

In a wireless communication system wherein a mobile station (M1, M2, M3) is movingfrom the coverage area of an origination system (51) operating at a first frequency intothe coverage area of a destination system (52) operating at a second frequency, amethod for providing handoff from said origination system to said destination system,the method comprising: predicting at least one PN offset associated with thedestination system; transmitting, at the first frequency, from said origination system tosaid mobile station a set of search parameter data associated with the at least one PNoffset; determining at said mobile station the availability of said destination system inaccordance with said set of search parameter data; transmitting from said mobilestation to said origination system a message indicative of the received strength ofsignals associated with the at least one PN offset measured at the mobile station;generating at said origination system a set of acquisition parameters in accordancewith said message from said mobile station; and attempting at said mobile station toacquire said destination system in accordance with said set of acquisition parameters.

]57[

ืงื” ืžื‘ืงืฉื” ื–ื• ื‘ืงืฉื•ืช ื—ืœื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198051,The applications for divisionfrom this application havenot yet been published

__________

Page 370: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 370

156858]21][11[

ืฉืœ ื”ืงืฆืืช ืงื‘ื•ืฆื•ืช ืฉืœ ืืœืžื ื˜ื™ืื‘ืžืขืจื›ืช) ื”ืกืจืช ื•ื•ื™ืกื•ืช(ื“ื™ืžื•ื“ื•ืœืืฆื™ื”

ื˜ื•ื•ื— ื ืจื—ื‘

ASSIGNING CLUSTERS OFDEMODULATION ELEMENTS INA SPREAD SPECTRUM SYSTEM

]54[

10.01.2002]22[US]33[11.01.2001]32[60/261402]31[US28.09.2001 09/968344

Int. Cl.(2008.04) H04B 17/07, 7/06, H04J 13/02, H04K 1/00]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2002/056495]87[ื˜ืกื ืค ',ืงื•ืœื‘ ื•ืฉื•ืช. ื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

An apparatus, such as a subscriber unit or a base station within a spread spectrumcommunication system, may add one or more additional 'virtual' paths to a list ofcandidate paths when assigning demodulation elements. These 'virtual' paths areadded as candidate paths even though a corresponding peak was not necessarilydetected within a received spread spectrum system. The list of paths may include a firstpath having a time offset approximately equal to a time offset for one of thedemodulation elements, and the virtual path having a short time separation from thefirst path. The time separation between the paths may be, for example, less than 2chips.

]57[

__________

Page 371: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009371

156871]21][11[

ืขืœ ืžื ื—ื” ืื•ืจ ืœืืžืฆืขื™ ืชืฆื•ื’ื” ื”ืžื•ืจื›ื‘ ื”ืจืืฉ ืื• ืขืœ ื”ื—ืœืง ื”ืขืœื™ ืฉืœ ื”ืจืืฉ

LIGHT GUIDE FOR DISPLAYDEVICES OF THE HEAD-MOUNTEDOR HEAD-UP TYPE

]54[

10.07.2003]22[IT]33[17.07.2002]32[TO2002A000625]31[

Int. Cl.(2009.01) G02B 27//14]51[C.R.F. SOCIETA CONSORTILE PERAZIONI, ITALY

]71[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•ื‘ืืจ, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

ืฉื‘ืข

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A light guide for display devices of the head-mounted or head-up type, comprising: abody of the light guide (22) at least in part transparent to visible light; a coupling device(24) associated to the body of the light guide and designed to couple the body to anoptical system designed to generate an image, the coupling device being obtained insuch a way the light beams coming from said optical system enter the ody of the lightguide and propagate in the body by total internal reflection; and an image-exteractiongrating (28) designed to extract the light beams which propagate in the body of the lightguide so as to enable an observer to visualize the extracted image on a backgroundvisible in transparency through the body of the light guide; wherein said extractiongrating is set in the proximity of one of the outer surfaces (22) of the guide; saidextraction grating has a saw-tooth profile; said extraction grating is coated with apartially reflecting coating deposited prevalently on the surfaces of the teeth (28) thatare least inclined with respect to the surfaces of the guide; and said coating is in turncoated with a layer of material having a refractive index that is substantially the sameas that of the body of the light guide and having a surface facing the extraction grating,which follows the saw-tooth profile, and another plane surface which is substantiallyparallel to the outer surface of the guide in an area corresponding to which the gratingis made.

]57[

__________

Page 372: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 372

156999]21][11[

WEIGHT ื“ืœืช ื‘ืขืœืช ืžืฉืงืœ ืžื•ืคื—ืชืช SAVING DOOR]54[

17.07.2003]22[Int. Cl.(2008.04) E06B 3/70]51[

RAV ื™ื‘ื ื”,ืž"ืจื‘ ื‘ืจื™ื— ืžื•ืฆืจื™ ื‘ื˜ื—ื•ืŸ ื‘ืข BARIACH SECURITYPRODUCTS LTD.

]71[

EYAL ืืœืคืจื“ ื’ื•ืœื“ื•ื‘ืจ, ืื™ื™ืœ ืืจืฆื™ืืœื™ ARTSIELY, ALFREDGOLDOVER

]72[

,ื“ ืขื•ืจื›ื™ ืคื˜ื ื˜ื™ื"ืขื•, ืืคืœืคืœื“ ื–ืจ ืคื™ืฉืจื‘2ื™ื•ืŸ ื‘ืŸ ื’ื•ืจ ื’ืŸ-ืจืžืช,16ืงื•ืžื”.ืจ.ืก.ืžื’ื“ืœ

APPELFELD ZER FISHER,B.S.R TOWER 1, FLOOR 16

2 BEN GURION ST.RAMAT GAN 52573

]74[

A door (10) comprising: a pair of first (12) and second (14) sheets which form front andrear faces of the door; and at least one filling element (20) placed between said firstand second sheets, wherein said at least one filling element has a non-straight shapecomprising at least one first surface (22) that abuts an inner surface of said first sheet,at least one second (24) surface that abuts an inner surface of said second sheet, andat least one intermediate portion (26) between and extending from said first and secondsurfaces, wherein said intermediate portion does not touch inner surfaces of said firstand second sheets.

]57[

__________

157015]21][11[

ABLATION ืฆื ืชืจ ืœื”ืกืจืช ืจืงืžื” ื‘ืขืœ ืžืขืจืš ืžืขืฆื‘ CATHETER HAVINGSTABILIZING ARRAY

]54[

18.07.2003]22[US]33[23.07.2002]32[10/201052]31[

Int. Cl.(2009.01) A61B 17//32]51[BIOSENSE WEBSTER, INC., U.S.A.]71[

ื›"ื“ ',ื”ืŸ ื•ืฉื•ืชืจ ืฉืœืžื” ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœ

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

A circumferential ablation catheter comprising: an elongated tubular catheter body (12)having an outer wall, proximal and distal ends, and at least one lumen extendingtherethrough; an ablation assembly (14) mounted at the distal end of the catheter body,the ablation assembly comprising a circumferential ablation element mounted on thedistal end of the catheter body; and an inflatable balloon (26) provided in surrounding

]57[

Page 373: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009373

relation to the circumferential ablation element that is adjustable between a radiallycollapsed position and a radially expanded position; and a stabilization assembly (17)mounted on the catheter distal to the ablation assembly, the stabilization assemblybeing capable of contacting a plurality of points about an inner circurnference of agenerally tubular region of or near the heart.

__________

157048]21][11[

ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœืงื‘ืœืช ืื™ืžื•ืช ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช

METHOD AND APPARATUS FORPROVIDING AUTHENTICATIONIN A COMMUNICATION SYSTEM

]54[

18.01.2002]22[US]33[16.02.2001]32[785722]31[

Int. Cl.(2008.04) H04L 9/32, H04Q 7/38]51[MOTOROLA, INC., U.S.A.]71[WO/2002/067495]87[

,ืคื™ื•ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืช ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method includes receiving an authentication request from a mobile station (401) anddetermining whether to forward the request to an authentication agent. When it isdetermined to forward the request, the request is forwarded to the authentication agent(107). A random number and a random seed are received from the authenticationagent (107). The random number and the random seed are forwarded to the mobilestation (401). A response to the random number and the random seed from the mobilestation (401) is received and forwarded to the authentication agent (107). Theauthentication agent (107) compares the response with an expected response. Whenthe authentication agent (107) authenticates the mobile station (401), a derived cipherkey is received from the authentication agent (107).

]57[

__________

Page 374: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 374

157097]21][11[

ืชืจื•ืžื‘ื™ืŸ, ืชืจื—ื™ืฃ ื”ืžื›ื™ืœ ืคื™ื‘ืจื™ื ื•ื’ืŸืฉื™ื˜ื” ืœืฆื™ืคื•ื™, ืฉื™ื˜ื•ืช ืœื”ื›ื ืชื•, ื•ืืœื›ื•ื”ื•ืœ

ื› ืฉื™ื˜ื” ืœื™ื‘ื•ืฉ,ื–ื”ื ืฉื ืขื ืชืจื—ื™ืฃ ื”ืฆื™ืคื•ื™ ืฉืœ ื”ื ืฉื ื•ืกืคื•ื’ ืงื•ืœื’ืŸ ืžืฆื•ืคื”

SUSPENSION COMPRISINGFIBRINOGEN,THROMBIN ANDALCOHOL, METHOD FORPREPARING SUCH ASUSPENSION, METHOD FORCOATING A CARRIER WITHSUCH A SUSPENSION, METHODOF DRYING A COATING OF ACARRIER AND COATEDCOLLAGEN SPONGE

]54[

25.01.2002]22[DK]33[25.01.2001]32[PA200100135]31[DK13.02.2001 PA200100235

Int. Cl.(2008.04) A61L 27/00]51[NYCOMED PHARMA AS, NORWAY]71[WO/2002/058750]87[

,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸื™ื”ื”ืจืฆืœ, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจ

EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

A suspension of fibrinogen, thrombin, alcohol and optionally aprotinin is obtained bymixing fibrinogen in alcohol with thrombin in alcohol. The suspension containsfibrinogen and thrombin particles with a Folk Ward mean diameter of 25 โ€“ 100 ยตm. Thethrombin may be human, bovine or recombinant. The fibrinogen may be human orrecombinant. A method for coating a carrier, such as a collagen sponge, with thesuspension, and a method for drying the coating is disclosed. The coated collagencarrier may be used as a ready-to-use absorbable composition for tissue gluing, tissuesealing and haemostasis wherein the carrier is coated with solidly fixed components offibrin glue, i.e. fibrinogen and thrombin.

]57[

__________

Page 375: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009375

157106]21][11[

CAROTENOID ืืกื˜ืจื™ื ืฉืœ ืงืจื•ื˜ื ื•ืื™ื“ ESTERS]54[

22.02.2002]22[US]33[23.02.2001]32[60/270817]31[US11.01.2002 60/347443

Int. Cl.(2008.04) C07C 403/12]51[LUIS W. LEVY, ECUADORRICHARD BINNINGTON, UNITEDKINGDOMANTHONY TABATZNIK, UNITEDKINGDOM

]71[

WO/2002/068385]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters arecarotenoid compounds. The synthetic ester linkage between two ormore carotenoids provides new compounds in which the similar andcomplementary properties of the individual carotenoids are combined.The new all-carotenoid esters may be useful as antioxidants, therapeuticagents, pigmenting ingredients in poultry feed or as coloring agents forfats. The polyesters have the potential to act as molecular wires withunique electrical conductance characteristics. The all-carotenoid estersmay be prepared from the esterification of at least one hydroxycarotenoid with at least one carboxylic carotenoid, or via the reaction ofthe acid chloride of a carboxylic carotenoid with a hydroxy carotenoid.Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin,violaxanthin, carotene diol, hydroxy carotene, hydroxylcopene,alloxanthin and dehydrocryptoxanthin. Preferred caroxylic carotenoidsinclude bixin, norbixin, $g(b)-apo-8-carotenoic acid, crocetin,diapocarotenoic acid, carboxylcarotene and azafrin.

]57[

__________

Page 376: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 376

157117]21][11[

DEVICE ื”ืชืงืŸ ืœืžื ื™ืขืช ื“ืœื™ืคืช ืฉืชืŸ ื‘ื ืฉื™ื FOR THE PREVENTIONOF URINARY INCONTINENCEIN FEMALES

]54[

27.07.2003]22[Int. Cl.(2008.04) A61F 50/48]51[

CONTIPI ืงื™ืกืจื™ื”,ืž"ืงื•ื ื˜ื™ืคื™ ื‘ืข LTD.]71[ELAN ืื™ืœืŸ ื–ื™ื• ZIV]72[

,ืž"ื‘ืข) 1995(ืืจืœื™ืš.ืื™.ื™'ื’,11ืจื—ื•ื‘ ืžื ื—ื ื‘ื’ื™ืŸ,15ืงื•ืžื”, ืžื’ื“ืœ ืื™ืœื•ืŸ

ืจืžืช ื’ืŸ

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

A disposable device (100) for minimizing involuntary urination in females adapted forbeing inserted into the vagina, comprising:(a) an internal support structure comprising:(i) a pressure providing member (101) capable of transition between a first collapsibleposition and a second expandable position, adapted for providing pressure, through thevaginal wall, on the mid-urethral region following insertion of the device into the vagina;(ii) an anchoring member (102), said anchoring member adapted for anchoring theinternal support structure following insertion of the device into the vagina, so as toprevent movement of the device into the apex of the vagina; the pressure providingmember and the anchoring member being spaced apart;(b) pulling means (107) for removal of the device from the vagina, so that when saidpressure providing member is in the collapsible position the internal device may beinserted or removed from the vagina; and when said pressure providing member is inthe second expanded position, the device is positioned in the vagina in such a mannerso at to provide pressure through the vaginal wall on the mid-urethra minimizinginvoluntary urination.

]57[

__________

Page 377: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009377

157477]21][11[

ืชืจื›ื•ื‘ืช ืžืœื—ื™ื ืจื•ืงื—ื™ื™ื ื”ืžื›ื™ืœื™ืืจื•ืงื—ื•ืช ืคืขื™ืœื” ื•ืชื—ืœื™ืฃ ืกื•ื›ืจ ื•ืชืจื•ืคื•ืช

ื”ืžื›ื™ืœื•ืช ืื•ืชื

PHARMACEUTICAL SALTSCOMPRISING APHARMACEUTICALLY ACTIVESUBSTANCE AND A SUGARSUBSTITUTE ANDMEDICAMENTS COMPRISINGTHEM

]54[

28.02.2002]22[DE]33[28.02.2001]32[10109763.8]31[

Int. Cl.(2008.04) A61K 31/18, 31/39, 31/44, 31/54, 311/37, 312/16, 313/43, 313/57,313/81, 314/25, 315/375, 316/615, 45/08, A61P 13/02, 29/00, C07C 211/26, 215/30,215/46, 217/54, 219/22, 225/16, 271/40, 307/08, 323/32, C07D 213/62, 265/30,275/02, 275/06, 291/06, 307/79, 317/50, 333/16, C07F 9/40

]51[

GRUNENTHAL GMBH, GERMANY]71[WO/2002/067916]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to pharmaceutical salts comprised of apharmaceutical active substance, particularly N,N-dimethylaminopropylphenol compounds or tradamol, and of at least onesugar substitute such as saccharin, cyclamate or acesulfame, tomedicaments containing these salts, and to the use of these salts forproducing medicaments.

]57[

__________

Page 378: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 378

157534]21][11[

, ืฆื•ืจื” ืจื•ืงื—ื™ืช ืฉืœ ืกื™ื“ืŸ ืื˜ื•ืจื‘ืกื˜ื˜ื™ืŸืชืจื›ื•ื‘ืช ืฉืœื• ื•ืคื•ืจืžื•ืœืฆื™ื” ืจื•ืงื—ื™ืช

ื”ืžื›ื™ืœื” ืกื™ื“ืŸ ืื˜ื•ืจื‘ืกื˜ื˜ื™ืŸ

ATORVASTATIN CALCIUM IN APHARMACEUTICAL FORM,COMPOSITION THEREOF ANDPHARMACEUTICALFORMULATION COMPRISINGATORVASTATIN CALCIUM

]54[

13.03.2002]22[SI]33[14.03.2001]32[P-200100069]31[

Int. Cl.(2008.04) A61K 31/40, 9/16, 9/20, A61P 3/06, C07D 207/34]51[LEK PHARMACEUTICAL ANDCHEMICAL COMPANY D.D.,SLOVENIA

]71[

JANEZ KERC, SALOBIR MATEJA,SASA BAVEC

]72[

WO/2002/072073]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Atorvastatin calcium can exist in an amorphous form or in one of the atleast four known crystalline forms (Form I, Form II, Form III and FormIV). Atorvastatin calcium is the substance which is sparingly soluble inwater, with pKa 4,5, and it has been found that the crystalline forms areless soluble than the amorphous form, which may cause problems inbioavailability of atorvastatin in the body. The present invention solvesthe problem of providing therapeutic equivalence of atorvastatinpharmaceutical formulation regardless the form (crystalline, amorphous,mixture of both) of atorvastatin calcium used for its preparation.

]57[

__________

Page 379: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009379

157588]21][11[

ืชืจื›ื•ื‘ื•ืช ืงืจื‘ืžื˜ ืœืฉื™ืžื•ืฉ ื‘ืžื ื™ืขื” ื•ื‘ื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ืคืกื™ื›ื•ืชื™ื•ืช

CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING PSYCHOTICDISORDERS

]54[

21.02.2002]22[US]33[27.02.2001]32[60/271889]31[US21.02.2002 10/081761

Int. Cl.(2008.04) A61K 31/27, A61P 25/18, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.

]71[

WO/2002/067927]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

This invention is directed to a method for preventing or treating psychotic disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of formula (I) and formula (II)wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2?, Rยฟ3?,Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).

]57[

__________

Page 380: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 380

157591]21][11[

ืชืจื›ื•ื‘ื•ืช ืงืจื‘ืžื˜ ืœืฉื™ืžื•ืฉ ื‘ืžื ื™ืขื” ื•ื‘ื˜ื™ืคื•ืœ ื‘ื”ืคืจืขื•ืช ื ื•ื™ืจื•ื“ื’ื ืจืื˜ื™ื‘ื™ื™ื

CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATINGNEURODEGENERATIVEDISORDERS

]54[

21.02.2002]22[US]33[27.02.2001]32[60/271682]31[US21.02.2002 10/081764

Int. Cl.(2008.04) A61K 31/27, A61P 25/28, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.

]71[

WO/2002/067925]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

This invention is directed to a method for preventing or treating neurodegenerativedisorders comprising administering to a subject in need thereof a therapeuticallyeffective amount of a compound selected from the group consisting of Formula (I) andFormula (II), wherein phenyl is substituted at X with one to five halogen atoms selectedfrom the group consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2?,Rยฟ3?, Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).

]57[

__________

Page 381: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009381

157592]21][11[

ืชืจื›ื•ื‘ื•ืช ืงืจื‘ืžื˜ ืœืฉื™ืžื•ืฉ ื‘ืžื ื™ืขื”ื”ื•ื‘ื˜ื™ืคื•ืœ ืฉืœ ื”ืคืจืขื•ืช ื‘ืชื ื•ืข

CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING MOVEMENTDISORDERS

]54[

21.02.2002]22[US]33[27.02.2001]32[60/271683]31[US21.02.2002 10/081501

Int. Cl.(2008.04) A61K 31/27, A61P 25/14, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.

]71[

WO/2002/067926]87[',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“

ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

This invention is directed to a method for preventing or treating movement disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of Formula (I) and Formula (II):wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2? Rยฟ3?,Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).

]57[

__________

Page 382: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 382

157678]21][11[

ืชื‘ื ื™ื•ืช ื‘ืขืœื•ืช ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื’ื™ืœื•ื™ ืจืขืฉ

SYSTEM AND METHOD FORDISCOVERING PATTERNS WITHNOISE

]54[

22.03.2002]22[US]33[22.03.2001]32[09/814512]31[

Int. Cl.(2008.04) G06F 19/00, G06K 9/00, 9/68]51[IBM CORPORATION, U.S.A.]71[WO/2002/077910]87[

,ืžื—ืœืงืช ืงื ื™ืŸ ืจื•ื—ื ื™ืžืขื‘ื“ื•ืช ื™ื‘ืž ื—ื™ืคื”, ืื•ื ื™ื‘ืจืกื™ื˜ืช ื—ื™ืคื” ื”ืจ ื”ื›ืจืžืœ

IBM LABORATORIES,HAIFA UNIVERSITY,

HAIFA 31905

]74[

A system and method for determining patterns in a data sequence (Fig. 1) constructs acompatibility matrix (100) which provides a probability between an actual occurrence ofan item and an observed occurrence of that or another item between each item in thedata sequence. Candidate patterns are generated (201). The candidate patternsinclude items in the data sequence. The candidate patterns are checked against thedata sequence to determine a match value (203) based on the compatibility matrix, andsignificant matches are determined based on candidate patterns having the matchvalue above a threshold (204).

]57[

__________

Page 383: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009383

157721]21][11[

ื”ืชืงืŸ ื•ืฉื™ื˜ื” ืœืขื™ื‘ื•ื“ ื•ื‘ื—ื™ื ื” ืฉืœ ื“ื’ื™ืžื” ื‘ื™ื•ืœื•ื’ื™ืช

APPARATUS AND METHOD FORPROCESSING AND TESTING ABIOLOGICAL SPECIMEN

]54[

06.03.2002]22[US]33[06.03.2001]32[799355]31[

Int. Cl.(2008.04) G01N 21/13]51[ื, ื“ื•ื“ ื•ืจื•ืŸ 'ื›ืคืจ ื‘ื™ืœื•

ืชืœืจืžื•ืช ืœื™ื“ ืื•ื ื™ื‘ ื‘ืข-ืจืกื™ื˜ืช ,ืž"ืื‘ื™ื‘ ืื‘ื™ื‘-ืชืœ

DAVID VARONRAMOT AT TEL-AVIVUNIVERSITY LTD.

]71[

WO/2002/071037]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

An apparatus for analyzing liquid specimens, the device comprising at least onespecimen handling station for obtaining preparation on a specimen carrying device, andan imaging station fitted with an optical image capturing device for analyzing thepreparation. A carriage with a specimen carrying device receptacle rotatably retains thespecimen carrying device and is displaceable between a loading station and anunloading station with respective positions at the stations. An incremental displacementmechanism for displacing at least one of the specimen carrying device and an imagingdevice so as to obtain at least one consecutive image of the preparation.

]57[

__________

Page 384: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 384

157818]21][11[

ืฉื™ื˜ื” ืœื ื™ื˜ื•ืจ ืชื ื•ืขื•ืช ืฉืœ ืื“ื ื‘ืชื•ืš ื—ื“ืจื™ื ื•ื›ื“ื•ืžื”, ื•ืžืกื‘ื™ื‘ ืœื‘ื ื™ื™ื ื™ื

METHOD FOR MONITORINGTHE MOVEMENTS OFINDIVIDUALS IN AND AROUNDBUILDINGS, ROOMS AND THELIKE

]54[

04.03.2002]22[SE]33[20.03.2001]32[0100973-7 ]31[

Int. Cl.(2008.04) G01S 13/00, 13/75, 13/78, G07C 9/00]51[JAN BENGTSSON, SWEDENLEIF NYFELT, SWEDEN

]71[

WO/2002/075352]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The present invention relates to a method of monitoring the movements of an individualin and around buildings, rooms and other spaces, wherein each individual carries apassive transponder which has an individual-unique identity and which is intended forco-action with an active antenna that is connected, either directly or indirectly, to amonitoring centre (13) for transmitting signals received from transponders, and whereina plurality of antennas (12) are placed in and around the buildings, rooms or otherspaces to be monitored. The signals transmitted to the exercise centre (13) are used toshow movements of the individual in the form of a three-dimensional animated pictureon a picture screen.

]57[

__________

Page 385: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009385

157878]21][11[

ืฉื™ื˜ื” ืœื”ื›ื ืช ืชืจื—ื™ืคื™ื ื™ืฆื™ื‘ื™ื ื•ืื‘ืงื•ืช ืฉืœ ื ื ื•ื˜ื•ื‘ื•ืช ื”ืขืฉื•ื™ื•ืช ืžืคื—ืžืŸ

METHOD FOR THEPREPARATION OF STABLESUSPENSIONS AND POWDERSOF SINGLE CARBONNANOTUBES

]54[

25.03.2002]22[IL]33[26.03.2001]32[142254]31[

Int. Cl.(2009.01) B01J 13//00, C01B 31//02]51[ื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ื‘ืืจ ืฉื‘ืข, ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

]71[

WO/2002/076888]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A method is provided for exfoliation of carbon nanotubes and for thepreparation of a stable aqueous suspension thereof containing dispersed,essentially single tubes, using a water-soluble polymeric material. Apowder of carbon nanotubes is further provided, that can be re-dispersedto form a stable suspension. Said nanotubes can be used in electronics,printing, coatings, thin layers, molecular machines, and for theproduction of composite materials.

]57[

__________

157895]21][11[

ืคื™ืจืื–ื•ืœื•ืคื™ืจื™ืžื™ื“ื™ื ื™ื ื•ืชื™ืื–ื•ืœื•ืคื™ืจื™ืžื™ื“ื™ื ื™ื ืžื•ืชืžืจื™ื

SUBSTITUTEDPYRAZOLOPYRIMIDINES ANDTHIAZOLOPYRIMIDINES

]54[

13.03.2002]22[DE]33[14.03.2001]32[10112197.0]31[DE29.10.2001 10153344.6

Int. Cl.(2009.01) A61K 31//505, A61P 25//00, 29//00, C07D 48/7/04, 51/3/04]51[GRUNENTHAL GMBH, GERMANY]71[WO/2002/072585]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Page 386: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 386

The invention relates to substituted pyrazolopyrimidines andthiazolopyrimidines with the general structures (I A), (I B) and (II), to amethod for their production, to substance libraries containing the same,to medicaments containing said compounds, to the use of saidcompounds in the production of medicaments for treating pain,epilepsy, schizophrenia, neurodegenerative diseases, in particularAlzheimer's disease, Huntington's disease and Parkinson's disease, fortreating cerebral ischaemia and infarcts, psychosis caused by increasedamino acid levels, cerebral oedema, conditions caused by an under-supply of the central nervous system, in particular in hypoxia, especiallynewborn hypoxia and anoxia, for treating AIDS-related dementia,encephalomyelitis, Tourette's syndrome, perinatal asphyxia, tinnitus,neuropathic pain, diseases of the respiratory tract, cancer, cardiacarrythmia, immune disorders and diseases, inflammatory conditions anddiseases, renal shutdown, dyssomnia, strokes, thromboses, urinaryincontinence, diabetes, psoriasis, septicaemic shock, cerebral traumas,glaucoma and/or congestive heart failure. The invention further relatesto pharmaceutical compositions containing said compounds.

]57[

__________

Page 387: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009387

157902]21][11[

ืขืœ ืืžืฆืขื™ ื–ื™ื”ื•ื™ ื”ื ืงืจื ืขืœ ื™ื“ื™ ืžื›ื•ื ื”ื”ืžื›ื™ืœื” ืงืคื” ื˜ื—ื•ืŸ, ื’ื‘ื™ ืืจื™ื–ืช ืžื ื”

ืœืžื›ื•ื ื•ืช ืืกืคืจืกื•

MACHINE-READABLEIDENTIFIER ON A PORTIONPACKAGE WHICH CONTAINSGROUND COFFEE FORESPRESSO MACHINES

]54[

20.03.2002]22[DE]33[31.03.2001]32[10116239.1]31[

Int. Cl.(2008.04) A47J 31/40, B65D 81/00]51[EUGSTER/FRISMAG AG,SWITZERLANDGOTTHARD MAHLICH, GERMANY

]71[

WO/2002/078498]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ื”ื’ื™ื ืฉืขืจ ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A machine-readable identifier on a portion package, which containsground coffee, for espresso machines is provided in a rotationallysymmetrical manner, whereby permitting it to be easily and reliablyread, on an essentially flat surface of the portion package. The portionpackage is preferably a portion capsule (1) with an essentially roundbottom (2) to which the identifier is coaxially applied.

]57[

__________

Page 388: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 388

158060]21][11[

ืœืฉื™ืžื•ืฉ ื‘ืžื ื™ืขื”25CDืžื•ืœืงื•ืœื•ืช ืงื™ืฉื•ืจืื• ื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ืืฆืœ ืžื˜ื•ืคืœื™ื ืขื

ืชื ื’ื•ื“ืช ืœืกื˜ืจื•ืื™ื“ื™ื

CD25 BINDING MOLECULES FORUSE IN THE PREVENTION ORTREATMENT OF DISEASES INSTEROID-RESISTANT PATIENTS

]54[

05.04.2002]22[GB]33[06.04.2001]32[0108816.0]31[GB06.04.2001 0108821.0 GB06.04.20010108817.8

Int. Cl.(2009.01) A61K 39//395, A61P 01//04, 01//16, 09//14, 11//06, 13//12, 17//02,19//02, 25//28, 35//02, 37//06, C07K 16//28

]51[

UNIVERSITY OF BRISTOL, UNITEDKINGDOM

]71[

WO/2002/081508]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A method for the treatment of a disease selected from the groupconsisting of autoimmune hepatitis, eczema, vasculitis, temporalarteritis, sarcoid and Crohn's disease, in a steroid-resistant or steroid-sensitive patient, comprising administering to the patient an effectiveamount of a CD25 binding molecule.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.๏ฟฝ ืคื•ืจืกืžื•ืฉื˜ืจ

198757,The applications for divisionfrom this application havenot yet been published

__________

158127]21][11[

ื–ื™ื”ื•ื™ ืงื•ืœื™ ื”ืžื‘ื•ืกืก ืขืœ ื”ืื™ื ื˜ืจื ื˜ ืขืืค ืงื•ื“ื•ืช ืœื‘ื™ืฆื•ืข ื•ืื•ื‘ื™ื™ืงื˜ื™ื ืกื“ืจืช ืกืžื ื˜ื™ื™ื

WEB-BASED SPEECHRECOGNITION WITHSCRIPTING AND SEMANTICOBJECTS

]54[

14.03.2002]22[US]33[23.03.2001]32[815726]31[

Int. Cl.(2009.01) G10L 15//00]51[ELIZA CORPORATION, U.S.A.]71[WO/2002/077973]87[

',ื–ืœื™ื’ืกื•ืŸ ื’ื‘ืจื™ืืœื™ ื•ืฉื•ืช ืชืœ ืื‘ื™ื‘, 1426.ื“.ืช,31ื™ื‘ื ื”' ืจื—

SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,

P.O.B. 1426,TEL AVIV 61013

]74[

Page 389: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009389

The present invention is a system and method for creating and implementingtransactional speech applications (SAs) using Web technologies, without reliance onserver-side standard or custom services. A transactional speech application may beany application that requires interpretation of speech in conjunction with a speechrecognition (SR) system (210), such as, for example, consumer survey systems. Aspeech application in accordance with the present invention is represented within aWeb page (220, 220'), as an application script (222, 222') that interprets semanticobjects (230) according to a context. Any commonly known scripting language can beused to write the application script, such as JavaScript (or ECMAScript), PerlScript, andVbscript. The present invention is 'Web-based' to the extent that it implements Webtechnologies, but it need not include or access the World Wide Web.

]57[

__________

158155]21][11[

ืฉื™ืžื•ืฉ ื‘ืืจื™ืชืจื•ืคื•ื™ื˜ื™ืŸ ืœื”ื›ื ืช ืชืจื•ืคื”ืช ื”ื ื•ื‘ืขืช ืžื›ื™ืžื•ืชืจืคื™ื”ืœื”ืคื—ืชืช ืจืขื™ืœื•

USE OF ERYTHROPOIETIN FORTHE PREPARATION OF AMEDICAMENT TO AMELIORATECHEMOTHERAPY-INDUCEDTOXICITY

]54[

08.04.2002]22[US]33[09.04.2001]32[60/282621]31[

Int. Cl.(2008.04) A01N 37/18, A61K 38/18]51[EAST CAROLINA UNIVERSITY,U.S.A.

]71[

WO/2002/080676]87[,ืจ ื™ืฆื—ืง ื”ืก ื•ืฉื•ืชืคื™ื•"ื“

ืชืœ ืื‘ื™ื‘, 6451.ื“.ืช, 279ืจื—ื•ื‘ ื”ื™ืจืงื•ืŸDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,

P.O.B. 6451,TEL AVIV 61063

]74[

A method of reducing organ toxicity in a subject being administered acytotoxic agent comprising concurrently administering with thecytotoxic agent erythropoietin (EPO), the EPO being administered in anamount effective to reduce pulmonary toxicity caused by the cytotoxicagent.

]57[

Page 390: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 390

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198783,The applications for divisionfrom this application havenot yet been published

__________

158161]21][11[

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืฉื™ืจื•ืฉื™ ืฉื™ื“ื•ืจ ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช

METHOD AND APPARATUS FORBROADCAST SERVICES IN AWIRELESS COMMUNICATIONSYSTEM

]54[

28.03.2002]22[US]33[28.03.2001]32[60/279970]31[US20.08.2001 09/933971

Int. Cl.(2008.04) H04B 7/26, H04H 1/00, H04L 12/00, 12/18, 12/56, 29/06, 29/08,9/08, 9/28, 9/30, H04Q 7/38

]51[

QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2002/080454]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Method and apparatus for providing a broadcast system parameter message in awireless communication system supporting a broadcast service. In one embodiment,the message identifies a service option number corresponding to a set of broadcastparameters. In an alternate embodiment, the message identifies a block of bytescorresponding to broadcast parameters. The message may be transmitted on achannel for transmitting overhead information. For a system supporting a broadcastservice, the message identifies a protocol stack for processing broadcast service, themessage identifies a protocol stack for processing broadcast content.

]57[

__________

Page 391: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009391

158162]21][11[

ื‘ืงืจืช ื›ื— ืœืฉื™ืจื•ืชื™ ื ืงื•ื“ื” ืœืžืกืคืจ ื ืงื•ื“ื•ืช ื”ืžืกื•ืคืงื™ื ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช

POWER CONTROL FOR POINT-TO-MULTIPOINT SERVICESPROVIDED IN COMMUNICATIONSYSTEMS

]54[

28.03.2002]22[US]33[28.03.2001]32[60/279970]31[

Int. Cl.(2008.04) H04B 7/00, 7/26, 70/05, H04L 12/18, 12/28, 9/08]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2002/080401]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

To enable point-to-multipoint communication services in an existing cellularcommunication system infrastructure, each member subscriber station (102), i.e., asubscriber station participating in such a service, is receiving a forward link sharedchannel (106), and in certain embodiments additionally a forward link dedicatedchannel. Because transmission on the forward link channels from neighboring sectorspresents interference to the transmission from the sector serving the subscriber station,it is desirable to control the forward link channel transmission power to the minimumacceptable power. Additionally, a transmission from each member subscriber station ona reverse link channel (108) presents interference to other subscriber stations.Therefore, it is desirable to control the reverse link channel transmission to theminimum signal level. Consequently, a method and apparatus for a power control thatenables point-to-multipoint services in an existing infrastructure of a wireless cellulartelephone system is disclosed.

]57[

__________

Page 392: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 392

158228]21][11[

ืฉื™ืžื•ืฉ ื‘ืืกื˜ืจื™ื ืฉืœ ื—ื•ืžืฆื•ืช ืฉื•ืžื ื™ื•ืชื‘ืขืœื•ืช ืฉืจืฉืจืช ืืจื•ื›ื” ืœื”ื›ื ืช ืชืจื•ืคื•ืช

ืœื˜ื™ืคื•ืœ ื‘ืžื—ืœื•ืช ืื•ื˜ื•ืื™ืžื•ื ื™ื•ืช

USE OF ESTERS OF LONG-CHAINFATTY ACIDS FOR THEPREPARATION OFMEDICAMENTS FOR THETREATMENT OF AUTOIMMUNEDISEASES

]54[

11.04.2002]22[IL]33[11.04.2001]32[142537]31[

Int. Cl.(2008.04) A61K 31/23, 312/31, 312/32, 317/024, A61P 29/00, 31/02, C07C233/08, 233/09, 69/00, 69/22, 69/33, 69/52, 69/58

]51[

YEDA ืจื—ื•ื‘ื•ืช,ืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH ANDDEVELOPMENT CO. LTD.

]71[

ื‘ืŸ, ืคื ื—ืก ื‘ื•ืจืฉื˜ื™ื™ืŸ PINCHAS ื ื•ืŸ- ืื‘ืจื”ื BURSTEIN, AVRAHAMBEN-NUN

]72[

WO/2002/083059]87[',ื‘ืŸ ืขืžื™ ื•ืฉื•ืช ืจื—ื•ื‘ื•ืช,94.ื“.ืช,8ืžื ื—ื ืคืœืื•ื˜

BEN-AMI & ASSOCIATES,8 PLAUT ST.,

PARK TAMAR,P.O.B. 94,REHOVOT 76100

]74[

Agents selected from: (i) a Cยฟ1? - Cยฟ24? alkyl ester of a saturated orcis-unsaturated Cยฟ10? - Cยฟ24? fatty acid; (ii) a monoester or polyesterof a polyol having at least four hydroxy groups with a saturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid or an anhydro derivative thereof;(iii) a monoester or polyester of a mono-, di- or poly-saccharide with asaturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid; (iv) an amide of asaturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid with an aliphaticor aromatic amine or with an amino acid, peptide, protein oraminosaccharide; and (v) combinations of any of (i) to (iv), can be usedfor treatment of autoimmune diseases and other immune-associatedinflammatory disorders. Preferred agents are ethyl oleate and mannidemonooleate or a combination thereof.

]57[

__________

Page 393: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009393

158285]21][11[

ืคืคื˜ื™ื“ื™ื ืœื”ื›ื ืช ืชื›ืฉื™ืจื™ื ืœื˜ื™ืคื•ืœ ื—ื™ืกื•ื ื™ื‘ื˜ืจืฉืช ืขื•ืจืงื™ื ื•ืคื™ืชื•ื— ื‘ื•ื—ืŸ ื”ืžื‘ื•ืกืก ืขืœ ืคืคื˜ื™ื“ื™ื ืœืงื‘ื™ืขืช ื”ืชื’ื•ื‘ื” ื”ื—ื™ืกื•ื ื™ืช ื ื’ื“

ืœื™ืคื•ืคืจื•ื˜ืื™ื ื™ื ืžื—ื•ืžืฆื ื™ื ื‘ืขืœื™ ืžืฉืงืœ ืกื’ื•ืœื™ ื ืžื•ืš

PEPTIDES FOR PREPARINGMEDICAMENT FOR IMMUNO-THERAPY OFATHEROSCLEROSIS ANDDEVELOPMENT OF PEPTIDE-BASE ASSAY FORDETERMINATION OF IMMUNERESPONSES AGAINST OXIDIZEDLOW DENSITY LIPOPROTEIN

]54[

05.04.2002]22[SE]33[05.04.2001]32[0101232-7 ]31[SE09.11.2001 0103754-8

Int. Cl.(2008.04) A61K 38/00, 38/17, 39/00, 393/95, A61P 9/10, C07K 147/75, G01N33/53

]51[

CEDARS-SINAI MEDICAL CENTER,U.S.A.FORSKARPATENT I SYD AB,SWEDEN

]71[

WO/2002/080954]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The present invention relates to fragments of apolipoprotein B, inparticular defined peptides thereof, for immunization or therapeutictreatment of mammals, including humans, against ischemiccardiovascular diseases, as well as diagnosing the presence or absenceof antibodies related to increased or decreased risk of developingischemic cardiovascular diseases, using one or more of said peptides inan ELISA (Enzyme Linked Immuno Sorbent Assay).

]57[

ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื• ื‘ืงืฉื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

195356,188286,The applications for divisionfrom this application havenot yet been published

__________

Page 394: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 394

158634]21][11[

ืชื”ืœื™ืš ืขื‘ื•ืจ ื”ื›ื ืช ืชื•ืœื“ื•ืชืคืจื•ืกื˜ืื’ืœืื ื™ื“ื™ืŸ ื”ื—ื•ืžืจ ื”ื›ื ื”

ืกื˜ืจื™ื•ืกืคืฆื™ืคื™ื™ื ืขื‘ื•ืจื•

PROCESS FOR PREPARINGPROSTAGLANDIN DERIVATIVESAND STEREOSPECIFICSTARTING MATERIALTHEREFOR

]54[

07.05.2002]22[KR]33[08.05.2001]32[2001/25011]31[

Int. Cl.(2009.01) C07C 40/5/00, 41//02, 43//02, 43//17, 43//174, C07F 07//00]51[YONSUNG FINE CHEMICAL CO.,REPUBLIC OF KOREA

]71[

WO/2002/090324]87[,ืจ ื™ืฆื—ืง ื”ืก ื•ืฉื•ืชืคื™ื•"ื“

ืชืœ ืื‘ื™ื‘, 6451.ื“.ืช, 279ืจื—ื•ื‘ ื”ื™ืจืงื•ืŸDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,

P.O.B. 6451,TEL AVIV 61063

]74[

The present invention relates to a process for effectively preparingprostaglandin derivatives and to a stereospecific alkyl halide containing 15S-alcohol group as a starting material.

]57[

__________

158932]21][11[

METHOD ืฉื™ื˜ื” ืœื”ื›ื™ืŸ ื‘ื™ืคืจื™ื“ืŸ FOR PRODUCINGBIPERIDEN

]54[

17.05.2002]22[DE]33[18.05.2001]32[10124452.5]31[DE18.05.2001 10124450.9

Int. Cl.(2009.01) C07B 57//00, C07D 29/5/08, 29/5/10]51[ABBOTT GMBH & CO. KG,GERMANY

]71[

WO/2002/094801]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a method for producing biperiden which ischaracterised in that an exo/endo mixture of 1-(bicyclo[2.2.1]hept-5-en-2-yl)-3-piperidino-l-propanone is reacted with an isomer ratio of the exo form to theendo form of at least 2.5:1 with diphenyl magnesium, an isomer mixturecontaining biperiden is obtained therefrom and biperiden is producedtherefrom.

]57[

__________

Page 395: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009395

158933]21][11[

METHOD ืฉื™ื˜ื” ืœื”ื›ื™ืŸ ื‘ื™ืคืจื™ื“ืŸ FOR THEPRODUCTION OF BIPERIDEN

]54[

17.05.2002]22[DE]33[18.05.2001]32[10124449.5]31[

Int. Cl.(2009.01) C07D 29/5/08, 29/5/10]51[ABBOTT GMBH & CO. KG,GERMANY

]71[

WO/2002/094781]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a method for the production of biperiden byreacting an exo/endo mixture of 1-(bicyclo[2.2.1.]hept-5-en-2-yl) 3-piperidino-1-propanone with a phenyl magnesium compound, whereinthe exo/endo ratio of 1-(bicyclo[2.2.1.]hept-5-en-2-yl)-3-piperidino-1-propanone is at least 4.5: 1.

]57[

__________

158935]21][11[

ืฆื™ืจื™ื™ื ื”ืžืชืคืจืงื™ื ื‘ืื•ืคืŸโ€“ืงืจื•ืžื™ื ื“ื• ื˜ื‘ืขื™ ื‘ืขืœื™ ื”ืชื ื’ื“ื•ืช ืžื‘ื•ืงืจืช ืœืงืจื™ืขื”

BIODEGRADABLE BIAXIALLYDRAWN FILM WITHCONTROLLED TEARRESISTANCE

]54[

31.05.2002]22[DE]33[06.06.2001]32[10127314.2]31[

Int. Cl.(2008.04) C08J 5/18, C08K 3/00, C08L 67/04]51[TRESPAPHAN GMBH, GERMANY]71[WO/2002/098982]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a film with controllable tear resistant properties,comprising at least one basic layer which contains at least one polymer Ifrom at least one hydroxycarboxylic acid, and >0.1 wt. %, in relation tothe weight of the layer, of a thermoplastic polymer II which is differentfrom polymer I, and/or inorganic additives.

]57[

__________

Page 396: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 396

158968]21][11[

SOLAR ืžื—ืžื ืžื™ื ืกื•ืœืืจื™ WATER HEATER]54[

20.11.2003]22[Int. Cl.(2008.04) F24J 2/04]51[

OFER ืขืคืจ ื“ื’ืŸ DAGAN]71[,ืขืคืจ ื“ื’ืŸ

ืฉืขืจ ื”ืขืžืงื™ืOFER DAGAN,SHA'AR HA'AMAKIM

]74[

An integral storage-collector solar water-heating system comprising: a tank (11) havingin inlet (13) for city water inlet โ€“ located in the lower side of said tank, a first outlet (14a)for supplying hot water โ€“ located in the upper side of said tank โ€“ and a second outlet(20) for feeding water to a fin โ€“ tube absorber (15) โ€“ located in the lower side of saidtank: a thermally insulated layer (12), which is attached to the inside walls of said tank;and an upper solar tank-absorber (16) and said lower solar fin-tube absorber, each forthe purpose of enabling a flow of water there-through to which solar heat collected bythe absorbers can be transferred, wherein: said upper solar tank-absorber is built insidethe exposed wall of said tank, by a water-flow-grid made of tunnels (25) that aregrooved in said thermally insulated layer, having an inlet (17) and an outlet into saidtank; and said lower solar fin-tube absorber has an inlet and an outlet, wherein saidinlet is connected to said second outlet of said tank and said fin-tube absorber's outletis connected to said inlet of said upper solar tank-absorber.

]57[

__________

Page 397: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009397

159017]21][11[

ืžื ื”ืœ ื ืชื•ื ื™ื ืœื”ืชืงื ื™ ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™ืช ื•ืฉื™ื˜ื” ืœื ื™ื”ื•ืœ ื ืชื•ื ื™ื ื‘ื”ืชืงืŸ ืืœื—ื•ื˜ื™

DATA MANAGER FOR WIRELESSCOMMUNICATION DEVICESAND METHOD OF MANAGINGDATA IN A WIRELESS DEVICE

]54[

31.05.2002]22[US]33[31.05.2001]32[09/871471]31[

Int. Cl.(2008.04) H04L 12/28, 12/56, 12/64, H04M 1/72, 12/53, 17/25, 34/93, 7/00]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2002/098078]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A data manager, and a method of managing data, for a wireless device. The datamanager includes a data receiver that receives voice data over the internet protocolconnection, a data sender that sends other voice data over the internet protocolconnection, a data recognizer that differentiates the voice data and the other voice datafrom non-voice data and non-data, and a controller that broadcasts the voice data andthe other voice data in an internet voice protocol format. The method includes the stepsof receiving voice data over the internet protocol connection at the wireless device,sending other voice data over the internet protocol connection from the wireless device,differentiating the voice data from non-voice data and non-data, differentiating the othervoice data from other non-voice data and non-data, and controlling the broadcast of thevoice data, and the other voice data.

]57[

__________

Page 398: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 398

159218]21][11[

ื ื’ื–ืจื•ืช ื‘ื ื–ื•ืคื™ืจืืŸ ืžื•ืชืžืจื•ืช ื ื’ื“ ื”ืคืจืขื•ืช ืงืฆื‘ ืœื‘

SUBSTITUTED BENZOPYRANDERIVATIVES AGAINSTARRHYTHMIA

]54[

17.06.2002]22[JP]33[25.06.2001]32[2001-190594]31[

Int. Cl.(2008.04) A61K 31/42, 313/53, 313/81, 314/96, 315/06, A61P 9/06, C07D311/00, 311/68, 405/12, 407/12, 409/12, 413/12, 417/12, 513/12

]51[

NISSAN CHEMICAL INDUSTRIESLTD., JAPAN

]71[

WO/2003/000675]87[',ื”ื•ืจื•ื‘ื™ืฅ ื•ืฉื•ืช.ืฉ

ืชืœ, 41-45ืฉื“ืจื•ืช ืจื•ื˜ืฉื™ืœื“, ื‘ื™ืช ืฆื™ื•ืŸ ืื‘ื™ื‘

S. HOROWITZ & CO.,ZION HOUSE,

41-45 ROTHSCHILD BLVD.,TEL AVIV 65784

]74[

This invention relates to benzopyran derivatives of the formula (1) or the formula (2)wherein R?1ยฟ and R?2ยฟ represent independently of each other hydrogen atom or Cยฟ1-6?alkyl group, R?3ยฟ represents hydroxyl group or Cยฟ1-6? alkylcarbonyloxy group,R?4ยฟ represents hydrogen atom or Cยฟ1-6? alkyl group, R?5ยฟ represents Cยฟ1-6? alkylgroup substituted with Cยฟ6-14? aryl group or heteroaryl group, R?6ยฟ represents Cยฟ1-6? alkyl group, Cยฟ1-6? alkoxy group, halogen atom, nitro group, C(O)NHยฟ2?,C(O)NHR?8ยฟ or C(O)NR?8ยฟR?9ยฟ, or pharmaceutically acceptable salts thereof. Thesecompounds are useful as an antiarrhythmic agent.

]57[

__________

Page 399: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009399

159534]21][11[

ืฉื™ื˜ื” ืœื”ื›ื ืช ืงื•ืจื•ืœื™ื ื”ืžื•ืชืžืจื™ื ื‘ืื•ืคืŸ ืกืœืงื˜ื™ื‘ื™ ื•ืงื•ืจื•ืœื™ื ืžื•ืชืžืจื™ื ื—ื“ืฉื™ื

METHOD FOR THEPREPARATION OFSELECTIVELY-SUBSTITUTEDCORROLES AND NEWSUBSTITUTED CORROLES

]54[

01.07.2002]22[US]33[02.07.2001]32[60/301851]31[

Int. Cl.(2008.04) A61K 31/40, 31/55, C07D 487/22]51[TECHNION ื—ื™ืคื”,ืž"ืžื•ืกื“ ื”ื˜ื›ื ื™ื•ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข RESEARCH AND

DEVELOPMENT FOUNDATIONLTD.

]71[

ZEEV ืื™ืจื ื” ื–ืœืฆืžืŸ, ืขืื˜ืฃ ืžื—ืืžื™ื“, ื–ืื‘ ื’ืจื•ืก GROSS, ATIF MAHAMMED,IRENA SALTSMAN

]72[

WO/2003/004021]87[',ื‘ืŸ ืขืžื™ ื•ืฉื•ืช ืจื—ื•ื‘ื•ืช,94.ื“.ืช,8ืžื ื—ื ืคืœืื•ื˜

BEN-AMI & ASSOCIATES,8 PLAUT ST.,

PARK TAMAR,P.O.B. 94,REHOVOT 76100

]74[

A corrole of the formula

wherein:Ar is aryl or heteroaryl;M is absent or is metal selected from the group consisting of Al, Ga, Co, Mn, Fe, Ru,Sn, Cr and Rh; E2, E3 and E17, the same or different, each is H, SO2Cl, SO3H,SO2NR1R2, CO2H, CO2R, COCl, CONR1R2, CHO or NO2 R is alkyl or aryl, and R1 andR2, the same or different, each is H, alkyl, aryl or together with the N atom to which theyare attached form a staturated 5-6 membered ring optionally containing a furtherheteroatom selected from the group consisting of O, S and N; and E18 is H or CHO; orE3 and E18 each is H and E2 and E17 each is SO2, both SO2 groups being linked by abridge R3N(R4)-phenyl-(R4)NR3, wherein R3 is H, alkyl, phenyl or aralkyl, and R4 isalkylene; and provided that at least one of E2, E3, E17 and E18 is not H.

]57[

__________

Page 400: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 400

159859]21][11[

ANTINEOPLASTIC ืฆื™ืจื•ืคื™ื ื ื•ื’ื“ื™ ืกืจื˜ืŸCOMBINATIONS

]54[

06.08.2002]22[US]33[07.08.2001]32[60/310646]31[

Int. Cl.(2008.04) A61K 313/95, 314/706, A61P 35/00]51[WYETH, U.S.A.]71[WO/2003/020266]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

This invention provides the use of a combination of CCI-779 and EKB-569 in thetreatment of neoplasms.

]57[

__________

159947]21][11[

ืฉื™ื˜ื•ืช ื•ืชื›ืฉื™ืจื™ื ืœื”ื’ื ื” ืžื—ืจืงื™ื ื‘ืืžืฆืขื•ืช ื ื’ื–ืจื•ืช ืื ืชืจืื ื™ืœืืžื™ื“

METHODS AND COMPOSITIONSFOR PROTECTION FROMARTHROPODS USINGANTHRANILAMIDEDERIVATIVES

]54[

10.09.2002]22[US]33[21.09.2001]32[60/323941]31[

Int. Cl.(2009.01) A01N 43//56, 55//10, C07D 23/1/00, 40/1/04, 40/3/04, 40/5/04,40/5/12, 41/3/04, 41/3/14, 41/7/04, C07F 07//18

]51[

E.I. DUPONT DE NEMOURS ANDCOMPANY, U.S.A.

]71[

WO/2003/024222]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

This invention pertains to methods for protecting a propagule or a plant grown therefrom from invertebrate pests comprising contacting the propagule or the locus of the propagule with a biologically effective amount of a compound of Formula I: its N-oxide or an agriculturally suitable salt thereof wherein A and B and R?1? through R?8? are as defined in

]57[

Page 401: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009401

the disclosure. This invention also relates to propagules treated with a compound of Formula I and compositions comprising a Formula I compound for coating propagules.

__________

159950]21][11[

ื”ืœื™ืš ืœื”ื›ื ืช ืื‘ืงื•ืช ื ื ื•ืžื˜ืจื™ื•ืช ื•ืื‘ืงื”ืชื‘ืขืœืช ืžืฆืจืคื™ื ื—ื•ืคืฉื™ื™ื ืฉืœ ื—ืœืงื™ืงื™ื

ื ื ื•ืžื˜ืจื™ื™ื

PROCESS FOR PRODUCINGNANO-POWDERS AND NANO-PARTICLE LOOSE AGGREGATESPOWDER

]54[

26.07.2002]22[CN]33[27.07.2001]32[01127978.8]31[

Int. Cl.(2009.01) B01F 03//08, B01J 19//00, C01F 03//02]51[ANSHAN UNIVERSITY OFSCIENCE AND TECHNOLOGY,CHINA

]71[

WO/2003/011761]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The present invention discloses a process for producing nano-powdersand powders of nano-particle loose aggregate, which comprises: (a)providing at least two reactant solutions A and B capable of rapidlyreacting to form deposits; (b) supplying the at least two solutions A andB at least at the reaction temperature into a mixing and reactionprecipitator respectively, in which mixing reaction and precipitation arecontinuously carried out in sequence, the said mixing and reactionprecipitator being selected from at least one of a tubular ejector mixingreactor, a tubular static mixing reactor and an atomizing mixing reactor;and (c) treating the deposit-containing slurry continuously dischargedfrom the mixing reaction precipitator. The process makes it possible tocontrol the size of the nano-particles, produces particles uniform in size,good in dispersibility and high in yield, while being simple and savingenergy. The process can be used to produce nano-powders of nano-particle aggregates of various kind of metals, oxides, hydroxides, salts,

]57[

Page 402: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 402

phosphor compounds, sulphur compounds, organic compounds, andinorganic organic compounds.

__________

160049]21][11[

LACTOBACILLUSื–ื ื™ SALIVARIUSืคื•ืจืžื•ืœืฆื™ื•ืช ืฉืœื”ื ื•ืฉื™ืžื•ืฉ, ืคืจื•ื‘ื™ื•ื˜ื™ื™ื

ื‘ื”ื ืœื™ื™ืฆื•ืจ ืชื›ืฉื™ืจื™ื ืจืคื•ืื™ื™ื

ISOLATED PROBIOTICLACTOBACILLUS SALIVARIUSSTRAINS, FORMULATIONSTHEREOF AND USES THEREOFFOR THE MANUFACTURE OFMEDICAMENTS

]54[

26.07.2002]22[IE]33[26.07.2001]32[01/0707]31[IE26.07.2001 01/0702 IE26.07.200101/0701IE26.07.200101/0705IE26.07.200101/0708

Int. Cl.(2008.04) A61K 35/74, A61P 29/00, C12N 1/20, C12R 12/25]51[ALIMENTARY HEALTH LIMITED,IRELAND

]71[

WO/2003/010298]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A Loctabacillus salivarius strain,AHlO2, AHlO3, AHlO5, AHlO9 or AHllO or mutants orvariants thereof are useful in the prophylaxis and/or treatment of inflammatory activityespecially undesirable gastrointestinal inflammatory activity, such as inflammatorybowel disease or irritable bowel syndrome.

]57[

__________

Page 403: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009403

160053]21][11[

ืฉื™ื˜ื” ืœื‘ื™ื“ื•ื“ ื•ืืคื™ื•ืŸ ืฉืœ ืชืฆืžื™ื“ื™ื ื”ืงืฉื•ืจื™ื ืœืงืจื•ื ื•ื”ืžื™ื•ื—ื“ื™ื ืœืœื™ื’ื ื“

METHOD TO ISOLATE ANDCHARACTERIZE MEMBRANEBOUND LIGAND SPECIFICCOMPLEXES

]54[

29.07.2002]22[US]33[27.07.2001]32[60/308655]31[US17.08.2001 09/932166

Int. Cl.(2009.01) C07K 01//14, 01//22, 14//705, 16//28, G01N 33//48, 33//566,33//577

]51[

AGENSYS, INC., U.S.A.]71[WO/2003/012047]87[

,ืžืŸ ื•ื’ื•ืœืจื‘ืจื’, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A method to recover or 'deracinate' receptors from intact membranes in their nativeconfiguration without removing microenvironmental components associated with themis described. The membranes containing the receptors are first associated with ligand-coupled solid supports to achieve association of the membranes through areceptor/ligand complex which includes the microenvironmental to the solid supportand then removing the membrane from the receptor and its microenvironment by shearforces. The thus isolated receptors and their microenvironments can then be analyzedfor their role in cellular differentiation, apoptosis, transformation and the like.

]57[

__________

Page 404: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 404

160330]21][11[

ื™ื™ืฉื•ื ืคืขื•ืœื” ืฉืœ ื‘ืงืฉืช ืฉื™ื“ื•ืจ ื—ื•ื–ืจืื•ื˜ื•ืžื˜ื™ืช ืขืœ ืฉื›ื‘ืช ืคื™ืกื™ืช ืขื‘ื•ืจ ื™ื—ื™ื“ืช

ืžื ื•ื™

IMPLEMENTING A PHYSICALLAYER AUTOMATIC REPEATREQUEST FOR A SUBSCRIBERUNIT

]54[

23.08.2002]22[US]33[24.08.2001]32[939410]31[US27.02.2002 085203

Int. Cl.(2009.01) H04B 07//26, H04L 01//16]51[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.

]71[

WO/2003/019844]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A subscriber unit implementing physical layer automatic repeat request includes atransmitter (12) and a receiver (16). The transmitter has a physical layer transmitter(12a); an acknowledge receiver (12b) for receiving the correspondingacknowledgment; and an adaptive modulation and coding controller (12c) forcollecting retransmission statistics and adjusting the particular dataencoding/modulation using the collected statistics. The receiver (16) has a physicallayer receiver (16a), and an acknowledgment generator (16c) for generating anacknowledgment for each packet if that packet has an acceptable error rate.

]57[

__________

Page 405: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009405

160338]21][11[

ื”ืœื™ืš ืœื™ื™ืฆื•ืจ ื—ืœื‘ื•ืŸ ืื• ืคื•ืœื™ืคืคื˜ื™ื“ ืฉื™ืฉื‘ื• ืขื ื™ื™ืŸ ื‘ืฆืžื— ืื• ื‘ืชืื™ ืฆืžื— ื”ืžืฉื˜ืžืฉ

ื‘ื—ืœื‘ื•ืŸ ืื™ื—ื•ื™ ื”ืžื›ื™ืœ ืคืคื˜ื™ื“ ื”ืžืชื—ื‘ืจ ืœื“ื•ืคืŸ ืชื

PROCESS OF PRODUCING APROTEIN OR POLYPEPTIDE OFINTEREST IN A PLANT OR INPLANT CELLS USING FUSIONPROTEIN COMPRISING CELLWALL-BINDING PEPTIDE

]54[

28.08.2002]22[DE]33[04.09.2001]32[10143205.4]31[

Int. Cl.(2009.01) A01H 05//00, C12N 15//62, 15//82, C12P 21//00]51[ICON GENETICS GMBH,GERMANY

]71[

YURII DOROKHOV, EUGENESKURAT, VICTOR KLIMYUK, YURIGLEBA

]72[

WO/2003/020938]87[ื‘ื™'ื’ ื‘ืข, ื™ื™ ืืž ,ืž"ืคืงื˜ื•ืจ ืื ื“ ืงื•

, 45087.ื“.ืช, ื”ืจ ื—ื•ืฆื‘ื™ื, ืจื—ื•ื‘ ื”ืžืจืคื ื™ืจื•ืฉืœื™ื

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,

P.O.B. 45087,JERUSALEM 91450

]74[

A process of producing a protein or polypeptide of interest in a plant orin plant is provided, comprising: (i) transforming or transfecting a plantof plant cells with a nucleotide sequence having a coding regionencoding a fusion protein comprising the protein or polypeptide ofinterest, a signal peptide functional for targeting said fusion protein tothe apoplast, and a polypeptide capable of binding the fusion protein toa cell wall component, (ii) enriching cell wall components havingexpressed and bound fusion protein, and separating the protein orpolypeptide of interest or a protein comprising the protein orpolypeptide interest.

]57[

__________

Page 406: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 406

160367]21][11[

ืคื™ืจื•ืœื• ืคื™ืจื™ืžื™ื“ื™ื ื™ื ื›ื—ื•ืžืจื™ื ืœืžื ื™ืขืช ืฆื™ืกื˜ืื™ืŸ ืคืจื•ื˜ืื–ื™ื

PYRROLO PYRIMIDINES ASAGENTS FOR THE INHIBITIONOF CYSTEINE PROTEASES

]54[

29.08.2002]22[GB]33[30.08.2001]32[0121033.5]31[

Int. Cl.(2008.04) A61K 315/19, A61P 29/00, C07D 471/10, 487/04]51[NOVARTIS AG, SWITZERLAND]71[WO/2003/020721]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The invention provides compounds of Formula I or a pharmaceutically acceptable saltor ester thereof wherein the symbols have meaning as defined, which are inhibitors ofcathepsin K and find use pharmaceutically for treatment of diseases and medicalconditions in which cathepsin K is implicated, e.g. various disorders includinginflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198643,The applications for divisionfrom this application havenot yet been published

__________

Page 407: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009407

160522]21][11[

ืื™ืžื™ื“ื–ื•ืœ ื‘ืขืœื•ืช ืคืขื™ืœื•ืชโ€“H1ืชื•ืœื“ื•ืช,CB1ืื’ื•ื ื™ืกื˜ื™ืช ืžืœืื” ืื• ื—ืœืงื™ืช ื›ืœืคื™

CB1ืื• ืคืขื™ืœื•ืช ืื ื˜ื’ื•ื ื™ืกื˜ื™ืช ื›ืœืคื™

1H - IMIDAZOLE DERIVATIVESHAVING CB1 AGONISTIC, CB1PARTIAL AGONISTIC OR CB1-ANTAGONISTIC ACTIVITY

]54[

17.09.2002]22[EP]33[21.09.2001]32[01203851.9]31[

Int. Cl.(2009.01) A61K 31//41, C07C 25/7/10, C07D 23/3/00, 23/3/54, 40/1/02,40/3/02, 40/3/12, 41/3/02

]51[

SOLVAY PHARMACEUTICALSB.V., THE NETHERLANDS

]71[

WO/2003/027076]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

AbstractThe present invention relates to a group of novel 1Hโˆ’imidazole derivatives, tomethods for the preparation of these compounds, and to pharmaceutical compositionscontaining one or more of these compounds as an active component.These1Hโˆ’imidazole derivatives are potent cannabinoidโˆ’CB1 receptor agonists, partialagonists or antagonists, useful for the treatment of psychiatric and neurologicaldisorders, as well as and other diseases involving cannabinoid neurotransmission.Thecompounds have the general formula (I) wherein R and R1โˆ’R4 have the meaningsgiven in the specification.

]57[

__________

Page 408: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 408

160575]21][11[

ืช ืขืจื•ืฅ ื”ืขื‘ืจืช ื•ืงื‘ืœืช ื”ื•ื“ืขื•ืช ื‘ืืžืฆืขื• ืชืงืฉื•ืจืช ืžื•ืชืื ื•ืžื•ื“ืœ ืชื›ื ื•ืช

TRANSMITTING ANDRECEIVING MESSAGESTHROUGH A CUSTOMIZABLECOMMUNICATION CHANNELAND PROGRAMMING MODEL

]54[

25.02.2004]22[US]33[26.03.2003]32[400747]31[

Int. Cl.(2008.04) G06F 13/00, 15/00, 17/00, 9/46, H04L 29/06, 29/08, 29/10]51[MICROSOFT CORPORATION,U.S.A.

]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A computer system for implementing a messaging infrastructure which abstractsvarious processing layers within the infrastructure, wherein the infrastructure is adaptedto provide a base level of messaging functionality, and wherein the abstract processinglayers are extensible such that changes or enhancements can be made withoutnecessarily having to re-implement the base level of messaging functionality providedin other abstract processing layers, the computer system comprising: one or moremessaging layer modules adapted to provide endpoint-to-endpoint transmission of oneor more messages and to implement support for one or more message transportprotocols; one or more channel layer modules adapted to provide message exchangesemantics on top of the one or more message layer modules; and one or more servicelayer modules adapted to provide one or more programming modules on top of the oneor more channel layer modules adapted to interact with the messaging infrastructure byexposing one or more features of the messaging infrastructure to be accessed bysoftware designed to use the messaging infrastructure; wherein the one or morechannel layer modules comprise a channel manager adapted to gather and correlatemessages and present a higher-level channel abstraction to the one or more servicelayer modules.

]57[

__________

Page 409: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009409

160580]21][11[

ืžืขืจื›ืช ืกื™ื ื•ืŸ ื–ืจื™ืžืช ืฆื•ืœื‘ืช ื•ืฉื™ืชื” ืœืžื ื™ืขืช ืกืชื™ืžื•ืช ื‘ืžืžื‘ืจื ื•ืช

CROSSFLOW FILTRATIONSYSTEM AND METHOD FORMEMBRANE FOULINGPREVENTION

]54[

26.02.2004]22[Int. Cl.(2009.01) B01D 65//02]51[

BORIS ื—ื™ืคื”, ื‘ื•ืจื™ืก ืคื•ื“ื•ืœืกืงื™ PODOLSKY]71[,ื‘ื•ืจื™ืก ืคื•ื“ื•ืœืกืงื™

ื—ื™ืคื”,,ื’26ื•ื•ื“'ื•ื•ื“ื’' ืฉื“BORIS PODOLSKY,26G WEDGWOOD AVE., HAIFA

]74[

A crossflow filtration system for membrane fouling prevention, comprising:(a) a pipe-line for feeding liquid to be cleaned;(b) a pressure pump associated via a hydraulic line with the pipe-line for feeding fluid tobe cleaned;(c) a membrane module, including a membrane enclosed in a body associated via apressure line with the pump and two exits, the first whereof serves for removingcleaned fluid, and the second โ€“ for removing waste concentrate, this membranemodule serves for separating the feed into pure fluid and concentrate containingimpurities;(d) a pipe-line for cleaned fluid associated with the first exit of said membrane body;(e) a pipe-line for removing waste concentrate connected with the second exit of saidmembrane body;(f) means for applying an additional reciprocal fluid pulse to the fluid passing through(a) membrane located in a membrane module for applying an additional reciprocal fluidpulse to the fluid passing through the membrane module, whereby there are preventedmembrane fouling in said membrane module and formation thereof of a boundaryconcentrate layer.

]57[

__________

160640]21][11[

CRYSTALLINE ื”ื™ื“ืจื˜ื™ื ื’ื‘ื™ืฉื™ื™ื ืฉืœ ืชื•ืœื“ื•ืช ืื ื™ืœื™ื“ HYDRATES OFANILIDE DERIVATIVES

]54[

14.09.2002]22[DE]33[25.09.2001]32[10147034.7]31[

Int. Cl.(2008.04) A01N 43/40, C07C 233/64, C07D 213/82]51[BASF SE, GERMANY]71[WO/2003/029219]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•ืœืจืžืช ื”ื—ื™ื™',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to crystalline hydrates of substituted nicotinic acid anilidederivatives and substituted benzoic acid anilide derivatives of formula (1), theproduction and use thereof to combat phytopathogenic fungi and undesirableinsect and accaride attacks and/or to regulate the growth of plants; wherein A

]57[

Page 410: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 410

represents (A1) or (A2), R?1ยฟ represents phenyl substituted by halogen, R?2ยฟrepresents difluoromethyl, trifluorormethyl, chlorine, bromine or iodine andR?3ยฟ represents trifluoromethyl or chlorine.

__________

160660]21][11[

OPTICAL ื—ืœื•ืŸ ืื•ืคื˜ื™ ืœืžืขืงื‘ ืื—ืจ ื“ื’ื™ืžื•ืช WINDOW FORMONITORING SAMPLES

]54[

13.09.2002]22[GB]33[20.09.2001]32[0122711.5]31[

Int. Cl.(2008.04) G01N 21/15]51[NDC INFRARED ENGINEERINGLTD., UNITED KINGDOM

]71[

WO/2003/025550]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

This invention is concerned with a material processing apparatus, e.g. a dryer such asa fluid bed dryer, for processing material, e.g. pharmaceuticals, in a compartment (12)having a wall (10). The wall has a window for transmitting radiation from an infraredspectrometer (30) into the dryer and for transmitting radiation from the material to thespectrometer. The spectrometer (30) can analyse the radiation transmitted from thematerial to measure a property of the material within the compartment, e.g. its moisturecontent. The radiation-transmitting element (28) is present in a moveable body (24),e.g. a sphere, that can be moved to bring the element (28) into a second position (31)in which the element is in contact with a duct (40) through which fluid can be passed toclean the element (28). In addition, a wiper member (34) may be provided that wipesthe element (28) as it passes over it as the moveable body (26) is moved into thesecond position.

]57[

__________

Page 411: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009411

160680]21][11[

ื•ืฉื™ื˜ื•ืช, ืื ื˜ื ืช ืคืก ื“ืงื“ื” ื—ืจื™ืฅ ืžื—ื•ื“ื“ื• ืชืฆื•ืจื” ืฉืœื”ื™ื™ืฆื•ืจ

DECADE BAND TAPERED SLOTANTENNA AND METHODS OFMAKING AND CONFIGURINGSAME

]54[

04.09.2002]22[US]33[04.09.2001]32[60/317410]31[US14.12.2001 10/023229 US14.12.200110/023800US14.12.200110/022753

Int. Cl.(2009.01) H01Q 09//04]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/021715]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

An antenna apparatus (10) includes an antenna element (12, 412, 512) that hasconductive material with a recess therein. The recess includes a balun hole (36, 536),and a tapered slot (37, 537) communicating at its narrow end with the balun hole. Thebalun hole is approximately rectangular, has a peripheral edge defined by conductivematerial, and contains air. The tapered slot has a shape which is optimized as afunction of factors that include the balun hole design. Each slot edge follows apredetermined curve other than a first-order exponential curve.

]57[

__________

Page 412: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 412

160769]21][11[

ืชืจื›ื•ื‘ื•ืช ื”ื˜ืจื•ืฆื™ืงืœื™ื•ืช ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

HETEROCYCLIC COMPOUNDSAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

04.10.2002]22[US]33[04.10.2001]32[60/327162]31[

Int. Cl.(2009.01) A61K 31//519, A61P 09//00, C07D 413/00]51[MORPHOCHEMAKTIENGESELLSCHAFT FURKOMBINATORISCHE CHEMIE,GERMANY

]71[

WO/2003/032962]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The present invention relates to compounds of the Formula (I) that are usefulantimicrobial agents and effective against a variety of multiโˆ’drug resistant bacteria.

]57[

__________

160981]21][11[

SYSTEM ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœืฉื™ื“ื•ืจ ืื•ืชื•ืช ืžื™ื“ืข AND METHOD FORCOMMUNICATING MEDIASIGNALS

]54[

26.09.2002]22[US]33[26.09.2001]32[60/325483]31[

Int. Cl.(2009.01) G06F 13//00, G06N 03//00, 03//08, H03M 07//30, H04L 29//06,H04N 07//26

]51[

INTERACT DEVICES, INC., U.S.A.]71[WO/2003/027876]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ,ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A media streaming system for streaming media signals is provided. The mediastreaming system takes a library of separate and distinct CODECs (145) that areprovided as a searchable CODEC library and used in determining specificcharacteristics in the media signal to identify similar sections of the signal. The media

]57[

Page 413: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009413

streaming system uses a computer implemented intelligence system, such as anintelligence mechanism to learn and capture the unique charateristics of a signal as thesignal is being streamed (150). The media streaming system also compresses anddecompresses the media signal as the signals are streamed from a source media (100)to a destination device (130, 135, 140).

__________

161165]21][11[

ืžืœื— ื ืชืจืŸ ื’ื‘ื™ืฉื™ ืฉืœ ื˜ืœืžื™ืกืจื˜ืŸื•ื”ืฉื™ืžื•ืฉ ื‘ื• ื‘ืื ื˜ื’ื•ื ื™ืกื˜ ืœืงื•ืœื˜ืŸ

ื”ืื ื’ื™ื•ื˜ื ืกื™ืŸ

CRYSTALLINE SODIUM SALT OFTELMISARTAN AND THE USE OFTHE SAME AS AN ANGIOTENSINANTAGONIST

]54[

11.10.2002]22[DE]33[31.10.2001]32[10153737.9]31[

Int. Cl.(2009.01) A61K 31//4184, C07D 23/5/20]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY

]71[

WO/2003/037876]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a crystalline sodium salt of 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: Telmisartan), to a methodfor the production thereof, and to the use of the same for producing apharmaceutical having an angiotensin II antagonistic action.

]57[

__________

Page 414: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 414

161401]21][11[

ORGANIC ื˜ื™ืคื•ืœ ื‘ืคืกื•ืœืช ืื•ืจื’ื ื™ืช WASTE TREATMENT]54[

17.10.2002]22[AU]33[17.10.2001]32[PR8333]31[

Int. Cl.(2008.04) C02F 11/14, 3/00]51[ADVANCED ENVIRONMENTALTECHNOLOGIES PTY LTD.,AUSTRALIA

]71[

WO/2003/033418]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method of treatment of sewage comprising adding at least one cell signallingchemical (CSC) to a sewage substrate, wherein the at least one CSCregulates activity of a microbial population in the sewage substrate. Inparticular, methods of reducing odour in sewage treatment systems,preventing corrosion in sewage treatment systems, enhancing microbialdigestion of sewage, managing methane gas production in a sewagetreatment system, enhancing digestion of sewage sludge, resuscitatingdormant microbes or microbes that are in a starvation or stationary phase in asewage substrate and controlling the bacteria responsible for oxidation orreduction of nitrogenous compounds in a sewage substrate, are provided.

]57[

__________

161402]21][11[

POURING ืคื™ื” ืœืฉืคื™ื›ื” SPOUT]54[

18.10.2002]22[GB]33[20.10.2001]32[0125296.4]31[

Int. Cl.(2009.01) B65D 05//74]51[SIG COMBIBLOC INTERNATIONALAG, SWITZERLAND

]71[

WO/2003/035491]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention describes a pouring spout device, comprising a spout fitment (4) and areclosable closure (2), said spout fitment (4) having a planar base (29) and a tubularside wall (24) defining a pouring zone therein and a flap (26) disposed at a lower end ofthe side wall (24), a cam follower (32) extending upward from said flap (26), whereinthe closure (2) retained on said fitment has an end wall (5) and a tubular side wall (3),

]57[

Page 415: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009415

wherein the end wall (5) has a first cam (8) depending therefrom and engageable withsaid cam follower (32), and wherein the first cam (8) contacting the cam follower (32)during rotation of the closure (2). In order to avoid breakage of the cam follower (32),when the reclosable closure (2) is replaced on the spout fitment (4), a second cam (10)is formed on the reclosable closure (2) and disposed radially outermost of the first cam(8). When the cam follower (32) reaches the end region (12), the cam follower (32) willbe able to move radially inwardly and return to the surface (11) of the first cam (8). Thecam follower (32) will then be correctly positioned for future opening operations.

__________

161559]21][11[

ืชื•ืœื“ื•ืช ื“ื™ื‘ื ื–ื™ืœ ืืžื™ืŸ ื•ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

DIBENZYLAMINE DERIVATIVES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAME

]54[

29.08.2003]22[JP]33[30.08.2002]32[2002-255604]31[JP10.04.2003 2003-107161

Int. Cl.(2008.04) A61K 31/41, 314/33, 315/05, C07C 229/28, 255/58, C07D 213/72,231/38, 233/44, 237/10, 239/42, 249/00, 257/04, 261/14, 263/00, 271/06, 277/38,405/12

]51[

JAPAN TOBACCO INC., JAPAN]71[WO/2004/020393]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A dibenzylamine compound represented by the general formula (1): (1)(wherein R1 and R2 each is optionally halogenated C1-6 alkyl, etc.; R3, R4, andR5 each is hydrogen, halogeno, etc., provided that R3 and R4 may form anoptionally substituted homocycle or heterocycle in cooperation with the carbonatoms bonded thereto; A is -N(R7)(R8), etc.; ring B is aryl or a heterocyclicresidue; R6 is hydrogen, halogeno, nitro, C1-6 alkyl, etc.; and n is an integer of 1to 3); a prodrug of the compound; or a pharmaceutically acceptable salt ofeither. They have selective and potent CETP inhibitory activity and are henceusable as, e.g., a therapeutic or preventive drug for hyperlipemia,arteriosclerosis, etc.

]57[

Page 416: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 416

__________

161587]21][11[

โ€“3(โ€“3ืชื›ืฉื™ืจ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœโ€“ืžืชื™ืœโ€“2โ€“ืืชื™ืœโ€“1โ€“ื ื• ื“ื™ืžืชื™ืœืืžื™

ืคื ื™ืœ ื•ืืฉืจ ืžืืคืฉืจ ืฉื—ืจื•ืจ) ืคืจื•ืคื™ืœ ืžื•ืฉื”ื” ืฉืœ ื”ืžืจื›ื™ื‘ ื”ืคืขื™ืœ

PHARMACEUTICALCOMPOSITION CONTAINING 3 -(3 - DIMETHYLAMINO - 1 -ETHYL - 2 - METHYL - PROPYL)PHENOL AND PROVIDINGDELAYED RELEASE OF THEACTIVE INGREDIENT

]54[

22.10.2002]22[DE]33[24.10.2001]32[10152469.2]31[DE16.10.2002 10248309.4

Int. Cl.(2009.01) A61K 09//22, C07C 21/5/00, 21/5/56]51[GRUNENTHAL GMBH, GERMANY]71[WO/2003/035053]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a pharmaceutical formulation which is characterised bydelayed release of the active ingredient. Said formulation contains 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol or one of its pharmaceutically acceptable salts in amatrix with delayed release of the active ingredient. Said matrix contains between 1and 80 wt. % of at least one hydrophilic or hydrophobic polymer as a pharmaceuticallyacceptable matrix forming agent and exhibits, in vitro, the following dissolution speed:between 3 and 35 wt. % (in relation to 100 wt. % of active ingredient) of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after half an hour, between 5and 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released afterone hour, between 10 and 75 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after two hours, between 15 and 82 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after three hours, between30 and 97 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released aftersix hours, more than 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol isreleased after twelve hours, more than 70 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after eighteen hours, and more than 80 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after twenty-four hours.

]57[

Page 417: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009417

__________

161643]21][11[

ื‘ืขืœ ื—ืœื•ืŸCDMAืžืขืจื™ืš ืคืจืžื˜ืจื™ ืœืžืงืœื˜ื• ืื• ืžื™ืงื•ื/ื—ื™ืคื•ืฉ ืขื ื’ื•ื“ืœ

PARAMETER ESTIMATOR FOR ACDMA RECEIVER WITH ASEARCH WINDOW OF VARIABLESIZE AND/OR PLACEMENT

]54[

25.10.2002]22[US]33[29.10.2001]32[60/336187]31[US24.01.2002 10/056877

Int. Cl.(2008.04) G01S 5/02, H04B 17/07]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2003/039020]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A parameter estimator for estimating one or more parameter(s) from a correlationfunction derived from a signal using a dynamically variable search window is described.The parameter estimator may be employed in a subscriber station to estimate the timeof arrival of one or more base station pilot signals in a wireless communication system.This information may be utilized in an overall advanced forward link trilateration (AFLT)process for estimating the location of the subscriber station.

]57[

__________

Page 418: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 418

161654]21][11[

โ€“ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจ ื ืชื‘ื™ื ืžื™ืงืจื•ื’ื ื˜ื™ื™ื ื”ืžื‘ื•ืกืกื™ื ืขืœ ืืœืงื˜ืจื•ืž

CMOSืžืฆืขืชื•ืื

METHOD OF FABRICATINGMICRO-ELECTROMECHANICALSWITCHES ON CMOSCOMPATIBLE SUBSTRATES

]54[

07.11.2002]22[US]33[07.11.2001]32[10/014660]31[

Int. Cl.(2008.04) B81C 1/00, H01L 21/00]51[IBM CORPORATION, U.S.A.]71[WO/2003/054938]87[

,ืžืขื‘ื“ื•ืช ื™ื‘ืž ืžื—ืœืงืช ืงื ื™ืŸ ืจื•ื—ื ื™ ื—ื™ืคื”, ืื•ื ื™ื‘ืจืกื™ื˜ืช ื—ื™ืคื” ื”ืจ ื”ื›ืจืžืœ

IBM LABORATORIES,HAIFA UNIVERSITY,

HAIFA 31905

]74[

A method of fabricating micro-electromechanical switches (MEMS) using a processstarting with a copper damascene interconnect layer, made of metal conductors inlaidin a dielectric (150). All, or portions, of the interconnects are recessed to a degreesufficient to provide a capacitive air gap when the switch is in the closed state, as wellas provide space for a protective layer of, for example, Ta/TaN. The metal structuresdefined within the area specified for the switch act as actuator electrodes to pull downthe movable beam (160) and provide one or more paths for the switched signal totraverse. The advantage of an air gap is that air is not subject to charge storage ortrapping that can cause reliability and voltage drift problems. Instead of recessing theelectrodes to provide a gap, one may just add dielectric on or around the electrode.The next layer is another dielectric layer which is deposited to the desired thickness ofthe gap formed between the moveable beam (160) that forms the switching device.Vias are fabricated through this dielectric to provide connections between the metalinterconnect layer and the next metal layer which will also contain the switchable beam.The via layer is then patterned and etched to provide a cavity area which contains thelower activation electrodes as well as the signal paths. The cavity is then back-filledwith a sacrificial release material.

]57[

__________

Page 419: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009419

161872]21][11[

RA1ื™ืฆื•ืจ โ€“ILื”ืžื•ืžืจืฅ ืขืœ ื™ื“ื™ ื ื•ื’ื“ืŸ ANTIBODY STIMULATING IL-1RA PRODUCTION

]54[

08.11.2002]22[FR]33[09.11.2001]32[01/14518]31[

Int. Cl.(2008.04) A61K 393/95, A61P 11/00, 17/00, 19/02, 19/10, 29/00, 35/00, C07K16/18

]51[

LABORATOIRE FRANCAIS DUFRACTIONNEMENT ET DESBIOTECHNOLOGIES, FRANCE

]71[

WO/2003/040188]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention concerns natural antibodies eventually monoclonalcapable of inducing a high production of IL-1Ra with monocytes ormacrophages and the use of said antibodies for treating inflammatory orautoimmune diseases.

]57[

__________

161876]21][11[

BLOCK ื’ื•ืฉ ื‘ื™ื ื™ื™ื ื™ ืžื’ื•ืจื™ื ื”ืฆืฃ ืขืœ ืคื ื™ ื”ื™ื OF RESIDENTIALBUILDINGS FLOATING ON THESEA SURFACE

]54[

09.05.2004]22[Int. Cl.(2009.01) B63B 35//44, E04H 03//02]51[

ื ืฆืจืช ืขืœื™ืช, ืงื•ื‘'ืฉืžืขื•ืŸ ืกื˜ืจื™ื– ื—ื™ืคื”, ืงื•ื‘'ืคืจื“ ืกื˜ืจื™ื–

SHIMON STRIZHAKOVFRED STRIZHAKOV

]71[

,ืงื•ื‘'ืฉืžืขื•ืŸ ืกื˜ืจื™ื– ื ืฆืจืช ืขืœื™ืช, 15555.ื“.ืช89ื”ื•ื•ืจื“ื™ื' ืจื—

SHIMON STRIZHAKOV,89 HAVRADIM ST., P.O.B. 15555,

NAZERETH-ILLIT

]74[

A block of residential buildings floating on the sea surface; the residential buildings 6-11 are each interlinked only to the two nearest buildings around the periphery of theblock by rigid connections (16) to form a block; the rigid connection interlink both thelower and upper of the residential buildings; the residential buildings are connected asstraight hexahedron prisms; center gravity of each residential building is situated on itsaxis symmetry.

]57[

Page 420: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 420

__________

161898]21][11[

ื™ื™ืฆื•ืจ ืžื™ืœื—ื™ ืืžื•ื ื™ื•ื ืฉืœ ื—ื•ืžืฆื•ืช ืงืจื‘ื•ื›ืกื™ืœื™ื•ืช ืืจื•ืžื˜ื™ื•ืช

PRODUCTION OF AMMONIUMSALTS OF AROMATICCARBOXYLIC ACIDS

]54[

03.12.2002]22[DE]33[04.12.2001]32[10159420.8]31[

Int. Cl.(2009.01) C07C 63//04, 63//08]51[BASF SE, GERMANY]71[WO/2003/048099]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method for the production of ammonium salts of aromatic carboxylic acidsby reaction of an aromatic carboxylic acid with ammonia in an aprotic solventis disclosed. Said reaction is carried out in a closed vessel and a solution ofthe aromatic carboxylic acid in an aprotic solvent and gaseous ammonia arecontinuously introduced into the vessel, such that a partial pressure ofammonia of 0.1 to 3 bars is maintained in the gas chamber of the vessel and asuspension of the ammonium salt separates out in the aprotic solvent. Themethod permits the production of ammonium salts with defined crystal sizeand a narrow size distribution.

]57[

__________

Page 421: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009421

161984]21][11[

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื”ืคืกืงืช ืคืขื™ืœื•ืช ืขืจื•ืฅ ืชื ื•ืขื” ื‘ืชืฆื•ืจืช ืฉืงืข ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™

SYSTEM AND METHOD FORTRAFFIC CHANNEL DORMANCYIN WIRELESS COMMUNICATIONSOCKET MODE

]54[

22.11.2002]22[US]33[26.11.2001]32[10/994189]31[

Int. Cl.(2008.04) H04J 13/00, H04L 1/00, 29/02, 29/06, 29/08]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2003/047212]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

In a wireless communication system such as a CDMA system, a traffic channelsupporting two applications running in socket mode on a mobile station is allowed to godormant and is released when respective idle periods associated with each socketexpire, i.e., when there is no transmission over the traffic channel for the longer of twopotentially unequal idle periods.

]57[

__________

162035]21][11[

โ€“Nืชื•ืœื“ื•ืชื”ื˜ืจื•ืืจื™ืœื ื™ืงื•ื˜ื™ื ืืžื™ื“ื•ืชื›ืฉื™ืจื™ื ืงื•ื˜ืœื™

ืžื–ื™ืงื™ื ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

N-HETEROARYLNICOTINAMIDEDERIVATIVES AND PESTICIDALCOMPOSITIONS CONTAININGTHE SAME

]54[

19.11.2002]22[JP]33[21.11.2001]32[2001-355561]31[JP11.03.2002 2002-65193

Int. Cl.(2009.01) A01N 43//80, C07D 41/3/12, C07D 413/00]51[SANKYO AGRO COMPANY,LIMITED, JAPAN

]71[

WO/2003/044013]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Page 422: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 422

Nโˆ’Heteroarylโˆ’4โˆ’(trifluoromethyl)nicotinamide derivatives represented by the generalformula (‖) or salts thereof; pesticides containing the same as the activeingredient; a process for the production thereof; and intermediatestherefor: (‖) wherein R is C1โˆ’6 haloalkyl; R1 is hydrogen, optionallysubstituted C1โˆ’6 alkyl, C2โˆ’6 alkenyl, or acyl; X is Cโˆ’R2 or nitrogen; and R2

and R3 are each independently hydrogen, halogeno, optionally substituted C1โˆ’6 alkyl,C3โˆ’7 cycloalkyl, C2โˆ’6 alkenyl, C3โˆ’7 cycloalkenyl, formyl, CH=NOR4, cyano, optionallysubstituted phenyl, a heterocyclic group which may be substituted, optionallysubstituted C1โˆ’6 alkoxy, C1โˆ’6 alkylthio, or optionally substituted phenoxy.

]57[

__________

162092]21][11[

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœืงืจื™ืื” ืœืžืกื•ืฃ ืืœื—ื•ื˜ื™ ื‘ืจืฉืช ืชืงืฉื•ืจืช ืืœื—ื•ื˜ื™

METHOD OF AND APPARATUSFOR PAGING A WIRELESSTERMINAL IN A WIRELESSTELECOMMUNICATIONSSYSTEM

]54[

29.05.1998]22[US]33[30.05.1997]32[08/865650]31[US09.07.1997 08/890355

Int. Cl.(2008.04) H04J 13/00, H04Q 7/20]51[DIVISION FROM 133157]62[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/1998/054919]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A method of and apparatus for paging a wireless terminal in a wirelesstelecommunications system reduce standby mode power consumption. A minimallyencoded quick paging channel is established over which short, quick page messages(30) are transmitted during one of a set of quick paging slots. The quick page messageindicates that a communications request has been received, and that the receivingcommunication terminals should process a highly encoded full paging channel overwhich more detailed, full page messages (32) are transmitted during the next fullpaging slot. A terminal monitors full paging channel only after a quick page messagehas been received on the quick paging channel.

]57[

Page 423: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009423

__________

162492]21][11[

ืฉื™ืžื•ืฉ ื‘ืืœืงื™ืœืคื•ืกืคื•ื›ื•ืœื™ื ื™ื ืœื”ื›ื ืชืœื˜ื™ืคื•ืœ ืžื ื™ืขืชื™ ื‘ืžื—ืœื•ืช ื”ื ื’ืจืžื•ืช ืชืจื•ืคื”

ืชืื™ื™ืโ€“ืžื™ืฆื•ืจื™ื ื—ื“

USE OFALKYLPHOSPHOCHOLINES FORPRODUCING A MEDICAMENTFOR THE PREVENTATIVETREATMENT OF PROTOZOANDISEASES

]54[

07.01.2003]22[DE]33[25.01.2002]32[10203195.9]31[

Int. Cl.(2008.04) A61K 316/85, A61P 1/12, 33/02, C07F 9/00]51[AETERNA ZENTARIS GMBH,GERMANY

]71[

WO/2003/061669]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to pharmaceutical compositions containingalkylphosphocholines, especially hexadecylphosphocholine oroctadecyl-(1, 1-dimethyl-piperidinio-4-yl)-phosphate for thepreventative treatment of protozoan diseases, especially leishmaniasis.The invention also relates to a dosing scheme of said compositions forthe preventative treatment of said illnesses.

]57[

__________

Page 424: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 424

162513]21][11[

ืฉื™ื˜ื” ื•ืขืจื›ื” ืœื’ื™ืœื•ื™ ืกืคื™ื ื’ื•ืžื™ืืœื™ื ื– ืืœืงืœื™

METHOD AND KIT FORDETECTING ALKALINESPHINGOMYELINASE

]54[

19.12.2002]22[IE]33[21.12.2001]32[011100]31[

Int. Cl.(2008.04) C12Q 1/44, G01N 33/48]51[ACTIAL FARMACEUTICA LDA,PORTUGAL

]71[

WO/2003/056031]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

An analytical fluorometric method and a kit for use in such method aredisclosed for assessing the presence of alkaline sphingomyelinase(SMase) in the stools of a patient in need of such an assessment sincealkaline SMase is a marker of serious pathological states, such as coloncancer.

]57[

__________

162522]21][11[

ืฉื™ื˜ื” ืœืฉื™ื“ื•ืจ ื ืชื•ื ื™ื ืขื‘ื•ืจ ืžืขืจื›ืชื ืงื•ื“ื•ืชโ€“ืฉื™ื“ื•ืจ ื ืชื•ื ื™ื ื“ื™ื’ื™ื˜ืœื™ื™ื ืจื‘

ืžืฉืชืžืฉื™ืโ€“ื ืงื•ื“ื•ืช ืœืจื‘โ€“ืœืจื‘

PROCESS FOR THETRANSMISSION OF DATA BY AMULTI-USER, POINT TO MULTI-POINT DIGITAL DATATRANSMISSION SYSTEM

]54[

14.01.2003]22[ES]33[18.01.2002]32[P200200101]31[

Int. Cl.(2009.01) H04B 03//54, H04J 03//16, 03//22, 11//00, H04L 05//14, 12//18,12//56

]51[

DISENO DE SISTEMAS EN SILICIO,S.A., SPAIN

]71[

WO/2003/061185]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The invention relates to a data transmission method for a multi-user, multipoint-to-multipoint digital data transmission system involving a plurality of pieces of userequipment (1) which are bidirectionally connected via a physical means (6). Theinventive method can be used to establish various communications from a piece ofuser equipment (1a) to different pieces of destination user equipment (1b-1d) at

]57[

Page 425: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009425

different speeds, while maintaining the bandwidth and maximum latency valuesrequired by each of the pieces of destination user equipment (1b-1d). Said methodconsists in sending multiple information frames (4) from a piece of equipment (1a) to amultitude of pieces of destination user equipment (1b-1d) at different speeds.Moreover, using the percentage reserve of the frame, the invention provides a qualityof service based on that required by the piece of user equipment and supplies acriterion for dynamically assigning the packets which are sent to each piece of userequipment in the frame, grouping or dividing the packets to be sent.

__________

162562]21][11[

ืฉื™ื˜ื”, ืื™ืžื™ื“ื–ื•ืœื™ื“ื™ื ื™ื ืžื•ืชืžืจื™ืืื•, ืœื”ื›ื ืชื ืœืžื˜ืจืช ืฉื™ืžื•ืฉื™ื”ื ื›ืชืจื•ืคื”

ืื‘ื—ื•ืŸ ื•ืชืจื•ืคื” ื”ื›ื•ืœืœืช ืื™ืžื™ื“ื–ื•ืœื™ื“ื™ื ื™ื ืžื•ืชืžืจื™ื

SUBSTITUTED IMIDAZOLIDINES,METHOD FOR THEPRODUCTION THEREOF, USETHEREOF AS A DRUG OR FORDIAGNOSIS AND DRUGCONTAINING SUBSTITUTEDIMIDAZOLIDINES

]54[

09.12.2002]22[DE]33[21.12.2001]32[10163239.8]31[

Int. Cl.(2008.04) A61K 314/164, A61P 43/00, C07D 233/44, 235/02]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2003/053434]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to new imidazolidine-type compounds of formula (I) in which R1to R7 have the meanings disclosed in the claims. Said compounds represent potentinhibitors of sodium/hydrogen exchanger (NHE), particularly NHE. These novelcompounds are used to produce a drug for the therapy or prophylaxis of the centralnervous system, lipometabolism, infestations by ectoparasites, dysfunctions of the galland for improving respiratory drive. The inventive compounds are therefore used for thetherapy of respiratory conditions in the following clinical states and diseases:malfunctioning central respiratory drive (e.g. sleep apnoea, sudden infant death,postoperative hypoxia), muscle-related breathing disturbances, breathing disturbancesfollowing long-term respiration, breathing disturbances when adapting to high mountainareas, obstructive sleep apnoea and a mixed type of sleep apnoea, acute and chronic

]57[

Page 426: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 426

lung diseases with hypoxia and hypercapnia. Said compounds also increase themuscle tone in the upper respiratory tract so as to suppress snoring.

__________

162567]21][11[

ื”ืกืจืช ื”ืคืจืขื” ืขืฆืžื™ืช ื‘ืืžืฆืขื•ืช ืคื™ืฆื•ื™ ืžืžื™ืจ

ื‘ืžืขืจื›ืช ืชืงืฉื•ืจืช ืžืžืกืจื™ืช

SELF-INTERFERENCE REMOVALUSING CONVERTERCOMPENSATION IN A RELAYEDCOMMUNICATION SYSTEM

]54[

12.11.2002]22[US]33[15.01.2002]32[10/051887]31[

Int. Cl.(2008.04) H04B 1/50, 1/52, 71/85, H04L 27/34, 27/36, 5/12]51[VIASAT, INC., U.S.A.]71[WO/2003/061184]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Self-interference cancellation (10) in two-way relayed communication is improved bycreating models of upconverter and downconverter imperfections and thencompensating for those imperfections before self interference cancellation processing(36). The model includes compensation for phase offset, for amplitude imbalance andfor leakage in the mixers.

]57[

__________

Page 427: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009427

162592]21][11[

CYSTINE-KNOT ืฆื™ืกื˜ื™ืŸโ€“ื—ืœื‘ื•ืŸ ืžืงื•ืคืœ ื‘ืฆื•ืจืช ืงืฉืจ FOLD PROTEIN]54[

20.12.2002]22[GB]33[21.12.2001]32[0130738.8]31[

Int. Cl.(2009.01) A01K 67//027, A61K 38//17, C07K 14//475, 14//52, 16//18, G01N33//53

]51[

ARES TRADING S.A.,SWITZERLAND

]71[

WO/2003/055911]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ,ื”ื’ืŸ ืชืขืฉื™ื™LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

This invention relates to a novel protein (INSP002), herein identified as a secretedprotein that is a member of the Dan family of the cystine-knot fold cytokine superfamilyand to the use of this protein and nucleic acid sequences from the encoding genes inthe diagnosis, prevention and treatment of disease.

]57[

__________

Page 428: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 428

162676]21][11[

ืชื”ืœื™ืš ืœื™ื™ืฆื•ืจ ืžื•ืฆืจื™ื ืฉืœ ื‘ื•ืจ ืงืจื‘ื™ื“ื™ ืฆืคื™ืคื•ืช ื’ื‘ื•ื”ื” ื‘ืขืœ

PROCESS FORMANUFACTURING HIGHDENSITY BORON CARBIDEARTICLES

]54[

22.06.2004]22[Int. Cl.(2008.04) C04B 355/63]51[

,ืž"ืจืคืืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช ื‘ืข ื—ื™ืคื”

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

ื–ื”ืจ, ื™ื”ื•ืฉืข ื—ื›ืžื•, ื“ื•ื“ ื’ื•ืจื ื™, ื–ื™ื•-ืฉืžืฉื•ืŸ ื‘ืจืฆื‘ื™, ื™ื•ืกืฃ ืคืจื™ื™, ืื™ืชืžืจ ื’ื•ื˜ืžืŸ, ืื•ืคื™ืจ

ื ื™ืกื ื”ื•ืœืฅ

SHIMSHON BAR-ZIV, DAVIDGORNI, YEHOSHUA HACHAMO,ZOHAR OPHIR, ITAMARGUTMAN, JOSEPH FREY, ZVINISENHOLZ

]72[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A process for manufacturing boron carbide objects comprising the steps of:(a) pre-washing a raw boron carbide powder;(b) mixing the washed boron carbide powder with a carbon precursor;(c) drying the mixture;(d) granulating the dried mixture;(e) compacting the granulated dried mixture to form a shaped object by applying apressure thereto;(f) carbonizing the shaped body in an inert atmosphere, by holding at a hightemperature for a predetermined period of time;(g) sintering the carbonized shaped body at a temperature between about 2,290oC andabout 2,350oC in an inert atmosphere for a time period of not less than about 30 min.

]57[

__________

Page 429: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009429

162721]21][11[

[dโ€“2,3]ืคื™ืจื™ื“ื•โ€“(ื™ืœืžื™ื ื•โ€“2โ€“ืคื™ืจื™ื“ื™ืŸ)โ€“2 ืื•ื ื™ืโ€“7โ€“ืจื™ืžื™ื“ื™ืŸืคื™

2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONES

]54[

10.01.2003]22[US]33[22.01.2002]32[60/350877]31[

Int. Cl.(2008.04) A61K 315/19, C07D 471/04]51[WARNER-LAMBERT COMPANYLLC, U.S.A.

]71[

WO/2003/062236]87[,ืืช ืœื•ืฆืื˜ื•ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The present invention provides substituted 2-aminopyridines useful in treating cellproliferative disorders. The novel compounds of the present invention are potentinhibitors of cyclin-dependent kinases 4 ( cdk4 ).

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198243,The applications for divisionfrom this application havenot yet been published

__________

162824]21][11[

APPARATUS ืžืชืงืŸ ืœื’ืจื™ื‘ืช ื’ืจื‘ื™ื™ื FOR DONNINGSOCKS

]54[

01.07.2004]22[Int. Cl.(2008.04) A47G 25/90]51[

REUVEN ื”ืจืฆืœื™ื”, ืจืื•ื‘ืŸ ื‘ื•ืืจื•ืŸ BOARON]71[,ืจืื•ื‘ืŸ ื‘ื•ืืจื•ืŸ

ื”ืจืฆืœื™ื”,51ืจืžื– ื“ื•ื“' ืจื—REUVEN BOARON,51 REMEZ ST.

HERZLIYA 46288

]74[

An apparatus (100) for aiding in donning a sock comprising:(a) a base (101) having proximate and distal ends;(b) an elongated caddy (113) having a U-shaped cross-section, a first end of saidcaddy being connected to said base at a location close to said distal end and a second

]57[

Page 430: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 430

end of said caddy over which a sock can be draped being displaceable with respect tosaid base;(c) a connecting pivot (110) for pivotally connecting said first end of the elongated U-shaped caddy with said base at a location close to the base distal end, allowing rotationof said elongated caddy about said pivot; and(d) counter weight means (103) by which said base is coupled to a fixed or heavyarticle, such as a furniture article, wherein said caddy is upwardly pivotable from aninitial substantially horizontal disposition, upon insertion of a foot within a sock drapedover the second end of said caddy, until a disposition at which said sock is releasedfrom said caddy after being fully donned on said foot and wherein said connectingmeans comprise a ribbon which is affixed to the base close to its proximate end.

__________

163048]21][11[

DISTORTION ื›ื™ื•ืœ ื”ืคื—ืชืช ืขื™ื•ื•ืช REDUCERCALIBRATION

]54[

03.02.2003]22[US]33[01.02.2002]32[10/066115]31[

Int. Cl.(2008.04) H04B 1/40]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2003/065602]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Techniques are disclosed for compensating for second-order distortion in a wirelesscommunication device. In a zero-intermediate frequency (IF) or low-IF architecture, IM2distortion generated by the mixer (20) results in undesirable distortion levels in thebaseband output signal. A compensation circuit (104) provides a measure of the IM2distortion current independent of the radio frequency (RF) pathway to generate an IM2calibration current. The IM2 calibration current is combined with the baseband outputsignal to thereby eliminate the IM2 currents generated within the RF pathway. In oneembodiment, the calibration is provided at the factory during final testing. In alternativeembodiment, additional circuitry (156, 158) may be added to the wirelesscommunication device to provide a pathway between the transmitter (150) and the

]57[

Page 431: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009431

receiver (146). The transmitter signal is provided to the receiver to permit automaticcalibration of the unit. An internal signal source (162) may be used in place of thetransmitter (150). The auto-calibration may be performed to eliminate IM2 distortion orpermit optimization of the circuit to minimize other forms of distortion or interference.

__________

163287]21][11[

โ€“2ื ื’ื–ืจื•ืช ืžื•ืชืžืจื•ืช ื”ื™ืชืจื•ืืจื™ืœื• โ€“ 6,7,8,9โ€“ืคื™ืจื™ืžื™ื“ื™ืœโ€“2ืคื™ืจื™ื“ื™ื ื™ืœ

โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ]aโ€“2,1[ื˜ื˜ืจื”ื”ื™ื“ืจื•ืคื™ืจื™ืžื™ื“ื• ืื•ืŸโ€“4

HETEROARYL SUBSTITUTED 2 -PYRIDINYL AND 2 -PYRIMIDINYL - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-A]PYRIMIDIN - 4 - ONEDERIVATIVES

]54[

26.02.2003]22[EP]33[28.02.2002]32[02290485.8]31[EP28.02.2002 02290486.6

Int. Cl.(2008.04) A61K 315/19, A61P 25/00, C07D 487/04]51[SANOFI AVENTIS, FRANCEMITSUBISHI TANABE PHARMACORPORATION, JAPAN

]71[

WO/2003/072579]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The invention relates to a pyrimidone derivative represented by formula (I) or a saltthereof wherein: (I) X represents two hydrogen atoms, a sulphur atom, an oxygen atomor a C1-2 alkyl group and a hydrogen atom; Y represents a bond, an ethenylene group,an ethynylene group or a methylene group optionally substituted; R1 represents a 2, 3or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring optionally substituted; R2 represents aheterocyclic bicyclic rings, having 1-4 heteroatoms selected from an oxygen atom, asulfur atom and a nitrogen atom and having 5-9 carbon atoms, of formula (II) R3represents a hydrogen atom, a C1-6 alkyl group, a hydroxy group, a C1-4 alkoxy group ora halogen atom; R4 represents a hydrogen atom, a C1-6 alkyl group, a C1-4 alkoxy groupor a halogen atom. The invention relates also to a medicament comprising the saidderivative or a salt thereof as an active ingredient which is used for preventive and/ortherapeutic treatment of a neurodegenerative disease caused by abnormal activity ofGSK3&bgr; or GSK3&bgr; and cdk5/p25, such as Alzheimer disease.

]57[

Page 432: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 432

__________

163288]21][11[

) ื”ื™ืชื™ืจื•ืืจื™ืœ[(โ€“]ืืœืงื™ืœ[โ€“1ื ื’ื–ืจื•ืช7โ€“] ืืœืงื™ืœ) ืืจื™ืœ[(โ€“1ื•ื ื’ื–ืจื•ืช] ืืœืงื™ืœ

]a1,2โ€“[ ืื™ืžื“ื–ื•โ€“)ืื™โ€“4โ€“ืคื™ืจื™ืžื™ื“ื™ืŸ(โ€“ ืื•ืŸโ€“)1H(โ€“5ืคื™ืจื™ืžื™ื“ื™ืŸ

1 - [ALKYL], 1 -(HETEROARYL)ALKYL] AND1 -[(ARYL) ALKYL] - 7 - (PYRIMIDIN- 4 - YL) - IMIDAZO [1,2-A]PYRIMIDIN - 5 (1H) - ONEDERIVATIVES

]54[

26.02.2003]22[EP]33[28.02.2002]32[02290487.4]31[

Int. Cl.(2008.04) A61K 314/37, A61P 25/28, C07D 487/04]51[SANOFI AVENTIS, FRANCEMITSUBISHI TANABE PHARMACORPORATION, JAPAN

]71[

WO/2003/072580]87[ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

The invention relates to a imidazo[1,2-a]pyrimidone derivative represented by formula(I) or a salt thereof: R1 wherein X represents a bond, an ethenylene group, anethenylene group, a methylene group optionally substituted; a carbonyl group, anoxygen atom, a sulfur atom, a sulfonyl group, a sulfoxide group or a nitrogen atombeing optionally substituted; R1 represents a 2, 4 or 5-pyrimidinyl optionally substituted;R2 represents a C1-6 alkyl group, a C1-2 perhalogenated alkyl group, a C1-3 halogenatedalkyl group, a benzyl group, a benzene ring, a naphthalene ring, 5,6,7,8-tetrahydronaphthalene ring, a pyridine ring, an indole ring, a pyrrole ring, a thiophenering, a furan ring or an imidazole ring, the benzyl group and the rings being optionallysubstituted; and n represents 0 to 3. The invention relates also to a medicamentcomprising the said derivative or a salt thereof as an active ingredient which is used forpreventive and/or therapeutic treatment of a neurodegenerative disease caused byabnormal activity of GSK3รŸ, such as Alzheimer disease.

]57[

__________

Page 433: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009433

163376]21][11[

DECOPPERING ื’ื•ืจื ืžืกื™ืจ ืžืฉืงืข ื ื—ื•ืฉืช AGENT]54[

13.01.2003]22[SE]33[08.02.2002]32[0200366-3 ]31[

Int. Cl.(2009.01) C06B 23//00]51[EURENCO BOFORS AB, SWEDEN]71[SVEN-ERIC JOHANSSON]72[WO/2003/066544]87[

,ืฆื“ืง ืœืฆืจ ืคืจืœ ื›ื”ืŸ, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

There is provided a decoppering agent that is incorporated into thepropellant to remove copper from the rifling of the internal bore of agun barrel. The decoppering agent consists essentially of a lead-freepulverized additive mixed together with the other propellantcompounds. We have found that a mixture of tin and bismuth is a verygood decoppering agent. Especially in the ratio 42% Sn/58%Bi, themelting point for this combination is 138 degree C. Much lower thaneach of the components. It can be all kinds of suitable tin and bismuthcompounds. The bismuth and tin either vaporizes or liquefies when thepropellant is ignited and either embrittles or dissolves the copperdeposits facilitating removal.

]57[

__________

163450]21][11[

GUIDED ื˜ื™ืœ ืžื•ื ื—ื” ืขื ืžื ื’ื ื•ืŸ ื”ื ื—ื™ื” ืžื‘ื•ื–ืจ MISSILE WITHDISTRIBUTED GUIDANCEMECHANISM

]54[

10.08.2004]22[Int. Cl.(2009.01) F41G 07//20]51[

,ืž"ืจืคืืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช ื‘ืข ื—ื™ืคื”

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

RONEN ืืกื ืคื™ื™ืŸ, ื—ื•ืจื™ืŸ- ืจื•ื ืŸ ื‘ืŸ BEN- HORIN, ASSA FINE]72[ื‘ืข"ื“ ,ืž"ืจ ืžืจืง ืคืจื™ื“ืžืŸ

ื–,54.ืง, ืžื’ื“ืœ ืžืฉื” ืื‘ื™ื‘ ,7ื‘ื•ื˜ื™ื ืกืงื™'ืจื—ื’ืŸ-ืจืžืช

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54TH

FLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

Page 434: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 434

A weapons system comprising:(a) a guided missile including:(i) a seeker for producing signals indicative of a position of a target, and(ii) a steering mechanism for steering said guided missile; and(b) a guidance mechanism, separate from said guided missile, for controlling saidsteering mechanism, based on said signals, so as to steer said guided missile tworadssaid target; wherein said guided missile is too small to carry an on-board guidancemechanism that activates said steering mechanism to guide said guided missileautonomously to said target in response to said signals.

]57[

__________

163734]21][11[

SHAPED ื˜ืžืคื•ืŸ ืžืขื•ืฆื‘ TAMPON]54[

12.03.2003]22[US]33[18.03.2002]32[60/365672]31[US16.05.2002 150055

Int. Cl.(2008.04) A61F 13/20]51[THE PROCTER & GAMBLECOMPANY, U.S.A.

]71[

WO/2003/079949]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Shaped tampons having varying perimeters are provided. Tampons disclosed comprisea mass of absorbent material formed into a self-sustaining shape comprising aninsertion end, a withdrawal end, and a center region. The center region has at least oneperimeter which is less than a largest insertion end perimeter and is less than awithdrawal end perimeter. The shaped tampons may also have varying average fiberdensity regions. The shaped tampons may be wrapped in tightly conforming wrapperswhich optionally aid in maintaining the self-sustaining shape prior to use. Optionally, theshaped tampons may utilize tampon applicators which enable a user to visually see theshape of the tampon prior to use.

]57[

__________

Page 435: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009435

163738]21][11[

ื“ื™ DISCืกืงืžื ืขื•ืœ ืœืžืกื•ื‘ื‘ TUMBLER LOCK]54[

14.03.2003]22[FI]33[27.03.2002]32[20020587]31[

Int. Cl.(2008.04) E05B 21/00]51[BJORKBODA LAS OY AB,FINLAND

]71[

WO/2003/080969]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A disc tumbler lock, which comprises a lock case (1), which includes a bolt (3)displaceable with a key of the lock and a number of locking discs (13) provided withlocking channels (17) and which are displaceable with the key of the lock against theforce of a spring (14) to open the lock and for guiding the movements of which the lockcase is provided with stationary guiding members (8,9), and a locking pin (12)dependent on the movements of the bolt and which is arranged to cooperate with thelocking channels (17) of the locking discs. At least one of the locking discs (13) isequipped with gripping means (18), which, when the bolt (3) is pressed inwards to thelock case are arranged to cooperate with counter means (19) arranged in the lock casefor preventing the displacement of the said at least one locking disc (13). Further, thesaid at least one locking disc (13) is spring-loaded to turn the locking disc around a firstguiding member (8) against a second guiding members (9) so that the said secondguiding member (9) guides the said at least one locking disc (13) substantially towardsthe head of the bolt (3) to be protruded out from the lock case.

]57[

__________

Page 436: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 436

163921]21][11[

ื•ื™ ื•ืœืกื™ื ืชื–ื” ืฉืœ ืชืจื›ื•ื‘ื•ืช ืฉื™ื˜ื” ืœื–ื™ื” ื›ื™ืžื™ื•ืช

METHOD FOR THEIDENTIFICATION ANDSYNTHESIS OF CHEMICALCOMPOUNDS

]54[

24.03.2003]22[US]33[22.03.2002]32[60/366548]31[

Int. Cl.(2008.04) B01J 19/00, G06F 19/00]51[ORIGENIS GMBH, GERMANY]71[WO/2003/080232]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A preferred embodiment of the present invention comprises method forplanning the synthesis of one or more chemical compounds withspecified chemical properties, comprising the steps of: (a) representinga space of synthesis plans, wherein each synthesis plan in the space ofsynthesis plans represents one or more vitual reaction schemas appliedto one or more classes of virtual input reactants; (b) representing a spaceof virtual compounds, wherein each compound in the space of virtualcompounds is a product of one or more of said synthesis plans; (c)constructing a first mapping from the space of virtual compounds torange space representing the desirability of a compound, wherein thefirst mapping is determined by one or more compound properties beingmeasured; and (d) searching the space of synthesis plans for desirablecompounds as represented in the range space.

]57[

__________

Page 437: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009437

164037]21][11[

ืžืขืจื›ืช ืกื™ื ื›ื•ืจื•ื ื™ื–ืฆื™ื” ืœื›ืœ ืจืฉืชื•ืชื˜ื‘ืขืชื™ื•ืช ื“ื™ื ืžืฆื™ื•ืช ื‘ืขืœื™ ื—ืจื™ืฆื™ื

ืื•ืคื˜ื™ื™ื

SYNCHRONIZATION SYSTEMFOR ALL OPTICAL SLOTTEDRING DYNAMIC NETWORKS

]54[

26.03.2003]22[US]33[26.03.2002]32[60/367275]31[US23.07.2002 10/200141

Int. Cl.(2008.04) H04J 14/08]51[MATISSE NETWORKS, U.S.A.]71[WO/2003/084109]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A method for communicating data over a network having a plurality of nodes (0-3)thereupon is discussed. A time slot clock signal is transmitted from one node (0-3) ofthe plurality of nodes (0-3) to other nodes of the plurality of nodes. After each of theother nodes of the plurality of nodes receives the time slot clock signal, the time slotclock signal is recalculated to achieve an integer number of slots on the network. Therecalculated time slot clock signal is transmitted from the one node of the plurality ofnodes (0-3) to the other nodes of the plurality of nodes.

]57[

__________

164066]21][11[

ืฉื“ื” ื‘ื ื•ื™ ืขืœ ื‘ืกื™ืกโ€“ื˜ืจื ื–ื™ืกื˜ื•ืจ ืชื•ืฆืื ื ื•ืฆื™ื ื•ืจื™ื•ืช ืขื ื™ื›ื•ืœืช ืœื”ืชื™ื™ืฉืจ ื‘ืฆื•ืจื”

ืขืฆืžื™ืช ื•ืฉื™ื˜ืช ื™ื™ืฆื•ืจื•

SELF-ALIGNED NANOTUBEFIELD EFFECT TRANSISTORAND METHOD OF FABRICATINGSAME

]54[

19.02.2003]22[US]33[20.03.2002]32[10/102365]31[

Int. Cl.(2009.01) H01L 29//76]51[IBM CORPORATION, U.S.A.]71[WO/2003/081687]87[

,ืžืขื‘ื“ื•ืช ื™ื‘ืž ืžื—ืœืงืช ืงื ื™ืŸ ืจื•ื—ื ื™ ื—ื™ืคื”, ืื•ื ื™ื‘ืจืกื™ื˜ืช ื—ื™ืคื” ื”ืจ ื”ื›ืจืžืœ

IBM LABORATORIES,HAIFA UNIVERSITY,

HAIFA 31905

]74[

Page 438: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 438

A self-aligned carbon-nanotube field effect transistor semiconductor device comprisesa carbon-nanotube [104] deposited on a substrate [102], a source and a drain [106-107] formed at a first end and a second end of the carbon-nanotube [104], respectively,and a gate [112] formed substantially over a portion of the carbon-nanotube [104],separated from 10 the carbon-nanotube by a dielectric film [111].

]57[

__________

164199]21][11[

ืื—ืจื™ ืขื ื”ื™ืกื˜ืจืกื™ืกโ€“ื‘ืงืจ ืžืขืจื›ืช ืขืงื•ื‘ ื•ืขื ืฉื™ื˜ืช ื‘ืงืจื” ืชื•ืืžืช

FOLLOW-UP SYSTEMCONTROLLER WITHHYSTERESIS ANDCORRESPONDING CONTROLMETHOD

]54[

07.05.2003]22[US]33[20.05.2002]32[10/152662]31[

Int. Cl.(2008.04) G05D 1/12]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/100539]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A control system (102) operates within a dynamic range, and a follow-up system (104)is commanded to reduce a positional error between the follow-up system and thecontrol system when the dynamic range is exceeded. A linear follow-up command maybe initially provided once a dead band value (208) is exceeded. The follow-up system(104) is driven relative to its base mount (103) in a direction to reduce the positionalerror to within a null value range (214). The follow-up command may also implement adecay function to control the follow-up system (104). A control variable transfer functionmay also be utilized to gradually subtract the dead band value from the follow-upsystem position error command as a function of time. The decaying function mayinclude linear as well as non-linear decaying functions. In one embodiment, a figureeight-type hysteresis control function may be implemented to control the inertialposition of an inertial element. The various embodiments of the present invention maybe suitable for space-based laser designating and targeting systems, space-basedcamera-positioning systems, space-based telescopes, and radar antenna positioningsystems.

]57[

Page 439: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009439

__________

164271]21][11[

ื™ื”ื•ืœ ื–ื›ื•ื™ื•ืช ืฉืœ ืชื•ื›ืŸ ืžืงื•ื“ื“ ืฉื™ื˜ื” ืœื  ื”ืžืื•ื—ืกืŸ ื‘ืจืฉื ืกื™ืคืจืชื™ ืื™ืฉื™

METHOD FOR MANAGING THERIGHTS OF AN ENCRYPTEDCONTENT STORED ON APERSONAL DIGITAL RECORDER

]54[

15.04.2003]22[CH]33[19.04.2002]32[0664/02]31[

Int. Cl.(2008.04) H04N 1/00, 5/00, 71/67]51[NAGRAVISION S.A.,SWITZERLAND

]71[

WO/2003/090465]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The aim of the invention is to provide a method for storing an event which is encryptedby control words (CW) guaranteeing access to said event at any moment, even ifcertain modifications occur in the designation of the identifiers of said events betweenthe moment of storage and the moment of visualization.This is achieved by means of amethod for storing such an event in a receiving and decrypting unit (STB) connected toa security unit (SC), said control words (CW) and the required rights being contained incontrol messages (ECM). The inventive method is characterized in that it comprises thefollowing steps: the encrypted event is stored, along with the control messages (ECM),on the storage unit; the control messages (ECM) are transmitted to the security unit(SC); verification occurs as to whether the access rights to said event are contained inthe security unit (SC), if this is the case, a receipt (Q) is provided for all or part of thecontrol message (ECM) by means of a secret key (K) which is contained in the securityunit (SC) and is proper to each security unit; said receipt (Q) is stored on the storageunit.

]57[

__________

Page 440: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 440

164696]21][11[

ืขืœ ืื–ืžืœ ื ื™ืชื•ื—ื™ื ืขื ื’ืฉืฉ ืฆืฃ ืœื‘ืงืจื” ืขื•ืžืง ื”ื—ื“ื™ืจื”

LANCING DEVICE WITH AFLOATING PROBE FORCONTROL OF PENETRATIONDEPTH

]54[

19.10.2004]22[US]33[20.10.2003]32[690083]31[

Int. Cl.(2008.04) A61B 05/151]51[LIFESCAN, INC., U.S.A.]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A lancing device comprising: a lancing mechanism having: a lancet carriage (614); alancet holder (676) slidably connected to the lancet carriage; a lancet (618) attached tothe lancet holder; and a lock-stop assembly; a floating probe (608); and a pressure tip(664) for engaging a target site and creating a target site bulge; wherein the floatingprobe is adapted to floatably rest upon said target site bulge as said target site bulge iscreated by the pressure tip and is configured to operatively interact with the lancetcarriage to control a penetration depth of the lancet into the target site bulge, andfurther configured to engage the lock-stop assembly to prevent movement of thefloating probe during penetration of the lancet into the target site bulge.

]57[

__________

Page 441: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009441

164709]21][11[

ืžืœื ื—ื™ืชื•ืš ื•ืจืงื•ืŸ, ื”ืชืงืŸ ืื•ื˜ื•ืžื˜ื™ ืœื”ืจืžืช ืฉืœ ืฉืงื™ื

APPARATUS FORAUTMATICALY LIFTINGSLITTING, SITTING AND FULLYEPTYING BAGS

]54[

19.10.2004]22[Int. Cl.(2009.01) B65B 69/00]51[

AYAL ืžืฉื’ื‘.ื .ื“,ืž"ืื™ืœ ืจื•ื‘ื•ื˜ื™ืงื” ื•ื”ื ื“ืกื” ื‘ืข ROBOTICS ANDENGINEERING LTD.

]71[

RAZ ืจื– ื™ืœื™ื ืง JELINEK]72[, 3148.ื“.ืช,2ื”ื˜ื•ื—ืŸ'ืจื—, ืฆื‘ื™ื•ืŸ ื™ื•ืจื

38900ืงื™ืกืจื™ื”YORAM TSIVION,2 HATOCHEN ST.P.O.B. 3148,CAESAREA 38900

]74[

An apparatus for emptying bags comprising a gripper having a plurality of pointedhooks for gripping at least one of said bags; a bag slitting and empting device, whereinsaid bag slitting and emptying device comprises at least two parallel blades for slittingsaid at least one bag, and at least two rods aligned in a row respectively with saidblades.

]57[

__________

164823]21][11[

ืค ื•ืœื™ืžืจ ื”ืžื’ืœื” ื”ืคืจืขื•ืช ื’ืœืื™ ื”ืžื›ื™ืœื‘ืžืžื‘ืจื ื” ื•ืžืงื˜ืขื™ื ืžืžื‘ืจื ืœื™ื™ื

ืคื•ื ืงืฆื™ื•ื ืœื™ื™ื

DETECTOR COMPRISING AMEMBRANE PERTURBATION -DETECTING POLYMER ANDFUNCTIONAL MEMBRANEFRAGMENTS

]54[

25.10.2004]22[Int. Cl.(2009.01) F01C 01//02, G01N 33//543]51[

ื”ืจืฉื•ืช ืœืžื—ืงืจ,ื‘ื’ื•ืจื™ื•ืŸ ื‘ื ื’-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ ืฉื‘ืข-ื‘ืืจ, ื•ืคื™ืชื•ื—

BEN GURION UNIVERSITY OFTHE NEGEV RESEARCH ANDDEVELOPMENT AUTHORITY

]71[

RAZ ืจื– ื™ืœื™ื ืง JELINEK]72[,ืค"ืคื™ื™ืจื ื™ืง ืจื•ื˜ืžืŸ ืขื•

, 10012.ื“.ืช,91ื”ืจืฆืœ'ืจื—, ื‘ื™ืช ืขืฆื™ื•ืŸ ื‘ืืจ ืฉื‘ืข

PYERNIK RUTMAN,BEIT ETSION,

91 HERZL ST.,P.O.B. 10012,BEER SHEVA

]74[

A construct comprising functional membrane fragments and one or more perturbation-detecting polymers associated therewith, wherein said construct responds toperturbations of said membrane fragments by means of a detectable change in one ormore physical or chemical properties associated with said construct.

]57[

__________

Page 442: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 442

164944]21][11[

ARTIFICIAL ืฉืจื™ืจ ืžืœืื›ื•ืชื™ MUSCLE]54[

04.05.2003]22[US]33[03.05.2002]32[10/137,387]31[

Int. Cl.(2008.04) F01B 19/00]51[ZALMAN ื–ื™ืื›ื•ืจ, ื–ืœืžืŸ ืคืœืก PELES]71[

WO/2003/093647]87[ืขื•' ื“ืจ ,ืค"ืื™ื™ืœ ื‘ืจืกืœืจ

ื’ืŸ-ืจืžืช,11ืชื•ื‘ืœDR. EYAL BRESSLER,11 TUVAL ST.,

RAMAT GAN 52522

]74[

A hydraulic actuated artificial muscle is use with orthetic devices, prosthetic devices oras an actuator for other applications in medical or robotic devices. Working fluid ispumped between two expandable fluid-containing cells (2,10), which arecomplimentary active elements of the artificial muscle. This eliminates the need for astorage reservoir, thereby providing a self-contained, and force efficient device. Each ofthe preferred embodiments described has one or more expandable fluid-containingcells (2,10) that are defined by at least one flexible wall (4). The flexible walls (4,12) areconfigured so as to have elastic properties that are limited to predefined directions ofexpansion and contraction.

]57[

__________

Page 443: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009443

164961]21][11[

ืชืขืจื•ื‘ื•ืช ืฉืœ ืืกื˜ืจื™ื ื˜ื˜ืจื”ืœื•ืคืชืืœืื˜ื•ื—ื•ืžืจื™ื ืžื•ื ืขื™ ื‘ืขื™ืจื” ื”ืžื›ื™ืœื™ื ื–ืจื—ืŸ

ืšืฉื™ืžื•ืฉ ื‘ื”ืจื›ื‘ื™ ืคื•ืœื™ืื•ืจืชืืŸ

BLENDS OFTETRAHALOPHTHALATEESTERS AND PHOSPHORUS-CONTAINING FLAMERETARDANTS FORPOLYURETHANECOMPOSITIONS

]54[

05.05.2003]22[US]33[06.05.2002]32[60/378299]31[

Int. Cl.(2008.04) C08K 3/00]51[GREAT LAKES CHEMICALCORPORATION, U.S.A.

]71[

WO/2003/095544]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Flame retardant flexible polyurethane foam compositions, methods of flame retardingflexible polyurethane foam compositions, articles made therefrom and flame retardantsthat comprise blends of tetrahalophthalate esters and phosphorus containing flameretardant having at least about 5 wt.% phosphorus additives. The combined weight ofthe tetrahalophthalate ester and the phosphorus-containing flame retardant comprisesabout 5 to about 20% by weight of the flexible polyurethane foam compositions orreaction mixtures. The ratio of the tetrahalophthalate ester to the phosphorus-containing flame retardant is from about 80:20 to about 20:80 percent by weight andpreferably from about 60:40 to about 40:60 percent by weight.

]57[

__________

164972]21][11[

EVENT ืชื–ืžื•ืŸ ืื™ืจื•ืขื™ื ืœืžืขืจื›ื•ืช ื’ื™ืœื•ื™ SYNCHRONIZATION FORDETECTOR SYSTEMS

]54[

12.06.2003]22[US]33[12.06.2002]32[60/319310]31[US11.06.2003 10/250189

Int. Cl.(2008.04) H04N 52/25]51[LITTON SYSTEMS, INC., U.S.A.]71[WO/2003/107650]87[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

An event synchronizing apparatus E for an image intensification camera system C forgathering image data includes an image intensifier (348) for amplifying received light(312). A relay optic assembly (316) is coupled between the image intensifier (348) and

]57[

Page 444: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 444

a digital image sensor (350), such as a CMOS or CCD device. Digital logic (352) isused to process or output an image or related data (334). An event detector (340)digitizes an input signal (342) from an illumination source (338) and generates anelectrical output synchronization signal (346) in response to the input optical signal(342). The image intensifier camera C derives imaging and control information for thesynchronization signal.

__________

165027]21][11[

ืฆื‘ื™ื ืขืœ ื‘ืกื™ืก ืฉืžืŸ ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ืžื™ื•ืฉืžืŸ ืงื™ืง ืžื˜ื•ื”ืจ ืฉืขื‘ืจ

ืคื•ืœื™ืื•ืงืกื™ืืชื™ืœืฆื™ื” ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจื

STABILIZED PHARMACEUTICALCOMPOSITIONS BASED ONPURIFIEDPOLYOXYETHYLATED CASTOROIL AND METHODS FORMANUFACTURING THE SAME

]54[

16.05.2003]22[CZ]33[10.06.2002]32[PV 2002-

2027]31[

Int. Cl.(2008.04) A61K 313/37, 47/00, 47/10, 47/44]51[PLIVA-LACHEMA, A.S., CZECHREPUBLIC

]71[

WO/2003/103714]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The invention relates to a stabilised pharmaceutical composition comprising apharmaceutically active substance poorly soluble in water, a solubilising agentwith a low content of both basic and acidic compounds and a polar organicsolvent, in particular a stabilised injection concentrate, methods for preparingsuch stabilised pharmaceutical compositions and the use of a solubilisingagent with a low content of both basic and acidic compounds to stabilisepharmaceutical compositions for pharmaceutically active substances.

]57[

__________

Page 445: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009445

165162]21][11[

ืฉืœ ื”ืชืงืŸ ืคืฉื•ื˜ ืœื”ืคืขืœื” ืžื’ื ื˜ื™ืช ืชืจื™ืกื™ื ื‘ืชื•ืš ืชื ืกื’ื•ืจ ื‘ื–ื›ื•ื›ื™ืช

SIMPLIFIED DEVICE FORMAGNETICALLY OPERATINGBLINDS WITHIN A GLASS-ENCLOSED CHAMBER

]54[

08.07.2002]22[IT]33[19.06.2002]32[MI2002A001351]31[

Int. Cl.(2009.01) E06B 09//264]51[PELLINI S.R.L., ITALY]71[WO/2004/000011]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A system for operating a blind (18) in a glass-enclosed chamber (10), comprising twopanes of glass, (17, 18) and a frame (20) having an upper section (25) a lower section(86) and two lateral sections (27) joined together by four corner pieces (30) the systemcomprising an upper fixed box (40) which is fixed to the upper section of the frame andholds one end of the blind; a movable box (60) which holds another end of the blindand is elongated; a pulling device (85, 86) extending through a pane and operating saidmovable box; and a guiding device for translating said movable box parallel to adirection of elongation of said movable box when the blind is being opened or closed,wherein said device for pulling said movable box includes a first means (150) and asecond means for generating reciprocal magnetic attraction, said first means beingfixed to said movable box, said second means having a free knob (170) so that,through one pane of the glass-enclosed chamber, said knob cooperates with said firstmeans fixed to said movable box to open or close the blind, wherein said first meansfixed to said movable box include a parallelepiped box inserted in a center of saidmovable box, a small box housing, a cage (155) permanent magnets (152, 153) placedside-by-side between two sets of free rollers (160) longitudinal pins (161) passingthrough an external surface of said permanent magnets and from a fron of said box toassist said first means to slide over a glass pane.

]57[

__________

Page 446: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 446

165439]21][11[

VOICE ื”ืชืงืŸ ื•ืžืขืจื›ืช ืœื”ืขื‘ืจืช ืงื•ืœ TRANSMISSION DEVICEAND VOICE TRANSMISSIONSYSTEM

]54[

04.04.2003]22[Int. Cl.(2009.01) H04M 03//00]51[MITSUBISHI DENKI KABUSHIKIKAISHA, JAPAN

]71[

WO/2004/091183]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A speech transmitter having a tandem pass through function in an STM, ATM and IPnetwork. A noise canceller (21) is provided at the succeeding stage of an echocanceller (12) in an encoding section. If not a tandem connection state, noise isremoved to carry out high-efficiency encoding; if the relay is in a tandem connectionstate, switching is carried out so that the operation of the noise canceller (21) isstopped so as to prevent degradation of speech quality due to excessive decoding andencoding. As a result, even if a portable telephone has no noise canceling function,high-quality speech transmission is realized in both normal and tandem pass throughmodes. By thus removing the noise component, the soundless portions in speech dataincrease, and the portions to be encoded decrease, thereby reducing the amount ofdata transmitted through the circuit.

]57[

__________

Page 447: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009447

165520]21][11[

ืืŸ โ€“ื“ื”ื™ื“ืจื•โ€“2,3โ€“ืื•ืงืกื•โ€“3((โ€“ื ื’ื–ืจื•ืช) ืืฆื˜ื™ืœ,)ืื™ืœโ€“1โ€“ืื™ื–ื•ืื™ื ื“ื•ืœโ€“ื”ื™ื“ืจื•ื’ืŸ

ืชื›ืฉื™ืจื™ืNHEโ€“1ื’ื•ืื ื™ื“ื™ืŸ ื›ืžืขื›ื‘ื•ืชืชื”ืœื™ืš ืœื”ื›ื ืชืŸ, ืจืคื•ืื™ื™ื ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

ื•ืฉื™ืžื•ืฉ ืฉืœื”ืŸ

N-((3-OXO-2, 3-DIHYDRO-1H-ISOINDOL-1-YL), ACETYL)GUANIDINE DERIVATIVES ASNHE - 1 - INHIBITORS,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM, PROCESS FOR THEIRPREPARATION AND USESTHEREOF

]54[

20.05.2003]22[FR]33[03.06.2002]32[02/06783]31[

Int. Cl.(2009.01) A61K 31//4035, A61P 03//10, 25//00, 35//00, C07D 20/9/46]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2003/101450]87[,ืœืฆืจ ื•ื›ื”ืŸ ืฆื“ืง, ืคืจืœ, ืื™ืชืŸ

ื”ืจืฆืœื™ื”, 12688.ื“.ืช,7ืจื—ื•ื‘ ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,

HERZLIYA 46733

]74[

Isoindolone derivatives, preparation process and intermediates of this process, theiruse as medicaments, and pharmaceutical compositions comprising them. The presentinvention relates to the novel isoindolone derivatives of the Formula (I), in which R1 toR6 have the meanings stated in the claims. The inventive compounds are suitable asantiarrhythmic medicaments with a cardioprotective component for infarctionprophylaxis and infarction treatment and for the treatment of angina pectoris. They alsoinhibit in a preventive manner the pathophysiological processes associated with thedevelopment of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure.

]57[

__________

Page 448: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 448

165694]21][11[

]B,F[ ื”ื™ื“ืจื•ื’ืŸ ื“ื™ื‘ื ื–5ืฉื™ื˜ื” ืœื”ื›ื ืช ืงืจื‘ื•ืงืกื™ืืžื™ื“โ€“5โ€“ืื–ืคื™ืŸ

METHOD OF PREPARING A 5H-DIBENZ[B,F] AZEPINE-5-CARBOXAMIDE

]54[

13.06.2003]22[US]33[14.06.2002]32[60/388811]31[

Int. Cl.(2008.04) C07D 233/22]51[TARO PHARMACEUTICALS U.S.A.,INC., U.S.A.

]71[

WO/2003/106414]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The present invention provides a method of preparing a 5H-dibenz[b,f]azepine-5-carboxamide of formula (1) wherein R1, R2, R3, and R4 are independently selectedfrom the group consisting of hydrogen, halogen, nitro, cyano, carboxyl, A, -CO(A), -OCO(A), -O(A), -N(A)2, -CON(A)2, and -COO(A), wherein A is selected from the groupconsisting of C-1-C10 alkyl, C3-C10 cycloalkyl, C-2-C10 alkenyl, C-5-C10 cycloalkenyl,C-2-C10 alkynyl, and C-6-C20 aryl, wherein the two A groups of -N(A)2 and -CON(A)2can be the same or different, and wherein R2 and R3 can together form a bond;comprising reacting a 5H-dibenz[b,f]azepine of formula (2) with a) a cyanate saltselected from the group consisting of alkali metal cyanate salts and alkaline-earth metalcyanate salts, and b) a salt of an amino compound having no N-H bonds, wherein thesalt has a Ka (25ยฐ C) of at least about 10 x 10-11.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198455,The applications for divisionfrom this application havenot yet been published

__________

Page 449: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009449

165715]21][11[

3โ€“ื”ื˜ืจื•ืืจื™ืœโ€“6โ€“ื™ื•ืจื™ื“ื•โ€“2ืชื•ืœื“ื•ืช ื—ื•ืžืฆื”Hโ€“ืงืจื‘ื•ืงืกื™ืœื™ืชโ€“4โ€“ื‘ื ื–ืื™ืžื™ื“ืื–ื•ืœ ,

ืชื›ืฉื™ืจื™ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ ื•ืชื”ืœื™ื›ื™ื ืœื”ื›ื ืชืŸ

2-UREIDO-6-HETEROARYL-3H-BENZIMIDAZOLE-4-CARBOXYLIC ACIDDERIVATIVES,PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME AND METHODS FORTHE PREPARATION THEREOF

]54[

11.06.2003]22[US]33[13.06.2002]32[60/388665]31[US11.11.2002 60/429077

Int. Cl.(2008.04) A61K 314/184, A61P 11/00, 13/00, 17/00, 29/00, 31/00, 35/00,37/00, C07D 401/00, 401/10, 401/14, 403/10, 403/14

]51[

VERTEX PHARMACEUTICALSINCORPORATED, U.S.A.

]71[

WO/2003/105846]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The present invention relates to compounds of formula I, wherein X, Q, W, R1, R2 andR3 are as defined in the claims, which inhibit bacterial gyrase and/or Topo IV andpharmaceutically acceptable compositions comprising said compounds. Thesecompounds, and composition thereof, are useful in treating bacterial infection.Accordingly, the present invention also relates to methods for treating bacterialinfections in, mammals. The present invention also relates to a method for preparingthese compounds.

]57[

__________

Page 450: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 450

165782]21][11[

ืช ืœื”ื’ื“ืœืช ืื™ื–ื•ืจ ืงืจื™ืื” ืฉื™ื˜ืช ื›ื— ืคื•ืœื™ืกื™ ืฉืœ ืงื•ืจื ื”ืžื–ื”ื” ืชื“ืจ ืจื“ื™ื•

PULSED POWER METHOD FORINCREASED READ RANGE FOR ARADIO FREQUENCYIDENTIFICATION READER

]54[

11.08.2003]22[US]33[09.08.2002]32[216476]31[

Int. Cl.(2008.04) H04Q 5/22]51[SENSORMATIC ELECTRONICSCORPORATION, U.S.A.

]71[

WO/2004/015613]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method to power a radio frequency identification (RFID) reader to increase multitagreading capability and increase the reading range of a passive tag without maximizingthe continuous transmitted power level is provided. The RFID reader transmits a pulsedinterrogation signal until an RFID tag response is received, and then switches to acontinuous and pulsed power scheme. The continuous power emitted maintains thepower supplied to the RFID tags so the tags will not reset due to loss of power. Thepulsed signal permits reading the tags at longer ranges, especially when there is aplurality of tags in the area.

]57[

__________

Page 451: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009451

165925]21][11[

, ืชื”ืœื™ื›ื™ื ืœื”ื›ื ืชื, ืคื ื™ืœ ื‘ื ื–ืืžื™ื“ื™ื ืชื›ืฉื™ืจื™ื ื”ืžื›ื™ืœื™ื ืื•ืชื ื•ืฉื™ืžื•ืฉื™ื”ื

PHENYL BENZAMIDES,PROCESSES FOR THEIRPREPARATION, COMPOSITIONSCOMPRISING THEM AND USESTHEREOF

]54[

20.06.2003]22[DE]33[02.07.2002]32[10229595.6]31[

Int. Cl.(2009.01) A01N 37//22, C07C 21/1/44, 23/3/64]51[BAYER CROPSCIENCE AG,GERMANY

]71[

WO/2004/005242]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to novel phenyl benzamides of formula (I), in which R1 representstrifluoromethyl, chlorine, bromium or iodine and R2 represents hydrogen, methyl orethyl. The invention also relates to a method for producing said substances and to theiruse for controlling undesired micro-organisms, in addition to novel intermediateproducts and the production thereof.

]57[

__________

Page 452: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 452

165965]21][11[

ื—ื•ืžืจ ืžืจื›ื™ื‘ ืœืืœืงื˜ืจื•ื“ื” ืฉืœื™ืœื™ืช ืขื‘ื•ืจ ื•ื ืžืฉื ื™ ื•ืฉื™ื˜ื” ืœื™ื™ืฆื•ืจื•ืžืฆื‘ืจ ืœื™ืชื™

LITHIUM SECONDARYBATTERY NEGATIVEELECTRODE COMPONENTMATERIAL AND METHOD OFITS MANUFACTURE

]54[

01.04.2004]22[Int. Cl.(2009.01) H01M 04//02, 04//40, 04//48]51[SUMITOMO ELECTRICINDUSTRIES, LTD., JAPAN

]71[

NOBUHIRO OTA, NOBUYUKIOKUDA, HIROYUKI UEKI,TOMOHIKO IHARA

]72[

WO/2005/101549]87[ื‘ื™'ื’ ื‘ืข, ื™ื™ ืืž ,ืž"ืคืงื˜ื•ืจ ืื ื“ ืงื•

, 45087.ื“.ืช, ื”ืจ ื—ื•ืฆื‘ื™ื, ืจื—ื•ื‘ ื”ืžืจืคื ื™ืจื•ืฉืœื™ื

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,

P.O.B. 45087,JERUSALEM 91450

]74[

It is intended to provide a secondary lithium battery in which short circuitcaused by the formation of dendrite from the metallic lithium negativeelectrode is regulated and which has a high energy density, a high stabilitywith excellent charge-discharge cycle properties and a high safety. A negativeelectrode member for a secondary lithium battery comprising a metallic lithiumfilm and an inorganic solid electrolyte film which are layered on a basematerial, characterized in that the inorganic solid electrolyte contains lithium,phosphorus, sulfur and oxygen, and is represented by the followingcompositional formula: aLiยทbPยทcSยทdO (Li: lithium, P: phosphorus, S: sulfur, O:oxygen) and the contents of the elements respectively fall within the followingranges: 0.20โ‰คaโ‰ค0.45 0.10โ‰คbโ‰ค0.20 0.35โ‰คcโ‰ค0.60 0.03โ‰คdโ‰ค0.13 (a+b+c+d=1).

]57[

__________

166014]21][11[

CULTURE ืžืฆืข ืœื’ื™ื“ื•ืœ ื•ืžืขืจื›ืช ืฉืœ ื›ื•ืจ ื‘ื™ื•ืœื•ื’ื™ DISH ANDBIOREACTOR SYSTEM

]54[

26.06.2003]22[US]33[02.07.2002]32[189300]31[

Int. Cl.(2008.04) C12M 1/12, 1/34, 3/06]51[ORGANOGENESIS INC., U.S.A.]71[WO/2004/005453]87[A bioreactor has a base for defining a well, a dish with a membrane suspended in thebase, and a lid with gas permeable membranes and self-sealing ports.

]57[

Page 453: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009453

__________

166354]21][11[

ASSEMBLY ืžื™ื›ืœืœ ื•ืฉื™ื˜ื” ืœื›ื™ื•ืœ ื‘ืกื™ืก ืชืฆื•ื’ื” ืขืœื™ืช AND METHOD FORHEAD-UP DISPLAY (HUD) TRAYHARMONIZATION

]54[

18.01.2005]22[Int. Cl.(2009.01) G02B 27//01]51[

ืื•ืคื˜ื™ืงื” ืืœืื•ืค-ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ืืœืงื˜ืจื• ืจื—ื•ื‘ื•ืช,ืž"ื‘ืข

ELBIT SYSTEMS ELECTRO-OPTICAL ELOP LTD.

]71[

MICHAEL ื™ืขืงื‘ ื™ื•ืฉืข, ืžื™ื›ืืœ ื‘ืจื•ื“ืกืงื™ BRODSKY, JACOBYOSHA

]72[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A head-up display (HUD) tray harmonization assembly, comprising: a mount alignmentjig (MAJ) (20) having a first end and a second end, said first end being connectable toan adjustable tray (18) affixed in an aircraft cabin (16) having a pilot's seat, located in afront end (6) of an aircraft, at a spaced-apart relationship to a front window (8) having alower edge (12) located adjacent the front end of said aircraft; a telescope (22)connected to the MAJ at, or adjacent, its second end oriented for viewing through saidwindow; an optical collimator holder (24) having a first portion (26) connectable to anoutside wall of said front end of the aircraft and a second portion (28) extendingtowards and terminating at least at least lower edge of said window, and an opticalcollimator (32) coupled to the second portion of said holder to form a line of sight withsaid telescope.

]57[

__________

Page 454: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 454

166439]21][11[

ืื ื“ื™ืื ื“ืจื™ืช ื›ืžืขื›ื‘ื™Hื ื’ื–ืจื•ืช ื—ื•ืžืฆื”Cโ€“MAFื”ื›ื ืชืŸ, ืœืฉื™ืžื•ืฉ ื ื’ื“ ืืกืชืžื”

ื•ืชื›ืฉื™ืจื™ื ืจื•ืงื—ื™ื™ื ื”ืžื›ื™ืœื™ื ืื•ืชืŸ

ENDIANDRIC ACID HDERIVATIVES AS C-MAFINHIBITORS FOR USINGAGAINST ASTHMA, THEIRPREPARATION ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM

]54[

18.07.2003]22[DE]33[02.08.2002]32[10235624.6]31[

Int. Cl.(2008.04) C07C 69/00]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY

]71[

WO/2004/001488]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ืื™-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

A compound of the formula

whereR1 and R2 are, independently of one another,1, 0 H or2.0 a โ€“O-C1-C6-alkyl, -O-C2-C6-alkenyl, -O-C2-C6-alkynyl or โ€“O-C6-C10-aryl group, inwhich alkyl, alkenyl and alkynyl are straight-chain or branched, and in which thealkyl, alkenyl and alkynyl groups are optionally mono- or disubstituted by:2.1 โ€“OH,2.2 =O,2.3 โ€“O-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 โ€“O-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 C6-C10-aryl,2.6 โ€“NH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 โ€“NH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 โ€“NH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or

]57[

Page 455: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009455

2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted byโ€“CN, -amide or โ€“oxime functions, and 2.5 may be further substituted by โ€“CN or amidefunctions, or R1 and R2 together form a group โ€“O-[(C1-C6)-alkylene]-O-, R3 is 1.0 H or2.0 a C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or C2-C10-aryl group, in which alkyl,alkenyl and alkynyl are straight-chain or branched, and in which the alkyl, alkenyl andalkynyl groups are optionally mono- or disubstituted by:2.1 โ€“OH,2.2 =O,2.3 โ€“O-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 โ€“O-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 โ€“C6-C10 aryl,2.6 โ€“NH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 โ€“NH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 โ€“NH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted byโ€“CN, -amide or โ€“oxime functions, and 2.5 may be further substituted by โ€“CN or amidefunctions, and R4 is CO2R3, CO2NHR3, CHO, CH2OR3, CH2OSi(R3)3, CH2CN, whereR3 is as defined above, or a stereoisomeric form of the compound of the formula (l) ora physiologically tolerated salt of the formula (l) or a salt of a stereoisomeric form ofthe compound of the formula (l).

__________

166557]21][11[

ECHINACEA ืชืžืฆื™ื•ืช ืื›ื™ื ืฆืื” ืื ื’ื•ืกื˜ื™ืคื•ืœื™ื” ANGUSTIFOLIAEXTRACTS

]54[

30.06.2003]22[IT]33[30.07.2002]32[MI2002A001691]31[

Int. Cl.(2008.04) A61K 35/00, 36/185, 36/28]51[INDENA S.P.A., ITALY]71[WO/2004/014404]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

An Echinacea angustifolia extract and a process for the preparation thereofare herein described. The extract is characterized by an alkylamides contentlower than 0.1 %, an echinacoside content ranging from 1 to 10% andcontaining from 1 to 15% of a polysaccharide characteristic of Echinaceaangustifolia. The extract can be used for the treatment of pathologicalconditions in which it is desirable to strengthen the immune defenses.

__________

]57[

Page 456: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 456

166746]21][11[

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื‘ื™ื˜ื•ืœ ื”ืคืจืขื” ื‘ื—ื™ืฉื•ื‘ ื—ื•ื˜ื™ืชโ€“ืžื™ืงื•ื ืœืฉื™ืžื•ืฉ ื‘ืžืขืจื›ืช ืžื™ืงื•ื ืืœ

SYSTEM AND METHOD FORINTERFERENCECANCELLATION IN ALOCATION CALCULATIONFOR USE IN A WIRELESSLOCATION SYSTEM

]54[

11.08.2003]22[Int. Cl.(2009.01) G01S 05//02, H04B 01//10]51[TRUEPOSITION, INC., U.S.A.]71[WO/2004/015878]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

In a Wireless Location System, reception and demodulation of signals is oftenperformed at many sites. A collision may occur, e.g., in a TDMA, AMPS, GSM, GPRS,EDGE, CDMA, CDMA 2000, or WCDMA system, when a signal of interest (atransmission from a mobile transmitter to be located) and an interfering signal arereceived at the same time and at the same site. In the event such a collision occurs,the interfering signal may have been demodulated by a receiver system, or SCS, atanother site, and the demodulated data be known by the TLP. This interferer can bereconstructed and subtracted from the raw data representing the combined signal ofinterest and interferer at the site where the collision occurred. This technique canprovide significant (e.g., approximately 10 - 15 dB) interference rejection, with littledegradation to the signal of interest.

]57[

__________

Page 457: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009457

166769]21][11[

CATALYST ื‘ืชื”ืœื™ืš ืื•ืกื•ื•ืœื“N2Oื–ืจื–ื™ื ืœืคื™ืจื•ืง FOR THEDECOMPOSITION OF N2O IN THEOSTWALD PROCESS

]54[

09.02.2005]22[DE]33[11.03.2004]32[102004012333.0]31[DE13.05.2004 102004024026.4

Int. Cl.(2008.04) B01D 53/86, B01J 23/46, C01B 21/26]51[W.C. HERAEUS GMBH, GERMANY]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Use of a composition comprising:(A) a carrier material, wherein the carrier material is alpha-Al2O3 or ZrO2 or CeO2 ormixtures thereof,(B) a coating made of rhodium or rhodium oxide or a Pd-Rh alloy for the preparation ofa catalyst for the decomposition of N2O under the conditions of the Ostwald process at750oC to 1000oC and 0.9 to 15 bar.

]57[

__________

166897]21][11[

SINGLE ื™ื”ืœื•ื ืžื’ื‘ื™ืฉ ื™ื—ื™ื“ CRYSTAL DIAMOND]54[

15.02.2005]22[Int. Cl.(2009.01) C30B 25//02, 28//04, 33//00]51[ELEMENT SIX LIMITED, UNITEDKINGDOM

]71[

WO/2004/027123]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method of producing a large area plate of single crystal diamond from CVD diamondgrown on a substrate substantially free of surface defects by chemical vapourdeposition (CVD). The homoepitaxial CVD grown diamond and the substrate aresevered transverse to the surface of the substrate on which diamond growth took placeto produce the large area plate of single crystal CVD diamond

]57[

Page 458: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 458

__________

167005]21][11[

CLOSED ืกื’ื•ืจ-ืžืขื’ืœ-ื›ื™ื ื•ืŸ ืืจื˜ื™ืœืจื™ื” ืขืœ ื™ื“ ืžืฉื•ื‘ LOOP-FEEDBACKARTILLERY FIRE CONTROL

]54[

21.02.2005]22[Int. Cl.(2009.01) F41G 05//06]51[

ื‘ืขืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืง"ืจืคื ,ืž"ื“ืžื•ืช ื—ื™ืคื”

RAFAEL ADVANCED DEFENSESYSTEMS LTD.

]71[

MENACHEM ืžื ื—ื ื“ื‘ื™ืจ DVIR]72[ื‘ืข"ื“ ,ืž"ืจ ืžืจืง ืคืจื™ื“ืžืŸ

ื–,54.ืง, ืžื’ื“ืœ ืžืฉื” ืื‘ื™ื‘ ,7ื‘ื•ื˜ื™ื ืกืงื™'ืจื—ื’ืŸ-ืจืžืช

DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54TH

FLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520

]74[

A method of directing fire of a gun at a target, comprising:(a) aiming the gun at the target in accordance with geographic coordinates of thetarget;(b) firing a shell at the target from the gun; and(c) if the shell misses the target:(i) acquiring an image of a region including an indication of an impact of the shell;(ii) inferring geographic coordinates of said indication from said image; and(iii)correcting an aim of the gun in accordance with said geographic coordinates of thetarget and said inferred geographic coordinates of said indication.

]57[

__________

Page 459: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009459

167081]21][11[

ืงื• โ€“ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื‘ื™ืฆื•ืข ืกื™ื•ืžืช ืฉืœืชืžืกื•ืจืช ื‘ืืžืฆืขื•ืช ื‘ื™ื˜ื•ืœ ืื•ืช ื•ื™ืฉื•ืžื™ื

ืฉืœื”ืŸ

SYSTEM AND METHOD FORTRANSMISSION-LINETERMINATION BY SIGNALCANCELLATION ANDAPPLICATIONS THEREOF

]54[

17.09.2000]22[Int. Cl.(2008.04) H04B 3/20, H04L 27/00, 5/14]51[DIVISION FROM 138517]62[MOSAID TECHNOLOGIESINCORPORATED, CANADA

]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method for signal termination with a device having terminating and transmittingstates, said method comprising: connecting the device to a connection point of a two-conductor transmission line; providing a termination circuit constructed for terminating asignal propagated over the two-conductor transmission line; providing a first driveroperative to conduct a signal over the two-conductor transmission line, the first driverhaving an input port selectively couplable to a signal source doe coupling the signalsource to the transmission line, and an output port; and placing the device in a selectedone of: a terminating state in which said termination circuit is coupled to the connectionpoint; and a transmitting state in which the first driver output port is coupled to theconnection point.

]57[

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

199120,The applications fordivision from thisapplication have not yetbeen published

__________

Page 460: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 460

167337]21][11[

ื™ ืื• ืฉื™ื•ืฆืจ ื‘ืฉื™ืงื•ืข ืžืจืงืข ืืœืงื˜ืจื•ื›ืจื•ืž ื—ืฉืžืœื™

ELECTROCHROMIC ORELECTRODEPOSITION DISPLAY

]54[

10.09.2003]22[AR]33[10.09.2002]32[60/409833]31[

Int. Cl.(2009.01) G02F 01//161]51[SIPIX IMAGING, INC., U.S.A.]71[WO/2004/025356]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ื•ื‘ ื”ื‘ืจื–ืœ ืจื—

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

An electrochromic or electrodeposition display comprising a plurality of cells, each ofsaid cells comprises surrounding partition walls, an electrochromic or electrolytic fluidfilled therein, and a polymeric sealing layer which encloses said fluid within each celland sealingly adheres to the surface of the partition walls. Microcups are formed byembossing or imagewise exposure.

]57[

__________

167624]21][11[

CELL ืชื›ืฉื™ืจื™ื ื•ืฉื™ื˜ื•ืช ืœื”ืคืจื“ืช ืชืื™ื SEPARATIONCOMPOSITIONS AND METHODS

]54[

26.09.2003]22[US]33[27.09.2002]32[60/414692]31[

Int. Cl.(2008.04) A61K 317/21, 317/27, 393/95, C07K 16/28, G01N 33/53]51[BIOE, INC., U.S.A.]71[WO/2004/029208]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The invention provides compositions and methods for cell separation. Thesereagents and techniques specially agglutinate cells via surface recognition andcan be used to recover even rare cell types in high yield.

]57[

__________

Page 461: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009461

167673]21][11[

HIGH ืžืจืื” ื“ื™ื•ืง ื’ื‘ื•ื” ื•ืฉื™ื˜ื” ืœืขืฉื•ืชื” PRECISION MIRROR ANDA METHOD OF MAKING IT

]54[

24.02.2003]22[US]33[24.02.2003]32[10/373448]31[

Int. Cl.(2009.01) G02B 01//10]51[RAYTHEON COMPANY, U.S.A.]71[WO/2004/077114]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A mirror includes: a substrate having a surface; and a thin-film finishlayer provided over the surface of the substrate and having aon a sidethereof opposite from the substrate a surface with a polished finish.According to a different aspect of the invention, a method of making amirror includes: providing a substrate having a surface thereon; forminga thin-film finish layer over the surface of the substrate using thin-filmtechniques, the finish layer having a surface on a side thereof oppositefrom the substrate; and polishing the surface of the finish layer.

]57[

__________

167935]21][11[

METHOD ืชื”ืœื™ืš ื—ืจื™ื˜ื” ื‘ืคืœื–ืžื” FOR PLASMAETCHING

]54[

06.10.2003]22[US]33[11.10.2002]32[60/417806]31[US14.11.2002 10/295601 US29.09.200310/674675

Int. Cl.(2008.04) H01L 213/065]51[LAM RESEARCH CORPORATION,U.S.A.

]71[

LUMIN LI, ZHISONG HUANG,REZA SADJADI

]72[

WO/2004/034445]87[ื‘ื™'ื’ ื‘ืข, ื™ื™ ืืž ,ืž"ืคืงื˜ื•ืจ ืื ื“ ืงื•

, 45087.ื“.ืช, ื”ืจ ื—ื•ืฆื‘ื™ื, ืจื—ื•ื‘ ื”ืžืจืคื ื™ืจื•ืฉืœื™ื

JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,

P.O.B. 45087,JERUSALEM 91450

]74[

A method for etching a feature in a layer through an etching mask is provided. Aprotective layer is formed on exposed surfaces of the etching mask and verticalsidewalls of the feature with a passivation gas mixture. The feature is etched through

]57[

Page 462: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 462

the etching mask with reactive etching mixtures containing at least one etchingchemical and at least one passivation chemical.

ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉื” ื–ื•.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

190716,The applications for divisionfrom this application havenot yet been published

__________

168014]21][11[

ืฉื™ื˜ื” ืœื™ืฆื•ืจ ื’ืœื™ืœ ื—ื•ืžืจ ืืจื•ื’ ื•ืžื›ื•ื ืช ื’ืœื™ืœื” ื”ืžื™ื™ืฉืžืช ืืช ื”ืฉื™ื˜ื”

METHOD FOR PRODUCING LOGSOF WEB MATERIAL ANDREWINDING MACHINEIMPLEMENTING SAID METHOD

]54[

14.10.2003]22[IT]33[16.10.2002]32[FI2002A000194]31[

Int. Cl.(2009.01) B65H 19//28]51[FABIO PERINI S.P.A., ITALY]71[WO/2004/035441]87[

,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘

ื”ืจืฆืœื™ื”, 12704

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

method for producing logs (Ll, L2) of web material (N) wound around tubular coreswherein the tubular core (Al-A4) is equipped with glue to secure the initial end of theweb material and allow winding. Part of the glue applied to the tubular core istransferred to the web material (N) before it is severed upon termination of winding thelog, to seal the final free end of the formed log.

]57[

__________

Page 463: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009463

168041]21][11[

METHOD ืฉื™ื˜ื” ืœื˜ื™ืคื•ืœ ื‘ื‘ื•ืฆืช ืฉืคื›ื™ื ื’ื•ืœืžื™ืช OF TREATING RAWSEWAGE SLURRY

]54[

14.04.2005]22[Int. Cl.(2009.01) B01D 21//02, 61//04, E03F 09//00]51[

BAR-EDAN ืงืจื™ืช ืžืœืื›ื™,ืž"ื‘ืจ ืขื™ื“ืŸ ื™ืฆื•ืจ ื•ืคื™ืชื•ื— ื‘ืข MANUFACTURINGAND DEVELOPMENT LTD.

]71[

AHIAM ืื—ื™ืขื ื‘ืŸ ื™ืขืงื‘ BEN YAACOV]72[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A method of treating a raw preconcentrated sewage slurry comprising(i) providing a preconcentrated sewage slurry having from about 10 to about 40% dryweight (%dw);(ii) irradiating said slurry with an electron dose of from 2.5 kGy to 20 kGy;(iii) mixing the irradiated slurry from the previous step with a base that is added in anamount of from about 20 to about 200 kg per 1 ton of dry weight of said irradiatedslurry, thereby obtaining an essentially homogeneous mixture; and(iv) allowing said base and said irradiated sludge to react in said mixture at a pH of atleast 11.5;thereby obtaining essentially disinfected and stabilized sludge.

]57[

__________

168245]21][11[

ASPERGILLUS ืคืจื•ื˜ืื–ื” ืืกืคืจื˜ื™ืช ื ื™ื™ื’ืจ NIGER ASPARTICPROTEASE

]54[

01.11.1994]22[EP]33[03.11.1993]32[93810764.6]31[

Int. Cl.(2008.04) C12N 1/14, 15/57, 9/60]51[DIVISION FROM 111482]62[NOVARTIS AG, SWITZERLAND]71[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

A isolated DNA molecule comprising a DNA sequence encoding an Aspergillus nigeraspartic protease having the amino acid sequence shown in SEQ ID NO.2.

]57[

Page 464: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 464

168608]21][11[

ืจืืฉ ืžื“ืคืกืช ืชืจืžื™ ืœื”ื–ืจืงืช ื“ื™ื• ื‘ืขืœื™ืขื™ืœื•ืช ื’ื‘ื•ื”ื” ื•ืฉื™ื˜ื” ืœื”ื–ืจืงืช ื˜ื™ืคื” ืฉืœ

ื ื•ื–ืœ ืžื•ื–ืจืง ืžืจืืฉ ื”ืžื“ืคืกืช

HIGH EFFICIENCY THERMALINK JET PRINTHEAD AND AMETHOD FOR EJECTING ADROP OF AN EJECTABLELIQUID FROM THE PRINTHEAD

]54[

17.11.2003]22[US]33[23.11.2002]32[10/302669]31[

Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[

WO/2004/048108]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is configured such that anactuation energy of less than 500 nanojoules (nJ) is required to be applied to thatelement to heat it sufficiently to form such a bubble (12) in the bubble forming liquid(which liquid can also be the ink). This configuration thus provides for a high efficiencyprinthead.

]57[

__________

Page 465: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009465

168700]21][11[

ืžืขืจื›ืช, ืจืืฉ ืžื“ืคืกืช ืœื”ื–ืจืงืช ื“ื™ื•ืžื“ืคืกืช ื”ืžื›ื™ืœื” ืื•ืชื• ื•ืฉื™ื˜ื” ืœื”ื–ืจืงืช

ื˜ืคื” ืฉืœ ื‘ื•ืขื” ื‘ืฆื•ืจืช ื ื•ื–ืœ ืžืžื ื•

INK JET PRINTHEAD, PRINTERSYSTEM COMPRISING IT ANDMETHOD OF EJECTING A DROPOF A BUBBLE FORMING FLUIDFROM IT

]54[

17.11.2003]22[US]33[23.11.2002]32[10/302297]31[

Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA

]71[

WO/2004/048104]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is substantially coveredby a conformal protective coating (77) which has been applied to all sides of the heaterelement (10) simultaneously so that the coating is seamless.

]57[

__________

Page 466: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 466

168770]21][11[

ืฉื™ื˜ื•ืช ืœื‘ืงืจืช ืžื–ื™ืงื™ื ืชื•ืš ืฉื™ืžื•ืฉ ื‘ื—ืœืงื™ืงื™ื ืžืชื›ืชื™ื™ื

METHODS FOR CONTROLLINGPESTS USING METALLICPARTICLES

]54[

05.12.2003]22[GB]33[05.12.2002]32[0228421.4]31[

Int. Cl.(2008.04) A01N 25/24, 59/16]51[EXOSECT LIMITED, UNITEDKINGDOM

]71[

WO/2004/049807]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

There is disclosed a method of controlling pests which comprises exposing asurface of the pest to a particulate composition containing particles of aninitially unmagnetized material, which is capable of becoming magneticallypolarized when subjected to an electric or magnetic field, the said particlesbeing associated with at least one pesticide or behaviour modifying chemical.

]57[

__________

168793]21][11[

STREPTOCOCCUS ืžื•ืœืงื•ืœื” ื“ื‘ื™ืงื” ืฉืœ ื™ื•ื‘ืจื™ืก ืกื˜ืจืคื˜ื•ืงื•ืงื•ืก UBERISADHESION MOLECULE

]54[

22.10.2003]22[US]33[26.11.2002]32[60/429499]31[

Int. Cl.(2009.01) A61K 39//09, C07K 14//315]51[UNIVERSITY OF TENNESSEERESEARCH FOUNDATION, U.S.A.

]71[

WO/2004/048515]87[,ืจ ื™ืฆื—ืง ื”ืก ื•ืฉื•ืชืคื™ื•"ื“

ืชืœ ืื‘ื™ื‘, 6451.ื“.ืช, 279ืจื—ื•ื‘ ื”ื™ืจืงื•ืŸDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,

P.O.B. 6451,TEL AVIV 61063

]74[

A polypeptide, designated as โ€œStreptococcus uberis Adhesion Moleculeโ€ (SUAM), andfragments of SUAM, prevent internalization and adherence of Streptococcus uberis andother streptococcal pathogens to cells. The SUAN polypeptide and fragments may beused diagnostically and therapeutically. Nucleic acid sequences encoding the SUAMpolypeptide and fragments are included in the invention.

]57[

Page 467: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009467

__________

168977]21][11[

CROSS ืฉื™ืชื•ืฃ ื—ื•ืฆื” ืžื—ื™ืฆื•ืช ืฉืœ ืžื™ื“ืข ืขืœ ืžืฆื‘ PARTITION SHARING OFSTATE INFORMATION

]54[

14.11.2003]22[US]33[05.12.2002]32[10/313330]31[

Int. Cl.(2009.01) G06F 05//16]51[IBM CORPORATION, U.S.A.]71[WO/2004/051471]87[

,ืžืขื‘ื“ื•ืช ื™ื‘ืž ืžื—ืœืงืช ืงื ื™ืŸ ืจื•ื—ื ื™ ื—ื™ืคื”, ืื•ื ื™ื‘ืจืกื™ื˜ืช ื—ื™ืคื” ื”ืจ ื”ื›ืจืžืœ

IBM LABORATORIES,HAIFA UNIVERSITY,

HAIFA 31905

]74[

A method and system are disclosed for managing saved process states in a memory ofa data processing system that has multiple partitions executing independent operatingsystems. A hypervisor manager affords access to any processor in the data processingsystem for the purpose of storing process states for that processor the memory,independent of the operating system running on the processor.

]57[

__________

Page 468: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 468

169351]21][11[

URINARY ืฉืกืชื•ื ื‘ืงืจืช ื–ืจื™ืžื” ืฉืœ ืฉืชืŸ FLOW CONTROLVALVE

]54[

09.01.2003]22[Int. Cl.(2009.01) A61F 02//02]51[OPMI FUNDING CORP., U.S.A.]71[WO/2004/062532]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A flow control valve (22) such as for a catheter (10) allows discharge of urine from abladder (12) by manual actuation. The valve (22) may be a doubleโˆ’duckbill valve (22)with a single slit (62) at one apex (60a) thereof. An elastomeric band (66) is positionedin a groove (68) of the valve member (22). An isolation member such as a stem (72)spaces the valve (22) from the walls (34, 36) of the valve housing (32). Crush limitingstructure, such as a tube (76) or blade (82), is provided within valve member (22), orstop elements (86 or 92) are positioned external to valve member (22).

]57[

__________

169463]21][11[

ืคื–ื•ืจ ืจื’ื™ืฉ ืื•ืจ ืขื ืฆืžื™ื’ื•ืช ื”ื ื™ืชื ืชืœื•ื™ืกื•ืช ืขื‘ื•ืจ ื”ืคืงื“ื” ืฉืœ ืžืชื›ืช ืขืœ ื’ื‘ื™

ืžืฆืข ืžื‘ื“ื“ ื•ื”ืฉื™ืžื•ืฉ ื‘ื•

PHOTOSENSITIVE DISPERSIONWITH ADJUSTABLE VISCOSITYFOR METAL DEPOSITION ON ANINSULATING SUBSTRATE ANDUSE OF SAME

]54[

24.12.2003]22[BE]33[03.01.2003]32[2003/0007]31[

Int. Cl.(2008.04) C23C 18/00, 18/30, C25D 5/56]51[SEMIKA S.A., LUXEMBOURG]71[WO/2004/061157]87[

,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

Page 469: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009469

The invention relates to a photosensitive dispersion with adjustable viscosityfor metal deposition on an insulating substrate, which combines the following:a pigment providing oxidation-reduction properties under light irradiation, ametallic salt, a complex-forming agent for the metallic salt, a liquid film-formingpolymer formulation, a basic compound, an organic solvent and water. Theinvention also relates to the use of said dispersion.

]57[

__________

169515]21][11[

ืฉื™ืžื•ืฉ ื‘ืคื™ืจื˜ืจื•ื™ื“ ืื• ืคื™ืจื˜ืจื™ืŸ ื‘ื™ื—ื“ ืขื ืื’ื•ื ื™ืกื˜ ื ื™ืงื•ื˜ื™ื ื™ ืœื“ื™ื—ื•ื™ ืืจื˜ืจื•ืคื“ื™ื

USE OF A PYRETHROID ORPYRETHRIN IN COMBINATIONWITH A NICOTINIC AGONISTFOR REPELLING ARTHROPODS

]54[

05.01.2004]22[DE]33[17.01.2003]32[10301906.5]31[

Int. Cl.(2008.04) A01N 37/34, 53/00]51[BAYER ANIMAL HEALTH GMBH,GERMANY

]71[

WO/2004/064522]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to the use of an arthropod-repelling constituent of thepyrethroid/pyrethrin class combined with an agonist of the nicotine-producingacetylcholine receptors of arthropods, for efficiently repelling arthropods,preferably on animals, for a long time.

]57[

__________

169612]21][11[

FREIGHT ืžืขืจื›ืช ื”ืฉื’ื—ืช ืžื™ื›ืœ ืžื˜ืขืŸ CONTAINERMONITORING SYSTEM

]54[

10.07.2005]22[Int. Cl.(2009.01) G01S 13//04, 13//88]51[PHALANX GROUP, LLC, U.S.A.]71[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ืฉืœื™ืื™ืจื•, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A system for monitoring a freight container comprising: means for monitoring the freightcontainer including means for generating a resonant spectrum representative of aninitial condition of internal surfaces and contents of the freight container; and means forsaving said resonant spectrum representative of an initial condition of internal surfaces

]57[

Page 470: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 470

and contents of the freight container; and means for saving said resonant spectrum forfuture comparison purposes.

__________

170010]21][11[

ืฉื™ื˜ื” ืœืฉื™ืคื•ืจ ื”ื–ืจื™ืžื” ื‘ืžืžื‘ืจื ื” ื‘ืจื™ืืงื˜ื•ืจ ื‘ื™ื•ืœื•ื’ื™

METHOD FOR IMPROVING FLUXIN A MEMBRANE BIOREACTOR

]54[

01.08.2005]22[US]33[01.06.2005]32[11/142745]31[

Int. Cl.(2009.01) B01D 61//04, C02F 01//56, 03//12]51[NALCO COMPANY, U.S.A.]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A method for improving flux in a membrane bioreactor of which the influent has aconcentration of salts or inorganic oxides sufficient to cause scaling or inorganic foulingconditions comprising adding an effective amount of one or more cationic, amphoteric,or zwitterionic polymers, or a combination thereof to said membrane bioreactor,wherein a membrane bioreactor system comprises said membrane bioreactor, whereinsaid membrane bioreactor comprises an aerobic reactor wherein said membranebioreactor system further comprises a reactor selected from the group consisting ofanaerobic reactors and anoxic reactors and wherein said effective amount of cationicpolymer is about 10 to about 2,000 ppm as active based on the total membranebioreactor volume.

]57[

__________

170046]21][11[

SINGLE-BLOW ื”ืœื ื™ื—ื™ื“-ืžื›ืฉื™ืจ ืžื—ื•ืœืœ ื’ืœ SHOCKWAVEGENERATION DEVICE

]54[

30.01.2004]22[FR]33[14.02.2003]32[03/01793]31[

Int. Cl.(2008.04) A61B 17/22]51[DULIVER INTERNATIONAL LTD.,BRITISH VIRGIN ISLANDS

]71[

WO/2004/078048]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ืœื™ื”ื”ืจืฆ

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to a single-blow mechanical shockwave generation device usedin urological surgery for disintegration of urinary duct stones (1), comprising strikingmeans (2) which strike shock wave generation means (3) at high speed. The shock

]57[

Page 471: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009471

waves are transmitted by shock wave transfer means (4) to an object for destructionwith which said shock wave transfer means are in direct or indirect contact. The strikingmeans (2) are displaced by means of the expansion of a high-pressure gas introducedprior to each shock wave generation into accumulation means (5) supplied with highpressure gas from independent gas stores (7) and with supply and sealing meanswhereby the stored gas is released by the manual manipulation of control means (8)which connect the accumulation means (5) to the striking means (2).

__________

170190]21][11[

ืžืขืจื›ืช ืฉืœ ื’ื– ืื™ื ืจื˜ื™ ืœื“ื™ื›ื•ื™ ืืฉ ื”ืžื•ื•ืกืชืช ื‘ืื•ืคืŸ ืขืฆืžื™

SELF-MODULATING INERT GASFIRE SUPPRESSION SYSTEM

]54[

19.12.2003]22[US]33[27.02.2003]32[10/377558]31[

Int. Cl.(2008.04) F16K 1/12, G05D 16/00, 16/16]51[FIKE CORPORATION, U.S.A.]71[WO/2004/079678]87[

ืขื•ืจื›ื™ ื“ื™ืŸ ื•ืขื•ืจื›ื™, ืงื‘ื•ืฆืช ืื™ืชืŸ ืžื”ื•ืœืœ,ืคื˜ื ื˜ื™ื

ื”ืจืฆืœื™ื”, 2081.ื“.ืช,10ืฉื“ืจื•ืช ืื‘ื ืื‘ืŸ

EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,

P.O. B. 2081,HERZLIYA 46120

]74[

A valve unit (26) comprising: a valve body (48) presenting an inlet (58) adapted forcoupling with a source of pressurized gas (24) and an outlet (60) adapted for couplingwith a gas receiver (30); a shiftable valve member (56) located within said bodybetween said inlet and said outlet and shiftable between a closed, gas flow-blockingposition and an open position permitting flow of gas from said source to said receiver; aspring (186) operably coupled with said valve member and biasing the member towardthe open position thereof; first and second operating surfaces (S1, S2) forming a part ofsaid member, said first surface exposed to said pressurized gas from said source andsaid member being normally maintained in said closed position against the bias of saidspring, there being a modulation chamber (182) formed between at least a part of saidsecond operating surface and adjacent portions of said valve body, and a passageway(168) communicating said source with said modulation chamber; and an actuator (50)operable upon actuation thereof to cause flow of pressurized gas from said source intoand out of said modulation chamber, said passageway presenting a gas flow restriction(169) operable to limit the flow rate of gas between said source and said modulationchamber, said operating surface, modulation chamber, and spring being correlated sothat when said member is shifted to the open position thereof, gas from said source isdelivered to said receiver at a pressure of between 1MPa to 10MPa (10 to 100 bar)over a substantial part of the time gas flows from the source to the receiver by flow ofsaid gas into and out of said modulation chamber.

]57[

Page 472: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 472

__________

170324]21][11[

ืžื–ืจืง ืœืœื ืžื—ื˜ ื”ืžื›ื™ืœ ื›ืœื™ ืงื™ื‘ื•ืœ ื™ืขื™ืœ ืœืžื–ืจืง

NEEDLELESS SYRINGECOMPRISING AN OPTIMIZEDINJECTOR-RECEPTACLE

]54[

09.04.2004]22[FR]33[16.04.2003]32[03/04761]31[

Int. Cl.(2008.04) A61M 5/00]51[CROSSJECT, FRANCE]71[WO/2004/093944]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to the realm of needleless syringes used for injecting liquid activesubstances. Said syringe comprises a reservoir that is enclosed by means ofdisplaceable plugs which trap the liquid. The reservoir is initially isolated from aninjector-receptacle (37) which is provided with at least two peripheral injection conduits(38) that are arranged outside the receptacle (37). Said receptacle (37) encompasses apocket bore (31) which accommodates the plug located downstream such that theoptimized inlets (39) of the conduits are unobstructed. The face of the receptacle (37),which is located upstream, comprises a multilobed sealing joint (34) which is disposedparallel to and as close as possible to the edges of the bore (31) and the inlets (39).The aim of the invention is to create an injector-receptacle (37) that is optimizedregarding discharging and the resistance thereof to the injection pressure.

]57[

Page 473: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009473

__________

170728]21][11[

OPTICALLY ืชืจื›ื•ื‘ืช ืœื–ื™ืจื•ื– ื ื—ื•ืฉืช ืื•ืคื˜ื™ืช ืคืขื™ืœื” ACTIVE COPPERCATALYST COMPOSITION

]54[

25.03.2004]22[JP]33[31.03.2003]32[2003-093750]31[

Int. Cl.(2008.04) B01J 31/18, 31/28]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN

]71[

WO/2004/087317]87[,ืจ ื™ืฆื—ืง ื”ืก ื•ืฉื•ืชืคื™ื•"ื“

ืชืœ ืื‘ื™ื‘, 6451.ื“.ืช, 279ืจื—ื•ื‘ ื”ื™ืจืงื•ืŸDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,

P.O.B. 6451,TEL AVIV 61063

]74[

An optically active copper catalyst composition comprising (a) an optically activesalicylideneamino alcohol represented by the general formula (1): (1) [wherein R1 andR2 are each independently substituted or unsubstituted lower alkyl, substituted orunsubstituted aralkyl, or substituted or unsubstituted aryl; X1 and X2 are eachindependently hydrogen, lower alkoxy, nitro, lower alkoxy- carbonyl, cyano, orhalogeno; and * represents an asymmetric center, with the proviso that both of X1 andX2 are not hydrogen], (b) a mono- or di-valent copper compound, and (c-1) a lithiumcompound or (c-2) a compound selected from among aluminum compounds havingLewis acidity, titanium compounds having Lewis acidity, boron compounds havingLewis acidity, zirconium compounds having Lewis acidity, and hafnium compoundshaving Lewis acidity; and a process for the production of optically activecyclopropanecarboxylic acids with the composition.

]57[

__________

Page 474: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 474

170901]21][11[

DEAD ื˜ื›ื ื•ืœื•ื’ื™ืช ื“ื™ืกืง ื”ืžืฉืžื™ื“ื” ืืช ืชื•ื›ื ื• ON DEMAND DISKTECHNOLOGY

]54[

18.03.2004]22[US]33[18.03.2003]32[60/455501]31[

Int. Cl.(2008.04) G06F 1/00, G11B 23/28]51[ENSCONCE DATA TECHNOLOGY,U.S.A.

]71[

WO/2004/084470]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A system for rendering data stored on a data storage device (14) unrecoverable uponthe occurrence of a certain event, the system comprising: a reactant reservoir (18)including at least one chamber for holding a reactant chemical, the reactant reservoir influid communication with at least an area proximate at least one surface of said datastorage device; an activation device (44) coupled to said reactant reservoir andresponsive to at least one event, for causing at least a portion of the reactant chemicalto flow from the reactant reservoir into the at least an area proximate at least onesurface of said data storage device, thereby destroying the stored data, the at least oneevent being selected from the group consisting of removal of the data storage devicefrom a host computer, removal of data storage device from a primary power circuit (22),detected movement of the data storage device from its resting point, a certain numberof detected unsuccessful login attempts, an infrared signal sent from an infraredcontroller, a remote transmitter signal sent from a remote transmitter, a cellular signalsent from a cellular telephone, a wireless transmitter signal sent by a wirelesstransmitter, a keyboard signal sent from a wired controller, detected physical tamperingwith the data storage device, detected loss of power from the primary power circuit andbackup batteries, a command sent through an Internet, a key command sequenceentered from the keyboard, a voice command through a voice recognition system, abiometric signal, an incorrect biometric signal, and detected temperature outside arange of temperatures; and an event interface (42), coupled to said activation device,for establishing selected predetermined criteria for said at least one event, wherein theselected predetermined criteria include a countdown time before the reactant chemicalflows from the reactant reservoir.

]57[

__________

Page 475: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009475

171104]21][11[

COMPACT ืžืขื’ืœ ืžืฉื•ืœื‘ OPTIC SENSOR]54[

23.02.1999]22[Int. Cl.(2008.04) G01B 9/00, G01N 21/01]51[DIVISION FROM 128659]62[CONMED CORPORATION, U.S.A.]71[

,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื• ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ, ื’ืŸ ืชืขืฉื™ื™ื”

LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

An integrated circuit (16) for the use in a compact optical sensor comprising a packageof at least two light sources (38, 40) concentrically surrounded by at least two waveguides (20, 22) being ring-like in cross-section, the integrated circuit comprises a pair ofsubstantially ring-like areas of photodiodes (26, 28) having different diameters andpositioned concentrically one inside the other; said integrated circuit being alsoprovided with a plurality of printed contact areas (30) and electric conductors (32),respectively intended for mounting thereon said light sources, controlling said lightsources, and for transmitting electric signals produced by said photodiodes areas tofurther processing.

]57[

__________

Page 476: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 476

171165]21][11[

RELEASABLE ืžืฆืžื“ ื”ื ื™ืชืŸ ืœืฉื—ืจื•ืจ ืžื›ืœื•ืœ COUPLINGASSEMBLY

]54[

29.04.2004]22[US]33[30.04.2003]32[10/425934]31[US15.04.2004 10/824490

Int. Cl.(2009.01) E02F 09//28]51[ESCO CORPORATION, U.S.A.]71[WO/2004/099511]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A lock (10) that includes a wedge (12) and spool (14) are used to releasably secureseparable components of an assembly together. The wedge (12) and spool (14) arethreadedly coupled together to drive the wedge into and out of an opening in theassembly without hammering or prying. The direct coupling of the wedge (12) andspool eliminates the need for bolts, washers, nuts and other hardware so as tominimize the number of parts. As a result, the lock is inexpensive to make, easy to use,and unlikely to become inoperative because of lost or broken parts or due to fines orother difficulties encountered in harsh digging environments. Further, the wedge (12)can be driven into the assembly to provide the degree of tightness necessary for theintended operation and/or to re-tighten the assembly after incurring wear during use. Alatch assembly (56) is preferably provided to securely hold the wedge (12) in place andavoid and undesired loss of parts during use.

]57[

__________

171508]21][11[

DAMAGED ืœื•ืœื‘ ืคื’ื•ื ื•ื”ืชืงื ื™ื ืœื”ืกืจืช ื‘ื•ืจื’ BOLT AND SCREWREMOVING DEVICES

]54[

23.04.2004]22[US]33[25.04.2003]32[60/465506]31[US23.04.2004 10/831391

Int. Cl.(2009.01) B25B 13//50]51[EAZYPOWER CORPORATION,U.S.A.

]71[

WO/2004/096471]87[,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ

ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A bit for removing a broken fastener comprises a tip from which extend two or morenotches separated by scraping surfaces formed from two-sided frusto-conically-shapedregions. The scraping surfaces are bounded on one side by a cutting edge and on theother side by a non-cutting edge and are configured to cut into the fastener when thebit is rotated in a direction opposite to the fastener's direction of engagement. Specificembodiments include configurations where the cutting edges extend at different angles

]57[

Page 477: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009477

with respect to the bit axis and where the scraping surfaces comprise a plurality ofserrations.

__________

171576]21][11[

PALLET ืžื™ื›ืœ ืœืžืฉื˜ื— CONTAINER]54[

15.04.2004]22[DE]33[25.04.2003]32[20306550.6]31[

Int. Cl.(2008.04) B65D 77/06]51[MAUSER-WERKE GMBH & CO.KG,GERMANY

]71[

WO/2004/096660]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a pallet container (10) comprising: a thin-walled inner container(12) made of thermoplastic material for storing and transporting liquid or free-flowingproducts; a lattice tube frame (14), which closely surrounds the plastic container (12) inthe form of a supporting cage and which consists of vertical and horizontal tubular rods(20, 22) that are welded to one another, and; a base pallet (16) upon which the plasticcontainer (12) rests and to which the lattice tube frame (14) is joined in a fixed manner.Prior art pallet containers have shortcomings with regard to strength (tubular rod fatiguefailure) that are considerable in the event of longer lasting shaking during transport thatinvolves dynamic cyclic stresses. In order to improve the lattice tube frame durabilitywhile maintaining sufficient stacking load-bearing capacity, the invention achieves anadapted optimal elasticity for dynamic alternating loads. This is realized by virtue of thefact that the tubular rods (20, 22) with a closed tubular profile have a varying tubularprofile height, which is discontinuously higher in the intersection areas and continuouslylower between the intersection areas.

]57[

Page 478: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 478

__________

171585]21][11[

ืžื›ืฉื™ืจ ืœื—ื™ืชื•ืš ื—ื•ืžืจ ื‘ืืžืฆืขื™ื ืฉืœ ืงืจืŸ ืœื™ื™ื–ืจ

DEVICE FOR CUTTINGMATERIAL BY MEANS OF ALASER BEAM

]54[

27.10.2005]22[EP]33[04.03.2005]32[05075533.9]31[

Int. Cl.(2009.01) B23K 26//38, B28D 01//22]51[BETTONVILLE INTEGRATEDSOLUTIONS, NAAMLOZEVENNOOTSCHAP, BELGIUM

]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Device for cutting material by means of a laser beam, which device (1) comprises alaser source (2) for generating a laser beam (3) with an optical axis (10) and a focusinglens (8) for focusing said beam, characterized in that, between said laser source andsaid focusing lens are provided a first and a second retardation plate (4, 5) and arefraction element in between them, which is provided rotatable and tiltable withrespect to said optical axis of the incoming light beam.

]57[

__________

Page 479: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009479

171598]21][11[

ืฉื™ื˜ื” ื•ืžืชืงืŸ ืœื”ืงืžืช ืงืฉืจ ืžื”ืจ ื‘ืžืขืจื›ืช ื—ื•ื˜ื™ืชโ€“ืืœ

WIDEBAND CONSTANT-GAINVOLTAGE AMPLIFIER

]54[

10.05.2004]22[US]33[09.05.2003]32[10/434675]31[

Int. Cl.(2008.04) H03F 3/45]51[QUALCOMM INCORPORATED,U.S.A.

]71[

WO/2004/102789]87[ื˜ืกื  ',ืงื•ืœื‘ ื•ืฉื•ืช. ืคื•ืจื“

, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

A wideband, constant-gain voltage amplifier. An input transistor has atransconductance that is a function of temperature and fabrication process. Atransimpedance amplifier is connected to the input transistor. The transimpedanceamplifier has a transimpedance that is a function of temperature and process that issubstantially the inverse of the function of temperature and fabrication process of thetransconductance of the input transistor.

]57[

__________

171860]21][11[

FOOD ืืจื™ื–ืช ืžื–ื•ืŸ PACKAGING]54[

18.06.2004]22[GB]33[18.06.2003]32[0314189.2]31[

Int. Cl.(2009.01) B32B 27//32]51[TOMMEN GRAM HOLDING AS,NORWAYBOREALIS AG, AUSTRIA

]71[

WO/2004/113072]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

Page 480: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 480

The use of a polyolefin film comprising a polypropylene polymer and apolyethylene polymer for the packaging of fresh produce.

]57[

__________

171947]21][11[

ืชื•ืชื‘ืช ืœื™ืจืš ื”ืžืกื•ืคืงืช ืขื ืžื•ื˜ ื”ืžื•ื—ื“ืจ ืœืชื•ืš ืขืฆื ื”ื™ืจืš

HIP PROSTHESIS PROVIDEDWITH A SHAFT INSERTED INTOTHE FEMUR

]54[

16.06.2004]22[EP]33[16.07.2003]32[03016157.4]31[

Int. Cl.(2008.04) A61F 2/36]51[WALDEMAR LINK GMBH & CO.KG, GERMANY

]71[

WO/2005/007039]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The invention relates to a hip prosthesis provided with a shaft (1) which can be insertedinto a hole in the femur without using cement. The proximal section of the shaft is madeup of a base body and the form thereof corresponds to the complementary form of thehole which is to be formed in the bone by means of a corresponding tool. A cuneus rib(12) is raised on the dorsal or ventral side of the base body and the width in the centrethereof is at least three times greater than the height thereof. The rear surface thereof(13) has rough and abrasive properties.

]57[

__________

Page 481: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009481

171955]21][11[

ืฉื™ืœื•ื‘ ืฉืœ ืžื—ืœืง ื•ืžื™ื›ืœ ืขื‘ื•ืจ ืฉืชื™ื” ืžื•ื’ื–ืช

COMBINATION OF A DISPENSERAND CONTAINER FORCARBONATED DRINK

]54[

14.05.2004]22[NL]33[14.05.2003]32[1023429]31[

Int. Cl.(2008.04) B67D 1/04, 1/08]51[HEINEKEN TECHNICAL SERVICESB.V., THE NETHERLANDS

]71[

ENGBERT HERMANNES PAKKERT,QUINTIJN INNIKEL

]72[

WO/2004/101424]87[,ืž"ื‘ืข) 1995(ืืจืœื™ืš.ืื™.ื™'ื’

ืจื—ื•ื‘ ืžื ื—ื ื‘ื’ื™ืŸ,15ืงื•ืžื”, ืžื’ื“ืœ ืื™ืœื•ืŸื’ืŸ, 11 ืจืžืช

G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,

11 MENACHEM BEGIN ST.,RAMAT GAN 52521

]74[

Combination of a dispenser (1) and container (7) for carbonated drink, the containerbeing provided at the top with an outflow channel (10), extending in the directio of thecentral axis of the container, and a dispensing valve (11), closed under spring tension,for dispensing carbonated drink via a dispensing line (12, 13) connected to the outflowchannel (10), the dispenser (1) being provided with a chill chamber (4) foraccommodating the container (7) and with a dispensing head (15) with a handle (17)whereby the handle (17) is connected to an operating member (18, 20) that, duringuse, engages on the dispensing valve (11).

]57[

__________

Page 482: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 482

172437]21][11[

ื˜ื” ืœื™ืฆื•ืจ ืžืกื™ืœื” ืžืกื™ืœื” ืขื ืฆื“ื•ื“ื™ืช ื•ืฉื™ ืขื ืฆื“ื•ื“ื™ืช

PROFILED RAIL AND METHODFOR PRODUCING A PROFILEDRAIL

]54[

28.05.2004]22[DE]33[11.06.2003]32[10326333.0]31[

Int. Cl.(2009.01) E04B 09//06]51[PROTEKTORWERK FLORENZMAISCH GMBH & CO. KG,GERMANY

]71[

WO/2004/109030]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The invention relates to a profiled rail for supporting plate-shaped elements, particularlyfor inlay mounting of ceiling plates for louvered ceilings. The profiled rail comprises abase body, which is provided, at least in areas with a T-profile and which has alongitudinally extended web as well as a lower flange. The lower flange is placed alonga longitudinal edge of the web and comprises two lower flange sections each extendingfrom the web essentially in opposite directions. The lower flange is formed by bendingthe web, and the side of the lower flange, which is oriented away from the web, isprovided with a facing board. A multitude of openings are provided in the web, wherebyat least one of the lower flange sections is formed by material sections of the web thatare folded out from the openings, and the web is provided as a single layer essentiallyover its entire surface. The invention also relates to a method for producing a profiledrail of this type.

]57[

__________

Page 483: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009483

172670]21][11[

ืžืชืงืŸ ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื–ื™ื”ื•ื™ ืคืจื™ื˜ ื‘ืื•ืคืŸ ืžืคื•ืจืฉ

APPARATUS, METHOD ANDSYSTEM FOR POSITIVELYIDENTIFYING AN ITEM

]54[

24.06.2004]22[US]33[26.06.2003]32[10/608872]31[

Int. Cl.(2009.01) G01G 19//414, G06K 07//10, G07G 01//00]51[IBM CORPORATION, U.S.A.]71[WO/2005/001783]87[

,ืžืขื‘ื“ื•ืช ื™ื‘ืž ืžื—ืœืงืช ืงื ื™ืŸ ืจื•ื—ื ื™ ื—ื™ืคื”, ืื•ื ื™ื‘ืจืกื™ื˜ืช ื—ื™ืคื” ื”ืจ ื”ื›ืจืžืœ

IBM LABORATORIES,HAIFA UNIVERSITY,

HAIFA 31905

]74[

checkout station, for positively identifying items includes a reader that reads codedan item. The system further includes a capture module, such as a camera. The capture

sual characteristic of the item to be identified, such as the color, size, shape, or texture ofcharacteristic of the item is compared with visual characteristics of candidate items storedmultiple items within the database are associated with the item to be identified, theate items may be displayed to a user. The user may then select the candidate item thattem to be identified. The coded information of the item being identified is then compared

on of the selected item within the database. If the coded information of both itemsm is positively identified and is accepted for purchase by a consumer.

]57[

__________

172839]21][11[

ืขืฆื•ื‘ ืชืจื—ื™ืฃ ืžื™ืžื™ ืฉืœ ืงื•ื˜ืœ ื—ื™ื™ื“ืงื™ื ืœื™ื™ืฉื•ื ืขื ืขืœื™ื

AQUEOUS SUSPENSIONFORMULATION OF ABACTERICIDE FOR FOLIARAPPLICATION

]54[

07.07.2004]22[JP]33[18.07.2003]32[2003-199289]31[

Int. Cl.(2009.01) A01N 25//04, 43//56, 65//00]51[MITSUI CHEMICALS, INC., JAPAN]71[WO/2005/006863]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Page 484: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 484

It is intended to provide an aqueous suspension preparation of (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide showing stable residual effectiveness whilelittle affected by rainfall. An aqueous suspension preparation for foliageapplication, which is characterized by containing a bactericidalcomponent (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide together with apolyoxyalkyelne rosin acid ester or liquid paraffin, shows an improvedrain resistance on foliage and excellent residual effectiveness.

]57[

__________

173158]21][11[

ืคื•ืœื™ืคืคื˜ื™ื“ื™ื ื‘ืขืœื™ ืคืขื™ืœื•ืช ืฆื™ื˜ื•ื–ื™ืŸ ื“ืืžื™ื ืื– ืžืฉื•ืคืจืช

POLYPEPTIDE HAVING ANIMPROVED CYTOSINEDEAMINASE ACTIVITY

]54[

29.06.2004]22[EP]33[21.07.2003]32[03360087.5]31[US06.10.2003 60/508274

Int. Cl.(2009.01) A61K 38//43, C07K 14//195, C12N 15//62]51[TRANSGENE S.A., FRANCE]71[WO/2005/007857]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The present invention relates to a polypeptide possessing a CDase activity,characterized in that it is derived from a native CDase by addition of an amino acidsequence with the proviso that said polypeptide has no UPRtase or Thymidine Kinaseactivity.

]57[

ื” ื–ื• ื‘ืงืฉื•ืช ื—ืœื•ืงื” ืžื‘ืงืฉ.ืฉื˜ืจ๏ฟฝ ืคื•ืจืกืžื•

198433,The applications for divisionfrom this application havenot yet been published

__________

Page 485: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009485

173505]21][11[

MACHINING ื”ืชืงืŸ ืขื™ื‘ื•ื“ ืžื›ื ื™ APPARATUS]54[

02.02.2006]22[JP]33[04.02.2005]32[2005-28893]31[

Int. Cl.(2009.01) B24B 23//00, 27//08]51[DISCO CORPORATION, JAPAN]71[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

A machining apparatus, comprising: a mounting member (6) to be rotationally driven; atool support member (28) mounted on the mounting member; and a fixing member(30), fixed to the mounting member, for fixing the tool support member to the mountingmember, the mounting member having a mounting outer peripheral surface (24) of agenerally cylindrical shape, a cylindrical mounting hole (32) as a through-hole beingformed in the tool support member, and the tool support member being mounted on themounting member by fitting the mounting hole of the tool support member onto themounting outer peripheral surface of the mounting member, and wherein the mountingouter peripheral surface of the mounting member has a guide region, a support region,and a relief region arranged sequentially in a central axial direction, the support regionis of a cylindrical shape having an outer diameter D1, an outer diameter D2 of the guideregion increases up to D1 toward the support region, an outer diameter D3 of the reliefregion decreases from D1 with increasing distance from the support region, themounting hole of the tool support member has an inner diameter D4, D4 is larger thanD1 (D4>D1), a length in the central axial direction of the support region of the mountingouter peripheral surface is Wl, andWl is โˆš D42-Dl2 or smaller (Wl โ‰ค โˆš D42-D12).

]57[

__________

Page 486: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 486

173681]21][11[

ื’ืœ OSCILLATOR ืฉื˜ื— ืืงื•ืกื˜ื™โ€“ืžืชื ื“ ื‘ืขืœ ืžื”ื•ื“ WITH ACOUSTICSURFACE WAVE RESONATOR

]54[

24.08.2004]22[DE]33[25.08.2003]32[10339865.1]31[DE04.06.2004 102004028421.0

Int. Cl.(2008.04) H03B 5/32]51[TELE FILTER GMBH, GERMANY]71[WO/2005/041403]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

The invention relates to an oscillator or a sensor comprising a unit consisting of twofrequency determining elements each of which comprises at least one interdigitalconverter (24, 34) for acoustic surface waves and a back-coupling circuit comprising anamplifier, wherein the frequency determining elements (2, 3) are distinguished by atemperature dependence of a synchronous frequency. Said invention is characterisedin that a) the frequency determining elements are embodied in the form of acousticsurface wave resonators, b) the temperature coefficients of n-th order of thesynchronous frequency of the two acoustic surface wave resonators have differentsings if they are not equal to zero and the temperature coefficients of (n+1st) order ofthe synchronous frequency of the two acoustic surface wave resonators have the samesign and the temperature coefficients from the first order to (n-1st) order of thesynchronous frequency of the two acoustic surface wave resonators are equal to zero ifn is greater than 1, wherein n being equal to or greater than 1, c) the ratio between theconverter openings and the ratio between the lengths in the direction perpendicular tothe edge teeth of the converter and to strips of the object reflectors having differentfrequency determining elements which are assembled in one unit are selected in sucha way that the oscillator frequency variation is minimum within the range of giventemperatures.

]57[

__________

Page 487: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009487

175109]21][11[

BEAK ื˜ื™ืคื•ืœ ื‘ืžืงื•ืจ ืขื ื”ื’ื ื” ืœืœืฉื•ืŸ TREATMENT WITHTONGUE PROTECTION

]54[

04.11.2004]22[US]33[06.11.2003]32[10/702369]31[

Int. Cl.(2009.01) A01K 45//00]51[NOVA-TECH ENGINEERING, INC.,U.S.A.

]71[

WO/2005/046323]87[,ืคืจืœ ื›ื”ืŸ ืฆื“ืง ืœืฆืจ

, 12704.ื“.ืช,5ืฉื ืงืจ'ืจื—,1ื™ื-ืžืจื›ื– ื’ื‘ ื”ืจืฆืœื™ื”

PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,

P.O.B. 12704,HERZLIYA 46733

]74[

The present invention provides apparatus and methods for treating the beaks of poultryto prevent further growth by non-contact heating while protecting the birds' tongues.The birds' tongues are protected by providing pressure on underside of the lower beakof the bird, proximate the base of the lower beak.

]57[

__________

175191]21][11[

ืžื•ืฆืจ ืชื•ื›ื ื” ืขื‘ื•ืจ ื”ื“ืžื™ื” ืงืจื“ื™ืืœื™ืชืžื™ืžื“ื™ืช ื”ืžืฉืชืžืฉืชโ€“ืชืœืช

ื‘ืจืงื•ื ืกื˜ืจื•ืงืฆื™ืช ืžืชืืจ ืื•ืœื˜ืจืกื•ื ื™ืช

SOFTWARE PRODUCT FORTHREE-DIMENSIONAL CARDIACIMAGING USING ULTRASOUNDCONTOUR RECONSTRUCTION

]54[

25.04.2006]22[US]33[26.04.2005]32[11/114800]31[

Int. Cl.(2009.01) A61B 08//00, G06T 17//40]51[BIOSENSE WEBSTER, INC., U.S.A.]71[

',ืจ ืฉืœืžื” ื›ื”ืŸ ื•ืฉื•ืช"ื“ ืชืœ ืื‘ื™ื‘, 11490.ื“.ืช, 124ืื‘ืŸ ื’ื‘ื™ืจื•ืœ

DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,

P.O.B. 11490,TEL AVIV 62038

]74[

A computer software product for modeling of an anatomical structure, the productcomprising a computer-readable medium, in which program instructions are stored,which instructions, when read by the computer, cause the computer to acquire aplurality of ultrasonic images of the anatomical structure using an ultrasonic sensor, ata respective plurality of spatial positions of the ultrasonic sensor, to measure location

]57[

Page 488: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 488

and orientation coordinates of the ultrasonic sensor at each of the plurality of spatialpositions, to receive a manual input marking contours-of-interest that refer to featuresof the anatomical structure in one or more of the ultrasonic images and to construct a3-D model of the anatomical structure based on the contours-of-interest and on themeasured location and orientation coordinates.

__________

175454]21][11[

ืžืขืจื›ืช ืœืืคืงื˜ ื˜ื™ื”ื•ืจ ืžืฉื•ืคืจ ื‘ืชืขืœืช ื’ื–ื™ื

SYSTEM FOR ENHANCED PURGEEFFECT IN GAS CONDUIT

]54[

04.05.2006]22[US]33[13.05.2005]32[11/128515]31[

Int. Cl.(2009.01) B08B 09//027, F17C 13//04, G05D 07//00]51[AIR PRODUCTS AND CHEMICALS,INC., U.S.A.

]71[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

A system for transferring gas from a gas supply vessel (2) to a delivery point of usewhich comprises: a vessel containing a gas source; a pigtail conduit (8) having an initialend and a terminal end adapted for delivery of gas to a point of use; a surge chamber(22) having a first end, a body section and a second end, said first end incommunication with the initial end of said pigtail conduit, said body section of saidsurge chamber having a cross-section larger than the cross-section of said pigtailconduit and a second end in communication with said vessel containing said gassource; a purge gas source for delivery of a purge gas in the direction from the terminalend toward the vessel containing a gas source within said pigtail conduit during analternating cycle of pressurization of said pigtail conduit with said purge gas; and adepressurization source within said pigtail conduit allowing for removal of impuritygases retained within said pigtail conduit.

]57[

__________

Page 489: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009489

175846]21][11[

, ืคื•ืœ ื‘ื“ืœืงืช ืขื•ืจ ืื˜ื•ืคื™ืชืชื›ืฉื™ืจื™ื ืœื˜ื™ ืชื ืื™ื ืœืืœืจื’ื™ื” ื‘ืขื•ืจ ื•ืคืฆืขื™ ื‘ื’ืจื•ืช

COMPOSITIONS FOR THETREATMENT OF ATOPICDERMATITIS, SKIN ALLERGICCONDITIONS AND ACNE

]54[

08.11.2004]22[IT]33[24.11.2003]32[MI2003A002286]31[

Int. Cl.(2009.01) A61K 35//00, 36//00, A61P 17//00]51[INDENA S.P.A., ITALY]71[WO/2005/053720]87[

,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื• ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœ

REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The present invention relates to topical compositions containing: a) Ginkgo bilobaterpenes; b) floroglucinols pure or in mixture thereof, extracted from Humulus lupulus,Hypericum sp and Mirtus sp; c) Zanthoxylum bungeanum or Echinacea angustifolialipophilic extract; for the treatment of atopic dermatitis, skin allergic conditions andacne.

]57[

__________

176518]21][11[

BALLISTIC-RESISTANT ืขืฆื ืขืžื™ื“ ื‘ืœื™ืกื˜ื™ืชARTICLE

]54[

01.01.2004]22[Int. Cl.(2008.04) F41H 5/04]51[DSM IP ASSETS B.V., THENETHERLANDS

]71[

WO/2005/066577]87[,ืœื•ืฆืื˜ื• ืืช ืœื•ืฆืื˜ื•

ื‘ืืจ ืฉื‘ืข, 5352.ื“.ืช, ืขื•ืžืจ,ื’ืŸ ืชืขืฉื™ื™ื”LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,

P.O.B. 5352,BEER-SHEVA 84152

]74[

The invention relates to a preformed sheet comprising at least two mono-layers, eachmono-layer containing unidirectionally oriented fibers having a tensile strength of atleast about 1.2 GPa and a tensile modulus of at least 40 GPa, and a binder, with a fibredirection in each mono-layer being rotated with respect to the fibre direction in anadjacent mono-layer, and a separating film on both outer surfaces, characterized in thatthe separating film has a porosity of between 40 and 90 %. With this preformed sheetassemblies and articles offering a substantially higher ballistic protection level at acertain weight can be obtained. The invention further relates to an assembly of at leasttwo such sheets and to a flexible ballistic-resistant article comprising said assembly.

]57[

Page 490: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 490

__________

176731]21][11[

ืฉื™ื˜ื” ืœื™ืฆื•ืจ ืงื• ืชืื™ื ืกื•ื‘ืœื ื™ ืœืฉื›ืคื•ืœHCVื•ืงื• ืชืื™ื ื”ืžื™ื•ืฆืจ ื‘ืฉื™ื˜ื” ื–ื•

METHOD FOR PRODUCING ACELL LINE PERMISSIVE FORHCV REPLICATION AND A CELLLINE PRODUCED BY SAIDMETHOD

]54[

23.05.2001]22[US]33[23.05.2000]32[09/576989]31[

Int. Cl.(2008.04) A61K 39/29, C12Q 1/70]51[DIVISION FROM 152671]62[WASHINGTON UNIVERSITY,U.S.A.

]71[

WO/2001/089364]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfectionefficiency and ability to survive subpassage greater than HCV that have wild-typepolyprotein coding regions. Expression vectors comprising the above polynucleotidesand HCV variants are also described, as are the provision of cells and host cellscomprising the expression vectors. Methods for identifying a cell line that is permissivefor infection with HCV are also provided, as are vaccines comprising the abovepolynucleotides in a pharmaceutically acceptable carrier. Additionally, methods forinducing immunoprotection to HCV in a primate are described, as are methods fortesting a compound for inhibiting HCV replication.

]57[

__________

Page 491: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009491

179865]21][11[

โ€“4โ€“ืžืชื™ืœ3โ€“[4โ€“[[5โ€“ืชื›ืฉื™ืจ ืจื•ืงื—ื•ืช ื”ืžื›ื™ืœโ€“2โ€“ื“ืจื• ื“ื™ื”ื™โ€“4,3, ืื•ืงืกื•

โ€“ืคื ื™ืœ]ืžืชื•ืงืกื™]ืงื™ื ื–ื•ืœื™ื ื™ืœื“ื™ืื•ืŸ ื‘ืฆื•ืจื”โ€“4,2โ€“ืชื™ืื“ื™ืื–ื•ืœื™ื“ื™ืŸ]ืžืชื™ืœ ืื‘ืงื” ืื• ื›ืžื•ืกื” ื•ืชื”ืœื™ืš ืœื”ื›ื ืชื•, ื˜ื‘ืœื™ืช

PHARMACEUTICALCOMPOSITION COMPRISING 5 -[[4-[3 - METHYL- 4- OXO - 3,4 -DIHYDRO - 2 -QUINAZOLINYL]METHOXY]PHENYL-METHYL]THIADIAZOLIDINE-2,4-DIONE IN THE FORM OF ATABLET, A POWDER OR ACAPSULE AND PROCESS FORITS PREPARATION

]54[

29.11.1999]22[DK]33[01.12.1998]32[PA19980158]31[

Int. Cl.(2008.04) A61K 314/25, A61P 3/10, C07D 417/00, 417/06]51[DIVISION FROM 143299]62[DR. REDDY'S LABORATORIESLIMITED, INDIADR. REDDY'S LABORATORIES,INC., U.S.A.

]71[

WO/2000/032191]87[,ืจื™ื™ื ื”ื•ืœื“ ื›ื”ืŸ ื•ืฉื•ืชืคื™ื•

ืจืžืช ื”ื—ื™ื™ืœ',ื26ืจื—ื•ื‘ ื”ื‘ืจื–ืœREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,

RAMAT HACHAYAL 69710

]74[

The present invention provides a new stable pharmaceutical composition containing 5-[[4-[ 3-Methyl-4- oxo-3,4- dihydro-2- quinazolinyl] methoxy]phenyl -methyl]thiadiazolidine -2,4-dione as active ingredient.

]57[

__________

Page 492: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 492

180304]21][11[

ื”ืชื•ื™ืช ืคื’ืžื™ ืžืกื” ืขื‘ื•ืจ ืงื‘ื™ืขืช ืจืฆืคื™ ื•ืœื™ื’ื•ืžืจื™ืื

MASS DEFECT LABELING FORTHE DETERMINATION OFOLIGOMER SEQUENCES

]54[

19.10.2001]22[US]33[19.10.2000]32[60/242165]31[US19.10.2000 60/242398

Int. Cl.(2009.01) G01J 03//00, G01N 21//00, 27//62, 33//483]51[DIVISION FROM 155518]62[TARGET DISCOVERY, INC., U.S.A.]71[WO/2002/066952]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Mass tagging methods are provided that lead to mass spectrometer detectionsensitivities and molecular discriminations that are improved over other methods. Inparticular the methods are useful for discriminating tagged molecules and fragments ofmolecules from chemical noise in the mass spectrum. These mass tagging methodsare useful for oligomer sequencing, determining the relative abundances of moleculesfrom different samples, and identifying individual molecules or chemical processingsteps in combinatorial chemical libraries. The methods provided are useful for thesimultaneous analysis of multiple molecules and reaction mixtures by massspectrometric methods.

]57[

__________

184004]21][11[

ื”ืชืงืŸ ืœืžื“ื™ื“ืช ื•ื›ื™ื•ื•ื ื•ืŸ ืคืจืžื˜ืจื™ื ืจื›ื‘โ€“ื’ื™ืื•ืžื˜ืจื™ื™ื ืฉืœ ืชื•ืฉื‘ืช ื›ืœื™

APPARATUS FOR MEASURINGAND ADJUSTING CHASSISGEOMETRY OF A MOTORVEHICLE

]54[

18.06.2007]22[Int. Cl.(2009.01) G01M 17//06]51[

MYKHAYLO ื—ื™ืคื”, ืžื™ื›ืืœื• ืœื•ืงืฉื™ืŸ LOKSHYN]71[,ืฉื™ืžืขื•ืŸ ื’ื•ื–ืžืŸ

ื—ื™ืคื”, 13/3ืื”ื‘ื”' ืจื—SHIMON GOYZMAN,13/3 AHAVA ST.,

HAIFA 35418

]74[

Page 493: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009493

An apparatus for measuring and adjusting chassis geometry of a motor vehicle,comprising a pair of optically matched tools (1, 2), one of which includes device (7) witha laser emitter (20) and other tool (2) โ€“ device (8) with a plane target (22) deflecting alaser beam, each tool having a mounting support (3) adapted to mount the tool on aninternal side of a circular element of a wheel and an X-direction orienting level (6) whichperpendicular to the laser beam and parallel to the plane target, wherein the devicesand the mounting supports are pivotally connected to each other through a pivot pin (9,10) disposed parallel to abscissa axis of the X-direction orienting level, wherein themounting supports are designed as a bracket having faces formed mostly by a pair ofright dihedral angles (internal and external), said bracket having edges parallel to theabscissa axis of the X-direction orienting level; wherein the internal bracket faces (B, C)are equipped with a fixing means (4, 5) intended for holding the bracket on the internalside of the circular element of the wheel, and a first external bracket face (D) comprisesthe rigidly fixed X-direction orienting level, and a second external bracket face (E) bearssaid device as well as a Y-direction orienting level (17) (18) disposed mainlyperpendicular to the abscissa axis of the X-direction orienting level on the plane parallelto the said abscissa axis.

]57[

ืœืชืงื ื•ืช35ืคื™ืจื•ื˜ ื–ื” ื ื‘ื—ืŸ ื‘ื”ืชืื ืœืชืงื ื” 1968โ€“ื—"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968

__________

Page 494: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 494

187551]21][11[

ืชื›ืฉื™ืจื™, ืชืจื›ื•ื‘ื•ืช ืื ื˜ื™ืžื™ืงืจื•ื‘ื™ื•ืชืจื•ืงื—ื•ืช ื”ืžื›ื™ืœื™ื ืื•ืชืŸ ื•ืชื”ืœื™ื›ื™ื

ืœื”ื›ื ืชืŸ

ANTIMICROBIALCAPURAMYCIN DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME

]54[

09.07.1999]22[JP]33[09.07.1998]32[10-194285]31[JP24.09.1998 10-269445

Int. Cl.(2008.04) A61K 31/70, A61P 31/04, C07H 190/67, C12P 19/38, C12R 15/45]51[DIVISION FROM 140731]62[SEQUELLA, INC., U.S.A.]71[WO/2000/002892]87[

,ื‘ืจื’ืžืŸ ื•ื’ื•ืœืจ, ื•ื•ืœืฃ ื™ืจื•ืฉืœื™ื, 1352.ื“.ืช,

WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,

JERUSALEM 91013

]74[

Pharmacologically acceptable esters, ethers and carbamoyl N-alkylates derived fromcompounds represented by general formula (Ia), and pharmacologically acceptablesalts of the same, which exhibit an excellent antibacterial activity and are useful in thetreatment or prevention of infectious diseases, wherein R?1ยฟ is hydrogen or methyl;R?2ยฟยฟa? is hydrogen, a hydroxyl-protecting group or methyl; R?3ยฟ is hydrogen or ahydroxyl-protecting group; R?4ยฟยฟa? is hydrogen or optionally protected hydroxyl; R?5ยฟis hydrogen or a hydroxyl-protecting group; and X is methylene or sulfur.

]57[

__________

Page 495: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009495

188086]21][11[

ืฉื™ื˜ื•ืช ื•ืฆื™ื•ื“ ืœืขืฉื•ืช ื—ืœืงื™ืงื™ื ื‘ืฉื™ืžื•ืฉื‘ืžื™ื™ื‘ืฉ ื‘ืชืจืกื™ืก ื•ื‘ืžื˜ื—ื ืช ืกื™ืœื•ืŸ ื‘ืชื•ืš

ื”ืงื•

METHOD AND APPARATUS FORMAKING PARTICLES USINGSPRAY DRYER AND IN-LINE JETMILL

]54[

20.11.2003]22[US]33[19.12.2002]32[10/324943]31[

Int. Cl.(2008.04) A61K 9/16, B01D 1/18, B01J 2/04]51[DIVISION FROM 168746]62[ACUSPHERE, INC., U.S.A.]71[WO/2004/060547]87[

ื˜ ',ืงื•ืœื‘ ื•ืฉื•ืช. ืกื ืคื•ืจื“, 2273.ื“.ืช, ืžืจืžื•ืจืง,4ืฉืขืจ ื”ื’ื™ื

ืจื—ื•ื‘ื•ืช

SANFORD T.COLB & CO.,P.O.B. 2273,

REHOVOT 76122

]74[

Methods and apparatus are provided for making particles comprising: (a) spraying anemulsion, solution, or suspension, which comprises a solvent and a bulk material (e.g.,a pharmaceutical agent), through an atomizer (14) and into a primary drying chamber(12), having a drying gas flowing therethrough, to form droplets comprising the solventand bulk material dispersed in the drying gas; (b) evaporating, in the primary dryingchamber (12), at least a portion of the solvent into the drying gas to solidify the dropletsand form particles dispersed in drying gas; and (c) flowing the particles and at least aportion of the drying gas through a jet mill (24) to deagglomerate or grind the particles.By coupling spray drying with 'in-line' jet milling, a single step process is created fromtwo separate unit operations, and an additional collection step is advantageouslyeliminated. The one-step, in-line process has further advantages in time and cost ofprocessing.

]57[

__________

Page 496: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 496

PATENTS ืคื˜ื ื˜ื™ื

ืคื˜ื ื˜ื™ื ืฉื ื™ืชื ื•PATENTS GRANTED

151733 133137 131282 130961 130766 130664 130349 115352 152390 152347 152118 152113 152077 151894 151757 151743 153339 153230 153137 152988 152800 152757 152432 152397 154187 154035 153876 153845 153793 153690 153648 153437 154600 154564 154543 154461 154418 154278 154275 154274 155380 155335 155334 155294 155206 154718 154645 154643 155970 155805 155794 155760 155732 155677 155515 155385 156650 156542 156304 156270 156251 156238 156231 156140 163537 163336 163311 163147 163097 162787 162503 162451 164575 164526 164418 164297 164213 163761 163703 163569 166077 166007 165794 165634 165202 165137 164881 164765 166991 166865 166808 166713 166547 166333 166251 166088 146780 126864 168849 168767 167956 167915 167610 167181 149856 149416 149132 148994 148896 148535 148469 148382 151382 151236 151213 150840 150575 150516 150080 150066 140834 140819 140593 138592 105855 169665 169558 169473 134842 133950 184402 142492 141933 141801 141481 141308 144975 144722 143691 143666 138212 138033 137845 135989 157186 157143 146555 146478 145927 145802 145168 145167 158352 158128 158125 158008 158002 157775 157635 157529 158797 158769 158724 158721 158656 158469 158389 158387 159611 159345 159217 159189 159155 159119 159080 158886 160311 160202 160167 160079 160039 159873 159861 159674 160832 160613 160523 160476 160400 160393 160360 160332 161565 161459 161304 161292 161249 161240 161177 160956

188445 162339 162253 162073

Page 497: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009497

ืคื˜ื ื˜ื™ื ืฉื—ื•ื“ืฉื•PATENTS RENEWED

98192 98161 98152 98137 98101 98077 98027 98014 98341 98273 98255 98254 98237 98217 98216 98204 98432 98431 98426 98408 98392 98386 98385 98365 98564 98515 98506 98463 98462 98456 98441 98438 98636 98614 98611 98604 98599 98598 98575 98572

113591 112141 111804 111254 110669 107309 107308 104253 113788 113786 113758 113756 113746 113682 113658 113595 113851 113832 113816 113812 113804 113803 113794 113789 113901 113898 113889 113879 113870 113865 113864 113852 113969 113966 113965 113957 113932 113930 113918 113908 114018 114015 114010 113994 113984 113983 113978 113970 114088 114082 114073 114050 114049 114039 114038 114037 114146 114131 114126 114123 114119 114118 114093 114091 114179 114176 114173 114171 114155 114153 114152 114151 114294 114274 114272 114246 114244 114238 114191 114190 114404 114399 114390 114387 114382 114375 114338 114337 126597 125881 125425 122359 122358 119396 115352 114690 129752 129738 129412 129379 128087 127723 127330 126598 130141 130039 130018 129953 129948 129947 129835 129827 130248 130224 130204 130191 130176 130171 130169 130151 130383 130371 130370 130368 130343 130332 130310 130262 130961 130513 130511 130477 130475 130462 130461 130405 134080 133950 133890 133841 133840 133519 132974 132601 135160 134842 134532 134496 134409 134305 134292 134229 138079 138033 137845 137743 137412 137004 136551 136290 138930 138876 138867 138776 138743 138684 138437 138129 139230 139201 139184 139133 139130 139109 139045 138931 139354 139353 139336 139283 139273 139240 139236 139231 139486 139472 139464 139430 139422 139396 139383 139355 139597 139592 139569 139546 139529 139528 139514 139509 139642 139640 139638 139612 139609 139607 139600 139598 139813 139786 139779 139775 139774 139773 139703 139653 139858 139852 139850 139847 139837 139831 139816 139814 139944 139940 139935 139929 139926 139921 139905 139861 139993 139991 139974 139964 139955 139952 139951 139946 140062 140061 140056 140032 140028 140004 140000 139996 140128 140109 140108 140089 140080 140078 140072 140068 140219 140218 140215 140199 140178 140155 140151 140149 140276 140273 140263 140260 140245 140238 140236 140234 140434 140431 140412 140391 140372 140353 140312 140277 140721 140720 140704 140649 140644 140619 140590 140564 141999 141982 141933 141606 141267 141105 140834 140819 144334 144188 144017 143666 143604 143232 142766 142699 146208 146029 145908 145904 145815 145518 145412 144675

Page 498: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 498

147355 146819 146780 146716 146555 146544 146478 146255 148685 148638 148595 148469 148345 148014 147651 147579 149856 149531 149509 149416 149317 149291 148896 148891 150840 150678 150677 150575 150351 150080 150066 149974 151733 151644 151630 151399 151397 151236 151065 151035 152262 152261 152260 152259 152120 152077 151894 151757 153015 152778 152767 152592 152455 152432 152390 152347 153876 153758 153699 153654 153285 153163 153128 153049 154302 154231 154205 154187 154134 154044 153984 153883 154666 154652 154643 154575 154568 154564 154480 154450 155380 155337 155335 155334 155099 154905 154896 154696 155881 155831 155805 155760 155677 155659 155513 155385 156143 156140 156123 156080 156048 155973 155934 155923 156314 156310 156304 156226 156221 156189 156188 156178 156633 156560 156554 156537 156497 156446 156395 156350 157070 157064 157049 157020 156990 156948 156661 156650 158405 158389 158211 158150 157775 157529 157275 157073 158940 158921 158905 158886 158720 158409 158408 158406 159861 159753 159593 159552 159375 159345 159080 159072 160332 160223 160167 160079 159970 159918 159893 159873 161789 161444 161396 161249 161149 161141 160523 160334 162901 162587 162548 162525 162451 162253 161987 161904 164025 163761 163747 163703 163568 163537 163262 163173 164854 164765 164418 164348 164297 164213 164132 164034 165373 165345 165306 165219 165137 165135 165130 164959 166229 165908 165859 165746 165603 165601 165464 165463 166908 166738 166713 166697 166547 166480 166333 166251 169789 169636 169022 168225 167915 167798 167610 167203 175604 174098 173202 171479 171062 171061 171060 171015

188445 188300 184891 184402 182995 182994 180048

Page 499: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009499

ืช ื—ื™ื“ื•ืฉืคื˜ื ื˜ื™ื ืฉืชื•ืงืคื ืคืงืขื• ื‘ื’ืœืœ ืื™ ืชืฉืœื•ื ืื’ืจPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL

FEES

110973 110971 110958 110954 110918 110915 110909 110897 111068 111066 111057 111050 111048 111045 111035 111025 111151 111128 111118 111114 111095 111087 111086 111084 111278 111268 111246 111238 111208 111194 111188 111173 111365 111355 111350 111334 111323 111319 111315 111279 129606 111446 111441 111419 111414 111409 111392 111377 132699 130592 130544 130305 130287 130229 130208 129791 126094 151624 151588 151477 150983 149218 148627 133251 126278 126252 126244 126218 126194 126172 126122 126103 126457 126448 126398 126373 126346 126284 126281 126279 126688 126639 126637 126592 126585 126549 126522 126466 126790 126776 126775 126773 126736 126706 126704 126694 163057 144481 144466 144139 142640 126816 126807 126805 165742 165741 165740 165739 164868 163567 163318 163159 95742 95739 95722 95720 95657 95598 166209 165743 95956 95949 95924 95871 95866 95832 95803 95764 96146 96112 96023 96021 96014 95986 95974 95972

134930 134927 134920 134871 134778 134777 134710 133851 135068 135066 135018 134986 134976 134957 134953 134937 135146 135145 135144 135143 135142 135109 135103 135094 135231 135228 135206 135204 135197 135196 135179 135174 135356 135354 135353 135330 135263 135237 135235 135233 135404 135400 135390 135380 135379 135370 135364 135360 135612 135609 135584 135583 135529 135503 135439 135426 135743 135733 135732 135668 135652 135648 135632 135631 136636 135856 135842 135841 135834 135833 135828 135782 153158 152571 152515 152465 151895 151821 151697 138251 123910 120073 156538 156424 155983 155512 153460 153386 160688 158649 157682 142209 141812 141810 141313 138566

177522 161567 161094

Page 500: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 500

ืคื˜ื ื˜ื™ื ืฉื—ื•ื“ืฉื• ืœืขืฉืจื™ื ืฉื ื”PATENTS RENEWED FOR 20 YEARS

113776

Page 501: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009501

ืฆื•ื•ื™ ื”ืืจื›ื” ืฉื—ื•ื“ืฉื•EXTENSION ORDERS RENEWED

88363 84601 84497

Page 502: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 502

NOTICEื”ื•ื“ืขื”ืœื—ื•ืง60ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

Under section 60 of thePatent Law, 5727-1967

ื—ื–ืจ ืชื•ืงืคื• ื”ื•ื’ืฉื” ื‘ืงืฉื” ืœื”, ืฉืœ ื”ืคื˜ื ื˜ ื”ืžืคื•ืจื˜ ืžื˜ื”ืฉืชื•ืงืคื• ืคืงืข ืžื—ืžืช ืื™

ืชืฉืœื•ื ืื’ืจื•ืช ื”ื—ื™ื“ื•ืฉ :ื”ืงื‘ื•ืขื•ืช

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 137745 ื”ืคื˜ื ื˜' ืžืก of PatentAcceptance 3/2005:'ืงื™ื‘ื•ืœ ืคื•ืจืกื ื‘ื™ื•ืžืŸ ืžืก published in

journal no::Proprietors:ืฉื ื‘ืขืœ ื”ืคื˜ื ื˜

MOTOROLA, INC.Title:ืฉื ื”ืืžืฆืื” of invention:

ื—ื•ื˜ื™ืช-ืฉื™ื˜ื” ื•ืžืขืจื›ืช ืœื”ืขืจื›ืช ืžื™ืงื•ื ืฉืœ ืžื ื•ื™ ื‘ืื–ื•ืจ ืฉื™ืจื•ืช ื‘ืจืฉืช ืชืงืฉื•ืจืช ืืœMETHOD AND SYSTEM FOR ESTIMATING A SUBSCRIBER'S LOCATION IN A

WIRELESSCOMMUNICATION SYSTEM SERVICE AREAื›ืœ ืื“ื ืจืฉืื™ ืœื”ืชื ื’ื“ืœื‘ืงืฉื” ื”ืืžื•ืจื” ืชื•ืš

ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชืืจื™ืš ื›ืคื™ ืฉื ืงื‘ืข, ื™ื•ืžืŸ ืคื˜ื ื˜ื™ื ื–ื”

92ืœื—ื•ืง ื•ื‘ืชืงื ื”61ื‘ืกืขื™ืฃ -ื—"ืชืฉื›, ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968

Page 503: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009503

NOTICEื”ื•ื“ืขื”ืœื—ื•ืง60ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

Under section 60 of thePatent Law, 5727-1967

ื”ื•ื’ืฉื” ื‘ืงืฉื” ืœื”ื—ื–ืจ ืชื•ืงืคื•, ืฉืœ ื”ืคื˜ื ื˜ ื”ืžืคื•ืจื˜ ืžื˜ื”ืฉืชื•ืงืคื• ืคืงืข ืžื—ืžืช ืื™

ืชืฉืœื•ื ืื’ืจื•ืช ื”ื—ื™ื“ื•ืฉ :ื”ืงื‘ื•ืขื•ืช

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 138303 ื”ืคื˜ื ื˜' ืžืก of PatentAcceptance 6/2005:'ืงื™ื‘ื•ืœ ืคื•ืจืกื ื‘ื™ื•ืžืŸ ืžืก published in

journal no::Proprietors:ืฉื ื‘ืขืœ ื”ืคื˜ื ื˜

TELEFONAKTIEBOLAGET LM ERICSSONTitle:ืฉื ื”ืืžืฆืื” of invention:

ืฉื™ื˜ื” ื•ื”ืชืงืŸ ืœื‘ืงืจื” ืขืœ ื–ืจื™ืžืช ืžื™ื“ืขMETHOD AND DEVICE FOR DATA FLOW CONTROL

ืื“ื ืจืฉืื™ ืœื”ืชื ื’ื“ ื›ืœืœื‘ืงืฉื” ื”ืืžื•ืจื” ืชื•ืš

ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชืืจื™ืš ื›ืคื™ ืฉื ืงื‘ืข, ื™ื•ืžืŸ ืคื˜ื ื˜ื™ื ื–ื”

92ืœื—ื•ืง ื•ื‘ืชืงื ื”61ื‘ืกืขื™ืฃ -ื—"ืชืฉื›, ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968

Page 504: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 504

NOTICEื”ื•ื“ืขื”ืœื—ื•ืง60ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

Under section 60 of thePatent Law, 5727-1967

ื”ื•ื’ืฉื” ื‘ืงืฉื” ืœื”ื—ื–ืจ ืชื•ืงืคื•, ืฉืœ ื”ืคื˜ื ื˜ ื”ืžืคื•ืจื˜ ืžื˜ื”ืฉืชื•ืงืคื• ืคืงืข ืžื—ืžืช ืื™

ืฉืœื•ื ืื’ืจื•ืช ื”ื—ื™ื“ื•ืฉืช:ื”ืงื‘ื•ืขื•ืช

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 138324 ื”ืคื˜ื ื˜' ืžืก of PatentAcceptance 5/2005:'ืงื™ื‘ื•ืœ ืคื•ืจืกื ื‘ื™ื•ืžืŸ ืžืก published in

journal no::Proprietors:ืฉื ื‘ืขืœ ื”ืคื˜ื ื˜

ERICSSON, INC.Title:ืฉื ื”ืืžืฆืื” of invention:

ืžืขืจื›ืช ื•ืฉื™ื˜ื” ืœื™ื“ืข ืจืฉืช ืขืœ ื™ื›ื•ืœื•ืช ืฉื™ื˜ืช ืžื™ืงื•ื ืžื‘ื•ืกืก ืžืกื•ืฃSYSTEM AND METHOD FOR INFORMING NETWORK OF TERMINAL BASED

POSITIONING METHOD CAPABILITIESืœ ื”ืชื ื’ื“ ื›ืœ ืื“ื ืจืฉืื™

ืœื‘ืงืฉื” ื”ืืžื•ืจื” ืชื•ืš ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชืืจื™ืš

ื›ืคื™ ืฉื ืงื‘ืข, ื™ื•ืžืŸ ืคื˜ื ื˜ื™ื ื–ื”92ืœื—ื•ืง ื•ื‘ืชืงื ื”61ื‘ืกืขื™ืฃ

-ื—"ืชืฉื›, ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968

Page 505: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009505

NOTICEื”ื•ื“ืขื”ืœื—ื•ืง60ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

Under section 60 of thePatent Law, 5727-1967

ื”ื•ื’ืฉื” ื‘ืงืฉื” ืœื”ื—ื–ืจ ืชื•ืงืคื•, ืฉืœ ื”ืคื˜ื ื˜ ื”ืžืคื•ืจื˜ ืžื˜ื”ืฉืชื•ืงืคื• ืคืงืข ืžื—ืžืช ืื™

ืชืฉืœื•ื ืื’ืจื•ืช ื”ื—ื™ื“ื•ืฉ :ืชื”ืงื‘ื•ืขื•

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 165945 ื”ืคื˜ื ื˜' ืžืก of PatentAcceptance 11/2005:'ืงื™ื‘ื•ืœ ืคื•ืจืกื ื‘ื™ื•ืžืŸ ืžืก published in

journal no::Proprietors:ืœ ื”ืคื˜ื ื˜ืฉื ื‘ืข

ืฉืœืžื” ื–ื™ืœื‘ืจืžืŸSHLOMO ZILBERMAN

Title:ืฉื ื”ืืžืฆืื” of invention: ืžืขืจื›ืช ืœื’ืœื™ืœืช ืกืคืจื™ ืชื•ืจื”

APPARATUS FOR ROLLING A SEFER TORAHื›ืœ ืื“ื ืจืฉืื™ ืœื”ืชื ื’ื“ืœื‘ืงืฉื” ื”ืืžื•ืจื” ืชื•ืš

ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชืืจื™ืš ื›ืคื™ ืฉื ืงื‘ืข, ื™ื•ืžืŸ ืคื˜ื ื˜ื™ื ื–ื”

92ืœื—ื•ืง ื•ื‘ืชืงื ื”61ื‘ืกืขื™ืฃ -ื—"ืชืฉื›, ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968

Page 506: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 506

NOTICEื”ื•ื“ืขื”ืœื—ื•ืง60 ืœืคื™ ืกืขื™ืฃ 1967-ื–"ืชืฉื›, ื”ืคื˜ื ื˜ื™ื

Under section 60 of thePatent Law, 5727-1967

ื”ื•ื’ืฉื” ื‘ืงืฉื” ืœื”ื—ื–ืจ ืชื•ืงืคื•, ืฉืœ ื”ืคื˜ื ื˜ ื”ืžืคื•ืจื˜ ืžื˜ื”ืฉืชื•ืงืคื• ืคืงืข ืžื—ืžืช ืื™

ืชืฉืœื•ื ืื’ืจื•ืช ื”ื—ื™ื“ื•ืฉ :ื”ืงื‘ื•ืขื•ืช

Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:

.No 169950 ื”ืคื˜ื ื˜' ืžืก of PatentAcceptance 3/2006:'ืงื™ื‘ื•ืœ ืคื•ืจืกื ื‘ื™ื•ืžืŸ ืžืก published in

journal no::Proprietors:ืฉื ื‘ืขืœ ื”ืคื˜ื ื˜

ืฉืžืขื•ืŸ ื–ื™ืœื‘ืจืžืŸSHLOMO ZILBERMAN

Title:ืฉื ื”ืืžืฆืื” of invention:ืจ ืชื•ืจื” ื‘ืขืœ ืžื™ืกื‘ื™ืืกืค

SEFER TORAH WITH BEARINGSื›ืœ ืื“ื ืจืฉืื™ ืœื”ืชื ื’ื“ืœื‘ืงืฉื” ื”ืืžื•ืจื” ืชื•ืš

ืฉืœื•ืฉื” ื—ื•ื“ืฉื™ื ืžืชืืจื™ืš ื›ืคื™ ืฉื ืงื‘ืข, ื™ื•ืžืŸ ืคื˜ื ื˜ื™ื ื–ื”

92ืœื—ื•ืง ื•ื‘ืชืงื ื”61ื‘ืกืขื™ืฃ -ื—"ืชืฉื›, ืœืชืงื ื•ืช ื”ืคื˜ื ื˜ื™ื

1968

Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968

Page 507: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009507

ืชื™ืงื•ืŸ ื˜ืขื•ืชCORRIGENDUM

11/2008ื™ื•ืžืŸ

P. 4868 Patent application No 166919 166919'ื‘ืงืฉืช ืคื˜ื ื˜ ืžืก4868'ืขCorrect divisional application to- ืœ 153028-ืชืงืŸ ื‘ืงืฉืช ื—ืœื•ืงื”

3/2009ื™ื•ืžืŸ

P. 394 Patent application No 168609 168609'ื‘ืงืฉืช ืคื˜ื ื˜ ืžืก394'ืขCorrect date of priority to- ืœ 23.11.2002-ืชืงืŸ ืชืืจื™ืš ื“ื™ืŸ ืงื“ื™ืžื”

Page 508: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 508

ืงื•ื“ื™ื ืœืžื“ื™ื ืช ื”ืžื•ืคื™ืขื™ื ื‘ื™ื•ืžืŸCOUNTRY CODES APPEARING IN THIS JOURNAL

Code Country or OrganizationAR ArgentinaAT AustriaAU AustraliaBA HerzegovinaBE BelgiumBR BrazilCA CanadaCH SwitzerlandCN ChinaCU CubaCZ Czech RepublicDE GermanyDK DenmarkEC EcuadorEP European Patent OfficeES SpainFI FinlandFR FranceGB United KingdomGE GeorgiaGR GreeceGT GuatemalaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV LatviaMX Mexico

MY Malaysia

Page 509: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009509

NL The NetherlandsNO NorwayNZ New ZealandPL PolandPT PortugalRU Russian FederationSE SwedenSG SingaporeSI SloveniaSK SlovakiaTH ThailandTR TurkeyTW TaiwanUA UkraineUS United States of AmericaUY UruguayUZ UzbekistanWO World Intellectual Property Organization (W.I.P.O.)ZA South Africa

Page 510: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 510

DESIGNS ืžื“ื’ืžื™ื ืžื“ื’ืžื™ื ืฉื ืจืฉืžื•

DESIGNS REGISTERED

44267, 44268, 44269, 44270Class 8(08) ืกื•ื’

3. 6.2007XI MODULAR DESIGN LTD. ืž"ืงืกืื™ ืขื™ืฆื•ื‘ ืžื•ื“ื•ืœืืจื™ ื‘ืขProfile ืคืจื•ืคื™ืœ

44371Class 13(03) ืกื•ื’

18. 6.2007NISKO ELECTRICITY & ELECTRONICSPRODUCTS (1982) LTD.

ื ื™ืกืงื• ืžื•ืฆืจื™ ื—ืฉืžืœ ื•ืืœืงื˜ืจื•ื ื™ืงื”ืž"ื‘ืข) 1982(

Socket ืฉืงืข

44512Class 11(02) ืกื•ื’

18. 7.2007MEYTAL ZEMACH ืžื™ื˜ืœ ืฆืžื—Cutlery decoration ืž"ืงื™ืฉื•ื˜ ืœืกื›ื•

44548Class 24(03) ืกื•ื’

23. 7.2007

GARY PIERRE LAURYSSENMammary prosthesis ืชื•ืชื‘ืช ืฉื“Convention date (South Africa) 24.1.2007 )ื“ืจื•ื ืืคืจื™ืงื”(ืชืืจื™ืš ื”ืืžื ื”

44820, 47471, 47495Class 11(01) ืกื•ื’

19. 9.2007

H. STERN COMERCIO E INDUSTRIAJewel ืชื›ืฉื™ื˜

Page 511: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009511

45231Class 25(01) ืกื•ื’

18. 12.2007

PRESS PLAST LTD. ืž"ืคืจืก ืคืœืกื˜ ื‘ืขProfile ืคืจื•ืคื™ืœ

45277Class 19(04) ืกื•ื’

30. 12.2007

GIL FRIEDMAN ื’ื™ืœ ืคืจื™ื“ืžืŸNotepad for hanging ืคื ืงืก ืœืชืœื™ื”

45384, 45385Class 12(16) ืกื•ื’

22. 1.2008HADAR ROSEN LTD. ืž"ื”ื“ืจ ืจื•ื–ืŸ ื‘ืขVehicle seat cover ื›ื™ืกื•ื™ ืžื•ืฉื‘ ืœืจื›ื‘

45455Class 24(04) ืกื•ื’

12. 3.2007

GLAXO GROUP LIMITEDInhaler ืžืฉืืฃConvention date (United Kingdom) 14.9.2006 ื”ืžืžืœื›ื”(ืชืืจื™ืš ื”ืืžื ื”

)ื”ืžืื•ื—ื“ืช

45489, 45490Class 8(08) ืกื•ื’

7. 2.2008OZ GUM LTD. ืž"ืขื•ื–ื’ื•ื ื‘ืขRack ืœื‘ืžืง

45656, 45657, 45658,45659, 45660, 45661,45662, 45663, 45664,

45665, 45666Class 26(05) ืกื•ื’

9. 3.2008MARIELA BEN-SHACH ืš"ืฉ-ืžืจื™ืืœื” ื‘ืŸWall lamp ื’ืฃ ืชืื•ืจื” ืœืงื™ืจ

Page 512: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 512

45682Class 3(02) ืกื•ื’

12. 3.2008WGI-WORLD GEMOLOGICALINSTITUTE

ืžืขื‘ื“ื” ื’ืžื•ืœื•ื’ื™ืช ื‘ื™ื ืœืื•ืžื™ืช. ืื™ื™.ื“ื™.ืื™ื™ืž"ื‘ืข

Document envelope ืขื˜ื™ืคื” ืœืชืขื•ื“ื•ืช

45784Class 10(05) ืกื•ื’

1. 4.2008WGI-WORLD GEMOLOGICALINSTITUTE

ืžืขื‘ื“ื” ื’ืžื•ืœื•ื’ื™ืช ื‘ื™ื ืœืื•ืžื™ืช. ืื™ื™.ื“ื™.ืื™ื™ืž"ื‘ืข

Loupe with internal lighting ืจื” ื–ื›ื•ื›ื™ืช ืžื’ื“ืœืช ืœืื‘ื ื™ ื—ืŸ ืขื ืชืื•ืคื ื™ืžื™ืช

45910, 45911, 45912Class 11(01) ืกื•ื’

1. 5.2008GERALDO LTD. ื‘ืข'ื’ ืž"ืจืืœื“ื•Precious stone ืื‘ืŸ ื—ืŸ

46006Class 8(08) ืกื•ื’

26. 5.2008BARKAN MOUNTS LTD. ืž"ื–ืจื•ืขื•ืช ื‘ืจืงืŸ ื‘ืขLCD and plasma bracket ื•ืคืœื–ืžื” LCD ื–ืจื•ืข ืœืžืกื›ื™

46146Class 6(01) ืกื•ื’

30. 6.2008GILI GLICKMAN ื’ื™ืœื™ ื’ืœื™ืงืžืŸBaby cradle ืขืจื™ืกื” ืœืชื™ื ื•ืง

46185, 46202Class 2 (02) ืกื•ื’

3. 7.2008

DIESEL S.P.A.Pants ืžื›ื ืกื™ื™ื

Page 513: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009513

46257Class 23(04) ืกื•ื’

13. 7.2008TWITOPLAST LTD. ืž"ื˜ื•ื•ื™ื˜ื•ืคืœืกื˜ ื‘ืขAir conditioning system duct ืชืขืœื” ืœืžืขืจื›ืช ืžื™ื–ื•ื’ ืื•ื•ื™ืจ

46360Class 12(16) ืกื•ื’

31. 7.2008SHLOMO SHMUL ืฉืœืžื” ืฉืžื•ืœCar cover ื›ื™ืกื•ื™ ืœืจื›ื‘

46581Class 15(08) ืกื•ื’

2. 9.2008

SOCIETE DES PRODUITS NESTLE S.A.Beverage dispenser ืื•ืชืžื›ื•ื ืช ืžืฉืงConvention date (Switzerland) 10.4.2008 )ืฉื•ื•ื™ืฅ(ืชืืจื™ืš ื”ืืžื ื”

46584, 46585, 46586,46589, 46592, 46593,46598, 46600, 46601,46605, 46606, 46608

Class 2(04) ืกื•ื’7. 9.2008

CAPLA LTD AND JHONY ELBAZ ื‘ืขืงืค ื•ื’"ืœื” ื•ื ื™ ื™ื•ื ื™ ื™ื•ื ืชืŸ ืืœื‘ื–'ืžFootwear ื ืขืœ

46680Class 25(01) ืกื•ื’

24. 9.2008EXTAL LTD. ืž"ืืงืกื˜ืœ ื‘ืขProfile ืคืจื•ืคื™ืœ

46686Class 2(07) ืกื•ื’

25. 9.2008YOSSEF YACOV COHEN ื™ื•ืกืฃ ื™ืขืงื‘ ื›ื”ืŸSuspenders ื›ืชืคื™ื•ืช

Page 514: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 514

46691Class 9(01) ืกื•ื’

25. 9.2008

MARTELL & CO.Bottle ื‘ืงื‘ื•ืงConvention date (OHIM) 18.7.2008 )ืื•ื”ื™ื™ื(ืชืืจื™ืš ื”ืืžื ื”

46822Class 9(01) ืกื•ื’

6. 11.2008AMRAZ LTD. ืž"ืืžืจื– ื‘ืขBottle ื‘ืงื‘ื•ืง

46848Class 25(01) ืกื•ื’

18. 11.2008AUREKA ALFA LTD. ืž"ืืื•ืจื™ืงื” ืืœืคื ื‘ืขProfile ืคืจื•ืคื™ืœ

46864, 46865, 46866,46867, 46868, 46871,46872, 46873, 46874,46875, 46876, 46877,

46878Class 25(01) ืกื•ื’

23. 11.2008EXTAL LTD. ืž"ืืงืกื˜ืœ ื‘ืขProfile ืคืจื•ืคื™ืœ

46962, 46963, 46964,46965, 46966, 46967,46968, 46969, 46970,46971, 46972, 46973,46974, 46975, 46976,46977, 46978, 46979,46980, 46981, 46982,

46983, 46984Class 2 (02) ืกื•ื’

11. 12.2008

DIESEL S.P.A.Pants ืžื›ื ืกื™ื™ื

Page 515: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009515

47018, 47019, 47020,47021

Class 12(16) ืกื•ื’23. 12.2008

HADAR ROSEN LTD. ืž"ื”ื“ืจ ืจื•ื–ืŸ ื‘ืขCar seat cover ื›ื™ืกื•ื™ ืœืžื•ืฉื‘ ืจื›ื‘

47025Class 13(03) ืกื•ื’

23. 12.2008

MEIDENSHA CORPORATIONCapacitor ืงื‘ืœConvention date (Japan) 23.6.2008 )ื™ืคืŸ(ืžื ื”ืชืืจื™ืš ื”ื

47045Class 2(07) ืกื•ื’

30. 12.2008HAGIM NEHALIM MARKETING LTD. ืž"ื—ื’ื™ื ื ื—ืœื™ื ืฉื™ื•ื•ืง ื‘ืขZipper ืจื•ื›ืกืŸ

47048, 47049, 47050Class 13(03) ืกื•ื’

31. 12.2008PHOTAX MOLDS LTD. ืž"ืคื•ื˜ืงืก ืชื‘ื ื™ื•ืช ื‘ืขDistribution box ืชื™ื‘ืช ื”ืกืชืขืคื•ืช

47099Class 7(02) ืกื•ื’

12. 1.2009

SANTOSElectric fruit squeezer ืžืกื—ื˜ืช ืคื™ืจื•ืช ื—ืฉืžืœื™ืชConvention date (OHIM) 17.7.2008 )ืื•ื”ื™ื™ื(ืชืืจื™ืš ื”ืืžื ื”

47101Class 6(09) ืกื•ื’

13. 1.2009NEZARIM MARKETING LTD. ืž"ื ืฆืจื™ื ืฉื™ื•ื•ืง ื‘ืขBeach mat ืžื–ืจื•ืŸ ืžื—ืฆืœืช

Page 516: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 516

47106Class 12(16) ืกื•ื’

13. 1.2009HADAR ROSEN LTD. ืž"ื”ื“ืจ ืจื•ื–ืŸ ื‘ืขCar seat cover ื›ื™ืกื•ื™ ืœืžื•ืฉื‘ ืจื›ื‘

47471, 47495Class 11(01) ืกื•ื’

19. 9.2007

H. STERN COMERCIO E INDUSTRIA S.A.Jewel ืชื›ืฉื™ื˜

Page 517: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009517

ืžื“ื’ืžื™ื ืฉื—ื•ื“ืฉื•DESIGNS RENEWED

31796 31795 31728 31608 31607 31606 31548 31479 31804 31803 31802 31801 31800 31799 31798 31797 31821 31820 31819 31818 31817 31807 31806 31805 38988 36197 33548 32129 32063 31976 31974 31973 39364 39241 39184 39183 39182 39181 39180 39011

40962

Page 518: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009 518

ืžื“ื’ืžื™ื ืฉื‘ื•ื˜ืœื•DESIGNS VOID

30696 30691 30646 30629 22669 2266822642 22577 38586 38582 38575 38574 38555 3073930738 30737

38628 38625 38620 3861938598 38587

Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks

ืจ ืžืื™ืจ ื ื•ืขื"ื“ื”ืžื“ื’ืžื™ื, ืจืฉื ื”ืคื˜ื ื˜ื™ื ื•ืกื™ืžื ื™ ืžืกื—ืจ

Page 519: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื˜ื‘ืช'ื– 24, 2009i

ืฉื™ื ื•ื™ื™ื ื‘ืคืจื˜ื™ื ืจืฉื•ืžื™ื ื‘ืคื ืงืกCHANGES IN PARTICULARS ENTERED IN REGISTER

ืžืคืชื—ื•ืช ืœื‘ืงืฉื•ืช ืฉืงื•ื‘ืœื•INDICES OF APPLICATIONS ACCEPTED

NAMEืžืคืชื— ืฉืžื™ INDEX

149325ื ื•ืŸ-ืื‘ืจื”ื ื‘ืŸื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ 157878ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื”ืจืฉื•ืช, ื’ื•ืจื™ื•ืŸ ื‘ื ื’ื‘-ืื•ื ื™ื‘ืจืกื™ื˜ืช ื‘ืŸ 164823ืœืžื—ืงืจ ื•ืคื™ืชื•ื—

137462ืื•ืจืŸ ืืœื•ืกืื•ืคื˜ื™ืงื”-ืืœื‘ื™ื˜ ืžืขืจื›ื•ืช ืืœืงื˜ืจื•

166354ืž"ืืœืื•ืค ื‘ืข

160580ื‘ื•ืจื™ืก ืคื•ื“ื•ืœืกืงื™ 168041ืž"ื‘ืจ ืขื™ื“ืŸ ื™ืฆื•ืจ ื•ืคื™ืชื•ื— ื‘ืข

157721ื“ื•ื“ ื•ืจื•ืŸืž"ื“ื™ืกืงื•ื˜ืง ื˜ื›ื ื•ืœื•ื’ื™ื•ืช ืจืคื•ืื™ื•ืช ื‘ืข

131197

ืž"ื”ื“ืกื™ืช ืฉืจื•ืชื™ ืžื—ืงืจ ืจืคื•ืื™ ื•ืคื™ืชื•ื— ื‘ืข156115

164944ื–ืœืžืŸ ืคืœืก

152372ื—ื™ื™ื ื—ื–ืŸ

, 149325ืž"ื™ื“ืข ื—ื‘ืจื” ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข156626 ,158228

ื™ื™ืฉื•ื ื—ื‘ืจื” ืœืคื™ืชื•ื— ื”ืžื—ืงืจ ืฉืœืž"ื”ืื•ื ื™ื‘ืจืกื™ื˜ื” ื”ืขื‘ืจื™ืช ื‘ื™ืจื•ืฉืœื™ื ื‘ืข

129966

160580ืœืื•ื ื™ื“ ื‘ืœื™ืื ืงืžืŸ

ืž"ืžื•ืกื“ ื”ื˜ื›ื ื™ื•ืŸ ืœืžื—ืงืจ ื•ืคื™ืชื•ื— ื‘ืข129966 ,159534

184004ืžื™ื›ืืœื• ืœื•ืงืฉื™ืŸ

156330ืž"ื ื•ื‘ื” ืžื›ืฉื™ืจื™ ืžื“ื™ื“ื” ื‘ืข

139674ืž"ืกืื ื“ื™ืกืง ืื™ื™ืืœ ื‘ืข 171104ืž"ืกื™ื™ื‘ืจื• ืžื“ื™ืงืœ ื‘ืข

167081ืž"ืกืจืงื•ื ื˜ ื‘ืข

158968 ืขืคืจ ื“ื’ืŸ

155545ืž"ืคื™ื™ื ื˜ืง ืžืขื‘ื“ื•ืช ื‘ืข 155545ืž"ืคื™ื™ื ื˜ืง ืคืืจืžืฆื‘ื˜ื™ืงื” ื‘ืข

161876ืงื•ื‘'ืคืจื“ ืกื˜ืจื™ื–

157117ืž"ืงื•ื ื˜ื™ืคื™ ื‘ืข

162824ืจืื•ื‘ืŸ ื‘ื•ืืจื•ืŸ 156999ืž"ืจื‘ ื‘ืจื™ื— ืžื•ืฆืจื™ ื‘ื˜ื—ื•ืŸ ื‘ืขื‘ืข-ืจืžื•ืช ืœื™ื“ ืื•ื ื™ื‘ืจืกื™ื˜ืช ืชืœ ืž"ืื‘ื™ื‘

157721 ื‘ืข"ืจืคื ืž"ืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช

167005 ื‘ืขืจืคื ืž"ืœ ืžืขืจื›ื•ืช ืœื—ื™ืžื” ืžืชืงื“ืžื•ืช

162676 ,163450 154581ืจืคืืœ ืคืœื“

Page 520: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื˜ื‘ืช'ื– 24, 2009 ii

161876ืงื•ื‘'ืฉืžืขื•ืŸ ืกื˜ืจื™ื–ABBOTT GMBH & CO. KG 158932,

158933ABBOTT LABORATORIES 126626ABBOTT LABORATORIES 140492

ACTIAL FARMACEUTICA LDA162513

ACUSPHERE, INC. 188086ADVANCED ENVIRONMENTAL

TECHNOLOGIES PTY LTD. 161401AETERNA ZENTARIS GMBH 162492

AGENSYS, INC. 141061, 160053AIR PRODUCTS AND CHEMICALS,

INC. 175454ALIMENTARY HEALTH LIMITED

160049AMGEN INC. 153804

AMURA LIMITED 155183ANSHAN UNIVERSITY OF SCIENCE

AND TECHNOLOGY 159950ANTHONY TABATZNIK 157106

ARES TRADING S.A. 162592ARES-TRADING S.A. 156579

ARRAY BIOPHARMA INC. 153804ASEPTIC TECHNOLOGIES S.A.

154334ASTRAZENECA AB 149108

ATOFINA RESEARCH 151240AVRAHAM BEN-NUN 149325

BAR-EDAN MANUFACTURING ANDDEVELOPMENT LTD. 168041

BARLOVENTO INTERNATIONAL157106

BASF SE 160640, 161898BAYER ANIMAL HEALTH GMBH

169515BAYER CORPORATION 143351

BAYER CROPSCIENCE AG 165925BAYER HEALTHCARE AG 169515

BEN GURION UNIVERSITY OF THENEGEV RESEARCH AND

DEVELOPMENT AUTHORITY 157878BEN GURION UNIVERSITY OF THE

NEGEV RESEARCH ANDDEVELOPMENT AUTHORITY 164823

BETTONVILLE INTEGRATEDSOLUTIONS, NAAMLOZE

VENNOOTSCHAP 171585BETTONVILLE, NAAMLOZEVENNOOTSCHAP OF 171585

BIOE, INC. 167624BIOGEN IDEC MA INC. 142905

BIOSENSE WEBSTER, INC. 157015,175191

BJORKBODA LAS OY AB 163738BOEHRINGER INGELHEIM PHARMA

GMBH & CO. KG 156277, 161165BOREALIS AG 171860BOREALIS AS 171860

BORIS PODOLSKY 160580BOSTON SCIENTIFIC LIMITED

145145BRIGHAM YOUNG UNIVERSITY

154130BRISTOL-MYERS SQUIBB

COMPANY 151372BURTON KOZAK 171508

C.R.F. SOCIETA CONSORTILE PERAZIONI 156871

CABOT CORPORATION 154538CEDARS-SINAI MEDICAL CENTER

158285CONMED CORPORATION 171104

CONTIPI LTD. 157117CRODA INTERNATIONAL PLC

153100CROSSJECT 170324CURIS INC. 142905

CYBRO MEDICAL LTD. 171104

DAIICHI SANKYO COMPANYLIMITED 145759, 147214, 187551

DAVID VARON 157721DIABETES DIAGNOSTICS, INC.

156254DISCO CORPORATION 173505

DISC-O-TECH MEDICALTECHNOLOGIES, LTD. 131197

DISENO DE SISTEMAS EN SILICIO,S.A. 162522

DR. REDDY'S LABORATORIESLIMITED 179865

DR. REDDY'S LABORATORIES, INC.179865

Page 521: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009iii

DR. REDDY'S RESEARCHFOUNDATION 179865

DSM IP ASSETS B.V. 176518DULIVER INTERNATIONAL LTD.

170046DURAMED PHARMACEUTICALS,

INC. 151858

E.I. DUPONT DE NEMOURS ANDCOMPANY 159947

EAST CAROLINA UNIVERSITY158155

EAZYPOWER CORPORATION 171508ELBIT SYSTEMS ELECTRO-OPTICAL

ELOP LTD. 166354ELEMENT SIX LIMITED 166897

ELI LILLY & CO. 152528ELIZA CORPORATION 158127

ENSCONCE DATA TECHNOLOGY170901

ENVISION BIOMEDICALCONSULTING 140625

EPIGENOMICS AG 154663ESCO CORPORATION 171165

ESSILOR INTERNATIONAL(COMPAGNIE GENERALE

D'OPTIQUE) 148505EUGSTER/FRISMAG AG 157902EURENCO BOFORS AB 163376

EXOSECT LIMITED 168770

FABIO PERINI S.P.A. 168014FIKE CORPORATION 170190

FINETECH LABORATORIES LTD.155545

FINETECH PHARMACEUTICAL LTD.155545

FLEISSNER GMBH & CO.MASCHINENFABRIK 150636

FORSKARPATENT I SYD AB 158285FRED STRIZHAKOV 161876

GENENTECH, INC. 132251, 154495GENTIUM SPA 152328

GLAXOSMITHKLINE BIOLOGICALSS.A. 154334

GOTTHARD MAHLICH 157902GREAT LAKES CHEMICAL

CORPORATION 164961GREGORY S. KOPF 155801

GRUNENTHAL GMBH 157477,157895, 161587

H. LUNDBECK A/S 152645HADASIT MEDICAL RESEARCH

SERVICES & DEVELOPMENT LTD.156115

HAIM HAZAN 152372HEINEKEN TECHNICAL SERVICES

B.V 156049HEINEKEN TECHNICAL SERVICES

B.V. 171955

IBM CORPORATION 143015, 161654IBM CORPORATION 157678, 164066,

168977, 172670ICON GENETICS GMBH 160338

IMPERIAL CHEMICAL INDUSTRIESPLC 153100

INDENA S.P.A. 166557, 175846INTEL CORPORATION 153257

INTERACT DEVICES, INC. 160981INTERDIGITAL TECHNOLOGY

CORPORATION 160330ISHIHARA SANGYO KAISHA LTD.

155507

JAN BENGTSSON 157818JAPAN TOBACCO INC. 161559

JIYUL YOO 149249JOHNSON & JOHNSON VISION

CARE, INC. 148505

KI SEOK KIM 149249KWANG SEON SHIN 154897

KYPHON SARL 131197

LABORATOIRE FRANCAIS DUFRACTIONNEMENT ET DESBIOTECHNOLOGIES 161872

LAM RESEARCH CORPORATION167935

LEBET ALAIN 170046LECTEC CORPORATION 152786

LEIF NYFELT 157818LEK PHARMACEUTICAL AND

Page 522: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื˜ื‘ืช'ื– 24, 2009 iv

CHEMICAL COMPANY D.D. 157534LEONID BLYANKMAN 160580

LIFESCAN, INC. 164696LITTON SYSTEMS, INC. 164972

LUIS W. LEVY 157106

MASSACHUSETTS INSTITUTE OFTECHNOLOGY 140793

MATISSE NETWORKS 164037MAUSER-WERKE GMBH & CO.KG

171576MAXYGEN HOLDINGS LTD. 150153

MEDTRONIC SPINE LLC 131197MICROSOFT CORPORATION 160575

MITSUBISHI DENKI KABUSHIKIKAISHA 165439

MITSUBISHI TANABE PHARMACORPORATION 163287, 163288

MITSUI CHEMICALS, INC. 172839MORPHOCHEM

AKTIENGESELLSCHAFT FURKOMBINATORISCHE CHEMIE

160769, 163921MORPHOSYS AG 142025

MOSAID TECHNOLOGIESINCORPORATED 167081

MOTOROLA, INC. 157048MYKHAYLO LOKSHYN 184004

NAGRAVISION S.A. 164271NALCO COMPANY 170010

NDC INFRARED ENGINEERING LTD.160660

NEW YORK UNIVERSITY 152625NISSAN CHEMICAL INDUSTRIES

LTD. 126728, 159218NOVA MEASURING INSTRUMENTS

LTD. 156330NOVARTIS AG 149496, 160367, 168245

NOVA-TECH ENGINEERING, INC.175109

NOVO NORDISK A/S 179865NYCOMED PHARMA AS 157097

OFER DAGAN 158968ONCOLYTICS BIOTECH INC. 144043

OPMI FUNDING CORP. 169351OREN ALOUCE 137462

ORGANOGENESIS INC. 166014ORIGENIS GMBH 163921

ORTHOFIX INTERNATIONAL B.V152561

ORTHOFIX S.R.L. 152561ORTHOFIX S.R.L. 152561

ORTHO-MCNEILPHARMACEUTICAL, INC. 157588,

157591, 157592

PELLINI S.R.L. 165162PHALANX GROUP, LLC 169612PLIVA-LACHEMA, A.S. 165027

POTENCIA MEDICAL AG 147963PROTEKTORWERK FLORENZ

MAISCH GMBH & CO. KG 172437

QUALCOMM INCORPORATED151705, 156764, 159017, 161643,

161984, 163048, 171598QUALCOMM INCORPORATED

156858QUALCOMM INCORPORATED

158161, 158162, 162092

RAFAEL ADVANCED DEFENSESYSTEMS LTD. 167005

RAFAEL ADVANCED DEFENSESYSTEMS LTD. 162676, 163450

RAMOT AT TEL-AVIV UNIVERSITYLTD. 157721

RAS HOLDING CORPORATION146887

RAV BARIACH SECURITYPRODUCTS LTD. 156999

RAYTHEON COMPANY 156227RAYTHEON COMPANY 160680RAYTHEON COMPANY 164199RAYTHEON COMPANY 167673

REFAEL PELED 154581REUVEN BOARON 162824

RICHARD BINNINGTON 157106

SANDISK IL LTD. 139674SANKYO AGRO COMPANY,

LIMITED 162035SANOFI AVENTIS 163287, 163288

SANOFI-AVENTIS DEUTSCHLAND

Page 523: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื›ืกืœื•'ื– 24, 2009v

GMBH 151216SANOFI-AVENTIS DEUTSCHLAND

GMBH 162562, 165520SANOFI-AVENTIS DEUTSCHLAND

GMBH 166439SCHLUMBERGER TECHNOLOGY

CORPORATION 150972SEMIKA S.A. 169463

SENSORMATIC ELECTRONICSCORPORATION 165782

SEQUELLA, INC. 187551SERCONET LTD. 167081

SHIMON STRIZHAKOV 161876SHIRE HUMAN GENETICTHERAPIES, INC. 145381

SIG COMBIBLOC INTERNATIONALAG 161402

SILVERBROOK RESEARCH PTY.LTD. 146679, 168608, 168700

SIPIX IMAGING, INC. 167337SMITHKLINE BEECHAM

BIOLOGICALS S.A. 145982SOLVAY PHARMACEUTICALS B.V.

160522SUMITOMO CHEMICAL COMPANY,

LIMITED. 170728SUMITOMO ELECTRIC INDUSTRIES,

LTD. 165965SUNTORY FLOWERS LIMITED

138716SUNTORY LIMITED 138716SUNTORY LIMITED 138716

TARGET DISCOVERY, INC. 180304TARO PHARMACEUTICALS U.S.A.,

INC. 165694TECHNION RESEARCH AND

DEVELOPMENT FOUNDATION LTD.129966, 159534

TELE FILTER GMBH 173681THE CHILDREN'S HOSPITAL OF

PHILADELPHIA 151772THE CHILDREN'S MEDICAL CENTER

CORPORATION 126626THE JOHNS HOPKINS UNIVERSITY

SCHOOL OF MEDICINE 124636THE PROCTER & GAMBLE

COMPANY 163734

TOMMEN GRAM HOLDING AS171860

TRANSGENE S.A. 173158TRESPAPHAN GMBH 158935TRUEPOSITION, INC. 166746

UHDE GMBH 151139UMD, INC. 153719

UNIVERSITY OF BRISTOL 158060UNIVERSITY OF TENNESSEE

RESEARCH FOUNDATION 168793UNIVERSITY OF VIRGINIA PATENT

FOUNDATION 155801UOP LLC 155901

VAST POWER PORTFOLIO, LLC138380

VERTEX PHARMACEUTICALSINCORPORATED 165715

VIASAT, INC. 162567

W.C. HERAEUS GMBH 166769WALDEMAR LINK GMBH & CO. KG

171947WARNER-LAMBERT COMPANY LLC

152770, 162721WASHINGTON UNIVERSITY 176731

WYETH 145688, 159859

XACCT TECHNOLOGIES, INC. 136219

YEDA RESEARCH ANDDEVELOPMENT CO. LTD. 149325,

156626, 158228YISSUM RESEARCH DEVELOPMENT

COMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD

129966YONSUNG FINE CHEMICAL CO.

158634

ZALMAN PELES 164944

Page 524: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื˜ื‘ืช'ื– 24, 2009 vi

ืžืคืชื— ืขื ื™ื™ื ื™SUBJECT MATTER INDEX

A01K โ€“ 155801, 175109

A01N โ€“ 155507, 159947, 168770,169515, 172839

A47G โ€“ 162824

A47J โ€“ 157902

A61B โ€“ 131197, 152561, 157015,164696, 170046

A61F โ€“ 146887, 147963, 151858,153719, 156115, 157117,163734, 169351, 171947

A61K โ€“ 140492, 140625, 144043,145381, 145688, 145982,149496, 151772, 152328,152528, 152786, 154495,157477, 158155, 158285,159859, 160769, 162492,165027, 166557, 168793,175846, 179865

A61L โ€“ 157097

A61M โ€“ 145145, 156579, 170324

B01D โ€“ 151139, 160580

B01F โ€“ 159950

B01J โ€“ 157878, 163921, 166769,170728, 188086

B23K โ€“ 171585

B24B โ€“ 173505

B25B โ€“ 171508

B32B โ€“ 171860

B41J โ€“ 168608, 168700

B62K โ€“ 154130B63B โ€“ 161876

B65D โ€“ 161402, 171576

B65H โ€“ 168014

B67D โ€“ 156049, 171955

C01G โ€“ 153100

C02F โ€“ 161401, 170010

C04B โ€“ 162676

C06B โ€“ 163376

C07C โ€“ 152770, 153804, 155901,157106, 157588, 157591,157592, 158228, 158634,161587, 161898, 165925,166439

C07D โ€“ 126728, 145759, 147214,149108, 151372, 152645,155183, 155545, 156277,157534, 157895, 158932,158933, 159216,159534,160367, 160522, 160640,161165, 161559, 162035,162562, 162721, 163287,163288, 165520, 165694,165715

C07H โ€“ 187551

C07K โ€“ 132251, 150153, 152625,158060, 160053, 161872,162592

C08K โ€“ 164961

Page 525: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉ ื‘ื˜ื‘ืช'ื– 24, 2009vii

C08L โ€“ 158935

C09C โ€“ 154538

C12M โ€“ 166014

C12N โ€“ 124636, 126626, 129966,138716, 142905, 143351,149325, 160049, 160338,168245, 173158

C12P โ€“ 151216

C12Q โ€“ 144061, 154663, 176731

C22C โ€“ 154897

C23C โ€“ 169463

C30B โ€“ 166897

C40B โ€“ 142025

D01F โ€“ 151240

D04H โ€“ 150636

E02F โ€“ 171165

E04B โ€“ 172437

E06B โ€“ 165162

E21B โ€“ 150972

F01B โ€“ 164944

F02C โ€“ 138380

F16B โ€“ 154581

F17C โ€“ 175454

F24H โ€“ 152372

F24J โ€“ 158968

F28F โ€“ 137462

F41G โ€“ 163450, 167005F41H โ€“ 176518

G01B โ€“ 171104

G01M โ€“ 184004

G01N โ€“ 156254, 156626, 157721,160660, 162513, 164823,167624, 180304

G01S โ€“ 157818, 161643, 166746,169612

G02B โ€“ 156871, 166354, 167673

G02C โ€“ 148505

G02F โ€“ 167337

G05D โ€“ 164196, 170046

G05G โ€“ 156330

G06F โ€“ 139674, 140793, 153257,168977, 170901

G06K โ€“ 146679, 157678

G06T โ€“ 175191

G07G โ€“ 172670

G10L โ€“ 158127

G21F โ€“ 154334

H01L โ€“ 156227, 161654, 164066,167935

H01M โ€“ 165965

H01Q โ€“ 160680

H03B โ€“ 173681

H03F โ€“ 171598

Page 526: PATENTS AND DESIGNS JOURNAL

Decemberโ€“ืข"ื”ืชืฉื‘ื˜ื‘ืช'ื– 24, 2009 viii

H04B โ€“ 156858, 163048H04H โ€“ 158161

H04J โ€“ 164037

H04L โ€“ 149249, 158162, 159017,160330, 160575, 161984,162522, 162567, 167081

H04M โ€“ 136219, 165439

H04N โ€“ 143015, 160981, 164271,164972

H04Q โ€“ 151705, 156764, 157048,162092, 165782

Page 527: PATENTS AND DESIGNS JOURNAL

ืข ื™ืจื•ืฉืœื™ื, ืžืฉืจื“ ื”ืžืฉืคื˜ื™ื,ื™ ืจืฉื•ืช ื”ืคื˜ื ื˜ื™ื"ื ืขืจืš ื™ืจื•ืฉืœื™ื, ื”ื•ืคืง ื•ื”ื•ื“ืคืก ื‘ืžื“ืคื™ืก ื”ืžืžืฉืœืชื™

EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM

PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER